Citrus Sinensis ID: 008288

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-
Protein Sequence
MVHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWLIHC
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccEEEEcccccccEEEEEEccccccHHHHHHHHHHHHHHHHHHccccccEEEEcccEEEEEcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEEEEEccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHcccccccEEEcccccEEEEEEEEccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHEEHHHHHHccccHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccccHHHHHHHHHHHHccccccccccccccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccccEEEccccccHHHHcccccccccccccHHHHHEHHHccccccccccccHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEEEccEEEEEccccHcccccccccEEEccccccccHHHHHHHHHHHHHHHHHHHHHcccccHEcccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEcccEEEEEEEEcccccccccccccccccccccccccccHEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccHEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEcccccccccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHcc
Coil and Loop (DISEMBL)
MVHKAIQLILIYCLTAnlhdlafgdsppynicststagsarastiDDNLQNVLTSLASnanaakfsnasfgndsdrvYGLYMCLNYISAETCNDCITTASQDisklcpnkteAIVWEEVCQLRYAYQNFFgqldvsgnipkynrlniseperyRSVVNNTLSDLITklsafdpfemyatdevpftnsdTFYALVQCtkdlpaddcitclhnatadilsccyfsrgarllsrncYLRYELYAfykgatepsilagnqasgggkqrKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLhkigdandtdfhyqhvqgrdndlkaQDFFIDLETlnlatsnfsdsnilgqggfgpvykgvlsdgKEVAVKRLSscseqgtaeFTNEVLLILKLQHKNLVKLLGfcvdgdekLLVYefmpngsldailfdprkrgilcwrkrtNIVNGIAKGMLYLHEDSRLRIVHRDLKASNvlldsdmnskisdfGMARIFAESEGEANTVRIVgtygymapeyameglyskksdvFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWLIHC
Flexible Loop (DISEMBL)
MVHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNanaakfsnasfgndsdRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFgqldvsgnipKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGyffatkkitrkrkgtarKQIQlhkigdandtDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKasnvlldsdmnsKISDFGMARIFAesegeantvrIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITgrrnagsnqlLAYGMYWSWLIHC
Low Complexity Region (SEG)
MVHKAIQLILIYCLTANLHDLAFGDSPPYNICststagsarastIDDNLQNVLTSLasnanaakfsnasfGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMIIvlasvvalllvvfasTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWLIHC
Disordered region (IsUnstruct)
***KAIQLILIYCLTANLHDLAFGDSPPYNICST**************LQNVLTSL********F**ASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQ***GGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWLIH*
Disordered Region (DISOPRED)
***KAIQ*ILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATE*********************IVLASVVALLLVVFASTGYFFATKKIT************************************KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWLIHC
Disordered Region (DISEMBL)
MVHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKIT**********IQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWLIHC
Disordered Region (DISPRO)
MVHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGA*******************MWMIIVLASVVALLLVVFASTGYFFATKKITRKRK*******************************LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS*QLLAYGMYWSWLIHC
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWLIHC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	571	2.2.26 [Sep-21-2011]
Q9M0X5	675	Cysteine-rich receptor-li	yes	no	0.872	0.737	0.430	1e-117
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.877	0.748	0.430	1e-113
O65468	676	Cysteine-rich receptor-li	no	no	0.865	0.730	0.429	1e-109
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.858	0.732	0.407	1e-105
O65479	666	Putative cysteine-rich re	no	no	0.900	0.771	0.423	1e-105
Q9ZP16	667	Cysteine-rich receptor-li	no	no	0.877	0.751	0.389	1e-105
Q8H199	658	Cysteine-rich receptor-li	no	no	0.805	0.699	0.407	1e-105
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.859	0.783	0.405	1e-104
Q9LDT0	700	Putative cysteine-rich re	no	no	0.889	0.725	0.408	1e-104
O65472	690	Putative cysteine-rich re	no	no	0.859	0.711	0.393	1e-103

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  421 bits (1082), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 235/546 (43%), Positives = 332/546 (60%), Gaps = 48/546 (8%)

Query: 29  YNICSTSTAGSARASTIDDNLQNVLTSLASN--ANAAKFSNASFG--NDSDRVYGLYMCL 84
           Y+IC  +T  S R S+   NL+ VL+SL+S   A A+ F NA+ G  NDS+RVYG+++C 
Sbjct: 31  YHICPNTTTYS-RNSSYLTNLRTVLSSLSSPNAAYASLFDNAAAGEENDSNRVYGVFLCR 89

Query: 85  NYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNR 144
             +SAE C DC+  A+ +  + CP +  A++W + C +RY+ Q+  GQ+ +   +   N+
Sbjct: 90  GDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRIRPGVFLTNK 149

Query: 145 LNISEPERYRSVVNNTLSDLITKLSAFDPF--EMYATDEVPFTNSDTFYALVQCTKDLPA 202
            NI+E +  R   N +L  L+  ++         +AT++  FT   T Y+LVQCT DL  
Sbjct: 150 QNITENQVSR--FNESLPALLIDVAVKAALSSRKFATEKANFTVFQTIYSLVQCTPDLTN 207

Query: 203 DDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY--------------KGATE 248
            DC +CL      +  CC  S G R+++ +C  RYELY FY                 T 
Sbjct: 208 QDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTA 267

Query: 249 PSILAGNQASGGGKQRKMWMIIV-LASVVALLLVVFASTGYFFATKKITRKRKGTARKQI 307
           P +   N  S  GK + + +I+  +A  V++ +++  +  +  A +   R  K +A  + 
Sbjct: 268 PPL---NIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR---RNNKLSAETE- 320

Query: 308 QLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYK 367
            L + G  +     +Q                    +  AT+ FS+SN LG GGFG VYK
Sbjct: 321 DLDEDGITSTETLQFQ-----------------FSAIEAATNKFSESNKLGHGGFGEVYK 363

Query: 368 GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 427
           G L  G+ VA+KRLS  S QG  EF NEV ++ KLQH+NL KLLG+C+DG+EK+LVYEF+
Sbjct: 364 GQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFV 423

Query: 428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
           PN SLD  LFD  KR +L W++R  I+ GIA+G+LYLH DSRL I+HRDLKASN+LLD+D
Sbjct: 424 PNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDAD 483

Query: 488 MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
           M+ KISDFGMARIF   + +ANT RIVGTYGYM+PEYA+ G YS KSDV+SFGVL++E+I
Sbjct: 484 MHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELI 543

Query: 548 TGRRNA 553
           TG++N+
Sbjct: 544 TGKKNS 549

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  408 bits (1049), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 244/567 (43%), Positives = 336/567 (59%), Gaps = 66/567 (11%)

Query: 29  YNICSTSTAGSARASTIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNY 86
           Y+ C  +TA     ST ++NL+ +L SL+S NA+ +  F NA+ G   DRV GL+ C   
Sbjct: 41  YHTCQ-NTANYTSNSTYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGD 99

Query: 87  ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
           +S E C  C++ A  D    CPN+ EA ++ + C LRY+ QN    L  +G +   N  N
Sbjct: 100 VSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVILVNTRN 159

Query: 147 ISEPERYRSVVNNTLSDLI------TKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDL 200
           ++  +       + LSDL+          A +  + + T +  FT   +FY LVQCT DL
Sbjct: 160 VTSNQL------DLLSDLVLPTLNQAATVALNSSKKFGTRKNNFTALQSFYGLVQCTPDL 213

Query: 201 PADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSIL-------- 252
              DC  CL      I +      GAR+++ +C  RYE+YAFY   TE ++         
Sbjct: 214 TRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFY---TESAVPPPPPPPSI 267

Query: 253 ------AGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQ 306
                 A  ++   G  + + + IV+  +VA+LL +    GY F T++        ARK 
Sbjct: 268 STPPVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFI---AGYCFLTRR--------ARKS 316

Query: 307 IQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY 366
                        ++       D+   A    +D  T+  AT +F +SN +GQGGFG VY
Sbjct: 317 -------------YYTPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVY 363

Query: 367 KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426
           KG LSDG EVAVKRLS  S QG  EF NEV+L+ KLQH+NLV+LLGFC+DG+E++LVYE+
Sbjct: 364 KGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEY 423

Query: 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
           +PN SLD  LFDP K+G L W +R  I+ G+A+G+LYLH+DSRL I+HRDLKASN+LLD+
Sbjct: 424 VPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDA 483

Query: 487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
           DMN KI+DFGMARIF   + E NT RIVGTYGYM+PEYAM G YS KSDV+SFGVL++EI
Sbjct: 484 DMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEI 543

Query: 547 ITGRRNA------GSNQLLAYGM-YWS 566
           I+G++N+      G++ L++Y    WS
Sbjct: 544 ISGKKNSSFYQTDGAHDLVSYAWGLWS 570

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  396 bits (1017), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 232/540 (42%), Positives = 322/540 (59%), Gaps = 46/540 (8%)

Query: 32  CSTSTAGSARASTIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNYISA 89
           C   T  S+  ST   NL+ +L+S AS NA+ +  F N   G   DRV GL++C   +S 
Sbjct: 44  CPNRTTYSSN-STYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSP 102

Query: 90  ETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISE 149
           E C++C+  +  +    CPN+ EA+ + E C LRY+++NF   +   G +   N  NIS 
Sbjct: 103 EVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNISS 162

Query: 150 PERYRSVVNNTLSDLITKLS--AFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCIT 207
            +  R    + +   + + +  A +    ++T +   T+  T Y LVQCT DL   DC +
Sbjct: 163 IQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFS 222

Query: 208 CLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY--------------KGATEPSILA 253
           CL ++   ++    F  GAR    +C  RYELYAFY               G+T P    
Sbjct: 223 CLTSSINRMMP--LFRIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSP 280

Query: 254 GNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIG 313
                 G     +  I+VLA ++ + LV     GY F  ++ T+K   TA       ++G
Sbjct: 281 SIPGKSGNSTVLVVAIVVLAVLLFIALV-----GYCFLAQR-TKKTFDTASAS----EVG 330

Query: 314 DANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDG 373
           D   T               A    +D  T+  AT++F++SN +G+GGFG VYKG  S+G
Sbjct: 331 DDMAT---------------ADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNG 375

Query: 374 KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD 433
           KEVAVKRLS  S QG AEF  EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD
Sbjct: 376 KEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLD 435

Query: 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493
            +LFDP K+  L W +R NI+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+D+N KI+
Sbjct: 436 CLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIA 495

Query: 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA 553
           DFGMARIF   + + NT RIVGTYGYMAPEYAM G +S KSDV+SFGVL++EII+GR+N+
Sbjct: 496 DFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNS 555

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  383 bits (984), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 217/533 (40%), Positives = 313/533 (58%), Gaps = 43/533 (8%)

Query: 43  STIDDNLQNVLTSLASNANAAK-FSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQ 101
           ST D N + +L++L+SN  +   F N+ FG   +RV+   MC+     ETC+DCI  AS 
Sbjct: 36  STYDLNRRQILSTLSSNVTSHNGFFNSKFGQAPNRVFINGMCIPGTKPETCSDCIKGASD 95

Query: 102 DISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTL 161
            IS+ CPNKT+A  W + C +RY+  +F G L +  +   Y+  +I +     +V +   
Sbjct: 96  KISESCPNKTDAYTWPDCCMVRYSNVSFSGSLVMEPSETLYHTGDIEDTGTNLTVFDRIW 155

Query: 162 SDLITK-LSAFDPF---------EMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHN 211
            +L+ + ++A             + +A +    T   T YA++QCT D+ + DC  CL  
Sbjct: 156 EELMLRTITAASLSSSNGSSFGQKYFAAEVASLTTFQTMYAMMQCTPDVSSKDCEFCLKT 215

Query: 212 ATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMIIV 271
           +  D  SCC   +G  ++  +C++R++LY  Y GA E ++           Q  + +I  
Sbjct: 216 SVGDYESCCRGKQGGAVIRPSCFVRWDLYP-YAGAFE-NVTFPPPPPQSLPQPPVSLIPP 273

Query: 272 LASVVALLLV----------VFASTGYFFATKKITRKRKGTARKQIQ-LHKIGDANDTDF 320
             S  A   +          +            + R++K     ++Q   +I   +   F
Sbjct: 274 PVSDRANTTIKGIIVAIVVPIIVILVSLVVLLVVCRRKKSYKTTEVQATDEITTTHSLQF 333

Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR 380
            ++ ++       A D F D             SN++G+GGFG VY+G LS G EVAVKR
Sbjct: 334 SFKTIEA------ATDKFSD-------------SNMIGRGGFGEVYRGKLSSGPEVAVKR 374

Query: 381 LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
           LS  S QG  EF NE +L+ KLQHKNLV+LLGFC++G+EK+LVYEF+PN SLD  LFDP 
Sbjct: 375 LSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPA 434

Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
           K+G L W +R NI+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGMARI
Sbjct: 435 KQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARI 494

Query: 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA 553
           F   + +ANT RI GT+GYM+PEYAM G +S KSDV+SFGVL++EII+G++N+
Sbjct: 495 FGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNS 547

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2

 Score =  383 bits (983), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 228/538 (42%), Positives = 317/538 (58%), Gaps = 24/538 (4%)

Query: 29  YNICSTSTAGSARASTIDDNLQNVLTSLAS-NAN-AAKFSNASFGNDSDRVYGLYMCLNY 86
           Y+ CS +T  S+  ST   NL+ +L+SL+S NA+ +  F NA+ G   D V GL++C   
Sbjct: 30  YHNCSITTTYSSN-STYSTNLKTLLSSLSSRNASYSTGFQNATAGQAPDMVTGLFLCRGN 88

Query: 87  ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
           +S E C  CI  +  +    CPN+ EA+ + E C LRY+ +N    L+  G +   N  N
Sbjct: 89  VSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNILSTLNTDGGVFMQNARN 148

Query: 147 -IS-EPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
            IS + +R+R +V N ++  +  + A    + +A  +       + Y +VQCT DL   D
Sbjct: 149 PISVKQDRFRDLVLNPMN--LAAIEAARSIKRFAVTKFDLNALQSLYGMVQCTPDLTEQD 206

Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYK--GATEPSILAGNQASGGGK 262
           C+ CL  +   I    Y   G R    +C  RY+ Y FY       P   +     GG  
Sbjct: 207 CLDCLQQS---INQVTYDKIGGRTFLPSCTSRYDNYEFYNEFNVGTPQDSSPRPGKGGNS 263

Query: 263 QRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHY 322
              +  ++V  +V+ LL V F      F+ ++  RK+   A   I L K+    +T+   
Sbjct: 264 SVIVIAVVVPITVLFLLFVAF------FSVRRAKRKKTIGA---IPLFKV-KRKETEVTE 313

Query: 323 QHVQGRDND--LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR 380
              +  D D    A     D + +  AT  F   N LGQGGFG VYKG    G +VAVKR
Sbjct: 314 PPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYKGTFPSGVQVAVKR 373

Query: 381 LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
           LS  S QG  EF NEV+++ KLQH+NLVKLLG+C++G+EK+LVYEF+PN SLD  LFDP 
Sbjct: 374 LSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDYFLFDPT 433

Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
            +G L W +R  I+ GIA+G+LYLH+DSRL I+HRDLKA N+LLD+DMN K++DFGMARI
Sbjct: 434 MQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARI 493

Query: 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL 558
           F   + EANT R+VGTYGYMAPEYAM G +S KSDV+SFGVL++EI++G +N+  +Q+
Sbjct: 494 FGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIVSGMKNSSLDQM 551

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2

 Score =  381 bits (979), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 217/557 (38%), Positives = 316/557 (56%), Gaps = 56/557 (10%)

Query: 32  CSTSTAGSARASTIDDNLQNVLTSLASNANAAK--FSNASFGNDSDRVYGLYMCLNYISA 89
           C+T         T D N + +L+SL SN       + N S G   +RVY + MC+   ++
Sbjct: 27  CTTDKGTFRPNGTYDVNRRLILSSLPSNVTDQDGLYYNGSIGQQPNRVYAIGMCIPGSTS 86

Query: 90  ETCNDCITTASQDISKLCPNKTEAIVWE---EVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
           E C+DCI   S+   K CPN+TEA  W     +C +RY+  +F G  D++      N  +
Sbjct: 87  EDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLCYVRYSNTSFSGSADLNPRNWLTNTGD 146

Query: 147 I-SEPERYRSVVNNTLSDLIT-----KLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDL 200
           + S    +  +    +  +I+     K +       Y+ D    T     YAL+QCT DL
Sbjct: 147 LDSNLTEFTKIWEGLMGRMISAASTAKSTPSSSDNHYSADSAVLTPLLNIYALMQCTPDL 206

Query: 201 PADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSI--------- 251
            + DC  CL  +  D  SCC   RG  ++  +C+LR++LY +       ++         
Sbjct: 207 SSGDCENCLRQSAIDYQSCCSQKRGGVVMRPSCFLRWDLYTYSNAFDNLTVASPPPEPPV 266

Query: 252 ----LAGNQASGGGKQRK-----MWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGT 302
                AG+Q +      K     + + I + +V+A+L+++      F       R+RK  
Sbjct: 267 TVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVIAILILLVLGFVLF-------RRRKSY 319

Query: 303 ARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFI-DLETLNLATSNFSDSNILGQGG 361
            R + +                    ++D+   D  + D +T+  AT+ FS SN LG+GG
Sbjct: 320 QRTKTE-------------------SESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGG 360

Query: 362 FGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421
           FG VYKG LS+G +VAVKRLS  S QGT EF NE +L+ KLQH+NLV+LLGFC++ +E++
Sbjct: 361 FGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQI 420

Query: 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481
           L+YEF+ N SLD  LFDP K+  L W +R  I+ GIA+G+LYLH+DSRL+I+HRDLKASN
Sbjct: 421 LIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASN 480

Query: 482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGV 541
           +LLD+DMN KI+DFG+A IF   + + NT RI GTY YM+PEYAM G YS KSD++SFGV
Sbjct: 481 ILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGV 540

Query: 542 LLIEIITGRRNAGSNQL 558
           L++EII+G++N+G  Q+
Sbjct: 541 LVLEIISGKKNSGVYQM 557

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2

 Score =  381 bits (978), Expect = e-105,   Method: Compositional matrix adjust.
 Identities = 218/535 (40%), Positives = 304/535 (56%), Gaps = 75/535 (14%)

Query: 52  VLTSLASNANA-AKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNK 110
           +L+SL SN +A   F N+S G   DRVY L MC+     + C+DCI  AS  +   C N+
Sbjct: 44  LLSSLPSNVSARGGFYNSSIGQGPDRVYALGMCIEGAEPDVCSDCIEYASNLLLDTCLNQ 103

Query: 111 TEAIVWEE---VCQLRYAYQNFFGQL------------DVSGNIPKYNRLNISEPERYRS 155
           TE + W E   +C +RY+  +FFG L            D++ N+ +++++     E  R 
Sbjct: 104 TEGLAWPEKRILCMVRYSNSSFFGSLKAEPHFYIHNVDDITSNLTEFDQV---WEELARR 160

Query: 156 VVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATAD 215
           ++ +T S    +       + YA D    T     YAL+QCT DL  +DC  CL  +  D
Sbjct: 161 MIASTTSPSSKR-------KYYAADVAALTAFQIIYALMQCTPDLSLEDCHICLRQSVGD 213

Query: 216 ILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASG--------GGKQRK-- 265
             +CC   +G  +   +C  R+EL+ F +  +  S+    Q+              +K  
Sbjct: 214 YETCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAFPTLPAVTNTATKKGS 273

Query: 266 -------MWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
                  +W II+  +V+ + LV+ A  G+      + R+RK                  
Sbjct: 274 ITISIGIVWAIII-PTVIVVFLVLLA-LGFV-----VYRRRKS----------------- 309

Query: 319 DFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVA 377
                  QG   D+        D + +  AT+ FS+SNI+G+GGFG V+ GVL +G EVA
Sbjct: 310 ------YQGSSTDITITHSLQFDFKAIEDATNKFSESNIIGRGGFGEVFMGVL-NGTEVA 362

Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
           +KRLS  S QG  EF NEV+++ KL H+NLVKLLGFC++G+EK+LVYEF+PN SLD  LF
Sbjct: 363 IKRLSKASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNKSLDYFLF 422

Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
           DP K+G L W KR NI+ GI +G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGM
Sbjct: 423 DPTKQGQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGM 482

Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN 552
           ARIF   +  ANT +I GT GYM PEY  +G +S +SDV+SFGVL++EII GR N
Sbjct: 483 ARIFGIDQSGANTKKIAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEIICGRNN 537

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  380 bits (976), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 220/542 (40%), Positives = 318/542 (58%), Gaps = 51/542 (9%)

Query: 30  NICSTSTAGSARASTIDDNLQNVLTSL-ASNAN-AAKFSNASFGNDSDRVYGLYMCLNYI 87
           +IC  +T  S R S    NL+ +L+SL A NA+ +  F +A  G   DRV GL++C   +
Sbjct: 29  HICPNTTTYS-RNSPYLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDV 87

Query: 88  SAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYN---R 144
           S   C +C+  +  D    CP++ +++ + + C LRY+ QN    L   G   + N    
Sbjct: 88  SPAVCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMNGNIS 147

Query: 145 LNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
           ++ ++  R++  V++T++    K +A  P + Y T +  +T   T Y LVQCT DL   D
Sbjct: 148 IDQNQMNRFKDFVSSTMNQAAVK-AASSPRKFY-TVKATWTALQTLYGLVQCTPDLTRQD 205

Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILA--------GNQ 256
           C +CL ++   I     +  G R L  +C  RYEL+AFY   T  +  A           
Sbjct: 206 CFSCLESS---IKLMPLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPL 262

Query: 257 ASGGGKQRKMW------MIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLH 310
            +      K W      + IVL  +VA LL++    GY FA                   
Sbjct: 263 VTSPSLPGKSWNSNVLVVAIVLTILVAALLLI---AGYCFA------------------K 301

Query: 311 KIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL 370
           ++ +++D    +       +D+  +   +D   +  AT+ FS++N +GQGGFG VYKG  
Sbjct: 302 RVKNSSDNAPAFD-----GDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTF 356

Query: 371 SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
           S+G EVAVKRLS  S QG  EF NEV+++ KLQH+NLV+LLGF + G E++LVYE+MPN 
Sbjct: 357 SNGTEVAVKRLSKSSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNK 416

Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
           SLD  LFDP K+  L W +R  ++ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN 
Sbjct: 417 SLDYFLFDPAKQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNP 476

Query: 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           K++DFG+ARIF   + + NT RIVGT+GYMAPEYA+ G +S KSDV+SFGVL++EII+G+
Sbjct: 477 KLADFGLARIFGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGK 536

Query: 551 RN 552
           +N
Sbjct: 537 KN 538

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDT0|CRK30_ARATH Putative cysteine-rich receptor-like protein kinase 30 OS=Arabidopsis thaliana GN=CRK30 PE=3 SV=1

 Score =  380 bits (975), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 225/551 (40%), Positives = 311/551 (56%), Gaps = 43/551 (7%)

Query: 31  ICSTSTAGSARASTIDDNLQNVLTSLASNANAAK-FSNASFGNDSDRVYGLYMCLNYISA 89
           +CS          T D N + +L+SL S   A   F NAS G D D++Y + MC+     
Sbjct: 26  LCSEKFGTFTPGGTFDKNRRIILSSLPSEVTAQDGFYNASIGTDPDQLYAMGMCIPGAKQ 85

Query: 90  ETCNDCITTASQDISKLCPNKTEAIVW----EEVCQLRYAYQNFFGQLDVSGNIPKYNRL 145
           + C DCI   ++ + + CPN+T AI W    + VC  RY  Q     LD+      YN  
Sbjct: 86  KLCRDCIMDVTRQLIQTCPNQTAAIHWSGGGKTVCMARYYNQPSSRPLDLESVSIGYNVG 145

Query: 146 NISEP-ERYRSVVNNTLSDLITKLSA-------FDPFEMYATDEVPFTNSDTFYALVQCT 197
           N+S     +  +    ++ ++TK S+       FD    YA DE   TNS   YAL+QCT
Sbjct: 146 NLSTNLTDFDRLWERLIAHMVTKASSASIKYLSFDNSRFYAADETNLTNSQMVYALMQCT 205

Query: 198 KDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKG------ATEPSI 251
            D+   +C TCL  +  D + CC+  +G  +   +C  R++LY F         A  PS 
Sbjct: 206 PDVSPSNCNTCLKQSVDDYVGCCHGKQGGYVYRPSCIFRWDLYPFNGAFDLLTLAPPPSS 265

Query: 252 LAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHK 311
              +      K  K    I   +++ +++VV            ++  R   +RK+ Q   
Sbjct: 266 QLQSPPPVTNKDEK---TIHTGTIIGIVIVVAMVIIMALLALGVSVCR---SRKKYQAFA 319

Query: 312 IGDAND-TDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL 370
              A+D T   Y     +D              +  ATSNF  SN +GQGGFG VYKG L
Sbjct: 320 SETADDITTVGYLQFDIKD--------------IEAATSNFLASNKIGQGGFGEVYKGTL 365

Query: 371 SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
           S+G EVAVKRLS  S+QG  EF NEVLL+ KLQH+NLV+LLGF + G+EK+LV+EF+PN 
Sbjct: 366 SNGTEVAVKRLSRTSDQGELEFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNK 425

Query: 431 SLDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
           SLD  LF   +P K+G L W +R NI+ GI +G+LYLH+DSRL I+HRD+KASN+LLD+D
Sbjct: 426 SLDYFLFGSTNPTKKGQLDWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDAD 485

Query: 488 MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
           MN KI+DFGMAR F + + E +T R+VGT+GYM PEY   G +S KSDV+SFGVL++EI+
Sbjct: 486 MNPKIADFGMARNFRDHQTEDSTGRVVGTFGYMPPEYVAHGQFSTKSDVYSFGVLILEIV 545

Query: 548 TGRRNAGSNQL 558
           +GR+N+   Q+
Sbjct: 546 SGRKNSSFYQM 556

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2

 Score =  376 bits (966), Expect = e-103,   Method: Compositional matrix adjust.
 Identities = 218/554 (39%), Positives = 301/554 (54%), Gaps = 63/554 (11%)

Query: 43  STIDDNLQNVLTSLASNANAA-KFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQ 101
           ST D N + +L+ L SN  +   F N S G   +RVY + MCL     E+C  C+ +AS 
Sbjct: 34  STYDTNRRVILSLLPSNVTSHFGFFNGSIGQAPNRVYAVGMCLPGTEEESCIGCLLSASN 93

Query: 102 DISKLCPNKTEAIVW---EEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVN 158
            + + C  +  A++W     +C +RY+  +F G  ++    P    L+I   +   +  N
Sbjct: 94  TLLETCLTEENALIWIANRTICMIRYSDTSFVGSFELE---PHREFLSIHGYKTNETEFN 150

Query: 159 NTLSDLITKL---------SAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCL 209
              S L  ++         + +   + Y  D     +S T YA++QCT DL   +C  CL
Sbjct: 151 TVWSRLTQRMVQEASSSTDATWSGAKYYTADVAALPDSQTLYAMMQCTPDLSPAECNLCL 210

Query: 210 HNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGAT----------EPSILAGNQASG 259
             +  +  SCC   +G  ++  +C  R ELY F    T           PS++   +   
Sbjct: 211 TESVVNYQSCCLGRQGGSIVRLSCAFRAELYPFGGAFTVMTARPLSQPPPSLIKKGEFFA 270

Query: 260 ---GGKQRKMWMIIVLASVVALLLVVFASTGYF------------------FATKKITRK 298
                 Q  + MI  L  VV  L+  F  +G F                  F    +  +
Sbjct: 271 KFMSNSQEPVKMIQNLYVVV--LIFYFLDSGKFSTETIAAIVVPIIVVAIIFLVLLVLSR 328

Query: 299 RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILG 358
                RK  Q   +  +  T  H+Q               +D +T+ +AT NF+ +N LG
Sbjct: 329 LFARRRKSYQEIDLDQSGITTLHFQQ--------------LDFKTIEVATENFAKTNKLG 374

Query: 359 QGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD 418
           QGGFG VYKG L +G EVAVKRLS  SEQG  EF NEV+L+ KLQH+NLVKLLG+C++ +
Sbjct: 375 QGGFGEVYKGTLVNGTEVAVKRLSKTSEQGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPE 434

Query: 419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK 478
           EK+LVYEF+PN SLD  LFDP K+G L W KR NI+ GI +G+LYLH+DSRL I+HRDLK
Sbjct: 435 EKILVYEFVPNKSLDYFLFDPTKQGQLDWTKRYNIIGGITRGILYLHQDSRLTIIHRDLK 494

Query: 479 ASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFS 538
           ASN+LLD+DM  KI+DFGMARI    +  ANT RI GT+GYM PEY + G +S KSDV+S
Sbjct: 495 ASNILLDADMIPKIADFGMARISGIDQSVANTKRIAGTFGYMPPEYVIHGQFSMKSDVYS 554

Query: 539 FGVLLIEIITGRRN 552
           FGVL++EII G++N
Sbjct: 555 FGVLILEIICGKKN 568

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	571
224076497	591	predicted protein [Populus trichocarpa]	0.898	0.868	0.583	1e-177
302144055	698	unnamed protein product [Vitis vinifera]	0.959	0.785	0.587	1e-177
255555023	648	ATP binding protein, putative [Ricinus c	0.929	0.819	0.575	1e-176
359483378	678	PREDICTED: cysteine-rich receptor-like p	0.959	0.808	0.582	1e-175
356540317	647	PREDICTED: cysteine-rich receptor-like p	0.872	0.769	0.597	1e-167
224113911	657	predicted protein [Populus trichocarpa]	0.936	0.814	0.543	1e-160
357480739	644	Cysteine-rich receptor-like protein kina	0.921	0.816	0.555	1e-160
224113923	452	predicted protein [Populus trichocarpa]	0.788	0.995	0.537	1e-134
359496581	666	PREDICTED: cysteine-rich receptor-like p	0.877	0.752	0.449	1e-126
302144056	687	unnamed protein product [Vitis vinifera]	0.893	0.742	0.457	1e-126

>gi|224076497|ref|XP_002304952.1| predicted protein [Populus trichocarpa] gi|222847916|gb|EEE85463.1| predicted protein [Populus trichocarpa]

 Score =  629 bits (1622), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 328/562 (58%), Positives = 392/562 (69%), Gaps = 49/562 (8%)

Query: 8   LILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSN 67
           ++L+Y   ANL DLA+ D PPY +CS  +      S   +NL+ ++ SL+SNA+ +K  N
Sbjct: 1   ILLLYFSIANLLDLAYAD-PPYRLCSNKS-NYIDNSPFQNNLETLMASLSSNASVSKIFN 58

Query: 68  ASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQ 127
            S G D DRVY  YMCLNY++ E+C  C+  ASQDI +LCP   +A+VWEE+CQLRY+ Q
Sbjct: 59  TSTGIDPDRVYAQYMCLNYVTNESCRTCVAAASQDIRQLCPGDKKAVVWEELCQLRYSNQ 118

Query: 128 NFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDP-FEMYATDEVPFTN 186
            F G LDVSGN+P+YN  NIS PE    VVN  LS LI K +AFDP   MYAT + PFT+
Sbjct: 119 RFLGHLDVSGNVPQYNPKNISNPEHLSLVVNKILSSLIKK-AAFDPSANMYATRDEPFTD 177

Query: 187 SDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGA 246
           SD+F++LVQC+ DL  +DC TCL  A  ++ +CCYFSRGAR+LSR+CYLRYELY FY GA
Sbjct: 178 SDSFFSLVQCSTDLSPNDCYTCLEVAVKNVTTCCYFSRGARVLSRSCYLRYELYDFYDGA 237

Query: 247 TEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQ 306
           TE S    +  +G G                 LL              I + R G  R  
Sbjct: 238 TESS---KSPVTGKGTN---------------LL--------------IDQLRHGKFRV- 264

Query: 307 IQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY 366
                    N  DF  Q  Q RD     +   +DL ++N AT NFS++N+LGQGGFGPVY
Sbjct: 265 -----FDHPNHNDFQNQDFQ-RDGLNDRESAIMDLASINAATDNFSETNLLGQGGFGPVY 318

Query: 367 KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 426
           KG+LSDGKEVAVKRLS  SEQG  EFTNEVLLI+KLQHKNLVKLLGFCVDG+EKLLVYEF
Sbjct: 319 KGILSDGKEVAVKRLSDSSEQGKNEFTNEVLLIMKLQHKNLVKLLGFCVDGEEKLLVYEF 378

Query: 427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
           MPN SLD +LFDPRK   L WR R +I+NGIAKG LYLHEDSRLRI+HRDLKASN+LLD+
Sbjct: 379 MPNNSLDVVLFDPRKGAQLSWRSRIHIINGIAKGTLYLHEDSRLRIIHRDLKASNILLDN 438

Query: 487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
           +MN KISDFGMARI   +EGEANTVRI GTYGYMAPEYAMEGLYS KSDVFSFGV+L+EI
Sbjct: 439 NMNPKISDFGMARIMEANEGEANTVRIAGTYGYMAPEYAMEGLYSTKSDVFSFGVILLEI 498

Query: 547 ITGRRNAGSNQ------LLAYG 562
           ITGR+N+G ++      LLAY 
Sbjct: 499 ITGRKNSGFHKSKRAPSLLAYA 520

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302144055|emb|CBI23160.3| unnamed protein product [Vitis vinifera]

 Score =  629 bits (1621), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 330/562 (58%), Positives = 402/562 (71%), Gaps = 14/562 (2%)

Query: 2   VHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNAN 61
           V KAIQL+ I  + +   DL   D PPYN+CST+T      S    NL+N+L SL S A 
Sbjct: 31  VSKAIQLLFISSVLSGFPDLVCAD-PPYNVCSTTTTYGLN-SLFQSNLENLLDSLPSKAF 88

Query: 62  AAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQ 121
            + F N S GN  DRV G ++CLNY++ + C +CI+TA+  + KLCPN  EAIVWE+ CQ
Sbjct: 89  VSHFDNTSIGNGLDRVNGAFLCLNYVANDQCRNCISTAAYHVKKLCPNMNEAIVWEDECQ 148

Query: 122 LRYAYQNFFGQLDVSGNIPKYNRLNISEPE----RYRSVVNNTLSDLITKLSAFDPFEMY 177
           + Y+ + F G L  +GNIP  N  N+S+ E    R+RSVVN+TL +LI + +     +MY
Sbjct: 149 ILYSNETFLGHLSTTGNIPLDNMKNVSDLESEQLRFRSVVNDTLQNLIKQAAFNSSTDMY 208

Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
           AT  V FT+ D  YALVQCT DL  D+C  CL  AT +IL+  YFSRGARLLSR+CYLRY
Sbjct: 209 ATKPVVFTDVDILYALVQCTPDLSPDNCSICLQTATTEILAVYYFSRGARLLSRSCYLRY 268

Query: 238 ELYAFYKGATEPSILAGNQASGGGK--QRKMWMIIVLASV-VALLLVVFASTGYFFATKK 294
           E Y FY+ ATEP      Q  G  K  +RK  MI+++ SV V+L++   A   Y  AT+ 
Sbjct: 269 EFYPFYEVATEPQAPVSPQNPGTRKDGRRKTGMILIITSVSVSLVVATLAFYVYCLATRN 328

Query: 295 ITRK-RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLATSNFS 352
             +K RK    +++QL  I D + T  +  H  GR + L +Q+F FIDL T++ AT NFS
Sbjct: 329 GKKKERKQYLNREVQLPDIDDPSYTGPYQFH--GRKS-LNSQEFLFIDLATIHEATDNFS 385

Query: 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           + N LGQGGFGPVYKGVL DGKEVAVKRLSS SEQG+ EFTNEVLLI+KLQHKNLV+LLG
Sbjct: 386 ELNKLGQGGFGPVYKGVLRDGKEVAVKRLSSDSEQGSEEFTNEVLLIMKLQHKNLVRLLG 445

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           FCVD +E++LVYE+MPN SLD  LFDPR+R  L W +R NI+ GIA+G+LYLHEDSRLRI
Sbjct: 446 FCVDREERMLVYEYMPNSSLDVFLFDPRRRAQLDWSRRLNIIGGIARGILYLHEDSRLRI 505

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLKASNVLLD DM  KISDFGMARIF  SEGEANT  IVGT+GYMAPEYAMEGLYS 
Sbjct: 506 IHRDLKASNVLLDCDMKPKISDFGMARIFGGSEGEANTATIVGTHGYMAPEYAMEGLYSV 565

Query: 533 KSDVFSFGVLLIEIITGRRNAG 554
           KSDVFSFGVLL+EIITGRRN+G
Sbjct: 566 KSDVFSFGVLLLEIITGRRNSG 587

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555023|ref|XP_002518549.1| ATP binding protein, putative [Ricinus communis] gi|223542394|gb|EEF43936.1| ATP binding protein, putative [Ricinus communis]

 Score =  625 bits (1611), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 319/554 (57%), Positives = 397/554 (71%), Gaps = 23/554 (4%)

Query: 4   KAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAA 63
           K  + +L+  L  +  D A+ D PPY +C      +A      +NL+N+L SL SNA+  
Sbjct: 9   KIFEFLLLCFLVGSFLDFAYAD-PPYLLCPNINNQAANI-PFQNNLKNLLLSLPSNASGL 66

Query: 64  KFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLR 123
           K  ++S GN++D+VY  YMCLNY++++ C+ CI TAS+DI + C N  EAIVWEEVCQLR
Sbjct: 67  KVFDSSIGNNTDKVYSQYMCLNYVTSDKCSSCIQTASEDIKQSCANSAEAIVWEEVCQLR 126

Query: 124 YAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVP 183
           Y+ Q+F G LDVSGN    N  NIS P+++RS+VN T+S LI K +  +   MYAT E  
Sbjct: 127 YSNQSFLGHLDVSGNQFYDNEKNISNPDQFRSLVNQTVSGLIKKAAFNNSVNMYATGEAA 186

Query: 184 FTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY 243
           FT+++  YALVQCT DL +DDC TCL  A A++ SCCYFSRGARLLSR+CYLRYELYAFY
Sbjct: 187 FTSTEKLYALVQCTTDLSSDDCSTCLQVALANLSSCCYFSRGARLLSRSCYLRYELYAFY 246

Query: 244 KGATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTA 303
           KG       A NQ +G  KQ K WMI  L +  A+L+V+  S+  F  ++ + +      
Sbjct: 247 KGENGDPASAQNQGTGKSKQTKTWMIAFLTATTAILVVLALSS--FIYSRSMKK------ 298

Query: 304 RKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFG 363
                       ++  F  Q   G+D     +  F+D  +++ AT NF +SN+LGQGGFG
Sbjct: 299 ------------DNPAFQNQSFHGKDGLSAKESGFMDFASIHAATDNFCESNLLGQGGFG 346

Query: 364 PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423
           PVYKG+LSDGKE+AVKRL++CSEQG  EF  E+ LI+KLQHKNLV+LLGFC DG+EKLLV
Sbjct: 347 PVYKGILSDGKEIAVKRLATCSEQGIEEFKTEIQLIMKLQHKNLVRLLGFCFDGEEKLLV 406

Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
           YEFMPN SLD ILFDPRKR  L W KR NI+NGIAKG+LYLHEDSRLRI+HRDLK SN+L
Sbjct: 407 YEFMPNSSLDVILFDPRKRAQLDWCKRINIINGIAKGILYLHEDSRLRIIHRDLKPSNIL 466

Query: 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
           LD++MN KISDFG ARIF  SEGEANT R+VGTYGYMAPEYAMEGLYS KSDVFSFGVLL
Sbjct: 467 LDNEMNPKISDFGTARIFG-SEGEANTCRVVGTYGYMAPEYAMEGLYSTKSDVFSFGVLL 525

Query: 544 IEIITGRRNAGSNQ 557
           +EIITGR+N GS++
Sbjct: 526 LEIITGRKNTGSHK 539

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483378|ref|XP_002265659.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera]

 Score =  622 bits (1603), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 330/567 (58%), Positives = 402/567 (70%), Gaps = 19/567 (3%)

Query: 2   VHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNAN 61
           V KAIQL+ I  + +   DL   D PPYN+CST+T      S    NL+N+L SL S A 
Sbjct: 6   VSKAIQLLFISSVLSGFPDLVCAD-PPYNVCSTTTTYGLN-SLFQSNLENLLDSLPSKAF 63

Query: 62  AAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQ 121
            + F N S GN  DRV G ++CLNY++ + C +CI+TA+  + KLCPN  EAIVWE+ CQ
Sbjct: 64  VSHFDNTSIGNGLDRVNGAFLCLNYVANDQCRNCISTAAYHVKKLCPNMNEAIVWEDECQ 123

Query: 122 LRYAYQNFFGQLDVSGNIPKYNRLNISEPE----RYRSVVNNTLSDLITKLSAFDPFEMY 177
           + Y+ + F G L  +GNIP  N  N+S+ E    R+RSVVN+TL +LI + +     +MY
Sbjct: 124 ILYSNETFLGHLSTTGNIPLDNMKNVSDLESEQLRFRSVVNDTLQNLIKQAAFNSSTDMY 183

Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
           AT  V FT+ D  YALVQCT DL  D+C  CL  AT +IL+  YFSRGARLLSR+CYLRY
Sbjct: 184 ATKPVVFTDVDILYALVQCTPDLSPDNCSICLQTATTEILAVYYFSRGARLLSRSCYLRY 243

Query: 238 ELYAFYKGATEPSILAGNQASGGGK--QRKMWMIIVLASV-VALLLVVFASTGYFFATKK 294
           E Y FY+ ATEP      Q  G  K  +RK  MI+++ SV V+L++   A   Y  AT+ 
Sbjct: 244 EFYPFYEVATEPQAPVSPQNPGTRKDGRRKTGMILIITSVSVSLVVATLAFYVYCLATRN 303

Query: 295 ITRK-RKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLATSNFS 352
             +K RK    +++QL  I D + T  +  H  GR + L +Q+F FIDL T++ AT NFS
Sbjct: 304 GKKKERKQYLNREVQLPDIDDPSYTGPYQFH--GRKS-LNSQEFLFIDLATIHEATDNFS 360

Query: 353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           + N LGQGGFGPVYKGVL DGKEVAVKRLSS SEQG+ EFTNEVLLI+KLQHKNLV+LLG
Sbjct: 361 ELNKLGQGGFGPVYKGVLRDGKEVAVKRLSSDSEQGSEEFTNEVLLIMKLQHKNLVRLLG 420

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           FCVD +E++LVYE+MPN SLD  LFDPR+R  L W +R NI+ GIA+G+LYLHEDSRLRI
Sbjct: 421 FCVDREERMLVYEYMPNSSLDVFLFDPRRRAQLDWSRRLNIIGGIARGILYLHEDSRLRI 480

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY-----GYMAPEYAME 527
           +HRDLKASNVLLD DM  KISDFGMARIF  SEGEANT  IVGT+     GYMAPEYAME
Sbjct: 481 IHRDLKASNVLLDCDMKPKISDFGMARIFGGSEGEANTATIVGTHFSLDSGYMAPEYAME 540

Query: 528 GLYSKKSDVFSFGVLLIEIITGRRNAG 554
           GLYS KSDVFSFGVLL+EIITGRRN+G
Sbjct: 541 GLYSVKSDVFSFGVLLLEIITGRRNSG 567

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356540317|ref|XP_003538636.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max]

 Score =  595 bits (1534), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 320/536 (59%), Positives = 393/536 (73%), Gaps = 38/536 (7%)

Query: 21  LAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSN-ASFGNDSDRVYG 79
           + F D PPY ICSTS++  A+ S+ ++NL N+L+SL+S A+  KF N +S+G   DRVYG
Sbjct: 37  VVFAD-PPYYICSTSSS-FAKGSSFENNLTNLLSSLSSIASNYKFYNTSSYGIGPDRVYG 94

Query: 80  LYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNI 139
           LYMCL+YI+ E+C  CITTA++DI KLCP  TEA+VWEE+CQLRY+  NF G L+V+GNI
Sbjct: 95  LYMCLDYITNESCKTCITTATEDIVKLCPRATEAVVWEELCQLRYSNSNFMGMLNVTGNI 154

Query: 140 PKYNRLNISEPERYRSVVNNTLSDLITKLSAFD-PFEMYATDEVPFTNSDTFYALVQCTK 198
              N+ N+SEPE++ S VN T+S+L TK+++F     MYAT EVPF + +T YALVQCT+
Sbjct: 155 GLDNKQNLSEPEKFESAVNQTISNL-TKVASFGVSANMYATGEVPFED-ETIYALVQCTR 212

Query: 199 DLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQAS 258
           DL A DC  CL +A  DI  CCY S G R+LSR+CYLRYE YAFY GAT P+  +  +  
Sbjct: 213 DLTASDCSRCLQSAIGDIPGCCYASIGGRVLSRSCYLRYEFYAFYHGATGPTDSSIGKKE 272

Query: 259 GGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
           G     K+W+I  +  VV L++V F      F    +  KRK  ++  I  H+I      
Sbjct: 273 GENNSSKIWVITGIIVVVGLVIVFF-----IFGLYLVRNKRKRQSKNGIDNHQI------ 321

Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAV 378
                                +L +L +AT+NFSD N LGQGGFGPVYKG LSDG+EVA+
Sbjct: 322 ---------------------NLGSLRVATNNFSDLNKLGQGGFGPVYKGKLSDGQEVAI 360

Query: 379 KRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438
           KRLS+CSEQG+ EF NEVLLI++LQHKNLVKLLGFCVDG+EKLLVYEF+PNGSLD +LFD
Sbjct: 361 KRLSTCSEQGSEEFINEVLLIMQLQHKNLVKLLGFCVDGEEKLLVYEFLPNGSLDVVLFD 420

Query: 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
           P +R  L W KR +I+NGIA+G+LYLHEDSRL+I+HRDLKASN+LLD DMN KISDFGMA
Sbjct: 421 PNQRERLDWTKRLDIINGIARGILYLHEDSRLKIIHRDLKASNILLDYDMNPKISDFGMA 480

Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG 554
           RIFA SEGEANT  IVGTYGYMAPEYAMEGLYS KSDVF FGVLL+EII G+RNAG
Sbjct: 481 RIFAGSEGEANTATIVGTYGYMAPEYAMEGLYSIKSDVFGFGVLLLEIIAGKRNAG 536

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113911|ref|XP_002316612.1| predicted protein [Populus trichocarpa] gi|222859677|gb|EEE97224.1| predicted protein [Populus trichocarpa]

 Score =  573 bits (1476), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 307/565 (54%), Positives = 377/565 (66%), Gaps = 30/565 (5%)

Query: 8   LILIYCLTANL--HDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKF 65
           L+L+Y   A L  H   F   PPY  CS ++   A  S   +NLQ +++ LASNA+ +  
Sbjct: 15  LLLLYFSIATLSQHSSNFLTHPPYKFCSNTSLYEAN-SPFQNNLQTLMSYLASNASVSNQ 73

Query: 66  SNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYA 125
            +A  GND D VY  YMC NYI  E C+ CI  ASQDI +LCPN   A VWEE+CQLR++
Sbjct: 74  YHAYAGNDPDIVYAQYMCYNYI--ENCSACIYAASQDIMQLCPNNRNATVWEELCQLRFS 131

Query: 126 YQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFE-MYATDEVPF 184
            +NF GQLD+SGNI   N   I  P +Y SVVN   S+L TK +AFDP + MYAT ++  
Sbjct: 132 NKNFIGQLDISGNIIVANTETIENPGQYISVVNENFSNL-TKKAAFDPTQNMYATGKLAL 190

Query: 185 TNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYK 244
           ++ DT Y L QCT DL + DC TCL  A  +I SCCY  RG RLLS++CY RYELY FY+
Sbjct: 191 SDIDTLYTLGQCTTDLSSHDCSTCLQVAIQNISSCCYIGRGQRLLSQSCYFRYELYPFYE 250

Query: 245 GATEPSILAGNQASGGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTAR 304
           G  +         SG   +    + IVL + +  +++ F         ++I+RK     +
Sbjct: 251 GTAD---------SG---ETLTILKIVLGTCIPAVVLAFLIASCIIYFRRISRKETDEEK 298

Query: 305 KQIQ-LHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFG 363
             +  L ++  ++ +       +G     +   + +DL  +  AT NFS SN LGQGGFG
Sbjct: 299 SHLDFLQELRKSSGSTL----AEGNKVSSEELPWMMDLSVIRAATDNFSVSNKLGQGGFG 354

Query: 364 PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 423
            VYKG+LSDG EVAVKRLS  SEQG  EF  EVLLI+KLQHKNLV+LLGFCV+G+EKLLV
Sbjct: 355 SVYKGILSDGSEVAVKRLSRSSEQGVKEFKTEVLLIMKLQHKNLVRLLGFCVEGEEKLLV 414

Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
           YEFMPN SLD  LFDP KR  L W  R +I+NGIAKGMLYLHEDSRLRI+HRDLKASNVL
Sbjct: 415 YEFMPNSSLDVFLFDPTKRAELDWSSRIDIINGIAKGMLYLHEDSRLRIIHRDLKASNVL 474

Query: 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
           LD++MN KISDFGMARIF+ +E EANT RIVGTYGYMAPEYAMEGLYS KSDVFSFGVLL
Sbjct: 475 LDNEMNPKISDFGMARIFSSNEDEANTARIVGTYGYMAPEYAMEGLYSTKSDVFSFGVLL 534

Query: 544 IEIITGRRNAGSNQ------LLAYG 562
           +EII+GR+ AG +Q      LLAY 
Sbjct: 535 LEIISGRKKAGYHQSKCAPSLLAYA 559

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357480739|ref|XP_003610655.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355511990|gb|AES93613.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  572 bits (1475), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 325/585 (55%), Positives = 397/585 (67%), Gaps = 59/585 (10%)

Query: 1   MVHKAIQLILIYCLTANLHDLAFGDSPPYNICSTSTAGSARASTIDDNLQNVLTSLASN- 59
           +V K IQ  L+      L  LA  D PPY ICST     A  S+ D+NL N+L SL  N 
Sbjct: 6   IVFKFIQFFLVLYTLDFLSYLALAD-PPYEICSTRNI-YANGSSFDNNLSNLLLSLPFND 63

Query: 60  -ANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDISKLCPNKTEAIVWEE 118
             + +KF N S G   DRVYGLYMCL+++S ETC  C+T A  D  KLCP   EA+V+EE
Sbjct: 64  SNSISKFGNTSSGIGLDRVYGLYMCLDFVSNETCLKCVTNAIADTVKLCPQSKEAVVYEE 123

Query: 119 VCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFD-PFEMY 177
            CQ+RY+ +NF G L+V+GNI K N  NISEP ++ + VN  L+ L TK+++F+    MY
Sbjct: 124 FCQVRYSNKNFIGSLNVNGNIGKDNVQNISEPVKFETSVNKLLNGL-TKIASFNVSANMY 182

Query: 178 ATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGARLLSRNCYLRY 237
           AT EVPF +  T YALVQCT+DL A+DC  CL +A  DI  CCY S GAR++SR+CYLRY
Sbjct: 183 ATGEVPFEDK-TIYALVQCTRDLAANDCSRCLLSAIGDIPGCCYASIGARVMSRSCYLRY 241

Query: 238 ELYAFYKGATEPSILAGNQASGGGKQR--------KMWMIIVLASVVALLLVVFASTGYF 289
           E Y FY G  E +  + N    GGK +        K+WMI V+A  V L++++F     F
Sbjct: 242 EFYPFYLGEKEQTKSSTNL---GGKSKHFSSYNSSKIWMITVIAVGVGLVIIIFICYLCF 298

Query: 290 FATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDF-FIDLETLNLAT 348
                  R R+                           + N   ++DF FIDL +L +AT
Sbjct: 299 L------RNRQSN-------------------------KGNGKISKDFPFIDLASLRVAT 327

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
            NF+DSN LG+GGFGPVYKG+LSDG+EVA+KRLS CSEQG+ EF NEV+LILKLQHKNLV
Sbjct: 328 RNFTDSNKLGEGGFGPVYKGILSDGQEVAIKRLSICSEQGSEEFINEVMLILKLQHKNLV 387

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           KLLGFCVDG+EKLLVYE++PNGSLD +LF+   +  L W KR +I+NGIA+G+LYLHEDS
Sbjct: 388 KLLGFCVDGEEKLLVYEYLPNGSLDVVLFEQHAQ--LDWTKRLDIINGIARGILYLHEDS 445

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           RL+I+HRDLKASNVLLD+DMN KISDFGMARIFA SEGEANT  IVGTYGYMAPEYAMEG
Sbjct: 446 RLQIIHRDLKASNVLLDNDMNPKISDFGMARIFAGSEGEANTTTIVGTYGYMAPEYAMEG 505

Query: 529 LYSKKSDVFSFGVLLIEIITGRRNAG------SNQLLAYGMY-WS 566
           LYS KSDVF FGVLL+EIITG RNAG      +  LLAY  + W+
Sbjct: 506 LYSIKSDVFGFGVLLLEIITGIRNAGFCYSKTTPSLLAYAWHLWN 550

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113923|ref|XP_002316615.1| predicted protein [Populus trichocarpa] gi|222859680|gb|EEE97227.1| predicted protein [Populus trichocarpa]

 Score =  485 bits (1249), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 257/478 (53%), Positives = 319/478 (66%), Gaps = 28/478 (5%)

Query: 40  ARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTA 99
           A  S   +NL+++++ LASNA+ +   +A  GND DRVY  YMC NYI+ E C+ CI  A
Sbjct: 2   AANSPFQNNLKSLMSYLASNASVSNQYHAYAGNDPDRVYAHYMCYNYITFEKCSACIDAA 61

Query: 100 SQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNN 159
           SQDI +LCPN  +A VWEE+CQLR++ QNF G LD SGNIP  NR  I  PE+  S VN 
Sbjct: 62  SQDIMQLCPNIRDAAVWEELCQLRFSNQNFLGLLDFSGNIPLSNRKTIKNPEQLVSAVNE 121

Query: 160 TLSDLITKLSAFDPFE-MYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILS 218
             S+L TK +AF P   MYAT ++  ++ DT YAL QC+ DL + DC TCL  A  +I +
Sbjct: 122 NFSNL-TKKAAFVPARNMYATRKLTLSDIDTLYALGQCSTDLSSHDCNTCLQVAIQNIST 180

Query: 219 CCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQRKMWMIIVLASVVAL 278
           CCY SRGARLLSR+CY RYELY FY+G  +      N   G   +    + IVL + + +
Sbjct: 181 CCYISRGARLLSRSCYFRYELYPFYEGTADS---VYNFPVG---ETLTTLKIVLGTCIPV 234

Query: 279 LLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFF 338
           +++ F +     A  +  RK                ++++ F     +G     +   + 
Sbjct: 235 VVLAFLTASCHHAFLQELRK----------------SSESTF----AEGNKVSSEELPWM 274

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
           +DL  +  AT NFS SN LGQGGFG VYKG+LSDG EVAVKRLS  SEQG  EF NEVLL
Sbjct: 275 MDLSVIRAATDNFSVSNKLGQGGFGSVYKGILSDGSEVAVKRLSRSSEQGEKEFKNEVLL 334

Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           I+KLQHKNL++LLGFCV+G+EKLLVYEFMPN SLD  LFDP KR  L W  R +I+NGIA
Sbjct: 335 IMKLQHKNLIRLLGFCVEGEEKLLVYEFMPNSSLDVFLFDPTKRAKLDWSSRIDIINGIA 394

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           KGMLYLHEDSRLRI+HRDLKASNVLLD++MN KI DFGMARIF+ +E EA T RIVGT
Sbjct: 395 KGMLYLHEDSRLRIIHRDLKASNVLLDNEMNPKIPDFGMARIFSSNEDEAKTARIVGT 452

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera]

 Score =  459 bits (1182), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 240/534 (44%), Positives = 327/534 (61%), Gaps = 33/534 (6%)

Query: 29  YNICSTSTAGSARASTIDDNLQNVLTSLASNA---NAAKFSNASFGNDSDRVYGLYMCLN 85
           Y+ C T  +     ST   +L  +LTSL+S+A   N  KF N + G   D VYGLY+C  
Sbjct: 30  YSFC-TENSNYVPNSTYQSSLNVLLTSLSSDATILNGRKFHNTTAGQAPDMVYGLYLCRG 88

Query: 86  YISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRL 145
            ++   C DC+ TASQ+I   CPN+ EA+ W + C LRY+ ++ F  ++    +   N L
Sbjct: 89  DVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYSNRSIFSIMEERPMLTMSNSL 148

Query: 146 NISEPERYRSVVNNTLSDLITKLSA-FDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
           ++ +P+R+  +VN T+  LI K +      +M+ T E  F  S   Y LVQCT DL   +
Sbjct: 149 DMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEANFNASTKIYGLVQCTPDLSGSN 208

Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFY------KGATEPSILAGNQAS 258
           C TCL N  + I +CC   +GAR+L  +C  RYELY FY                   + 
Sbjct: 209 CSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPFYGDLAAATPPAPAPSPLSLLSP 268

Query: 259 GGGKQRKMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDT 318
            G K     ++I +   VA+ +V+F+   Y F  +K  +K   T  ++++          
Sbjct: 269 PGKKGNSSQLLIAIIVPVAVSVVIFSILCYCFICRKAKKKYSSTEEEKVE---------- 318

Query: 319 DFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVA 377
                      ND+   Q    D  TL  AT+NFSD N +G+GGFG VYKG LS GKE+A
Sbjct: 319 -----------NDITTVQSLQFDFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKEIA 367

Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
           +KRLS  S QG  EF NEV+L+ KLQH+NLV+LLGFC++G+EK+LVYE++PN SLD  LF
Sbjct: 368 IKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCFLF 427

Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
           DP K+G L W +R  I+ GIA+G+LYLHEDS+L+++HRDLKASNVLLD DMN KISDFGM
Sbjct: 428 DPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDFGM 487

Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           ARIF   +   +T R+VGTYGYM+PEYAM G +S KSDV+SFGVL++EII+G++
Sbjct: 488 ARIFGGDQTRGSTKRVVGTYGYMSPEYAMRGHFSAKSDVYSFGVLVLEIISGKK 541

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302144056|emb|CBI23161.3| unnamed protein product [Vitis vinifera]

 Score =  457 bits (1175), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 243/531 (45%), Positives = 333/531 (62%), Gaps = 21/531 (3%)

Query: 27  PPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSDRVYGLYMCLNY 86
           P Y  C + T      S+ ++NL+++L SL SN     F+  S G D++RV G  +C   
Sbjct: 63  PMYTFCDSGTGNYTSNSSFENNLKHLLQSLPSNTYLTCFNITSMGIDANRVSGRALCRGD 122

Query: 87  ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYN--R 144
           ++ + C  C+  AS++I K C ++ EAI+W E+CQ+ Y+Y+   G    +G  P +N   
Sbjct: 123 VTDKVCWICLENASREIMKECKSQ-EAIIWYELCQVHYSYRILSGMDAYTGKYPLWNNQE 181

Query: 145 LNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
            N+S+P  +  V+N+ + +L  K +      M+ TD+V F+ SDT Y LVQCT+DL  D 
Sbjct: 182 KNVSDPLSFYEVLNDLMRNLTIKAAQGPSKLMFGTDQVKFSRSDTIYGLVQCTRDLTVDS 241

Query: 205 CITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKGATEPSILAGNQASGGGKQR 264
           C  CL +A  D+ +CCY   G  + SR+C +RY L  FY     PS+           + 
Sbjct: 242 CRKCLSSALGDLKACCYGRGGGTIFSRSCNMRYGLTRFYD---TPSVKG---------EW 289

Query: 265 KMWMIIVLASVVALLLVVFASTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQH 324
           K WMI+++  V      V   +   +      R R GT   + +  +    N        
Sbjct: 290 KTWMIVLVICVPTFAAAVLVGSCVLYY-----RGRTGTQNDEEKSQRALLHNLATPTAAA 344

Query: 325 VQGRDNDLKAQDF-FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS 383
           +    N L +Q+  F++L T+  AT++FS+SN LG GGFG VYKGVL +GKE+AVKRLS 
Sbjct: 345 ITQEFNLLSSQELPFMELATIRAATNDFSESNKLGHGGFGTVYKGVLPNGKEIAVKRLSK 404

Query: 384 CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
            S QG  EF NE++LI KLQH+NLV+LLG   +G EKLL+YEFMPN SLD  +FD  KR 
Sbjct: 405 KSWQGIEEFKNEIILIAKLQHRNLVRLLGCGTEGQEKLLIYEFMPNKSLDIFIFDADKRQ 464

Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
            L W    NI++GIA+G+LYLHEDSRL+I+HRDLK +NVLL+ DM +KISDFGMARIF E
Sbjct: 465 QLNWEICHNIIDGIARGLLYLHEDSRLKIIHRDLKPNNVLLNHDMVAKISDFGMARIFGE 524

Query: 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG 554
           ++  ANT RIVGTYGYMAPEYAMEG++S KSDVFSFGV+L+EII+G+RN+G
Sbjct: 525 NQNAANTRRIVGTYGYMAPEYAMEGMFSMKSDVFSFGVILLEIISGKRNSG 575

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	571
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.401	0.342	0.624	6.6e-102
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.879	0.743	0.413	3e-101
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.893	0.762	0.412	3.4e-100
TAIR|locus:2123116	700	CRK30 "cysteine-rich RLK (RECE	0.383	0.312	0.608	5.3e-98
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.852	0.720	0.414	1.5e-97
TAIR|locus:2121691	667	CRK11 "cysteine-rich RLK (RECE	0.415	0.355	0.577	2.9e-97
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.392	0.339	0.593	2.9e-97
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.422	0.356	0.557	9.9e-95
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.401	0.355	0.6	4.3e-94
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.399	0.335	0.599	2.7e-92

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 763 (273.6 bits), Expect = 6.6e-102, Sum P(2) = 6.6e-102
 Identities = 143/229 (62%), Positives = 179/229 (78%)

Query:   325 VQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC 384
             VQ  D            +T+  AT  FSDSN++G+GGFG VY+G LS G EVAVKRLS  
Sbjct:   319 VQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKT 378

Query:   385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
             S QG  EF NE +L+ KLQHKNLV+LLGFC++G+EK+LVYEF+PN SLD  LFDP K+G 
Sbjct:   379 SGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGE 438

Query:   445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
             L W +R NI+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGMARIF   
Sbjct:   439 LDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVD 498

Query:   505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA 553
             + +ANT RI GT+GYM+PEYAM G +S KSDV+SFGVL++EII+G++N+
Sbjct:   499 QSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNS 547

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 1004 (358.5 bits), Expect = 3.0e-101, P = 3.0e-101
 Identities = 224/542 (41%), Positives = 309/542 (57%)

Query:    29 YNICXXXXXXXXXXXXIDDNLQNVLTSLXX--XXXXXXXXXXXXG--NDSDRVYGLYMCL 84
             Y+IC            +  NL+ VL+SL                G  NDS+RVYG+++C 
Sbjct:    31 YHICPNTTTYSRNSSYLT-NLRTVLSSLSSPNAAYASLFDNAAAGEENDSNRVYGVFLCR 89

Query:    85 NYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNR 144
               +SAE C DC+  A+ +  + CP +  A++W + C +RY+ Q+  GQ+ +   +   N+
Sbjct:    90 GDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRIRPGVFLTNK 149

Query:   145 LNISEPE--RYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPA 202
              NI+E +  R+   +   L D+  K +       +AT++  FT   T Y+LVQCT DL  
Sbjct:   150 QNITENQVSRFNESLPALLIDVAVKAALSS--RKFATEKANFTVFQTIYSLVQCTPDLTN 207

Query:   203 DDCITCLHNATADILSCCYFSRGARLLSRNCYLRYELYAFYKG-------ATEPS--ILA 253
              DC +CL      +  CC  S G R+++ +C  RYELY FY         A  PS  + A
Sbjct:   208 QDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPMAPPPSSTVTA 267

Query:   254 G--NQASGGGKQRKMWMIIXXXXXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHK 311
                N  S  GK + + +I+                  +   ++  R  K +A        
Sbjct:   268 PPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR--RNNKLSA-------- 317

Query:   312 IGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLS 371
               +  D D         D     +        +  AT+ FS+SN LG GGFG VYKG L 
Sbjct:   318 --ETEDLD--------EDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLI 367

Query:   372 DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431
              G+ VA+KRLS  S QG  EF NEV ++ KLQH+NL KLLG+C+DG+EK+LVYEF+PN S
Sbjct:   368 TGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKS 427

Query:   432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491
             LD  LFD  KR +L W++R  I+ GIA+G+LYLH DSRL I+HRDLKASN+LLD+DM+ K
Sbjct:   428 LDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPK 487

Query:   492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
             ISDFGMARIF   + +ANT RIVGTYGYM+PEYA+ G YS KSDV+SFGVL++E+ITG++
Sbjct:   488 ISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKK 547

Query:   552 NA 553
             N+
Sbjct:   548 NS 549

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 994 (355.0 bits), Expect = 3.4e-100, P = 3.4e-100
 Identities = 230/558 (41%), Positives = 313/558 (56%)

Query:    29 YNICXXXXXXXXXXXXIDDNLQNVLTSLXXXXXXXXXXX--XXXGNDSDRVYGLYMCLNY 86
             Y+ C             ++NL+ +L SL                G   DRV GL+ C   
Sbjct:    41 YHTCQNTANYTSNSTY-NNNLKTLLASLSSRNASYSTGFQNATVGQAPDRVTGLFNCRGD 99

Query:    87 ISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLN 146
             +S E C  C++ A  D    CPN+ EA ++ + C LRY+ QN    L  +G +   N  N
Sbjct:   100 VSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITTGGVILVNTRN 159

Query:   147 IS--EPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADD 204
             ++  + +    +V  TL+   T   A +  + + T +  FT   +FY LVQCT DL   D
Sbjct:   160 VTSNQLDLLSDLVLPTLNQAATV--ALNSSKKFGTRKNNFTALQSFYGLVQCTPDLTRQD 217

Query:   205 CITCLHNATADILSCCYFSR-GARLLSRNCYLRYELYAFYKGAT------EPSILAGNQA 257
             C  CL      I +     R GAR+++ +C  RYE+YAFY  +        PSI     +
Sbjct:   218 CSRCLQLVINQIPT----DRIGARIINPSCTSRYEIYAFYTESAVPPPPPPPSISTPPVS 273

Query:   258 SG--GGKQRKMWMIIXXXXXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHKIGDA 315
             +    GK     +++                GY F T++        ARK          
Sbjct:   274 APPRSGKDGNSKVLVIAIVVPIIVAVLLFIAGYCFLTRR--------ARKS--------- 316

Query:   316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE 375
                 ++       D+   A    +D  T+  AT +F +SN +GQGGFG VYKG LSDG E
Sbjct:   317 ----YYTPSAFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTE 372

Query:   376 VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI 435
             VAVKRLS  S QG  EF NEV+L+ KLQH+NLV+LLGFC+DG+E++LVYE++PN SLD  
Sbjct:   373 VAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYF 432

Query:   436 LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495
             LFDP K+G L W +R  I+ G+A+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DF
Sbjct:   433 LFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADF 492

Query:   496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA-- 553
             GMARIF   + E NT RIVGTYGYM+PEYAM G YS KSDV+SFGVL++EII+G++N+  
Sbjct:   493 GMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSF 552

Query:   554 ----GSNQLLAYGM-YWS 566
                 G++ L++Y    WS
Sbjct:   553 YQTDGAHDLVSYAWGLWS 570

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2123116 CRK30 "cysteine-rich RLK (RECEPTOR-like protein kinase) 30" [Arabidopsis thaliana (taxid:3702)]

 Score = 714 (256.4 bits), Expect = 5.3e-98, Sum P(2) = 5.3e-98
 Identities = 135/222 (60%), Positives = 175/222 (78%)

Query:   340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLI 399
             D++ +  ATSNF  SN +GQGGFG VYKG LS+G EVAVKRLS  S+QG  EF NEVLL+
Sbjct:   335 DIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVAVKRLSRTSDQGELEFKNEVLLV 394

Query:   400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF---DPRKRGILCWRKRTNIVNG 456
              KLQH+NLV+LLGF + G+EK+LV+EF+PN SLD  LF   +P K+G L W +R NI+ G
Sbjct:   395 AKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLFGSTNPTKKGQLDWTRRYNIIGG 454

Query:   457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
             I +G+LYLH+DSRL I+HRD+KASN+LLD+DMN KI+DFGMAR F + + E +T R+VGT
Sbjct:   455 ITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRDHQTEDSTGRVVGT 514

Query:   517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL 558
             +GYM PEY   G +S KSDV+SFGVL++EI++GR+N+   Q+
Sbjct:   515 FGYMPPEYVAHGQFSTKSDVYSFGVLILEIVSGRKNSSFYQM 556

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
 Identities = 217/524 (41%), Positives = 306/524 (58%)

Query:    48 NLQNVLTSLXXXXXXXXXXXXX--XGNDSDRVYGLYMCLNYISAETCNDCITTASQDISK 105
             NL+ +L+S                 G   DRV GL++C   +S E C++C+  +  +   
Sbjct:    59 NLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESLT 118

Query:   106 LCPNKTEAIVWEEVCQLRYAYQNFFGQLDVSGNIPKYNRLNISEPERYRSVVNNTLSDLI 165
              CPN+ EA+ + E C LRY+++NF   +   G +   N  NIS  +  R    + +   +
Sbjct:   119 RCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSNM 178

Query:   166 TKLS--AFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFS 223
              + +  A +    ++T +   T+  T Y LVQCT DL   DC +CL ++   ++    F 
Sbjct:   179 NQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMPL--FR 236

Query:   224 RGARLLSRNCYLRYELYAFYK----GA-TEPSILAGN-----QASGGGKQRKMWMIIXXX 273
              GAR    +C  RYELYAFY     G  + P +  G+       S  GK     +++   
Sbjct:   237 IGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLVVAI 296

Query:   274 XXXXXXXXXXXXTGYFFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLK 333
                          GY F  ++ T+K   TA       ++GD   T               
Sbjct:   297 VVLAVLLFIAL-VGYCFLAQR-TKKTFDTASAS----EVGDDMAT--------------- 335

Query:   334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT 393
             A    +D  T+  AT++F++SN +G+GGFG VYKG  S+GKEVAVKRLS  S QG AEF 
Sbjct:   336 ADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEAEFK 395

Query:   394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
              EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+  L W +R NI
Sbjct:   396 TEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQRYNI 455

Query:   454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
             + GIA+G+LYLH+DSRL I+HRDLKASN+LLD+D+N KI+DFGMARIF   + + NT RI
Sbjct:   456 IGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNTSRI 515

Query:   514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557
             VGTYGYMAPEYAM G +S KSDV+SFGVL++EII+GR+N+  ++
Sbjct:   516 VGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDE 559

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121691 CRK11 "cysteine-rich RLK (RECEPTOR-like protein kinase) 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 734 (263.4 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
 Identities = 138/239 (57%), Positives = 184/239 (76%)

Query:   322 YQHVQGR-DNDLKAQDFFI-DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVK 379
             YQ  +   ++D+   D  + D +T+  AT+ FS SN LG+GGFG VYKG LS+G +VAVK
Sbjct:   319 YQRTKTESESDISTTDSLVYDFKTIEAATNKFSTSNKLGEGGFGAVYKGKLSNGTDVAVK 378

Query:   380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
             RLS  S QGT EF NE +L+ KLQH+NLV+LLGFC++ +E++L+YEF+ N SLD  LFDP
Sbjct:   379 RLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQILIYEFVHNKSLDYFLFDP 438

Query:   440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
              K+  L W +R  I+ GIA+G+LYLH+DSRL+I+HRDLKASN+LLD+DMN KI+DFG+A 
Sbjct:   439 EKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASNILLDADMNPKIADFGLAT 498

Query:   500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL 558
             IF   + + NT RI GTY YM+PEYAM G YS KSD++SFGVL++EII+G++N+G  Q+
Sbjct:   499 IFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGVLVLEIISGKKNSGVYQM 557

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEP;RCA

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IEP

GO:0016020 "membrane" evidence=ISS

GO:0009611 "response to wounding" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 722 (259.2 bits), Expect = 2.9e-97, Sum P(2) = 2.9e-97
 Identities = 133/224 (59%), Positives = 177/224 (79%)

Query:   329 DNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG 388
             D+    +   +D   +  AT++FS++N +G+GGFG VYKG  S+G EVAVKRLS  SEQG
Sbjct:   314 DDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQG 373

Query:   389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
               EF NEV+++  L+HKNLV++LGF ++ +E++LVYE++ N SLD  LFDP K+G L W 
Sbjct:   374 DTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWT 433

Query:   449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
             +R +I+ GIA+G+LYLH+DSRL I+HRDLKASN+LLD+DMN KI+DFGMARIF   + + 
Sbjct:   434 QRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQ 493

Query:   509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN 552
             NT RIVGTYGYM+PEYAM G +S KSDV+SFGVL++EII+GR+N
Sbjct:   494 NTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKN 537

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 718 (257.8 bits), Expect = 9.9e-95, Sum P(2) = 9.9e-95
 Identities = 135/242 (55%), Positives = 181/242 (74%)

Query:   318 TDFHYQHVQGRDNDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV 376
             T++  + +    +D+  A     D + +  AT+ F ++N LGQGGFG VYKG+   G +V
Sbjct:   317 TNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQV 376

Query:   377 AVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
             AVKRLS  S QG  EF NEV+++ KLQH+NLV+LLGFC++ DE++LVYEF+PN SLD  +
Sbjct:   377 AVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFI 436

Query:   437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
             FD   + +L W +R  I+ GIA+G+LYLH+DSRL I+HRDLKA N+LL  DMN+KI+DFG
Sbjct:   437 FDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFG 496

Query:   497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
             MARIF   + EANT RIVGTYGYM+PEYAM G +S KSDV+SFGVL++EII+G++N+   
Sbjct:   497 MARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVY 556

Query:   557 QL 558
             Q+
Sbjct:   557 QM 558

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 707 (253.9 bits), Expect = 4.3e-94, Sum P(2) = 4.3e-94
 Identities = 138/230 (60%), Positives = 173/230 (75%)

Query:   330 NDLK-AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG 388
             ND+  A     D + +  AT+ F   N LGQGGFG VYKG LS G +VAVKRLS  S QG
Sbjct:   304 NDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQG 363

Query:   389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
               EF NEV+++ KLQH+NLVKLLG+C++G+EK+LVYEF+PN SLD  LFD   +  L W 
Sbjct:   364 EKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWT 423

Query:   449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
             +R  I+ GIA+G+LYLH+DSRL I+HRDLKA N+LLD DMN KI+DFGMARIF   + EA
Sbjct:   424 RRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEA 483

Query:   509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL 558
              T R+VGTYGYM+PEYAM G +S KSDV+SFGVL++EII+G +N+   Q+
Sbjct:   484 MTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQM 533

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 719 (258.2 bits), Expect = 2.7e-92, Sum P(2) = 2.7e-92
 Identities = 139/232 (59%), Positives = 172/232 (74%)

Query:   329 DNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG 388
             D     +   +  ETL  AT NFS  N LG+GGFG VYKGV   G+E+AVKRLS  S QG
Sbjct:   335 DEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQG 394

Query:   389 TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
               EF NE+LL+ KLQH+NLV+L+GFC+ G+E+LLVYEF+ N SLD  +FD  KR +L W 
Sbjct:   395 DNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWV 454

Query:   449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
              R  ++ GIA+G+LYLHEDSR RI+HRDLKASN+LLD +MN KI+DFG+A++F   +   
Sbjct:   455 VRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMT 514

Query:   509 N--TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN--AGSN 556
             +  T RI GTYGYMAPEYAM G +S K+DVFSFGVL+IEIITG+RN   GSN
Sbjct:   515 HRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSN 566

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	571
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-57
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-57
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-56
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-54
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-54
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-51
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-50
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-44
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-37
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-37
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-36
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-35
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-35
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-35
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-34
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-34
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-33
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-33
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-32
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-31
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-31
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-29
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-29
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-29
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-28
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-28
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-28
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-28
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-27
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-27
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-27
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-27
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-27
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-26
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-26
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-26
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-26
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-25
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-25
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-25
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-25
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-25
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-24
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-24
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-24
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-24
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-24
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-24
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-24
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	7e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	8e-24
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-24
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-23
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-23
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-23
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-23
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-23
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-22
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-22
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-22
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-22
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-21
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-21
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-21
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-21
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-20
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-20
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-20
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	6e-20
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-20
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-20
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-19
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	7e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-18
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-18
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-18
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-16
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-15
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-15
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-14
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-13
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	9e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-10
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	5e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	9e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	7e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  193 bits (492), Expect = 1e-57
 Identities = 80/200 (40%), Positives = 104/200 (52%), Gaps = 14/200 (7%)

Query: 356 ILGQGGFGPVYKGVLSDGK-----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
            LG+G FG VYKG L         EVAVK L    SEQ   EF  E  ++ KL H N+VK
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           LLG C + +   +V E+M  G L + L   R +  L      +    IA+GM YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE---S 120

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-GTYGYMAPEYAMEG 528
              +HRDL A N L+  ++  KISDFG++R     + +    R       +MAPE   EG
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 529 LYSKKSDVFSFGVLLIEIIT 548
            ++ KSDV+SFGVLL EI T
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  191 bits (488), Expect = 5e-57
 Identities = 79/200 (39%), Positives = 108/200 (54%), Gaps = 13/200 (6%)

Query: 356 ILGQGGFGPVYKGVLSDGK-----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
            LG+G FG VYKG L         EVAVK L    SEQ   EF  E  ++ KL H N+VK
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           LLG C + +  ++V E+MP G L   L   R + +       +    IA+GM YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLE---S 121

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              +HRDL A N L+  ++  KISDFG++R ++ +   +    ++     +MAPE   EG
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179

Query: 529 LYSKKSDVFSFGVLLIEIIT 548
            ++ KSDV+SFGVLL EI T
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  188 bits (481), Expect = 5e-56
 Identities = 81/211 (38%), Positives = 110/211 (52%), Gaps = 26/211 (12%)

Query: 355 NILGQGGFGPVYKGVLSDGK----EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
             LG+G FG VYKG L        EVAVK L    SE+   +F  E  ++ KL H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL------FDPRKRGILCWRKRTNIVNGIAKGMLY 463
           LLG C + +   LV E+M  G L   L      F   ++  L  +   +    IAKGM Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT-----VRIVGTY 517
           L      + VHRDL A N L+  D+  KISDFG++R ++ +      T     +R     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +MAPE   +G+++ KSDV+SFGVLL EI T
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  184 bits (470), Expect = 2e-54
 Identities = 76/199 (38%), Positives = 101/199 (50%), Gaps = 12/199 (6%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLG 412
            LG G FG VYK      GK VAVK L   SE  +       E+ ++ +L H N+V+L+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
              D D   LV E+   G L   L    + G L   +   I   I +G+ YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGI 119

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEGLYS 531
           +HRDLK  N+LLD +   KI+DFG+A+   +S     T   VGT  YMAPE       Y 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYG 177

Query: 532 KKSDVFSFGVLLIEIITGR 550
            K DV+S GV+L E++TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  183 bits (468), Expect = 4e-54
 Identities = 80/205 (39%), Positives = 106/205 (51%), Gaps = 23/205 (11%)

Query: 357 LGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG VYKG L    E     VAVK L    SE+   EF  E  ++ KL H N+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           LG C  G+   +V E+MP G L   L   +    L  +    +   IAKGM YL      
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES---K 121

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT-----VRIVGTYGYMAPEY 524
             VHRDL A N L+  ++  KISDFG++R I+ +            ++      +MAPE 
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK------WMAPES 175

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
             +G ++ KSDV+SFGVLL EI T 
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (445), Expect = 2e-51
 Identities = 76/194 (39%), Positives = 106/194 (54%), Gaps = 11/194 (5%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFC 414
           LG+GGFG VY       GK+VA+K +         E    E+ ++ KL H N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            D +   LV E+   GSL  +L      G L   +   I+  I +G+ YLH      I+H
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 475 RDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEGLYSK 532
           RDLK  N+LLDSD    K++DFG++++    +    T  IVGT  YMAPE    +G YS+
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 533 KSDVFSFGVLLIEI 546
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  173 bits (442), Expect = 2e-50
 Identities = 73/202 (36%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
           +     LG+G FG VY       GK VA+K +     ++       E+ ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +L     D D+  LV E+   G L  +L   +KRG L   +    +  I   + YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              IVHRDLK  N+LLD D + K++DFG+AR     E +  T   VGT  YMAPE  +  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTTF--VGTPEYMAPEVLLGK 171

Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
            Y K  D++S GV+L E++TG+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  156 bits (397), Expect = 7e-44
 Identities = 71/205 (34%), Positives = 110/205 (53%), Gaps = 17/205 (8%)

Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
            +LG+G FG VY  +  D G+ +AVK   LS  SE+       E+ ++  LQH N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 412 GFCVDGDEK-LLVY-EFMPNGSLDAILFDPRKRGILCWRKRTNI---VNGIAKGMLYLHE 466
           G   D ++  L ++ E++  GSL ++L   +K G L       I      I +G+ YLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKL---PEPVIRKYTRQILEGLAYLH- 118

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
                IVHRD+K +N+L+DSD   K++DFG A+   + E    T  + GT  +MAPE   
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
              Y + +D++S G  +IE+ TG+ 
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  143 bits (362), Expect = 6e-39
 Identities = 72/200 (36%), Positives = 109/200 (54%), Gaps = 6/200 (3%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
             F+    LG G FG V++G+  +   VA+K L S       +F  EV  + +L+HK+L+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            L   C  G+   ++ E M  GSL A L  P  + +L      ++   +A+GM YL E  
Sbjct: 66  SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ- 123

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
               +HRDL A N+L+  D+  K++DFG+AR+  E    ++  +I   Y + APE A  G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179

Query: 529 LYSKKSDVFSFGVLLIEIIT 548
            +S KSDV+SFG+LL E+ T
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  140 bits (356), Expect = 3e-38
 Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 17/205 (8%)

Query: 351 FSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           F     +G+GGFG VYK      GKEVA+K +   S++   +  NE+ ++ K +H N+VK
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML----YLH 465
             G  +  DE  +V EF   GSL  +L     + +      + I   + K +L    YLH
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTL----TESQIAY-VCKELLKGLEYLH 115

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRD+KA+N+LL SD   K+ DFG++   ++++       +VGT  +MAPE  
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVI 169

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
               Y  K+D++S G+  IE+  G+
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 1e-37
 Identities = 71/205 (34%), Positives = 111/205 (54%), Gaps = 13/205 (6%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKN 406
           N+   +++G+G FG VYKG+ L  G  VA+K++S     E+       E+ L+  L+H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           +VK +G     D   ++ E+  NGSL  I+   +K G          V  + +G+ YLHE
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YA 525
                ++HRD+KA+N+L   D   K++DFG+A    +   +  +V  VGT  +MAPE   
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV--VGTPYWMAPEVIE 172

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           M G  S  SD++S G  +IE++TG 
Sbjct: 173 MSGA-STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  137 bits (347), Expect = 8e-37
 Identities = 70/226 (30%), Positives = 113/226 (50%), Gaps = 36/226 (15%)

Query: 355 NILGQGGFGPVYKGVLS-DGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
            ++G G FG V +G L   GK+   VA+K L +  S++   +F  E  ++ +  H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G        +++ E+M NGSLD  L      G     +   ++ GIA GM YL   S 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SE 124

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAPE 523
           +  VHRDL A N+L++S++  K+SDFG++R   +SE    T      +R      + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAPE 178

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGM--YWSW 567
                 ++  SDV+SFG+++ E+++            YG   YW  
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS------------YGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  136 bits (344), Expect = 2e-36
 Identities = 71/200 (35%), Positives = 104/200 (52%), Gaps = 17/200 (8%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           LG G FG V+ G  +   +VAVK L   + S      F  E  ++ KL+H  LV+L   C
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            + +   +V E+M  GSL   L     + +    +  ++   IA+GM YL        +H
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLE---SRNYIH 126

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYS 531
           RDL A N+L+  ++  KI+DFG+AR+  + E  A      G      + APE A  G ++
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFT 182

Query: 532 KKSDVFSFGVLLIEIIT-GR 550
            KSDV+SFG+LL EI+T GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  134 bits (338), Expect = 1e-35
 Identities = 74/196 (37%), Positives = 108/196 (55%), Gaps = 14/196 (7%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G FG V  G    G++VAVK L    +   A+ F  E  ++  L+H NLV+LLG  +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKD--DSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            G+   +V E+M  GSL   L   R R ++   ++      + +GM YL E      VHR
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSD 535
           DL A NVL+  D+ +K+SDFG+A+  A    ++  + +  T    APE   E  +S KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKE-ASQGQDSGKLPVKWT----APEALREKKFSTKSD 181

Query: 536 VFSFGVLLIEIIT-GR 550
           V+SFG+LL EI + GR
Sbjct: 182 VWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  134 bits (338), Expect = 2e-35
 Identities = 73/211 (34%), Positives = 113/211 (53%), Gaps = 29/211 (13%)

Query: 356 ILGQGGFGPVYKGV-LSDGK----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           +LG G FG VYKGV + +G+     VA+K L    S +   E  +E  ++  + H ++V+
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
           LLG C+   +  L+ + MP G L   + + +       +L W  +      IAKGM YL 
Sbjct: 74  LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE----GEANTVRIVGTYGYMA 521
           E    R+VHRDL A NVL+ +  + KI+DFG+A++    E     E   V I     +MA
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI----KWMA 179

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
            E  +  +Y+ KSDV+S+GV + E++T G +
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  133 bits (336), Expect = 5e-35
 Identities = 71/205 (34%), Positives = 105/205 (51%), Gaps = 16/205 (7%)

Query: 354 SNILGQGGFGPVYKGVL-----SDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNL 407
              LG+G FG V          + G++VAVK L+ S  EQ  ++F  E+ ++  L H+N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 408 VKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           VK  G C     +   L+ E++P+GSL   L   R R  +  ++     + I KGM YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG--EANTVRIVGTYGYMAPE 523
                R +HRDL A N+L++S+   KISDFG+A++  E +             + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
                 +S  SDV+SFGV L E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  129 bits (327), Expect = 5e-34
 Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 29/212 (13%)

Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G+            VA+K ++  +      EF NE  ++ +    ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDPRKRGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M  G L + L        +    G    +K   +   IA GM 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE------GEANTVRIVGT 516
           YL      + VHRDL A N ++  D+  KI DFGM R   E++           VR    
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +MAPE   +G+++ KSDV+SFGV+L E+ T
Sbjct: 187 --WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  129 bits (326), Expect = 6e-34
 Identities = 70/198 (35%), Positives = 102/198 (51%), Gaps = 13/198 (6%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V++G+ ++   VAVK L   +     +F  E  ++ KL+H  L++L   C  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
            +   +V E M  GSL   L        L   +  ++   +A GM YL   +    +HRD
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128

Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYSKK 533
           L A NVL+  +   K++DFG+AR+  E   EA      G      + APE A+   +S K
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIK 184

Query: 534 SDVFSFGVLLIEIIT-GR 550
           SDV+SFG+LL EI+T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  129 bits (326), Expect = 7e-34
 Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G FG VY     SDGK   +K   LS+ SE+   +  NEV ++ KL H N++K    
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRL 470
             +  +  +V E+   G L   +   +K G         I++    +   + YLH     
Sbjct: 68  FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF--PEEQILDWFVQLCLALKYLHSR--- 122

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           +I+HRD+K  N+ L S+   K+ DFG++++ + +   A TV  VGT  Y++PE      Y
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV--VGTPYYLSPELCQNKPY 180

Query: 531 SKKSDVFSFGVLLIEIITGRR 551
           + KSD++S G +L E+ T + 
Sbjct: 181 NYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  129 bits (325), Expect = 1e-33
 Identities = 74/215 (34%), Positives = 105/215 (48%), Gaps = 31/215 (14%)

Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG+G FG V+ G     +       VAVK L  + S     +F  E  L+   QH+N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLD----------AILFDPR-KRGILCWRKRTNIVNGIA 458
             G C +GD  ++V+E+M +G L+          A L  P    G L   +   I   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANTVRIVGT- 516
            GM+YL   +    VHRDL   N L+  D+  KI DFGM+R ++       +  R+ G  
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT-----TDYYRVGGHT 184

Query: 517 ---YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +M PE  M   ++ +SDV+SFGV+L EI T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  127 bits (320), Expect = 3e-33
 Identities = 75/202 (37%), Positives = 106/202 (52%), Gaps = 22/202 (10%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKLLG 412
           +G+G FG VYKGVL    EVAVK   +C      +    F  E  ++ +  H N+VKL+G
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
            CV      +V E +P GSL  + F  +K+  L  +K   +    A GM YL  +S+   
Sbjct: 60  VCVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NC 114

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMAR-----IFAESEGEANTVRIVGTYGYMAPEYAME 527
           +HRDL A N L+  +   KISDFGM+R     I+  S+G    + I  T    APE    
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG-LKQIPIKWT----APEALNY 169

Query: 528 GLYSKKSDVFSFGVLLIEIITG 549
           G Y+ +SDV+S+G+LL E  + 
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  126 bits (318), Expect = 1e-32
 Identities = 77/219 (35%), Positives = 111/219 (50%), Gaps = 24/219 (10%)

Query: 355 NILGQGGFGPVYKGVLS--DGK----EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
             LG G FG VY+G+    DG     +VAVK L  SCSEQ  ++F  E L++ K  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLY 463
           V+L+G   +   + ++ E M  G L + L + R R      L  +        +AKG  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           L E+     +HRD+ A N LL        +KI+DFGMAR    +       R +    +M
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEII-------TGRRN 552
            PE  ++G+++ K+DV+SFGVLL EI         GR N
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 1e-32
 Identities = 77/202 (38%), Positives = 101/202 (50%), Gaps = 21/202 (10%)

Query: 357 LGQGGFGPVYKGV--LSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG G FG V KGV  +  GKE  VAVK L       G  EF  E  ++ +L H  +V+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
           G C  G+  +LV E  P G L   L   +KR  +       + + +A GM YL       
Sbjct: 63  GVCK-GEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK---H 115

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAPEYAM 526
            VHRDL A NVLL +   +KISDFGM+R    + G  +      T G     + APE   
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSR----ALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
            G +S KSDV+S+GV L E  +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  123 bits (310), Expect = 2e-31
 Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 25/219 (11%)

Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEV 396
           D+ +       + +   +G+G  G VYK    + GKEVA+K  RL   +++      NE+
Sbjct: 10  DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEI 66

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN---- 452
           L++   +H N+V      + GDE  +V E+M  GSL  I        I     R N    
Sbjct: 67  LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI--------ITQNFVRMNEPQI 118

Query: 453 --IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             +   + +G+ YLH      ++HRD+K+ N+LL  D + K++DFG A    + + + N+
Sbjct: 119 AYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           V  VGT  +MAPE      Y  K D++S G++ IE+  G
Sbjct: 176 V--VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  122 bits (308), Expect = 2e-31
 Identities = 81/217 (37%), Positives = 115/217 (52%), Gaps = 32/217 (14%)

Query: 355 NILGQGGFGPVYKG----VLSDGKE---VAVKRLSSCS-EQGTAEFTNEVLLILKLQHKN 406
           N LG G FG VY+G    +L  G     VAVK L   + +Q   EF  E  L+    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGML 462
           +VKLLG C+  + + ++ E M  G L + L D R       +L  ++  +I   +AKG +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 463 YLHEDSRLRIVHRDLKASNVLL-----DSDMNSKISDFGMARIFAES-----EGEAN-TV 511
           YL    ++  +HRDL A N L+     D+D   KI DFG+AR   +S     EGE    V
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           R      +MAPE  ++G ++ +SDV+SFGVL+ EI+T
Sbjct: 178 R------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  121 bits (307), Expect = 3e-31
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 29/214 (13%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKN 406
           S+     +LGQG  G VYK      GK  A+K++     E+   +   E+  +   +   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 407 LVKLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---------G 456
           +VK  G F  +G+  + V E+M  GSL  +L            K+   +           
Sbjct: 61  VVKCYGAFYKEGEISI-VLEYMDGGSLADLL------------KKVGKIPEPVLAYIARQ 107

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           I KG+ YLH  ++  I+HRD+K SN+L++S    KI+DFG++++   +  + NT   VGT
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGT 163

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             YM+PE      YS  +D++S G+ L+E   G+
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (312), Expect = 3e-31
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 17/207 (8%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE---FTNEVLLILKLQH-KNLVKLLG 412
           LG+G FG VY     D K VA+K L+   E  + E   F  E+ ++  L H  N+VKL  
Sbjct: 8   LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D     LV E++  GSL+ +L    ++G L   +   I+  I   + YLH      I
Sbjct: 66  FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122

Query: 473 VHRDLKASNVLLDSDMN-SKISDFGMARIFAE----SEGEANTVRIVGTYGYMAPEYAM- 526
           +HRD+K  N+LLD D    K+ DFG+A++  +    S   A     VGT GYMAPE  + 
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 527 --EGLYSKKSDVFSFGVLLIEIITGRR 551
                 S  SD++S G+ L E++TG  
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLP 209

Length = 384

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 1e-29
 Identities = 67/200 (33%), Positives = 99/200 (49%), Gaps = 21/200 (10%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           LG G FG V+ G      +VA+K  R  + SE    +F  E  +++KL H NLV+L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
                  +V E+M NG L   L    ++G L      ++ + + + M YL  +     +H
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123

Query: 475 RDLKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGL 529
           RDL A N L+  D   K+SDFG+AR      +  S+G    V+      +  PE      
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK------WAPPEVFDYSR 177

Query: 530 YSKKSDVFSFGVLLIEIITG 549
           +S KSDV+SFGVL+ E+ + 
Sbjct: 178 FSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  116 bits (292), Expect = 2e-29
 Identities = 67/199 (33%), Positives = 101/199 (50%), Gaps = 21/199 (10%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G G FG V+ G   + ++VA+K  R  + SE+   +F  E  +++KL H  LV+L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            +     LV+EFM +G L   L    +RG         +   + +GM YL   +   ++H
Sbjct: 69  TERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 475 RDLKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGL 529
           RDL A N L+  +   K+SDFGM R      +  S G    V+      + +PE      
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEVFSFSK 177

Query: 530 YSKKSDVFSFGVLLIEIIT 548
           YS KSDV+SFGVL+ E+ +
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  116 bits (292), Expect = 3e-29
 Identities = 73/208 (35%), Positives = 115/208 (55%), Gaps = 20/208 (9%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLS-SCSEQGTAE-----FTNEVLLILKLQHKNLV 408
            +LG+G +G VY G+ + G+ +AVK++    S    AE        EV L+  L+H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           + LG C+D +   +  EF+P GS+ +IL  F P    + C +    I++G+A    YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVA----YLHN 120

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA---ESEGEANTVRIV-GTYGYMAP 522
           +    +VHRD+K +NV+L  +   K+ DFG AR  A        +N ++ + GT  +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E   E  Y +KSD++S G  + E+ TG+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  115 bits (289), Expect = 6e-29
 Identities = 69/207 (33%), Positives = 115/207 (55%), Gaps = 15/207 (7%)

Query: 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKN 406
           +F   N +G+G FG V+K V  +D +  A+K+  LS  + +   E  +E  ++ KL    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI---LCWRKRTNIVNGIAKGMLY 463
           +++     +D  +  +V E+  NG L  +L   R R +     WR    I+ G+A    +
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           LH     +I+HRD+K+ N+ LD+  N KI D G+A++ +++   ANT  IVGT  Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGR 550
              +  Y++KSDV++ GV+L E  TG+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  114 bits (289), Expect = 6e-29
 Identities = 72/205 (35%), Positives = 103/205 (50%), Gaps = 26/205 (12%)

Query: 357 LGQGGFGPVYKGV--LSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLL 411
           LG+G FG V   V     GK  A+K L      ++   E T  E  ++ ++ H  +VKL 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 412 GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRT-----NIVNGIAKGMLYLH 465
            +    +EKL LV E+ P G L + L    K G     +R       IV  +     YLH
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALE----YLH 110

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
               L I++RDLK  N+LLD+D + K++DFG+A+  +      NT    GT  Y+APE  
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVL 165

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y K  D +S GVLL E++TG+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  114 bits (286), Expect = 1e-28
 Identities = 75/198 (37%), Positives = 109/198 (55%), Gaps = 14/198 (7%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VA+K L   S    A F  E  L+ +LQH  LV+L    V 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA-VVT 71

Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++    R   +HR
Sbjct: 72  QEPIYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLYSKK 533
           DL+A+N+L+   +  KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 534 SDVFSFGVLLIEIIT-GR 550
           SDV+SFG+LL EI+T GR
Sbjct: 184 SDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  114 bits (287), Expect = 2e-28
 Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 27/218 (12%)

Query: 349 SNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLSSCSEQGT-AEFTNEVLLILK 401
           SN  +   LG+G FG V+    KG+  +G E  V VK L    ++   +EF  E+ +  K
Sbjct: 5   SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64

Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL------FDPRKRGILCWRKRTNIVN 455
           L HKN+V+LLG C + +   ++ E+   G L   L       +  K   L  +++  +  
Sbjct: 65  LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANT--- 510
            IA GM +L   S  R VHRDL A N L+ S    K+S   +++    SE     N    
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +R      ++APE   E  +S KSDV+SFGVL+ E+ T
Sbjct: 182 LR------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  113 bits (285), Expect = 3e-28
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 10/196 (5%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
            LG+G +G VYK +    G+ VA+K +    E+   E   E+ ++ +     +VK  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
               +  +V E+   GS+  I+    K   L   +   I+    KG+ YLH     + +H
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLH---SNKKIH 122

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           RD+KA N+LL+ +  +K++DFG++    ++  + NTV  +GT  +MAPE   E  Y+ K+
Sbjct: 123 RDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV--IGTPFWMAPEVIQEIGYNNKA 180

Query: 535 DVFSFGVLLIEIITGR 550
           D++S G+  IE+  G+
Sbjct: 181 DIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  113 bits (284), Expect = 4e-28
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 21/210 (10%)

Query: 357 LGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V+           D   VAVK L   SE    +F  E  L+  LQH+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 411 LGFCVDGDEKLLVYEFMPNGSL---------DAILFDPRKR---GILCWRKRTNIVNGIA 458
            G C +G   L+V+E+M +G L         DA +    +    G L   +   I + IA
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            GM+YL   + L  VHRDL   N L+   +  KI DFGM+R    ++      R +    
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +M PE  +   ++ +SD++SFGV+L EI T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (283), Expect = 5e-28
 Identities = 71/199 (35%), Positives = 100/199 (50%), Gaps = 16/199 (8%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK----NLVKLL 411
           LG G  G V K +    GK +AVK +    E   A    ++L  L + HK     +V   
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQ-KQILRELDILHKCNSPYIVGFY 65

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
           G   +  +  +  E+M  GSLD IL     +G +  R    I   + KG+ YLHE    +
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--HK 121

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           I+HRD+K SN+L++S    K+ DFG++     S  +      VGT  YMAPE      YS
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQGNDYS 177

Query: 532 KKSDVFSFGVLLIEIITGR 550
            KSD++S G+ LIE+ TGR
Sbjct: 178 VKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  113 bits (284), Expect = 5e-28
 Identities = 79/202 (39%), Positives = 107/202 (52%), Gaps = 17/202 (8%)

Query: 357 LGQGGFGPVYK---GVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V       L D  G+ VAVK+L   + +   +F  E+ ++  LQH N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 412 GFCVD-GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C   G   L LV E++P GSL   L   R+R  L  RK     + I KGM YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---GS 126

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG---TYGYMAPEYAM 526
            R VHRDL   N+L++S+   KI DFG+ ++  + + E   VR  G    + Y APE   
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLT 184

Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
           E  +S  SDV+SFGV+L E+ T
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 1e-27
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 26/212 (12%)

Query: 356 ILGQGGFGPVYKGVLS--DGK--EVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           ILG+G FG V +G LS  DG   +VAVK  +L   +     EF +E   +    H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 410 LLGFCVDGDEK------LLVYEFMPNGSLDAILFDPRKRGI---LCWRKRTNIVNGIAKG 460
           L+G C +          +++  FM +G L + L   R  G+   L  +     +  IA G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAES---EGEANTVRIVGT 516
           M YL   S    +HRDL A N +L  DM   ++DFG+++ I++     +G    + +   
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             ++A E   + +Y+ KSDV++FGV + EI T
Sbjct: 180 -KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  111 bits (279), Expect = 1e-27
 Identities = 73/205 (35%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 357 LGQGGFGPVYKG--VLSDGK--EVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLL 411
           LG G FG V +G    S GK   VAVK L S        +F  E  ++  L H+NL++L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLHED 467
           G  +     ++V E  P GSL   L            LC     +    IA GM YL   
Sbjct: 63  GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLC-----DYAVQIANGMRYLESK 116

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV----RIVGTYGYMAPE 523
              R +HRDL A N+LL SD   KI DFG+ R  A  + E + V      V  + + APE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMR--ALPQNEDHYVMEEHLKV-PFAWCAPE 170

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
                 +S  SDV+ FGV L E+ T
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 3e-27
 Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 25/212 (11%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE-----FTNEVLLILKLQ 403
           N+    +LGQG FG VY     D G+E+AVK++    +    +        E+ L+  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 404 HKNLVKLLGFCVDGDEKLLVY-EFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-----I 457
           H+ +V+  G C+  DE L ++ E+MP GS+   L   +  G L     T  V       I
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGAL-----TETVTRKYTRQI 113

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVGT 516
            +G+ YLH +    IVHRD+K +N+L DS  N K+ DFG + R+            + GT
Sbjct: 114 LEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGT 170

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +M+PE      Y +K+DV+S G  ++E++T
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  110 bits (277), Expect = 3e-27
 Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 16/201 (7%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA-----EFTNEVLLILKLQHKNLVKL 410
           LG G FG VY+G+ L DG   AVK +S   +  T      +   E+ L+ KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           LG   + D   +  E +P GSL  +L   +K G             I  G+ YLH+    
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHDR--- 121

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGL 529
             VHRD+K +N+L+D++   K++DFGMA+   +    +      G+  +MAPE    +G 
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAK---QVVEFSFAKSFKGSPYWMAPEVIAQQGG 178

Query: 530 YSKKSDVFSFGVLLIEIITGR 550
           Y   +D++S G  ++E+ TG+
Sbjct: 179 YGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  110 bits (277), Expect = 3e-27
 Identities = 72/209 (34%), Positives = 117/209 (55%), Gaps = 20/209 (9%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAE-------FTNEVLLILKLQHK 405
           ++G G FG VY G+  S G+ +AVK+  L S S                E+ L+ +LQH+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+V+ LG  +D D   +  E++P GS+ A+L      G        N V  I KG+ YLH
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH 123

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES--EGEANTVR--IVGTYGYMA 521
             +R  I+HRD+K +N+L+D+    KISDFG+++    +    + N  R  + G+  +MA
Sbjct: 124 --NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           PE   +  Y++K+D++S G L++E++TG+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  110 bits (276), Expect = 3e-27
 Identities = 72/201 (35%), Positives = 113/201 (56%), Gaps = 19/201 (9%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   +    + F  E  ++ KL+H  LV+L  + V 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL--YAVV 70

Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRLRI 472
            +E + +V E+M  GSL   L D   R +    K  N+V+    +A GM Y+    R+  
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKDGEGRAL----KLPNLVDMAAQVAAGMAYIE---RMNY 123

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLY 530
           +HRDL+++N+L+   +  KI+DFG+AR+  ++E    T R    +   + APE A+ G +
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180

Query: 531 SKKSDVFSFGVLLIEIITGRR 551
           + KSDV+SFG+LL E++T  R
Sbjct: 181 TIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 4e-27
 Identities = 61/208 (29%), Positives = 106/208 (50%), Gaps = 25/208 (12%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT----NEVLLILKLQHKNLVK 409
             +G+G +G VYK      G+ VA+K++    E     F      E+ L+ KL+H N+V+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLY 463
           L        +    +V+E+M +  L  +L  P  +     I C+ K+      + +G+ Y
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQ------LLEGLQY 115

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           LH +    I+HRD+K SN+L+++D   K++DFG+AR + +      T R++ T  Y  PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171

Query: 524 YAM-EGLYSKKSDVFSFGVLLIEIITGR 550
             +    Y  + D++S G +L E+  G+
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  110 bits (276), Expect = 7e-27
 Identities = 69/210 (32%), Positives = 99/210 (47%), Gaps = 23/210 (10%)

Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG+G FG VYKG L           VA+K L  +   +   EF  E  L+  LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILF-------------DPRKRGILCWRKRTNIVNG 456
           LLG C       +++E++ +G L   L              D   +  L      +I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           IA GM YL   S    VHRDL A N L+   +  KISDFG++R    ++      + +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
             +M PE  + G ++ +SD++SFGV+L EI
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  109 bits (274), Expect = 7e-27
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 13/209 (6%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
                +  +LG+G +G VY    LS    +A+K +     +       E+ L   L+H+N
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--IAKGMLYL 464
           +V+ LG   +     +  E +P GSL A+L    K G L   ++T I     I +G+ YL
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYL 124

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           H+    +IVHRD+K  NVL+++     KISDFG ++  A       T    GT  YMAPE
Sbjct: 125 HD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAPE 179

Query: 524 YAMEGL--YSKKSDVFSFGVLLIEIITGR 550
              +G   Y   +D++S G  ++E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  109 bits (273), Expect = 2e-26
 Identities = 75/211 (35%), Positives = 111/211 (52%), Gaps = 22/211 (10%)

Query: 357 LGQGGFGPVYKGV---LSDGKE---VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V+      LS  K+   VAVK L   +     +F  E  L+  LQH+++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDA----------ILFD--PRK-RGILCWRKRTNIVNGI 457
            G C DGD  ++V+E+M +G L+           IL D  PR+ +G L   +  +I + I
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           A GM+YL   +    VHRDL   N L+ +++  KI DFGM+R    ++        +   
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +M PE  M   ++ +SDV+SFGV+L EI T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  108 bits (271), Expect = 2e-26
 Identities = 67/211 (31%), Positives = 116/211 (54%), Gaps = 14/211 (6%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLILKLQ 403
           S+ +   ++G G FG V++G+L   G++   VA+K L    +E+   +F +E  ++ +  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+++L G        +++ E+M NG+LD  L D    G     +   ++ GIA GM Y
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKY 122

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMA 521
           L   S +  VHRDL A N+L++S++  K+SDFG++R+  E + E       G     + A
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIRWTA 178

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
           PE      ++  SDV+SFG+++ E+++ G R
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  108 bits (270), Expect = 2e-26
 Identities = 80/221 (36%), Positives = 117/221 (52%), Gaps = 33/221 (14%)

Query: 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV 396
           + ++L+ L L         I+G+G FG V +G  + G++VAVK +  C     A F  E 
Sbjct: 1   WLLNLQKLTLGE-------IIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQA-FLEET 50

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN- 455
            ++ KL HKNLV+LLG  +  +   +V E M  G+L   L   R RG    R   +++  
Sbjct: 51  AVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFL---RTRG----RALVSVIQL 102

Query: 456 -----GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                 +A+GM YL      ++VHRDL A N+L+  D  +K+SDFG+AR    S G  N+
Sbjct: 103 LQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNS 157

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GR 550
              V    + APE      +S KSDV+S+GVLL E+ + GR
Sbjct: 158 KLPV---KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (273), Expect = 2e-26
 Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 33/227 (14%)

Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKL-Q 403
            +F    I+G+G F  V         KE A+K L       E+       E  ++ +L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           H  ++KL  +    +E L  V E+ PNG L   I    RK G L  +        I   +
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI----RKYGSLDEKCTRFYAAEILLAL 115

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF---------------AESEG 506
            YLH      I+HRDLK  N+LLD DM+ KI+DFG A++                 +S+ 
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 507 EANTVR---IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E N  R    VGT  Y++PE   E    K SD+++ G ++ +++TG+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  107 bits (268), Expect = 3e-26
 Identities = 71/198 (35%), Positives = 110/198 (55%), Gaps = 13/198 (6%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 70

Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L        L   +  ++   IA GM Y+    R+  VHR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 184 SDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  107 bits (269), Expect = 6e-26
 Identities = 74/213 (34%), Positives = 116/213 (54%), Gaps = 20/213 (9%)

Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRLSSCS-EQGTAEFTNEVLLI 399
           L  +      +LG G FG VYKG+ + +G+ V    A+K L+  +  +   EF +E L++
Sbjct: 4   LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63

Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVN 455
             + H +LV+LLG C+    +L V + MP+G L   + + +     + +L W  +     
Sbjct: 64  ASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ----- 117

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            IAKGM+YL E    R+VHRDL A NVL+ S  + KI+DFG+AR+    E E N      
Sbjct: 118 -IAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              +MA E      ++ +SDV+S+GV + E++T
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  106 bits (266), Expect = 8e-26
 Identities = 75/201 (37%), Positives = 113/201 (56%), Gaps = 19/201 (9%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +   +VA+K L   +    A F  E  ++ KL+H  LV L  + V 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPL--YAVV 70

Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRLRI 472
            +E + +V EFM  GSL     D  K G   + K   +V+    IA GM Y+    R+  
Sbjct: 71  SEEPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLY 530
           +HRDL+A+N+L+  ++  KI+DFG+AR+  ++E    T R    +   + APE A+ G +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180

Query: 531 SKKSDVFSFGVLLIEIITGRR 551
           + KSDV+SFG+LL E++T  R
Sbjct: 181 TIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 24/205 (11%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE----QGTAEFTNEVLLILKLQHKNLVKL 410
            LG+G +G VYK      G+ VA+K++   +E      TA    E+ L+ +L+H N+VKL
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHPNIVKL 63

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA----KGMLYLHE 466
           L       +  LV+E+     L   L D R   +       N++  I     +G+ Y H 
Sbjct: 64  LDVIHTERKLYLVFEYCDM-DLKKYL-DKRPGPL-----SPNLIKSIMYQLLRGLAYCH- 115

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
            S  RI+HRDLK  N+L++ D   K++DFG+AR F        T  +V T  Y APE  +
Sbjct: 116 -SH-RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILL 171

Query: 527 -EGLYSKKSDVFSFGVLLIEIITGR 550
               YS   D++S G +  E+ITG+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  106 bits (265), Expect = 2e-25
 Identities = 72/224 (32%), Positives = 105/224 (46%), Gaps = 41/224 (18%)

Query: 357 LGQGGFGPVYK----GVLSDGKE--VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           +GQG FG V++    G+L       VAVK L    S    A+F  E  L+ +  H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFD-------------------PRKRGILCWRKR 450
           LLG C  G    L++E+M  G L+  L                           L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAE-----S 504
             I   +A GM YL E    + VHRDL   N L+  +M  KI+DFG++R I++      S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E +A  +R      +M PE      Y+ +SDV+++GV+L EI +
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  105 bits (263), Expect = 2e-25
 Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 17/206 (8%)

Query: 357 LGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY    KGV+ D  E  VA+K ++ + S +   EF NE  ++ +    ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-------GILCWRKRTNIVNGIAKGML 462
           LLG    G   L++ E M  G L + L   R              +K   +   IA GM 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+ +   + VHRDL A N ++  D   KI DFGM R   E++      + +    +M+P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SDV+SFGV+L EI T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  105 bits (264), Expect = 3e-25
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 16/208 (7%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL----QHK 405
              + + LG+G  G V K  L +   +   +  +       +   ++L  L++    +  
Sbjct: 2   KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSP 59

Query: 406 NLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNGIAKGML 462
            +VK  G  +D     +    E+   GSLD+I    +KRG     K    I   + KG+ 
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YLH     +I+HRD+K SN+LL      K+ DFG++     S   A T    GT  YMAP
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSFYMAP 172

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E      YS  SDV+S G+ L+E+   R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 3e-25
 Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 13/202 (6%)

Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL 407
           F+    +G+G FG VYK +     + VA+K   L   +E    +   E+  + + +   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYI 61

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
            K  G  + G +  ++ E+   GS      D  K G L       I+  +  G+ YLHE+
Sbjct: 62  TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
                +HRD+KA+N+LL  + + K++DFG++     +  + NT   VGT  +MAPE   +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172

Query: 528 GLYSKKSDVFSFGVLLIEIITG 549
             Y +K+D++S G+  IE+  G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  105 bits (263), Expect = 3e-25
 Identities = 76/202 (37%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V    Y       G+ VAVK L   C +Q T+ +  E+ ++  L H+N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 411 LGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            G C +   K   L+ E++P GSL   L  P+ +  L   +       I +GM YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAM 526
               +HRDL A NVLLD+D   KI DFG+A+   E   E   VR  G     + A E   
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYAVECLK 183

Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
           E  +S  SDV+SFGV L E++T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  104 bits (261), Expect = 3e-25
 Identities = 71/195 (36%), Positives = 105/195 (53%), Gaps = 12/195 (6%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  ++  +VAVK L   +    A F  E  L+  LQH  LV+L      
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M  GSL D +  D   + +L   K  +    IA+GM Y+    R   +HR
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLYSKK 533
           DL+A+NVL+   +  KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 534 SDVFSFGVLLIEIIT 548
           SDV+SFG+LL EI+T
Sbjct: 185 SDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  104 bits (262), Expect = 4e-25
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
             +G+G FG V K    SDGK +  K +   + +E+   +  +EV ++ +L+H N+V+  
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 412 GFCVDGDEKLL--VYEFMPNGSLDAILFDPRK-RGIL----CWRKRTNIVNGIAKGMLYL 464
              +D   + L  V E+   G L  ++   +K R  +     WR  T ++       L L
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL-------LAL 118

Query: 465 HE-----DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           +E     D    ++HRDLK +N+ LD++ N K+ DFG+A+I       A T   VGT  Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYY 176

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           M+PE      Y +KSD++S G L+ E+    
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  103 bits (258), Expect = 6e-25
 Identities = 70/202 (34%), Positives = 103/202 (50%), Gaps = 23/202 (11%)

Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKLL 411
           +LG+G FG V+KG L D   VAVK   +C E    E    F +E  ++ +  H N+VKL+
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
           G C       +V E +P G  D + F  +K+  L  ++        A GM YL   +   
Sbjct: 59  GVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--- 113

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMAR-----IFAESEGEANTVRIVGTYGYMAPEYAM 526
            +HRDL A N L+  +   KISDFGM+R     I++ S  +   ++      + APE   
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALN 167

Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
            G YS +SDV+S+G+LL E  +
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  103 bits (258), Expect = 7e-25
 Identities = 73/198 (36%), Positives = 106/198 (53%), Gaps = 16/198 (8%)

Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFC 414
            +G+G FG V  G    G +VAVK + +     TA+ F  E  ++ +L+H NLV+LLG  
Sbjct: 13  TIGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 415 VDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
           V+    L +V E+M  GSL   L   R R +L           + + M YL  ++    V
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           HRDL A NVL+  D  +K+SDFG+ +   E+    +T ++     + APE   E  +S K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTK 179

Query: 534 SDVFSFGVLLIEIIT-GR 550
           SDV+SFG+LL EI + GR
Sbjct: 180 SDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score =  105 bits (262), Expect = 7e-25
 Identities = 67/209 (32%), Positives = 113/209 (54%), Gaps = 12/209 (5%)

Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++    VA+K L  + S +   E  +E  ++
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 63

Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L + + MP G L   + + +    +  +   N    IAK
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAK 120

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL E    R+VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  103 bits (259), Expect = 9e-25
 Identities = 71/209 (33%), Positives = 109/209 (52%), Gaps = 12/209 (5%)

Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRLSSCSEQGT-AEFTNEVLLI 399
           L  +      +LG G FG V+KG+ + +G      VA+K +   S + T  E T+ +L +
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             L H  +V+LLG C  G    LV +  P GSL  +    + R  L  ++  N    IAK
Sbjct: 64  GSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAK 120

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL E    R+VHR+L A N+LL SD   +I+DFG+A +    + +           +
Sbjct: 121 GMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  + G Y+ +SDV+S+GV + E+++
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  103 bits (259), Expect = 1e-24
 Identities = 72/203 (35%), Positives = 106/203 (52%), Gaps = 12/203 (5%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
            ++G G    VY  + L + ++VA+KR  L  C      E   EV  + +  H N+VK  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYY 65

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
              V GDE  LV  ++  GSL  I+     RG L       ++  + KG+ YLH + +  
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGTYGYMAPEYAMEGL 529
            +HRD+KA N+LL  D + KI+DFG++   A+       VR   VGT  +MAPE  ME +
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQV 181

Query: 530 --YSKKSDVFSFGVLLIEIITGR 550
             Y  K+D++SFG+  IE+ TG 
Sbjct: 182 HGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  103 bits (258), Expect = 1e-24
 Identities = 71/221 (32%), Positives = 104/221 (47%), Gaps = 31/221 (14%)

Query: 356 ILGQGGFGPVYKGVLSDGK------EVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLV 408
            LG+G FG V K      K       VAVK L   +      +  +E  L+ ++ H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-----RGILCWRKRTNIVNG------- 456
           KL G C      LL+ E+   GSL + L + RK      G    R  + + N        
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 457 ---------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I++GM YL E   +++VHRDL A NVL+      KISDFG++R   E +  
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +      +MA E   + +Y+ +SDV+SFGVLL EI+T
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  102 bits (255), Expect = 2e-24
 Identities = 69/199 (34%), Positives = 99/199 (49%), Gaps = 21/199 (10%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           LG G FG V+ G      +VA+K     + SE+   +F  E  +++KL H  LV+L G C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
                  +V EFM NG L  + +  +++G L      ++   + +GM YL  +S    +H
Sbjct: 69  TQQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123

Query: 475 RDLKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGL 529
           RDL A N L+ S    K+SDFGM R      +  S G    V+      +  PE      
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK------WSPPEVFNFSK 177

Query: 530 YSKKSDVFSFGVLLIEIIT 548
           YS KSDV+SFGVL+ E+ T
Sbjct: 178 YSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  102 bits (255), Expect = 3e-24
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 23/210 (10%)

Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V+           D   VAVK L   S+    +F  E  L+  LQH+++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 411 LGFCVDGDEKLLVYEFMPNGSL---------DAILF---DPRKRGILCWRKRTNIVNGIA 458
            G CV+GD  ++V+E+M +G L         DA+L    +      L   +  +I   IA
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQMLHIAQQIA 130

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            GM+YL   +    VHRDL   N L+  ++  KI DFGM+R    ++        +    
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +M PE  M   ++ +SDV+S GV+L EI T
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  101 bits (254), Expect = 4e-24
 Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 14/205 (6%)

Query: 356 ILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKL 410
           ++G G FG V +G L   GK    VA+K L S  +E+   +F +E  ++ +  H N++ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
            G        +++ EFM NG+LD+ L   +  G     +   ++ GIA GM YL E   +
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG---TYGYMAPEYAME 527
             VHRDL A N+L++S++  K+SDFG++R   +   +      +G      + APE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 528 GLYSKKSDVFSFGVLLIEIIT-GRR 551
             ++  SDV+S+G+++ E+++ G R
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  102 bits (257), Expect = 4e-24
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 36/229 (15%)

Query: 349 SNFSDSNI---LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKL 402
           S   D  I   LG+G FG VYK   +  G+ VA+K++   +E+     T   E+ ++ KL
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64

Query: 403 QHKNLVKLLGFCVD-----GDEKLLVYEFMP--NGSLDAILFDPRKR----GILCWRKRT 451
           +H N+V L+   V+       ++  VY   P  +  L  +L +P  +     I C+  + 
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQ- 123

Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES------- 504
                + +G+ YLHE+    I+HRD+KA+N+L+D+    KI+DFG+AR +          
Sbjct: 124 -----LLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 505 --EGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
              G      +V T  Y  PE  + E  Y+   D++  G +  E+ T R
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  101 bits (253), Expect = 5e-24
 Identities = 70/218 (32%), Positives = 113/218 (51%), Gaps = 22/218 (10%)

Query: 346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKE---VAVKRLSS-CSEQGTAEFTNEVLLIL 400
           +  S      ++G G FG V  G L   GK    VA+K L +  +E+   +F +E  ++ 
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N++ L G        ++V E+M NGSLDA L   +  G     +   ++ GIA G
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASG 118

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-- 518
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R     G  
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGK 170

Query: 519 ----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
               + APE      ++  SDV+S+G+++ E+++ G R
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score =  101 bits (254), Expect = 5e-24
 Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)

Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILF-------DPRKRGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L        +   R     ++   +   IA GM 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHRDL A N ++  D   KI DFGM R   E++      + +    +MAP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  100 bits (252), Expect = 6e-24
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS--CSEQG-TAEFTNEVLLILKLQHK 405
           +F    ++G+G FG V      D K++ A+K ++   C E+G      NE  ++ +L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 406 NLVKL-LGFCVDGDEKLLVYEFMPNGSLDAILFDPRK------RGILCWRKRTNIVNGIA 458
            LV L   F  D +   LV + +  G L   L    K      +  +C          I 
Sbjct: 61  FLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC---------EIV 110

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
             + YLH      I+HRD+K  N+LLD   +  I+DF +A        +  T    GT G
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPG 164

Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           YMAPE      YS   D +S GV   E + G+R
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 96.0 bits (239), Expect = 7e-24
 Identities = 38/106 (35%), Positives = 59/106 (55%), Gaps = 5/106 (4%)

Query: 29  YNICSTSTAGSARA--STIDDNLQNVLTSLASNA---NAAKFSNASFGNDSDRVYGLYMC 83
           +++CS++T+G+     ST + NL  +L+SL+SNA   +   F+  + G   D VYGL  C
Sbjct: 1   FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQC 60

Query: 84  LNYISAETCNDCITTASQDISKLCPNKTEAIVWEEVCQLRYAYQNF 129
              +SA  C  C+ TA  ++ + CPNK    +W + C LRY    F
Sbjct: 61  RGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  100 bits (251), Expect = 8e-24
 Identities = 67/199 (33%), Positives = 97/199 (48%), Gaps = 21/199 (10%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           LG G FG V  G      +VA+K  +  S SE    EF  E  +++KL H+ LV+L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
                  +V E+M NG L   L +  KR      +   +   + +GM YL      + +H
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIH 123

Query: 475 RDLKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGL 529
           RDL A N L+D     K+SDFG++R      +  S G    VR      +  PE  +   
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSK 177

Query: 530 YSKKSDVFSFGVLLIEIIT 548
           +S KSDV++FGVL+ E+ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  100 bits (251), Expect = 8e-24
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 31/211 (14%)

Query: 355 NILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVK 409
            ++G+G FG VY G L  SDG+++  AVK L+  ++ +   +F  E +++    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 410 LLGFCVDGD-EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-------IAKGM 461
           LLG C+  +   L+V  +M +G L   +                 V         +AKGM
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---------THNPTVKDLIGFGLQVAKGM 111

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE----GEANTVRIVGTY 517
            YL      + VHRDL A N +LD     K++DFG+AR   + E          ++    
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PV 166

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +MA E      ++ KSDV+SFGVLL E++T
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  100 bits (251), Expect = 8e-24
 Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 19/209 (9%)

Query: 350 NFSDSNILGQGGFGPVYK-GVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKN 406
           +F     LG+G +G VYK   LSD +  A+K   L S S++   +  NE+ ++  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGM 461
           ++      +DG++  +V E+ P G L   +   +K+  L      WR    I   + +G+
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
             LHE    +I+HRDLK++N+LL ++   KI D G++++    +  A T   +GT  YMA
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQ--IGTPHYMA 169

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           PE      YS KSD++S G LL E+ T  
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 67/199 (33%), Positives = 90/199 (45%), Gaps = 13/199 (6%)

Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG+GGFG V    +   GK  A K+L        +G     NE   IL+      +  L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKK-ILEKVSSRFIVSLA 59

Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
           +  +  + L LV   M  G L   +++  + G    R        I  G+ +LH   + R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLH---QRR 115

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           IV+RDLK  NVLLD   N +ISD G+A    E +G        GT GYMAPE     +Y 
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 532 KKSDVFSFGVLLIEIITGR 550
              D F+ G  L E+I GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 1e-23
 Identities = 57/200 (28%), Positives = 110/200 (55%), Gaps = 15/200 (7%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQH---KNLVKL 410
           ++G+G +G VY+G  +  G+ VA+K ++    +   ++   EV L+ +L+     N+ K 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
            G  + G    ++ E+   GS+  ++    K G +  +  + I+  +   + Y+H+    
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-L 529
            ++HRD+KA+N+L+ +  N K+ DFG+A +  ++  + +T   VGT  +MAPE   EG  
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKY 178

Query: 530 YSKKSDVFSFGVLLIEIITG 549
           Y  K+D++S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =   99 bits (249), Expect = 2e-23
 Identities = 68/203 (33%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           + LG G +G VY+GV       VAVK L         EF  E  ++ +++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGIAKGMLYLHED 467
           C       ++ EFM  G+L   L +       C R+  N V        I+  M YL + 
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQISSAMEYLEKK 123

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYA 525
           +    +HRDL A N L+  +   K++DFG++R+     G+  T      +   + APE  
Sbjct: 124 N---FIHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESL 177

Query: 526 MEGLYSKKSDVFSFGVLLIEIIT 548
               +S KSDV++FGVLL EI T
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  101 bits (252), Expect = 3e-23
 Identities = 70/220 (31%), Positives = 106/220 (48%), Gaps = 34/220 (15%)

Query: 347 ATSNFSD---SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA-EFTNEVLLILK 401
           A  + S+    N +G G  G VYK +    G+  A+K +    E     +   E+ ++  
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128

Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT------NIVN 455
           + H N+VK         E  ++ EFM  GSL+         G     ++        I++
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVARQILS 179

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
           GIA    YLH   R  IVHRD+K SN+L++S  N KI+DFG++RI A++    N+   VG
Sbjct: 180 GIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VG 230

Query: 516 TYGYMAPEYA----MEGLYSKKS-DVFSFGVLLIEIITGR 550
           T  YM+PE        G Y   + D++S GV ++E   GR
Sbjct: 231 TIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 98.7 bits (246), Expect = 5e-23
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 19/209 (9%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK----------RLSSCSEQGTAEFTNEVLLILKLQH 404
           ++G+G +G VY  + ++ G+ +AVK          R  S  +       +E+  +  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
            N+V+ LGF    +   +  E++P GS+ + L   R  G    +        + +G+ YL
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE- 523
           H      I+HRDLKA N+L+D+D   KISDFG+++   +       + + G+  +MAPE 
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 524 -YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
            ++    YS K D++S G +++E+  GRR
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 98.5 bits (245), Expect = 6e-23
 Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 24/208 (11%)

Query: 356 ILGQGGFGPVYKGVLS-DGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           ILG G FG + +G L    K    VA+  L + CS++    F  E L + +  H N+V+L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
            G    G+  ++V E+M NG+LD+ L   +  G L   +   ++ G+A GM YL E   +
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFG------MARIFAESEGEANTVRIVGTYGYMAPEY 524
             VH+ L A  VL++SD+  KIS F          I+    G++  +       + APE 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-------WAAPEA 179

Query: 525 AMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
                +S  SDV+SFG+++ E+++ G R
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 33/209 (15%)

Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRLSSCS-EQGTAEFT-NEVLLILKLQHKNLVKLLGF 413
           +G+G  G V+K      G+ VA+K+++    E G       E+  +   QH  +VKLL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGMLYLHE 466
              G   +LV E+MP   L  +L D  +       +  +       ++ G+A    Y+H 
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYM-----RMLLKGVA----YMHA 117

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
                I+HRDLK +N+L+ +D   KI+DFG+AR+F+E E    + + V T  Y APE   
Sbjct: 118 ---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL-- 171

Query: 527 EGLYSKKS-----DVFSFGVLLIEIITGR 550
             LY  +      D+++ G +  E++ G 
Sbjct: 172 --LYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 98.2 bits (244), Expect = 8e-23
 Identities = 70/201 (34%), Positives = 112/201 (55%), Gaps = 16/201 (7%)

Query: 356 ILGQGGFGPVYKGV-LSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           +LG G FG VYKG+ + DG+     VA+K L  + S +   E  +E  ++  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           LLG C+    +L V + MP G L   + + + R  +  +   N    IAKGM YL E   
Sbjct: 74  LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE--- 127

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIF--AESEGEANTVRIVGTYGYMAPEYAME 527
           +R+VHRDL A NVL+ S  + KI+DFG+AR+    E+E  A+  ++     +MA E  + 
Sbjct: 128 VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALESILH 185

Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             ++ +SDV+S+GV + E++T
Sbjct: 186 RRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 28/216 (12%)

Query: 356 ILGQGGFGPVYKGVLSD------GKEVAVKRL-SSCSEQGTAEFTNEVLLILKL--QHKN 406
            LG+G FG V K              VAVK L    +E+  ++  +E + ++K+  +HKN
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE-MEMMKMIGKHKN 77

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
           ++ LLG C       +V E+  +G+L   L   R  G                       
Sbjct: 78  IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA-SPDDPRPPEETLTQKDLVS 136

Query: 457 ----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
               +A+GM +L   S+ + +HRDL A NVL+  D   KI+DFG+AR     +    T  
Sbjct: 137 FAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                 +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 354 SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHKNLVKL 410
            N +G G FG VY  V L  G+ +AVK +           E  +E+ ++  L+H NLVK 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
            G  V  ++  +  E+   G+L+ +L   R       R  T     + +G+ YLH     
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL---QLLEGLAYLHSH--- 118

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAES-----EGEANTVRIVGTYGYMAPEYA 525
            IVHRD+K +N+ LD +   K+ DFG A     +     E   +     GT  YMAPE  
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL---AGTPAYMAPEVI 175

Query: 526 MEGLYSKK---SDVFSFGVLLIEIITGRR 551
             G        +D++S G +++E+ TG+R
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 20/213 (9%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC----SEQGTA--EFTNEVLLILKL 402
            +     LG G F   Y+   +  G  +AVK+++      SEQ         E+ L+ +L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRTNIVNGIAKG 460
            H +++++LG   +     L  E+M  GS+  +L  +   K  ++      N    + +G
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVR--IVGTY 517
           + YLHE+   +I+HRD+K +N+L+DS     +I+DFG A   A     A   +  ++GT 
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            +MAPE      Y +  DV+S G ++IE+ T +
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 97.3 bits (242), Expect = 3e-22
 Identities = 71/215 (33%), Positives = 110/215 (51%), Gaps = 26/215 (12%)

Query: 357 LGQGGFGPVYK----GVLSDGKE----VAVKRLS-SCSEQGTAEFTNEV-LLILKLQHKN 406
           LG+G FG V +    G+     +    VAVK L  + +++  A+  +E+ L+ L  +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-----------FDPRK--RGILCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L           FD  K     L ++   + 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL  +SR R +HRDL A NVL+  D   KI+DFG+AR   + +    T   
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFG+L+ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 96.9 bits (241), Expect = 3e-22
 Identities = 75/203 (36%), Positives = 112/203 (55%), Gaps = 18/203 (8%)

Query: 357 LGQGGFGPVY------KGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVK 409
           LG+G FG V       +G  + G++VAVK L   S     A+   E+ ++  L H+N+VK
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 410 LLGFCV-DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
             G C  DG   + L+ EF+P+GSL   L  PR +  +  +++      I KGM YL   
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--G 126

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGTYGYMAPEYA 525
           SR + VHRDL A NVL++S+   KI DFG+ +   E++ E  TV+  +     + APE  
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 526 MEGLYSKKSDVFSFGVLLIEIIT 548
           ++  +   SDV+SFGV L E++T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 96.9 bits (241), Expect = 3e-22
 Identities = 60/196 (30%), Positives = 107/196 (54%), Gaps = 14/196 (7%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLVKLLGFC 414
           +GQG  G VY  + ++ G+EVA+K+++   +Q   E   NE+L++ + +H N+V  L   
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 415 VDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
           + GDE  +V E++  GSL D +       G +       +     + + +LH +   +++
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQI-----AAVCRECLQALEFLHSN---QVI 137

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           HRD+K+ N+LL  D + K++DFG        + + +T  +VGT  +MAPE      Y  K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195

Query: 534 SDVFSFGVLLIEIITG 549
            D++S G++ IE++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 16/207 (7%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQ 403
             NF     +G+G F  VYK + L DG+ VA+K++        +   +   E+ L+ +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCWRKRT--NIVNGIAK 459
           H N++K L   ++ +E  +V E    G L  ++  F  +KR I    +RT       +  
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLI---PERTIWKYFVQLCS 117

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
            + ++H     RI+HRD+K +NV + +    K+ D G+ R F+     A++  +VGT  Y
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEI 546
           M+PE   E  Y+ KSD++S G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
           S   +   +G+G  G V      S G++VAVK++    +Q      NEV+++   QH N+
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--KRGILCWRKRTNIVNGIAKGMLYLH 465
           V++    + GDE  +V EF+  G+L  I+   R  +  I        +   + K + +LH
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLAVLKALSFLH 132

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEY 524
                 ++HRD+K+ ++LL SD   K+SDFG  A++   S+       +VGT  +MAPE 
Sbjct: 133 AQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPEV 186

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
                Y  + D++S G+++IE++ G
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 95.5 bits (237), Expect = 4e-22
 Identities = 71/198 (35%), Positives = 108/198 (54%), Gaps = 14/198 (7%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+    +   +VAVK +   S    A F  E  ++  LQH  LVKL    V 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 71

Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ EFM  GSL D +  D   +  L   K  +    IA+GM ++ + +    +HR
Sbjct: 72  KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHR 126

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLYSKK 533
           DL+A+N+L+ + +  KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 534 SDVFSFGVLLIEIIT-GR 550
           SDV+SFG+LL+EI+T GR
Sbjct: 184 SDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 95.9 bits (238), Expect = 6e-22
 Identities = 67/197 (34%), Positives = 110/197 (55%), Gaps = 15/197 (7%)

Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG-FC 414
           LG G FG VYK    + G   A K + + SE+   ++  E+ ++    H  +VKLLG F 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            DG   +++ EF P G++DAI+ +   RG+   + +  I   + + + YLH    ++I+H
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGL 529
           RDLKA NVLL  D + K++DFG++    ++    ++   +GT  +MAPE  M     +  
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTP 191

Query: 530 YSKKSDVFSFGVLLIEI 546
           Y  K+D++S G+ LIE+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 95.6 bits (238), Expect = 6e-22
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 14/198 (7%)

Query: 356 ILGQGGFGPVYKGVLSDGK----EVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKL 410
            +G+G FG VY+GV    +     VAVK   +C+     E F  E  ++ +  H ++VKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           +G   + +   +V E  P G L + L     +  L           ++  + YL      
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPEYAMEGL 529
           R VHRD+ A NVL+ S    K+ DFG++R   +    +A+  ++     +MAPE      
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184

Query: 530 YSKKSDVFSFGVLLIEII 547
           ++  SDV+ FGV + EI+
Sbjct: 185 FTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 95.7 bits (239), Expect = 7e-22
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 25/206 (12%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN-----EVLLILKLQHKNLVKL 410
           LG+G +  VYK      G+ VA+K++     +   +  N     E+ L+ +L+H N++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLHE 466
           L          LV+EFM    L+ ++ D         I  +   T       +G+ YLH 
Sbjct: 68  LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLEYLH- 119

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
                I+HRDLK +N+L+ SD   K++DFG+AR F  S     T ++V T  Y APE   
Sbjct: 120 --SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYRAPELLF 175

Query: 527 EG--LYSKKSDVFSFGVLLIEIITGR 550
            G   Y    D++S G +  E++   
Sbjct: 176 -GARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 95.1 bits (236), Expect = 8e-22
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 11/201 (5%)

Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLV 408
           F+    +G+G FG VYKG+ +  KEV   ++     +E    +   E+ ++ +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +  G  + G +  ++ E++  GS      D  K G L       I+  I KG+ YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
             R +HRD+KA+NVLL    + K++DFG+A    +++ + NT   VGT  +MAPE   + 
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y  K+D++S G+  IE+  G
Sbjct: 177 AYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 19/207 (9%)

Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC-SEQGTAEFT-NEVLLILKLQ---H 404
           + +   +G+G +G VYK   L+ G+ VA+K++    SE+G    T  E+ L+ +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 405 KNLVKLLGFC--VDGDEKL---LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
            N+V+LL  C     D +L   LV+E + +  L   L    K G+     + +++  + +
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           G+ +LH     RIVHRDLK  N+L+ SD   KI+DFG+ARI++    E     +V T  Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF---EMALTSVVVTLWY 172

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEI 546
            APE  ++  Y+   D++S G +  E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 94.4 bits (234), Expect = 2e-21
 Identities = 69/210 (32%), Positives = 106/210 (50%), Gaps = 15/210 (7%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRL-----SSCSEQGTAEFTNEVLLILKLQ 403
           N+    +LGQG FG VY     D G+E+A K++     S  + +  +    E+ L+  LQ
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 404 HKNLVKLLGFCVDGDEKLLV--YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           H+ +V+  G   D  EK L    E+MP GS+   L   +  G L           I +GM
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGM 119

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYM 520
            YLH +    IVHRD+K +N+L DS  N K+ DFG ++           +R + GT  +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           +PE      Y +K+DV+S G  ++E++T +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 15/211 (7%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRL-----SSCSEQGTAEFTNEVLLILKL 402
           +N+    +LGQG FG VY    +D G+E+AVK++     S  + +       E+ L+  L
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61

Query: 403 QHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
            H+ +V+  G   D  E+ L    E MP GS+   L   +  G L           I +G
Sbjct: 62  LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEG 118

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVGTYGY 519
           + YLH +    IVHRD+K +N+L DS  N K+ DFG + R+            + GT  +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           M+PE      Y +K+D++S G  ++E++T +
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL-GFC 414
           LG G FG VYK      G   A K +   SE+   +F  E+ ++ + +H N+V L   + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            +    +L+ EF   G+LD+I+    +RG+   + R  +   + + + +LH     +++H
Sbjct: 73  YENKLWILI-EFCDGGALDSIM-LELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGL 529
           RDLKA N+LL  D + K++DFG++     +  + +T   +GT  +MAPE        +  
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184

Query: 530 YSKKSDVFSFGVLLIEIITGR 550
           Y  K+D++S G+ LIE+    
Sbjct: 185 YDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 63/199 (31%), Positives = 101/199 (50%), Gaps = 14/199 (7%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLGF 413
           +G+G +G VYK      G+ VA+K++    E      T   E+ L+ +L H N++KLL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
                +  LV+EFM       I    R+RG L      + +  + +G+ + H      I+
Sbjct: 67  FRHKGDLYLVFEFMDTDLYKLI--KDRQRG-LPESLIKSYLYQLLQGLAFCH---SHGIL 120

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE--YAMEGLYS 531
           HRDLK  N+L++++   K++DFG+AR F  S     T  +V T  Y APE     +G YS
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVV-TRWYRAPELLLGDKG-YS 177

Query: 532 KKSDVFSFGVLLIEIITGR 550
              D++S G +  E+++ R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 357 LGQGGFGPVY---KGVLSDGKEVAVKRLSSCSEQGTAEFTN---EVLLILKLQHKNLVKL 410
           + +G +G V+   K   S G   A+K +         +      E  ++ + Q   +VKL
Sbjct: 1   ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
             +   G + L LV E++P G L ++L      G L        +  I   + YLH    
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLH---S 111

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFG------MARIFAESEGEANTVRIVGTYGYMAPE 523
             I+HRDLK  N+L+DS+ + K++DFG      + R    ++ E    RIVGT  Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITG 549
             +   +SK  D +S G +L E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 27/213 (12%)

Query: 354 SNILGQGGFGPVYKGVLSDGK-----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNL 407
           S++L +G FG ++ G+L D K     EV VK +    SE        E  L+  L H+N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 408 VKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGI-----LCWRKRTNIVNGIAKGM 461
           + +L  C+ DG+   ++Y +M  G+L   L   R         L  ++  ++   IA GM
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAES-----EGEANTVRIVG 515
            YLH   +  ++H+D+ A N ++D ++  KI+D  ++R +F        + E   V+   
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK--- 184

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              +MA E  +   YS  SDV+SFGVLL E++T
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 30/217 (13%)

Query: 356 ILGQGGFGPVYKGVL----SDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           +LG+G FG   +  L     D   V  K   L+  SE+   +  NE++++  LQH N++ 
Sbjct: 7   VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63

Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
                +D +  L+  E+   G+L          LF+        ++    IV+ ++    
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ----IVSAVS---- 115

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y+H+     I+HRD+K  N+ L      K+ DFG+++I       A TV  VGT  YM+P
Sbjct: 116 YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV--VGTPYYMSP 170

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRN-AGSNQL 558
           E      Y+ KSD+++ G +L E++T +R    +N L
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 50/131 (38%), Positives = 72/131 (54%), Gaps = 19/131 (14%)

Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
           EFM  GSLD I    +K G +       I   + +G+ YL+     RI+HRD+K SN+L+
Sbjct: 83  EFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILV 137

Query: 485 DSDMNSKISDFGMARIFAESEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSF 539
           +S    K+ DFG++       GE     A+T   VGT  YM+PE    G Y+ KSDV+S 
Sbjct: 138 NSRGQIKLCDFGVS-------GELINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWSL 188

Query: 540 GVLLIEIITGR 550
           G+ +IE+  G+
Sbjct: 189 GISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 93.3 bits (231), Expect = 6e-21
 Identities = 58/198 (29%), Positives = 107/198 (54%), Gaps = 18/198 (9%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +GQG  G V+  + ++ G+EVA+K+++   +       NE+L++ +L++ N+V  L   +
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            GDE  +V E++  GSL  ++     D  +   +C            + + +LH +   +
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVC--------RECLQALEFLHAN---Q 135

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           ++HRD+K+ NVLL  D + K++DFG        + + +T  +VGT  +MAPE      Y 
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 193

Query: 532 KKSDVFSFGVLLIEIITG 549
            K D++S G++ IE++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 93.1 bits (231), Expect = 6e-21
 Identities = 68/219 (31%), Positives = 103/219 (47%), Gaps = 32/219 (14%)

Query: 357 LGQGGFGPVY----KGVLS---------DGKE--VAVKRL-SSCSEQGTAEFTNEVLLIL 400
           LG+G FG V+    +G+           DG+   VAVK L +  ++    +F  E+ ++ 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI------- 453
           +L++ N+++LLG CV  D   ++ E+M NG L+  L               NI       
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT--HANNIPSVSIAN 130

Query: 454 ----VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
                  IA GM YL   + L  VHRDL   N L+ +    KI+DFGM+R     +    
Sbjct: 131 LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             R V    +MA E  + G ++  SDV++FGV L E+ T
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 92.8 bits (231), Expect = 7e-21
 Identities = 63/187 (33%), Positives = 90/187 (48%), Gaps = 22/187 (11%)

Query: 376 VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA 434
           VAVK L    S+    +F  EV ++ +L   N+ +LLG C       ++ E+M NG L+ 
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 435 IL--FDPRKRGILCWRK---RTNIVN---GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
            L        G+ C  K    + ++     IA GM YL     L  VHRDL   N L+  
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165

Query: 487 DMNSKISDFGMARIFAES-----EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGV 541
           +   KI+DFGM+R    S     +G     R      +MA E  + G ++ KSDV++FGV
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQG-----RAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220

Query: 542 LLIEIIT 548
            L EI+T
Sbjct: 221 TLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 92.5 bits (229), Expect = 1e-20
 Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 18/198 (9%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +GQG  G VY  + ++ G+EVA+K+++   +       NE+L++ + ++ N+V  L   +
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            GDE  +V E++  GSL  ++     D  +   +C            + + +LH +   +
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALDFLHSN---Q 135

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           ++HRD+K+ N+LL  D + K++DFG        + + +T  +VGT  +MAPE      Y 
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 193

Query: 532 KKSDVFSFGVLLIEIITG 549
            K D++S G++ IE++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 26/211 (12%)

Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF 413
           ++G+G +G VYK      G+ VA+K +    ++   E   E  ++ K   H N+    G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGA 71

Query: 414 ------CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----IVNGIAKGMLY 463
                   + D+  LV E    GS+  ++   RK+G    R +      I+    +G+ Y
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG---KRLKEEWIAYILRETLRGLAY 128

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           LHE+   +++HRD+K  N+LL  +   K+ DFG++     + G  NT   +GT  +MAPE
Sbjct: 129 LHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGTPYWMAPE 183

Query: 524 -----YAMEGLYSKKSDVFSFGVLLIEIITG 549
                   +  Y  +SDV+S G+  IE+  G
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 69/208 (33%), Positives = 106/208 (50%), Gaps = 15/208 (7%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLS-SCSEQGTAEFTN----EVLLILKLQ 403
           N+    +LG+G FG VY    +D G+E+AVK++      Q T++  N    E+ L+  L+
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 404 HKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           H  +V+  G   D +EK L    E+MP GS+   L   +  G L           I +G+
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGV 119

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVGTYGYM 520
            YLH +    IVHRD+K +N+L DS  N K+ DFG + RI            + GT  +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176

Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +PE      Y +K+DV+S    ++E++T
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 73/217 (33%), Positives = 114/217 (52%), Gaps = 34/217 (15%)

Query: 355 NILGQGGFGPVYKGVLS-DGKEV--AVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVK 409
           +++G+G FG V + ++  DG ++  A+K L    SE    +F  E+ ++ KL  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP---RKRGI---LCWRKRTNIVNG 456
           LLG C +     +  E+ P G+L   L        DP   ++ G    L  ++     + 
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +A GM YL E    + +HRDL A NVL+  ++ SKI+DFG++R      GE   V +  T
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR------GE--EVYVKKT 176

Query: 517 YG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            G     +MA E     +Y+ KSDV+SFGVLL EI++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 59/199 (29%), Positives = 108/199 (54%), Gaps = 20/199 (10%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +GQG  G VY  + ++ G+EVA+++++   +       NE+L++ + ++ N+V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            GDE  +V E++  GSL  ++     D  +   +C            + + +LH +   +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 136

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           ++HRD+K+ N+LL  D + K++DFG  A+I  E   ++    +VGT  +MAPE      Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 531 SKKSDVFSFGVLLIEIITG 549
             K D++S G++ IE+I G
Sbjct: 194 GPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 74/211 (35%), Positives = 103/211 (48%), Gaps = 20/211 (9%)

Query: 350 NFSDSNILGQGGFGPVYKGV---LSDGK---EVAVKRLSSCSEQGTAE-FTNEVLLILKL 402
           N S    LG G FG V +     LS      +VAVK L   +     E   +E+ ++  L
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95

Query: 403 -QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNGIAKG 460
             H+N+V LLG C  G   L++ E+   G  D + F  RKR   L      +    +AKG
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYG--DLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE--GEANTVRIVGTY 517
           M +L   +    +HRDL A NVLL      KI DFG+AR I  +S    + N    V   
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-- 208

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +MAPE     +Y+ +SDV+S+G+LL EI +
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 69/198 (34%), Positives = 94/198 (47%), Gaps = 21/198 (10%)

Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE----QGTAEFTNEVLLILKLQHKNLVKLL 411
           +G+G FG V+ G L +D   VAVK   SC E       A+F  E  ++ +  H N+V+L+
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
           G C       +V E +  G     L     R  L  ++   +V   A GM YL       
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH--- 114

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAE----SEGEANTVRIVGTYGYMAPEYAME 527
            +HRDL A N L+      KISDFGM+R   +    S G    + +  T    APE    
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT----APEALNY 170

Query: 528 GLYSKKSDVFSFGVLLIE 545
           G YS +SDV+SFG+LL E
Sbjct: 171 GRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 61/195 (31%), Positives = 103/195 (52%), Gaps = 12/195 (6%)

Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G  G V    V S GK VAVK++    +Q      NEV+++   QH+N+V++    +
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            GDE  +V EF+  G+L  I+   R    +   +   +   + K +  LH      ++HR
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQG---VIHR 140

Query: 476 DLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           D+K+ ++LL  D   K+SDFG  A++  E     +   +VGT  +MAPE      Y  + 
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS---LVGTPYWMAPELISRLPYGPEV 197

Query: 535 DVFSFGVLLIEIITG 549
           D++S G+++IE++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 34/217 (15%)

Query: 355 NILGQGGFGPVYKGVLS-DGKEV--AVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVK 409
           +++G+G FG V K  +  DG  +  A+KR+    S+    +F  E+ ++ KL  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP---RKRGI---LCWRKRTNIVNG 456
           LLG C       L  E+ P+G+L   L        DP           L  ++  +    
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +A+GM YL +    + +HRDL A N+L+  +  +KI+DFG++R      G+   V +  T
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR------GQ--EVYVKKT 169

Query: 517 YG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            G     +MA E     +Y+  SDV+S+GVLL EI++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 56/178 (31%), Positives = 96/178 (53%), Gaps = 11/178 (6%)

Query: 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
           GK+VAVK++    +Q      NEV+++    H+N+V +    + GDE  +V EF+  G+L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
             I+   R    +   +   +   + + + YLH      ++HRD+K+ ++LL SD   K+
Sbjct: 107 TDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159

Query: 493 SDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           SDFG  A++  E     +   +VGT  +MAPE      Y  + D++S G+++IE+I G
Sbjct: 160 SDFGFCAQVSKEVPKRKS---LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 84.8 bits (210), Expect = 6e-20
 Identities = 32/90 (35%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 153 YRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNA 212
           + S +N  LS L +  +A    + +A         DT Y L QC  DL A DC +CL  A
Sbjct: 19  FESNLNALLSSLSSN-AASSSGKGFAAGTSG-AAPDTVYGLAQCRGDLSASDCRSCLATA 76

Query: 213 TADILSCCYFSRGARLLSRNCYLRYELYAF 242
            +++  CC   +G R+   +C+LRYE Y F
Sbjct: 77  VSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 89.3 bits (221), Expect = 9e-20
 Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 35/230 (15%)

Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQG-TAEFTNEV 396
           +NL+T  F +   LG+  FG VYKG L         + VA+K L   +E     EF +E 
Sbjct: 2   INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF-------------DPRKRG 443
           ++  +LQH N+V LLG         +++ +  +  L   L              D   + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFA 502
            L      +IV  IA GM +L   S   +VH+DL   NVL+   +N KISD G+ R ++A
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 503 ESEGEANTVRIVGT----YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                A+  +++G       +M+PE  M G +S  SD++S+GV+L E+ +
Sbjct: 177 -----ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 90.1 bits (223), Expect = 9e-20
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 32/218 (14%)

Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   V+++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 26  LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
           HKN++ LLG C       ++ E+   G+L   L   R  G+             L ++  
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 18/207 (8%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
           +NF     +G+G F  VY+   L D K VA+K++        +   +   E+ L+ +L H
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGI---LCWRKRTNIVNGIAK 459
            N++K L   ++ +E  +V E    G L  ++  F  +KR I     W+    + + +  
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE- 120

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
                H  SR R++HRD+K +NV + +    K+ D G+ R F+     A++  +VGT  Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEI 546
           M+PE   E  Y+ KSD++S G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 17/206 (8%)

Query: 357 LGQGGFGPVYKGVLSDGK---EVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V +G L+      +VAVK  +++ C+     +F +E + + +  H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 412 GFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGML 462
           G C+   E       +++  FM +G L + L   R       L  +     +  IA GM 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL   S    +HRDL A N +L+ +MN  ++DFG+++     +             ++A 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   + +Y+ KSDV+SFGV + EI T
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 17/201 (8%)

Query: 357 LGQGGFGPV------YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+GGFG V        G +   K++  KRL   S +  A    E   IL+  +   +  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE---ILEKVNSPFIVN 57

Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L +  +    L LV   M  G L   +++  +RG+   R   +    I  G+L+LH    
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV-IHYSAQITCGILHLHS--- 113

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
           + IV+RD+K  NVLLD   N ++SD G+A    E +      +  GT GYMAPE   E  
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILKEEP 170

Query: 530 YSKKSDVFSFGVLLIEIITGR 550
           YS   D F+ G  + E++ GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 54/178 (30%), Positives = 96/178 (53%), Gaps = 11/178 (6%)

Query: 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
           G++VAVK +    +Q      NEV+++   QH+N+V++    + G+E  ++ EF+  G+L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
             I+   R    L   +   +   + + + YLH      ++HRD+K+ ++LL  D   K+
Sbjct: 106 TDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158

Query: 493 SDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           SDFG  A+I   S+       +VGT  +MAPE      Y  + D++S G+++IE++ G
Sbjct: 159 SDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 26/221 (11%)

Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHK 405
            +     +G+G FG +Y  K   SD +   +K   L+    +       EV+L+ K++H 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIA 458
           N+V       +     +V E+   G L         +LF   +  IL W  +      I+
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQ------IS 111

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGTY 517
            G+ ++H+    +I+HRD+K+ N+ L  + M +K+ DFG+AR   +S   A T   VGT 
Sbjct: 112 LGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTP 166

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL 558
            Y++PE      Y+ K+D++S G +L E+ T +     N L
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 11/193 (5%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G G +G VYK   ++ G+ VA+K +             E+ ++ + +H N+V   G  +
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
             D+  +V E+   GSL  I      RG L   +   +     KG+ YLHE      +HR
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHR 125

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA---MEGLYSK 532
           D+K +N+LL  D + K++DFG++     +  +  +   +GT  +MAPE A    +G Y  
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDG 183

Query: 533 KSDVFSFGVLLIE 545
           K D+++ G+  IE
Sbjct: 184 KCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 17/209 (8%)

Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQ 403
            +    ++G+G FG V+  +   +D K V +K++    EQ T +      NE  ++  L 
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPV--EQMTKDERLAAQNECQVLKLLS 57

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+++     ++    ++V E+ P G+L A     R   +L       I++   + +L 
Sbjct: 58  HPNIIEYYENFLEDKALMIVMEYAPGGTL-AEYIQKRCNSLL---DEDTILHFFVQILLA 113

Query: 464 LHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           LH      I+HRDLK  N+LLD   M  KI DFG+++I + S+ +A TV  VGT  Y++P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTV--VGTPCYISP 170

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           E      Y++KSD+++ G +L E+ + +R
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 19/198 (9%)

Query: 357 LGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHKNLVKLL 411
           LG G FG V KG+       K VAVK L + +       E   E  ++ +L +  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
           G C + +  +LV E    G L+  L   +K   +  +  T +V+ ++ GM YL E +   
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN--- 115

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-- 529
            VHRDL A NVLL +   +KISDFG+++     E   N  +      +    YA E +  
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMNY 172

Query: 530 --YSKKSDVFSFGVLLIE 545
             +S KSDV+SFGVL+ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 11/201 (5%)

Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
           F+    +G+G FG V+KG+ +  ++V A+K +    +E    +   E+ ++ +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           K  G  + G +  ++ E++  GS      D  + G     +   ++  I KG+ YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           +   +HRD+KA+NVLL    + K++DFG+A    +++ + NT   VGT  +MAPE   + 
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176

Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y  K+D++S G+  IE+  G
Sbjct: 177 AYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 29/218 (13%)

Query: 357 LGQGGFGPVY------------KGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLL 398
           LG+G FG V+            K    D        VAVK L    ++    +F  E+ +
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-- 456
           + +L+  N+++LL  C+  D   ++ E+M NG L+  L     +          I     
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 457 ------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                 IA GM YL   S L  VHRDL   N L+  +   KI+DFGM+R     +     
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            R V    +M+ E  + G ++  SDV++FGV L EI+T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 68/226 (30%), Positives = 111/226 (49%), Gaps = 34/226 (15%)

Query: 346 LATSNFSDSNILGQGGFGPVYKG-VLSDG--KEVAVKRLSS-CSEQGTAEFTNEVLLILK 401
           L  ++    +++G+G FG V K  +  DG   + A+KR+    S+    +F  E+ ++ K
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63

Query: 402 L-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDP------RKRGILCW 447
           L  H N++ LLG C       L  E+ P+G+L   L        DP           L  
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
           ++  +    +A+GM YL   S+ + +HRDL A N+L+  +  +KI+DFG++R        
Sbjct: 124 QQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------- 172

Query: 508 ANTVRIVGTYG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              V +  T G     +MA E     +Y+  SDV+S+GVLL EI++
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 36/215 (16%)

Query: 358 GQGGFGPVYKGVL---SDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQHKNLVKLL 411
           G+G +G VYK       DGKE A+K+     EQ T        E+ L+ +L+H+N+V L+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 412 GFCVDGDEKL--LVYEFMPNGSLDAILFDPRKRGI---------LCWRKRTNIVNGIAKG 460
              ++  +K   L++++  +     I F  + + +         L W+    I+NG+   
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----ILNGVH-- 122

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIF-AESEGEANTVRIVG 515
             YLH +    ++HRDLK +N+L+  +       KI D G+AR+F A  +  A+   +V 
Sbjct: 123 --YLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 516 TYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIIT 548
           T  Y APE  + G   Y+K  D+++ G +  E++T
Sbjct: 178 TIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 5e-19
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 42/213 (19%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--------EVLLILKLQ-HKN 406
           LG G FG VY       G+ VA+K++         +F +        EV  + KL  H N
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRK-RGILCWRKRTNIVNGIA 458
           +VKL     + DE   V+E+M  G+L           F     R         +I+  I 
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR---------SIIYQIL 109

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           +G+ ++H   +    HRDLK  N+L+      KI+DFG+AR   E          V T  
Sbjct: 110 QGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRW 163

Query: 519 YMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
           Y APE  +    YS   D+++ G ++ E+ T R
Sbjct: 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 87.1 bits (216), Expect = 7e-19
 Identities = 58/166 (34%), Positives = 93/166 (56%), Gaps = 23/166 (13%)

Query: 394 NEVLLILKLQHK----NLVKLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
           N+++  LK+ H+     +V   G F  DG+  + + E M  GSLD +L   +K G    R
Sbjct: 44  NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAG----R 95

Query: 449 KRTNIVNGIA----KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
              NI+  I+    +G+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S
Sbjct: 96  IPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153

Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
              AN+   VGT  YM+PE      Y+ +SD++S G+ L+E+  GR
Sbjct: 154 M--ANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 357 LGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKL 410
           LG+  FG +YKG L        + VA+K L   +  Q   EF  E  L+ +L H N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILF--------------DPRKRGILCWRKRTNIVNG 456
           LG         +++E++  G L   L               D   +  L      +I   
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           IA GM YL   S    VH+DL A N+L+   ++ KISD G++R    ++      + +  
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +M PE  M G +S  SD++SFGV+L EI +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.8 bits (215), Expect = 7e-19
 Identities = 67/205 (32%), Positives = 110/205 (53%), Gaps = 11/205 (5%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNL 407
           NF     LG+G +  VYKG   + G+ VA+K +   +E+GT +    E+ L+ +L+H+N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           V+L       ++ +LV+E+M +  L   +     RG L      +    + KG+ + HE+
Sbjct: 61  VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-VGTYGYMAPEYAM 526
              R++HRDLK  N+L++     K++DFG+AR F       NT    V T  Y AP+  +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---VNTFSNEVVTLWYRAPDVLL 173

Query: 527 EG-LYSKKSDVFSFGVLLIEIITGR 550
               YS   D++S G ++ E+ITGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 86.8 bits (216), Expect = 8e-19
 Identities = 69/208 (33%), Positives = 94/208 (45%), Gaps = 37/208 (17%)

Query: 357 LGQGGFGPV----YKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILK-LQHKNLVK 409
           LG G FG V    +KG    GK  A+K LS     +    E       IL+ ++H  LV 
Sbjct: 9   LGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--------GM 461
           L G   D     LV E++P G L + L           RK       +A+         +
Sbjct: 66  LYGSFQDDSNLYLVMEYVPGGELFSHL-----------RKSGRFPEPVARFYAAQVVLAL 114

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            YLH    L IV+RDLK  N+LLDSD   KI+DFG A+          T  + GT  Y+A
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLA 166

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE  +   Y K  D ++ G+L+ E++ G
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 86.7 bits (214), Expect = 8e-19
 Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 13/202 (6%)

Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLV 408
           F+    +G+G FG V+KG+ +  ++V   ++     +E    +   E+ ++ +     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 409 KLLGFCVDGDEKLLVYEFMPNGS-LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           K  G  +   +  ++ E++  GS LD  L +P   G L   +   I+  I KG+ YLH +
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
            +   +HRD+KA+NVLL      K++DFG+A    +++ + N    VGT  +MAPE   +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQ 175

Query: 528 GLYSKKSDVFSFGVLLIEIITG 549
             Y  K+D++S G+  IE+  G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 42/214 (19%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G VYKG     G+ VA+K  RL S  E   +    E+ L+ +LQH N+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 414 CVDGDEKLLVYEFM------------PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            +      L++EF+                +DA L       IL             +G+
Sbjct: 68  LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL-------------QGI 114

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTY 517
           L+ H     R++HRDLK  N+L+D+    K++DFG+AR F         VR+    V T 
Sbjct: 115 LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP------VRVYTHEVVTL 165

Query: 518 GYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGR 550
            Y APE  +    YS   D++S G +  E+ T +
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 26/215 (12%)

Query: 357 LGQGGFGPVYK----GVLSDG-KE---VAVKRLS-SCSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V      G+  D  KE   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 29/204 (14%)

Query: 357 LGQGGFGPVYKGVLSDGKEV----AVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL- 411
           LG G FG VYK   +  KE     A K + + SE+   ++  E+ ++    H N+VKLL 
Sbjct: 13  LGDGAFGKVYK---AQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            F  + +  +L+ EF   G++DA++ +  +   L   +   +     + + YLHE+   +
Sbjct: 70  AFYYENNLWILI-EFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---K 123

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR----IVGTYGYMAPEYAM- 526
           I+HRDLKA N+L   D + K++DFG+      S     T++     +GT  +MAPE  M 
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGV------SAKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 527 ----EGLYSKKSDVFSFGVLLIEI 546
               +  Y  K+DV+S G+ LIE+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 18/207 (8%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
           +NF     +G+G F  VY+   L DG  VA+K++        +  A+   E+ L+ +L H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGI---LCWRKRTNIVNGIAK 459
            N++K     ++ +E  +V E    G L  ++  F  +KR I     W+    + + +  
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE- 120

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
                H  SR R++HRD+K +NV + +    K+ D G+ R F+     A++  +VGT  Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEI 546
           M+PE   E  Y+ KSD++S G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 357 LGQGGFGPVYKGVLSDGKE-----------------VAVKRL-SSCSEQGTAEFTNEVLL 398
           LG+G FG V+   + + ++                 VAVK L    ++    +F  EV +
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA-----ILFDPRKRG---------- 443
           + +L+  N+++LLG CVD D   ++ E+M NG L+       L D  + G          
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 444 -ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
             + +    ++   IA GM YL   S L  VHRDL   N L+  ++  KI+DFGM+R   
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
             +      R V    +MA E  + G ++  SDV++FGV L EI+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 85.0 bits (210), Expect = 2e-18
 Identities = 60/195 (30%), Positives = 100/195 (51%), Gaps = 13/195 (6%)

Query: 357 LGQGGFGPVYKGVLSDGK---EVAVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLVKLLG 412
           LG G FG V KGV    K   +VA+K L + +E+    E   E  ++ +L +  +V+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
            C + +  +LV E    G L+  L    K+  +       +++ ++ GM YL   +    
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---F 116

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY--GYMAPEYAMEGLY 530
           VHRDL A NVLL +   +KISDFG+++    ++      R  G +   + APE      +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALG-ADDSYYKARSAGKWPLKWYAPECINFRKF 175

Query: 531 SKKSDVFSFGVLLIE 545
           S +SDV+S+G+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.8 bits (220), Expect = 3e-18
 Identities = 74/324 (22%), Positives = 131/324 (40%), Gaps = 56/324 (17%)

Query: 246 ATEPSILAGNQASGGG------------KQRKMWMIIVLASVVALLLVVFASTGYFFATK 293
           A   S +AGN    GG            ++   W   +  ++ A L++   + G+ F   
Sbjct: 595 AINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVF--- 651

Query: 294 KITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSD 353
              R R     K+++        D  +  Q    +              T+N   S+  +
Sbjct: 652 --IRGRNNLELKRVE------NEDGTWELQFFDSK---------VSKSITINDILSSLKE 694

Query: 354 SNILGQGGFGPVYKG-VLSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVK 409
            N++ +G  G  YKG  + +G +  VK ++   S      A+         KLQH N+VK
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG-------KLQHPNIVK 747

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L+G C       L++E++   +L  +L     R  L W +R  I  GIAK + +LH    
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVL-----RN-LSWERRRKIAIGIAKALRFLHCRCS 801

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             +V  +L    +++D      +         +         +   +  Y+APE      
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKD 854

Query: 530 YSKKSDVFSFGVLLIEIITGRRNA 553
            ++KSD++ FG++LIE++TG+  A
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPA 878

Length = 968

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K   +    VAVK L    +++  ++  +E+ ++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             L ++   + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T   
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 27/206 (13%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G VYK      G+ VA+K  RL +  E   +    E+ L+ +L H N+V+LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 414 CVDGDEKL-LVYEFMP---NGSLDAILFDPRKRGILCWRKRTN-IVNGIAKGMLYLHEDS 468
            V  + KL LV+EF+       +D+         ++  +     ++ GIA    Y H  S
Sbjct: 67  -VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI--KSYLYQLLQGIA----YCH--S 117

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRIVGTYGYMAPEYA 525
             R++HRDLK  N+L+D +   K++DFG+AR F    G      T  +V T  Y APE  
Sbjct: 118 H-RVLHRDLKPQNLLIDREGALKLADFGLARAF----GVPVRTYTHEVV-TLWYRAPEIL 171

Query: 526 MEG-LYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++  R
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 30/212 (14%)

Query: 357 LGQGGFGPVYKGVLSDGKEVA---VKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           +G G FG V  G    G   A   VK L +S +      F  EV    +L H N+++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT--NIVNGIAKGMLYLHEDSRL 470
            C++    LLV EF P G L   L   R       +K     +   +A G+L+LH   + 
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMAR------IFAESEGEANTVRIVGTYGYMAPEY 524
             +H DL   N  L +D++ KI D+G+A        +   +  A  +R      ++APE 
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLAPE- 172

Query: 525 AMEGLYS--------KKSDVFSFGVLLIEIIT 548
            +E            KKS+++S GV + E+ T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 19/203 (9%)

Query: 351 FSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
           F+D   +G G FG VY        E VA+K++S   +Q   ++ +   EV  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
            ++  G  +      LV E+    + D  + +  K+  L   +   I +G  +G+ YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKP-LQEVEIAAICHGALQGLAYLHS 133

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE--Y 524
             R   +HRD+KA N+LL      K++DFG A + +     AN+   VGT  +MAPE   
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVIL 184

Query: 525 AM-EGLYSKKSDVFSFGVLLIEI 546
           AM EG Y  K DV+S G+  IE+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 83.7 bits (207), Expect = 7e-18
 Identities = 66/214 (30%), Positives = 106/214 (49%), Gaps = 29/214 (13%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKN 406
           NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 407 LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----IAKGM 461
           +VKLL   +  + KL LV+EF+ +  L   +      GI        ++      + +G+
Sbjct: 61  IVKLLD-VIHTENKLYLVFEFL-HQDLKKFMDASPLSGI-----PLPLIKSYLFQLLQGL 113

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTY 517
            + H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T 
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYTHEVVTL 164

Query: 518 GYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
            Y APE  +    YS   D++S G +  E++T R
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 19/203 (9%)

Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
           FSD   +G G FG VY    + + + VA+K++S   +Q   ++ +   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
            ++  G  +      LV E+    + D  L +  K+  L   +   + +G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAVTHGALQGLAYLHS 133

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
            +   ++HRD+KA N+LL      K+ DFG A I A     AN    VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANX--FVGTPYWMAPEVIL 184

Query: 527 ---EGLYSKKSDVFSFGVLLIEI 546
              EG Y  K DV+S G+  IE+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 84.0 bits (207), Expect = 1e-17
 Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 19/203 (9%)

Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
           F+D   +G G FG VY        EV A+K++S   +Q   ++ +   EV  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
            ++  G  +      LV E+    + D  L +  K+  L   +   I +G  +G+ YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAITHGALQGLAYLHS 143

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
            +   ++HRD+KA N+LL      K++DFG A I +     AN+   VGT  +MAPE  +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS--FVGTPYWMAPEVIL 194

Query: 527 ---EGLYSKKSDVFSFGVLLIEI 546
              EG Y  K DV+S G+  IE+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 68/204 (33%), Positives = 112/204 (54%), Gaps = 18/204 (8%)

Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRL-SSCSEQGTAEFT-NEVLLILKL-QHKNLVKLLG 412
           LG+G +G V+K +    KE VA+K++  +      A+ T  E++ + +L  H N+VKLL 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 413 -FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
               + D+ + LV+E+M    L A++    +  IL    +  I+  + K + Y+H  S  
Sbjct: 75  VIKAENDKDIYLVFEYMET-DLHAVI----RANILEDVHKRYIMYQLLKALKYIH--SG- 126

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI---VGTYGYMAPEYAME 527
            ++HRDLK SN+LL+SD   K++DFG+AR  +E E       +   V T  Y APE  + 
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG 186

Query: 528 G-LYSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E++ G+
Sbjct: 187 STRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 67/223 (30%), Positives = 114/223 (51%), Gaps = 27/223 (12%)

Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLL 411
             +G+G +G VYK    D G+ VA+K++   +E+     T   E+ ++ +L H+N+V L 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 412 GFCVDGDEKL----------LVYEFMPN---GSLDAILFDPRKRGILCWRKRTNIVNGIA 458
               D  + L          LV+E+M +   G L++ L    +  I  + K+      + 
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ------LL 126

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           +G+ Y H+ + L   HRD+K SN+LL++    K++DFG+AR++   E    T +++ T  
Sbjct: 127 EGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182

Query: 519 YMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA 560
           Y  PE  + E  Y    DV+S G +L E+ T +    +NQ LA
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 81.5 bits (201), Expect = 3e-17
 Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 17/199 (8%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG VY  ++ D K VA +RL    E          T +   E  L+ KL H  +V
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHED 467
           K     ++ D   ++ E+     LD  L + +  G  L   +       +  G+ Y+H+ 
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
              RI+HRDLKA N+ L +++  KI DFG++R+   S   A T    GT  YM+PE    
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKH 179

Query: 528 GLYSKKSDVFSFGVLLIEI 546
             Y  KSD++S G +L E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEV-------LLILK-LQHKNL 407
           +G+G +G V K    + G+ VA+K+         +E   +V       + +L+ L+H+N+
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFK------ESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNGIAKGMLYLHE 466
           V L           LV+E++    L+ +   P        R     ++  IA    Y H 
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIA----YCH- 117

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
                I+HRD+K  N+L+      K+ DFG AR        +     V T  Y APE  +
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYVATRWYRAPELLV 174

Query: 527 -EGLYSKKSDVFSFGVLLIEIITGR 550
            +  Y K  DV++ G ++ E++ G 
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)

Query: 351 FSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
           F   + +G G FG VY    S   E VAVK++S   +Q   ++ +   EV  + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
            ++  G  +      LV E+    + D  L +  K+  L   +   I +G  +G+ YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAITHGALQGLAYLHS 139

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
            +   ++HRD+KA N+LL      K++DFG A   +     AN+   VGT  +MAPE  +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS--FVGTPYWMAPEVIL 190

Query: 527 ---EGLYSKKSDVFSFGVLLIEI 546
              EG Y  K DV+S G+  IE+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.7 bits (199), Expect = 7e-17
 Identities = 63/217 (29%), Positives = 107/217 (49%), Gaps = 26/217 (11%)

Query: 351 FSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQH 404
           F+   +LG+G FG V +  L       ++VAVK L +   S     EF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 405 KNLVKLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVN 455
            N++KL+G  +    K      +++  FM +G L   L   R   +   L  +     + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAES---EGEANTV 511
            IA GM YL   S    +HRDL A N +L+ +M   ++DFG+++ I++     +G A+ +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +     ++A E   + +Y+  SDV++FGV + EI+T
Sbjct: 178 PV----KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 64/200 (32%), Positives = 93/200 (46%), Gaps = 17/200 (8%)

Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLG 412
           LG GGFG V    V S  +  A+K +      E G  E   +E  ++ +  H  +VKL  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 413 FCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           +    D+K +  + E+   G L  IL   R RG+         +  +     YLH     
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIACVVLAFEYLH---NR 112

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
            I++RDLK  N+LLDS+   K+ DFG A+     +    T    GT  Y+APE  +   Y
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGY 169

Query: 531 SKKSDVFSFGVLLIEIITGR 550
               D +S G+LL E++TGR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 43/219 (19%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LLILK-LQH 404
             +G G +G V   V    G++VA+K++S+        F + +        + +L+ L+H
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRH 58

Query: 405 KNLVKLLGFCVDGD----EKL-LVYEFMPNGSLDAILFDPRK------RGILCWRKRTNI 453
           +N++ LL             + +V E M    L  ++  P+       +  L        
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLY------- 110

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-R 512
              I +G+ YLH  +   ++HRDLK SN+L++S+ + KI DFG+AR     E E   +  
Sbjct: 111 --QILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165

Query: 513 IVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            V T  Y APE  +    Y+K  D++S G +  E++T +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 69/202 (34%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSS--CSEQGTAEFT--NEVLLILKLQHKNLVKL 410
           +LG+G FG V    L    E  A+K L      E    E T     +L L  +H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 411 LGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
             FC    ++ L  V E++  G L   +F  +  G     +       I  G+ +LH+  
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              I++RDLK  NVLLD D + KI+DFGM +     EG+A+T    GT  Y+APE     
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQ 171

Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
            Y++  D +SFGVLL E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 67/210 (31%), Positives = 95/210 (45%), Gaps = 23/210 (10%)

Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
           F    +LG+GGFG V    V + GK  A K+L        +G +   NE  ++ K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD------PRKRGILCWRKRTNIVNGIAKG 460
           +V L       D   LV   M  G L   ++          R +            I  G
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEICCG 114

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           +  LH++   RIV+RDLK  N+LLD   + +ISD G+A      EG+    R VGT GYM
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYM 168

Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           APE      Y+   D ++ G LL E+I G+
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 20/206 (9%)

Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK----LQHKNLVK 409
           +G+G +G V+K   + + G+ VA+KR+     E+G    T   + +L+     +H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 410 LLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           L   C     D + KL LV+E + +  L   L    + G+       +++  + +G+ +L
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT-ETIKDMMFQLLRGLDFL 126

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H     R+VHRDLK  N+L+ S    K++DFG+ARI++    +     +V T  Y APE 
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 180

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGR 550
            ++  Y+   D++S G +  E+   +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 357 LGQGGFGPVYKGVLSDG-------KEVAVKRLS-----SCSEQGTAEFTNEVLLILK-LQ 403
           LG G FG VYK    +        KE+ V   +        ++   +  +EV +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           H N+V+     ++ D   +V + +    L +       K+      +  NI   +   + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YLH++ R  IVHRDL  +N++L  D    I+DFG+A+   + + E+    +VGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E      Y +K+DV++FG +L ++ T
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE--FTNEVLLILKLQHKNLVKLLG 412
           ++G+G +G V K    + G+ VA+K+     +    +     E+ ++ +L+H+NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
                    LV+EF+ +  LD +   P        RK    +  I +G+ + H  +   I
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK---YLFQILRGIEFCHSHN---I 121

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYS 531
           +HRD+K  N+L+      K+ DFG AR  A + GE  T   V T  Y APE  + +  Y 
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYT-DYVATRWYRAPELLVGDTKYG 179

Query: 532 KKSDVFSFGVLLIEIITG 549
           +  D+++ G L+ E++TG
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
           I  G+ +LHE     I++RDLK  NVLLDS+ + KI+DFGM +   E      T     G
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCG 158

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE      Y    D ++ GVLL E++ G+
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 26/214 (12%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
           + F   N +G+G +G VY+   +   E VA+K++   +E+     ++  E+ L+L L+H 
Sbjct: 7   TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66

Query: 406 NLVKLLGFCVDG--DEKLLVYEFMPNGSLD-AILFDPRKR-----GILCWRKRTNIVNGI 457
           N+V+L    V    D   LV E+      D A L D          + C      ++  +
Sbjct: 67  NIVELKEVVVGKHLDSIFLVMEYCEQ---DLASLLDNMPTPFSESQVKC------LMLQL 117

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
            +G+ YLHE+    I+HRDLK SN+LL      KI+DFG+AR +     +  T ++V T 
Sbjct: 118 LRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TL 172

Query: 518 GYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            Y APE  +    Y+   D+++ G +L E++  +
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 20/222 (9%)

Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           +G G FG V  G ++ G    +V VK L  S S Q   +F  E      LQH NL++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT--NIVNGIAKGMLYLHEDSRL 470
            C +    LLV EF P G L   L   RK  ++     T   +   IA G+L+LH+++  
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME--- 527
             +H DL   N LL +D+  KI D+G++    + +      ++     ++APE   E   
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 528 ----GLYSKKSDVFSFGVLLIEII----TGRRNAGSNQLLAY 561
                  +K+S+V+S GV + E+        R+    Q+L Y
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY 221

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 22/225 (9%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
           IDL  L      F    ++G G +G VYKG      ++A  ++   +E    E   E+ +
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65

Query: 399 ILKL-QHKNLVKLLGFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR- 450
           + K   H+N+    G  +        D+  LV EF   GS+  ++ + +       ++  
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---ALKEDW 122

Query: 451 -TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
              I   I +G+ +LH     +++HRD+K  NVLL  +   K+ DFG++     + G  N
Sbjct: 123 IAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179

Query: 510 TVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITG 549
           T   +GT  +MAPE        +  Y  +SD++S G+  IE+  G
Sbjct: 180 T--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 26/216 (12%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQH-K 405
            +  D   +G+G FG V K +    G  +AVKR+ S   E+       ++ ++++     
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLD---AILFDPRKRGILCWRKRTNIVNGIA---- 458
            +VK  G      +  +  E M + SLD     +++  K  I        I+  IA    
Sbjct: 64  YIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVI-----PEEILGKIAVATV 117

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           K + YL E+  L+I+HRD+K SN+LLD + N K+ DFG++    +S   A T R  G   
Sbjct: 118 KALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKT-RDAGCRP 172

Query: 519 YMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
           YMAPE     A +G Y  +SDV+S G+ L E+ TG+
Sbjct: 173 YMAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 71/218 (32%), Positives = 97/218 (44%), Gaps = 39/218 (17%)

Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
           F    +LG+GGFG V    V + GK  A K+L        +G A   NE  ++ K+  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 407 LVKLL-------GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
           +V L          C+       GD K  +Y     G      FD  +R +         
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FD-EERAVF-------Y 107

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR- 512
              I  G+  LH   R RIV+RDLK  N+LLD   + +ISD G+A    E E    T+R 
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRG 160

Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            VGT GYMAPE      Y+   D +  G L+ E+I G+
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 77.3 bits (190), Expect = 8e-16
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 20/201 (9%)

Query: 356 ILGQGGFGP--VYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL-G 412
           ++G+G FG   + + V SD K    +     S     +   E +L+ K++H N+V     
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKR-----GILCWRKRTNIVNGIAKGMLYLHED 467
           F  DG    +V E+   G L   +   R +      IL W  +      +  G+ ++HE 
Sbjct: 67  FEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK 119

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
              R++HRD+K+ N+ L  +   K+ DFG AR+       A T   VGT  Y+ PE    
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEIWEN 174

Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             Y+ KSD++S G +L E+ T
Sbjct: 175 MPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 27/203 (13%)

Query: 359 QGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAEFTN----EVLLILKLQHKNLVKLLG 412
           +G FG VY  K   + G   A+K L         + TN      +++++ +   + KL  
Sbjct: 6   KGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC--WRKR--TNIVNGIAKGMLYLHEDS 468
                D   LV E++  G   +++   +  G L   W K+    +V G+      LH+  
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVE----DLHQRG 117

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              I+HRD+K  N+L+D   + K++DFG++R   E++      + VGT  Y+APE  +  
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGV 168

Query: 529 LYSKKSDVFSFGVLLIEIITGRR 551
              K SD +S G ++ E + G  
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 38/214 (17%)

Query: 357 LGQGGFGPVYK------GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK----N 406
           LG+G +G VYK      GV    KE+   RL    E   ++F N++++ L + HK     
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI---RL----ELDESKF-NQIIMELDILHKAVSPY 60

Query: 407 LVKLLG-FCVDGDEKLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +V   G F ++G     VY   E+M  GSLD +         +       I   + KG+ 
Sbjct: 61  IVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           +L E+    I+HRD+K +NVL++ +   K+ DFG++     S  + N    +G   YMAP
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAP 170

Query: 523 EY------AMEGLYSKKSDVFSFGVLLIEIITGR 550
           E            Y+ +SDV+S G+ ++E+  GR
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 26/203 (12%)

Query: 355 NILGQGGFGPVYKG-VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
            ILG G  G VYK   L   + +AVK +    + +   +  +E+ ++ K     ++   G
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 413 -FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA----KGMLYLHED 467
            F V+ +   +  EFM  GSLD           +  +   +++  IA    KG+ YL   
Sbjct: 67  AFFVE-NRISICTEFMDGGSLD-----------VYRKIPEHVLGRIAVAVVKGLTYLWS- 113

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
             L+I+HRD+K SN+L+++    K+ DFG++     S  +      VGT  YMAPE    
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERISG 167

Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
             Y   SDV+S G+  +E+  GR
Sbjct: 168 EQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 71/231 (30%), Positives = 110/231 (47%), Gaps = 33/231 (14%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTN 394
           + LE+L   T  +     +G+G +G VYK     DG   AVK L   S   E+  AE+  
Sbjct: 12  LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN- 70

Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRK 449
            +L  L   H N+VK  G     D+ +     LV E    GS+  ++     +G+L   +
Sbjct: 71  -ILQSLP-NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQ 123

Query: 450 RTN------IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
           R +      I+ G   G+ +LH +   RI+HRD+K +N+LL ++   K+ DFG++     
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180

Query: 504 SEGEANTVRIVGTYGYMAPEY-----AMEGLYSKKSDVFSFGVLLIEIITG 549
           +    NT   VGT  +MAPE        +  Y  + DV+S G+  IE+  G
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 18/202 (8%)

Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNE--VLLILKLQHKNLVK 409
           I+G+GGFG VY    +D GK  A+K L       +QG     NE  +L ++       + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            + +     +KL  + + M  G L   L    + G+    +       I  G+ ++H  +
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH--N 115

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           R  +V+RDLK +N+LLD   + +ISD G+A  F++ +  A+    VGT+GYMAPE   +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170

Query: 529 L-YSKKSDVFSFGVLLIEIITG 549
           + Y   +D FS G +L +++ G
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 17/210 (8%)

Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK 405
           L   +F   + LG G  G V+K        +  ++L     +      N+++  L++ H+
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHE 59

Query: 406 -NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
            N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + KG
Sbjct: 60  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKG 115

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  YM
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRSYM 169

Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           +PE      YS +SD++S G+ L+E+  GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 17/211 (8%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKN 406
             + + + +G+G +G V        G +VA+K++S    Q   + T  E+ ++ + +H+N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 407 LVKLLGFCVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           ++ +L            +  +V E M       I         + +      +  I +G+
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY-----FLYQILRGL 119

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA-ESEGEANTVRIVGTYGYM 520
            Y+H  +   ++HRDLK SN+LL+++ + KI DFG+ARI   E +        V T  Y 
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 521 APEYAMEG-LYSKKSDVFSFGVLLIEIITGR 550
           APE  +    Y+K  D++S G +L E+++ R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 22/215 (10%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHK 405
           S +     +GQG FG V+K       + VA+K++   +E+     T   E+ ++  L+H+
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71

Query: 406 NLVKLLGFCVDGDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           N+V L+  C               LV+EF  +  L  +L +   +  L   K+  ++  +
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKK--VMKML 128

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIV 514
             G+ Y+H   R +I+HRD+KA+N+L+  D   K++DFG+AR F+ S+       T R+V
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 515 GTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIIT 548
            T  Y  PE  + E  Y    D++  G ++ E+ T
Sbjct: 186 -TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 356 ILGQGGFGPV----YKGVLSDGKEVAVKRL----SSCSEQGTAEFTNEVLLILKLQHKNL 407
           ++G+G +G V    ++   +DGK+  +K+L    +S  E+  AE   E  L+ +L+H N+
Sbjct: 7   VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNI 61

Query: 408 VKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           V         D  L +V  F   G L   L   +K  +L   +       IA  + YLHE
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQYLHE 120

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
                I+HRDLK  NV L      K+ D G+AR+       A+T  ++GT  YM+PE   
Sbjct: 121 K---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFS 175

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR--NAGSNQLLAY 561
              Y+ KSDV++ G  + E+ T +   NA     L Y
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 27/206 (13%)

Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN----EVLLILKLQHKNLVKLL 411
           +G G +G V     +     VA+K+LS   +  +A        E+ L+  + H+N++ LL
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 412 G-FCVDG-----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
             F          +  LV   M    L+ I+    K   L       +V  I +G+ Y+H
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIH 135

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+ ++ D   KI DFG+AR   + E        V T  Y APE  
Sbjct: 136 S---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDE----MTGYVATRWYRAPEIM 187

Query: 526 MEGL-YSKKSDVFSFGVLLIEIITGR 550
           +  + Y++  D++S G ++ E++TG+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 68/205 (33%), Positives = 94/205 (45%), Gaps = 13/205 (6%)

Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
           F    +LG+GGFG V    V + GK  A K+L        +G A   NE  ++ K+  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           +V L       D   LV   M  G L   +++    G          +   A+    L +
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF----DEQRAIFYAAELCCGLED 117

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMAPEYA 525
             R RIV+RDLK  N+LLD   + +ISD G+A    E E    TVR  VGT GYMAPE  
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVI 173

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
               Y+   D +  G L+ E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 4e-15
 Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 37/208 (17%)

Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTNEVLLILK-------LQHKNLV 408
           +GQGG+G V+     D  E VA+KR+     +      NEV  +L         + + LV
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMK----KSLLFKLNEVRHVLTERDILTTTKSEWLV 64

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-- 466
           KLL    D +   L  E++P G    +L +    G+L            A+   Y+ E  
Sbjct: 65  KLLYAFQDDEYLYLAMEYVPGGDFRTLLNN---LGVLS--------EDHAR--FYMAEMF 111

Query: 467 ---DS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
              D+   L  +HRDLK  N L+D+  + K++DFG+++        AN+V  VG+  YMA
Sbjct: 112 EAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSV--VGSPDYMA 166

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE      Y    D +S G +L E + G
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.5 bits (188), Expect = 4e-15
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
           +LG+G FG V    L   G+  AVK L        +      T + +L L   H  L +L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61

Query: 411 LGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
              C    ++L  V EF+  G L   +F  +K       +       I   +++LH+   
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIVGTYGYMAPEYAM 526
             I++RDLK  NVLLD + + K++DFGM +     EG  N   T    GT  Y+APE   
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGIFNGKTTSTFCGTPDYIAPEILQ 169

Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
           E LY    D ++ GVLL E++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 67/204 (32%), Positives = 94/204 (46%), Gaps = 11/204 (5%)

Query: 351 FSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKN 406
           F    +LG+GGFG V    V + GK  A KRL        +G +   NE  ++ K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           +V L       D   LV   M  G L   +++    G    R        I  G+  LH 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHR 120

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
           ++    V+RDLK  N+LLD   + +ISD G+A      EGE+   R VGT GYMAPE   
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEVLN 174

Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
              Y+   D +  G L+ E+I G+
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)

Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
           F    ++G G +G VYKG      ++A  ++   +     E   E+ ++ K   H+N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 410 LLGFCVD------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
             G  +        D+  LV EF   GS+  ++ +  K   L       I   I +G+ +
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSH 126

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           LH+    +++HRD+K  NVLL  +   K+ DFG++     + G  NT   +GT  +MAPE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPE 181

Query: 524 YAM-----EGLYSKKSDVFSFGVLLIEIITG 549
                   +  Y  KSD++S G+  IE+  G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 18/202 (8%)

Query: 356 ILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKN--LVK 409
           I+G+GGFG VY    +D GK  A+K L       +QG     NE +++  +   +   + 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            + +     +KL  + + M  G L   L    + G+   ++       I  G+ ++H  +
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--N 115

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           R  +V+RDLK +N+LLD   + +ISD G+A  F++ +  A+    VGT+GYMAPE   +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170

Query: 529 L-YSKKSDVFSFGVLLIEIITG 549
             Y   +D FS G +L +++ G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 19/201 (9%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKL 410
           +G G +G VYK      G  VA+K  R+ +  +        EV L+ +L+   H N+V+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 411 LGFC----VDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           +  C     D + K+ LV+E + +  L   L      G L      +++    +G+ +LH
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG-LPAETIKDLMRQFLRGLDFLH 125

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            +    IVHRDLK  N+L+ S    K++DFG+ARI++    +     +V T  Y APE  
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVL 179

Query: 526 MEGLYSKKSDVFSFGVLLIEI 546
           ++  Y+   D++S G +  E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 24/206 (11%)

Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG+GGFG V    + + GK  A K+L+       +G      E  ++ K+  + +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFD--------PRKRGILCWRKRTNIVNGIAKGMLYL 464
                 +  LV   M  G L   +++        P  R              I  G+ +L
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-------YTAQIISGLEHL 113

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H+    RI++RDLK  NVLLD+D N +ISD G+A      +G++ T    GT G+MAPE 
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK--DGQSKTKGYAGTPGFMAPEL 168

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGR 550
                Y    D F+ GV L E+I  R
Sbjct: 169 LQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 76.0 bits (187), Expect = 6e-15
 Identities = 40/96 (41%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR--IFAESEGEANTVRIV 514
           IA G+ +LH      I++RDLK  NV+LD++ + KI+DFGM +  IF    G   T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF----GGKTTRTFC 162

Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           GT  Y+APE      Y K  D ++FGVLL E++ G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 39/216 (18%)

Query: 357 LGQGGFGPVYKGVLS--DGKEVAVKRLS---SCSEQGTAEFTNEVLLILKL--QHKNLVK 409
           +G+G +G V+K VL+  +G + AVK L       E+  AE+      ILK    H N+VK
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYN-----ILKALSDHPNVVK 79

Query: 410 LLGF-----CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN------IVNGIA 458
             G        +GD+  LV E    GS+  ++    KRG     +R        I++   
Sbjct: 80  FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG-----ERMEEPIIAYILHEAL 134

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            G+ +LH +   + +HRD+K +N+LL ++   K+ DFG++     +    NT   VGT  
Sbjct: 135 MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPF 189

Query: 519 YMAPEY-----AMEGLYSKKSDVFSFGVLLIEIITG 549
           +MAPE       ++  Y  + DV+S G+  IE+  G
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 14/207 (6%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
            +   N + +G +G VY+      G+ VA+K+L    E+     T+  E+ ++LKLQH N
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65

Query: 407 LVKLLGFCV--DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           +V +    V  + D+  +V E++ +  L +++   ++  +    K   ++  +  G+ +L
Sbjct: 66  IVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGVAHL 122

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H++    I+HRDLK SN+LL++    KI DFG+AR +          ++V T  Y APE 
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPEL 177

Query: 525 AM-EGLYSKKSDVFSFGVLLIEIITGR 550
            +    YS   D++S G +  E++T +
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 20/212 (9%)

Query: 350 NFSDSNILGQGGFGPVY----KGVLSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL 402
           NF    +LG G +G V+     G    GK  A+K L   +   +  TAE T     +L+ 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 403 QHKN--LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             +   LV L  +    D KL L+ +++  G L   L+  R+           +   IA+
Sbjct: 61  VRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQ-REHFTE---SEVRVY--IAE 113

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
            +L L    +L I++RD+K  N+LLDS+ +  ++DFG+++ F   E E       GT  Y
Sbjct: 114 IVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEY 172

Query: 520 MAPEYAM--EGLYSKKSDVFSFGVLLIEIITG 549
           MAPE      G + K  D +S GVL  E++TG
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 41/103 (39%), Positives = 59/103 (57%), Gaps = 11/103 (10%)

Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
           I   I K + YLH   +L ++HRD+K SNVL++ +   K+ DFG++    +S   A T+ 
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTID 163

Query: 513 IVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
             G   YMAPE        +G Y  KSDV+S G+ +IE+ TGR
Sbjct: 164 A-GCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 55/164 (33%), Positives = 91/164 (55%), Gaps = 19/164 (11%)

Query: 394 NEVLLILKLQHK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRK--RGILC 446
           N+++  L++ H+ N   ++GF      DG E  +  E M  GSLD +L + ++    IL 
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKRIPEEIL- 105

Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
                 +   + +G+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S  
Sbjct: 106 ----GKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158

Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            AN+   VGT  YM+PE      YS +SD++S G+ L+E+  GR
Sbjct: 159 -ANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 70/255 (27%), Positives = 106/255 (41%), Gaps = 45/255 (17%)

Query: 305 KQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGP 364
           K +QLHK  D++ T         R N +K +DF            NF  +  LG G FG 
Sbjct: 5   KNLQLHKKKDSDSTK-----EPKRKNKMKYEDF------------NFIRT--LGTGSFGR 45

Query: 365 VYKGVLSDGK--EVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 419
           V      +     VA+KR        ++      +E  ++  + H   V L G   D   
Sbjct: 46  VILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105

Query: 420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI-----AKGMLYLHEDSRLRIVH 474
             LV EF+  G     L           R+     N +     A+ +L       L IV+
Sbjct: 106 LYLVLEFVIGGEFFTFL-----------RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           RDLK  N+LLD D   K++DFG A++      +  T  + GT  Y+APE  +   + K +
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHGKAA 209

Query: 535 DVFSFGVLLIEIITG 549
           D ++ G+ + EI+ G
Sbjct: 210 DWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 13/200 (6%)

Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
           +LG+G FG V    L   G+  AVK L        +        + +L L  ++  L  L
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
                  +    V EF+  G L   +F  + +G     + T     I  G+ +LH     
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG-- 116

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
            I++RDLK  NV+LD D + KI+DFGM +     +  A+T    GT  Y+APE      Y
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKY 173

Query: 531 SKKSDVFSFGVLLIEIITGR 550
           +   D +SFGVLL E++ G+
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 27/229 (11%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
           S + D   LG G  G V+  V SD  K VAVK++     Q       E+ +I +L H N+
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64

Query: 408 VKLLGFCVDGDEKL--------------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
           VK+          L              +V E+M     +  L +  ++G L        
Sbjct: 65  VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF 119

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIF-AESEGEANTV 511
           +  + +G+ Y+H  +   ++HRDLK +NV +++ D+  KI DFG+ARI       +    
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176

Query: 512 RIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRR-NAGSNQL 558
             + T  Y +P   +    Y+K  D+++ G +  E++TG+   AG+++L
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 19/211 (9%)

Query: 350 NFSDSNILGQGGFGPVY---KGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILKL 402
           NF    +LG G +G V+   K    D GK  A+K L   +   +  T E T     +L+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 403 --QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             Q   LV L  +    + KL L+ +++  G +   L+   +R      +       I  
Sbjct: 61  VRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIIL 116

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
            + +LH   +L IV+RD+K  N+LLDS+ +  ++DFG+++ F   E E  T    GT  Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEY 172

Query: 520 MAPEYAM-EGLYSKKSDVFSFGVLLIEIITG 549
           MAPE    +G + K  D +S G+L+ E++TG
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 37/233 (15%)

Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV----YKGVLSDGKEVAVKRLSS---C 384
           +KA   F   +T +   S+F     LG G FG V    +KG    G+  A+K L      
Sbjct: 1   MKAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREIL 57

Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
             +       E  ++++L H  +V ++    D +    + EF+  G L   L        
Sbjct: 58  KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-------- 109

Query: 445 LCWRKRTNIVNGIAK--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
              RK     N +AK           YLH      I++RDLK  N+LLD+  + K++DFG
Sbjct: 110 ---RKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFG 163

Query: 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            A+   +      T  + GT  Y+APE      + K  D ++ GVLL E I G
Sbjct: 164 FAKKVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 10/198 (5%)

Query: 356 ILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLG 412
           ++G+G +G V K    + KE VA+K+     E    + T   E+ ++  L+ +N+V+L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
                 +  LV+E++    L+  L +    G+   + R+ I   I K + + H++    I
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND---I 121

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           VHRD+K  N+L+  +   K+ DFG AR  +E    AN    V T  Y +PE  +   Y K
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGK 180

Query: 533 KSDVFSFGVLLIEIITGR 550
             D++S G +L E+  G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 73.4 bits (180), Expect = 4e-14
 Identities = 63/202 (31%), Positives = 98/202 (48%), Gaps = 20/202 (9%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V   +    G++VA+K+LS    SE        E+ L+  +QH+N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 414 ---CVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
               V GDE    Y  MP    D      +  G  L   K   +V  +  G+ Y+H    
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDL----QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG- 137

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             I+HRDLK  N+ ++ D   KI DFG+AR       +A     V T  Y APE  +  +
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWM 190

Query: 530 -YSKKSDVFSFGVLLIEIITGR 550
            Y++  D++S G ++ E++TG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 20/203 (9%)

Query: 356 ILGQGGFGPVY---KGVLSD-GKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           +LGQG FG V+   K    D G+  A+K L  ++   +       E  ++ ++ H  +VK
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 410 L-LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           L   F  +G  KL L+ +F+  G L   L    K  +         +  +A  + +LH  
Sbjct: 63  LHYAFQTEG--KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH-- 115

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES-EGEANTVRIVGTYGYMAPEYAM 526
             L I++RDLK  N+LLD + + K++DFG+++   ES + E       GT  YMAPE   
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
              +++ +D +SFGVL+ E++TG
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 29/205 (14%)

Query: 357 LGQGGFGPVYKGVL----SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKL 410
           +G+G FG   K +L     DGK+  +K ++    S +   E   EV ++  ++H N+V+ 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 411 LGFCVDGDEKLLVYEFMPNGSL-------DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
                +     +V ++   G L         +LF   +  IL W  +      I   + +
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ--ILDWFVQ------ICLALKH 116

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           +H+    +I+HRD+K+ N+ L  D   K+ DFG+AR+   +   A T   +GT  Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYLSPE 171

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
                 Y+ KSD+++ G +L E+ T
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 13/200 (6%)

Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQHKNLVKL 410
           +LG+G FG V+   L    +  A+K L        +        + +L L  +H  L  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
                  +    V E++  G L   +F  +        + T     I  G+ +LH     
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
            IV+RDLK  N+LLD+D + KI+DFGM +      G+A T    GT  Y+APE  +   Y
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY 173

Query: 531 SKKSDVFSFGVLLIEIITGR 550
           +   D +SFGVLL E++ G+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 350 NFSDSNILGQGGFGPVY---KGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLILK- 401
           NF    +LG G +G V+   K    D GK  A+K L   +   +  T E T     +L+ 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           ++    +  L +    D KL L+ +++  G L   L    +R     ++       I   
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + +LH   +L I++RD+K  N+LLDS+ +  ++DFG+++ F E E E       GT  YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173

Query: 521 APEYAM--EGLYSKKSDVFSFGVLLIEIITG 549
           AP+     +G + K  D +S GVL+ E++TG
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 18/197 (9%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G G +G VYK   ++ G+  A+K +     +  A    E++++   +H N+V   G  +
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 416 DGDEKLLVYEFMPNGSLDAI--LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             D+  +  EF   GSL  I  +  P     + +  R  +     +G+ YLH   ++   
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGKM--- 128

Query: 474 HRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAM---EGL 529
           HRD+K +N+LL  + + K++DFG+ A+I A     A     +GT  +MAPE A    +G 
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 530 YSKKSDVFSFGVLLIEI 546
           Y++  D+++ G+  IE+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 49/231 (21%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE------------FT--NEVLLI 399
             LG+G +G V K      GK VA+K++                      FT   E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI------LFDPRKRGILCWRKRTNI 453
            +++H+N++ L+   V+GD   LV + M    L  +      L + + + IL       I
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-----LQI 128

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA----------- 502
           +NG+      LH+      +HRDL  +N+ ++S    KI+DFG+AR +            
Sbjct: 129 LNGLNV----LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 503 --ESEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
                 E  T ++V T  Y APE  M    Y    D++S G +  E++TG+
Sbjct: 182 ETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 37/216 (17%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKR-LSSCSEQGTAEFT-NEVLLILKLQHKN-LVKLL 411
            +G+G +G VYK    + GK VA+K+      E+G       E+ L+  L     +V+LL
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 412 GFCVDGDEK-------LLVYEFMPNGSLDAILFDPRKRGILCWRKR-----TNIVNG--- 456
              V+  E+        LV+E++ +        D +K      R          +     
Sbjct: 68  --DVEHVEEKNGKPSLYLVFEYLDS--------DLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 457 -IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIV 514
            + KG+ + H   +  ++HRDLK  N+L+D      KI+D G+ R F+     + T  IV
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIV 173

Query: 515 GTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITG 549
            T  Y APE  +    YS   D++S G +  E+   
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKE-VAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
            +      +G G FG V+       +   A+K ++       +      NE  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 405 KNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
             +++L  F  + D++ L  + E++P G L + L   R  G           + I   + 
Sbjct: 61  PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRFSNSTGLFYASEIVCALE 115

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YLH      IV+RDLK  N+LLD + + K++DFG A+     +    T  + GT  Y+AP
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAP 167

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITG 549
           E      ++K  D ++ G+L+ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 72.2 bits (177), Expect = 3e-13
 Identities = 69/235 (29%), Positives = 106/235 (45%), Gaps = 31/235 (13%)

Query: 337 FFIDLETLNLATSNFSDSNILGQGGFGPV-YKGVLSDGKEVAVK--RLSSCSEQGTAEFT 393
           F  D  T       +  S +LG G  G V     +SDG+  AVK   +   SE       
Sbjct: 20  FAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ 79

Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
            EV  +L     ++VK        D +        N  + A++ D    G L    R  I
Sbjct: 80  AEVCCLLNCDFFSIVKCHEDFAKKDPRNPE-----NVLMIALVLDYANAGDL----RQEI 130

Query: 454 VNGIAK----------GMLYL-------HEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
            +  AK          G+L++       H  S+  ++HRD+K++N+LL S+   K+ DFG
Sbjct: 131 KSR-AKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFG 188

Query: 497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
            ++++A +  +       GT  Y+APE      YSKK+D+FS GVLL E++T +R
Sbjct: 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 20/214 (9%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHK 405
           S +     +G G +G V   +    GK+VA+K++    +  T A+ T   L IL+  +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 406 NLVKLLGFCV----DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           N++ +         D  +  +V + M +  L  I+        L        +  + +G+
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHII---HSDQPLTEEHIRYFLYQLLRGL 120

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV--RIVGTYGY 519
            Y+H  +   ++HRDLK SN+L++ D   +I DFGMAR  + S  E        V T  Y
Sbjct: 121 KYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWY 177

Query: 520 MAPE--YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
            APE   ++   Y+   D++S G +  E++ GRR
Sbjct: 178 RAPELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 51/219 (23%)

Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAEFTNEVLL---ILKLQH--KNLVKL 410
           +G G  G VYK      G  +AVK++      G  E    +L+   ++   H    +VK 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 411 LG-FCVDGD------------EKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
            G F  D D            +KLL  +   +P    + IL                +  
Sbjct: 80  YGYFITDSDVFICMELMSTCLDKLLKRIQGPIP----EDIL--------------GKMTV 121

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            I K + YL E     ++HRD+K SN+LLD+  N K+ DFG++    +S  +A T R  G
Sbjct: 122 AIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS--KAKT-RSAG 176

Query: 516 TYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITGR 550
              YMAPE          Y  ++DV+S G+ L+E+ TG+
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRLSSC----SEQGTAEFTNEVLLILKLQHKNL 407
           +LG+GG+G V++     G +     A+K L       +++ TA    E  ++  ++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 408 VKLL-GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           V L+  F   G  KL L+ E++  G L   L    + GI         ++ I+  + +LH
Sbjct: 63  VDLIYAFQTGG--KLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLH 117

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES-EGEANTVRIVGTYGYMAPEY 524
              +  I++RDLK  N+LLD+  + K++DFG+ +   ES      T    GT  YMAPE 
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEGTVTHTFCGTIEYMAPEI 171

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
            M   + K  D +S G L+ +++TG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 71.1 bits (174), Expect = 3e-13
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 9/153 (5%)

Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           E +L+  + H +++++    V G    +V   +P+ S D   +  ++   L   +   I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             I +G+ YLH     RI+HRD+K  N+ ++      I D G A+           + + 
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
           GT    APE      Y+ K+D++S G++L E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 40/213 (18%)

Query: 357 LGQGGFGPVYKGVLSDGKE-VAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G VYK       E +A+K  RL    E   +    E+ L+ ++QH N+V+L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD- 68

Query: 414 CVDGDEKL-LVYEFMPNGSLDAILF---------DPRKRGILCWRKRTNIVNGIAKGMLY 463
            V  +++L LV+E++    LD             +PR      ++    I+ GIA    Y
Sbjct: 69  VVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA----Y 117

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRI----VGTYG 518
            H  S  R++HRDLK  N+L+D   N+ K++DFG+AR F         VR     V T  
Sbjct: 118 CH--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP------VRTFTHEVVTLW 168

Query: 519 YMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           Y APE  +    YS   D++S G +  E++  +
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 69.1 bits (169), Expect = 9e-13
 Identities = 40/97 (41%), Positives = 59/97 (60%), Gaps = 13/97 (13%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE----GEANTV 511
           +A+GM +L   SR + +HRDL A N+LL  +   KI DFG+AR I+ + +    G+A   
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                  +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 238 ----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 60/234 (25%), Positives = 94/234 (40%), Gaps = 55/234 (23%)

Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSSC----SEQGTAEFTNEVLLILKLQHKNLVKL 410
           ++G+G FG V+     D  +V A+K L         Q  A    E  ++       +VKL
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66

Query: 411 LGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG------IAKGML 462
             +    DE+ L  V E+MP G L           +L    R ++         IA+ +L
Sbjct: 67  --YYSFQDEEHLYLVMEYMPGGDL---------MNLLI---RKDVFPEETARFYIAELVL 112

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-------RIFAESEGEANTVR--- 512
            L    +L  +HRD+K  N+L+D+D + K++DFG+                  N +    
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 513 -----------------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                             VGT  Y+APE      Y  + D +S GV+L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 7/95 (7%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
           I+ G+ +LH      I++RDLK  NV+LDS+ + KI+DFGM +   E   +  T R   G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE      Y K  D +++GVLL E++ G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 12/194 (6%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G G +G VYK   L  G+  AVK +        +    E+ ++ + +H N+V   G  +
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
             ++  +  E+   GSL  I       G L   +   +     +G+ YLH   ++   HR
Sbjct: 77  SREKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLAYLHSKGKM---HR 130

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSK 532
           D+K +N+LL  + + K++DFG+A     +  +  +   +GT  +MAPE A     G Y++
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNGGYNQ 188

Query: 533 KSDVFSFGVLLIEI 546
             D+++ G+  IE+
Sbjct: 189 LCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 15/209 (7%)

Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQ 403
           A +++ +   LG+G +  VYKG+   +G+ VA+K +S  +E+G   FT   E  L+  L+
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61

Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           H N+V LL   +   E L  V+E+M       ++  P   G+  +  R  +   + +G+ 
Sbjct: 62  HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLRGLA 117

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y+H      I+HRDLK  N+L+      K++DFG+AR  A+S         V T  Y  P
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172

Query: 523 EYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           +  +    YS   D++  G + IE++ G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 54/222 (24%)

Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V+K    +  E VA+KR  L    E   +    E+ L+ +L+HKN+V+L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD- 66

Query: 414 CVDGDEKL-LVYEFMP----------NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
            +  D+KL LV+E+            NG +D  +               + +  + KG+ 
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK-------------SFMFQLLKGLA 113

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF--------AESEGEANTVRIV 514
           + H      ++HRDLK  N+L++ +   K++DFG+AR F        AE          V
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE----------V 160

Query: 515 GTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGS 555
            T  Y  P+      LYS   D++S G +  E+     NAG 
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL----ANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE----FTNEVLLILKLQHKNLVKL 410
           ++G+G FG V      +DGK  AVK L   +     E         +L+  ++H  LV L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
             +     +KL  V +++  G L   L   R+R     R R      IA  + YLH    
Sbjct: 62  -HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS--- 114

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
           L I++RDLK  N+LLDS  +  ++DFG+ +     E    T    GT  Y+APE   +  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 530 YSKKSDVFSFGVLLIEIITG 549
           Y +  D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 39/95 (41%), Positives = 57/95 (60%), Gaps = 7/95 (7%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
           IA G+ +LH      I++RDLK  NV+LDS+ + KI+DFGM +   E+  +  T +   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE      Y K  D ++FGVLL E++ G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 357 LGQGGFGPVYKGV---LSDGK-----EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           LGQG F  ++KG+   + D       EV +K L       +  F     ++ +L HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
              G CV GDE ++V E++  GSLD  L   +    + W  +  +   +A  + +L +  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 469 RLRIVHRDLKASNVLL--DSDMNS------KISDFGMARIFAESEGEANTVRIVGTYGYM 520
              + H ++ A NVLL  + D  +      K+SD G++        E    RI     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI----PWV 171

Query: 521 APEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
            PE        S  +D +SFG  L EI +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 66.9 bits (163), Expect = 6e-12
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 17/207 (8%)

Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNL 407
           + D   +G G +G V   +    G +VA+K+L     SE        E+ L+  ++H+N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 408 VKLLG-FCVDG--DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           + LL  F  D   D     Y  MP    D  L    K   L   +   +V  + KG+ Y+
Sbjct: 77  IGLLDVFTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H      I+HRDLK  N+ ++ D   KI DFG+AR   +SE     V    T  Y APE 
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSEMTGYVV----TRWYRAPEV 186

Query: 525 AMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +  + Y++  D++S G ++ E++TG+
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 21/204 (10%)

Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKL 410
           +LG+G FG V    L    EV A+K L        +      T + +L L  +H  L  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                  D    V E++  G L   +F   R R     R R      +   +++LH    
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG- 116

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIVGTYGYMAPEYAM 526
             +++RDLK  N+LLD++ + K++DFGM +     EG  N   T    GT  Y+APE   
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCK-----EGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
           E  Y    D ++ GVL+ E++ G+
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 63/217 (29%), Positives = 95/217 (43%), Gaps = 48/217 (22%)

Query: 356 ILGQGGFGPV----YKGVLSDGKEVAVKRL------------SSCSEQGTAEFTNEVLLI 399
           +LG+G FG V    YK     G+  A+K L            S   E+   E  N     
Sbjct: 6   VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN----- 57

Query: 400 LKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSL-----DAILFDPRKRGILCWRKRTNI 453
              +H  LV L   C   ++ +  V E+   G L       +  +PR             
Sbjct: 58  -SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAA------- 108

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TVR 512
              +  G+ YLHE+   +IV+RDLK  N+LLD++   KI+DFG+ +   E  G  + T  
Sbjct: 109 --CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTST 160

Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             GT  ++APE   E  Y++  D +  GVL+ E++ G
Sbjct: 161 FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG- 412
           +G+G +G VYK    DG   ++ A+K++       +A    E+ L+ +L+H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66

Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY-----LHE 466
           F    D K+ L++++  +     I F    R     +K   +  G+ K +LY     +H 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKF---HRASKANKKPVQLPRGMVKSLLYQILDGIHY 123

Query: 467 DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF-AESEGEANTVRIVGTYGYMA 521
                ++HRDLK +N+L+  +       KI+D G AR+F +  +  A+   +V T+ Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIIT 548
           PE  +    Y+K  D+++ G +  E++T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.5 bits (165), Expect = 1e-11
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 41/226 (18%)

Query: 356 ILGQGGFGPVYKGVLSD---GKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           ++G+GG G VY     D    + VA+K++    S +      F  E  +   L H  +V 
Sbjct: 9   LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 410 LLGFCVDGDEKLLVYEFMP---NGSLDAILFDPRKRGILC--WRKRTN------IVNGIA 458
           +   C DGD    VY  MP     +L ++L    ++  L     ++T+      I + I 
Sbjct: 67  VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEAN-------- 509
             + Y+H  S+  ++HRDLK  N+LL       I D+G A     E E   +        
Sbjct: 124 ATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 510 -----TV--RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                T+  +IVGT  YMAPE  +    S+ +D+++ GV+L +++T
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 356 ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVK 409
           ++G+G FG V      SDG   AVK L   +     EQ        VLL   L+H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-KNLKHPFLVG 60

Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L  +     EKL  V +++  G L       R+R  L  R R      +A  + YLH   
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS-- 114

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
            L I++RDLK  N+LLDS  +  ++DFG+ +   E E   +T    GT  Y+APE   + 
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST--FCGTPEYLAPEVLRKE 171

Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y +  D +  G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 26/223 (11%)

Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNE 395
            +  L +   +F    ++G+G FG V        K+V A+K LS         +A F  E
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFD---PRKRGILCWRKR 450
             ++     + +V+L       D+K L  V E+MP G L  ++ +   P K     W + 
Sbjct: 94  RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----WARF 146

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                  A+ +L L     +  +HRD+K  N+LLD   + K++DFG   +  ++ G    
Sbjct: 147 Y-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRC 200

Query: 511 VRIVGTYGYMAPEYAM----EGLYSKKSDVFSFGVLLIEIITG 549
              VGT  Y++PE       +G Y ++ D +S GV L E++ G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 20/209 (9%)

Query: 348 TSNFSDSNILGQGGFGPV--YKGVLSDGKEVAVKRL-SSCSEQGTAEFT-NEVLLILKLQ 403
           T+ + D   +G G FG V   +  L+ G+ VA+K++    S    A+ T  E+ L+  L+
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67

Query: 404 HKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           H+N++ L    +   E +  V E +    L  +L        L  +     +  I +G+ 
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLGT-DLHRLL----TSRPLEKQFIQYFLYQILRGLK 122

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y+H      +VHRDLK SN+L++ + + KI DFG+ARI      +      V T  Y AP
Sbjct: 123 YVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYRAP 174

Query: 523 EYAME-GLYSKKSDVFSFGVLLIEIITGR 550
           E  +    Y  + D++S G +  E++ G+
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.8 bits (163), Expect = 2e-11
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 18/191 (9%)

Query: 373 GKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMP 428
           G EVA+K L + + +     A F  E  L  +L H N+V LL         L  V+E++P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---D 485
             +L  +L      G L   +   ++  +   +   H      IVHRDLK  N+++    
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116

Query: 486 SDMNSKISDFGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFG 540
              ++K+ DFG+  +              T  ++GT  Y APE       +  SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 541 VLLIEIITGRR 551
           ++ +E +TG+R
Sbjct: 177 LIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 45/206 (21%), Positives = 81/206 (39%), Gaps = 20/206 (9%)

Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
                    + K        VAVK+  L SCS++       E++   +LQH N++  +  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT---NIVNGIAKGMLYLHEDSRL 470
            +   E  +V   M  GS + +L      G+           I+  +   + Y+H     
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLLKTHFPEGL----PELAIAFILKDVLNALDYIH---SK 120

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAPEYA 525
             +HR +KAS++LL  D    +S    +    +       V            +++PE  
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180

Query: 526 MEGL--YSKKSDVFSFGVLLIEIITG 549
            + L  Y++KSD++S G+   E+  G
Sbjct: 181 QQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 44/128 (34%), Positives = 64/128 (50%), Gaps = 10/128 (7%)

Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
           Y+   +  +  +L D    G L      +    +A+GM +L   +    VHRDL A NVL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEG-LTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269

Query: 484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTY---GYMAPEYAMEGLYSKKSDVFSFG 540
           L      KI DFG+AR       ++N V    T+    +MAPE   + LY+  SDV+S+G
Sbjct: 270 LAQGKIVKICDFGLARDIMH---DSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYG 326

Query: 541 VLLIEIIT 548
           +LL EI +
Sbjct: 327 ILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 5/95 (5%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           I +G+ YLH      I+HRD+K  N+L++S+   KI DFG+AR+    E +  T  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 517 YGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           Y Y APE  M    Y+   D++S G +  E++  R
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 39/94 (41%), Positives = 59/94 (62%), Gaps = 7/94 (7%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEG-EANTVRIV 514
           +A+GM +L   SR + +HRDL A N+LL  +   KI DFG+AR I+ + +     + R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 37/211 (17%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +    A+ T   L +LK ++H+N++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 85  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 132

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR   +          V T  Y 
Sbjct: 133 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYR 184

Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 13/197 (6%)

Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGF 413
           LG+G +  VYKG    +GK VA+K +    E+GT  FT   E  L+  L+H N+V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHANIVLLHDI 71

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
               +   LV+E++     D   +  +  G L        +  + +G+ Y+H+     I+
Sbjct: 72  IHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---IL 125

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSK 532
           HRDLK  N+L+      K++DFG+AR  A+S         V T  Y  P+  +    YS 
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 533 KSDVFSFGVLLIEIITG 549
             D++  G + +E+I G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 21/208 (10%)

Query: 357 LGQGGFGPVYKGVLSDG---KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG- 412
           +G+G +G VYK    DG   KE A+K++       +A    E+ L+ +L+H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66

Query: 413 FCVDGDEKL-LVYEFMPNGSLDAILF----DPRKRGILCWRKRT-NIVNGIAKGMLYLHE 466
           F    D K+ L++++  +     I F       K+ +   R    +++  I  G+ YLH 
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 467 DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF-AESEGEANTVRIVGTYGYMA 521
           +    ++HRDLK +N+L+  +       KI+D G AR+F +  +  A+   +V T+ Y A
Sbjct: 127 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIIT 548
           PE  +    Y+K  D+++ G +  E++T
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 41/97 (42%), Positives = 59/97 (60%), Gaps = 13/97 (13%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE----GEANTV 511
           +AKGM +L   SR + +HRDL A N+LL  +   KI DFG+AR I+ + +    G+A   
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                  +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 244 ----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 21/191 (10%)

Query: 371 SDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 429
           SD KE  V +    +++  A +  +E+  +    H  +VK        D+ LL+ E+   
Sbjct: 90  SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149

Query: 430 GSLDAIL---------FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480
           G L+  +         F   + G+L ++    IV       L L E    +++HRDLK++
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQ----IV-------LALDEVHSRKMMHRDLKSA 198

Query: 481 NVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFG 540
           N+ L      K+ DFG ++ +++S          GT  Y+APE      YSKK+D++S G
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258

Query: 541 VLLIEIITGRR 551
           V+L E++T  R
Sbjct: 259 VILYELLTLHR 269

Length = 478

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 56/225 (24%)

Query: 357 LGQGGFGPV----YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLI-----LKL----- 402
           LGQG +G V         S+ + VA+K++++        F+ ++L       LKL     
Sbjct: 8   LGQGAYGIVCSARNAET-SEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFR 59

Query: 403 QHKNLVKLLGFCV---DGDEKLLVYEFMPNGSLDAILFDPRKRG----------ILCWRK 449
            HKN+  L    +       +L +YE +    L  I+   +             ILC   
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC--- 116

Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
                     G+ Y+H  +   ++HRDLK  N+L+++D   KI DFG+AR F+E+ GE N
Sbjct: 117 ----------GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-N 162

Query: 510 TVRI---VGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
              +   V T  Y APE  +    Y+K  DV+S G +L E++  +
Sbjct: 163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILK-LQHKNLVKL 410
           ++G+G FG V      ++ K  AVK L       ++      +E  ++LK ++H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
                  D+   V +++  G L   L   R+R  L  R R      IA  + YLH    L
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 115

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
            IV+RDLK  N+LLDS  +  ++DFG+ +   E  G  +T    GT  Y+APE   +  Y
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST--FCGTPEYLAPEVLHKQPY 173

Query: 531 SKKSDVFSFGVLLIEIITG 549
            +  D +  G +L E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 26/223 (11%)

Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE----QGTAEFTNE 395
            +  L +   ++    ++G+G FG V        ++V   +L S  E      +A F  E
Sbjct: 34  KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFD---PRKRGILCWRKR 450
             ++       +V+L  FC   D+K L  V E+MP G L  ++ +   P K     W K 
Sbjct: 94  RDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKF 146

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                  A+ +L L     + ++HRD+K  N+LLD   + K++DFG      E+ G    
Sbjct: 147 YT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVRC 200

Query: 511 VRIVGTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITG 549
              VGT  Y++PE       +G Y ++ D +S GV L E++ G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 31/207 (14%)

Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGF 413
           LG+G +  VYKG   L+D   VA+K +    E+G       EV L+  L+H N+V L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---------GIAKGMLYL 464
                   LV+E++ +  L   L D       C     N +N          + +G+ Y 
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDD-------C----GNSINMHNVKLFLFQLLRGLNYC 120

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H   R +++HRDLK  N+L++     K++DFG+AR  A+S         V T  Y  P+ 
Sbjct: 121 H---RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDI 175

Query: 525 AMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +    YS + D++  G +  E+ TGR
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 22/204 (10%)

Query: 356 ILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLV 408
           +LG+G FG V   +L    + GK  A+K L      ++   A    E  ++   +H  L 
Sbjct: 2   LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
            L       D    V E++  G L    F    R  +    RT      I   + YLH  
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMAPEYAM 526
              +IV+RDLK  N++LD D + KI+DFG+ +   E   +A T++   GT  Y+APE   
Sbjct: 115 ---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLE 168

Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
           +  Y +  D +  GV++ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 20/185 (10%)

Query: 373 GKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGFCV------DGDEKLLVY 424
           G  VAVK+LS   +  T A+     L++LK + HKN++ LL          +  +  LV 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
           E M       I  +      L   + + ++  +  G+ +LH      I+HRDLK SN+++
Sbjct: 106 ELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156

Query: 485 DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLI 544
            SD   KI DFG+AR          T  +V  Y Y APE  +   Y +  D++S G ++ 
Sbjct: 157 KSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213

Query: 545 EIITG 549
           E++ G
Sbjct: 214 ELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 9/95 (9%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +A GM +L   +    VHRDL A NVL+      KI DFG+AR       ++N +    T
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMR---DSNYISKGST 301

Query: 517 Y---GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +    +MAPE     LY+  SDV+SFG+LL EI T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 15/199 (7%)

Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGF 413
           LG+G +  V+KG   L++   VA+K +    E+G       EV L+  L+H N+V L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
            V  D+ L LV+E++ +  L   + D     I+        +  I +G+ Y H   R ++
Sbjct: 73  -VHTDKSLTLVFEYL-DKDLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKV 125

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYS 531
           +HRDLK  N+L++     K++DFG+AR  A+S         V T  Y  P+  +    YS
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 532 KKSDVFSFGVLLIEIITGR 550
            + D++  G +  E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 37/212 (17%)

Query: 357 LGQGGFGPVYKGVL---SDGK--------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHK 405
           LGQG F  +YKGVL   SD           V +K L S   + +  F     L+ +L HK
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           +LVKL G CV  DE ++V E++  G LD  L   +    L W  + ++   +A  + YL 
Sbjct: 62  HLVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 466 EDSRLRIVHRDLKASNVLL--DSDMNS-----KISDFGMAR-IFAESEGEANTVRIVGTY 517
           +    ++VH ++   N+L+             K+SD G+   + +  E      RI    
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RI---- 168

Query: 518 GYMAPEYAMEGLYSKKS---DVFSFGVLLIEI 546
            ++APE  +    +  +   D +SFG  L+EI
Sbjct: 169 PWIAPEC-IRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 37/210 (17%)

Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGF 413
           LG+G +  VYKG     G+ VA+K +    E+G A FT   E  L+  L+H N+V  L  
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIV-TLHD 70

Query: 414 CVDGDEKL-LVYEFM-----------PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            +   + L LV+E++             G             +  ++        + +G+
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYMDDCGGG------LSMHNVRLFLFQ--------LLRGL 116

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            Y H   + R++HRDLK  N+L+      K++DFG+AR  A+S         V T  Y  
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTLWYRP 171

Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           P+  +    YS   D++  G +  E+ TGR
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 62/244 (25%), Positives = 104/244 (42%), Gaps = 52/244 (21%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQ 403
            +F    ++G+G FG V      D G   A+K+L        EQ  A    E  ++ +  
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59

Query: 404 HKNLVKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           +  +VKL  +    DE    L+ E++P G +  +L    K+      + T     IA+ +
Sbjct: 60  NPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM---KKDTFT-EEETRFY--IAETI 111

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM------------ARIFAESEGEAN 509
           L +    +L  +HRD+K  N+LLD+  + K+SDFG+             RI + +     
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171

Query: 510 TVRI------------------------VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIE 545
              I                        VGT  Y+APE  ++  Y+K+ D +S GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231

Query: 546 IITG 549
           ++ G
Sbjct: 232 MLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 24/248 (9%)

Query: 314 DANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDG 373
           D    +    H      D + ++  ID +       ++   NI+G G FG VY+ +  D 
Sbjct: 32  DKKLDEEERSHNNNAGED-EDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDT 90

Query: 374 KE-VAVKRLSSCSEQGTAEFTNEVLLILK-LQHKNLVKLLGF----CVDGDEKLL----V 423
            E VA+K++         ++ N  LLI+K L H N++ L  +    C   +EK +    V
Sbjct: 91  SEKVAIKKVLQ-----DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145

Query: 424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL 483
            EF+P      +    R    L           + + + Y+H      I HRDLK  N+L
Sbjct: 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLL 202

Query: 484 LDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGV 541
           +D + ++ K+ DFG A+          +V  + +  Y APE  +    Y+   D++S G 
Sbjct: 203 IDPNTHTLKLCDFGSAKNLL---AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGC 259

Query: 542 LLIEIITG 549
           ++ E+I G
Sbjct: 260 IIAEMILG 267

Length = 440

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 59/201 (29%), Positives = 86/201 (42%), Gaps = 50/201 (24%)

Query: 373 GKEVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLLGFCVDGDEKL-- 421
           G+ VA+K+LS         F N         E++L+  + HKN++ LL       + L  
Sbjct: 41  GQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLN-VFTPQKSLEE 92

Query: 422 -----LVYEFMPNGSLDAILFD-PRKR------GILCWRKRTNIVNGIAKGMLYLHEDSR 469
                LV E M       I  D   +R       +LC             G+ +LH    
Sbjct: 93  FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLC-------------GIKHLHSAG- 138

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             I+HRDLK SN+++ SD   KI DFG+AR          T  +V  Y Y APE  +   
Sbjct: 139 --IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMG 193

Query: 530 YSKKSDVFSFGVLLIEIITGR 550
           Y +  D++S G ++ E+I G 
Sbjct: 194 YKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 11/197 (5%)

Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLGFC 414
           LG+G +  V+KG        VA+K +    E+G       EV L+  L+H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
                  LV+E++ +   D   +      ++        +  + +G+ Y H   + +I+H
Sbjct: 73  HTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILH 126

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSKK 533
           RDLK  N+L++     K++DFG+AR  A+S         V T  Y  P+  +    YS  
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTP 184

Query: 534 SDVFSFGVLLIEIITGR 550
            D++  G +L E+ TGR
Sbjct: 185 IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 357 LGQGGFGPVYKGVLSDGKEVA---VKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           +G G FG V    +     VA   VK L   +S  EQ       +   IL  QH N+++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL--QHPNILQC 60

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           LG CV+    LLV+E+   G L + L      R+   L   +R  +   IA G+ ++H  
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHMH-- 116

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI-FAESEGEANTVRIVGTYGYMAPEYAM 526
            +   +H DL   N  L SD+  K+ D+G+    + E   E    + V    ++APE   
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174

Query: 527 E---GLYS----KKSDVFSFGVLLIEI 546
           E   GL +    K S+V++ GV L E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTN-----EVLLILKLQHKNLVKL 410
           +G+G FG VY+    D + + A+K LS        E  +      +L+   L     +  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L F    D  L LV ++M  G L    +  +K G     +    +  +   + +LH+   
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD- 116

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EG 528
             IV+RDLK  N+LLD+  +  + DFG+++  A       T    GT  Y+APE  + E 
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEK 172

Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y+K  D +S GVL+ E+  G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 67/204 (32%), Positives = 92/204 (45%), Gaps = 23/204 (11%)

Query: 356 ILGQGGFGPVYKGVLS-DGKEVAVKRLS-----SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           ++G+G FG V       DGK  AVK L      +  EQ        VLL   ++H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL-KNVKHPFLVG 60

Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L  +     EKL  V +F+  G L       R+R     R R      IA  + YLH   
Sbjct: 61  L-HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAE-IASALGYLHS-- 114

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA---NTVRIVGTYGYMAPEYA 525
            + IV+RDLK  N+LLDS  +  ++DFG+ +     EG A    T    GT  Y+APE  
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK-----EGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
            +  Y    D +  G +L E++ G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 36/96 (37%), Positives = 57/96 (59%), Gaps = 11/96 (11%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +A+GM +L   +    +HRD+ A NVLL     +KI DFG+AR   +   ++N V + G 
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR---DIMNDSNYV-VKGN 273

Query: 517 ----YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                 +MAPE   + +Y+ +SDV+S+G+LL EI +
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.0 bits (146), Expect = 7e-10
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 38/209 (18%)

Query: 357 LGQGGFGPVYKG-VLSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLL 411
           +G+G F  V K      GK  A+K +       EQ       E+  + +L  H N+++L+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64

Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFD---PRKRGILCWRKRTNIVNGIAKGMLYLHE 466
               D       LV+E M     D  L++    RKR  L  ++  + +  + K + ++H 
Sbjct: 65  EVLFDRKTGRLALVFELM-----DMNLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMH- 117

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI------FAESEGEANTVRIVGTYGYM 520
             R  I HRD+K  N+L+  D   K++DFG  R       + E          + T  Y 
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---------YISTRWYR 165

Query: 521 APEYAM-EGLYSKKSDVFSFGVLLIEIIT 548
           APE  + +G Y  K D+++ G +  EI++
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.9 bits (147), Expect = 9e-10
 Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 19/163 (11%)

Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLV--------YEFMPNGSLDAILFDPRKRGIL 445
           NE+L + +L H+N++K+           ++        Y FM + + D       K   L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW------KDRPL 265

Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
             + R  I+  +   + Y+H+    +++HRD+K  N+ L+ D    + DFG A  F E E
Sbjct: 266 LKQTRA-IMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKE 320

Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            EA     VGT    +PE      Y + +D++S G++L+++++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
            A+ +  L    +  +++RDLK  N+LLD   +  + DFG+ ++  + + + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             Y+APE  +   Y+K  D ++ GVLL E++TG
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 37/96 (38%), Positives = 56/96 (58%), Gaps = 11/96 (11%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +AKGM +L   +    +HRDL A N+LL     +KI DFG+AR   +   ++N V + G 
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR---DIRNDSNYV-VKGN 275

Query: 517 ----YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                 +MAPE     +Y+ +SDV+S+G+LL EI +
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 7/89 (7%)

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMA 521
           +LHE     I++RDLK  NVLLD++ + K++D+GM +   E     +T     GT  Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIA 164

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           PE      Y    D ++ GVL+ E++ GR
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 25/202 (12%)

Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 83  NVFTPQKSLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 136

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 190

Query: 526 MEGLYSKKSDVFSFGVLLIEII 547
           +   Y +  D++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 11/97 (11%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRI 513
           I   + YLH      +V+RD+K  N++LD D + KI+DFG+ +     EG    A     
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTF 155

Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            GT  Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 7/95 (7%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
           I   + YLH      +V+RDLK  N++LD D + KI+DFG+ +   E   +  T++   G
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 157

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 20/213 (9%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSD---GKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQH 404
           +F   +++G+G FG V   V+ +   G   A+K +  S    Q T  F  E   IL + +
Sbjct: 2   DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 405 KNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
              +  L +   D D   LV E+ P G L ++L   R                +A+ +L 
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQF---DEDMAQFYLAELVLA 114

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           +H   ++  VHRD+K  NVL+D   + K++DFG A     +    N+   VGT  Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAPE 173

Query: 524 Y--AMEG----LYSKKSDVFSFGVLLIEIITGR 550
               M G     Y  + D +S GV+  E+I GR
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 12/197 (6%)

Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE--FTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V+K    + G+ VA+K+     +    +     E+ ++ +L+H NLV L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
                +  LV+E+  +  L+ +  +PR       +K   I+    + + + H   +   +
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCH---KHNCI 122

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSK 532
           HRD+K  N+L+      K+ DFG ARI   +    +    V T  Y APE  +    Y  
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLVGDTQYGP 180

Query: 533 KSDVFSFGVLLIEIITG 549
             DV++ G +  E++TG
Sbjct: 181 PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 37/211 (17%)

Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGF 413
           +G G +G V     +  ++ VAVK+LS   +    A  T   L +LK ++H+N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  S++          L       I+  +K ++     ++  + +G
Sbjct: 83  ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SNV ++ D   +I DFG+AR     + +      V T  Y 
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYR 182

Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)

Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89

Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E+I G 
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 20/204 (9%)

Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGT-AEFT-NEVLLILKLQHKNLVKLLGF 413
           +G+G +G V     S+  ++VA+K++++  +    A+ T  E+ L+  L H+N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71

Query: 414 CVDGDEK------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
            +    +       +VYE M +  L  I+   R    L        +  + +G+ Y+H  
Sbjct: 72  IMPPPHREAFNDVYIVYELM-DTDLHQII---RSSQTLSDDHCQYFLYQLLRGLKYIHSA 127

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
           +   ++HRDLK SN+LL+++ + KI DFG+AR    SE        V T  Y APE  + 
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 528 -GLYSKKSDVFSFGVLLIEIITGR 550
              Y+   DV+S G +  E++  +
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 6/95 (6%)

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI-FAESEGEANTVRIVGTY 517
           + + Y+H  +   + HRDLK  N+L ++D   KI DFG+AR+ F ++         V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 518 GYMAPEY--AMEGLYSKKSDVFSFGVLLIEIITGR 550
            Y APE   +    Y+   D++S G +  E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 35/89 (39%), Positives = 51/89 (57%), Gaps = 7/89 (7%)

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMA 521
           +LHE     I++RDLK  NVLLD+D + K++D+GM +   E  G  +T     GT  Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIA 164

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           PE      Y    D ++ GVL+ E++ GR
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 6/95 (6%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
           I   + YLH  S   +V+RDLK  N++LD D + KI+DFG+ +   E   +  T++   G
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCG 158

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRI 513
           I+  + YLHE     I++RDLK  NVLLDS+ + K++D+GM +     EG      T   
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTF 156

Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            GT  Y+APE      Y    D ++ GVL+ E++ GR
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 29/236 (12%)

Query: 329 DNDL-KAQDFFIDLETLNLATSNFSDSNILGQGGFGPV----YKGVLSDGKEVAVKRLSS 383
           DN L + +D    +  L +   ++    ++G+G FG V    +K   S  K  A+K LS 
Sbjct: 22  DNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK---STRKVYAMKLLSK 78

Query: 384 CS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFD-- 438
               ++  + F  E   I+   +   V  L +    D  L +V E+MP G L  ++ +  
Sbjct: 79  FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 138

Query: 439 -PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
            P K     W +        A+ +L L     +  +HRD+K  N+LLD   + K++DFG 
Sbjct: 139 VPEK-----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188

Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITG 549
             +    EG       VGT  Y++PE       +G Y ++ D +S GV L E++ G
Sbjct: 189 C-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 43/237 (18%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHK 405
           +F    ++G+G FG V      D G   A+K L       ++  A    E  ++++    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
            +VK+     D     L+ EF+P G +  +L    K+  L   + T     IA+ +L + 
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLS-EEATQFY--IAETVLAID 115

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE---------------------- 503
              +L  +HRD+K  N+LLD+  + K+SDFG+     +                      
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175

Query: 504 --SEGEANTVR---------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             S+ +A T +          VGT  Y+APE  M+  Y+K  D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 57.8 bits (139), Expect = 6e-09
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 43/237 (18%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHK 405
           +F    ++G+G FG V      D G   A+K L       ++       E  ++++    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
            +VK+     D     L+ EF+P G +  +L    K+  L   + T     IA+ +L + 
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLT-EEETQFY--IAETVLAID 115

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE---------------------- 503
              +L  +HRD+K  N+LLDS  + K+SDFG+     +                      
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175

Query: 504 --SEGEANTVR---------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             S+ +A T +          VGT  Y+APE  M+  Y+K  D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 6/98 (6%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           IA+ +L +H   +L  VHRD+K  NVLLD + + +++DFG   +    +G   +   VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGT 166

Query: 517 YGYMAPEY--AME---GLYSKKSDVFSFGVLLIEIITG 549
             Y++PE   AME   G Y  + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 8/99 (8%)

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVG 515
           +A+ +L +    +L  VHRD+K  NVLLD + + +++DFG   R+ A+   ++N    VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165

Query: 516 TYGYMAPEY--AME---GLYSKKSDVFSFGVLLIEIITG 549
           T  Y++PE   AME   G Y  + D +S GV + E++ G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 16/100 (16%)

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI--------FAESEGEANT---- 510
           YLH      IVHRDLK  N+L+ S  + K++DFG+++I          E   E +T    
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 511 -VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             ++ GT  Y+APE  +   Y K  D ++ G++L E + G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 44/223 (19%)

Query: 357 LGQGGFGPVYKGVL-----------------------SDGKE--VAVKRLSSCSEQGTAE 391
           LGQG    +Y G L                       ++G+E  V +K L          
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 392 FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
           F     L+ ++ H +L  + G CV G E ++V EF+ +G LD  L   + R  + W  + 
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD----SDMNS---KISDFGMARIFAES 504
            +   +A  + YL ED  L  VH ++ A N+LL     ++  S   K+SD G++  F   
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175

Query: 505 EGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEI 546
             E    RI     ++APE    G   S  +D +SFG  L+EI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 50/189 (26%), Positives = 91/189 (48%), Gaps = 17/189 (8%)

Query: 373 GKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG 430
           G  V V+   L +C+E+      NEV+L    +H N++        G    ++  FM  G
Sbjct: 25  GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84

Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
           S +++L      G+       NI+ G  +G+ YLH++     +HR++KAS++L+  D   
Sbjct: 85  SANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLV 140

Query: 491 KISDFGMARIFA-ESEGEANTVRI------VGTYGYMAPEYAMEGL--YSKKSDVFSFGV 541
            +S  G++ +++    G+   V             +++PE   + L  Y+ KSD++S G+
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198

Query: 542 LLIEIITGR 550
              E+ TGR
Sbjct: 199 TACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEVLLILKLQHK 405
           +F    ++G+G FG V    L +  +V A+K L+         TA F  E  +++   ++
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
            +  L     D +   LV ++   G L  +L     R          +   +A+   YL 
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR----------LPEDMAR--FYLA 109

Query: 466 E-----DS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           E     DS  +L  VHRD+K  N+L+D + + +++DFG      E +G   +   VGT  
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPD 168

Query: 519 YMAPEY--AME---GLYSKKSDVFSFGVLLIEIITG 549
           Y++PE   AME   G Y  + D +S GV + E++ G
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 32/211 (15%)

Query: 357 LGQGGFGPVYKGVLSDGKE-------------VAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
           LG+G    +Y G+L+   +             V +K L       +  F     ++ ++ 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           HK++V L G CV   E ++V EF+  G LD  LF  RK  +L    +  +   +A  + Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 464 LHEDSRLRIVHRDLKASNVLL-----DSDMNS--KISDFGMARIFAESEGEANTVRIVGT 516
           L ED  L  VH ++   N+LL     D +     K+SD G+  I   S  E      V  
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQEC-----VER 171

Query: 517 YGYMAPEYAMEG-LYSKKSDVFSFGVLLIEI 546
             ++APE   +    S  +D +SFG  L EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 47/201 (23%), Positives = 78/201 (38%), Gaps = 14/201 (6%)

Query: 372 DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYEFMPNG 430
             K+V VK ++     G      E+ ++  + H+ ++ L    +     K  V   MP  
Sbjct: 118 QRKKVIVKAVTGGKTPGR-----EIDILKTISHRAIINL----IHAYRWKSTVCMVMPKY 168

Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
             D   +  R  G L   +   I   + + + YLH      I+HRD+K  N+ LD   N+
Sbjct: 169 KCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224

Query: 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            + DFG A                GT    +PE      Y  K+D++S G++L E+    
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284

Query: 551 RNAGSNQLLAYGMYWSWLIHC 571
                 Q+ +       +I C
Sbjct: 285 VTLFGKQVKSSSSQLRSIIRC 305

Length = 392

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 60/257 (23%), Positives = 101/257 (39%), Gaps = 71/257 (27%)

Query: 350 NFSDSNILGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
           +F    ++G+G FG V + V     GK  A+K L       +  F  + L  +K +   L
Sbjct: 2   DFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLK-----SEMFKKDQLAHVKAERDVL 55

Query: 408 --------VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--I 457
                   V L     D     L+ EF+P G L  +L          +   +  V    +
Sbjct: 56  AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--------YDTFSEDVTRFYM 107

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES----------EGE 507
           A+ +L +    +L  +HRD+K  N+L+D   + K+SDFG++  F +           +G+
Sbjct: 108 AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 508 ANTVRI-----------------------------------VGTYGYMAPEYAMEGLYSK 532
           +N  RI                                   VGT  Y+APE  ++  Y +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227

Query: 533 KSDVFSFGVLLIEIITG 549
           + D +S G ++ E + G
Sbjct: 228 ECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 53/247 (21%), Positives = 94/247 (38%), Gaps = 51/247 (20%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS---EQGTAEFTNEVLLILKLQH 404
           S F     +G G FG V      D   + A+K L           A    E  ++ +  +
Sbjct: 1   SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           + +VKL     D D    V +++P G + ++L    + GI         +  +   +  +
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESV 117

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF----------------------- 501
           H   ++  +HRD+K  N+L+D D + K++DFG+   F                       
Sbjct: 118 H---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 502 ----AESEGEANTVR--------------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
                        +               +VGT  Y+APE  +   Y++  D +S GV+L
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234

Query: 544 IEIITGR 550
            E++ G+
Sbjct: 235 YEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 13/165 (7%)

Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-L 445
            GTA    E  ++  + H ++++L G         L+   +P    D   +   KR I +
Sbjct: 128 GGTA---TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI 181

Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           C      I   + + + YLHE+   RI+HRD+KA N+ ++   +  + DFG A  F    
Sbjct: 182 C--DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDI 235

Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
                    GT    APE      Y    D++S G++L E+ T  
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 49/192 (25%), Positives = 89/192 (46%), Gaps = 31/192 (16%)

Query: 386 EQGTAEFTNEVLLILKLQHKNLVKLLG-FCVDGDEKL-LVYEFMPNGSLDAILFDPRKR- 442
           E+  ++   EV ++ +L+HKN+V+ +  F    ++KL ++ EF   G L   +    K  
Sbjct: 53  EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112

Query: 443 GILCWRKRTNIVNGIAKGMLYLHE----DSRLRIVHRDLKASNVLLDSDMN--------- 489
           G +      +I   +   + Y H      +  R++HRDLK  N+ L + +          
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172

Query: 490 --------SKISDFGMAR-IFAESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFS 538
                   +KI DFG+++ I  ES   +     VGT  Y +PE  +     Y  KSD+++
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIESMAHS----CVGTPYYWSPELLLHETKSYDDKSDMWA 228

Query: 539 FGVLLIEIITGR 550
            G ++ E+ +G+
Sbjct: 229 LGCIIYELCSGK 240

Length = 1021

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 32/150 (21%), Positives = 58/150 (38%), Gaps = 15/150 (10%)

Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV--KLLGF 413
           +L  G    VY  + +  ++  +K   S   +  A+   EV ++  L  K L   K+L  
Sbjct: 5   LLKGGLTNRVYL-LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
                   L+ E++   +LD +  + ++           +   +AK    LH+   L + 
Sbjct: 62  GESDGWSYLLMEWIEGETLDEVSEEEKED------IAEQLAELLAK----LHQLPLLVLC 111

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAE 503
           H DL   N+L+D      I D+  A     
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 44/198 (22%), Positives = 93/198 (46%), Gaps = 26/198 (13%)

Query: 365 VYKGVLSDGKEVAVKRLSSCSEQGTA----EFTNEVLLILKLQHKNLVKLLGFCVDGDEK 420
           +YKG+  + KEV ++       +G         NE+  + ++   N++K+ GF +D  + 
Sbjct: 36  IYKGIF-NNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 421 L----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHR 475
           L    L+ E+   G L  +L    K   L ++ + ++     KG+  L++  ++    ++
Sbjct: 94  LPRLSLILEYCTRGYLREVL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYK 147

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK--- 532
           +L + + L+  +   KI   G+ +I +         + V    Y + +  +  ++S+   
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKM-LNDIFSEYTI 201

Query: 533 KSDVFSFGVLLIEIITGR 550
           K D++S GV+L EI TG+
Sbjct: 202 KDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 57/251 (22%), Positives = 98/251 (39%), Gaps = 55/251 (21%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS---EQGTAEFTNEVLLILKLQH 404
           S F     LG G FG V      D K + A+K L           A    E  ++ +  +
Sbjct: 1   SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           + +V+L     D D    V +++P G + ++L    + GI            IA+    +
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMGIF---PEDLARFYIAELTCAV 114

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM----------------------ARIFA 502
               ++  +HRD+K  N+L+D D + K++DFG+                      +  F+
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174

Query: 503 ESEGEANTVR-----------------------IVGTYGYMAPEYAMEGLYSKKSDVFSF 539
              G+    R                       +VGT  Y+APE  +   Y++  D +S 
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234

Query: 540 GVLLIEIITGR 550
           GV+L E++ G+
Sbjct: 235 GVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 55/251 (21%), Positives = 97/251 (38%), Gaps = 55/251 (21%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
           S F     LG G FG V      D     A+K L      +    A    E  ++ +  +
Sbjct: 1   SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           + +VKL     D D    V +++P G + ++L    +  +            IA+  L +
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFY---IAELTLAI 114

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG-----EANTVR------- 512
               ++  +HRD+K  N+L+D D + K++DFG+   F  +       + + +R       
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS 174

Query: 513 ---------------------------------IVGTYGYMAPEYAMEGLYSKKSDVFSF 539
                                            +VGT  Y+APE  +   Y++  D +S 
Sbjct: 175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234

Query: 540 GVLLIEIITGR 550
           GV+L E++ G+
Sbjct: 235 GVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 8e-05
 Identities = 54/236 (22%), Positives = 84/236 (35%), Gaps = 57/236 (24%)

Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS-----SCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G  G V+   L    ++ A+K L        ++        E+L  L   H  L  L
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--HPFLPTL 66

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--------GML 462
                      LV ++ P G L  +L   +    L           +A+         + 
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLS--------EEVARFYAAEVLLALE 117

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA------------------------ 498
           YLH    L IV+RDLK  N+LL    +  +SDF ++                        
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174

Query: 499 ----RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
                 F+E      +   VGT  Y+APE      +    D ++ G+LL E++ G 
Sbjct: 175 SIPSETFSEEPS-FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 57/240 (23%), Positives = 99/240 (41%), Gaps = 40/240 (16%)

Query: 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNE 395
           F DL T+NLA                  YK     G+ V V+R  L +C+ +       E
Sbjct: 10  FEDLMTVNLAR-----------------YK---PTGEYVTVRRINLEACTNEMVTFLQGE 49

Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
           + +     H N+V      +  +E  +V  FM  GS   ++      G +       I+ 
Sbjct: 50  LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MSELAIAYILQ 108

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE-SEGEANTV--- 511
           G+ K + Y+H    +  VHR +KAS++L+  D   K+   G+    +  + G+   V   
Sbjct: 109 GVLKALDYIHH---MGYVHRSVKASHILISVD--GKVYLSGLRSNLSMINHGQRLRVVHD 163

Query: 512 ---RIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGR---RNAGSNQLLAYGM 563
                V    +++PE   + L  Y  KSD++S G+   E+  G    ++  + Q+L   +
Sbjct: 164 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 223

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.9 bits (102), Expect = 2e-04
 Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 17/149 (11%)

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGML 462
           + N +KL          +L+ +++ +G L    FD  +K G L   +   I+  + + + 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIF-AESEGEANTVRIVGTYGYM 520
            LH   +  I+H D+K  NVL D   +   + D+G+ +I    S  +       GT  Y 
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------GTLDYF 173

Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE      Y    D ++ GVL  E++TG
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 32/181 (17%)

Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL- 436
           +K L   SE      T     I+     N+V L  + V  D   LV +    G L + + 
Sbjct: 23  LKGLRKSSEYSRERLT-----IIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77

Query: 437 --FDPRKRGILCWRKRTNIVNGIAKGMLY----LHEDSRLRIVHRDLKASNVLLDSDMNS 490
              +  +  +  W          A  M+     LH +    IV RDL  +N+LLD   + 
Sbjct: 78  KFLNIPEECVKRW----------AAEMVVALDALHREG---IVCRDLNPNNILLDDRGHI 124

Query: 491 KISDFGMARIFAES-EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +++ F       +S +GEA    +     Y APE       ++  D +S G +L E++TG
Sbjct: 125 QLTYFSRWSEVEDSCDGEA-VENM-----YCAPEVGGISEETEACDWWSLGAILFELLTG 178

Query: 550 R 550
           +
Sbjct: 179 K 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 8e-04
 Identities = 15/38 (39%), Positives = 27/38 (71%), Gaps = 3/38 (7%)

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
           YLH      I+HRDLK  N+L+ ++ + K++DFG++++
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 42/182 (23%), Positives = 68/182 (37%), Gaps = 44/182 (24%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQGTAE-FTNEVLL----- 398
           +F     LG+G FG VYK  L +       +  +K+    +E G  E + NE +      
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK---ATEYGAVEIWMNERVRRACPN 189

Query: 399 -ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL--------------DAILFDPRK-- 441
                 +  L  +       DE  LV+ +    +L                +L   +   
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 442 RGILCWRKRTNIVNGIAKGMLY----LHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFG 496
           +G+    +   I+  I + +L+    LH      IVHRD+K  N++      S KI D G
Sbjct: 248 KGL---ERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG 301

Query: 497 MA 498
            A
Sbjct: 302 AA 303

Length = 566

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 7/96 (7%)

Query: 454 VNGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
           V  +A+ +L    Y+H +    I+HRD+K  NVL++   +  + DFG A     S     
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318

Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIE 545
              I GT    APE      Y+   D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 32/85 (37%), Positives = 39/85 (45%), Gaps = 8/85 (9%)

Query: 356 ILGQGGFGPVYKGV-LSDGKE-----VAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNL 407
            LG G FG V +      GKE     VAVK L + +     E     L IL    QHKN+
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI 104

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSL 432
           V LLG C  G   L++ E+   G L
Sbjct: 105 VNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	571
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.98
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.98
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.98
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.98
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.98
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.98
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.98
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.98
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.98
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.98
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.98
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.98
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.98
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.98
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.98
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.98
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.98
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.98
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.98
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.98
KOG0586	596	consensus Serine/threonine protein kinase [General	99.98
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.98
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.98
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.98
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.98
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.98
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.98
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.98
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.98
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.98
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.98
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.98
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.98
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.98
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.98
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.98
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.98
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.98
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.98
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.98
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.98
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.98
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.98
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.98
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.98
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.98
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.98
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.91
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.89
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PLN00181	793	protein SPA1-RELATED; Provisional	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.81
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.8
PRK10345	210	hypothetical protein; Provisional	99.78
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
smart00090	237	RIO RIO-like kinase.	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.7
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.62
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.33
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
KOG3087	229	consensus Serine/threonine protein kinase [General	99.19
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.01
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.0
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.98
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.79
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.79
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.68
COG4248	637	Uncharacterized protein with protein kinase and he	98.64
PRK09902	216	hypothetical protein; Provisional	98.62
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.51
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.47
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.37
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.32
PF01636	239	APH: Phosphotransferase enzyme family This family	98.3
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.3
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.17
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.15
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.07
PLN02876	822	acyl-CoA dehydrogenase	98.04
PRK10593	297	hypothetical protein; Provisional	98.03
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.98
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.89
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.86
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.83
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.82
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.67
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.6
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.45
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.29
PRK05231	319	homoserine kinase; Provisional	97.27
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.22
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.18
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.14
PLN02236	344	choline kinase	97.08
KOG2270	520	consensus Serine/threonine protein kinase involved	96.93
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.74
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.63
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.56
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.52
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.44
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.39
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.37
PLN02756	418	S-methyl-5-thioribose kinase	96.34
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.24
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.15
PRK11768	325	serine/threonine protein kinase; Provisional	95.72
COG2334	331	Putative homoserine kinase type II (protein kinase	95.65
PRK06148	1013	hypothetical protein; Provisional	95.46
PRK12396	409	5-methylribose kinase; Reviewed	95.38
PTZ00384	383	choline kinase; Provisional	95.11
PTZ00296	442	choline kinase; Provisional	95.1

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=375.57  Aligned_cols=219  Identities=53%  Similarity=0.890  Sum_probs=194.4

Q ss_pred             cccccChHHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       335 ~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      ....++++++..+|++|...+.||+|+||.||+|.++++..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568899999999999999999999999999999998999999988764433155699999999999999999999999


Q ss_pred             EcCc-eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEe
Q 008288          415 VDGD-EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS  493 (571)
Q Consensus       415 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~  493 (571)
                      .+.+ +.+||||||++|+|+++|+..... +++|..+++|+.++|+||+|||+...++||||||||+|||+|+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 499999999999999999764444 89999999999999999999999988899999999999999999999999


Q ss_pred             ecccccccccCCCccceeee-cccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          494 DFGMARIFAESEGEANTVRI-VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       494 DfGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      |||+++.........  ... .||.+|++||++..+..+.|+|||||||+|+||+||++|.+..
T Consensus       220 DFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             CccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence            999996544311111  112 7999999999999999999999999999999999999988754

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-44  Score=348.88  Aligned_cols=200  Identities=33%  Similarity=0.550  Sum_probs=180.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .+|...+.||+|+|++||+|+++ ++..||||.+...  ..+..+.+..|+.+|++++|||||+++++++.++..+||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            46777888999999999999975 6899999999764  55666778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC------CcEEEeeccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD------MNSKISDFGMAR  499 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~------~~~kL~DfGla~  499 (571)
                      ||.+|+|..++   ++.+.+++..++.++.|++.||++||+++   ||||||||.||||+..      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi---~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYI---RRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999   45667999999999999999999999999   9999999999999764      358999999999


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .+.....   ....+|++-|||||++..++|+.|+|+||+|+|||||++|+.||+..+
T Consensus       164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            8864332   234699999999999999999999999999999999999999998653

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-42  Score=334.69  Aligned_cols=208  Identities=28%  Similarity=0.426  Sum_probs=185.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      +..++|++.++||+|+||+|+.++.+ +++.+|+|++++.   .....+...+|..++.+++||.||+++-.|++.+.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            44578999999999999999999954 6889999999753   2345677899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      ||+||+.||.|...|   ++.+.+++..+..++.+|+.||.|||+++   ||||||||+|||+|++|+++|+||||++..
T Consensus       102 lVld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999999   56778999999999999999999999999   999999999999999999999999999864


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhh
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY  561 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~  561 (571)
                      .....  .+..++||+.|||||++.+..|+..+|+||||+++|||++|.+||-..+....
T Consensus       176 ~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~  233 (357)
T KOG0598|consen  176 LKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM  233 (357)
T ss_pred             ccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence            44332  33447999999999999999999999999999999999999999987764443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-42  Score=350.78  Aligned_cols=208  Identities=29%  Similarity=0.463  Sum_probs=188.9

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccc---cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .+|...+.||+|||+.||+++. .+|+.||+|++.+   ......+...+||++.++++|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999996 7899999999975   24455667899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      |+|++++|..++   +.++++++.+++.+..||+.||.|||+++   |+|||||..|+|++++.++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999999   46778999999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhhh
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMY  564 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~~  564 (571)
                      ....  ..++|||.|.|||++.....+..+||||+||+||.|+.|++||+..++.+..-+
T Consensus       172 ~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~  229 (592)
T KOG0575|consen  172 GERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK  229 (592)
T ss_pred             cccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH
Confidence            4333  356999999999999999999999999999999999999999999877665443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=338.73  Aligned_cols=204  Identities=37%  Similarity=0.620  Sum_probs=175.5

Q ss_pred             CCCCCceecccCceeEEEEEEcCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-eeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~  426 (571)
                      ++...+.||+|+||+||+|.+.....||||++....  ....++|.+|+.+|.+++|||||+++|++.+.. ...+||||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            334456699999999999999544449999997532  222568999999999999999999999999988 78999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~~~~~~  505 (571)
                      +++|+|..+++.. ....+++..++.++.||++||.|||+.++  ||||||||+|||++.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999653 46779999999999999999999999873  99999999999999997 99999999998655432


Q ss_pred             Cccceeeecccccccchhhhc--cCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          506 GEANTVRIVGTYGYMAPEYAM--EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                        .......||+.|||||++.  ...|+.|+|||||||++|||+||+.||..-..
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence              1122257999999999999  56899999999999999999999999986643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-41  Score=324.65  Aligned_cols=198  Identities=33%  Similarity=0.477  Sum_probs=177.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcc-ccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce-eEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~e  425 (571)
                      ++++..+.||+|..|+|||+.++ +++.+|+|.+. ...+...+++.+|++++++.+||+||.++|.|..++. ..++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35556788999999999999986 68889999996 3455667789999999999999999999999999994 999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||++|+|+.++.   ..+.+++...-+|+.+|++||.|||+ .+   ||||||||+||||+..|++||+|||.+..+.+.
T Consensus       159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999993   44679999999999999999999996 55   999999999999999999999999999887665


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .    -...+||..|||||.+.+..|+.++||||||+.++|+.+|+-||-..
T Consensus       233 ~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  233 I----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             h----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence            2    23468999999999999999999999999999999999999999764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-42  Score=320.00  Aligned_cols=210  Identities=27%  Similarity=0.444  Sum_probs=181.2

Q ss_pred             CCCCCCceecccCceeEEEEE-EcCCcEEEEEEcc--ccCccchHHHHHHHHHHHhcccCCeeeEee-EEEcCce-eEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLG-FCVDGDE-KLLV  423 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~-~~~~~~~-~~lv  423 (571)
                      .+|++.++||.|.||.|||+. +.+|..+|.|.++  ..+.+..+....|+.+|++++|||||++++ -+.++++ .++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            357778899999999999998 5689999999887  334556677899999999999999999998 4444445 7899


Q ss_pred             EEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC-CCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          424 YEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSR-LRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~-~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      ||++.+|+|..++... +....+++..+++++.|++.||+.+|++-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998643 334568999999999999999999999431 23999999999999999999999999999988


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhh
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA  560 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~  560 (571)
                      .......  ...+|||.||+||.+.+..|++||||||+||++|||..-+.||.+.++++
T Consensus       179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~  235 (375)
T KOG0591|consen  179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS  235 (375)
T ss_pred             cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH
Confidence            7655443  34699999999999999999999999999999999999999998886554

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=308.71  Aligned_cols=201  Identities=31%  Similarity=0.432  Sum_probs=182.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .-++|+..+.||.|+||.|.+++.+ +|.-+|+|++++..   -++.+...+|..+|+.+.||+++++.+.+.+.+..+|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            3457888999999999999999975 68889999997633   2345567899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||++||.|.+++   ++.+.+++..++.++.||+.||+|||+.+   |++|||||+|||+|.+|.+||.|||.|+...
T Consensus       122 vmeyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  122 VMEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            99999999999999   56677999999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .     .+..++|||.|+|||++..+.+..++|+|||||++|||+.|.+||-..+.
T Consensus       196 ~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  196 G-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             C-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            3     35678999999999999999999999999999999999999999977654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-40  Score=324.83  Aligned_cols=200  Identities=30%  Similarity=0.460  Sum_probs=171.1

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCcc-------chHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQ-------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      .+.|.+.+.||+|+||.|-++.. ++|+.||||++++....       ......+|+++|++++|||||++.+++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            45577789999999999999984 58999999999752111       12235799999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CcEEEeecc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFG  496 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~---~~~kL~DfG  496 (571)
                      .|+||||++||+|.+.+.   .++.+.+..-..++.||+.|+.|||++|   |+||||||+|||+..+   -.+||+|||
T Consensus       251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999998883   4556778888999999999999999999   9999999999999765   679999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccCC---CCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ||+....   ......++||+.|.|||++.++.   +..++|+||+||+||-+++|.+||...
T Consensus       325 lAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~  384 (475)
T KOG0615|consen  325 LAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEE  384 (475)
T ss_pred             hhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccc
Confidence            9997653   23344579999999999998655   345889999999999999999999765

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-39  Score=345.53  Aligned_cols=211  Identities=35%  Similarity=0.531  Sum_probs=183.0

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      ....+.+.+.+..+.||+|.||+||+|+..      +.+.||||.++...+. ..++|.+|++++++++|||||+|+|+|
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            344566677788899999999999999843      3457999999865554 788999999999999999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCC----------C-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeE
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPR----------K-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL  483 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NIL  483 (571)
                      .+++..++|+|||..|||.+||....          . ..+++..+.+.|+.|||.||+||-++.   +|||||..+|+|
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL  635 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL  635 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence            99999999999999999999995211          1 345889999999999999999999988   999999999999


Q ss_pred             ecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008288          484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGS  555 (571)
Q Consensus       484 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~  555 (571)
                      |.++..+||+||||++.+...+.......-.-..+||+||.++.++||.+||||||||+|||+++ |+.||..
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~g  708 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYG  708 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccc
Confidence            99999999999999998766554443323345679999999999999999999999999999999 9999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=327.20  Aligned_cols=209  Identities=39%  Similarity=0.571  Sum_probs=180.4

Q ss_pred             cccccChHHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       335 ~~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      ....++.+++.+       .+.||+|-||.||.|.++...+||+|.++.. ......|.+|+.+|++++|+|||+++++|
T Consensus       199 d~wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~  270 (468)
T KOG0197|consen  199 DPWEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVC  270 (468)
T ss_pred             CCeeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEE
Confidence            345566666555       4679999999999999987789999999864 34456789999999999999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      ..++.++||||||+.|+|.++|.. ...+.+...+.+.++.|||+||+||+++.   +|||||.++||||+++..+||+|
T Consensus       271 ~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsD  346 (468)
T KOG0197|consen  271 TKQEPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISD  346 (468)
T ss_pred             ecCCceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcc
Confidence            999999999999999999999965 34567899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |||++...++..... ....-...|.|||.+..+.++.|||||||||+||||+| |+.|+..-
T Consensus       347 FGLAr~~~d~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m  408 (468)
T KOG0197|consen  347 FGLARLIGDDEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM  408 (468)
T ss_pred             cccccccCCCceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence            999995444332221 12234567999999999999999999999999999999 99998654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.3e-39  Score=324.91  Aligned_cols=214  Identities=24%  Similarity=0.381  Sum_probs=186.6

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEc
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD  416 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~  416 (571)
                      .....+..++|+..+.||+|+||.||+++- .+|+.+|+|++++.   ...+.+....|-.+|....+|+||+|+..|.+
T Consensus       133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD  212 (550)
T KOG0605|consen  133 LRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD  212 (550)
T ss_pred             hccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence            334456778999999999999999999995 47999999999863   34556778999999999999999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      .+.+||||||++||++..+|   .+.+.|++..+..++.+++-|++.||+.|   +|||||||+|+|||..|++||+|||
T Consensus       213 ~~~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             CCeeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccc
Confidence            99999999999999999999   56788999999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccCC--------------------Cc-c------ce------------------eeecccccccchhhhccCCCC
Q 008288          497 MARIFAESE--------------------GE-A------NT------------------VRIVGTYGYMAPEYAMEGLYS  531 (571)
Q Consensus       497 la~~~~~~~--------------------~~-~------~~------------------~~~~gt~~y~aPE~~~~~~~~  531 (571)
                      |+.-+....                    .. .      .+                  ...+|||.|||||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            985332100                    00 0      00                  124899999999999999999


Q ss_pred             cchhhHhHHHHHHHHHhCCCCCCCCchhh
Q 008288          532 KKSDVFSFGVLLIEIITGRRNAGSNQLLA  560 (571)
Q Consensus       532 ~~~Dv~slGvil~elltG~~p~~~~~~~~  560 (571)
                      ..+|+||||+|+||||.|-+||.+.+...
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~  395 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQE  395 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999999998876544

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=323.51  Aligned_cols=205  Identities=31%  Similarity=0.476  Sum_probs=182.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      ...++|...+.||+|+|++|++++. .+++++|||++.+.   .+...+-...|-+.|.+| .||.|++|+-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3457899999999999999999994 57999999998642   333444577899999999 899999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      |+|+||.++|+|-+++   .+.+.+++..++.++.||+.||+|||+.|   ||||||||+|||||+|++++|.|||-|+.
T Consensus       150 YFvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999   56688999999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCc---------cce--eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGE---------ANT--VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +......         ...  ..++||..|.+||++..+..++.+|+|+||||||+|+.|++||...
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~  290 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA  290 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence            7644322         111  4479999999999999999999999999999999999999999765

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-39  Score=319.89  Aligned_cols=203  Identities=29%  Similarity=0.469  Sum_probs=176.6

Q ss_pred             cCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL  422 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~l  422 (571)
                      .+.|+.+++||+|.||.||+++ ..+|+.||+|+++...  +....-..+||.+|++++||||++|.+...+.  ...||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4567778899999999999999 4689999999987433  55566678999999999999999999999877  68999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      |+|||++ +|.-++..  ..-.+++.++..++.|++.||+|+|+++   |.|||||.+|||||.+|.+||+|||||+.+.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999965 77777633  2345999999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .......+ ..+-|..|.+||++.|. .|+.+.|+||.||||.||+.|++.+.+++
T Consensus       270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t  324 (560)
T KOG0600|consen  270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT  324 (560)
T ss_pred             CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence            65544333 34779999999999874 59999999999999999999999998873

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=317.53  Aligned_cols=198  Identities=35%  Similarity=0.553  Sum_probs=170.4

Q ss_pred             cCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc--ccCCeeeEeeEEEcCc----eeE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLVKLLGFCVDGD----EKL  421 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~nIv~l~~~~~~~~----~~~  421 (571)
                      ....+..++||+|.||.||||.+ +++.||||++..   ++.+.+.+|-++.+..  +|+||+++++.-....    +++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            34455678899999999999999 569999999864   4556788888887764  8999999999877665    889


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC------CCCCeeeCCCCCCCeEecCCCcEEEeec
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED------SRLRIVHRDLKASNVLLDSDMNSKISDF  495 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~------~~~~iiH~DLkp~NILl~~~~~~kL~Df  495 (571)
                      ||+||.+.|+|.++|    +...++|....+|+..|++||+|||+.      -+++|+|||||++||||.+|++..|+||
T Consensus       285 LVt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            999999999999999    556799999999999999999999975      3578999999999999999999999999


Q ss_pred             ccccccccCCCccceeeecccccccchhhhccCCC------CcchhhHhHHHHHHHHHhCCCCC
Q 008288          496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY------SKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~slGvil~elltG~~p~  553 (571)
                      |||..+............+||.+|||||++.+...      -.+.||||+|.+||||+++-.-.
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            99999887665555556799999999999986432      24799999999999999976554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=298.34  Aligned_cols=201  Identities=24%  Similarity=0.390  Sum_probs=174.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +.|+...++|+|+||.|||++++ +|+.||||++....  +.-.+-.++|+++|++++|+|+|.|+++|......+||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35677788999999999999976 69999999997532  2334457899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |++..-|+++-   +....++.....+++.|+++|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+....
T Consensus        82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99988887765   33345888999999999999999999999   9999999999999999999999999999887422


Q ss_pred             Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  ..+..+.|..|.|||.+.+ .+|...+||||+||++.||++|.+.|-+..
T Consensus       156 d--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S  206 (396)
T KOG0593|consen  156 D--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS  206 (396)
T ss_pred             c--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc
Confidence            2  2233578999999999987 779999999999999999999999997663

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-38  Score=318.19  Aligned_cols=199  Identities=31%  Similarity=0.491  Sum_probs=180.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|.+.+.||+|.||.||||+-+ +.+.||+|.+.+.  .+++.+.+.+|++++++++||||+.++++|+...+.++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46778899999999999999954 6889999998753  45567789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+.+ +|..++   ...+.++++.+..|+.++..||.|||+.+   |.|||+||.|||++..+++|++|||+|+..... 
T Consensus        82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9977 999999   45667999999999999999999999998   999999999999999999999999999976543 


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                       .....++.|||.|||||++.++.|+..+|+||+|||+|||++|++||-..
T Consensus       154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~  203 (808)
T KOG0597|consen  154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR  203 (808)
T ss_pred             -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence             33445678999999999999999999999999999999999999999654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-37  Score=286.97  Aligned_cols=200  Identities=30%  Similarity=0.457  Sum_probs=176.0

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|...++||+|.||.||+|+. ++|+.||||+++..  .+.......+||+.|++++|+||+.++++|-..+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4577788999999999999994 58999999999743  33345568999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      || ..+|+..+++  +...++..++..++.++++||+|||++.   |.||||||.|+|++++|.+||+|||+++.+....
T Consensus        82 fm-~tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FM-PTDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ec-cccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            99 4589999954  4567999999999999999999999999   9999999999999999999999999999887655


Q ss_pred             CccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....  .+-|..|.|||.+.|. .|+...||||.|||+.||+-|.+-|.+.
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~  205 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD  205 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence            44332  2678999999999875 5999999999999999999999888665

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=320.06  Aligned_cols=216  Identities=30%  Similarity=0.472  Sum_probs=187.1

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      ++.++..+.+.+.+.||+|.||+||+|.+.  ..||||+++.  .+++..+.|++|+..+++-+|.||+-+.|+|.+.+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            455555666667789999999999999984  4699999863  455678889999999999999999999999999887


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                       .+|.-+++|.+|+.+++..+  ..+...+.+.|++||++||.|||.++   |||||||..||++.++++|||+||||+.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999997644  44889999999999999999999999   9999999999999999999999999997


Q ss_pred             ccccCCCccceeeecccccccchhhhcc---CCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhhhc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYW  565 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~~~  565 (571)
                      ....-..........|...|||||++..   .+|++++||||||+++|||++|..||...+-..+.|++
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV  605 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV  605 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe
Confidence            6555444444445678889999999974   45899999999999999999999999977777777765

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-38  Score=316.74  Aligned_cols=208  Identities=32%  Similarity=0.518  Sum_probs=185.9

Q ss_pred             CCCCCCceecccCceeEEEEE-EcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ..|...++||+|..|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.++..+...+++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            467778899999999999998 4578999999998755556667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++|+|.+++.    ...+++.++..|++++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+......
T Consensus       353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            9999999983    344999999999999999999999999   999999999999999999999999999988776654


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhhhc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYW  565 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~~~  565 (571)
                      ..  ..+||+.|||||++....|.+|.||||||++++||+-|++||=..+.+...|++
T Consensus       426 R~--TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI  481 (550)
T KOG0578|consen  426 RS--TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI  481 (550)
T ss_pred             cc--cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence            43  459999999999999999999999999999999999999999666666555544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=314.53  Aligned_cols=209  Identities=28%  Similarity=0.440  Sum_probs=180.4

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc----Cc-cchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC----SE-QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~  418 (571)
                      ....+|...+.||+|+||+|+.+.+ .+++.||+|++...    .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456788899999999999999985 47899999977642    11 23445678999999998 999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeeccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGM  497 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfGl  497 (571)
                      ..++||||+.+|+|.+++.   +.+.+.+.++..+++|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999994   3677999999999999999999999999   9999999999999999 9999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCC-CC-cchhhHhHHHHHHHHHhCCCCCCCCchhhhh
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YS-KKSDVFSFGVLLIEIITGRRNAGSNQLLAYG  562 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slGvil~elltG~~p~~~~~~~~~~  562 (571)
                      +.....  ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..+.....
T Consensus       168 s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~  232 (370)
T KOG0583|consen  168 SAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY  232 (370)
T ss_pred             ccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence            987641  122233469999999999999877 75 8999999999999999999999987644443

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-38  Score=305.23  Aligned_cols=199  Identities=28%  Similarity=0.500  Sum_probs=180.9

Q ss_pred             CCCCCCceecccCceeEEEEE-EcCCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .+|++.+.||+|.||+|-++. +..|+.||||.+++.   ++++...+.+||++|+.++||||++++.+|++.+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            467788999999999999998 478999999998753   4555666889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||..+|.|.+++   ..++.+++.++..+++||..|+.|+|+++   ++|||||.+|||+|+++++||+||||+.++.+.
T Consensus       133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            999999999999   45677999999999999999999999998   999999999999999999999999999887654


Q ss_pred             CCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .-   ...++|++.|.+||++.+..| .+.+|-|||||+||.|+.|..||++.
T Consensus       207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~  256 (668)
T KOG0611|consen  207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR  256 (668)
T ss_pred             cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence            32   335799999999999999887 58999999999999999999999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=318.51  Aligned_cols=203  Identities=27%  Similarity=0.423  Sum_probs=180.0

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCce
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~  419 (571)
                      .+.-++|...++||+|.||+|+++.++ +++.+|||++++.   ...+.+..+.|.+++.-. +||.++.++.+|..++.
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456678999999999999999999976 6888999999864   345567788888888877 59999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+.||++..+.    ..+.+++..+..++..|+.||+|||+++   ||+||||.+|||+|.+|.+||+||||++
T Consensus       444 l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999954443    4466999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..-..  ...+..++||+.|||||++.+..|+..+|+|||||+||||+.|+.||...
T Consensus       517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd  571 (694)
T KOG0694|consen  517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD  571 (694)
T ss_pred             ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence            54322  23455689999999999999999999999999999999999999999865

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=327.04  Aligned_cols=203  Identities=31%  Similarity=0.543  Sum_probs=178.4

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-C---CcEEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-D---GKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ++.+...+.+.||.|.||.|++|.++ .   ...||||.++. ..++...+|+.|+.||.+++||||++|.|+.......
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            45566677899999999999999975 2   34799999984 4677788999999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      .+|.|||++|+|+.||+.  +.+.+++.+..-+.++|+.||.||-+.+   +|||||.++||||+.+...|++||||++.
T Consensus       706 MIiTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             EEEhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999954  4577999999999999999999999988   99999999999999999999999999998


Q ss_pred             cccCCCcccee-eecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 008288          501 FAESEGEANTV-RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNA  553 (571)
Q Consensus       501 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~  553 (571)
                      +.++.....+. .-.-..+|.|||.+...++|.++|||||||+|||.++ |.+||
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY  835 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY  835 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence            86655222221 1122568999999999999999999999999999998 99996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=303.80  Aligned_cols=203  Identities=31%  Similarity=0.535  Sum_probs=171.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc--eeEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLVY  424 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~  424 (571)
                      ..++...+.||+|.||.||++... +|...|||.+...+....+.+.+|+.+|++++|||||+.+|......  .+.+.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345667889999999999999965 48999999987543333667899999999999999999999854444  688999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~~~~  503 (571)
                      ||+++|+|.+++...  .+.+++..+..+.+||++||.|||+++   |+|+||||+|||++. ++.+||+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~--g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRY--GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999999432  226999999999999999999999999   999999999999999 79999999999987664


Q ss_pred             -CCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          504 -SEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       504 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                       ...........||+.|||||++..+ ...+++|||||||++.||+||++||..
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence             1112223346899999999999854 344699999999999999999999975

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=335.12  Aligned_cols=208  Identities=39%  Similarity=0.620  Sum_probs=181.3

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC--Cc----EEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD--GK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +..++.+....||+|.||.||+|...+  +.    .||||.+++ .+.+...+|.+|..+|++++|||||+++|++.+..
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            456677778899999999999999643  33    489999975 46677888999999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      ..++++|||++|+|..+|++.+.    ...++..+.+.++.|||+|+.|||++.   +|||||..+|+||++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999976432    345899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ||||+.+...+......+-.-...|||||.+..+.++.|+|||||||++||++| |..||...
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~  908 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR  908 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc
Confidence            999996665554433332234568999999999999999999999999999999 99999765

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.9e-36  Score=312.27  Aligned_cols=203  Identities=27%  Similarity=0.411  Sum_probs=175.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|+||.||++... +++.||+|++++..   ......+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999864 68899999987432   233456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++.   +.+.+++..+..++.|++.||+|||+.+   |+||||||+|||+++++++||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999984   3456899999999999999999999998   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCC
Q 008288          505 EGE---------------------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR  551 (571)
Q Consensus       505 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~  551 (571)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123479999999999999999999999999999999999999


Q ss_pred             CCCCCc
Q 008288          552 NAGSNQ  557 (571)
Q Consensus       552 p~~~~~  557 (571)
                      ||...+
T Consensus       235 Pf~~~~  240 (363)
T cd05628         235 PFCSET  240 (363)
T ss_pred             CCCCCC
Confidence            997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=305.43  Aligned_cols=209  Identities=28%  Similarity=0.391  Sum_probs=180.1

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccc-hHHHHHHHHHHHhcc-cCCeeeEeeEEEcCc-eeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQG-TAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD-EKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~-~~~lv  423 (571)
                      .++|...++||.|.||.||+++. .+++.||||++++.-..+ ...-++|+..|++++ ||||++|.+++.+.+ .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            45788889999999999999994 579999999997543332 223569999999998 999999999999988 89999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||| ..+|.+++.+.  +..+++..+..|+.||++||+|+|++|   ++||||||+|||+.....+||+||||||.+..
T Consensus        89 fE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence            9999 55899999653  678999999999999999999999999   99999999999999999999999999997755


Q ss_pred             CCCccceeeecccccccchhhhc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhhhc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYW  565 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~~~  565 (571)
                      ....   +..+.|..|.|||++. .+.|+.+.|||++|+|++|+.+-++.|-+.+-.+-.|++
T Consensus       163 kpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI  222 (538)
T KOG0661|consen  163 KPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI  222 (538)
T ss_pred             CCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH
Confidence            4332   3457899999999886 567999999999999999999999999887666655554

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-36  Score=310.57  Aligned_cols=207  Identities=29%  Similarity=0.437  Sum_probs=182.3

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      -|+..+.||+|+-|.|-.|++ .+|+..|||++.+.   ++.....+.+||.+|+-++||||++++++++++.++|||.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            366788999999999999996 47999999999754   34445678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++|-|.+++   ..++++++.++.++++||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|.+-....
T Consensus        93 yv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   93 YVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             ecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            99999999998   56788999999999999999999999998   9999999999999999999999999997643322


Q ss_pred             CccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCchhhhhhhc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYW  565 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~~~  565 (571)
                         ....-||++.|.+||++.|..| ..++||||-||||+.|++|+.||+..++.....++
T Consensus       167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV  224 (786)
T KOG0588|consen  167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV  224 (786)
T ss_pred             ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence               2223499999999999999887 58999999999999999999999988765554443

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=294.77  Aligned_cols=207  Identities=29%  Similarity=0.419  Sum_probs=178.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ...++|+..+.||.|..+.||+++ .+.++.||||++.- .-......+.+|+..|+.++||||++++..|..+..+|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            356788999999999999999999 45789999999973 2233368899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |+||.+|++.++++..-..+ +++..+..|.+++++||.|||++|   .||||||+.||||+++|.+||+|||.+-.+..
T Consensus       103 mpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             ehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            99999999999996543333 899999999999999999999999   99999999999999999999999998765544


Q ss_pred             CCCccc-e-eeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEAN-T-VRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...... . ..++||+.|||||+++.  ..|+.|+|||||||..+||.+|+.||+..
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~  235 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY  235 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence            332211 1 34689999999999654  45999999999999999999999999765

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=305.34  Aligned_cols=208  Identities=31%  Similarity=0.455  Sum_probs=183.0

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccc-hHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +++.+.+.+.++||+|.||.|.++....+.+||||++++..... ..+|.+|+++|.+++||||++|+|+|..++.+++|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            46667788899999999999999999888999999999654444 57899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      +|||++|+|.+++.... ...+.......|+.||+.||+||.+..   ++||||.++|+|++.++++||+|||+++.+..
T Consensus       614 ~EYmEnGDLnqFl~ahe-apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHE-LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHhcCcHHHHHHhcc-CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence            99999999999995421 122455667789999999999999988   99999999999999999999999999997776


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh--CCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--G~~p~~~~  556 (571)
                      .+......+.+-..+|||||.+..++++.++|||+||+.+||+++  ..+||+.-
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l  744 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL  744 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh
Confidence            666555555677889999999999999999999999999999965  89998743

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.3e-36  Score=285.51  Aligned_cols=201  Identities=28%  Similarity=0.408  Sum_probs=172.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc--cchHHHHHHHHHHHhcccCCeeeEeeEEEc--CceeEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLL  422 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~l  422 (571)
                      .++|+..+.|++|.||.||+|+.+ +++.||+|+++...+  ...-.-++||.+|.+++|||||.+..+...  -+..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356888899999999999999964 789999999985332  233456899999999999999999988764  456899


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||++. +|..++..-  ..++...+...+..|+++|++|||...   |+||||||+|+|+...|.+||+|||||+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999965 888888432  246889999999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....  .+..+-|..|.|||++.+. .|+...|+||+|||+.||+++++.|.+.
T Consensus       229 sp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  229 SPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             CCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence            65332  2345779999999999875 5999999999999999999999999765

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.2e-36  Score=306.48  Aligned_cols=209  Identities=30%  Similarity=0.473  Sum_probs=172.9

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEc
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD  416 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~  416 (571)
                      .+..++|++.+.||+|+||.||++.+      .+++.||||+++... ......+.+|+.++.++ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            35567889999999999999999974      235689999987432 33456789999999999 89999999998876


Q ss_pred             Cc-eeEEEEEccCCCChhhhhcCCCC------------------------------------------------------
Q 008288          417 GD-EKLLVYEFMPNGSLDAILFDPRK------------------------------------------------------  441 (571)
Q Consensus       417 ~~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  441 (571)
                      .+ ..+++|||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            54 57899999999999998853211                                                      


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeeccc
Q 008288          442 -----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT  516 (571)
Q Consensus       442 -----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt  516 (571)
                           ..++++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++...............++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 134788899999999999999999998   999999999999999999999999999865433222222223456


Q ss_pred             ccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       517 ~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~  280 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV  280 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence            78999999999999999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-37  Score=307.81  Aligned_cols=195  Identities=33%  Similarity=0.513  Sum_probs=172.3

Q ss_pred             CCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCC
Q 008288          352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      ...+-||.|+.|.||+|++ .++.||||+++...       ..+|+-|++|+||||+.+.|+|....-+++||||+..|-
T Consensus       127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            3467899999999999999 57999999886432       357888999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcccee
Q 008288          432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV  511 (571)
Q Consensus       432 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~  511 (571)
                      |..+|   +...+++......+..+||.||.|||.+.   |||||||.-||||..+..+||+|||-++...+..   ...
T Consensus       199 L~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkM  269 (904)
T KOG4721|consen  199 LYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKM  269 (904)
T ss_pred             HHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhh
Confidence            99999   44566888899999999999999999998   9999999999999999999999999998765542   234


Q ss_pred             eecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhh
Q 008288          512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGM  563 (571)
Q Consensus       512 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~  563 (571)
                      .+.||..|||||++.+...++|+|||||||+||||+||..||..-+-..+.|
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw  321 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW  321 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence            5789999999999999999999999999999999999999997554444444

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-35  Score=310.99  Aligned_cols=202  Identities=25%  Similarity=0.377  Sum_probs=173.2

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +|+..+.||+|+||.||++... +++.||+|++...   .......+.+|++++.+++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999864 6889999998642   23345568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++|+|.+++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++++||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999984   3456889999999999999999999998   9999999999999999999999999976432110


Q ss_pred             Cc---------------------------------------------cceeeecccccccchhhhccCCCCcchhhHhHH
Q 008288          506 GE---------------------------------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFG  540 (571)
Q Consensus       506 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG  540 (571)
                      ..                                             ......+||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            00                                             001124799999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCCc
Q 008288          541 VLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       541 vil~elltG~~p~~~~~  557 (571)
                      |++|||++|+.||...+
T Consensus       236 ~il~elltG~~Pf~~~~  252 (381)
T cd05626         236 VILFEMLVGQPPFLAPT  252 (381)
T ss_pred             hHHHHHHhCCCCCcCCC
Confidence            99999999999997653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=299.57  Aligned_cols=198  Identities=25%  Similarity=0.354  Sum_probs=174.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888899999999999999975 68999999986422   233456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++.   ..+.+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999984   3456899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                           .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  202 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN  202 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                 123468999999999998889999999999999999999999997654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-36  Score=310.91  Aligned_cols=203  Identities=26%  Similarity=0.381  Sum_probs=173.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|...+.||+|+||.||++... +++.||||++...   .......+.+|++++.+++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36888899999999999999864 7899999988642   2234456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++.   ..+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999984   3456889999999999999999999998   999999999999999999999999999643211


Q ss_pred             CCc------------c---------------------------------ceeeecccccccchhhhccCCCCcchhhHhH
Q 008288          505 EGE------------A---------------------------------NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSF  539 (571)
Q Consensus       505 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl  539 (571)
                      ...            .                                 .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012368999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCc
Q 008288          540 GVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       540 Gvil~elltG~~p~~~~~  557 (571)
                      ||++|||++|+.||...+
T Consensus       235 Gvil~elltG~~Pf~~~~  252 (377)
T cd05629         235 GAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             chhhhhhhcCCCCCCCCC
Confidence            999999999999997653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-35  Score=309.03  Aligned_cols=203  Identities=26%  Similarity=0.415  Sum_probs=175.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|+||.||++... +++.||||++...   .......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999965 6899999998742   2233456788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999984   3456899999999999999999999998   999999999999999999999999998754321


Q ss_pred             CCcc------------------------------------ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh
Q 008288          505 EGEA------------------------------------NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT  548 (571)
Q Consensus       505 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt  548 (571)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0012368999999999999999999999999999999999


Q ss_pred             CCCCCCCCc
Q 008288          549 GRRNAGSNQ  557 (571)
Q Consensus       549 G~~p~~~~~  557 (571)
                      |+.||...+
T Consensus       235 G~~Pf~~~~  243 (364)
T cd05599         235 GYPPFCSDN  243 (364)
T ss_pred             CCCCCCCCC
Confidence            999997654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-35  Score=310.64  Aligned_cols=202  Identities=25%  Similarity=0.390  Sum_probs=173.0

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +|+..+.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788899999999999999964 68899999986432   2345568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++|+|.+++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999884   3456889999999999999999999998   9999999999999999999999999975332100


Q ss_pred             C---------------------------------------------ccceeeecccccccchhhhccCCCCcchhhHhHH
Q 008288          506 G---------------------------------------------EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFG  540 (571)
Q Consensus       506 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG  540 (571)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCc
Q 008288          541 VLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       541 vil~elltG~~p~~~~~  557 (571)
                      |++|||++|+.||...+
T Consensus       236 vil~elltG~~Pf~~~~  252 (382)
T cd05625         236 VILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=304.35  Aligned_cols=199  Identities=28%  Similarity=0.408  Sum_probs=175.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++...   ......+.+|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888899999999999999975 58899999987432   234456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999983   3456899999999999999999999998   99999999999999999999999999976543 


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                          ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~  203 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP  203 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence                12234789999999999999999999999999999999999999976543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-35  Score=303.14  Aligned_cols=199  Identities=28%  Similarity=0.395  Sum_probs=175.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|++.+.||+|+||.||++... +++.||+|+++..   .......+.+|+.++.+++||||+++++.+.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            356888899999999999999975 6889999998642   223455688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999884   3456889999999999999999999998   99999999999999999999999999986533


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..     ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  219 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT  219 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence            21     23478999999999999999999999999999999999999997553

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-35  Score=301.44  Aligned_cols=195  Identities=27%  Similarity=0.351  Sum_probs=169.8

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      +.||+|+||.||++... +|+.||+|+++..   .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 7899999998743   2334456789999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccce
Q 008288          431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT  510 (571)
Q Consensus       431 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~  510 (571)
                      +|..++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  152 (323)
T cd05571          81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence            9998883   3456899999999999999999999998   99999999999999999999999999875322211  12


Q ss_pred             eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       511 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  199 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence            23579999999999999999999999999999999999999996553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-35  Score=303.92  Aligned_cols=200  Identities=28%  Similarity=0.363  Sum_probs=174.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcC--CcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|+..+.||+|+||.||++...+  +..||+|++...   .......+.+|+.++..++||||+++++++.+++..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            44578888999999999999998543  368999988642   2334556889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++|+|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++++||+|||++...
T Consensus       108 lv~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            9999999999999984   3456899999999999999999999998   999999999999999999999999999765


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence            321     123578999999999998889999999999999999999999997654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5e-35  Score=293.64  Aligned_cols=199  Identities=31%  Similarity=0.419  Sum_probs=172.2

Q ss_pred             CCCCceecccCceeEEEEEE-cCCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      |+..+.||+|+||.||++.. .+++.||+|++....   ......+.+|+.++.+++|+||+++++.+.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999999999986 479999999886422   22334578999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++|+|..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.++|+|||++........
T Consensus        82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            9999998877432 2345899999999999999999999998   99999999999999999999999999976533221


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                         .....||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  204 (285)
T cd05631         158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR  204 (285)
T ss_pred             ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence               12347899999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.2e-35  Score=306.77  Aligned_cols=209  Identities=25%  Similarity=0.354  Sum_probs=177.6

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG  417 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~  417 (571)
                      ..+....++|+..+.||+|+||.||++... +++.+|+|++.+.   .......+.+|+.+++.++||||+++++.+.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            344556678999999999999999999975 5889999998642   223345578999999999999999999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999999832    34788999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccC----CCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEG----LYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      +........ .......||+.|+|||++.+.    .++.++||||||+++|||++|+.||...+.
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~  252 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL  252 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence            986543221 111235799999999998754    378899999999999999999999976643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-35  Score=309.39  Aligned_cols=203  Identities=26%  Similarity=0.393  Sum_probs=173.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||++... +++.||+|++.+.   .......+.+|++++.+++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36888999999999999999964 6899999998642   1233456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999983   3456889999999999999999999998   999999999999999999999999997533110


Q ss_pred             CC-----------------------------------------ccceeeecccccccchhhhccCCCCcchhhHhHHHHH
Q 008288          505 EG-----------------------------------------EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL  543 (571)
Q Consensus       505 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil  543 (571)
                      ..                                         .......+||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00                                         0001124799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCc
Q 008288          544 IEIITGRRNAGSNQ  557 (571)
Q Consensus       544 ~elltG~~p~~~~~  557 (571)
                      |||++|+.||...+
T Consensus       235 yell~G~~Pf~~~~  248 (376)
T cd05598         235 YEMLVGQPPFLADT  248 (376)
T ss_pred             eehhhCCCCCCCCC
Confidence            99999999997664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.9e-35  Score=299.07  Aligned_cols=195  Identities=26%  Similarity=0.358  Sum_probs=169.2

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      +.||+|+||.||++... +|+.||+|+++..   .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999964 6899999998743   2334556788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccce
Q 008288          431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT  510 (571)
Q Consensus       431 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~  510 (571)
                      +|..++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++........  ..
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~  152 (323)
T cd05595          81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence            9988883   3456899999999999999999999998   99999999999999999999999999875322221  11


Q ss_pred             eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       511 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  199 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence            23478999999999999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-35  Score=297.28  Aligned_cols=193  Identities=25%  Similarity=0.354  Sum_probs=169.0

Q ss_pred             ecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ||+|+||.||++... +++.||+|+++..   .......+.+|+.++.+++||||+++++.+.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999975 5889999998642   234456688999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                      .+++.   ..+.+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~  152 (312)
T cd05585          81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT  152 (312)
T ss_pred             HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence            99884   3456899999999999999999999998   99999999999999999999999999875433222  1223


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~  197 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN  197 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence            578999999999999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.7e-35  Score=298.19  Aligned_cols=194  Identities=28%  Similarity=0.365  Sum_probs=169.2

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      +.||+|+||.||++... +++.||+|++.+.   .......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999964 6899999998743   2334567889999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccce
Q 008288          431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT  510 (571)
Q Consensus       431 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~  510 (571)
                      +|..++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~  152 (328)
T cd05593          81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM  152 (328)
T ss_pred             CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence            9988883   3456899999999999999999999998   99999999999999999999999999875332221  12


Q ss_pred             eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       511 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~  198 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence            2347899999999999889999999999999999999999999654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-35  Score=286.78  Aligned_cols=207  Identities=25%  Similarity=0.295  Sum_probs=178.0

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcC-CcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .-+.|+..+.||+|.-|+||++.+.+ +..+|+|++.+.   +.+...+...|-+||+.++||.++.|+..++.++..+|
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl  154 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL  154 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence            33456677899999999999999864 588999999763   34455668889999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      +||||+||+|..+++. +..+.+++..++.++.+++-||+|||..|   ||.|||||+||||.++|++.|+||.|+....
T Consensus       155 ~meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             EEecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            9999999999998854 56677999999999999999999999999   9999999999999999999999999875321


Q ss_pred             cC--------------------------------C-C---------------------ccceeeecccccccchhhhccC
Q 008288          503 ES--------------------------------E-G---------------------EANTVRIVGTYGYMAPEYAMEG  528 (571)
Q Consensus       503 ~~--------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~  528 (571)
                      ..                                . .                     ......++||..|+|||++.+.
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            10                                0 0                     0111235899999999999999


Q ss_pred             CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          529 LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       529 ~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..+.++|+|+|||++|||+.|+.||.+.+
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~  339 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSN  339 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCC
Confidence            99999999999999999999999998763

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.6e-35  Score=303.99  Aligned_cols=210  Identities=24%  Similarity=0.336  Sum_probs=178.6

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEc
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD  416 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~  416 (571)
                      ...+.+..++|+..+.||+|+||.||++... +++.+|+|++...   .......+.+|+.+++.++||||+++++.+.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455667789999999999999999999975 6889999998632   22334457899999999999999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      ++..++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999842    34788889999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccC----CCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEG----LYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ++......... ......||+.|+|||++.+.    .++.++||||||+++|||++|+.||...+.
T Consensus       188 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  252 (371)
T cd05622         188 TCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL  252 (371)
T ss_pred             ceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence            99865432211 12234799999999998753    378999999999999999999999987654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.9e-35  Score=304.46  Aligned_cols=203  Identities=27%  Similarity=0.414  Sum_probs=175.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|+||.||++... +++.||+|+++..   .......+.+|+.++.+++||||+++++.+.+++..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46788899999999999999965 6899999998642   2334556788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++.   +.+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999983   3456899999999999999999999998   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCC
Q 008288          505 EGE---------------------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR  551 (571)
Q Consensus       505 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~  551 (571)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113479999999999999999999999999999999999999


Q ss_pred             CCCCCc
Q 008288          552 NAGSNQ  557 (571)
Q Consensus       552 p~~~~~  557 (571)
                      ||...+
T Consensus       235 Pf~~~~  240 (360)
T cd05627         235 PFCSET  240 (360)
T ss_pred             CCCCCC
Confidence            997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.9e-35  Score=282.22  Aligned_cols=202  Identities=30%  Similarity=0.448  Sum_probs=171.3

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCc--cchHHHHHHHHHHHhcccCC-eeeEeeEEEcCc------
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGD------  418 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~------  418 (571)
                      ..|...++||+|.||.||+|+. .+|+.||+|+++-..+  .-.....+|+.++++++|+| |+.|.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3466678899999999999995 4789999999974333  34556789999999999999 999999999877      


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      ..++|+||+ ..+|..++...... ..++...+..+++||++||.|||+++   |+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            788999999 56898888543221 34667889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      |+.+.-+....  ...++|..|.|||++.+. .|+...||||+|||+.||++++..|...
T Consensus       167 Ara~~ip~~~y--t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~  224 (323)
T KOG0594|consen  167 ARAFSIPMRTY--TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGD  224 (323)
T ss_pred             HHHhcCCcccc--cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCC
Confidence            99765333322  234789999999999987 6999999999999999999999999665

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=288.78  Aligned_cols=206  Identities=29%  Similarity=0.414  Sum_probs=171.1

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCc--------------cchHHHHHHHHHHHhcccCCeee
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE--------------QGTAEFTNEVLLILKLQHKNLVK  409 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~nIv~  409 (571)
                      ...-+.|++.+.||+|.||.|-++.. .+++.||||++.+...              ...+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34457899999999999999999995 4799999999864211              11346889999999999999999


Q ss_pred             EeeEEEcC--ceeEEEEEccCCCChhhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 008288          410 LLGFCVDG--DEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       410 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~  486 (571)
                      |+++..+.  +..|||+||+..|.+...-    ...+ +++.+++++++++..||+|||.++   ||||||||+|+||++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence            99998764  5789999999998875542    2333 999999999999999999999999   999999999999999


Q ss_pred             CCcEEEeecccccccccCC---CccceeeecccccccchhhhccCC----CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          487 DMNSKISDFGMARIFAESE---GEANTVRIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       487 ~~~~kL~DfGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +|++||+|||.+.......   ......+.+||+.|+|||...++.    .+.+.||||+||.||.|+.|+.||-.+.
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            9999999999998663321   122233468999999999987633    3678999999999999999999997663

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=305.91  Aligned_cols=208  Identities=33%  Similarity=0.470  Sum_probs=175.1

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEcC--C---cEEEEEEccc---cCccchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD--G---KEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      .+++.-++....++||+|+||.||+|.+..  +   ..||||..+.   .......++++|+++|++++|||||+++|++
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344445556666899999999999999642  2   2389998874   3466788899999999999999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      ..+..+++|||+++||+|.++|...  ...++..+.+.++.+.++||+|||+++   +|||||.++|+|+..++.+||+|
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence            9999999999999999999999542  235999999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      |||++.-.........  ..-..+|+|||.+..+.|+.++|||||||++||+++ |..||..-.
T Consensus       306 FGLs~~~~~~~~~~~~--~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~  367 (474)
T KOG0194|consen  306 FGLSRAGSQYVMKKFL--KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK  367 (474)
T ss_pred             cccccCCcceeecccc--ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence            9998754311111101  123568999999999999999999999999999999 899997653

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-35  Score=271.20  Aligned_cols=203  Identities=28%  Similarity=0.418  Sum_probs=179.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .-++|++.+.||+|-||.||.++.+ ++-.||+|++.+.   ..+-.+++.+|+++-+.++||||+++++++.++...||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4568899999999999999999964 6778999998652   23345678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ++||.++|.|...|.+ .....+++.....++.|+|.||.|+|...   +|||||||+|+|++.++.+||+|||.+....
T Consensus       100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999954 34566899999999999999999999988   9999999999999999999999999986432


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        .+.  ....+||..|++||...+..++..+|+|++|++.||++.|.+||++.+
T Consensus       176 --~~k--R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  176 --SNK--RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             --CCC--ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence              222  234699999999999999999999999999999999999999998764

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2e-34  Score=294.74  Aligned_cols=200  Identities=28%  Similarity=0.368  Sum_probs=171.2

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccC-CeeeEeeEEEcCceeEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHK-NLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~  424 (571)
                      +|++.+.||+|+||.||++... +++.||+|+++..   .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999965 5789999998742   234456678899999999764 5888999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|..++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999998883   3456889999999999999999999998   999999999999999999999999998743222


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            11  2234579999999999999999999999999999999999999997553

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-34  Score=295.20  Aligned_cols=200  Identities=29%  Similarity=0.365  Sum_probs=170.8

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      +|+..+.||+|+||.||++... +++.||+|++++..   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4777899999999999999965 57899999987532   23344567788888777 5899999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|..++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999998883   3456899999999999999999999998   999999999999999999999999998754322


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~  205 (323)
T cd05616         155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  205 (323)
T ss_pred             CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence            21  1223578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-34  Score=295.94  Aligned_cols=195  Identities=29%  Similarity=0.449  Sum_probs=168.5

Q ss_pred             ceecccCceeEEEEEE----cCCcEEEEEEcccc----CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVL----SDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +.||+|+||.||++..    .+++.||+|+++..    .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    35789999998642    223345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++.   ..+.+.+..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999883   4456888999999999999999999998   99999999999999999999999999875432221


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~  204 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN  204 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence              1223478999999999998889999999999999999999999997654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.8e-35  Score=303.39  Aligned_cols=206  Identities=24%  Similarity=0.337  Sum_probs=175.1

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      ..+..++|+..+.||+|+||.||++... +++.||+|+++..   .......+.+|+.+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3455678899999999999999999965 6889999998642   22334457889999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999998842    34788889999999999999999998   9999999999999999999999999997


Q ss_pred             ccccCCCccceeeecccccccchhhhccC----CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEG----LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ........ ......||+.|+|||++.+.    .++.++||||||+++|||++|+.||...+
T Consensus       191 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  251 (370)
T cd05596         191 KMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (370)
T ss_pred             eccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence            65432211 11234789999999998653    47899999999999999999999997654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.4e-34  Score=289.11  Aligned_cols=202  Identities=26%  Similarity=0.399  Sum_probs=171.1

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            356888999999999999999965 68899999987432 3334567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++ +|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          84 YLDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            9975 88888742  2345789999999999999999999998   9999999999999999999999999987543322


Q ss_pred             Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  .....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...+
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         158 KT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             cc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            11  122367899999998875 568999999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=301.75  Aligned_cols=203  Identities=26%  Similarity=0.411  Sum_probs=177.3

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|.+.+.||+|+||.||++... +++.||+|+++..   .......+.+|++++..++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888899999999999999975 6899999998742   2244567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..   .+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999843   366899999999999999999999988   999999999999999999999999999865443


Q ss_pred             CC---------------------------ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EG---------------------------EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..                           ........||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            20                           011223478999999999999999999999999999999999999997664

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.5e-34  Score=292.95  Aligned_cols=195  Identities=29%  Similarity=0.422  Sum_probs=166.1

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.||+|+++..   .+.....+..|..++... +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5789999998742   223344556677777654 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |+|..++.   ..+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99998884   3456899999999999999999999998   9999999999999999999999999997543322  12


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~  200 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED  200 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence            223578999999999999899999999999999999999999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.2e-34  Score=289.10  Aligned_cols=201  Identities=25%  Similarity=0.396  Sum_probs=173.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|++.+.||+|+||.||+++.+ +++.+|+|+++..  .+...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999975 6889999998743  23345568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |++++.+..+.   .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99998877665   22346899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .. ......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence            21 122346899999999999888999999999999999999999999765

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.1e-34  Score=293.33  Aligned_cols=202  Identities=28%  Similarity=0.385  Sum_probs=176.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ..++|+..+.||+|+||.||+++.. ++..+|+|.+... .......+.+|++++++++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            4578899999999999999999975 6888999988753 2334567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+.+  +|+||||||+|||+++++.+||+|||++......
T Consensus        83 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          83 EHMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            9999999999984   3445889999999999999999999853  3999999999999999999999999998765332


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .    .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  206 (331)
T cd06649         158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD  206 (331)
T ss_pred             c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2    123468999999999999899999999999999999999999997543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=295.24  Aligned_cols=203  Identities=25%  Similarity=0.338  Sum_probs=173.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||++... +++.||+|++.+.   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46888999999999999999965 6899999998642   2233455889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999843  2345889999999999999999999998   999999999999999999999999998765433


Q ss_pred             CCccceeeecccccccchhhhcc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .... .....||+.|+|||++..     ..++.++||||||+++|||++|+.||...+
T Consensus       156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         156 GTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             CCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            2211 122468999999999863     457889999999999999999999997654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=285.19  Aligned_cols=194  Identities=30%  Similarity=0.472  Sum_probs=162.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHh--cccCCeeeEeeEEEcCc----eeE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDGD----EKL  421 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~~~~~~----~~~  421 (571)
                      .......+.||+|.||.||+|.+ .|+.||||++...   +.+...+|.++...  ++|+||+.+++.-..++    +++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            34567789999999999999999 6899999999753   33456677777776  49999999998876554    578


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-----DSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-----~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      ||.+|.+.|+|.++|    .+.+++...+++++..++.||++||.     +|+|.|.|||||++||||.++++..|+|+|
T Consensus       286 LvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG  361 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  361 (513)
T ss_pred             EeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence            999999999999999    34679999999999999999999994     578889999999999999999999999999


Q ss_pred             cccccccCCCc--cceeeecccccccchhhhccCC----C--CcchhhHhHHHHHHHHHhC
Q 008288          497 MARIFAESEGE--ANTVRIVGTYGYMAPEYAMEGL----Y--SKKSDVFSFGVLLIEIITG  549 (571)
Q Consensus       497 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~slGvil~elltG  549 (571)
                      ||.........  ......+||.+|||||++...-    +  -..+||||||.++||+..+
T Consensus       362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            99876655322  2333469999999999986532    1  2469999999999999764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3e-34  Score=290.73  Aligned_cols=205  Identities=32%  Similarity=0.471  Sum_probs=170.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEcC-----------------CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSD-----------------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK  409 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~  409 (571)
                      .++|...+.||+|+||.||++.+.+                 +..||+|.+... ......++.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4578888999999999999998532                 336999998753 3334567899999999999999999


Q ss_pred             EeeEEEcCceeEEEEEccCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 008288          410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV  473 (571)
Q Consensus       410 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ii  473 (571)
                      +++++.+.+..++||||+++++|.+++....                ....+++..+..++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999884311                1134788899999999999999999998   99


Q ss_pred             eCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh--CCC
Q 008288          474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRR  551 (571)
Q Consensus       474 H~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--G~~  551 (571)
                      ||||||+|||+++++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986544332222223355788999999988889999999999999999987  566


Q ss_pred             CCCC
Q 008288          552 NAGS  555 (571)
Q Consensus       552 p~~~  555 (571)
                      ||..
T Consensus       241 p~~~  244 (304)
T cd05096         241 PYGE  244 (304)
T ss_pred             CCCc
Confidence            7754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.7e-34  Score=287.00  Aligned_cols=192  Identities=22%  Similarity=0.381  Sum_probs=166.2

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccc---hHHHHHHHHHHHhcccCCeeeEeeEEEc----CceeEEEEEc
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVYEF  426 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~  426 (571)
                      ...||+|+++.||+|.+ +|+.||||+++......   .+.+.+|+.++.+++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 78999999997543332   4668899999999999999999999877    3467899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      +++|+|.+++..   ...+++.....++.|++.||.|||+. +   ++||||||+|||+++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999943   45689999999999999999999985 5   7899999999999999999999999988654322


Q ss_pred             Cccceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                           ....|+..|+|||++.+  ..++.++||||||+++|||++|+.||...+
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence                 12367889999999976  678999999999999999999999998654

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.4e-34  Score=296.09  Aligned_cols=195  Identities=27%  Similarity=0.355  Sum_probs=168.3

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      +.||+|+||.||++... +++.||+|+++..   .......+.+|++++..++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 7899999998742   2234456788999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       431 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      +|..++.   ....+++..+..++.||+.||.|||+ .+   |+||||||+|||+++++.+||+|||+++........  
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence            9998883   34568999999999999999999997 67   999999999999999999999999998753322211  


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~  200 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  200 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence            123468999999999999999999999999999999999999996553

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.7e-34  Score=293.40  Aligned_cols=195  Identities=25%  Similarity=0.379  Sum_probs=168.0

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||+++.. +++.||+|+++..   .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999975 5789999998753   233445677888888876 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|...+.   ..+.+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++.........  
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--  152 (321)
T cd05591          81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--  152 (321)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence            99998883   3456899999999999999999999998   999999999999999999999999998754322221  


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~  200 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN  200 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence            223478999999999999899999999999999999999999997654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-34  Score=295.77  Aligned_cols=203  Identities=24%  Similarity=0.329  Sum_probs=173.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+.   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999965 6788999998642   2233445788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|..++..  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999853  2346889999999999999999999998   999999999999999999999999999765433


Q ss_pred             CCccceeeecccccccchhhhcc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ... ......||+.|+|||++.+     +.++.++||||||+++|||++|+.||...+
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            221 1123478999999999875     467889999999999999999999997654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.1e-34  Score=292.69  Aligned_cols=195  Identities=30%  Similarity=0.418  Sum_probs=168.2

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++..+ +++.||+|++++.   .+.....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 6889999998742   233455677888888877 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |+|..++.   ....+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......  .
T Consensus        81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~  152 (320)
T cd05590          81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T  152 (320)
T ss_pred             chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence            99998883   3456899999999999999999999998   99999999999999999999999999875322211  1


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  200 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN  200 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            223578999999999998899999999999999999999999997664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.1e-34  Score=293.32  Aligned_cols=198  Identities=28%  Similarity=0.416  Sum_probs=168.3

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHH---HhcccCCeeeEeeEEEcCceeEEE
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLI---LKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l---~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      |++.+.||+|+||.||++... +++.||||++++.   .....+.+.+|++++   ..++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456789999999999999965 6899999998742   223344566676655   456899999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|...+.    .+.+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999988873    245899999999999999999999998   99999999999999999999999999875332


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       154 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~  205 (324)
T cd05589         154 FGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD  205 (324)
T ss_pred             CCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence            221  1223578999999999999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-34  Score=307.22  Aligned_cols=205  Identities=23%  Similarity=0.311  Sum_probs=177.2

Q ss_pred             CCCCCceecccCceeEEEEEEc-C-CcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-D-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      .|...+.||+|+||.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3778899999999999999853 3 6788888776545555566888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          428 PNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       428 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      ++|+|.+++... ....++++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887532 23456899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~  275 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS  275 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            222334579999999999999999999999999999999999999997653

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5e-34  Score=288.96  Aligned_cols=201  Identities=27%  Similarity=0.391  Sum_probs=169.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|++.+.||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467889999999999999999975 68899999987432 2334467899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |++ ++|.+++..  ..+.+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 577766632  3456889999999999999999999998   9999999999999999999999999987543222


Q ss_pred             Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..  .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         158 HT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             cc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            11  122467899999999875 45889999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=279.99  Aligned_cols=203  Identities=29%  Similarity=0.474  Sum_probs=175.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEc-----Ccee
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-----GDEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-----~~~~  420 (571)
                      ..|...+.||+|+||.|..+..+ +|+.||||++..  ......++..+|+.+++.++|+||+.+.+++..     -+..
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            44555788999999999999964 789999999873  345556778999999999999999999999875     3568


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      |+|+|+| ..+|..++   +.+..++...+..+..||++||.|+|+.+   |+||||||+|+|++.+..+||+|||||+.
T Consensus       102 YiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             EEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence            9999999 77999999   34445999999999999999999999999   99999999999999999999999999998


Q ss_pred             cccCCCccceeeecccccccchhhhc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ..........+..+.|..|.|||++. ...|+.+.||||.|||+.||++|++.|-+.+-
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~  233 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY  233 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence            86543333334567899999999986 46799999999999999999999999987743

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.4e-34  Score=292.01  Aligned_cols=200  Identities=28%  Similarity=0.372  Sum_probs=170.6

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      +|+..+.||+|+||.||++... +++.||+|+++..   .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3667789999999999999964 6889999998743   2233456778888888885 577888999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|..++.   ..+.+++.++..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999883   3456899999999999999999999998   999999999999999999999999998754322


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence            21  1223468999999999998889999999999999999999999997653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-34  Score=298.94  Aligned_cols=208  Identities=31%  Similarity=0.431  Sum_probs=172.8

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG  417 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~  417 (571)
                      +..++|+..+.||+|+||.||+++.      .++..||||+++... ....+.+.+|+.++..+ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            3455788899999999999999973      245689999987432 33445688999999999 899999999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCC--------------------------------------------------------
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRK--------------------------------------------------------  441 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  441 (571)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999988853211                                                        


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          442 ----------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       442 ----------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                                      ...+++..++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                            124788999999999999999999998   9999999999999999999999999998654332


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            2211112234567999999999999999999999999999998 89998654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.6e-34  Score=293.42  Aligned_cols=192  Identities=26%  Similarity=0.363  Sum_probs=167.1

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.||+|++++.   .......+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999965 6889999998742   223345678899999998 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |+|..++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.......  .
T Consensus        81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~  152 (329)
T cd05588          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence            99988873   3456999999999999999999999998   99999999999999999999999999874322111  2


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  197 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence            223578999999999999999999999999999999999999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4e-34  Score=293.51  Aligned_cols=204  Identities=25%  Similarity=0.346  Sum_probs=172.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||++..+ +++.+|+|++.+.   .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888899999999999999975 5788999998642   2223445788999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999953  2345899999999999999999999998   999999999999999999999999998755332


Q ss_pred             CCccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          505 EGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .. .......||+.|+|||++.     ...++.++||||||+++|||++|+.||...+.
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~  213 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL  213 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence            22 1122347899999999986     34578999999999999999999999976543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.9e-34  Score=293.13  Aligned_cols=192  Identities=27%  Similarity=0.364  Sum_probs=166.3

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.+|+|++++.   .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 6889999998753   223345577888888877 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~  152 (329)
T cd05618          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence            99988873   3456899999999999999999999998   99999999999999999999999999875322221  1


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      .....||..|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence            223578999999999999999999999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.2e-34  Score=293.40  Aligned_cols=195  Identities=28%  Similarity=0.368  Sum_probs=165.6

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHH-HHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +|+.+|+|++...   .......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999964 6899999998642   2223344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++.   ..+.+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence            99988883   4456899999999999999999999998   99999999999999999999999999875322221  2


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD  200 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence            233578999999999999999999999999999999999999997664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.1e-34  Score=298.82  Aligned_cols=209  Identities=31%  Similarity=0.449  Sum_probs=173.3

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEc
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD  416 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~  416 (571)
                      ....++|++.+.||+|+||.||+++..      +++.||+|+++... ......+.+|+.+++.+ +|+||+++++.+..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            345668889999999999999998742      34579999997532 33345688999999999 89999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCC--------------------------------------------------------
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPR--------------------------------------------------------  440 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  440 (571)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999998874311                                                        


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          441 -----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       441 -----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                                 ....+++..+++++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++..........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                       1134788899999999999999999998   99999999999999999999999999976543322211


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~  318 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI  318 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence            112234567999999998899999999999999999997 99999654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.8e-34  Score=290.64  Aligned_cols=203  Identities=30%  Similarity=0.424  Sum_probs=175.9

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +..++|+..++||+|+||.||++... +++.+++|.+... .......+.+|++++++++||||+++++++.+++..++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            34578999999999999999999975 6888999988743 333445689999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++.   ..+.+++..+..++.|+++||.|||+..  +++|+||||+|||+++++.+||+|||++..+..
T Consensus        82 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999984   3456889999999999999999999752  399999999999999999999999999875533


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...    ....|+..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       157 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         157 SMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             hcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            211    22468999999999998889999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.6e-34  Score=288.87  Aligned_cols=195  Identities=29%  Similarity=0.421  Sum_probs=166.9

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.||+|+++..   .+........|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 5789999998753   123345567778888764 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |+|..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++........  .
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05619          81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence            99999884   3456889999999999999999999998   99999999999999999999999999875322221  2


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD  200 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence            234578999999999999899999999999999999999999997653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4e-34  Score=293.53  Aligned_cols=199  Identities=28%  Similarity=0.378  Sum_probs=170.3

Q ss_pred             CCCCCceecccCceeEEEEEE----cCCcEEEEEEcccc----CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      +|++.+.||+|+||.||++..    .+++.||+|++.+.    .....+.+..|+.++..+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999999875    35789999998642    223345678899999999 599999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++|+|.+++.   .+..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999884   3456899999999999999999999998   99999999999999999999999999986


Q ss_pred             cccCCCccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      +...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~  209 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL  209 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence            5433222 223457999999999988654 78999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.9e-34  Score=291.75  Aligned_cols=195  Identities=29%  Similarity=0.379  Sum_probs=165.4

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHH-HHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.||+|++....   .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68999999986422   222344555554 55778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++.   ..+.+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.......  .
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (323)
T cd05575          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T  152 (323)
T ss_pred             CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence            99998883   3456899999999999999999999998   99999999999999999999999999875322221  2


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  200 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence            233578999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.7e-34  Score=291.60  Aligned_cols=195  Identities=28%  Similarity=0.385  Sum_probs=164.8

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHH-HHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||+++.. +++.||+|++.+..   ......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 68899999986422   222334555554 57788999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|...+.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence            99988873   3456888999999999999999999998   99999999999999999999999999875322221  2


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence            233578999999999998889999999999999999999999997664

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.2e-34  Score=306.63  Aligned_cols=216  Identities=28%  Similarity=0.365  Sum_probs=181.0

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD  416 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~  416 (571)
                      +..+.....++|.+.+.||+|+||.||++.. .+++.||||++...  ++.....+.+|+..+..++|+||+++...+..
T Consensus        23 d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         23 DEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             CcccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            3444555667999999999999999999985 47899999998642  34445668899999999999999999877654


Q ss_pred             Cc--------eeEEEEEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 008288          417 GD--------EKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD  487 (571)
Q Consensus       417 ~~--------~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~  487 (571)
                      .+        ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+   |+||||||+|||++++
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSN  179 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCC
Confidence            32        357999999999999988542 23456899999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          488 MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       488 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      +.+||+|||+++.+.............||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~  250 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM  250 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            99999999999876543333223345799999999999999999999999999999999999999976543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.6e-34  Score=289.33  Aligned_cols=195  Identities=30%  Similarity=0.418  Sum_probs=166.8

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.||+|+++...   .........|..++... +||||+++++++.+++..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999975 68899999987531   23345567788887765 899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++.   ..+.+++..+..++.||++||+|||+.+   |+||||||+|||+++++.++|+|||+++......  ..
T Consensus        81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            99998883   3456899999999999999999999998   9999999999999999999999999987432211  12


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~  200 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD  200 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            234578999999999999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.7e-34  Score=295.98  Aligned_cols=203  Identities=27%  Similarity=0.356  Sum_probs=174.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||++... +++.||+|+++..   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888899999999999999964 6899999998753   2234556889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999843  2356899999999999999999999998   999999999999999999999999999866443


Q ss_pred             CCccceeeecccccccchhhhc------cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAM------EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ... ......||+.|+|||++.      ...++.++||||||+++|||++|+.||...+
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~  213 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT  213 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence            222 222347899999999986      4567899999999999999999999997653

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=289.74  Aligned_cols=200  Identities=28%  Similarity=0.479  Sum_probs=178.9

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEcc-ccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..|...+.||+|.||.||+|.. ..++.||+|++. ...+....++.+|+.++.+++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4566678999999999999995 478999999997 44566678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +.+|++.+.+   +....+++..+.-+.++++.||.|||.++   .+|||||+.|||+.++|.+||+|||.+-.+.....
T Consensus        93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999998   44455688888899999999999999998   99999999999999999999999999987665544


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..  ..++||+-|||||++....|+.|+||||||++.+||.+|.+||..-
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~  214 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL  214 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence            43  4569999999999999889999999999999999999999998643

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-33  Score=282.95  Aligned_cols=195  Identities=31%  Similarity=0.416  Sum_probs=168.2

Q ss_pred             ecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ||+|+||+||++... +++.+|+|++....   ......+..|+.++++++|+||+++.+++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999864 68899999986422   22335677899999999999999999999999999999999999999


Q ss_pred             hhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcccee
Q 008288          433 DAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV  511 (571)
Q Consensus       433 ~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~  511 (571)
                      ..++... .....+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++|+|||++..+......  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            8877432 23456899999999999999999999998   999999999999999999999999999765433222  22


Q ss_pred             eecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       512 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            346899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.6e-34  Score=290.56  Aligned_cols=195  Identities=29%  Similarity=0.393  Sum_probs=164.1

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHH-HHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEV-LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.+|+|++....   ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999975 57889999986421   22233444444 456778999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++.   ..+.+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~  152 (325)
T cd05602          81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T  152 (325)
T ss_pred             CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence            99999884   3455788889999999999999999998   99999999999999999999999999875432222  2


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  200 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence            234579999999999999999999999999999999999999997653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.9e-34  Score=290.65  Aligned_cols=192  Identities=26%  Similarity=0.359  Sum_probs=166.8

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.+|+|+++..   .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 6789999998753   223445678899999888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++.   ..+.+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++........  .
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  152 (327)
T cd05617          81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T  152 (327)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence            99988873   3456999999999999999999999998   99999999999999999999999999874322211  2


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~  197 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD  197 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence            233579999999999999999999999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=292.90  Aligned_cols=210  Identities=27%  Similarity=0.410  Sum_probs=185.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcc--ccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce-eEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~  424 (571)
                      ++|...+++|+|+||.++.++++ +++.+++|.+.  ..++...+...+|+.++++++|||||.+.+.|..++. .++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56788899999999999999865 67899999886  3445555678999999999999999999999999988 89999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      +|++||++.+.+... +...++++.+..++.||+.|++|||+..   |.|||||+.||+++.++.+||+|||+++.+...
T Consensus        84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            999999999999653 3566899999999999999999999877   999999999999999999999999999988776


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhhh
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMY  564 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~~  564 (571)
                      .....  ..+||+.||.||++.+.+|..|+|||||||++|||++=+++|+..++..-..+
T Consensus       160 ~~~a~--tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k  217 (426)
T KOG0589|consen  160 DSLAS--TVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK  217 (426)
T ss_pred             hhhhh--eecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH
Confidence            53333  45899999999999999999999999999999999999999998876655443

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.5e-34  Score=291.35  Aligned_cols=201  Identities=24%  Similarity=0.443  Sum_probs=168.1

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-----eeE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL  421 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~~  421 (571)
                      +|++.+.||+|+||.||+++.. +++.||||+++..  .......+.+|+.++++++||||+++++++...+     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4777899999999999999964 6899999998642  2234456889999999999999999999886433     478


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||++ ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888873   3456899999999999999999999998   999999999999999999999999999865


Q ss_pred             ccCCCc-cceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGE-ANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...... .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~  212 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN  212 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            332221 11123478999999999865  678999999999999999999999997653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-33  Score=280.99  Aligned_cols=204  Identities=31%  Similarity=0.467  Sum_probs=172.0

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc----CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      +.++|++.+.||+|+||.||++.+.    .+..||+|.++.. +......+.+|+..+.+++||||+++++++..++..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            4567888899999999999999853    3568999998753 3334557889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++|+|.+++..  ....+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.++++|||.+...
T Consensus        83 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999853  2346899999999999999999999998   999999999999999999999999987653


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~  212 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            22111 11112234678999999999999999999999999999875 99999654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-34  Score=291.63  Aligned_cols=195  Identities=28%  Similarity=0.395  Sum_probs=169.3

Q ss_pred             ceecccCceeEEEEEE----cCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          355 NILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      +.||+|+||.||++..    .+++.+|+|+++...  ......+..|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    357899999987532  2234457789999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|.+++.   +...+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++........  
T Consensus        82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--  153 (318)
T cd05582          82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--  153 (318)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence            999999883   3456899999999999999999999998   99999999999999999999999999876543321  


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~  202 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD  202 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence            2234578999999999998889999999999999999999999997654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-33  Score=287.18  Aligned_cols=194  Identities=30%  Similarity=0.402  Sum_probs=167.6

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.||+|++++.   .......+..|++++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 5789999998743   233445677888898888 799999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++.   ..+.+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  152 (318)
T cd05570          81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T  152 (318)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence            99998883   3456899999999999999999999998   99999999999999999999999999874322221  1


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~  199 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD  199 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence            22347899999999999999999999999999999999999999755

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-33  Score=281.41  Aligned_cols=200  Identities=32%  Similarity=0.426  Sum_probs=172.6

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +|+..++||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4677889999999999999964 68999999986422   2223457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|..++... ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887532 3346899999999999999999999998   9999999999999999999999999987653322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .   .....|+..|++||.+.+..++.++||||+|+++|||++|+.||...
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~  204 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR  204 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence            1   12346899999999999888999999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=296.34  Aligned_cols=200  Identities=33%  Similarity=0.470  Sum_probs=174.8

Q ss_pred             CCCCceecccCceeEEEEEE-cCCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------eeEE
Q 008288          351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------EKLL  422 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~l  422 (571)
                      +...+.||+|+||.||+|++ .+|+.||||.+++.. ....+....|++++++++|+|||+++++-+...      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            34457899999999999995 479999999998633 344556789999999999999999999876544      5689


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCCc--EEEeecccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMN--SKISDFGMA  498 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~--~~~~--~kL~DfGla  498 (571)
                      +|||+.+|+|...|.++++...+++.+.+.+...+..||.|||+++   |+||||||.||++-  ++|+  -||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999998888888999999999999999999999998   99999999999993  3343  699999999


Q ss_pred             cccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +.+.+..   ....+.||..|++||.... +.|+..+|.|||||++||.+||..||.+.
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            9876654   4456799999999999984 88999999999999999999999999765

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-33  Score=293.71  Aligned_cols=211  Identities=31%  Similarity=0.440  Sum_probs=175.4

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccC-ccchHHHHHHHHHHHhcc-cCCeeeEeeEE
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNLVKLLGFC  414 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~  414 (571)
                      ...+..++|.+.+.||+|+||.||+|+..      .+..||||+++... ....+.+.+|+.+++++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            34456778899999999999999999852      23479999997532 334557899999999995 99999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCC-----------------------------------------------------
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRK-----------------------------------------------------  441 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  441 (571)
                      .+.+..++||||+++|+|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            999999999999999999988753210                                                     


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 008288          442 ----------------------------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN  481 (571)
Q Consensus       442 ----------------------------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~N  481 (571)
                                                              ...+++..+..++.||++||.|||+.+   |+|+||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence                                                    124788889999999999999999998   9999999999


Q ss_pred             eEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       482 ILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            9999999999999999986544332222223356778999999998889999999999999999997 99998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4e-33  Score=280.35  Aligned_cols=201  Identities=27%  Similarity=0.430  Sum_probs=166.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc--CCcEEEEEEccccC--ccchHHHHHHHHHHHhc---ccCCeeeEeeEEEc-----
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS--DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVD-----  416 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~-----  416 (571)
                      ++|++.+.||+|+||.||++...  +++.||+|+++...  +.....+.+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888899999999999999863  46789999886422  22334566787777766   69999999999862     


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      ....++||||++ ++|.+++... ....+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345789999996 6888888432 2345899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +++......   ......|++.|+|||.+.+..++.++||||||+++|||++|++||...+
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            997654321   2223468999999999998899999999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.9e-33  Score=286.51  Aligned_cols=204  Identities=32%  Similarity=0.550  Sum_probs=171.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCc----EEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ...+|+..+.||+|+||.||+|++. +++    .||+|+++.. .....+++.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            3457888999999999999999853 333    4899998743 334556789999999999999999999998765 56


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++++||+++|+|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence            799999999999999853  2345889999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..............++..|++||.+.+..++.++||||||+++|||++ |+.||+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~  215 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  215 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            654333222222234668999999999999999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-33  Score=293.55  Aligned_cols=195  Identities=21%  Similarity=0.304  Sum_probs=168.1

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      +...+|++.+.||+|+||.||++... +++.||+|....      ..+.+|++++++++||||+++++++..+...++|+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            44568999999999999999999964 688999996532      34679999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      |++. ++|..++.   ....+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       163 e~~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        163 PRYK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             ecCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            9985 68887773   3345889999999999999999999998   999999999999999999999999999754322


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+-
T Consensus       236 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        236 NAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            211 1223579999999999999899999999999999999999998763

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.4e-33  Score=308.90  Aligned_cols=205  Identities=25%  Similarity=0.368  Sum_probs=173.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.++||+|+||.||++... +++.||+|+++...   +...+++.+|++++++++||||+++++++.+++..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            46888999999999999999965 68999999987432   223456899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          425 EFMPNGSLDAILFDPR--------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      ||+++++|.+++....        ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885311        1234567788999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCc----------------cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          497 MARIFAESEGE----------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +++........                ......+||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence            99865221100                0111247999999999999999999999999999999999999999654

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4e-33  Score=275.07  Aligned_cols=202  Identities=34%  Similarity=0.487  Sum_probs=173.3

Q ss_pred             CCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      ++|+..+.||+|+||.||++.++++..+++|.+... .....++.+|+.++++++||||+++++++...+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457778899999999999999888889999988642 3345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +|+|.+++...  .+.+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999988532  345899999999999999999999998   9999999999999999999999999987653322211


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~  206 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS  206 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence             112234567999999988889999999999999999999 999997654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.7e-33  Score=279.98  Aligned_cols=206  Identities=34%  Similarity=0.526  Sum_probs=174.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEcC------CcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..+|.+.+.||+|+||.||++...+      ++.|++|.++..... ..+.+.+|++++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4567788999999999999998632      478999998754433 456799999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 008288          421 LLVYEFMPNGSLDAILFDPR-----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN  489 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~  489 (571)
                      +++|||+++++|.+++....           ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999985321           2345789999999999999999999998   999999999999999999


Q ss_pred             EEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       490 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999976543322211122345678999999999999999999999999999999 99998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-34  Score=277.32  Aligned_cols=195  Identities=30%  Similarity=0.500  Sum_probs=161.3

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce-----eEEEE
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-----KLLVY  424 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-----~~lv~  424 (571)
                      |...+++|.|+||.||+|+.. ++++||||++-...+.    -..|+++|+++.|||||+|+-+|....+     ..+||
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            445689999999999999964 5799999987643332    2489999999999999999988865432     23899


Q ss_pred             EccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeecccccccc
Q 008288          425 EFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFA  502 (571)
Q Consensus       425 e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfGla~~~~  502 (571)
                      |||+. +|..+++. ...+..++...+.-+..||++||.|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.+.
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            99976 77777753 123455788888899999999999999988   9999999999999976 999999999999887


Q ss_pred             cCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..+...   ...-|.-|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+.
T Consensus       178 ~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~  229 (364)
T KOG0658|consen  178 KGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD  229 (364)
T ss_pred             cCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence            655442   23457789999999874 5999999999999999999999999765

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-33  Score=290.36  Aligned_cols=195  Identities=32%  Similarity=0.488  Sum_probs=164.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..+.||+|+||.||+++.. +++.||||++... .......+.+|++++++++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45566788999999999999965 6899999998643 233456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|....       ...+..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999985432       3567788899999999999999998   99999999999999999999999999986543322


Q ss_pred             ccceeeecccccccchhhhcc-----CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .  .....||..|+|||.+..     ...+.++|||||||++|||++|+.||..
T Consensus       224 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        224 P--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             c--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            1  123478999999998743     2345689999999999999999999974

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5e-33  Score=279.50  Aligned_cols=208  Identities=34%  Similarity=0.514  Sum_probs=176.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|.+.+.||+|+||.||++...      ++..+++|.+..........+.+|++++++++||||+++++++...+..
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4567888999999999999999842      3456899998866656667899999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcE
Q 008288          421 LLVYEFMPNGSLDAILFDPR----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS  490 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~  490 (571)
                      +++|||+++++|.+++....          ....+++..++.++.|++.+|+|||+.+   ++||||||+|||+++++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence            99999999999999885321          2235899999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      +|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~  227 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  227 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999986543322211122345678999999998889999999999999999998 999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.7e-33  Score=278.77  Aligned_cols=206  Identities=33%  Similarity=0.514  Sum_probs=173.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEcC------CcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      .++|+..+.||+|+||.||++....      .+.|++|.++... ......+.+|+.++.+++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            3467888999999999999998643      2579999887432 33455689999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 008288          421 LLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD  487 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~  487 (571)
                      +++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            999999999999998853211             145889999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          488 MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       488 ~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      +.++|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF  230 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999986544332222233456788999999988899999999999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.9e-33  Score=278.54  Aligned_cols=208  Identities=33%  Similarity=0.524  Sum_probs=173.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +..++|+..+.||+|+||.||++...      ++..||+|+++.. ......++.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999998753      2567999988642 2234456889999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEE
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK  491 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~k  491 (571)
                      ..++||||+++++|.+++.....       ...+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999999854221       234678899999999999999999988   99999999999999999999


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999876544332222122345778999999998899999999999999999999 78898654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-34  Score=280.03  Aligned_cols=209  Identities=32%  Similarity=0.416  Sum_probs=182.7

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEc
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD  416 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~  416 (571)
                      ++...+..+.|..-+.||+|+||.|+-++.. +|+.+|.|++.+.   ..+.....++|-.++.+++.+.||.+-..++.
T Consensus       177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT  256 (591)
T KOG0986|consen  177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET  256 (591)
T ss_pred             HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence            3344566678888999999999999999854 7999999988542   23344557899999999999999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      .+.+++|+..|.||+|.-+|..- .++.+++..++.++.+|+.||++||+..   ||.|||||+|||+|+.|+++|+|+|
T Consensus       257 kd~LClVLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  257 KDALCLVLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             CCceEEEEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccc
Confidence            99999999999999999888653 2356999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ||..+.......   ..+||.+|||||++.+..|+...|+|||||++|||+.|+-||...
T Consensus       333 LAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~  389 (591)
T KOG0986|consen  333 LAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR  389 (591)
T ss_pred             eEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence            998776544332   348999999999999999999999999999999999999999654

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-33  Score=274.13  Aligned_cols=206  Identities=33%  Similarity=0.484  Sum_probs=176.3

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +..++|+..+.||+|++|.||++...+++.|++|.++... ...+++.+|+.++++++||||+++++++...+..+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            4556788899999999999999998778899999987533 345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            999999999985422 346899999999999999999999998   9999999999999999999999999998765322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .. .......+..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  209 (261)
T cd05068         158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT  209 (261)
T ss_pred             cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            11 1111223457999999998889999999999999999999 999997643

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-33  Score=277.33  Aligned_cols=201  Identities=40%  Similarity=0.649  Sum_probs=167.2

Q ss_pred             CCceecccCceeEEEEEEc-----CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          353 DSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       353 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.. ......++.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999976     2678999999653 334477899999999999999999999999988889999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++|+|.+++... ....+++..+..|+.||++||.|||+.+   ++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999643 2456899999999999999999999998   99999999999999999999999999987633222


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ............|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~  210 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD  210 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            221222346778999999999889999999999999999999 789987653

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.3e-33  Score=281.25  Aligned_cols=202  Identities=26%  Similarity=0.418  Sum_probs=170.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|...+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888899999999999999965 67889999987432 23344678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++ +|.+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 77777643  2345889999999999999999999998   99999999999999999999999999875433222


Q ss_pred             ccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ..  ....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.
T Consensus       160 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  210 (309)
T cd07872         160 TY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV  210 (309)
T ss_pred             cc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            11  12367889999998865 4588999999999999999999999976543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.5e-33  Score=274.34  Aligned_cols=205  Identities=33%  Similarity=0.510  Sum_probs=176.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +..++|+..++||+|+||.||++...+++.|++|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            3456788899999999999999998888899999887532 345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          82 YMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             cCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            99999999998542 3345888999999999999999999988   9999999999999999999999999998654322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  208 (261)
T cd05072         158 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM  208 (261)
T ss_pred             eec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence            111 112245678999999988889999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.4e-33  Score=289.16  Aligned_cols=200  Identities=28%  Similarity=0.429  Sum_probs=169.1

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-----eeE
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL  421 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~~  421 (571)
                      +|+..+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999996 47899999998642  2234467889999999999999999999998776     789


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +|+||+. ++|...+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 57777773   3456899999999999999999999998   999999999999999999999999999865


Q ss_pred             ccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       154 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         154 EPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             ccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence            4332221 1223678899999998874 47999999999999999999999997653

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.8e-33  Score=277.71  Aligned_cols=205  Identities=32%  Similarity=0.473  Sum_probs=172.2

Q ss_pred             CCCCCCceecccCceeEEEEEE-----cCCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ++|+..+.||+|+||.||+|..     .+++.+++|.+... .......+.+|++++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5677789999999999999984     24678999998743 33344678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          423 VYEFMPNGSLDAILFDPR--------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      +|||+++++|.+++....              ....+++...+.++.||+.||+|||+.+   ++|+||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999884211              1235788999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999986544332222222345678999999988889999999999999999999 99998543

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-32  Score=274.79  Aligned_cols=192  Identities=31%  Similarity=0.425  Sum_probs=165.0

Q ss_pred             ecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ||+|+||.||++..+ +|+.+|+|++....   ......+..|++++.+++||||+++.+.+.++...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999864 68999999986421   12233456799999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                      ..++... ....+++..+..++.||+.||+|||+.+   |+||||||+||++++++.++|+|||++.......   ....
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence            8887432 2334889999999999999999999998   9999999999999999999999999987654322   1123


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ..|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~  196 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD  196 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            4689999999999988899999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-33  Score=283.71  Aligned_cols=201  Identities=32%  Similarity=0.446  Sum_probs=177.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc---cchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~  421 (571)
                      ....|++.+.||+|.||.||+++.+ +|+.+|+|.+.+...   .....+.+|+.+|+++. ||||+++.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3456788899999999999999976 599999999975433   24468999999999998 999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC----CcEEEeeccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISDFGM  497 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~----~~~kL~DfGl  497 (571)
                      +|||++.+|.|.+.+...    .+++.++..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999888543    2999999999999999999999998   9999999999999543    4799999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.....   .......+||+.|+|||++....|+...||||+|+++|.|++|..||...+
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            987765   334456799999999999999999999999999999999999999997653

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-33  Score=272.36  Aligned_cols=202  Identities=31%  Similarity=0.469  Sum_probs=171.9

Q ss_pred             CCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      .+|.+.+.||+|+||.||++..+++..+++|++... .....++.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            457778999999999999999877788999988642 2334568899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|.+++...  ...+++..+..++.||++||+|||+.+   ++||||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999998532  336899999999999999999999998   9999999999999999999999999987654322111


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  206 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS  206 (256)
T ss_pred             -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence             111123457999999998899999999999999999999 899997654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.2e-33  Score=290.47  Aligned_cols=196  Identities=27%  Similarity=0.393  Sum_probs=171.4

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcc-c-----CCeeeEeeEEEcCceeEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-H-----KNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~nIv~l~~~~~~~~~~~l  422 (571)
                      +|.+.+.||+|.||+|.++.. ++++.||||++++. .....+...|+.+|..++ |     -|+|+++++|...++.+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788899999999999999994 57999999999863 445567789999999996 4     589999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC--CcEEEeecccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARI  500 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~--~~~kL~DfGla~~  500 (571)
                      |+|.+ ..+|.++++..+.+ .++...++.|+.||+.+|.+||+.+   |||+||||+||||.+-  ..+||+|||.+..
T Consensus       266 VfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99988 67999999765444 4999999999999999999999998   9999999999999754  4699999999986


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ......     ..+.+.-|.|||++.|.+|+.+.||||||||+.||++|.+.|.+.
T Consensus       341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            544322     335677899999999999999999999999999999999888665

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-32  Score=273.48  Aligned_cols=204  Identities=32%  Similarity=0.528  Sum_probs=173.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEcC----CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .++|+..+.||+|+||.||+|.+..    ...|++|.++.. ......++.+|+.++++++||||+++++.+...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4678889999999999999998742    457899988743 33445678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      +|||+++++|.+++..  ..+.+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            9999999999999853  2346899999999999999999999988   9999999999999999999999999998775


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ............++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~  212 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence            3222222222244678999999998899999999999999999998 99998543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.9e-33  Score=285.20  Aligned_cols=208  Identities=29%  Similarity=0.452  Sum_probs=171.8

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG  417 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~  417 (571)
                      +..++|++.+.||+|+||.||++...      +++.||+|+++... ......+..|+.++.++ +|+||+++++++...
T Consensus         4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            45567889999999999999999632      24789999987432 23345678899999999 899999999988654


Q ss_pred             -ceeEEEEEccCCCChhhhhcCCCC-------------------------------------------------------
Q 008288          418 -DEKLLVYEFMPNGSLDAILFDPRK-------------------------------------------------------  441 (571)
Q Consensus       418 -~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  441 (571)
                       ...+++|||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             567899999999999998843211                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeeccccc
Q 008288          442 ---RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG  518 (571)
Q Consensus       442 ---~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~  518 (571)
                         ...+++..+..++.||++||+|||+.+   |+||||||+|||++++++++|+|||+++.+.............++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               136899999999999999999999998   99999999999999999999999999987644332222223355678


Q ss_pred             ccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       519 y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~  279 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV  279 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=261.43  Aligned_cols=213  Identities=24%  Similarity=0.300  Sum_probs=179.8

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc--
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--  418 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--  418 (571)
                      ..+.+..++|.+.+.||+|||+.||.++ ..+++.+|+|++.-.+.++.+..++|++..++++||||++++++...+.  
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            3456778899999999999999999999 5689999999998767778888999999999999999999998876544  


Q ss_pred             ---eeEEEEEccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          419 ---EKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       419 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                         ..|++++|...|+|.+.+...+ +...+++.+.+.|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEe
Confidence               4899999999999998886533 3447999999999999999999999987 5899999999999999999999999


Q ss_pred             cccccccccCCCc-------cceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          495 FGMARIFAESEGE-------ANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       495 fGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ||.+....-....       +.-....-|..|.|||.+.   +...+.++|||||||+||+|+.|.-||+.
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            9998754221111       0011124688899999875   45678999999999999999999999964

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.3e-33  Score=291.58  Aligned_cols=198  Identities=22%  Similarity=0.301  Sum_probs=171.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc---CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ...+|.+.+.||+|+||.||++...   .++.|++|.+...     ....+|++++++++||||+++++.+...+..+++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            3457999999999999999999753   3578999987642     2356899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      ||++. ++|..++   ...+.+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++..+..
T Consensus       165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99985 6787777   34467999999999999999999999998   99999999999999999999999999986655


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...........||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            44333333457999999999999999999999999999999999999999654

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-32  Score=277.02  Aligned_cols=206  Identities=34%  Similarity=0.515  Sum_probs=174.8

Q ss_pred             cCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..+|...+.||+|+||.||++...      ++..+++|.++.......+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            345777889999999999999742      34568999987655555677999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          422 LVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      +||||+++++|.+++....             ..+.+++..++.++.||+.||+|||+++   |+||||||+|||+++++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            9999999999999985321             2245899999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999976544322222222356788999999999999999999999999999999 99998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=287.17  Aligned_cols=193  Identities=27%  Similarity=0.379  Sum_probs=162.5

Q ss_pred             ecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhc---ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      ||+|+||.||++... +++.||+|++....   .........|..++...   +||||++++..+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999965 68999999986421   22333455667777665   699999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |+|..++.   ..+.+++..+..++.||++||+|||+.+   |+||||||+|||+++++.++|+|||++.........  
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence            99998883   3456899999999999999999999998   999999999999999999999999998754332221  


Q ss_pred             eeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~  201 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED  201 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence            2234789999999998764 48999999999999999999999997654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.6e-32  Score=272.41  Aligned_cols=200  Identities=26%  Similarity=0.425  Sum_probs=172.9

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|++.+.||+|+||.||+++. .+++.+++|++..........+.+|+.++.+++||||+++++.+..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45788899999999999999996 46889999998755545556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++.   ..+.+++..+..++.|+++||.|||+.+   |+||||+|+||++++++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999999884   3456899999999999999999999998   99999999999999999999999999986543221


Q ss_pred             ccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .  .....++..|+|||.+.   ...++.++||||||+++|||++|+.||..
T Consensus       162 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~  211 (267)
T cd06646         162 K--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             c--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence            1  12246788999999874   34578899999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-32  Score=271.31  Aligned_cols=202  Identities=31%  Similarity=0.494  Sum_probs=173.1

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC-----ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ++|+..+.||+|++|.||++.. .+++++++|.+....     ......+.+|++++++++||||+++++++.+++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5688899999999999999986 468999999876422     1224568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ++||+++++|.+++.   ..+.+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999884   3456889999999999999999999998   9999999999999999999999999987654


Q ss_pred             cCCCccc-eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  210 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF  210 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence            3221111 02235778999999999888999999999999999999999999654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=299.14  Aligned_cols=211  Identities=27%  Similarity=0.351  Sum_probs=176.8

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEcCC-cEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEee-EEEcC---
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLSDG-KEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLG-FCVDG---  417 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~-~~~~~---  417 (571)
                      +.+...++++.+.|.+|||+.||.+.+..+ .++|+|++-..++...+.+.+|+++|++|. |+|||.+++ .....   
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            445667778889999999999999997655 999999987668888999999999999995 999999999 33221   


Q ss_pred             ---ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          418 ---DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       418 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                         -+.+|.||||++|.|-+++..... ..|++.++++|+.++++|+++||... +||||||||-+||||..+++.||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq-~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQ-TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHh-ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence               256799999999999999854333 33999999999999999999999986 7899999999999999999999999


Q ss_pred             cccccccccCCCccc-------eeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          495 FGMARIFAESEGEAN-------TVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       495 fGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ||.+...........       .....-|+.|.+||++.   +..+++|+|||+|||+||-|+..+.||+..
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            999875433321110       11124589999999874   677899999999999999999999999876

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.7e-32  Score=270.82  Aligned_cols=201  Identities=30%  Similarity=0.468  Sum_probs=172.2

Q ss_pred             CCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      ++|...+.||+|+||.||++...++..+|+|.++.. .....++.+|+.++.+++||||+++++++...+..+++|||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            456778899999999999999877778999988743 2345678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999998532  236899999999999999999999998   999999999999999999999999998765433211 


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ......++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  205 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF  205 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence            1112235567999999988889999999999999999999 99999754

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-32  Score=274.40  Aligned_cols=203  Identities=34%  Similarity=0.511  Sum_probs=168.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCc----EEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ++|+..+.||+|+||.||++.+. +++    ++++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46777899999999999999963 444    47788775432 233456788888999999999999999875 455788


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ++||+++|+|.+++..  ..+.+++..+..++.||+.||+|||+.+   ++|+||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            9999999999999853  3356899999999999999999999988   9999999999999999999999999998664


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ............++..|++||.+.++.++.++||||||+++|||++ |+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  216 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR  216 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            4332222223456778999999998899999999999999999998 999997653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-32  Score=269.05  Aligned_cols=202  Identities=31%  Similarity=0.461  Sum_probs=176.1

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|++|.||++... +++.|++|.+..  ........+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4677789999999999999965 689999998863  2345566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999998642 2356899999999999999999999988   99999999999999999999999999886654332


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  ....+++.|+|||+..+..++.++|+||||+++|||++|+.||...+
T Consensus       157 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         157 FA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             hh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            21  23467889999999999889999999999999999999999997654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.6e-32  Score=274.59  Aligned_cols=208  Identities=30%  Similarity=0.476  Sum_probs=175.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC-----CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEc-Cc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~  418 (571)
                      +..++|+..+.||+|+||.||+|...+     ++.|++|++... .......+.+|+.++++++||||+++++++.. +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            566788889999999999999999765     688999988743 34445668899999999999999999998776 46


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEe
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKR-----GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS  493 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~  493 (571)
                      ..++++||+++++|.+++......     ..+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            788999999999999998543222     56899999999999999999999988   9999999999999999999999


Q ss_pred             ecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       494 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  223 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI  223 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence            9999986644332211122345678999999988889999999999999999999 99999754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-32  Score=292.00  Aligned_cols=200  Identities=26%  Similarity=0.425  Sum_probs=163.8

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-------
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-------  417 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-------  417 (571)
                      ....+|...+.||+|+||.||+|... +++.||||++....    ....+|+.++++++||||+++++++...       
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            45568999999999999999999964 68899999885422    2345799999999999999998876432       


Q ss_pred             -ceeEEEEEccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEee
Q 008288          418 -DEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISD  494 (571)
Q Consensus       418 -~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~D  494 (571)
                       ...++||||+++ +|..++.. ......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence             235689999975 66555532 234566899999999999999999999998   99999999999998664 799999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ||+++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|++||...
T Consensus       215 FGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  274 (440)
T PTZ00036        215 FGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ  274 (440)
T ss_pred             cccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999986643322   1234689999999998764 6899999999999999999999999765

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-35  Score=272.51  Aligned_cols=197  Identities=30%  Similarity=0.507  Sum_probs=178.7

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      |.+.++||+|+||.||++.++ .|+.+|+|.+..  +.+.+++..|+.++.+...|++|+++|.+.....+|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            456788999999999999975 699999998874  45778899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |+..++++  .++.++++.++..+.+..++||+|||...   -||||||+.|||++.+|..||.|||.+..+.+.....+
T Consensus       113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN  187 (502)
T ss_pred             CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence            99999995  35667999999999999999999999987   89999999999999999999999999987766554444


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                        ...||+-|||||++..-.|..++||||||+...||..|++||..-
T Consensus       188 --TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI  232 (502)
T KOG0574|consen  188 --TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI  232 (502)
T ss_pred             --ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence              358999999999999989999999999999999999999999643

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-32  Score=274.02  Aligned_cols=207  Identities=33%  Similarity=0.506  Sum_probs=174.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ...++...++||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++...+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            4567788899999999999999632      3568899998876666677899999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          421 LLVYEFMPNGSLDAILFDPRK------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      +++|||+++++|.+++.....            ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCC
Confidence            999999999999999853221            135889999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  228 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL  228 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence            999999999875543222111122245678999999999999999999999999999998 99998543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.6e-32  Score=273.96  Aligned_cols=199  Identities=31%  Similarity=0.418  Sum_probs=171.3

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      |...+.||+|+||.||++... +++.+|+|.+....   ......+.+|++++++++|+||+++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            556788999999999999864 68899999986432   22334578899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999999887532 2346899999999999999999999998   99999999999999999999999999876433221


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                         .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence               12346899999999999889999999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-32  Score=272.38  Aligned_cols=204  Identities=35%  Similarity=0.557  Sum_probs=177.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ...+|+..++||+|+||.||++...+++.+++|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            44568888999999999999999888999999999866555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999653 3356899999999999999999999998   99999999999999999999999999976543221


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..  ....++..|++||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus       160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~  208 (261)
T cd05148         160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM  208 (261)
T ss_pred             cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence            11  12245678999999988889999999999999999998 89999654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.5e-32  Score=273.99  Aligned_cols=199  Identities=31%  Similarity=0.431  Sum_probs=170.8

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      |+..+.||+|+||.||++... +++.+|+|.+....   ......+.+|+.++++++|++|+++++.+.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667789999999999999964 68899999886432   22234577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999888432 2335889999999999999999999988   99999999999999999999999999875433221


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                         .....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence               12246899999999999989999999999999999999999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=265.52  Aligned_cols=203  Identities=30%  Similarity=0.459  Sum_probs=173.6

Q ss_pred             ceecccCceeEEEEE-EcCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ++||+|+|+.|-.++ +.+|.++|||++.+..........+|++++... .|+||++|+++|+++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            679999999999988 678999999999987666677899999999998 599999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---cEEEeecccccccccC-----
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIFAES-----  504 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~---~~kL~DfGla~~~~~~-----  504 (571)
                      -..+   .++..+++.++..++++|+.||.|||.+|   |.||||||+|||..+-.   -+||+||.|..-+...     
T Consensus       164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            8888   45667999999999999999999999999   99999999999996544   4799999987643211     


Q ss_pred             CCccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhh
Q 008288          505 EGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGM  563 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~  563 (571)
                      ........++|+..|||||+..     ...|+.+.|.||||||||-|++|.+||.++=--+..|
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW  301 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW  301 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence            1223334578999999999874     2458999999999999999999999998763344444

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=307.27  Aligned_cols=219  Identities=27%  Similarity=0.340  Sum_probs=190.7

Q ss_pred             cccChHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccc---cCccchHHHHHHHHHHHhcccCCeeeEee
Q 008288          337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLG  412 (571)
Q Consensus       337 ~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~nIv~l~~  412 (571)
                      +.....++++..++|.+.+.||+|+||.|..++++ +++.+|+|++++   -......-|.+|-.+|..-+.+.|+++.-
T Consensus        63 ~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy  142 (1317)
T KOG0612|consen   63 IVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY  142 (1317)
T ss_pred             HHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence            34456778889999999999999999999999975 688899999986   33455667999999999999999999999


Q ss_pred             EEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       413 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                      .|.++..+|+|||||+||+|-.++.   +...+++..++.++..|.-||.-||+.|   +|||||||+|||||..|++||
T Consensus       143 AFQD~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  143 AFQDERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             HhcCccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEee
Confidence            9999999999999999999999993   3347999999999999999999999998   999999999999999999999


Q ss_pred             eecccccccccCCCccceeeecccccccchhhhc----c-CCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhh
Q 008288          493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM----E-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYG  562 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~  562 (571)
                      +|||.+-.+..+. .......+|||.|.+||++.    + +.|.+..|+||+||++|||+.|..||-..++.+..
T Consensus       217 ADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY  290 (1317)
T KOG0612|consen  217 ADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY  290 (1317)
T ss_pred             ccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH
Confidence            9999997765432 23333458999999999985    3 56999999999999999999999999777666543

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-32  Score=273.10  Aligned_cols=200  Identities=27%  Similarity=0.442  Sum_probs=173.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|...+.||+|+||.||++... +++.+++|.++.........+.+|+.+++.++||||+++++.+...+..+++|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            346777889999999999999864 6889999998765545556688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++.   ..+.+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999999883   3456899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             ccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                        ......|+..|+|||.+.   ...++.++||||||+++|||++|+.||..
T Consensus       162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~  211 (267)
T cd06645         162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence              122347899999999874   45588999999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.6e-32  Score=271.77  Aligned_cols=202  Identities=29%  Similarity=0.432  Sum_probs=170.9

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|++|.||++... +++.|++|+++..  .+.....+.+|+.++.+++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4677889999999999999975 6899999998643  223346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      ++ ++|.+++........+++..+..++.||++||+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 688888754444467899999999999999999999998   99999999999999999999999999875433221


Q ss_pred             ccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~  206 (285)
T cd07861         157 V--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS  206 (285)
T ss_pred             c--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            1  1123568889999988654 47899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-33  Score=260.57  Aligned_cols=197  Identities=32%  Similarity=0.493  Sum_probs=170.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc----CccchH----HHHHHHHHHHhc-ccCCeeeEeeEEEcCc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC----SEQGTA----EFTNEVLLILKL-QHKNLVKLLGFCVDGD  418 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~----~~~~~~----~~~~e~~~l~~l-~h~nIv~l~~~~~~~~  418 (571)
                      .+|...+.||.|..+.|.++.++ +|+++|+|++...    +.....    .-..|+.+|+++ .||+|+++.++++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            45677789999999999999864 7899999988531    111122    346789999998 7999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++|+|.|+.|.|.++|   ...-.+++....+|++|+.+|++|||...   |+||||||+|||+|++.++||+|||++
T Consensus        97 F~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa  170 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA  170 (411)
T ss_pred             hhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence            999999999999999999   45567999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhc------cCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAM------EGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ..+.....   ....+|||+|+|||.+.      ...|+...|+|+.|||||.|+.|-+||=
T Consensus       171 ~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  171 CQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             eccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            87765443   33469999999999985      2348899999999999999999999973

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-32  Score=275.73  Aligned_cols=205  Identities=31%  Similarity=0.441  Sum_probs=170.8

Q ss_pred             CCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      .+|...+.||+|+||.||+|...      +++.||+|+++..... ....+.+|+.++.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34566788999999999999853      2578999999754322 3456889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          422 LVYEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      +++||+++++|.+++...             .....+++..+..++.|++.||+|||+.+   |+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999988421             11345888999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||...
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999886543332222222345778999999988889999999999999999998 88898754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.3e-32  Score=272.24  Aligned_cols=193  Identities=29%  Similarity=0.413  Sum_probs=169.0

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..++||+|+||.||++.. .+++.+++|++... ......++.+|++++.+++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577789999999999999985 47889999988643 333456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++....... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999997553       3678889999999999999999998   9999999999999999999999999997654322 


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                         .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence               1224789999999999988999999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.7e-32  Score=272.79  Aligned_cols=204  Identities=33%  Similarity=0.517  Sum_probs=170.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCc----EEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|+..+.||+|+||.||+|.+. +++    +||+|.++.. ......++.+|+.++..++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            4467888899999999999999853 444    4899988743 33445678899999999999999999999875 457


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++++||+++|+|.+++..  ..+.+++..++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence            799999999999999853  2346899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..............++..|++||.+.+..++.++||||||+++|||++ |+.||+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  215 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI  215 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            654332221222234678999999998899999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-32  Score=274.88  Aligned_cols=200  Identities=27%  Similarity=0.490  Sum_probs=175.2

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      .+|+..+.||+|+||.||++.. .+++.+++|.+..........+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5788889999999999999985 468899999987655555677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++.    ...+++.++..++.|++.||+|||+.+   |+|+||||+||++++++.++|+|||++.........
T Consensus       100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            9999999983    235789999999999999999999998   999999999999999999999999998764332211


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence              122367889999999998889999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-32  Score=270.36  Aligned_cols=205  Identities=31%  Similarity=0.446  Sum_probs=173.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ...+|...+.||+|+||.||++... +++.+++|+++.. .....++.+|++++++++||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            3445777889999999999999964 5889999998753 3345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++... ....+++..++.++.|+++||+|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          83 FMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             eCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            99999999998542 3345899999999999999999999988   9999999999999999999999999998654332


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~  210 (263)
T cd05052         159 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  210 (263)
T ss_pred             ee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            11 1111234567999999998899999999999999999998 999987653

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-32  Score=276.18  Aligned_cols=210  Identities=32%  Similarity=0.481  Sum_probs=176.0

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      +.+..++|+..+.||+|+||.||++...      +...+++|.+... ......++.+|++++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            4456677888999999999999999863      2367899988743 334455688999999999 8999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                      .++..+++|||+++++|..++...             .....+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence            999999999999999999998532             22456899999999999999999999988   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ++++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            999999999999999987654332222222234667999999988889999999999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.6e-32  Score=283.23  Aligned_cols=198  Identities=28%  Similarity=0.386  Sum_probs=167.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|+..+.||+|+||.||++... +++.||+|++...  .......+.+|+.+++.++||||+++++++...+      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            467899999999999999999864 6899999998642  2334556889999999999999999999986543      


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+++ +|...+.     ..+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence            46899999975 4555542     23788899999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.......   .....||..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         171 RTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             cccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            75433221   123468999999999999999999999999999999999999997653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=267.33  Aligned_cols=202  Identities=28%  Similarity=0.356  Sum_probs=177.7

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      +.-++|...++||+|.||+|-+++-+ +++.+|+|++++..   ......-+.|-++|...+||.+..|...|+..+.++
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            44578899999999999999999854 79999999998642   334445678899999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||..||.|..+|   .....+++...+.+-..|..||.|||+++   ||.||||.+|.|+|.+|++||.||||++.-
T Consensus       245 FVMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  245 FVMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence            999999999998888   34556889999999999999999999998   999999999999999999999999999753


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ..  ....+..++|||.|+|||++....|..++|+|.+||++|||++|+.||-.
T Consensus       319 I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  319 IK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             cc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence            22  22344567999999999999999999999999999999999999999853

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-32  Score=272.50  Aligned_cols=209  Identities=33%  Similarity=0.510  Sum_probs=175.7

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC------CcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +..++|.+.+.||+|+||.||++...+      +..+++|.+.... ......+.+|+.++..++||||+++++++....
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            345678888999999999999998642      4689999986432 334557889999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEE
Q 008288          419 EKLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK  491 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~k  491 (571)
                      ..++||||+++++|.+++....       ....+++..++.++.|++.||.|||+.+   ++|+||||+||++++++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEE
Confidence            9999999999999999985422       2235788999999999999999999988   99999999999999999999


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      |+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||...+
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  226 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS  226 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence            999999986544332222223356788999999988889999999999999999998 999997553

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.1e-32  Score=272.15  Aligned_cols=208  Identities=33%  Similarity=0.544  Sum_probs=172.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC------CcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +..++|.+.+.||+|++|.||++.+.+      +..|++|.+.... ......+.+|+.++++++|+||+++++++.+.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345678889999999999999999743      5678999886433 333456899999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---cEE
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSK  491 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~---~~k  491 (571)
                      ..+++|||+++++|.+++.....    ...+++..++.++.||++||+|||+.+   ++|+||||+||++++++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence            99999999999999999854321    235899999999999999999999998   99999999999998754   599


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |+|||+++................+..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~  225 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR  225 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999987633222111112233567999999998899999999999999999997 99999764

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=292.45  Aligned_cols=200  Identities=38%  Similarity=0.564  Sum_probs=175.5

Q ss_pred             CCCCceecccCceeEEEEEE-cCCc----EEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          351 FSDSNILGQGGFGPVYKGVL-SDGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      +...++||+|+||+||+|.+ +.|+    +||+|++.. ...+...++++|+.+|.+++|||+++|+++|.... ..||.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34468899999999999985 4444    689998864 45666789999999999999999999999998776 78999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      +||+.|+|.++++.  .+..+..+..+.|..||++||.|||++.   ++||||..+||||.+-..+||.|||+++.+..+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999965  4556889999999999999999999988   999999999999999999999999999988776


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..........-.+.|||-|.+....|+.++|||||||.+||++| |.+|++..
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi  904 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI  904 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC
Confidence            65554444455678999999999999999999999999999999 99999765

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.6e-32  Score=275.25  Aligned_cols=198  Identities=29%  Similarity=0.411  Sum_probs=172.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|++.+.||+|+||.||++... ++..+++|.++.. ......++.+|++++.+++||||+++++++..++..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36888899999999999999965 6788999988643 333445688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      +++++|.+++.   +.+.+++..+..++.|+++||.|||+ .+   ++|+||||+|||+++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            99999999984   33568999999999999999999997 45   9999999999999999999999999987553321


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .    ....++..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus       155 ~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         155 A----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             c----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence            1    2346889999999998888999999999999999999999998644

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-32  Score=277.33  Aligned_cols=210  Identities=32%  Similarity=0.474  Sum_probs=173.9

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc--------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      +..++|.+.+.||+|+||.||++...        +...+|+|.++.. ......++.+|++++.++ +||||+++++++.
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            34567888999999999999999752        2346999998753 234456788999999999 7999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                      ..+..++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||+.+   ++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence            99999999999999999999954221             235889999999999999999999988   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCch
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQL  558 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~~  558 (571)
                      ++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+.
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            999999999999999876543222111111234568999999998889999999999999999998 8899876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.9e-32  Score=267.75  Aligned_cols=204  Identities=24%  Similarity=0.363  Sum_probs=175.7

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      +|+..+.||+|+||.||++... +++.+++|.++. ......+.+.+|+.++++++|+||+++++.+..++..+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4677899999999999999965 689999998863 23345567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++.. .....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            99999888743 23445789999999999999999999998   999999999999999999999999998765432221


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                        .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~  206 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK  206 (255)
T ss_pred             --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH
Confidence              12346888999999999888999999999999999999999999876543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.3e-32  Score=284.86  Aligned_cols=210  Identities=31%  Similarity=0.461  Sum_probs=173.9

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccC-ccchHHHHHHHHHHHhcc-cCCeeeEeeEEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCV  415 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~  415 (571)
                      ..+..++|.+.++||+|+||.||++++.      .++.||+|+++... ....+.+.+|+.++.++. ||||+++++.+.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3455567788899999999999999853      34689999997532 333456889999999997 999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCC-------------------------------------------------------
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPR-------------------------------------------------------  440 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------  440 (571)
                      ..+..++||||+++|+|.++++...                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999885321                                                       


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCC
Q 008288          441 ----------------------------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS  480 (571)
Q Consensus       441 ----------------------------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~  480 (571)
                                                              ....+++..++.++.||+.||+|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                    1124678888999999999999999988   999999999


Q ss_pred             CeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          481 NVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       481 NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |||+++++.+||+|||+++.+.............++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999986543322111222356788999999998889999999999999999998 89998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-32  Score=289.42  Aligned_cols=194  Identities=25%  Similarity=0.294  Sum_probs=166.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ...|.+.+.||+|+||.||++.+. .++.|+||...      ...+.+|++++++++|+||+++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            456888999999999999999975 57889999543      22457899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +. ++|..++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 688777743  2346999999999999999999999998   99999999999999999999999999986644332


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~  553 (571)
                      ........||..|+|||++.+..++.++|||||||++|||++|..|+
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            22223457999999999999999999999999999999999987654

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=263.09  Aligned_cols=199  Identities=29%  Similarity=0.443  Sum_probs=172.4

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcc--ccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++.|++-+.||+|.|+.|+++.+ .+|+.+++|++.  +.+....+++.+|+.+-+.++||||++|.......+..++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45677778999999999999985 479999999875  345557788999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CcEEEeeccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIF  501 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~---~~~kL~DfGla~~~  501 (571)
                      |+|+|++|..=+.   .+...++..+...++||+++|.|+|.++   |||||+||+|+|+.+.   --+||+|||++..+
T Consensus        90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            9999999954442   2345778888999999999999999999   9999999999999544   34899999999877


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .   ....-..++|||+|||||++...+|+..+|||+-|||||-|+.|.+||-.
T Consensus       164 ~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  164 N---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             C---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            6   22233456899999999999999999999999999999999999999865

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.1e-32  Score=273.78  Aligned_cols=208  Identities=32%  Similarity=0.489  Sum_probs=172.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +..++|++.+.||+|+||.||+|..+      .+..||+|.++... ......+.+|+.+++.++||||+++++++.+.+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678899999999999999999753      24579999886432 233446788999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEE
Q 008288          419 EKLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK  491 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~k  491 (571)
                      ..++||||+++|+|.+++....       ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            9999999999999999985321       1244677889999999999999999998   99999999999999999999


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |+|||+++...............++..|++||.+.++.++.++||||||+++|||++ |+.||...
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~  225 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL  225 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999986543332222222245678999999998899999999999999999999 78898654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.8e-32  Score=267.38  Aligned_cols=197  Identities=32%  Similarity=0.460  Sum_probs=165.5

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      +.||+|+||.||+++.. +++.+++|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999964 7899999987643 234456789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                      .+++..  ....+++..++.++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            999843  2345889999999999999999999998   99999999999999999999999999875432211111111


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~  200 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL  200 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            122456999999998889999999999999999998 99998643

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.5e-32  Score=273.61  Aligned_cols=198  Identities=33%  Similarity=0.438  Sum_probs=174.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|+||.||++... +++.+++|++...   .......+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46788899999999999999965 6899999988642   2234556889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++.   ..+.+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999984   3456899999999999999999999988   999999999999999999999999998865443


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                           .....+++.|++||.+.+...+.++||||||+++|||++|+.||...+
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence                 223468899999999988888999999999999999999999997653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.1e-32  Score=272.16  Aligned_cols=202  Identities=31%  Similarity=0.452  Sum_probs=174.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|++.+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            467888999999999999999975 5889999999876666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|..++..  ....+++..+..++.|++.+|+|||+.+   ++||||||+||+++.+++++|+|||++........
T Consensus        91 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          91 CPGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            999999888743  2345899999999999999999999988   99999999999999999999999999875433221


Q ss_pred             ccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .  .....++..|+|||.+.     ...++.++||||||+++|||++|+.||...
T Consensus       166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  218 (292)
T cd06644         166 R--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  218 (292)
T ss_pred             c--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence            1  12346788999999884     344688999999999999999999999654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.8e-32  Score=272.00  Aligned_cols=205  Identities=34%  Similarity=0.473  Sum_probs=171.2

Q ss_pred             CCCCCceecccCceeEEEEEEc------CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... .....++.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4677899999999999999853      23578888886433 3345678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 008288          423 VYEFMPNGSLDAILFDPR---------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN  481 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~N  481 (571)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1235889999999999999999999988   9999999999


Q ss_pred             eEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       482 ILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ||+++++.+||+|||+++...............++..|++||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999986543332222222345678999999988889999999999999999998 999997543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-32  Score=267.11  Aligned_cols=206  Identities=33%  Similarity=0.517  Sum_probs=176.7

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +..++|.+.+.||+|+||.||++..++++.++||.+... ....+++.+|+.++++++|+||+++++++......+++||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            456788899999999999999999888889999998753 3345678999999999999999999999999899999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999998542 2346899999999999999999999998   9999999999999999999999999987654321


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  209 (261)
T cd05034         158 YT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT  209 (261)
T ss_pred             hh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            11 1112234567999999998889999999999999999999 999996543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-32  Score=292.89  Aligned_cols=202  Identities=22%  Similarity=0.343  Sum_probs=165.5

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhccc------CCeeeEeeEEE
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH------KNLVKLLGFCV  415 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~nIv~l~~~~~  415 (571)
                      .+....++|++.++||+|+||.||++... +++.||||+++... ....+...|+.++.+++|      ++++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34456788999999999999999999964 68889999986422 234456678888877755      45888888887


Q ss_pred             cC-ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCC-----
Q 008288          416 DG-DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDM-----  488 (571)
Q Consensus       416 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~-----  488 (571)
                      .+ +..++|||++ +++|.+++.   +.+.+++..+..|+.||+.||.|||++ +   |+||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            65 4678999987 778877773   345699999999999999999999984 7   99999999999998765     


Q ss_pred             -----------cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          489 -----------NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       489 -----------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                                 .+||+|||++.....     .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       499999998764321     1223579999999999999999999999999999999999999997654

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.9e-32  Score=267.37  Aligned_cols=205  Identities=34%  Similarity=0.511  Sum_probs=174.1

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +..++|+..++||+|+||.||++..++++.+++|.+.... ....++.+|+.++++++|+||+++++++. .+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            4456788899999999999999998889999999987533 34567899999999999999999999864 457899999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++... ....+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          81 YMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999999988542 3446899999999999999999999988   9999999999999999999999999997654322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       157 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  208 (260)
T cd05067         157 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT  208 (260)
T ss_pred             ccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            111 112245678999999988889999999999999999999 999997553

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.7e-32  Score=273.76  Aligned_cols=199  Identities=27%  Similarity=0.495  Sum_probs=175.2

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      .+|+..+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5788889999999999999996 479999999987655555667889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++..    ..+++..+..++.|++.+|.|||+.+   ++||||||+|||++.++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999998832    35789999999999999999999998   999999999999999999999999998765433221


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .  ....+++.|++||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       172 ~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         172 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             c--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1  2236788999999999988999999999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.8e-32  Score=269.68  Aligned_cols=203  Identities=27%  Similarity=0.439  Sum_probs=174.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||+++.. +++.|+||.++..   .......+.+|+++++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57888999999999999999964 7899999987532   2333456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      ||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999887532 23456889999999999999999999998   99999999999999999999999999886543


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....  ....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       159 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             hhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            32211  1236788999999998888999999999999999999999998543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.3e-32  Score=269.75  Aligned_cols=198  Identities=28%  Similarity=0.389  Sum_probs=160.9

Q ss_pred             eecccCceeEEEEEEcC---CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCC
Q 008288          356 ILGQGGFGPVYKGVLSD---GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      .||+|+||.||+|...+   ...+++|.+... .......+.+|+..++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997533   457888887643 23345568899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          432 LDAILFDPRK--RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       432 L~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||+++++++||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999854322  234567888999999999999999998   99999999999999999999999999875433221111


Q ss_pred             eeeecccccccchhhhcc-------CCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAME-------GLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .....++..|+|||++..       ..++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            122345678999998743       356889999999999999999 88888654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.6e-32  Score=267.05  Aligned_cols=204  Identities=32%  Similarity=0.511  Sum_probs=172.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..++|++.+.||+|+||.||++..+++..+++|.++... ...+.+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            345788889999999999999998888899999987533 24567899999999999999999999875 4568899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++..+.....
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            9999999998542 2345899999999999999999999998   99999999999999999999999999976543221


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~  208 (260)
T cd05070         158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN  208 (260)
T ss_pred             cc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            11 111234567999999988889999999999999999999 899996543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.1e-32  Score=268.85  Aligned_cols=198  Identities=35%  Similarity=0.567  Sum_probs=171.4

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchH--HHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      |+..+.||+|+||.||++... +++.+|+|++.........  ...+|+.++++++||||+++++++.+....+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            456789999999999999976 5678999999864433222  3456999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++.   ....+++..+..++.||++||.+||+.+   ++|+||||+||++++++.++|+|||.+......  .
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--N  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST--T
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence            9999999994   4566899999999999999999999998   999999999999999999999999998754111  1


Q ss_pred             cceeeecccccccchhhhc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          508 ANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .......++..|+|||.+. +..++.++||||||+++|+|++|+.||...
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            2223347889999999998 888999999999999999999999999876

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1e-31  Score=269.27  Aligned_cols=201  Identities=24%  Similarity=0.378  Sum_probs=172.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|+..+.||+|+||.||++... +++.|++|++....  ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46788899999999999999975 68999999886432  2234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|..++.   ....+++..++.++.|++++|+|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999999988773   3345899999999999999999999988   9999999999999999999999999998765433


Q ss_pred             Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       155 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         155 DD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             cc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            21  112356788999999876 557899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.2e-32  Score=270.63  Aligned_cols=199  Identities=30%  Similarity=0.454  Sum_probs=171.2

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      |++.+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++||||+++++.+..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            455678999999999999975 5778899988765566677889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++..  ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||++.........  
T Consensus        87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--  159 (282)
T cd06643          87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--  159 (282)
T ss_pred             CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccc--
Confidence            999888743  3456899999999999999999999998   999999999999999999999999998765432211  


Q ss_pred             eeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....++..|+|||.+.     +..++.++||||||+++|||++|++||...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  211 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL  211 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence            12346889999999874     445788999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-31  Score=266.44  Aligned_cols=203  Identities=28%  Similarity=0.459  Sum_probs=175.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|+||.||++... +++.+++|.++..   .....+.+.+|++++++++|+||+++++.+...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888999999999999999976 7999999988632   2333567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      ||+++++|..++... .....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988542 23456899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....  ....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            32221  2246788999999999888999999999999999999999998544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-32  Score=268.09  Aligned_cols=203  Identities=31%  Similarity=0.480  Sum_probs=168.5

Q ss_pred             CCCCceecccCceeEEEEEEcC----CcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce-----
Q 008288          351 FSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-----  419 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-----  419 (571)
                      |++.+.||+|+||.||++....    +..||+|+++..  .......+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998642    367999998743  23345678999999999999999999998876554     


Q ss_pred             -eEEEEEccCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 008288          420 -KLLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF  495 (571)
Q Consensus       420 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~Df  495 (571)
                       .++++||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998885422   2346899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |+++...............++..|++||.+.+..++.++||||||+++|||++ |..||...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~  219 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV  219 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            99986644332222222234678999999988889999999999999999999 89998654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.8e-32  Score=268.24  Aligned_cols=202  Identities=30%  Similarity=0.455  Sum_probs=170.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-----ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--cee
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~  420 (571)
                      .+|+..+.||+|+||.||++... +++.|++|.+....     ......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888899999999999999964 68999999875321     12345688899999999999999999988764  457


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +++|||+++++|.+++.   ....+++.....++.|++.+|+|||+.+   ++|+||||+||++++++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            79999999999999884   3345788999999999999999999998   99999999999999999999999999876


Q ss_pred             cccCCCc-cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  212 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF  212 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence            5432111 1122346888999999998888999999999999999999999999654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.8e-32  Score=267.01  Aligned_cols=203  Identities=33%  Similarity=0.497  Sum_probs=171.1

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..++|.+.++||+|+||.||++...++..|++|+++... .....+.+|+.++++++||||+++++.+. .+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            446688899999999999999998777789999987522 23457899999999999999999999874 4567899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++.++|+|||+++.+.....
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999998532 2345789999999999999999999988   99999999999999999999999999976543322


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .. .....++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~  207 (262)
T cd05071         158 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  207 (262)
T ss_pred             cc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            11 112245678999999988889999999999999999999 88898654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.8e-32  Score=272.94  Aligned_cols=201  Identities=27%  Similarity=0.506  Sum_probs=176.2

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..+|+..+.||.|++|.||++.. .+++.|++|.+..........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            34688889999999999999985 47899999998765555567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|..++.    ...+++.++..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          98 LAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             cCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999999883    235899999999999999999999998   99999999999999999999999999876543322


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         171 KR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             cC--CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            11  22367889999999998889999999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.6e-32  Score=275.21  Aligned_cols=197  Identities=26%  Similarity=0.433  Sum_probs=159.8

Q ss_pred             CceecccCceeEEEEEEc---CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEc--CceeEEEEEccC
Q 008288          354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP  428 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  428 (571)
                      .++||+|+||.||++...   +++.+|+|.+...  .....+.+|+.++++++||||+++++++..  +...+++|||++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            467999999999999864   4678999988643  223457899999999999999999998864  445789999985


Q ss_pred             CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCcEEEeecccc
Q 008288          429 NGSLDAILFDP------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA  498 (571)
Q Consensus       429 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl----~~~~~~kL~DfGla  498 (571)
                       ++|..++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5777776321      12235889999999999999999999998   9999999999999    45678999999999


Q ss_pred             cccccCCCc-cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGE-ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +.+...... .......+|+.|+|||++.+. .++.++||||+|+++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433211 122235789999999998774 5899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-31  Score=263.70  Aligned_cols=197  Identities=33%  Similarity=0.485  Sum_probs=167.6

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCChh
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD  433 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  433 (571)
                      ++||+|+||.||++...+++.+++|.++... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3689999999999998889999999987543 233446889999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeee
Q 008288          434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI  513 (571)
Q Consensus       434 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~  513 (571)
                      +++..  ....+++..+..++.|++.+|.|||+.+   ++|+||||+||++++++.+||+|||++.......... ....
T Consensus        81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~  154 (250)
T cd05085          81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK  154 (250)
T ss_pred             HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence            98843  2345889999999999999999999998   9999999999999999999999999987543322111 1112


Q ss_pred             cccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       514 ~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~  199 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT  199 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence            34567999999988889999999999999999998 999997653

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-32  Score=266.81  Aligned_cols=202  Identities=28%  Similarity=0.427  Sum_probs=176.4

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++.+.+.+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            357888899999999999999964 6788999998865555677899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            999999998843  2356899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             ccceeeecccccccchhhhccC---CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEG---LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..  ....++..|++||.+.+.   .++.++||||||+++|||++|+.||...
T Consensus       157 ~~--~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~  207 (262)
T cd06613         157 KR--KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL  207 (262)
T ss_pred             cc--ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            11  224678899999998776   7899999999999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-32  Score=270.62  Aligned_cols=202  Identities=28%  Similarity=0.418  Sum_probs=174.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|++.+.||+|+||.||++... +++.+++|.++.........+.+|++++++++||||+++++.+..++..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456888899999999999999974 6889999998766666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|..++..  ....+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            999999999843  2346899999999999999999999998   99999999999999999999999999875433222


Q ss_pred             ccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .  .....+++.|++||.+.     ...++.++||||||+++|||++|+.||...
T Consensus       159 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         159 K--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             c--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence            1  12346889999999875     344678999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8e-32  Score=268.12  Aligned_cols=202  Identities=29%  Similarity=0.492  Sum_probs=165.3

Q ss_pred             CCCceecccCceeEEEEEEcC-Cc--EEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC------cee
Q 008288          352 SDSNILGQGGFGPVYKGVLSD-GK--EVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEK  420 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~  420 (571)
                      .+.+.||+|+||.||+|...+ ++  .+|+|.++..  +....+.+.+|+.+++.++||||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999754 32  6899988643  344466788999999999999999999987542      246


Q ss_pred             EEEEEccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          421 LLVYEFMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +++|||+++|+|..++...   .....+++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999998887421   12345899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ++...............+++.|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  218 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV  218 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            986643322111112245678999999998899999999999999999999 89998654

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.4e-32  Score=266.64  Aligned_cols=201  Identities=34%  Similarity=0.540  Sum_probs=172.2

Q ss_pred             CCCCCceecccCceeEEEEEEcCCcEEEEEEccccC------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +|...+.||+|+||.||++...+++.+|+|.++...      ......+.+|++++++++|+||+++.+++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467788999999999999998789999999886322      12234588999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      +||+++++|.+++.   +.+.+++..+..++.|++.+|+|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999983   3356889999999999999999999988   99999999999999999999999999876432


Q ss_pred             CCC----ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEG----EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...    ........++..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  211 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM  211 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence            111    11112346788999999998888999999999999999999999999654

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-31  Score=266.31  Aligned_cols=201  Identities=33%  Similarity=0.572  Sum_probs=171.6

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCcc---------chHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQ---------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      +|.....||+|++|.||+|... +++.+++|.+......         ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667789999999999999864 6889999988643221         12457899999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .+++|||+++++|..++.   ..+.+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999983   3456889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc----cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGE----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ........    .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            76532111    1112245788999999999888999999999999999999999999754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.98  E-value=5.1e-32  Score=274.36  Aligned_cols=209  Identities=30%  Similarity=0.471  Sum_probs=174.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc--------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      +..++|.+.+.||+|+||.||++...        ++..+++|.+... ......++.+|+.++..+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            45667888899999999999999741        2457999988743 234456789999999999 8999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                      ..+..+++|||+++++|.+++....             ....+++..+..++.||++||+|||+.+   ++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            9999999999999999999985422             1235788999999999999999999998   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999986644332222222345678999999988889999999999999999998 888886553

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.98  E-value=9.4e-32  Score=264.92  Aligned_cols=200  Identities=28%  Similarity=0.469  Sum_probs=176.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|+..+.||+|+||.||++... +++.+++|.++....  ..++.+|++++++++||||+++++.+......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            467888999999999999999976 488999999875432  67899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999999843  3456899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .  .....++..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus       155 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~  202 (256)
T cd06612         155 K--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI  202 (256)
T ss_pred             c--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            1  12235788999999999889999999999999999999999998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.98  E-value=7.2e-32  Score=274.61  Aligned_cols=208  Identities=31%  Similarity=0.483  Sum_probs=172.3

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc--------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      ...++|.+.+.||+|+||.||++...        ....+++|.++.. ......++.+|+.++.++ +||||+++++++.
T Consensus         9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099           9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34467788899999999999999742        2457899988743 233456788999999999 6999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                      ..+..+++|||+++++|.+++....             ....+++.++..++.||+.||.|||+.+   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            9999999999999999999985422             1245889999999999999999999998   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |+++++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999986543322211112234467999999998889999999999999999999 89998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.98  E-value=8.5e-32  Score=272.35  Aligned_cols=201  Identities=26%  Similarity=0.395  Sum_probs=169.8

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|...+.||+|+||.||++... +++.||+|.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888899999999999999865 68899999987432 33345678999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      ++ ++|..++..  ....+++..+..++.||++||+|||+.+   |+|+||||+||++++++.++|+|||++........
T Consensus        86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 588887743  2345889999999999999999999998   99999999999999999999999999875433221


Q ss_pred             ccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  ....+++.|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus       160 ~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         160 TY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             cc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            11  123568899999988654 47889999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.6e-32  Score=267.99  Aligned_cols=200  Identities=28%  Similarity=0.456  Sum_probs=175.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..+.||.|++|.||++... +++.+++|++... .......+.+|+.++++++|+||+++.+.+.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36778889999999999999965 6889999998743 244556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++..    ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999999843    26899999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  .....++..|++||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       154 ~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~  202 (274)
T cd06609         154 K--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH  202 (274)
T ss_pred             c--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence            1  223467889999999998889999999999999999999999997543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.98  E-value=5e-32  Score=274.19  Aligned_cols=208  Identities=31%  Similarity=0.454  Sum_probs=174.5

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEc
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD  416 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~  416 (571)
                      .+..++|...+.||+|+||.||++...      .+..+|+|+++... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            345567888999999999999999741      34579999887532 33455788999999999 79999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      .+..+++|||+++++|.+++... ....+++.++..++.|++.||+|||+.+   ++|+||||+|||+++++.++|+|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            99999999999999999998532 2234899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      +++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~  247 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM  247 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence            9986544322111112345678999999998889999999999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.98  E-value=7e-32  Score=280.48  Aligned_cols=198  Identities=28%  Similarity=0.373  Sum_probs=167.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC------c
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~  418 (571)
                      .++|...+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467899999999999999999964 6889999998742  233455688999999999999999999987643      3


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+++ +|...+.     ..+++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            46899999965 6666652     23788899999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.......   .....+|..|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       174 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         174 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             cccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            76533221   123468999999999999999999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.98  E-value=9.7e-32  Score=267.30  Aligned_cols=198  Identities=30%  Similarity=0.407  Sum_probs=162.4

Q ss_pred             eecccCceeEEEEEEcC---CcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCC
Q 008288          356 ILGQGGFGPVYKGVLSD---GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      .||+|+||.||+|...+   +..+++|.++... ......+.+|+.++++++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999998643   4578999887433 2334578899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          432 LDAILFDPR--KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       432 L~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |.+++....  ....+++..+..++.|+++||+|||+.+   ++|+||||+||++++++++||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999985422  2234677888899999999999999998   99999999999999999999999999875433222112


Q ss_pred             eeeecccccccchhhhccC-------CCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEG-------LYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence            2234567889999988642       35789999999999999996 99999643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.98  E-value=9.9e-32  Score=267.01  Aligned_cols=204  Identities=30%  Similarity=0.453  Sum_probs=173.0

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +.+++++.....||+|+||.||++... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..+++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            456677777789999999999999964 6788999998765556667899999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeecccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGIL--CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARI  500 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~  500 (571)
                      +||+++++|.+++....  ..+  ++..+..++.||++||+|||+.+   |+||||||+||+++. ++.++|+|||++..
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          84 MEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            99999999999985422  234  78888999999999999999988   999999999999976 67999999999876


Q ss_pred             cccCCCccceeeecccccccchhhhccCC--CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .......  .....++..|+|||.+.+..  ++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~  213 (268)
T cd06624         159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE  213 (268)
T ss_pred             cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence            5432211  12235788999999986543  78899999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=6.1e-32  Score=272.57  Aligned_cols=207  Identities=30%  Similarity=0.422  Sum_probs=170.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcC---------------CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSD---------------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKL  410 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l  410 (571)
                      ..++|++.+.||+|+||.||++...+               ...||+|.++.. .......+.+|++++++++|+||+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            34678889999999999999987532               225899998753 33344568899999999999999999


Q ss_pred             eeEEEcCceeEEEEEccCCCChhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 008288          411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPR---------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN  481 (571)
Q Consensus       411 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~N  481 (571)
                      ++++...+..++||||+++++|.+++....         ....+++..++.++.|+++||+|||+.+   ++|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence            999999999999999999999999885321         1124688999999999999999999998   9999999999


Q ss_pred             eEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh--CCCCCCCC
Q 008288          482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRRNAGSN  556 (571)
Q Consensus       482 ILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--G~~p~~~~  556 (571)
                      |++++++.+||+|||++................++..|+|||.+.++.++.++||||||+++|||++  |..||...
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999999976543322222222345678999999998899999999999999999998  66677643

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.98  E-value=1.5e-31  Score=265.54  Aligned_cols=202  Identities=31%  Similarity=0.481  Sum_probs=170.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-----ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--cee
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~  420 (571)
                      .+|+..+.||+|+||.||++... +++.+++|+++...     ......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999999864 68899999886321     12345688999999999999999999998763  567


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++++||+++++|.+++.   ....+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999884   3345889999999999999999999988   99999999999999999999999999876


Q ss_pred             cccCCCc-cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence            5332111 1112245788999999999888999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=5.5e-32  Score=271.50  Aligned_cols=201  Identities=27%  Similarity=0.427  Sum_probs=171.8

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..+.||+|+||.||++... +++.+++|.++.. .+.....+.+|++++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36778899999999999999975 7899999988643 334456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      +++++|..++........+++..+..++.|+++||.|||+. +   |+|+||||+||++++++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999985433345789999999999999999999974 6   9999999999999999999999999987653322


Q ss_pred             CccceeeecccccccchhhhccC------CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEG------LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .    ....++..|++||.+.+.      .++.++||||||+++|||++|+.||...
T Consensus       158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence            2    123578899999998543      3588999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.98  E-value=1.1e-31  Score=264.51  Aligned_cols=199  Identities=33%  Similarity=0.524  Sum_probs=173.1

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-----ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +|+..+.||+|++|.||+|... +++.|++|.+....     ++..+.+.+|+.++++++|+||+++++++.++...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667789999999999999976 78999999886432     23456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      +||+++++|.+++.   +...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999984   3346889999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCCccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..   ......++..|++||.+.... ++.++|+||||+++|||++|+.||+...
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~  206 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE  206 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence            32   122346788999999987766 8999999999999999999999997654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.98  E-value=9.3e-32  Score=267.14  Aligned_cols=205  Identities=31%  Similarity=0.570  Sum_probs=172.1

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCc---EEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGK---EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|+..+.||+|+||.||++... +++   .+++|.++.. .....+++.+|++++++++||||+++.+++...+..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            3457788899999999999999974 333   6899988753 3344567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++++|..++..  ..+.+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          83 IITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999999843  3356899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccCCCccce-eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          502 AESEGEANT-VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ......... .....+..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~  214 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM  214 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence            433222111 11123457999999988889999999999999999998 99998644

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.98  E-value=7.3e-32  Score=268.12  Aligned_cols=203  Identities=32%  Similarity=0.543  Sum_probs=170.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CC---cEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DG---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .+|+..+.||+|+||.||+|... ++   ..|++|.++.. .+....++..|+.++++++||||+++.+++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            34677889999999999999964 33   36999998753 344566799999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++..  ..+.+++.+++.++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999999853  2356899999999999999999999998   99999999999999999999999999876544


Q ss_pred             CCCccceeeec---ccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          504 SEGEANTVRIV---GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ...........   .+..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            32221111111   1357999999998899999999999999999987 99998654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=1e-31  Score=269.20  Aligned_cols=203  Identities=34%  Similarity=0.493  Sum_probs=169.8

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-----CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--cee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~  420 (571)
                      ..+|++.+.||+|+||.||++..+     +++.|++|++........+.+.+|++++++++||||+++++++...  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            356788899999999999999742     5789999998876666667899999999999999999999987543  467


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++|+||+++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++||||||+||++++++.+||+|||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            899999999999999843  2345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccce-eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANT-VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .......... ....++..|+|||.+.+..++.++||||||+++|||++|..|+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  213 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS  213 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence            6433221111 111234459999999988899999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.98  E-value=1.5e-31  Score=263.72  Aligned_cols=204  Identities=26%  Similarity=0.413  Sum_probs=176.6

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|+||.||.+.. .+++.+++|.+...  +.....++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477889999999999999885 46889999987642  345566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++... ....+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            9999999998542 2456899999999999999999999998   99999999999999999999999999876544332


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                        ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+..
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~  207 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL  207 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH
Confidence              122346889999999998888899999999999999999999999776443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.98  E-value=9.5e-32  Score=271.49  Aligned_cols=203  Identities=33%  Similarity=0.511  Sum_probs=168.4

Q ss_pred             CCCCCCceecccCceeEEEEEEcC-Cc--EEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSD-GK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ++|++.+.||+|+||.||++..++ +.  .+++|.++.. .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578888999999999999998753 33  4688887742 334456789999999999 799999999999999999999


Q ss_pred             EEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcE
Q 008288          424 YEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS  490 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~  490 (571)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1235889999999999999999999988   9999999999999999999


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ||+|||++........   ......+..|++||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~  223 (297)
T cd05089         159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT  223 (297)
T ss_pred             EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999864321111   111123457999999988889999999999999999998 999996553

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=6.1e-32  Score=278.64  Aligned_cols=197  Identities=28%  Similarity=0.435  Sum_probs=167.5

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC------c
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~  418 (571)
                      .++|...+.||+|+||.||++.. .+++.||||++....  ......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            46789999999999999999986 468899999986432  22345677999999999999999999887643      3


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++++|++ +++|..++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence            468999987 788988773    345899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +......     ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus       166 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  220 (343)
T cd07878         166 RQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND  220 (343)
T ss_pred             eecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            8654321     23468999999999876 568999999999999999999999997654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.98  E-value=1.2e-31  Score=269.35  Aligned_cols=199  Identities=29%  Similarity=0.461  Sum_probs=164.2

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhc---ccCCeeeEeeEEEcC-----c
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDG-----D  418 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~~-----~  418 (571)
                      +|+..+.||+|+||.||++... +++.||+|.++...  ......+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4777899999999999999965 68899999887432  22233566777777665   799999999988642     4


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..+++|||++ ++|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            5789999997 4888877432 2345899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ........   .....++..|+|||.+.+..++.++||||||+++|||++|++||...
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            86643221   12246789999999999888999999999999999999999999655

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=2e-32  Score=280.43  Aligned_cols=205  Identities=30%  Similarity=0.435  Sum_probs=180.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ....|.+..+||+|.|++|..+++. ++..||||.+++..  ....+.+.+|+++|..++|||||+++.+.+....+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467888999999999999999964 69999999998643  23345588999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||..+|.+.+++   .+.+.+.+..+..++.|+.++++|||++.   |+|||||++||||+.+.++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl---~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYL---VKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHH---HhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            9999999999999   45666777899999999999999999999   99999999999999999999999999987763


Q ss_pred             CCCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCchhh
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQLLA  560 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~~~~~  560 (571)
                      ..   .....+|++.|.|||+..+..| .++.|+||+|++||-|+.|..||+..++..
T Consensus       208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~  262 (596)
T KOG0586|consen  208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE  262 (596)
T ss_pred             cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence            32   2234689999999999998775 689999999999999999999999875543

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=1.4e-31  Score=265.31  Aligned_cols=192  Identities=27%  Similarity=0.415  Sum_probs=162.0

Q ss_pred             ceecccCceeEEEEEEcC-------------CcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          355 NILGQGGFGPVYKGVLSD-------------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      +.||+|+||.||+|+..+             ...+++|.+..........+.+|+.++..++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258899887655555667889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-------EEEee
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-------SKISD  494 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~-------~kL~D  494 (571)
                      ++|||+++++|+.++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999988843  3356899999999999999999999998   999999999999987664       89999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhc-cCCCCcchhhHhHHHHHHHHH-hCCCCCCCCc
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEII-TGRRNAGSNQ  557 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~ell-tG~~p~~~~~  557 (571)
                      ||++.......      ...++..|+|||.+. +..++.++||||||+++|||+ .|+.||....
T Consensus       156 ~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~  214 (262)
T cd05077         156 PGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT  214 (262)
T ss_pred             CCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            99987543221      235678899999886 466899999999999999998 5888886554

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.98  E-value=5.8e-32  Score=280.18  Aligned_cols=199  Identities=27%  Similarity=0.366  Sum_probs=167.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-----
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----  418 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----  418 (571)
                      ..++|+..+.||+|+||.||++... .++.+|||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3468899999999999999999864 6889999998743  2334456789999999999999999999886543     


Q ss_pred             -eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          419 -EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       419 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                       ..++||||+++ +|...+.     ..+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence             46899999965 5655552     23788999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++.......   .....||..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       166 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         166 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             cccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            976533221   123468999999999999899999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.98  E-value=1.6e-31  Score=264.89  Aligned_cols=205  Identities=32%  Similarity=0.478  Sum_probs=177.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|++.+.||.|+||.||++... ++..+++|++... .......+.+|++.++.++|+||+++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999964 6889999998642 233567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999854333356899999999999999999999998   99999999999999999999999999876654433


Q ss_pred             cc--ceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EA--NTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..  ......|+..|++||.+... .++.++|+||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence            21  22234688999999998876 7899999999999999999999999754

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.98  E-value=1.1e-31  Score=267.14  Aligned_cols=203  Identities=29%  Similarity=0.484  Sum_probs=170.5

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC------c
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG------D  418 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~------~  418 (571)
                      +++.|+..+.||+|+||.||++... +++.+++|++.... .....+..|+.++.++ +||||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            4567888899999999999999964 68899999986533 3456788999999998 799999999998753      4


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            578999999999999998542 3346889999999999999999999998   999999999999999999999999998


Q ss_pred             cccccCCCccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .........  .....|+..|+|||++.     +..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~  219 (272)
T cd06637         159 AQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  219 (272)
T ss_pred             eeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            765432221  22346889999999986     345788999999999999999999999643

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.98  E-value=4.8e-32  Score=272.94  Aligned_cols=197  Identities=29%  Similarity=0.469  Sum_probs=171.5

Q ss_pred             CCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCC
Q 008288          352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      .....||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            33467999999999999864 68899999987655555667899999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccce
Q 008288          431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT  510 (571)
Q Consensus       431 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~  510 (571)
                      +|.+++.    .+.+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++|+|||++.........  .
T Consensus       105 ~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~  175 (292)
T cd06658         105 ALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--R  175 (292)
T ss_pred             cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--C
Confidence            9999873    235889999999999999999999998   999999999999999999999999998755332221  1


Q ss_pred             eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       511 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~  222 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP  222 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            23468899999999988889999999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=6.2e-32  Score=272.84  Aligned_cols=195  Identities=28%  Similarity=0.471  Sum_probs=170.3

Q ss_pred             CceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ...||+|+||.||++... +++.|++|++..........+.+|+.++..++||||+++++.+..++..++++||+++++|
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence            456999999999999864 6899999998754445566788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                      ..++.    ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++..+......  ...
T Consensus       106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~  176 (297)
T cd06659         106 TDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKS  176 (297)
T ss_pred             HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccc
Confidence            98873    245889999999999999999999998   999999999999999999999999998755432221  123


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  221 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS  221 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            468899999999998889999999999999999999999996553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=9.4e-32  Score=267.09  Aligned_cols=204  Identities=32%  Similarity=0.519  Sum_probs=171.4

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-C---CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-D---GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ..+|++.+.||+|+||.||+|... +   +..+++|.++.. .......+.+|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            356788899999999999999863 2   337899988743 23345678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++++|.+++..  ..+.+++.++..++.|++.||+|||+.+   ++||||||+|||+++++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            9999999999999853  2346899999999999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCccce-eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          503 ESEGEANT-VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ........ ....++..|++||.+.+..++.++|+||||+++||+++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence            43221111 11223567999999998889999999999999999887 99999654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.98  E-value=1.6e-31  Score=263.64  Aligned_cols=199  Identities=39%  Similarity=0.582  Sum_probs=172.3

Q ss_pred             ceecccCceeEEEEEEcC----CcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++....    +..+++|.++..... ....+.+|++.+..++|+||+++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999999753    789999998754333 367789999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          430 GSLDAILFDPRK------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       430 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      ++|.+++.....      ...+++..+..++.|+++||.|||+++   ++|+||+|+||++++++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999955321      367999999999999999999999988   99999999999999999999999999987655


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ...........++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence            432222233467889999999988889999999999999999999 69999765

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.98  E-value=8.2e-32  Score=272.76  Aligned_cols=204  Identities=31%  Similarity=0.504  Sum_probs=169.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCc--EEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|++.+.||+|+||.||++.+. ++.  .+++|.++.. .......+.+|++++.++ +||||+++++++..++..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            4567888899999999999999964 454  4577776642 333456788999999999 8999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          422 LVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      +||||+++++|.+++....             ....+++..++.++.||++||+|||+.+   ++||||||+|||+++++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCC
Confidence            9999999999999985422             1235889999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .+||+|||++.......   ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       162 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  227 (303)
T cd05088         162 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  227 (303)
T ss_pred             cEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence            99999999986432111   1111234567999999988889999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.98  E-value=1.8e-31  Score=263.56  Aligned_cols=194  Identities=34%  Similarity=0.495  Sum_probs=162.9

Q ss_pred             eecccCceeEEEEEE---cCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCC
Q 008288          356 ILGQGGFGPVYKGVL---SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      .||+|+||.||+|.+   .+++.+++|+++...  ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999975   357889999986432  234567899999999999999999999875 45678999999999


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc-
Q 008288          431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-  509 (571)
Q Consensus       431 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~-  509 (571)
                      +|.+++.   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999983   3346899999999999999999999998   99999999999999999999999999986644332211 


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            111234578999999988889999999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.98  E-value=7.2e-32  Score=267.71  Aligned_cols=203  Identities=27%  Similarity=0.443  Sum_probs=174.4

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|+||.||++.. .+++.++||.+...   ......++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999995 47899999987642   2234457889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      ||+++++|.+++... .....+++..+..++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988532 23456899999999999999999999998   99999999999999999999999999876543


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....  ....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             CCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            32211  2246888999999998888999999999999999999999998543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-32  Score=272.13  Aligned_cols=200  Identities=26%  Similarity=0.356  Sum_probs=174.5

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      -|...+.||+|-|..|-++++ -+|++||||++.+..  ......+..|++-|+-++|||||+||++......+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            366678999999999999985 389999999997643  33455688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~~~~~~  505 (571)
                      =.+|+|.+++..-  ...+.+..+.+++.||+.|+.|+|+..   +|||||||+||.+-+ -|-+||.|||++..+....
T Consensus        99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK  173 (864)
T ss_pred             cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence            9999999999642  334899999999999999999999988   999999999998865 4789999999998775543


Q ss_pred             CccceeeecccccccchhhhccCCCC-cchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYS-KKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                         .....+|+..|-|||++.+..|+ +++||||||||||.|++|+.||+..+
T Consensus       174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN  223 (864)
T KOG4717|consen  174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN  223 (864)
T ss_pred             ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc
Confidence               23346999999999999998885 78999999999999999999998764

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=1.5e-31  Score=268.05  Aligned_cols=198  Identities=35%  Similarity=0.474  Sum_probs=165.8

Q ss_pred             CCCCceecccCceeEEEEEE-----cCCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeEE
Q 008288          351 FSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL  422 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~l  422 (571)
                      |+..+.||+|+||+||++..     .+++.||+|.++... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            37789999999999988653     357889999987532 33456788999999999999999999988754  35789


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      +|||+++++|.+++..    ..+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.++|+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999842    34899999999999999999999998   9999999999999999999999999998664


Q ss_pred             cCCCccc-eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          503 ESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       503 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ....... .....++..|++||.+.+..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            4322111 1112345679999999888899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.98  E-value=1.2e-31  Score=270.46  Aligned_cols=207  Identities=31%  Similarity=0.425  Sum_probs=173.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcC-----------------CcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSD-----------------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLV  408 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv  408 (571)
                      ...+|++.+.||+|+||.||++...+                 +..|++|++.... ......+.+|++++.+++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            35678889999999999999988542                 2458999987532 34456788999999999999999


Q ss_pred             eEeeEEEcCceeEEEEEccCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCC
Q 008288          409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS  480 (571)
Q Consensus       409 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~  480 (571)
                      ++++++..++..+++|||+++++|..++....        ....+++..++.++.|++.||.|||+.+   ++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            99999999999999999999999999985422        1236899999999999999999999998   999999999


Q ss_pred             CeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh--CCCCCCCC
Q 008288          481 NVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRRNAGSN  556 (571)
Q Consensus       481 NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--G~~p~~~~  556 (571)
                      ||++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++  |..||...
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            99999999999999999986544332222233456778999999988889999999999999999998  77787643

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.98  E-value=6.4e-32  Score=278.42  Aligned_cols=208  Identities=30%  Similarity=0.459  Sum_probs=170.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG  417 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~  417 (571)
                      +..++|++.+.||+|+||.||++..      .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3456889999999999999999973      347789999997532 33455688999999999 789999999988654


Q ss_pred             -ceeEEEEEccCCCChhhhhcCCCC-------------------------------------------------------
Q 008288          418 -DEKLLVYEFMPNGSLDAILFDPRK-------------------------------------------------------  441 (571)
Q Consensus       418 -~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------  441 (571)
                       ...+++|||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             457899999999999998853210                                                       


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          442 ---------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       442 ---------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                               ...+++..+..++.||++||+|||+.+   |+||||||+|||+++++++||+|||++..............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     124678888999999999999999998   99999999999999999999999999986543322222222


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            245677999999998899999999999999999997 99998643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.98  E-value=1e-31  Score=269.93  Aligned_cols=208  Identities=32%  Similarity=0.482  Sum_probs=172.9

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +..++|+..+.||+|+||.||++...      ++..+++|.++.. ......++.+|+.++++++||||+++++++.+++
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            34567889999999999999999863      4678999998743 2334567889999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 008288          419 EKLLVYEFMPNGSLDAILFDPR-------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKA  479 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp  479 (571)
                      ..+++|||+++++|.+++....                   ....+++..++.++.|++.||.|||+.+   ++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccH
Confidence            9999999999999999985321                   1234788999999999999999999998   99999999


Q ss_pred             CCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          480 SNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       480 ~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      +||++++++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999876543322111111234567999999998899999999999999999998 88888543

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.98  E-value=1.4e-31  Score=269.98  Aligned_cols=207  Identities=29%  Similarity=0.431  Sum_probs=171.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-----------------CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-----------------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLV  408 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv  408 (571)
                      ..++|++.+.||+|+||.||++...                 ++..+|+|.++.. ......++.+|+.++++++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            3467889999999999999998532                 2346899998753 333456789999999999999999


Q ss_pred             eEeeEEEcCceeEEEEEccCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCC
Q 008288          409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS  480 (571)
Q Consensus       409 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~  480 (571)
                      ++++++...+..+++|||+++++|.+++....        ....+++..+..++.|++.||+|||+.+   ++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence            99999999999999999999999999885422        1234778899999999999999999998   999999999


Q ss_pred             CeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh--CCCCCCCC
Q 008288          481 NVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT--GRRNAGSN  556 (571)
Q Consensus       481 NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt--G~~p~~~~  556 (571)
                      |||+++++.++|+|||+++.+.............++..|++||...++.++.++||||||+++|||++  |..||...
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99999999999999999986543322221222234678999999888889999999999999999998  77888643

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.98  E-value=2e-31  Score=265.37  Aligned_cols=202  Identities=29%  Similarity=0.503  Sum_probs=170.4

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc---c-------chHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---Q-------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~-------~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +|...+.||+|+||.||+|... +++.+++|.++....   .       ..+.+.+|+.++++++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667789999999999999854 689999998753111   1       1245788999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+++++|.+++..   .+.+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999999843   357899999999999999999999988   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCC--CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ................++..|++||.+....  ++.++|+||||+++|||++|+.||...+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  216 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE  216 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence            7654332222223346788999999987654  7899999999999999999999996543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.98  E-value=1.6e-31  Score=263.61  Aligned_cols=197  Identities=35%  Similarity=0.490  Sum_probs=168.1

Q ss_pred             ceecccCceeEEEEEEcC--C--cEEEEEEccccCc-cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLSD--G--KEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|++|.||++.+.+  +  ..+++|.++.... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3689999986544 556679999999999999999999999988 889999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc-
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA-  508 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~-  508 (571)
                      ++|.+++..... ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||++..+....... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999854332 56899999999999999999999998   9999999999999999999999999998765432211 


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ......++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            1112356778999999998899999999999999999999 99999643

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.98  E-value=2e-31  Score=270.14  Aligned_cols=203  Identities=24%  Similarity=0.339  Sum_probs=171.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|+||.||++... +++.|++|.+....   ......+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36788899999999999999975 57899999887532   233456889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++.   ..+.+++..+..++.|+++||.|||+.+   ++||||||+||++++++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999983   3456899999999999999999999988   999999999999999999999999998642111


Q ss_pred             CC-------------ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EG-------------EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..             ........++..|+|||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~  220 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  220 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            00             001112357888999999988889999999999999999999999997543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.98  E-value=2.3e-31  Score=262.85  Aligned_cols=194  Identities=29%  Similarity=0.483  Sum_probs=161.7

Q ss_pred             ecccCceeEEEEEEc---CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          357 LGQGGFGPVYKGVLS---DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999863   35579999987543 333456899999999999999999999875 4578899999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc-ee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TV  511 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~-~~  511 (571)
                      .+++..  ....+++..++.++.|+++||.|||+.+   ++||||||+|||++.++.+||+|||++..+........ ..
T Consensus        82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            998843  3456899999999999999999999998   99999999999999999999999999986543322111 11


Q ss_pred             eecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       512 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  202 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM  202 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence            1123568999999988889999999999999999996 99999643

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.98  E-value=1.4e-31  Score=274.88  Aligned_cols=209  Identities=32%  Similarity=0.474  Sum_probs=172.9

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc--------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      +...+|++.+.||+|+||.||++...        .+..+++|.++.. ......++.+|+.++.++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            34456888999999999999999742        1236899988743 334456789999999999 8999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                      .++..++++||+++++|.+++....             ....+++..++.++.|+++||.|||+.+   ++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence            9999999999999999999985421             1235788999999999999999999998   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      |+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999986544322222222234567999999999999999999999999999999 889987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.7e-31  Score=266.98  Aligned_cols=205  Identities=33%  Similarity=0.546  Sum_probs=171.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCc----EEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ...+|+..+.||+|+||.||++..+ +++    .+++|.+.... .....++.+|+.++.+++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            3456788899999999999999864 333    58999887543 3345678899999999999999999999987 788


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +++|||+++|+|.+++..  ....+++..+..++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999999853  2345899999999999999999999988   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ..............++..|++||.+....++.++|+||||+++|||++ |+.||...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  216 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP  216 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence            653332221111223567999999988889999999999999999999 999997653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.98  E-value=2.1e-31  Score=271.31  Aligned_cols=197  Identities=27%  Similarity=0.438  Sum_probs=159.2

Q ss_pred             CceecccCceeEEEEEEc---CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEc--CceeEEEEEccC
Q 008288          354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP  428 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  428 (571)
                      ..+||+|+||.||++...   ++..+|+|.++...  ....+.+|+.++++++||||+++++++..  +...+++|||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            367999999999999964   35789999887532  33467899999999999999999998854  456789999986


Q ss_pred             CCChhhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCcEEEeecccc
Q 008288          429 NGSLDAILFD------PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA  498 (571)
Q Consensus       429 ~gsL~~~l~~------~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl----~~~~~~kL~DfGla  498 (571)
                      + +|.+++..      ......+++..+..++.||+.||.|||+.+   |+||||||+|||+    ++++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 66666531      112335889999999999999999999998   9999999999999    56678999999999


Q ss_pred             cccccCCCc-cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGE-ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +........ .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876443221 11223468999999999876 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.98  E-value=2.6e-31  Score=262.80  Aligned_cols=202  Identities=34%  Similarity=0.506  Sum_probs=169.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      .++|...+.||+|++|.||++...++..+++|++.... ...+.+.+|+.++++++|||++++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            35577788999999999999998777789999886532 34467889999999999999999999875 45688999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            999999998542 2345889999999999999999999988   999999999999999999999999999765432211


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      . .....++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       159 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  207 (260)
T cd05069         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             c-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1 112245678999999988889999999999999999999 99999654

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=9.8e-32  Score=269.50  Aligned_cols=199  Identities=29%  Similarity=0.414  Sum_probs=173.3

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|+..+.||+|+||.||++... +++.+++|++... .......+.+|+++++.++||||+++++.+...+..++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            456778899999999999999964 6889999987643 33445678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      |+++++|..++.   +.+.+++..+..++.|++.+|.|||+ .+   ++|+||+|+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999999883   34568999999999999999999997 45   999999999999999999999999998654322


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..    ....|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~  205 (284)
T cd06620         158 IA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS  205 (284)
T ss_pred             cc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            21    2346899999999998888999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.98  E-value=3.3e-31  Score=261.33  Aligned_cols=203  Identities=28%  Similarity=0.401  Sum_probs=172.5

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc-CceeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e  425 (571)
                      +|+..+.||+|++|.||++... +++.+++|++...  .....+.+.+|++++++++|+|++++.+.+.. +...+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4778899999999999999964 5789999998642  23445568899999999999999999988764 446789999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++... ....+++.++..++.|++.+|++||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999988542 3346899999999999999999999998   9999999999999999999999999997664322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ..  .....+++.|+|||.+.+..++.++||||||++++||++|+.||...+.
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~  207 (257)
T cd08223         157 DM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM  207 (257)
T ss_pred             Cc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence            21  2234678999999999999999999999999999999999999976654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.4e-32  Score=277.99  Aligned_cols=219  Identities=25%  Similarity=0.380  Sum_probs=184.3

Q ss_pred             cChHHHHhhcCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       339 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      +.++.-..+.+-|..++.||-|+||+|.++. .++...+|+|.+++.+   .......+.|..||++-..+.||+|+-.|
T Consensus       619 iRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF  698 (1034)
T KOG0608|consen  619 IRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF  698 (1034)
T ss_pred             HHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence            3344444556678889999999999999997 4567788999987643   34556688999999999999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      .+++.+|+||+|++||++-.+|   -+.+.+.+..++.++.++..|+++.|..|   +|||||||+|||||.+|++||.|
T Consensus       699 QDkdnLYFVMdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  699 QDKDNLYFVMDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             ccCCceEEEEeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeee
Confidence            9999999999999999998888   46678999999999999999999999988   99999999999999999999999


Q ss_pred             ccccccc---------ccCCCccc-------------------------------eeeecccccccchhhhccCCCCcch
Q 008288          495 FGMARIF---------AESEGEAN-------------------------------TVRIVGTYGYMAPEYAMEGLYSKKS  534 (571)
Q Consensus       495 fGla~~~---------~~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~  534 (571)
                      |||+.-+         ...+....                               -...+||+.|+|||++....++...
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c  852 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC  852 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence            9998632         11110000                               0125899999999999999999999


Q ss_pred             hhHhHHHHHHHHHhCCCCCCCCchhhhhh
Q 008288          535 DVFSFGVLLIEIITGRRNAGSNQLLAYGM  563 (571)
Q Consensus       535 Dv~slGvil~elltG~~p~~~~~~~~~~~  563 (571)
                      |+||.|||||||+.|+.||......+...
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~tq~  881 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGETQY  881 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCccee
Confidence            99999999999999999998776555544

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=2.4e-31  Score=262.28  Aligned_cols=199  Identities=36%  Similarity=0.538  Sum_probs=173.5

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..++|+..+.||+|+||.||++.. .|+.|++|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            346788889999999999999987 488999999976443 567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~  157 (256)
T cd05039          82 MAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD  157 (256)
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence            9999999998532 2236899999999999999999999998   99999999999999999999999999986632221


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                           ....+..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence                 1234567999999988889999999999999999998 99998655

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.98  E-value=3.3e-31  Score=309.25  Aligned_cols=190  Identities=28%  Similarity=0.537  Sum_probs=162.2

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ..+...+.||+|+||.||+|+. .+++.||||+++.....    ..+|++.+++++||||+++++++.+++..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4567788999999999999996 47899999998753322    235688999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++|+|.++++      .++|..+.+++.|+++||+|||....++|+||||||+||+++.++..++. ||........   
T Consensus       766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---  835 (968)
T PLN00113        766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---  835 (968)
T ss_pred             CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence            9999999983      28899999999999999999996655569999999999999999888875 6665433211   


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                         ....+|+.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence               112678999999999999999999999999999999999999853

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.98  E-value=2.5e-31  Score=262.15  Aligned_cols=203  Identities=31%  Similarity=0.535  Sum_probs=172.8

Q ss_pred             cCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ..+|+..+.||+|+||.||++...+++.+++|.++... ....++.+|++++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            34677788999999999999998778899999887532 33457899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++..  ..+.+++..+..++.|++.+|+|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          82 EHGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999998843  2345889999999999999999999998   999999999999999999999999998765332211


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      . .....++..|++||.+.++.++.++||||||+++|||++ |+.||....
T Consensus       157 ~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  206 (256)
T cd05112         157 S-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS  206 (256)
T ss_pred             c-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            1 111234568999999998889999999999999999998 999997553

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.98  E-value=1.3e-31  Score=297.65  Aligned_cols=207  Identities=24%  Similarity=0.385  Sum_probs=170.1

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~  421 (571)
                      ..++|.+.+.||+|+||.||++... +++.+++|.+...  .......+..|+.++.+++||||+++++++...  ...+
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4467899999999999999999965 5778899988642  334456788999999999999999999988653  5688


Q ss_pred             EEEEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCeeeCCCCCCCeEecCC---------
Q 008288          422 LVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSR----LRIVHRDLKASNVLLDSD---------  487 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~----~~iiH~DLkp~NILl~~~---------  487 (571)
                      |||||+++++|..++... ...+.+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.+         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999988542 224569999999999999999999998542    249999999999999642         


Q ss_pred             --------CcEEEeecccccccccCCCccceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          488 --------MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       488 --------~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                              ..+||+|||++..+.....   .....||+.|+|||++.+  ..++.++|||||||+||||++|+.||...
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    3489999999986543221   123478999999999864  45889999999999999999999999654

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-33  Score=282.24  Aligned_cols=191  Identities=34%  Similarity=0.512  Sum_probs=166.5

Q ss_pred             CCCCceecccCceeEEEEEE-cCCcEEEEEEccc---cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          351 FSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      |...+.||.|+||.||.+.. .+.+.||||+++.   .+.....++..|+.+|.+++|||++.+.|++..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            45567899999999999995 4788999999874   3344466799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      | -|+-.+++.  ....++-+.++..|..+.+.||+|||+++   .||||||+.|||+.+.|.+||+|||.+.+..... 
T Consensus       108 C-lGSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-  180 (948)
T KOG0577|consen  108 C-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-  180 (948)
T ss_pred             H-hccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence            9 556666662  23456888999999999999999999999   9999999999999999999999999998654432 


Q ss_pred             ccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~  553 (571)
                           .++|||.|||||++.   .+.|+-|+|||||||...||.-.++|.
T Consensus       181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl  225 (948)
T KOG0577|consen  181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL  225 (948)
T ss_pred             -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence                 468999999999986   578999999999999999999999994

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=278.94  Aligned_cols=210  Identities=31%  Similarity=0.449  Sum_probs=182.0

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      .++++....++...++||.|.||.||.|.++ -...||||.++. +.-..++|+.|..+|+.++|||+|+|+|+|..+..
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            4556667777888899999999999999986 467899999986 34567899999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      +|+|.|||..|+|-++|++. ++..++.--.+.++.||..||+||..+.   +|||||..+|+|+.++..+|+.||||++
T Consensus       338 FYIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             eEEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence            99999999999999999653 3445677778899999999999999988   9999999999999999999999999999


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      +...+.... ...-.-...|.|||.+....++.|+|||+|||+||||.| |--||-+-
T Consensus       414 lMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi  470 (1157)
T KOG4278|consen  414 LMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI  470 (1157)
T ss_pred             hhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence            876544322 112233567999999999999999999999999999999 99998665

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-31  Score=267.63  Aligned_cols=208  Identities=25%  Similarity=0.377  Sum_probs=176.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|+..+.||+|+||.||++... +++.|++|+++..  .......+.+|++++++++|+||+++++++..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36788899999999999999975 5889999988642  23345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |++++.+..+..   +...+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999887776662   3345899999999999999999999998   9999999999999999999999999998765543


Q ss_pred             CccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhh
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGM  563 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~  563 (571)
                      ... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..+..|
T Consensus       155 ~~~-~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~  212 (288)
T cd07833         155 ASP-LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY  212 (288)
T ss_pred             ccc-ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            211 1234678899999999887 78999999999999999999999997665444443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=2.7e-31  Score=262.70  Aligned_cols=204  Identities=32%  Similarity=0.483  Sum_probs=173.4

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +..++|+..+.||+|+||.||++...++..+++|.+... ......+.+|++++++++|+||+++.+.+.. ...+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            445678889999999999999999877888999988753 2345678899999999999999999999887 77899999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999998542 3456888999999999999999999988   9999999999999999999999999987654322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ... .....++..|++||.+..+.++.++|+||||+++|||++ |+.||...
T Consensus       157 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         157 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             ccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence            211 112245677999999998889999999999999999999 99999654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=4e-31  Score=260.83  Aligned_cols=200  Identities=34%  Similarity=0.472  Sum_probs=169.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEE-cCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV-DGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e  425 (571)
                      ..++|+..+.||+|+||.||++.. .++.+++|.++..  ...+.+.+|+.++++++|+|++++++++. .++..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   80 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence            345788889999999999999987 4788999988643  23557889999999999999999999765 4567899999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++... ....+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          81 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999998542 2335889999999999999999999998   9999999999999999999999999987543322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCch
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQL  558 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~~  558 (571)
                      .     ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...++
T Consensus       157 ~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~  205 (256)
T cd05082         157 D-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  205 (256)
T ss_pred             C-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence            1     1234567999999998889999999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=276.30  Aligned_cols=204  Identities=32%  Similarity=0.539  Sum_probs=174.8

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcC---Cc--EEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSD---GK--EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      ++..+.....++||+|.||.||+|++.+   |+  .||||..+. ......+.|+.|..+|++++||||++|+|+|.+ .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            3445556667899999999999999533   33  578998875 556668889999999999999999999999976 4


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..|+|||..+-|.|..+|..  +...++......++.||+.+|+|||+..   +|||||..+|||+.+..-+||+||||+
T Consensus       464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence            78999999999999999954  3445888899999999999999999988   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGS  555 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~  555 (571)
                      +.+........+ +..-...|||||.+...+++.++|||-|||.+||+++ |.+||..
T Consensus       539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg  595 (974)
T KOG4257|consen  539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG  595 (974)
T ss_pred             hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence            987665443322 2344667999999999999999999999999999988 9999964

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=2.9e-31  Score=266.96  Aligned_cols=202  Identities=27%  Similarity=0.410  Sum_probs=168.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++++|...+.||+|+||.||++... +++.+++|++.... ......+.+|+.+++.++|+||+++.+++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3467888999999999999999864 68899999986432 333446789999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+. ++|.+.+..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||+++.+++++|+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 677666532  2345788889999999999999999998   999999999999999999999999998754332


Q ss_pred             CCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....  ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         157 SQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             CCCC--CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            2111  123568899999998754 4788999999999999999999999654

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=3.8e-31  Score=264.29  Aligned_cols=198  Identities=28%  Similarity=0.484  Sum_probs=172.3

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      .|+..+.||+|+||.||++... +++.|++|.+... .......+.+|+.++++++||||+++++.+.+++..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667788999999999999965 6889999988743 3445667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++.    .+.+++.....++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        85 ~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06640          85 GGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence            9999999883    245889999999999999999999988   999999999999999999999999999765433221


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                        .....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       158 --~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         158 --RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             --cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence              12236788899999998888999999999999999999999998644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.7e-32  Score=273.86  Aligned_cols=208  Identities=28%  Similarity=0.377  Sum_probs=179.5

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEcc--ccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCc
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD  418 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~  418 (571)
                      +.+.+....|++.++||+||.+.||++...+.+.+|+|++.  ..+.+...-+.+|+..|.++ .|.+|++|++|-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            45667788899999999999999999998888889988775  34566677899999999999 5999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      .+||||||= ..+|..+|..  +...+....++.+..||+.++.++|+++   |||.||||.|+|+ -.|.+||+|||+|
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k--~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA  506 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKK--KKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIA  506 (677)
T ss_pred             eEEEEeecc-cccHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechh
Confidence            999999964 6789999943  3333443478889999999999999999   9999999999999 5678999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCC-----------CCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGL-----------YSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..+..+.........+||+.||+||.+....           .++++||||||||||+|+.|+.||+..
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~  575 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI  575 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence            9988877776666779999999999985322           468999999999999999999999754

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-31  Score=262.87  Aligned_cols=202  Identities=30%  Similarity=0.463  Sum_probs=170.8

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-----CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--cee
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~  420 (571)
                      .+|...+.||+|+||.||++... +++.+++|.+...     .......+.+|++++++++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999964 6899999987531     223445788999999999999999999998764  457


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++++||+++++|.+++.   ..+.+++.....++.|++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999883   3345889999999999999999999998   99999999999999999999999999986


Q ss_pred             cccCCCc-cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence            5332111 1112346888999999999888999999999999999999999999754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.5e-31  Score=259.51  Aligned_cols=197  Identities=35%  Similarity=0.493  Sum_probs=167.4

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCc-cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCChh
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD  433 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  433 (571)
                      ++||+|+||.||++...+++.|++|.++.... .....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999999986799999998875333 34567899999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeee
Q 008288          434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI  513 (571)
Q Consensus       434 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~  513 (571)
                      +++...  ...+++.....++.+++.+|.|||+++   ++||||+|+||+++.++.++|+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            998432  345789999999999999999999998   999999999999999999999999998765422211111112


Q ss_pred             cccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       514 ~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..+..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~  199 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM  199 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence            33567999999988889999999999999999999 88898654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=3e-31  Score=266.82  Aligned_cols=201  Identities=27%  Similarity=0.414  Sum_probs=169.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..+.||+|++|.||++..+ +++.|++|.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888899999999999999965 68999999986432 22334577899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++ +|.+++..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            974 89888743  2346889999999999999999999998   99999999999999999999999999875432221


Q ss_pred             ccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  ....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+
T Consensus       159 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         159 TY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             cc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            11  11246788999998875 458899999999999999999999996543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=2.3e-31  Score=269.54  Aligned_cols=204  Identities=35%  Similarity=0.576  Sum_probs=168.8

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCc----EEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|+..+.||+|+||.||++... +++    .+++|.+.... .....++.+|+.++++++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            3456778899999999999999853 444    57888886532 23344688999999999999999999998754 46


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++++||+++|+|.+++..  ....+++..+..++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence            799999999999998843  2345889999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..............++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~  215 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI  215 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            654332222222345678999999998889999999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=2.3e-31  Score=264.70  Aligned_cols=204  Identities=27%  Similarity=0.424  Sum_probs=169.8

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcC----CcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|...+.||+|+||.||+|...+    ...+++|...... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            44567888999999999999998643    2468999887544 4455678999999999999999999998875 4578


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++..
T Consensus        83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence            999999999999998432  335899999999999999999999988   999999999999999999999999998765


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ........ ....++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus       158 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         158 EDESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             ccccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            44321111 12234567999999988889999999999999999996 999997654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=2.4e-31  Score=268.03  Aligned_cols=200  Identities=28%  Similarity=0.500  Sum_probs=174.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|...+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67888899999999999999854 68899999987544555667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999832    34789999999999999999999998   999999999999999999999999998765433222


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  ....+++.|++||.+.++.++.++||||||+++|||++|+.||...+
T Consensus       172 ~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~  219 (293)
T cd06647         172 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (293)
T ss_pred             c--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            1  22367889999999988889999999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4e-31  Score=269.33  Aligned_cols=204  Identities=25%  Similarity=0.319  Sum_probs=174.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc---cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..+.||+|++|.||++... +++.+++|.+.....   ...+.+.+|++++..++|+||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36788899999999999999975 589999999875332   24556889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++.. .....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998853 23456899999999999999999999998   999999999999999999999999998754322


Q ss_pred             CCc---------------------------cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          505 EGE---------------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       505 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...                           .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            110                           0111236788999999999888999999999999999999999999654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=4.4e-31  Score=261.24  Aligned_cols=200  Identities=31%  Similarity=0.452  Sum_probs=176.8

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc-cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..+.||+|++|.||+++.. +++.+++|++..... .....+.+|+..+.+++|+||+++++++...+..+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36788899999999999999976 599999999875433 4467799999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      +++++|.+++..   ...+++..+..++.|++++|+|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999843   3668999999999999999999999 88   9999999999999999999999999998765433


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...  ....++..|++||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  203 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP  203 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            322  2346788999999999888999999999999999999999999665

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=2.4e-31  Score=266.63  Aligned_cols=200  Identities=32%  Similarity=0.481  Sum_probs=168.8

Q ss_pred             CCCCCCceecccCceeEEEEEE-----cCCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--cee
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~  420 (571)
                      ..|++.+.||+|+||.||++..     .+++.|++|.++... ......+.+|+.++++++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4567889999999999999974     257889999987543 34456789999999999999999999998875  567


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++++|.+++..  ....+++..+..++.||+.||+|||+.+   ++||||||+||++++++.++|+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            899999999999999843  2235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008288          501 FAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~  553 (571)
                      +....... ......++..|+|||.+.+..++.++||||||+++|||++++.|.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence            65433221 111235677899999998888999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=1.5e-31  Score=267.16  Aligned_cols=196  Identities=30%  Similarity=0.499  Sum_probs=170.0

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      |+..+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++||||+++++.+..++..++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            455678999999999999864 5788999988743 23445678999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|.+++.    ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++..+...... 
T Consensus        86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06642          86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-  157 (277)
T ss_pred             CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchh-
Confidence            999999883    245889999999999999999999988   999999999999999999999999999765433221 


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                       .....++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  203 (277)
T cd06642         158 -RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             -hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence             1223678899999999988899999999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=3.5e-31  Score=265.57  Aligned_cols=210  Identities=26%  Similarity=0.406  Sum_probs=173.8

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEE---
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV---  415 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~---  415 (571)
                      ++.+....++|+..+.||+|+||.||++... +++.+++|+++.. .....++.+|+.++.++ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3455667889999999999999999999864 6889999987652 22345678899999999 6999999999884   


Q ss_pred             --cCceeEEEEEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          416 --DGDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       416 --~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                        .++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++||||||+||++++++.++|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence              345689999999999999887532 23456889999999999999999999988   999999999999999999999


Q ss_pred             eecccccccccCCCccceeeecccccccchhhhcc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +|||++..........  ....|+..|+|||.+..     ..++.++||||||+++|||++|+.||...
T Consensus       166 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         166 VDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             ccCCceeecccCCCcc--ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999987654322211  22368899999998753     44788999999999999999999998654

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.5e-31  Score=263.84  Aligned_cols=201  Identities=30%  Similarity=0.504  Sum_probs=172.0

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      +|+..+.||+|++|.||++.. .+++.+++|.+....      ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477789999999999999985 578999999886432      1234578899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEeeccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIF  501 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~~  501 (571)
                      ||||+++++|.+++.   ..+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999984   3456889999999999999999999998   99999999999998776 5999999998766


Q ss_pred             ccCCCcc--ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          502 AESEGEA--NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .......  ......++..|+|||.+.+..++.++||||+|++++||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  211 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE  211 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            5432111  112346788999999998888999999999999999999999999654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=4.7e-31  Score=260.15  Aligned_cols=204  Identities=23%  Similarity=0.395  Sum_probs=174.8

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|+||.||++... +++.+++|++...  ......++.+|+.++++++||||+++.+++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4778899999999999999864 6889999988632  334456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999988532 2335789999999999999999999988   99999999999999999999999999976544322


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                      .  .....|++.|+|||.+.+..++.++|+||||++++||++|+.||...+..
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~  207 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK  207 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH
Confidence            1  12235788999999999888999999999999999999999999765433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=1.8e-31  Score=267.63  Aligned_cols=201  Identities=26%  Similarity=0.421  Sum_probs=171.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|+..+.||+|+||.||++..+ +++.+++|++....  ....+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36788899999999999999975 58999999886422  2234568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|..+..   ....+++..+..++.||+++|.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999988763   2344899999999999999999999998   9999999999999999999999999987654432


Q ss_pred             Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  .....++..|+|||.+.+ ..++.++||||||+++|||++|++||....
T Consensus       155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~  205 (286)
T cd07846         155 EV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS  205 (286)
T ss_pred             cc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence            21  122457889999999875 447889999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=281.31  Aligned_cols=194  Identities=35%  Similarity=0.528  Sum_probs=171.0

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCChh
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLD  433 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  433 (571)
                      -.||+|.||+||.|+.. +...+|||.+........+.+++||.+.+.++|.|||+++|.+.+++..-+.||.++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            46999999999999965 56678999998767777788999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccccCCCccce
Q 008288          434 AILFDPRKRGIL--CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANT  510 (571)
Q Consensus       434 ~~l~~~~~~~~l--~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~~~~~~~~~~~  510 (571)
                      ++|.  .+-+++  ++..+-.+.+||++||.|||++.   |||||||-+||||+- .|.+||+|||-++.+..-.  ..+
T Consensus       661 sLLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~T  733 (1226)
T KOG4279|consen  661 SLLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCT  733 (1226)
T ss_pred             HHHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccc
Confidence            9994  356777  78889999999999999999998   999999999999974 6899999999988764332  234


Q ss_pred             eeecccccccchhhhccCC--CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          511 VRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       511 ~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ..+.||..|||||++..+.  |.+++|||||||.+.||.||++||-.
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E  780 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE  780 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence            4568999999999997654  89999999999999999999999953

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=4.3e-31  Score=265.79  Aligned_cols=211  Identities=30%  Similarity=0.400  Sum_probs=174.3

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC-
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG-  417 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~-  417 (571)
                      ...+....++|...+.||+|+||.||++.. .+++.+++|++.... .....+.+|+.++.++ +||||+++++++... 
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            344555678899999999999999999996 468899999886532 2345678899999999 899999999998754 


Q ss_pred             ----ceeEEEEEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          418 ----DEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       418 ----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                          +..++||||+++++|.+++... .....+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence                3578999999999999987532 23456899999999999999999999988   999999999999999999999


Q ss_pred             eecccccccccCCCccceeeecccccccchhhhccC-----CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-----LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +|||++..........  ....++..|+|||.+...     .++.++||||||+++|||++|+.||...+
T Consensus       170 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~  237 (291)
T cd06639         170 VDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH  237 (291)
T ss_pred             eecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence            9999988654332211  123678899999987543     36889999999999999999999987553

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=3.3e-31  Score=264.32  Aligned_cols=190  Identities=28%  Similarity=0.407  Sum_probs=158.6

Q ss_pred             eecccCceeEEEEEEcC-------------------------CcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeE
Q 008288          356 ILGQGGFGPVYKGVLSD-------------------------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL  410 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l  410 (571)
                      +||+|+||.||+|.+..                         ...|++|++.........++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13588998875444445678899999999999999999


Q ss_pred             eeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC--
Q 008288          411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM--  488 (571)
Q Consensus       411 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~--  488 (571)
                      ++++......++||||+++++|+.++..  ..+.+++..+..++.||++||+|||+.+   |+||||||+|||+++++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999998843  3456889999999999999999999988   99999999999997644  


Q ss_pred             -----cEEEeecccccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHH-hCCCCCCCC
Q 008288          489 -----NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEII-TGRRNAGSN  556 (571)
Q Consensus       489 -----~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~ell-tG~~p~~~~  556 (571)
                           .+|++|||++.......      ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||...
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             cCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence                 37999999876432211      1246788999998865 56899999999999999995 699998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=4.7e-31  Score=270.21  Aligned_cols=199  Identities=21%  Similarity=0.283  Sum_probs=163.9

Q ss_pred             CCceeccc--CceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          353 DSNILGQG--GFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       353 ~~~~lG~G--~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      +.++||+|  +|++||++.. .+|+.||+|+++..  .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  7899999986 47899999998743  2333456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+++.||+...........
T Consensus        82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            999999998432 2335899999999999999999999998   999999999999999999999999865433211110


Q ss_pred             c-----ceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          508 A-----NTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       508 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .     ......++..|+|||.+.+  ..++.++||||||+++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            0     0111246778999999876  4589999999999999999999999964

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=6.4e-31  Score=263.35  Aligned_cols=202  Identities=31%  Similarity=0.484  Sum_probs=170.8

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      +|+..+.||+|++|.||+++.. +++.|++|+++... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4778899999999999999975 68899999987543 233456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++ +|.+++........+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            85 88887754443456899999999999999999999998   999999999999999999999999999755432221


Q ss_pred             cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  ....++..|++||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       157 ~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         157 F--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             c--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1  12356888999998865 457899999999999999999999997553

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=2.9e-31  Score=263.66  Aligned_cols=200  Identities=37%  Similarity=0.581  Sum_probs=167.0

Q ss_pred             ceecccCceeEEEEEEcC-------CcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVLSD-------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +.||+|+||.||+++..+       ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            358999999999998642       2578999886432 34566789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-----cEEEeeccc
Q 008288          427 MPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-----NSKISDFGM  497 (571)
Q Consensus       427 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-----~~kL~DfGl  497 (571)
                      +++++|.+++....    ....+++.+++.++.|+++||.|||+.+   ++|+||||+||++++++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999985421    2344789999999999999999999988   99999999999999877     899999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      +................++..|++||.+.++.++.++||||||+++|||++ |+.||...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~  218 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN  218 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence            976543322222222345678999999999999999999999999999998 999986543

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=5.2e-31  Score=262.79  Aligned_cols=205  Identities=32%  Similarity=0.463  Sum_probs=172.4

Q ss_pred             cCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      .++|+....||+|+||.||+++.+      +.+.+++|.+...... ...++.+|++++++++|+||+++++++.+.+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            367888899999999999999853      2467899988754433 456799999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          421 LLVYEFMPNGSLDAILFDPRKR------GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      ++||||+++++|.+++......      ..+++..+..++.|++.+|+|||+.+   |+|+||||+||++++++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999998543321      26899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ||++......... ......++..|++||.+.+...+.++||||||+++|||++ |..||...
T Consensus       161 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~  222 (275)
T cd05046         161 LSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL  222 (275)
T ss_pred             cccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            9998754322211 1122355678999999988888999999999999999999 88888643

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=7.3e-31  Score=261.17  Aligned_cols=196  Identities=32%  Similarity=0.530  Sum_probs=162.6

Q ss_pred             ceecccCceeEEEEEEc-CCc--EEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGK--EVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++..+ ++.  .+++|.++.. .......+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999975 343  4688888743 234456788999999999 899999999999999999999999999


Q ss_pred             CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          430 GSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       430 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      ++|.+++....             ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985422             1234789999999999999999999988   9999999999999999999999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ++.......   .......+..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~  215 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  215 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            986322111   1111133567999999988889999999999999999997 99999654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=5.6e-31  Score=272.79  Aligned_cols=193  Identities=23%  Similarity=0.335  Sum_probs=164.7

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ....+|.+.+.||+|+||.||++... +++.||+|+....      ....|+.++++++||||+++++++...+..++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            45568999999999999999999975 5778999975432      2356899999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      |++. ++|..++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 678777743  3456899999999999999999999998   999999999999999999999999998753322


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~  553 (571)
                      .   ......||..|+|||++.+..++.++||||||+++|||+++..|+
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            1   122346899999999999999999999999999999999965554

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=6.7e-31  Score=260.09  Aligned_cols=201  Identities=30%  Similarity=0.491  Sum_probs=173.8

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc--cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|+||.||++... +++.+++|.++....  .....+.+|++++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4777899999999999999964 688999999875433  3567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++.   ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999984   3345889999999999999999999998   99999999999999999999999999887654332


Q ss_pred             ccc--eeeecccccccchhhhccCC---CCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EAN--TVRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...  .....++..|++||.+.+..   .+.++||||||+++|||++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            211  11245788999999998766   889999999999999999999999643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=2e-31  Score=263.20  Aligned_cols=199  Identities=29%  Similarity=0.384  Sum_probs=174.6

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +|+..+.||+|+||.||++... +++.+++|.+....   ....+.+.+|++++++++||||+++++.+.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4778899999999999999975 68999999986432   2446678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|..++..   ...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999999843   357899999999999999999999998   9999999999999999999999999987654432


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .   .....|+..|++||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus       155 ~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         155 L---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             c---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence            1   123467889999999988889999999999999999999999997653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.6e-32  Score=278.86  Aligned_cols=195  Identities=30%  Similarity=0.508  Sum_probs=166.9

Q ss_pred             CCCceecccCceeEEEEEEc-CCcEEEE---EEcc-ccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce--eEEEE
Q 008288          352 SDSNILGQGGFGPVYKGVLS-DGKEVAV---KRLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE--KLLVY  424 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~-~~~~vav---K~~~-~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~--~~lv~  424 (571)
                      +....||+|.|-+||||.+. +|-+||=   |.-+ ..++...+.|..|+.+|+.|+||||++++..+.+...  ..+|.
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44578999999999999964 5666653   3211 1345566889999999999999999999999988765  67899


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfGla~~~~~  503 (571)
                      |.+..|+|..|+   ++.+.++...+..|++||++||.|||++. |||||||||=+||+|+.+ |.+||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~---kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYR---KKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHH---HHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999   45566888999999999999999999987 789999999999999865 8999999999987765


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ....    ..+|||.|||||+.. ..|+..+||||||++|+||+|+..||..
T Consensus       199 s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE  245 (632)
T KOG0584|consen  199 SHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE  245 (632)
T ss_pred             cccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence            4433    258999999999876 6799999999999999999999999964

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-32  Score=266.75  Aligned_cols=205  Identities=28%  Similarity=0.379  Sum_probs=175.6

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCce
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~  419 (571)
                      .+...+|.....||+|+||+|.++.-+ +.+.+|||++++..   ..+.+--+.|-++|+-. +-|.++++..+++.-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            455668999999999999999999865 57789999998642   22233345677777766 56888999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      +|+||||+.+|+|-..+   +.-+.+-+..+..++..|+-||-|||+++   ||.||||.+|||+|.+|++||.|||+++
T Consensus       425 LyFVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeeEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence            99999999999998877   45566888899999999999999999999   9999999999999999999999999997


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .-.-  ....+..++||+.|+|||++..++|...+|+||+||+||||+.|++||++.+
T Consensus       499 Eni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD  554 (683)
T KOG0696|consen  499 ENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED  554 (683)
T ss_pred             cccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            5322  2334556799999999999999999999999999999999999999998763

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=3.7e-32  Score=256.16  Aligned_cols=203  Identities=28%  Similarity=0.440  Sum_probs=168.8

Q ss_pred             CCCCCceecccCceeEEEEEEc---C--CcEEEEEEccccCc--cchHHHHHHHHHHHhcccCCeeeEeeEEEc-CceeE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS---D--GKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKL  421 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~  421 (571)
                      .|+....||+|.||.||+++-.   +  .+.+|+|+++..++  .......+|+-++++++||||+.|..++.+ +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            5777889999999999999632   2  33789999975432  334567899999999999999999999887 77889


Q ss_pred             EEEEccCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC----CcEEEeec
Q 008288          422 LVYEFMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISDF  495 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~----~~~kL~Df  495 (571)
                      |++||.+. +|..+++.  ..+...++......|..||+.|+.|||+..   |+||||||.||||..+    |.+||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999976 77777742  223457889999999999999999999998   9999999999999877    89999999


Q ss_pred             ccccccccCCCcc-ceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          496 GMARIFAESEGEA-NTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       496 Gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      |+++.+.+.-... .....+-|..|.|||.+.+. .||++.|||+.|||+.||++-++.|...
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999887653322 23345779999999999875 4999999999999999999998887654

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=3.1e-31  Score=265.66  Aligned_cols=197  Identities=26%  Similarity=0.392  Sum_probs=165.8

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|+||.||++... +|+.+++|+++..  .......+.+|+.++++++||||+++++++.+.+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777889999999999999975 6899999998642  222345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      ++ ++|.+++..  ..+.+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.++|+|||+++.......
T Consensus        81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 577776632  2456899999999999999999999998   99999999999999999999999999976543222


Q ss_pred             ccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ..  ....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+.
T Consensus       155 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         155 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             Cc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            11  1235688999999987644 7899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.9e-31  Score=261.06  Aligned_cols=200  Identities=28%  Similarity=0.538  Sum_probs=172.5

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc-CccchHHHHHHHHHHHhcc---cCCeeeEeeEEEcCceeEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .|+..+.||+|+||.||++.. .+++.+++|.++.. ......++.+|+.++++++   |||++++++++..+...+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999996 47899999998643 3445567889999999996   999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..    +.+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999998832    36899999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ...  .....|+..|+|||.+.++ .++.++|+||||+++|||++|+.||...+.
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~  207 (277)
T cd06917         155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA  207 (277)
T ss_pred             ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            322  2234688899999988654 468999999999999999999999976543

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=1.4e-30  Score=260.19  Aligned_cols=197  Identities=29%  Similarity=0.486  Sum_probs=170.7

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      |+..+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++.+++||||+++++.+..++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            566788999999999999864 6889999987642 23345678899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|..++.    ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++..+...... 
T Consensus        86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-  157 (277)
T cd06641          86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-  157 (277)
T ss_pred             CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh-
Confidence            999999883    345899999999999999999999988   999999999999999999999999998765432211 


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                       .....++..|++||.+.+..++.++|+||||+++|||++|+.||...
T Consensus       158 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  204 (277)
T cd06641         158 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL  204 (277)
T ss_pred             -hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence             12236788999999998888999999999999999999999999654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=1.2e-30  Score=261.80  Aligned_cols=199  Identities=29%  Similarity=0.465  Sum_probs=172.4

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      +|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            345567899999999999986 4688999998875444455668899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|.+++..    +.+++..+..++.|++.+|+|||+.+   ++||||+|+||++++++.++|+|||++......... 
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-  171 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-  171 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence            9999999843    45889999999999999999999998   999999999999999999999999988755432221 


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                       .....|+..|++||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~  219 (285)
T cd06648         172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP  219 (285)
T ss_pred             -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence             122468899999999988889999999999999999999999986553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=7e-31  Score=261.08  Aligned_cols=198  Identities=27%  Similarity=0.358  Sum_probs=158.7

Q ss_pred             eecccCceeEEEEEEcCCc---EEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCC
Q 008288          356 ILGQGGFGPVYKGVLSDGK---EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      .||+|+||.||++...++.   .+++|.++.. .......+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5899999999999854433   4566766532 23445679999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccce
Q 008288          432 LDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT  510 (571)
Q Consensus       432 L~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~  510 (571)
                      |.+++..... ...+++..+..++.||++||+|||+.+   ++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999864322 234667788899999999999999988   999999999999999999999999998643222111112


Q ss_pred             eeecccccccchhhhcc-------CCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          511 VRIVGTYGYMAPEYAME-------GLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       511 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |+.||...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence            23467889999998753       235789999999999999997 57788644

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=6.9e-31  Score=265.13  Aligned_cols=199  Identities=29%  Similarity=0.430  Sum_probs=168.3

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCcc-----chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQ-----GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +|+..+.||+|+||.||+|... +++.|++|.++.....     ....+..|++++++++|+||+++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677889999999999999964 6899999998753322     234577899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 999999984322  36999999999999999999999998   99999999999999999999999999986644


Q ss_pred             CCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....  ....++..|+|||.+.+ ..++.++||||||+++|||++|.+||...
T Consensus       155 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~  206 (298)
T cd07841         155 PNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD  206 (298)
T ss_pred             CCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence            32211  12245778999998865 45789999999999999999998877543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1e-30  Score=262.27  Aligned_cols=203  Identities=30%  Similarity=0.491  Sum_probs=176.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .+++|+..+.||+|++|.||++..+ +++.+++|++..... ....+.+|++++++++|+||+++++.+...+..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4566788889999999999999976 689999999875443 56678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            999999999995422  37999999999999999999999988   9999999999999999999999999987554332


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  .....++..|++||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~  220 (286)
T cd06614         171 SK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP  220 (286)
T ss_pred             hh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            21  122357889999999988889999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=7.5e-31  Score=262.70  Aligned_cols=210  Identities=29%  Similarity=0.480  Sum_probs=173.5

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEc-
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD-  416 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~-  416 (571)
                      ++..+....++|+..+.||+|+||.||++.. .+++.+++|++.... ....++..|+.++.++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4444555667889999999999999999996 468899999886532 3445688899999998 79999999999863 


Q ss_pred             -----CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEE
Q 008288          417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK  491 (571)
Q Consensus       417 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~k  491 (571)
                           .+..+++|||+++++|.+++... ....+++..+..++.||++||.|||+.+   |+|+||+|+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 45678999999999999988542 2345788889999999999999999998   99999999999999999999


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      |+|||++.........  .....|+..|+|||.+.     +..++.++||||||+++|||++|+.||...
T Consensus       162 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         162 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             EeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence            9999998755332211  12346889999999875     345788999999999999999999999643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=7.7e-31  Score=262.58  Aligned_cols=200  Identities=30%  Similarity=0.388  Sum_probs=164.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHH-HHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|++.+.||+|+||.||++... +|+.||+|+++... .....++..|+.+ ++..+||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888899999999999999975 68999999987532 2233455566665 556689999999999999999999999


Q ss_pred             ccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          426 FMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       426 ~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |++ ++|.+++.. ......+++..++.++.||+.||+|||++ +   ++||||||+||++++++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 688777743 22345689999999999999999999986 6   99999999999999999999999999986543


Q ss_pred             CCCccceeeecccccccchhhhcc----CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAME----GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ...   .....++..|++||.+.+    ..++.++|+||||+++|||++|+.||..
T Consensus       157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            221   122367889999998864    4468899999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.4e-30  Score=257.03  Aligned_cols=195  Identities=38%  Similarity=0.545  Sum_probs=162.9

Q ss_pred             ceecccCceeEEEEEEc-C---CcEEEEEEccccCc-cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-D---GKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      ++||+|+||.||+|+.. .   +..+++|.+..... ...+++.+|+.+++++.||||+++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999853 2   26899999875433 34567889999999999999999999876 4567999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|.+++..   ...+++..+..++.|++.+|+|||+.+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999943   336899999999999999999999998   99999999999999999999999999986644332211


Q ss_pred             -eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          510 -TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       510 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                       .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~  202 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM  202 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence             111123467999999998899999999999999999998 99999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=6e-31  Score=259.64  Aligned_cols=189  Identities=31%  Similarity=0.486  Sum_probs=159.9

Q ss_pred             ceecccCceeEEEEEEcCCc-----------EEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          355 NILGQGGFGPVYKGVLSDGK-----------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +.||+|+||.||++.+.+..           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999975433           5778877643332 6788999999999999999999999988 788999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-------cEEEeecc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-------NSKISDFG  496 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-------~~kL~DfG  496 (571)
                      |||+++++|.+++...  ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            9999999999998532  226899999999999999999999988   99999999999999887       79999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccC--CCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ++......      ....++..|+|||.+.+.  .++.++||||||+++|||++ |..||...
T Consensus       154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            98865431      123466789999998876  78999999999999999999 57777654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-31  Score=266.54  Aligned_cols=204  Identities=27%  Similarity=0.434  Sum_probs=168.5

Q ss_pred             CCCCCceecccCceeEEEEEEc---CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL  421 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~  421 (571)
                      +|+..+.||+|+||.||++...   +++.||+|.+....   ......+.+|+.++.+++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3677889999999999999964   47899999987632   34456678999999999999999999999988  7899


Q ss_pred             EEEEccCCCChhhhhcCC-C-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC----CCcEEEeec
Q 008288          422 LVYEFMPNGSLDAILFDP-R-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDF  495 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~-~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~----~~~~kL~Df  495 (571)
                      +||||+++ +|..++... . ....+++..+..++.||+.||.|||+.+   |+||||||+||++++    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 565555321 1 2246899999999999999999999998   999999999999999    899999999


Q ss_pred             ccccccccCCCc-cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          496 GMARIFAESEGE-ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       496 Gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      |++......... .......++..|+|||.+.+. .++.++||||||++++||++|+.||...+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            999865443221 112234678899999988764 57899999999999999999999997553

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=1.5e-30  Score=256.37  Aligned_cols=201  Identities=38%  Similarity=0.569  Sum_probs=171.1

Q ss_pred             CCCCceecccCceeEEEEEEcC-----CcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          351 FSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      +++.+.||+|+||.||++...+     +..+++|+++..... ....+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999753     388999999754433 5678899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..... ..+++..+..++.|++.+|+|||+.+   ++|+||||+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999853221 12899999999999999999999998   999999999999999999999999999866544


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ...... ...++..|++||.+.+..++.++||||||++++||++ |+.||...
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~  208 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM  208 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            222211 1236788999999988889999999999999999998 88888754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=8e-32  Score=277.06  Aligned_cols=200  Identities=36%  Similarity=0.509  Sum_probs=174.3

Q ss_pred             CCCceecccCceeEEEEEEc--CCc--EEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          352 SDSNILGQGGFGPVYKGVLS--DGK--EVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ...++||+|.||.|++|.++  +|+  .||||.++..... ...+|.+|+.+|.+++|||+++|+|+..+ ....||||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34578999999999999975  344  5799999876554 67789999999999999999999999988 778899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      .+.|+|.+.|++ ..+..|-....-.++.|||.||+||.++.   +|||||..+|+|+-....+||+||||.+.+...+.
T Consensus       192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            999999999976 56677888888899999999999999998   99999999999999999999999999998876655


Q ss_pred             ccceee-ecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          507 EANTVR-IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ...... ..-...|.|||.+....++.++|||+|||.+|||+| |+.||-+-
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~  319 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC  319 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC
Confidence            442211 223557999999999999999999999999999999 99999764

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=7.8e-31  Score=262.88  Aligned_cols=200  Identities=30%  Similarity=0.437  Sum_probs=171.7

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|++.+.||+|+||.||++... +++.|++|++....  ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4677889999999999999964 68999999987533  33456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      + +++|.+++...  ...+++.+++.++.||+++|+|||+.+   ++|+||||+||++++++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999988532  356899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      . ......++..|+|||.+.+. .++.++||||+|++++||++|++||...
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         155 R-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             C-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            1 11224688899999988654 4689999999999999999998888654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=1.1e-30  Score=259.56  Aligned_cols=203  Identities=27%  Similarity=0.449  Sum_probs=170.8

Q ss_pred             CCCCCceecccCceeEEEEEEcC--CcEEEEEEcccc----------CccchHHHHHHHHHHHh-cccCCeeeEeeEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSC----------SEQGTAEFTNEVLLILK-LQHKNLVKLLGFCVD  416 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~nIv~l~~~~~~  416 (571)
                      +|+..+.||+|+||.||++....  ++.+++|.+...          ......++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            46778899999999999999754  688999987532          22234457788888875 699999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          417 GDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      ++..+++|||+++++|.+++.. ......+++..++.++.|++.+|.|||+ .+   ++|+||+|+||++++++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999888743 1234568999999999999999999996 55   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ||++.......   ......++..|++||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~  218 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM  218 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH
Confidence            99998654432   22234688899999999988899999999999999999999999976643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=1.1e-30  Score=261.20  Aligned_cols=190  Identities=31%  Similarity=0.446  Sum_probs=157.6

Q ss_pred             eecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHh---cccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          356 ILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILK---LQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~---l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      .||+|+||.||++... +++.+|+|.+.+..   ......+.+|..++..   .+||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999964 68899999886432   1122234455444333   479999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|.+++.   ..+.+++..+..++.|++.||+|||+.+   |+|+||||+|||+++++.++|+|||++........  
T Consensus        81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            999998884   3456999999999999999999999998   99999999999999999999999999875533221  


Q ss_pred             ceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                        ....|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||..
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  198 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ  198 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence              12368999999998864 5589999999999999999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=8.9e-31  Score=262.38  Aligned_cols=201  Identities=28%  Similarity=0.448  Sum_probs=169.2

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|++|.||+++.. +++.|+||+++...  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4778899999999999999865 68999999886432  22345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +. ++|..++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            95 6888887442 3456899999999999999999999998   99999999999999999999999999876543222


Q ss_pred             ccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...+
T Consensus       156 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         156 TY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             cc--ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            11  1224678899999887644 6889999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=5e-31  Score=261.22  Aligned_cols=199  Identities=34%  Similarity=0.472  Sum_probs=173.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..+.||+|++|.||++... +++.+++|++.... .....++.+|++++++++||||+++++.+..++..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999975 68899999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      +++++|.+++....  ..+++.....++.|++++|.|||+ .+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999985322  568899999999999999999999 77   9999999999999999999999999987654322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...    ..++..|++||.+.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         156 AKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             hhc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            211    46788999999999989999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=2.7e-30  Score=253.10  Aligned_cols=199  Identities=35%  Similarity=0.552  Sum_probs=176.3

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      +|...+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+||+++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3667789999999999999975 688999999986555566789999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|.+++...  ...+++..+..++.|++++|.+||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999998432  256899999999999999999999988   99999999999999999999999999887654332  


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                       .....++..|++||.+.+..++.++||||||+++++|++|+.||...
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence             22346888999999998888999999999999999999999999755

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=234.33  Aligned_cols=205  Identities=26%  Similarity=0.383  Sum_probs=172.4

Q ss_pred             CCCCCceecccCceeEEEEEE-cCCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|...++||+|.||+||+++. ++++.||+|+++-  ..+.-.....+|+-++++++|+|||+++++...+....+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            456678899999999999995 4688999999863  3444456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      + ..+|..+..  .-++.++.+....++.|+++||.|+|++.   +.||||||.|.||+.+|++||.|||+++.+.-...
T Consensus        83 c-dqdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 C-DQDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             h-hHHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            9 457777763  34677999999999999999999999998   99999999999999999999999999997654321


Q ss_pred             ccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHh-CCCCCCCCchhhhh
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYG  562 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~ellt-G~~p~~~~~~~~~~  562 (571)
                      -.  ...+-|..|.+|.++.+.. |+...|+||-|||+.|+.. |++.|.+++..+-.
T Consensus       157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql  212 (292)
T KOG0662|consen  157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  212 (292)
T ss_pred             ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence            11  1235688999999998755 8999999999999999988 77778777554443

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=1.5e-30  Score=257.40  Aligned_cols=196  Identities=32%  Similarity=0.489  Sum_probs=159.4

Q ss_pred             ceecccCceeEEEEEEc----CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEE-cCceeEEEEEccC
Q 008288          355 NILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCV-DGDEKLLVYEFMP  428 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~  428 (571)
                      +.||+|+||.||+|...    +...+++|++... .......+.+|+.+++.++||||+++++++. .++..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999988642 3344567889999999999999999999876 4556789999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc-
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-  507 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~-  507 (571)
                      +++|.+++..  ....+++..+..++.|+++||.|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999999843  2334678888999999999999999988   999999999999999999999999999765432111 


Q ss_pred             -cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhC-CCCCCC
Q 008288          508 -ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG-RRNAGS  555 (571)
Q Consensus       508 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG-~~p~~~  555 (571)
                       .......++..|+|||.+.+..++.++||||||+++|||++| .+||..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence             111122456789999999888899999999999999999995 556654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=1.5e-30  Score=256.24  Aligned_cols=201  Identities=26%  Similarity=0.443  Sum_probs=172.7

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|+||.||++... +++.+++|.+...  +......+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4777899999999999999864 6889999988643  334456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfGla~~~~~~~  505 (571)
                      +++++|.+++... ....+++..+..++.|++++|.|||+++   ++|+||+|+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999998542 2345899999999999999999999998   9999999999999865 458999999998664332


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||+..+
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  205 (256)
T cd08220         157 KA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN  205 (256)
T ss_pred             cc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence            21   22467889999999998889999999999999999999999997654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=1.4e-30  Score=260.18  Aligned_cols=193  Identities=32%  Similarity=0.415  Sum_probs=165.5

Q ss_pred             ecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ||+|+||.||++... +++.+++|.+....   ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999854 68899999886422   22344567899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                      .+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++........   ...
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~  153 (277)
T cd05577          81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG  153 (277)
T ss_pred             HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---ccc
Confidence            99885422 236899999999999999999999998   99999999999999999999999999876543211   122


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..++..|++||.+.+..++.++||||||+++++|++|+.||...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  197 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR  197 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence            35788999999998888999999999999999999999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=2.3e-30  Score=260.88  Aligned_cols=203  Identities=25%  Similarity=0.360  Sum_probs=167.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCce-----
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE-----  419 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~-----  419 (571)
                      ++|+..+.||+|+||.||++... +++.|++|.++...  ......+.+|+.+++.+ +||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888899999999999999965 68999999876432  22345688999999999 46999999999887665     


Q ss_pred             eEEEEEccCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeecc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRK--RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFG  496 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfG  496 (571)
                      .+++|||+++ +|..++.....  ...+++..+..++.||++||+|||+.+   |+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78777743221  346899999999999999999999998   999999999999998 8899999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++..+........  ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~  216 (295)
T cd07837         157 LGRAFSIPVKSYT--HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS  216 (295)
T ss_pred             cceecCCCccccC--CcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9876543322111  1246788999998865 457899999999999999999999997653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=272.91  Aligned_cols=204  Identities=27%  Similarity=0.375  Sum_probs=181.2

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCc-EEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      .+.-.+++.+..||-|+||.|-++..++.. .+|+|++++.   ...+.+....|-.+|.+.+.|.||+++..|.+....
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            345567777889999999999999875433 3788888642   334455688999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      |+.||-|-||.|+.+|   +.++.++...+..++..+.+|++|||+++   ||.|||||+|++++.+|-+||.|||+|+.
T Consensus       496 YmLmEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  496 YMLMEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhhHHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHH
Confidence            9999999999999999   56788999999999999999999999999   99999999999999999999999999997


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +...   ..+..++||+.|.|||++.++..+.++|.||||+++|||++|++||...+
T Consensus       570 i~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d  623 (732)
T KOG0614|consen  570 IGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD  623 (732)
T ss_pred             hccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc
Confidence            7543   45677899999999999999999999999999999999999999998763

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=1.4e-30  Score=256.61  Aligned_cols=197  Identities=35%  Similarity=0.533  Sum_probs=167.2

Q ss_pred             CCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      ++|++.+.||+|+||.||++.. +++.+++|.++..  .....+.+|+.++++++||||+++++++..+ ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4577889999999999999986 6888999988643  2345788999999999999999999998764 4789999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|.+++... ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||++........  
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~--  155 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--  155 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence            99999998542 2345889999999999999999999988   99999999999999999999999999875432211  


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCch
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQL  558 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~~  558 (571)
                         ....+..|++||.+.++.++.++|+||||+++|||++ |+.||...+.
T Consensus       156 ---~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  203 (254)
T cd05083         156 ---NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL  203 (254)
T ss_pred             ---CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence               1233567999999988899999999999999999998 9999976543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=7.8e-32  Score=240.41  Aligned_cols=210  Identities=27%  Similarity=0.389  Sum_probs=175.6

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccc-cCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEc
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD  416 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~  416 (571)
                      ..+.++++.+++.....||+|++|.|-+.++ .+|+..|+|+++. -+.+..++.+.|+.+..+. .+|.+|.++|....
T Consensus        37 ~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r  116 (282)
T KOG0984|consen   37 GDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR  116 (282)
T ss_pred             ecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence            3344667777778888999999999999886 4799999999974 3445566788888877765 79999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 008288          417 GDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF  495 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~Df  495 (571)
                      +.+.++.||.| ..+|+.+..+ ..+.+.+++.-.-+|+..+.+||.|||++-  .+||||+||+||||+.+|++||+||
T Consensus       117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence            99999999999 6688877643 245667888889999999999999999864  6999999999999999999999999


Q ss_pred             ccccccccCCCccceeeecccccccchhhhcc----CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          496 GMARIFAESEGEANTVRIVGTYGYMAPEYAME----GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      |.+-.+.++.....   -.|-..|||||.+..    ..|+.|+||||||+.+.||.+++.||..
T Consensus       194 GIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  194 GISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            99988766543321   246778999998853    3689999999999999999999999864

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=1.9e-30  Score=256.81  Aligned_cols=192  Identities=30%  Similarity=0.437  Sum_probs=167.9

Q ss_pred             ecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ||+|++|.||+++.. +++.+++|++....   ....+.+.+|+.++++++||||+++++.+.+++..++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999975 58999999986432   23446789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                      .+++.   +...+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......   ....
T Consensus        81 ~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILR---DRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            99984   3345899999999999999999999988   9999999999999999999999999998665432   1223


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..++..|++||.+.+..++.++|+||||+++|||++|+.||...+
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence            467889999999988889999999999999999999999997554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1.1e-30  Score=258.14  Aligned_cols=195  Identities=29%  Similarity=0.429  Sum_probs=168.3

Q ss_pred             ecccCceeEEEEEEc-CCcEEEEEEccccCc---cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ||+|+||.||+++.. +++.+++|.+.....   .....+.+|++++++++||||+++++.+..++..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 489999999865332   4456788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC------
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG------  506 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~------  506 (571)
                      .+++..   .+.+++..+..++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            999843   346899999999999999999999998   99999999999999999999999999875433321      


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ........++..|++||...+...+.++||||||+++|||++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  205 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET  205 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            111223467889999999988889999999999999999999999997654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=3e-30  Score=253.90  Aligned_cols=202  Identities=32%  Similarity=0.504  Sum_probs=176.0

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVY  424 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~  424 (571)
                      +|...+.||+|++|.||++... +++.+++|++....  ....+.+.+|+.++++++||||+++++.+...  +..++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4667789999999999999976 68999999987543  24567789999999999999999999999988  8899999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..   ...+++..+..++.|++++|+|||+.+   ++|+||+|+||++++++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999843   337899999999999999999999988   999999999999999999999999998876554


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..........++..|++||.+.+...+.++||||||+++++|++|+.||...+
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            43111223467889999999988889999999999999999999999997653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-30  Score=258.59  Aligned_cols=204  Identities=29%  Similarity=0.473  Sum_probs=172.0

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCc------
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~------  418 (571)
                      .+++|+..+.||+|++|.||++... +++.+++|++.... .....+.+|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            5678999999999999999999975 67899999887533 3446789999999999 7999999999997654      


Q ss_pred             eeEEEEEccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      ..+++|||+++++|.+++.... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4789999999999999885422 2457899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhcc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +.........  .....++..|+|||.+..     ..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  221 (275)
T cd06608         160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM  221 (275)
T ss_pred             ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence            8765432222  122468889999998753     34678999999999999999999999643

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=1.6e-30  Score=261.88  Aligned_cols=194  Identities=29%  Similarity=0.458  Sum_probs=169.5

Q ss_pred             CceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ..+||+|+||.||++... +++.|++|++..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            367999999999999874 7899999998754545566789999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                      .+++.    .+.+++.....++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||++.........  ...
T Consensus       105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~  175 (292)
T cd06657         105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS  175 (292)
T ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence            99873    235789999999999999999999998   999999999999999999999999998765432211  122


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..++..|++||.+.+..++.++|+||+|+++|||++|+.||...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~  219 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  219 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            46788999999998888999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=1.8e-30  Score=261.10  Aligned_cols=199  Identities=29%  Similarity=0.390  Sum_probs=168.8

Q ss_pred             CCCCCceecccCceeEEEEEE----cCCcEEEEEEccccC----ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      +|++.+.||+|+||.||++..    .+|+.||+|+++...    ....+.+.+|+.++.++ +|+||+++++.+..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999999999985    368899999987422    22345678899999999 699999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++|+||+++++|.+++.   ....+++..+..++.|+++||.|||+.+   ++||||+|+|||+++++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999984   3456889999999999999999999988   99999999999999999999999999986


Q ss_pred             cccCCCccceeeecccccccchhhhccC--CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ....... ......|+..|++||.+.+.  .++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            5433221 12234688999999998753  467899999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=2.2e-30  Score=256.13  Aligned_cols=203  Identities=27%  Similarity=0.442  Sum_probs=172.0

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc--CceeEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVY  424 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~  424 (571)
                      +|+..+.||.|+||.||++... +++.+++|++...  .....+.+.+|++++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4777889999999999999854 6889999988642  33445668899999999999999999998764  44578999


Q ss_pred             EccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHh-----hCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          425 EFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLH-----EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       425 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH-----~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ||+++++|.+++... .....+++..++.++.||++||.|||     +.+   ++|+||+|+||++++++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999988542 23467899999999999999999999     655   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .........  .....++..|++||.+.+..++.++|+||||+++++|++|+.||...+
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  214 (265)
T cd08217         158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN  214 (265)
T ss_pred             ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence            876543321  122468899999999998889999999999999999999999997653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=300.62  Aligned_cols=201  Identities=31%  Similarity=0.468  Sum_probs=171.7

Q ss_pred             cCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      +-++....+||+|.||.||.+. .++|+..|||.++.  ..........+|..++..++|||+|+++|+-.+.+..++.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3456778899999999999999 45789999998863  23444566889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      |||++|+|.+++.   ..+..++.....+..|++.|+.|||++|   ||||||||.||+++.+|.+|++|||.|..+...
T Consensus      1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999983   3444566666778899999999999999   999999999999999999999999999987665


Q ss_pred             CCc--cceeeecccccccchhhhccCC---CCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          505 EGE--ANTVRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       505 ~~~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ...  .......||+.|||||++.+..   ...+.|||||||+++||+||++||.
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~ 1442 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWA 1442 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchh
Confidence            311  1122458999999999997643   5678999999999999999999995

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=2.6e-30  Score=258.49  Aligned_cols=191  Identities=31%  Similarity=0.447  Sum_probs=158.5

Q ss_pred             eecccCceeEEEEEEc-CCcEEEEEEccccCc---cchHHHHHHHHH---HHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          356 ILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLL---ILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~---l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      .||+|+||.||++... +++.||+|.+.+...   .....+.+|..+   ++...||+|+++.+.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 688999998864321   111223444433   444579999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      +++|..++.   ..+.+++..+..++.|+++||.|||+.+   ++||||||+||++++++.++|+|||++..+.....  
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            999998883   3457999999999999999999999988   99999999999999999999999999876543221  


Q ss_pred             ceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                        ....|+..|++||.+.++ .++.++||||+|+++|||++|+.||...
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence              223689999999998754 5899999999999999999999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=2.9e-30  Score=257.02  Aligned_cols=203  Identities=29%  Similarity=0.465  Sum_probs=166.2

Q ss_pred             CCCCceecccCceeEEEEEEc----CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          351 FSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      |.+.+.||+|+||.||++.+.    +++.+|||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999853    3688999988643  3344567889999999999999999999886543      


Q ss_pred             eeEEEEEccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 008288          419 EKLLVYEFMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF  495 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~Df  495 (571)
                      ..++++||+++++|..++...   .+...+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            236889999999998877432   12235788999999999999999999988   999999999999999999999999


Q ss_pred             ccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      |+++...............++..|++||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            99986644332222222345678999999988889999999999999999999 89998654

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.4e-30  Score=260.62  Aligned_cols=202  Identities=34%  Similarity=0.499  Sum_probs=170.3

Q ss_pred             CCCCCCceecccCceeEEEEEEc-----CCcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEc--Ccee
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~  420 (571)
                      ..|+..+.||+|+||.||++.+.     +++.+|+|.++..... ....+.+|++++++++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677789999999999999853     3678999998754433 46679999999999999999999999887  5578


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +++|||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999532  235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccc-eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ......... .....++..|++||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            653322111 1112345569999999888899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=2.7e-30  Score=259.49  Aligned_cols=201  Identities=29%  Similarity=0.415  Sum_probs=170.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~  424 (571)
                      ++|...+.||.|++|.||++... +++.+++|.+... ......++.+|++++++++||||+++++++...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35777899999999999999974 6889999988743 223456789999999999999999999988654  4678999


Q ss_pred             EccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      ||+++++|.+++.. ......+++..+..++.||+++|.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999888743 123456889999999999999999999998   99999999999999999999999999875543


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....    ...++..|++||.+.+..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         158 SLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            2211    235688899999999889999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=3.3e-30  Score=261.53  Aligned_cols=198  Identities=31%  Similarity=0.475  Sum_probs=167.3

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ...|+..+.||+|+||.||++... +++.|++|++....   .....++.+|+++++.++||||+++.+++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            355888899999999999999965 68999999886432   23345688999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      +||++ |++.+++..  ....+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 566666532  2345899999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCCccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..      ...++..|+|||.+.   ...++.++||||||+++|||++|+.||...+
T Consensus       168 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~  218 (307)
T cd06607         168 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (307)
T ss_pred             CC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence            21      235788899999874   4568899999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=266.76  Aligned_cols=196  Identities=33%  Similarity=0.507  Sum_probs=172.0

Q ss_pred             CceecccCceeEEEEEEc-CCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCC
Q 008288          354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      .+.||+|.||+||-|+++ +|+.||||++.+  ...+...++.+|+.+|.+++||.||.+.--|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            478999999999999964 899999999975  33445577899999999999999999999999999999999999665


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CcEEEeecccccccccCCCc
Q 008288          431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       431 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~---~~~kL~DfGla~~~~~~~~~  507 (571)
                      -|+-+|.  ...+.+++.....++.||+.||.|||.++   |+|.||||+|||+.+.   -++||+|||.|+.+....-.
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            5666653  45567999999999999999999999999   9999999999999654   36999999999988765433


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                         ...+||+.|+|||++.++.|.+.-|+||.|||+|--++|.-||+..+
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence               24689999999999999999999999999999999999999998763

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.7e-30  Score=252.21  Aligned_cols=201  Identities=33%  Similarity=0.498  Sum_probs=175.7

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc--cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|+..+.||+|++|.||++... +++.+++|.+.....  .....+.+|++++.+++|||++++++++.+.+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4677899999999999999865 678999999876443  4556789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++.   ....+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            99999999984   3367899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .  .....++..|++||...+...+.++|||++|+++|+|++|+.||...+.
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~  204 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP  204 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence            2  1234678899999999887889999999999999999999999975543

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=2.5e-30  Score=254.95  Aligned_cols=203  Identities=26%  Similarity=0.444  Sum_probs=172.8

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|...+.||+|+||.||++... +++.+++|.+...  .......+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4677889999999999999975 5889999988642  223455688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-EEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-SKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~-~kL~DfGla~~~~~~~  505 (571)
                      +++++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988542 2335799999999999999999999998   999999999999998864 6999999987664332


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ...  ....|+..|+|||.+.+..++.++|+||||+++|||++|+.||...+.
T Consensus       157 ~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  207 (257)
T cd08225         157 ELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL  207 (257)
T ss_pred             ccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence            211  123578899999999888899999999999999999999999976543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=2.6e-30  Score=260.32  Aligned_cols=200  Identities=29%  Similarity=0.426  Sum_probs=168.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV  423 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv  423 (571)
                      ++|+..+.||+|+||.||++... +++.+++|.++...  +.....+.+|+.++.+++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46788899999999999999975 68899999987432  22334567899999999999999999998877  889999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      +||++ ++|.+++..  ....+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.++|+|||++.....
T Consensus        85 ~e~~~-~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 488888743  2236899999999999999999999998   99999999999999999999999999986654


Q ss_pred             CCCccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....  ....++..|+|||.+.+.. ++.++|+||||+++|||++|+.||...
T Consensus       159 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         159 PLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             Ccccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            32211  2235688899999887544 689999999999999999999999755

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=6.3e-30  Score=257.66  Aligned_cols=202  Identities=26%  Similarity=0.397  Sum_probs=166.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|+..+.||+|++|.||++... +++.|++|++....  ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888899999999999999965 68899999986432  2334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccccC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAES  504 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~~~~~  504 (571)
                      |++ ++|.+++.. .....+++..+..++.||+.||+|||+.+   ++|+||+|+||++++ ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 577776632 22234678888899999999999999998   999999999999985 567999999999765332


Q ss_pred             CCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....  ....++..|++||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       157 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~  208 (294)
T PLN00009        157 VRTF--THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS  208 (294)
T ss_pred             cccc--ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2111  12356789999998866 457899999999999999999999997653

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-30  Score=257.90  Aligned_cols=200  Identities=28%  Similarity=0.432  Sum_probs=167.7

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      |+..+.||.|++|.||++... +|+.|++|++....  ......+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999964 79999999987432  233456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      + ++|.+++... ....+++..+..++.|+++||+|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 6898888432 2246899999999999999999999988   999999999999999999999999999755332211


Q ss_pred             cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       156 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  204 (283)
T cd07835         156 Y--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS  204 (283)
T ss_pred             c--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1  122567889999987654 57899999999999999999999997554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.7e-30  Score=254.42  Aligned_cols=191  Identities=26%  Similarity=0.382  Sum_probs=161.0

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHH-HhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLI-LKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||++... +++.||+|+++...   ......+..|..++ ...+|+||+++++.+..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999864 68999999986532   12223344554444 445899999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|..++.   ..+.+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++......     
T Consensus        82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  150 (260)
T cd05611          82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----  150 (260)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence            99999983   3456899999999999999999999998   999999999999999999999999998754321     


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                       ....++..|++||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  197 (260)
T cd05611         151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET  197 (260)
T ss_pred             -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence             12357889999999988888999999999999999999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-30  Score=266.28  Aligned_cols=202  Identities=26%  Similarity=0.451  Sum_probs=167.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-----ee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~  420 (571)
                      .++|++.+.||+|+||.||++... +++.||+|+++.. .......+.+|+.++++++||||+++++++....     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            467899999999999999999864 6899999998743 2334456888999999999999999998876543     47


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++++||++ ++|..++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            89999996 47777762    345899999999999999999999998   99999999999999999999999999876


Q ss_pred             cccCCCcc-ceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEA-NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~  214 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD  214 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            54322211 1123468899999998754 568999999999999999999999997553

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=3e-30  Score=260.17  Aligned_cols=204  Identities=18%  Similarity=0.226  Sum_probs=153.4

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC----CcEEEEEEccccCccchH-----------HHHHHHHHHHhcccCCeeeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQGTA-----------EFTNEVLLILKLQHKNLVKL  410 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~nIv~l  410 (571)
                      +..++|++.++||+|+||.||++...+    +..+++|+.....+....           ....+...+..++|+||+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            445678999999999999999999654    345666654322211111           11223334456689999999


Q ss_pred             eeEEEcCc----eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 008288          411 LGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       411 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~  486 (571)
                      ++++....    ..++++|++. .++.+.+.   .....++..+..++.|+++||+|||+.+   |+||||||+|||++.
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~  161 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG  161 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence            99776543    3357777763 35655552   2233578888999999999999999998   999999999999999


Q ss_pred             CCcEEEeecccccccccCCCc-----cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          487 DMNSKISDFGMARIFAESEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       487 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ++.++|+|||+++.+......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999866432211     1112246899999999999999999999999999999999999999644

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=276.13  Aligned_cols=198  Identities=29%  Similarity=0.454  Sum_probs=172.7

Q ss_pred             CCCCceecccCceeEEEEEEcC-CcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          351 FSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      ++++..||.|+||.||+++.++ +-..|-|++...++....+++-||+||+...||+||+|++.|..++.+++..|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            3455669999999999999764 334467888877888899999999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |-.+.++.+  -...+++.++..+++|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+-.....  ...
T Consensus       114 GAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk  186 (1187)
T KOG0579|consen  114 GAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK  186 (1187)
T ss_pred             chHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence            999998854  3456999999999999999999999998   999999999999999999999999997643322  222


Q ss_pred             eeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ...++|||.|||||+++     ..+|+.++|||||||.|.||..+.+|...
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe  237 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE  237 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence            33469999999999875     56799999999999999999999999754

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=4.6e-30  Score=260.66  Aligned_cols=202  Identities=29%  Similarity=0.459  Sum_probs=167.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~  421 (571)
                      ..++|+..+.||+|+||.||++... +|+.||+|+++...  ......+.+|+.++.+++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            3467888999999999999999974 68999999986432  22233567899999999999999999998765  4679


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++ +|.+++..  ....+++.++..++.||++||+|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        85 lv~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          85 LVMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence            99999964 78877743  2356899999999999999999999998   999999999999999999999999999866


Q ss_pred             ccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .......  ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         159 GLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             CCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4432211  12245778999999875 45789999999999999999999999755

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=5.1e-30  Score=260.08  Aligned_cols=204  Identities=28%  Similarity=0.444  Sum_probs=166.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|+..+.||+|+||.||++... +++.||||++....  +.....+.+|+.++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            346888999999999999999965 68999999886432  223345678999999999999999999987654      


Q ss_pred             --eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          419 --EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       419 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                        ..++||||+. ++|...+..  ....+++.++..++.||++||+|||+.+   ++|+||||+||++++++.+||+|||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              3489999996 477777632  2346899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCc--cceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          497 MARIFAESEGE--ANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       497 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++..+......  .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            99866443222  1112235788899999887643 7889999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.5e-30  Score=257.11  Aligned_cols=191  Identities=28%  Similarity=0.445  Sum_probs=159.9

Q ss_pred             ceecccCceeEEEEEEcC--------CcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +.||+|+||.||++....        ..++++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999998632        234888887655555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--------EEEeecccc
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--------SKISDFGMA  498 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~--------~kL~DfGla  498 (571)
                      +++|+|..++...  ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998532  335889999999999999999999998   999999999999987765        699999998


Q ss_pred             cccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCC-CCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR-RNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~-~p~~~~  556 (571)
                      ......      ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+...
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~  209 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL  209 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence            654322      12357888999999876 45799999999999999999985 565543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=9.5e-30  Score=252.82  Aligned_cols=192  Identities=23%  Similarity=0.332  Sum_probs=159.8

Q ss_pred             cCCCCCCcee--cccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNIL--GQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~l--G~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|++.+.+  |+|+||.||++..+ ++..+++|.+.......     .|+.....+ +||||+++++.+...+..++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            3456666665  99999999999964 68889999886432111     122222222 799999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFA  502 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~~~  502 (571)
                      |||+++++|.+++..   ...+++.++..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         88 MDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999843   347899999999999999999999998   99999999999999998 99999999987553


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...      ...++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        162 TPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             CCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            321      235788999999999888999999999999999999999999743

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=2.8e-30  Score=257.78  Aligned_cols=202  Identities=31%  Similarity=0.469  Sum_probs=175.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ++|...+.||+|+||.||++... +++.+++|++...   .......+.+|.+++.+++ ||||+++++++..++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46788899999999999999965 7899999988642   2333466889999999998 99999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      ||++++++|.+++.   +.+.+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999984   3457999999999999999999999998   99999999999999999999999999886544


Q ss_pred             CCCc------------------cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGE------------------ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....                  .......++..|++||.+.+...+.++||||||++++|+++|+.||...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS  225 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence            3321                  1122346788999999998888999999999999999999999999765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=260.96  Aligned_cols=207  Identities=31%  Similarity=0.450  Sum_probs=171.5

Q ss_pred             cCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccc---cC----ccchHHHHHHHHHHHhcccCCeeeEeeEEEc-Cc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GD  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~---~~----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~  418 (571)
                      .++|-..++||+|||+.||++. +...+-||||+-.-   ..    +...+...+|..+.+.+.||.||++++++.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            3456677899999999999998 45678899997532   11    1223346789999999999999999999864 55


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeec
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDF  495 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~Df  495 (571)
                      .++-|+||++|.+|+.+|   +....+++.+++.|+.||+.||.||.+.. +||||-||||.|||+-+   -|.+||.||
T Consensus       542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence            678999999999999999   45567999999999999999999999975 78999999999999954   478999999


Q ss_pred             ccccccccCCCc-----cceeeecccccccchhhhcc----CCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          496 GMARIFAESEGE-----ANTVRIVGTYGYMAPEYAME----GLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       496 Gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ||+++...+...     ..+....||..|++||.+.-    ...+.|+||||+|||+|..+.|++||+.+.-
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs  689 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS  689 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence            999987665433     23345689999999998753    3478899999999999999999999998743

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.5e-30  Score=280.68  Aligned_cols=199  Identities=21%  Similarity=0.381  Sum_probs=157.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEcC--CcEEEEE------------------EccccCccchHHHHHHHHHHHhcccCCe
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSD--GKEVAVK------------------RLSSCSEQGTAEFTNEVLLILKLQHKNL  407 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~nI  407 (571)
                      .++|++.+.||+|+||.||++..+.  +...++|                  .+. ........+.+|+.++.+++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            4679999999999999999987532  2222222                  111 122234567899999999999999


Q ss_pred             eeEeeEEEcCceeEEEEEccCCCChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec
Q 008288          408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD  485 (571)
Q Consensus       408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~  485 (571)
                      +++++++...+..++++|++. ++|..++....  .........+..++.||+.||+|||+++   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999985 56666653321  1223446677889999999999999998   99999999999999


Q ss_pred             CCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCC
Q 008288          486 SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN  552 (571)
Q Consensus       486 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p  552 (571)
                      .++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~  367 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC  367 (501)
T ss_pred             CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999876443221 12235789999999999999999999999999999999998754

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=7.9e-30  Score=255.52  Aligned_cols=200  Identities=28%  Similarity=0.473  Sum_probs=169.0

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeEEEEE
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVYE  425 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e  425 (571)
                      |++.+.||+|++|.||++... +++.+++|++...  .......+.+|+.++++++|+|++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456788999999999999975 5889999999754  234456688999999999999999999999988  88999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++ +|..++...  ...+++..++.++.||++||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9974 888887432  246899999999999999999999998   9999999999999999999999999998665443


Q ss_pred             Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       155 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         155 SAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             ccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            211 122356788999998765 457899999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=6.6e-30  Score=264.56  Aligned_cols=198  Identities=29%  Similarity=0.388  Sum_probs=167.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|+..+.||+|+||.||++... +++.||+|++...  .......+.+|+.++++++||||+++++++....      
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            467889999999999999999964 7899999998642  2334456778999999999999999999886443      


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+. ++|...+..     .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence            4689999995 577777632     2888999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.......   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+
T Consensus       166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            86543221   122357889999999999999999999999999999999999997553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=9.6e-30  Score=257.23  Aligned_cols=205  Identities=28%  Similarity=0.436  Sum_probs=169.3

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc----
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----  418 (571)
                      ...++|++.+.||+|+||.||+|... +++.|++|+++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            34577888999999999999999975 58899999987432  233456788999999999999999999987655    


Q ss_pred             ------eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          419 ------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       419 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                            ..++++||+++ ++..++..  ....+++..+..++.|++.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78899999976 66666632  2346899999999999999999999998   999999999999999999999


Q ss_pred             eecccccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +|||++........... ....++..|++||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       158 ~dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~  222 (302)
T cd07864         158 ADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ  222 (302)
T ss_pred             CcccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999986654332111 12245778999998865 457899999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-32  Score=253.97  Aligned_cols=204  Identities=30%  Similarity=0.424  Sum_probs=168.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~l  422 (571)
                      +..++++....||.|.||+|+|-.++ .|+.+|||+++.. .+.+.++++.|.+...+- +.||||+++|.+..++..|+
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi  140 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI  140 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence            34456667788999999999999875 6999999999843 346677888888876665 78999999999999999999


Q ss_pred             EEEccCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          423 VYEFMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      .||.| ..+|+.+...  ...+..+++.-.-.|..-..+||.||.+.-  .|||||+||+|||+|..|.+||+|||++-.
T Consensus       141 CMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  141 CMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHh
Confidence            99999 6677665521  123445888888889999999999998754  699999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      +..+-...   .-.|-..|||||.+..  ..|+.++||||||+.|||+.||+-|+..
T Consensus       218 Lv~SiAkT---~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~  271 (361)
T KOG1006|consen  218 LVDSIAKT---VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK  271 (361)
T ss_pred             HHHHHHhh---hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence            65543332   2367888999999863  4489999999999999999999999864

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=1.4e-29  Score=249.16  Aligned_cols=203  Identities=26%  Similarity=0.428  Sum_probs=176.4

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|...+.||.|+||.||++... +++.+++|++....  ......+.+|++++++++|||++++.+.+...+..++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4677889999999999999965 68999999987532  24566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      +++++|.+++.... ....+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999885422 2467999999999999999999999998   9999999999999999999999999998664433


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  ......+++.|++||.+.+..++.++|+||+|+++++|++|+.||...+
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  207 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN  207 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence            1  1223468889999999988889999999999999999999999997653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=5.2e-30  Score=257.40  Aligned_cols=200  Identities=30%  Similarity=0.440  Sum_probs=164.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35566788999999999999964 68999999987432 334557889999999996 9999999999999999999999


Q ss_pred             ccCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      |++. ++.++...  ......+++..+..++.|+++||+|||+. +   ++||||||+||++++++.++|+|||++..+.
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9864 55443311  12335689999999999999999999975 6   9999999999999999999999999997654


Q ss_pred             cCCCccceeeecccccccchhhhccC---CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEG---LYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .....   ....|+..|+|||.+.+.   .++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  212 (288)
T cd06616         160 DSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             cCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence            33221   223578899999998766   689999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=6.8e-30  Score=251.51  Aligned_cols=202  Identities=30%  Similarity=0.467  Sum_probs=174.8

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +|++.+.||+|+||.||++... +++.+++|.+...  ......++.+|++++++++|+||+++.+++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4677889999999999999854 6889999998643  234456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      +++++|..++.... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            99999999885421 2356899999999999999999999998   9999999999999999999999999998765441


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .    ....++..|++||.+.+..++.++|+||||+++|||++|+.||...+.
T Consensus       158 ~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~  206 (256)
T cd08530         158 A----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM  206 (256)
T ss_pred             c----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            1    123578899999999998899999999999999999999999976654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=2.1e-29  Score=256.76  Aligned_cols=194  Identities=31%  Similarity=0.481  Sum_probs=164.7

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      |+..+.||+|+||.||++... +++.+++|++...   .......+.+|+.++++++|||++++++++.+++..++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            566788999999999999964 6889999998643   223345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++ +|.+++..  ....+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus       107 ~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         107 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            974 77666632  2455899999999999999999999998   999999999999999999999999998754322  


Q ss_pred             ccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                          ....++..|+|||.+.   ++.++.++||||||+++|||++|+.||...
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  227 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  227 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence                1236788999999874   456889999999999999999999998543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=1.4e-29  Score=253.31  Aligned_cols=197  Identities=24%  Similarity=0.370  Sum_probs=163.0

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcC--ceeEEEEE
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG--DEKLLVYE  425 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e  425 (571)
                      |+..+.||+|+||.||++... +++.+++|+++.. .........+|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999964 6889999998753 2223334567888999885 99999999999987  88999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |++ ++|.+.+..  ....+++..+..++.|++.||+|||+.+   ++||||+|+||++++ +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 577777643  2356899999999999999999999998   999999999999999 999999999998664332


Q ss_pred             Cccceeeecccccccchhhhc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..   ....++..|+|||.+. ++.++.++||||||+++|||++|+.||...+
T Consensus       154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~  203 (282)
T cd07831         154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN  203 (282)
T ss_pred             Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence            21   1235788999999765 4557899999999999999999999997653

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=6.7e-30  Score=262.80  Aligned_cols=201  Identities=31%  Similarity=0.498  Sum_probs=167.2

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC--ceeE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG--DEKL  421 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~--~~~~  421 (571)
                      .++|+..+.||+|+||.||+|... +++.+++|++...  .......+.+|+.+++++ +||||+++++++...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            456888899999999999999965 6889999988532  233445677899999999 999999999998654  3579


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||++ ++|..++..    ..+++..+..++.||+.||+|||+.+   |+|+||||+||++++++.+||+|||++...
T Consensus        86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9999997 589888732    26889999999999999999999998   999999999999999999999999999866


Q ss_pred             ccCCCc---cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          502 AESEGE---ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ......   .......|+..|++||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence            443322   12223468899999998765 45788999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=246.39  Aligned_cols=202  Identities=25%  Similarity=0.347  Sum_probs=176.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccc---cCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      +.-.+|.....||+|+|.+|..++++ +.+.+|+|++++   ..+++..-...|-.+..+. +||.+|-+..+|..+..+
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            45578889999999999999999964 688899999875   2344455566777777766 899999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++|.||+++|+|--.+   +.+..++++.++.+...|.-||.|||+.|   ||.||||.+|||+|.+|++||.|+|+++.
T Consensus       327 ffvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence            9999999999997766   55667999999999999999999999999   99999999999999999999999999985


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      --.+.  ..+..++||+.|.|||++.+..|....|+|+|||+++||+.|+.||+.
T Consensus       401 ~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  401 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             CCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            43322  234467999999999999999999999999999999999999999963

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=7.2e-30  Score=262.23  Aligned_cols=201  Identities=25%  Similarity=0.427  Sum_probs=168.3

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEc----CceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~  421 (571)
                      ++|+..+.||+|+||.||++... +++.|++|++....  ......+.+|+.++++++||||+++.+++..    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            67888899999999999999964 69999999987532  2345567889999999999999999988763    34678


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+. ++|..++.   ....+++..+..++.||++||+|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus        85 lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          85 VVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9999995 68888883   3455899999999999999999999998   999999999999999999999999998765


Q ss_pred             ccCCCc--cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          502 AESEGE--ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ......  .......++..|++||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~  215 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK  215 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence            433221  11123468889999998865 45889999999999999999999999654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.1e-29  Score=256.32  Aligned_cols=202  Identities=28%  Similarity=0.470  Sum_probs=167.0

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcC-CcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  421 (571)
                      .+..++|+..+.||+|+||.||++...+ ++.||||.++... .....++..|+.++.+. .||||+++++++......+
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            3455778889999999999999999864 8999999987432 23445567787777777 4999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++|||++ ++|..++..  ....+++..+..++.|+++||+|||+ .+   |+||||+|+||++++++.+||+|||++..
T Consensus        91 ~v~e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          91 ICMELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             EEeeccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchh
Confidence            9999985 477776633  23478999999999999999999997 46   99999999999999999999999999876


Q ss_pred             cccCCCccceeeecccccccchhhhccCC----CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      +......   ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         165 LVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             ccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            5433222   1235778899999987553    78899999999999999999999965

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2e-29  Score=260.02  Aligned_cols=202  Identities=29%  Similarity=0.444  Sum_probs=168.5

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-  417 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-  417 (571)
                      ..+...+++|...+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.++.+++||||+++.+++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34556678899999999999999999985 47899999998743  222345678899999999999999999988643 


Q ss_pred             -----ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          418 -----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       418 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                           ...+++++++ +++|.+++.    ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3367788876 789988873    235899999999999999999999998   999999999999999999999


Q ss_pred             eecccccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +|||++.......     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       162 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         162 LDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             ecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999987543221     22367889999998866 56889999999999999999999999654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1.1e-29  Score=255.05  Aligned_cols=199  Identities=28%  Similarity=0.392  Sum_probs=168.4

Q ss_pred             CCCCCceecccCceeEEEEEE----cCCcEEEEEEccccC----ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      +|+..+.||+|++|.||++..    .+++.++||.+++..    ......+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366788999999999999874    257889999886422    22345678999999999 699999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++++|..++.   ....+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999884   3356889999999999999999999988   99999999999999999999999999876


Q ss_pred             cccCCCccceeeecccccccchhhhccCC--CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      +....... .....|+..|++||.+.+..  .+.++||||||+++|||++|+.||..
T Consensus       155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            54432221 12346788999999987655  78899999999999999999999953

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=1.3e-29  Score=260.61  Aligned_cols=200  Identities=26%  Similarity=0.442  Sum_probs=167.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-----e
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----E  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~  419 (571)
                      .++|...+.||+|+||.||++... +++.|+||.++..  .......+.+|+.+++.++|+||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            346888899999999999999964 6899999998642  2333456788999999999999999999886543     4


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++++||+. ++|.+++.   ..+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            789999995 68888873   3456999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .......  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         157 TTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             ccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence            6543321  1122357889999998865 46889999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-29  Score=259.16  Aligned_cols=198  Identities=29%  Similarity=0.445  Sum_probs=167.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-----
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----  418 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----  418 (571)
                      ..++|+..+.||+|+||.||++.. .+++.||||++...  .......+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456799999999999999999985 47899999988642  2223456889999999999999999999987654     


Q ss_pred             -eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          419 -EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       419 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                       ..++||||+ +++|..++.    ...+++..+..++.||++||+|||+.+   |+||||||+||++++++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             358999998 778988873    345899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.......     ....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...+
T Consensus       165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  220 (343)
T cd07880         165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD  220 (343)
T ss_pred             ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            87653321     12356889999999876 458899999999999999999999997653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=7.9e-30  Score=247.02  Aligned_cols=214  Identities=26%  Similarity=0.413  Sum_probs=184.4

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEee
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLG  412 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~  412 (571)
                      ...++.+...++....++-+|.||.||+|.+.      +.+.|.+|.++. .++-+...++.|.-.+..+.|||+.++.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            35677788888999999999999999999653      355788898874 45666677899999999999999999999


Q ss_pred             EEEcC-ceeEEEEEccCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 008288          413 FCVDG-DEKLLVYEFMPNGSLDAILF-----DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       413 ~~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~  486 (571)
                      ++.++ ..++++++++.-|+|..+|.     +......++..+...++.|++.||+|||+++   +||.||..+|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            98764 56789999999999999997     5555667888999999999999999999999   999999999999999


Q ss_pred             CCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       487 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..++||+|=.|++.+...+.............||+||.+.+..|+.++|||||||+||||+| |+.|+-.-
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI  502 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI  502 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence            99999999999998877665543333344678999999999999999999999999999999 99998654

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=2.6e-29  Score=258.15  Aligned_cols=202  Identities=27%  Similarity=0.398  Sum_probs=165.7

Q ss_pred             CCCC-CCceecccCceeEEEEEEc-CCcEEEEEEccccCccc--------------hHHHHHHHHHHHhcccCCeeeEee
Q 008288          349 SNFS-DSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQG--------------TAEFTNEVLLILKLQHKNLVKLLG  412 (571)
Q Consensus       349 ~~~~-~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~nIv~l~~  412 (571)
                      ++|. ..+.||+|+||.||++... +++.||+|+++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3444 3577999999999999965 68999999886432211              124778999999999999999999


Q ss_pred             EEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       413 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                      ++..++..+++|||++ ++|.+++.   ....+++.....++.|+++||+|||+.+   ++|+||+|+||+++.++.++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999996 68888883   3456899999999999999999999998   999999999999999999999


Q ss_pred             eecccccccccCCC------------ccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          493 SDFGMARIFAESEG------------EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       493 ~DfGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +|||++........            ........++..|++||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999976541110            0111123467889999998764 46899999999999999999999997653

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=1.8e-29  Score=256.15  Aligned_cols=204  Identities=28%  Similarity=0.443  Sum_probs=165.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|+..+.||+|+||.||++... +++.+++|++....  ......+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467888999999999999999965 68999999886432  222345778999999999999999998875443      


Q ss_pred             --eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          419 --EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       419 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                        ..++|+||++. +|...+..  ....+++..+..++.|+++||.|||+.+   |+|+||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45899999865 56666532  2346999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccc---------eeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          497 MARIFAESEGEAN---------TVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       497 la~~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +++..........         .....+++.|+|||.+.+. .++.++||||||+++|||++|++||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            9976543321111         1223567889999987654 57899999999999999999999997553

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=241.43  Aligned_cols=199  Identities=28%  Similarity=0.484  Sum_probs=165.6

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccc-cCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +++....||.|..|.|++.++. +|..+|||.+.. .+.+..++++..+.++.+- ..|.||+.+|+|..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3444567999999999999965 689999999874 4455566677777777666 489999999999999999999998


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      | ..-++.++.  +..+++++.-+-++...+.+||.||.++.  .|+|||+||+|||+|+.|++||+|||++-.+.++..
T Consensus       173 M-s~C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA  247 (391)
T KOG0983|consen  173 M-STCAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA  247 (391)
T ss_pred             H-HHHHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence            8 445566663  34566888888899999999999998765  599999999999999999999999999987765544


Q ss_pred             ccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..   +..|-+.|||||.+.   ...|+.++||||||+.|+||.||+.||...
T Consensus       248 ht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c  297 (391)
T KOG0983|consen  248 HT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC  297 (391)
T ss_pred             cc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence            33   347889999999885   345899999999999999999999999764

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=2.6e-29  Score=255.62  Aligned_cols=198  Identities=21%  Similarity=0.243  Sum_probs=162.3

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCC
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      .+.+|.|+++.|+++.. +++.||||+++..  .......+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            34455556666666555 7899999998743  34556679999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc----
Q 008288          432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE----  507 (571)
Q Consensus       432 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~----  507 (571)
                      |.+++... ....+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||.+.........    
T Consensus        86 l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            99998542 2345889999999999999999999998   999999999999999999999999988755322111    


Q ss_pred             -cceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          508 -ANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       508 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                       .......++..|+|||.+..  ..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence             11122356778999999875  35889999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=2.7e-29  Score=251.19  Aligned_cols=199  Identities=29%  Similarity=0.443  Sum_probs=169.3

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc--cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      |+..+.||+|++|.||++... +++.+++|+++....  .....+.+|+.++++++|+||+++++++..++..++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            456788999999999999964 788999999875322  24567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++ +|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||.+.........
T Consensus        81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~  154 (283)
T cd05118          81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP  154 (283)
T ss_pred             CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence            75 88777743  2357899999999999999999999998   999999999999999999999999998766543311


Q ss_pred             cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        .....++..|++||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus       155 --~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         155 --YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             --ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence              1123577889999998876 78999999999999999999999996654

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.7e-29  Score=258.99  Aligned_cols=201  Identities=29%  Similarity=0.451  Sum_probs=171.6

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-----eeE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL  421 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~~  421 (571)
                      +|++.+.||+|++|.||+++.. +++.+++|++....  ....+.+.+|+.+++.++||||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999975 58999999987533  344567899999999999999999999988775     789


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      ++|||++ ++|..++.   ....+++..+..++.||++||.|||+.+   |+|+||||+|||+++++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 57888873   3347999999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCc-cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGE-ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            544311 112234678889999999877 78999999999999999999999997654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=4.2e-29  Score=255.79  Aligned_cols=198  Identities=28%  Similarity=0.432  Sum_probs=167.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc-CceeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKL  421 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~  421 (571)
                      ..+++|+..+.||+|+||.||++... +++.|++|++...  .....+.+.+|++++.+++||||+++.+++.. .+..+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45778999999999999999999854 7899999987532  23345668899999999999999999999876 55788


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +++||+ +++|..++.    ...+++..+..++.|+++||.|||+.+   |+|+||+|+||++++++.++|+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 568988873    345788888999999999999999998   999999999999999999999999998754


Q ss_pred             ccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....     ....++..|++||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         159 DPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             CCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            3211     12356788999998765 56899999999999999999999999654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=9.9e-29  Score=251.38  Aligned_cols=194  Identities=32%  Similarity=0.480  Sum_probs=163.5

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      |...+.||+|+||.||+|+.. +++.+++|++....   ......+.+|++++++++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            455678999999999999964 68899999986432   23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +. +++.+++..  ....+++..+..++.||+.+|.|||+.+   ++|+||+|+||++++++.++|+|||++......  
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            96 567666632  3346899999999999999999999998   999999999999999999999999998643211  


Q ss_pred             ccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                          ....|+..|+|||.+.   ...++.++||||||+++|||++|+.||...
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                1246788999999974   456889999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=4e-29  Score=245.21  Aligned_cols=193  Identities=32%  Similarity=0.439  Sum_probs=168.0

Q ss_pred             ecccCceeEEEEEEc-CCcEEEEEEccccCc---cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE---QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      ||+|+||.||++... +++.+++|.++....   .....+.+|+.++++++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999975 589999999875332   2455788999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceee
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR  512 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~  512 (571)
                      .+++.   ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++........  ....
T Consensus        81 ~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (250)
T cd05123          81 FSHLS---KEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT  152 (250)
T ss_pred             HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence            99984   3346899999999999999999999988   99999999999999999999999999876544321  1223


Q ss_pred             ecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       513 ~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..++..|++||.+.+...+.++|+||||+++|||++|+.||...+
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  197 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED  197 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            467889999999988888999999999999999999999997654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=7.9e-29  Score=248.36  Aligned_cols=199  Identities=30%  Similarity=0.464  Sum_probs=165.2

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhc---ccCCeeeEeeEEEcCce-----
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDE-----  419 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~~~~-----  419 (571)
                      |++.+.||+|+||.||+++.+ +++.+++|+++...  ......+.+|+.++.++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456788999999999999976 48999999987422  22234566788777666   69999999999988776     


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .+++|||++ ++|.+++... ....+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            899999997 4788877432 2235899999999999999999999998   9999999999999999999999999997


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .+......   ....++..|++||.+.+..++.++||||||+++|||++|+.||....
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            76443221   12356888999999998889999999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=3.4e-30  Score=280.40  Aligned_cols=197  Identities=31%  Similarity=0.517  Sum_probs=158.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-------
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-------  417 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-------  417 (571)
                      -..+|++.+.||+||||.|||++.+ ||..+|||++.- .+......+.+|+..+++++|||||+++..+.+.       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            4467888899999999999999976 899999999973 3555566789999999999999999987533100       


Q ss_pred             --------------------------------------------------------------------------------
Q 008288          418 --------------------------------------------------------------------------------  417 (571)
Q Consensus       418 --------------------------------------------------------------------------------  417 (571)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 008288          418 --------------------------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH  465 (571)
Q Consensus       418 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH  465 (571)
                                                      ..+|+-||||+..+|.+++.......  .....++++++|++||.|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence                                            01356788888888888884322111  35678899999999999999


Q ss_pred             hCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc---c-------------CCCccceeeecccccccchhhhccCC
Q 008288          466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA---E-------------SEGEANTVRIVGTYGYMAPEYAMEGL  529 (571)
Q Consensus       466 ~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~---~-------------~~~~~~~~~~~gt~~y~aPE~~~~~~  529 (571)
                      +++   ||||||||.||+++++..+||+|||++....   .             .......+..+||..|+|||++.+..
T Consensus       715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            999   9999999999999999999999999998621   0             01112334568999999999997644


Q ss_pred             ---CCcchhhHhHHHHHHHHHh
Q 008288          530 ---YSKKSDVFSFGVLLIEIIT  548 (571)
Q Consensus       530 ---~~~~~Dv~slGvil~ellt  548 (571)
                         |+.|+|+|||||||+||+.
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc
Confidence               9999999999999999984

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=4.7e-29  Score=256.97  Aligned_cols=197  Identities=29%  Similarity=0.456  Sum_probs=164.8

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|...+.||+|+||.||+|+.. +++.||+|++...  .+.....+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            357888899999999999999964 6899999988642  2233456889999999999999999999987543      


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++|+||+. .+|..++     ...+++..+..++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        94 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            4589999986 4676654     235889999999999999999999998   999999999999999999999999998


Q ss_pred             cccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      +......     ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.
T Consensus       165 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~  220 (342)
T cd07879         165 RHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY  220 (342)
T ss_pred             cCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            7543221     12356888999999876 4588999999999999999999999987653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=5e-29  Score=255.72  Aligned_cols=201  Identities=29%  Similarity=0.426  Sum_probs=164.1

Q ss_pred             CCCCCceecccCceeEEEEEEc-C--CcEEEEEEcccc--CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC----ce
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-D--GKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG----DE  419 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~----~~  419 (571)
                      +|+..+.||+|+||.||++... +  ++.+|+|++...  .....+.+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4677789999999999999964 3  778999988642  222345678899999999 599999999875432    34


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++++||+. ++|.+++.   ....+++..+..++.||++||+|||+.+   ++||||||+|||+++++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678889885 68888873   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc--cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGE--ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .+......  .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~  214 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD  214 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence            65432221  11223478999999998765 468999999999999999999999997653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=4.4e-29  Score=249.56  Aligned_cols=199  Identities=32%  Similarity=0.464  Sum_probs=169.5

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      |+..+.||+|++|.||+++.. +++.+++|++....  +.....+..|+.++++++|+||+++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            455678999999999999975 58999999987542  334567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      + ++|.+++...  ...+++..+..++.|+++||+|||+.+   |+|+||+|+||++++++.++|+|||++.........
T Consensus        81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            7 5899988432  146899999999999999999999998   999999999999999999999999998765433221


Q ss_pred             cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  203 (282)
T cd07829         155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS  203 (282)
T ss_pred             --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence              1122456789999998776 78999999999999999999999997654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=3.6e-29  Score=257.87  Aligned_cols=200  Identities=29%  Similarity=0.446  Sum_probs=165.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC----------
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG----------  417 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~----------  417 (571)
                      .+|...+.||+|+||.||++... +++.|++|++........+.+.+|++++++++||||+++++.+...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67888999999999999999964 6899999998765555667789999999999999999999776554          


Q ss_pred             ----ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEE
Q 008288          418 ----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKI  492 (571)
Q Consensus       418 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL  492 (571)
                          ...++||||++ ++|..++.    .+.+++..+..++.||++||.|||+.+   |+||||||+||+++. ++.++|
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 58888773    345889999999999999999999998   999999999999974 567899


Q ss_pred             eecccccccccCCCcc-ceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          493 SDFGMARIFAESEGEA-NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +|||++.......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999987653321111 1112357888999998754 55788999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=6e-29  Score=248.91  Aligned_cols=199  Identities=30%  Similarity=0.418  Sum_probs=166.6

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc-cchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEEcc
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      |++.+.||+|++|.||+|+.. +++.|++|++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456788999999999999975 578899999864322 22334567899999998 999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                       +++|.+++.... ...+++..+..++.|++++|.|||+.+   ++|+||+|+||++++++.++|+|||++.........
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence             889988874322 346899999999999999999999998   999999999999999999999999999765432221


Q ss_pred             cceeeecccccccchhhhc-cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                         ....++..|+|||.+. +..++.++|+||||++++||++|+.||...+
T Consensus       156 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~  203 (283)
T cd07830         156 ---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS  203 (283)
T ss_pred             ---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence               1235788899999875 4457899999999999999999999996554

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=7.6e-29  Score=253.94  Aligned_cols=198  Identities=24%  Similarity=0.329  Sum_probs=161.2

Q ss_pred             ceeccc--CceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQG--GFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      ..||+|  +||+||++.+. +++.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++++||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  89999999964 7999999998642  233456788999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc-
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA-  508 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~-  508 (571)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99999885422 234889999999999999999999988   9999999999999999999999998654332211110 


Q ss_pred             ----ceeeecccccccchhhhccC--CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          509 ----NTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       509 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                          ......++..|++||++.+.  .++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                00111345679999998764  4789999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-29  Score=274.34  Aligned_cols=209  Identities=33%  Similarity=0.478  Sum_probs=175.7

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEc----C----CcEEEEEEccc-cCccchHHHHHHHHHHHhc-ccCCeeeEee
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLS----D----GKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLG  412 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~  412 (571)
                      .+++..+++++.+.||+|.||.|++|...    .    ...||||.++. ....+.+.+..|+++|+.+ .|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45566667777779999999999999843    1    45789999984 3445677899999999999 6999999999


Q ss_pred             EEEcCceeEEEEEccCCCChhhhhcCCC------C-----C--CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 008288          413 FCVDGDEKLLVYEFMPNGSLDAILFDPR------K-----R--GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKA  479 (571)
Q Consensus       413 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp  479 (571)
                      +|.+++..++|+||++.|+|..+++..+      .     .  ..++..+.+.++.||+.||+||++..   ++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999996544      0     0  24889999999999999999999987   99999999


Q ss_pred             CCeEecCCCcEEEeecccccccccCCCccceeeec--ccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008288          480 SNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV--GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGS  555 (571)
Q Consensus       480 ~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~  555 (571)
                      +|||+.++..+||+|||+++............ -.  -...|||||.+....|+.|+|||||||+||||+| |..||..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999999655443332111 11  2345999999999999999999999999999999 9999975

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=6.2e-29  Score=245.68  Aligned_cols=202  Identities=28%  Similarity=0.387  Sum_probs=166.4

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccc-----cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS-----CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~-----~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +|.+.+.||+|+||.||++... .+..+++|.++.     .......++..|+.++++++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4777899999999999999864 344555555442     1223344577899999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          424 YEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      +||+++++|..++.. ......+++..++.++.|+++||.|||+.+   ++|+||+|+||++++ +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988853 223457899999999999999999999998   999999999999975 569999999987654


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....  .....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus       157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~  209 (260)
T cd08222         157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN  209 (260)
T ss_pred             CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            33221  122457889999999988888999999999999999999999997553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=1.4e-28  Score=249.79  Aligned_cols=194  Identities=34%  Similarity=0.504  Sum_probs=163.7

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .|+..+.||+|+||.||+++.. +++.+++|.+...   ......++.+|+++++.++|+|++++.+++...+..++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            3566788999999999999964 6788999988632   22334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+. ++|.+++..  ....+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  169 (308)
T cd06634          96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  169 (308)
T ss_pred             ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence            996 577776632  2345889999999999999999999988   9999999999999999999999999987653321


Q ss_pred             Cccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                            ...++..|+|||.+.   ...++.++||||||+++|||++|+.||..
T Consensus       170 ------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  216 (308)
T cd06634         170 ------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (308)
T ss_pred             ------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence                  235788999999974   35678899999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=1.4e-28  Score=239.95  Aligned_cols=180  Identities=23%  Similarity=0.238  Sum_probs=153.5

Q ss_pred             cCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCChhhhhcC
Q 008288          360 GGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD  438 (571)
Q Consensus       360 G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  438 (571)
                      |.+|.||++... +++.+|+|+++..+     .+..|...+....||||+++++++.+.+..+++|||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999964 78999999987543     233455556667899999999999999999999999999999998843


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeeccccc
Q 008288          439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG  518 (571)
Q Consensus       439 ~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~  518 (571)
                         ...+++..+..++.|+++||.|||+.+   ++||||||+||++++++.++|+|||++.......     ....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence               345899999999999999999999998   9999999999999999999999999876543321     12245678


Q ss_pred             ccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       519 y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      |+|||.+.+..++.++||||+|+++|||++|+.|+..
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            9999999888899999999999999999999987653

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.1e-28  Score=254.48  Aligned_cols=198  Identities=29%  Similarity=0.463  Sum_probs=167.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce----
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----  419 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~----  419 (571)
                      ..++|+..+.||+|++|.||++... +++.|++|++...  .......+.+|+.++++++||||+++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3567888999999999999999975 6889999988642  22334567789999999999999999988776554    


Q ss_pred             --eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          420 --KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       420 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                        .++|+||+ +++|.+++..    ..+++..+..++.|+++||+|||+.+   |+|+||||+||++++++.++|+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              78999998 6799888832    46899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +......     .....++..|++||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~  220 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD  220 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9765432     122357888999999865 357899999999999999999999996553

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.9e-29  Score=262.06  Aligned_cols=210  Identities=31%  Similarity=0.496  Sum_probs=182.2

Q ss_pred             ccChHHHHhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       338 ~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      .++++.+...++.|++.+.||+|.+|.||+++. ++++..|+|+.... ....++...|.++++.. .|||++.++|++.
T Consensus         8 ~~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    8 DIDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             ccchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            456666777888899999999999999999994 57899999988763 34456788899999988 7999999999987


Q ss_pred             c-----CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcE
Q 008288          416 D-----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS  490 (571)
Q Consensus       416 ~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~  490 (571)
                      .     ++++|||||||.+|+..+++.... ...+.|..+..|++.++.||++||...   ++|||||-.|||++.++.+
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence            4     568999999999999999996644 677999999999999999999999988   9999999999999999999


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhcc-----CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ||+|||++..++.......+  .+||+-|||||++.-     ..|+..+|+||||++..||--|.+|+-
T Consensus       163 KLvDFGvSaQldsT~grRnT--~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~  229 (953)
T KOG0587|consen  163 KLVDFGVSAQLDSTVGRRNT--FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC  229 (953)
T ss_pred             EEeeeeeeeeeecccccccC--cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence            99999999877655444443  489999999999853     347889999999999999999999974

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=3.8e-28  Score=270.02  Aligned_cols=145  Identities=25%  Similarity=0.395  Sum_probs=130.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|.+.++||+|+||.||++... +++.||||+++...   ......+..|+.++..++||||+++++.+...+..++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888899999999999999975 68999999987432   233466889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      ||+++++|..++.   ..+.+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~---~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLH---IYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999984   3346889999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=236.45  Aligned_cols=197  Identities=30%  Similarity=0.395  Sum_probs=163.4

Q ss_pred             cCCCCCC-ceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC----cee
Q 008288          348 TSNFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG----DEK  420 (571)
Q Consensus       348 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~----~~~  420 (571)
                      +++|.+. ++||-|-.|+|..+.++ +++++|+|++...     ....+|+++.-.. .|||||++++++++.    .-+
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            3445443 67999999999999875 7999999998642     2456777766555 799999999998753    346


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeeccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGM  497 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~DfGl  497 (571)
                      .+|||.|+||.|.+.+.+ +....+++.++..|+.||+.|+.|||+..   |.||||||+|+|...   |-.+||+|||+
T Consensus       135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence            789999999999998854 34456999999999999999999999998   999999999999964   44689999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      |+.-...   ......+-|+.|.|||++...+|+...|+||+||++|-|++|-+||=++
T Consensus       211 AK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  211 AKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             ccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccccc
Confidence            9865432   2233458899999999999889999999999999999999999998554

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=4.1e-29  Score=252.68  Aligned_cols=196  Identities=28%  Similarity=0.399  Sum_probs=167.4

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--------ccchHHHHHHHHHHHhcc---cCCeeeEeeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQ---HKNLVKLLGFCV  415 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~  415 (571)
                      ..+|...+.+|+|+||.|+.++++ +...|+||.+.+..        +...-..-.||.+|+.++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            346888999999999999999976 56789999886522        112223678999999997   999999999999


Q ss_pred             cCceeEEEEEcc-CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          416 DGDEKLLVYEFM-PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       416 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      +++.+||++|-. ++.+|.+++   .....+++.++..|++|++-|+++||+++   |||||||-+||.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            999999999976 455788888   45566999999999999999999999999   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCC
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~  553 (571)
                      ||.+.......-    ..++||..|.|||++.+..| ...-|||++|++||.++....||
T Consensus       714 fgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999876543332    23689999999999988776 56789999999999999998887

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4.1e-28  Score=257.06  Aligned_cols=205  Identities=22%  Similarity=0.318  Sum_probs=154.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE-----------------cCCcEEEEEEccccCccchHH--------------HHH
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL-----------------SDGKEVAVKRLSSCSEQGTAE--------------FTN  394 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~  394 (571)
                      ...++|++.++||+|+||.||+|..                 ..++.||||++........++              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3577899999999999999999964                 235679999987533322222              344


Q ss_pred             HHHHHHhcccCCe-----eeEeeEEEc--------CceeEEEEEccCCCChhhhhcCCCC--------------------
Q 008288          395 EVLLILKLQHKNL-----VKLLGFCVD--------GDEKLLVYEFMPNGSLDAILFDPRK--------------------  441 (571)
Q Consensus       395 e~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------  441 (571)
                      |+.++.+++|.++     +++++++..        ++..+|||||+++++|.++++....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777876654     667777653        3567999999999999998853210                    


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeeccccccc
Q 008288          442 -RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM  520 (571)
Q Consensus       442 -~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~  520 (571)
                       ...+++..+..++.|++++|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+++.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence             123567788999999999999999988   999999999999999999999999999755332211 111224478999


Q ss_pred             chhhhccCCC----------------------CcchhhHhHHHHHHHHHhCCC-CCC
Q 008288          521 APEYAMEGLY----------------------SKKSDVFSFGVLLIEIITGRR-NAG  554 (571)
Q Consensus       521 aPE~~~~~~~----------------------~~~~Dv~slGvil~elltG~~-p~~  554 (571)
                      +||.+.....                      ..+.||||+||+++||++|.. |+.
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence            9998764321                      134799999999999999986 664

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=253.68  Aligned_cols=193  Identities=31%  Similarity=0.432  Sum_probs=163.9

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++.|.....+|.|+|+.|-.+.+ .+++..+||++.+.    ..+..+|+.++... +||||+++.+.+.+..+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            56677888899999999999985 47889999999764    22344677666666 79999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe-cCCCcEEEeecccccccccC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL-DSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl-~~~~~~kL~DfGla~~~~~~  504 (571)
                      .+.++-+.+-+.   ....+. .++..|+.+|+.++.|||+++   ++||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999988766652   222233 778889999999999999999   9999999999999 58999999999999876543


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                           ....+-|..|.|||++....|++++||||||++||||++|+.||..+
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~  516 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH  516 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence                 22346688999999999999999999999999999999999999765

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.2e-27  Score=228.49  Aligned_cols=198  Identities=34%  Similarity=0.478  Sum_probs=171.5

Q ss_pred             CCCCceecccCceeEEEEEEcC-CcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          351 FSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++.+......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4556889999999999999764 899999999865444 56788999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCCCCC-CCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          429 NGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      +++|.+++...   .. +++.....++.++++++.+||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            99999998432   22 789999999999999999999998   999999999999999999999999999876544311


Q ss_pred             cceeeecccccccchhhh-ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          508 ANTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                       ......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             11234677889999998 667788899999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1e-29  Score=233.17  Aligned_cols=203  Identities=29%  Similarity=0.498  Sum_probs=168.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcc--ccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--------
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--------  417 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--------  417 (571)
                      +.|....+||+|.||.||+++.+ +|++|++|++-  +..+.......+|+.++..+.|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45566778999999999999964 68888998764  33444456688999999999999999999888642        


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      ...++||.+++. +|.-+|.+  ....++..++.+++.++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347899999965 77777743  2345889999999999999999999988   99999999999999999999999999


Q ss_pred             ccccccCCCccc--eeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEAN--TVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++.+........  .+..+-|..|.+||.+.+ ..|+++.|||+-|||+.||++|.+-++.+.
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh
Confidence            987765543322  223456899999999886 559999999999999999999999998874

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-28  Score=237.07  Aligned_cols=212  Identities=24%  Similarity=0.303  Sum_probs=177.7

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcc-c-CC----eeeEeeEEEcCce
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-H-KN----LVKLLGFCVDGDE  419 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----Iv~l~~~~~~~~~  419 (571)
                      -+++|.+..++|+|.||.|-++... .+..||||+++.- ....+..+-|++++.++. + |+    ++++.++|.-.+.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            3678999999999999999999854 5789999999853 334455778999999993 2 22    7888999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-------------
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------------  486 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-------------  486 (571)
                      .++|+|.+ |.++.+++.. .+..+++...+..|+.|+++++.|||+.+   ++|-||||+|||+-+             
T Consensus       166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence            99999987 6689999954 34456889999999999999999999998   999999999999932             


Q ss_pred             -------CCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          487 -------DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       487 -------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                             +..++|+|||.|..-....     ..++.|..|.|||++.+-.++..+||||+||||.|+.+|...|+.++..
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                   2348999999998543332     3467899999999999999999999999999999999999999999877


Q ss_pred             hhhhhceeec
Q 008288          560 AYGMYWSWLI  569 (571)
Q Consensus       560 ~~~~~~~~~~  569 (571)
                      ++.-+|..++
T Consensus       316 EHLaMMerIl  325 (415)
T KOG0671|consen  316 EHLAMMERIL  325 (415)
T ss_pred             HHHHHHHHhh
Confidence            7766665554

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=232.90  Aligned_cols=195  Identities=28%  Similarity=0.448  Sum_probs=162.7

Q ss_pred             CceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-----eeEEEEE
Q 008288          354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKLLVYE  425 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e  425 (571)
                      .+.||-|+||.||.++.. +|+.|++|++.+-  +-...+.+.+|+.++..++|.|++..+++....+     +.|++.|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            467999999999999864 7999999988642  2334567889999999999999999888876543     4578888


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      .| ..+|+.++.   ....++...+.-+..||++||.|||+.+   |.||||||.|.|++++-.+||+||||++.-..++
T Consensus       138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence            88 558888884   3445888888899999999999999999   9999999999999999999999999998655443


Q ss_pred             CccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ... .+..+-|..|.|||++++.+ |+.+.||||.|||+.||+..+-.|+..
T Consensus       211 ~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  211 RLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             hhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            332 23346688899999999754 899999999999999999999998765

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=2.6e-28  Score=220.98  Aligned_cols=201  Identities=21%  Similarity=0.429  Sum_probs=168.6

Q ss_pred             cChHHHHhh---cCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeE
Q 008288          339 IDLETLNLA---TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGF  413 (571)
Q Consensus       339 ~~~~~l~~~---~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~  413 (571)
                      .|++...+.   .++|++.+++|+|.++.||.|. ..++++++||++++-   ..+.+.+|+.+|..+. ||||+.|+++
T Consensus        25 WdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~Di  101 (338)
T KOG0668|consen   25 WDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDI  101 (338)
T ss_pred             cchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhh
Confidence            455544433   3678889999999999999998 467899999999863   3456889999999996 9999999999


Q ss_pred             EEcCc--eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcE
Q 008288          414 CVDGD--EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNS  490 (571)
Q Consensus       414 ~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~  490 (571)
                      ..+..  .+.||+||+++.+...+.      ..++..++..++.++++||.|+|+.|   |+|||+||.|++||.. -.+
T Consensus       102 V~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen  102 VKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             hcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhcee
Confidence            98765  467999999999887766      34888899999999999999999999   9999999999999865 569


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      +|+|||||..+.......   ..+.+..|..||.+.. +.|+..-|+|||||+|..|+..+.||-
T Consensus       173 rlIDWGLAEFYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             eeeecchHhhcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence            999999999876654332   2355667889998875 558899999999999999999999983

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.94  E-value=1.1e-26  Score=225.76  Aligned_cols=186  Identities=36%  Similarity=0.535  Sum_probs=164.1

Q ss_pred             CceeEEEEEEc-CCcEEEEEEccccCccc-hHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCChhhhhcC
Q 008288          361 GFGPVYKGVLS-DGKEVAVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD  438 (571)
Q Consensus       361 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  438 (571)
                      +||.||+++.. +++.+++|++....... ...+.+|++.+++++|+||+++.+.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999997654444 67899999999999999999999999999999999999999999999843


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeeccccc
Q 008288          439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG  518 (571)
Q Consensus       439 ~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~  518 (571)
                         ...+++..+..++.++++++.+||+.+   ++|+||+|+||++++++.++|+|||.+.......   ......++..
T Consensus        81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence               223889999999999999999999998   9999999999999999999999999998765432   1223467889


Q ss_pred             ccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       519 y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      |++||.+.+..++.++|||+||+++++|++|+.||..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999888899999999999999999999999976

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=6.6e-27  Score=253.98  Aligned_cols=202  Identities=21%  Similarity=0.261  Sum_probs=142.7

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-C----CcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeE------E
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-D----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF------C  414 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~------~  414 (571)
                      ...++|+..+.||+|+||.||+|++. +    +..||+|++......  +...+|  .+....+.++..++..      .
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            35678999999999999999999975 4    689999987643221  111111  1122222222222111      2


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCC
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRKR-----------------GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL  477 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DL  477 (571)
                      ..+...++||||+++++|.+++......                 .......+..++.||++||+|||+++   |+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence            4566789999999999999988532110                 01123345679999999999999998   999999


Q ss_pred             CCCCeEecC-CCcEEEeecccccccccCCCccceeeecccccccchhhhccC----------------------CCCcch
Q 008288          478 KASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG----------------------LYSKKS  534 (571)
Q Consensus       478 kp~NILl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  534 (571)
                      ||+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 579999999999865433222 22345789999999966422                      234567


Q ss_pred             hhHhHHHHHHHHHhCCCCCCC
Q 008288          535 DVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       535 Dv~slGvil~elltG~~p~~~  555 (571)
                      |||||||+||||+++..|++.
T Consensus       361 DVwSlGviL~el~~~~~~~~~  381 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS  381 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch
Confidence            999999999999998877654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-27  Score=221.38  Aligned_cols=206  Identities=22%  Similarity=0.407  Sum_probs=162.3

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeE-EEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF-CVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~-~~~~~~~~lv~e  425 (571)
                      +.|.+.+.||+|.||.+-++.++ +++.+++|-+.. .....++|.+|..---.+ .|.||+.-+++ |+..+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            45788899999999999999986 577889997764 334567888887766666 58999987765 455667779999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCCcEEEeeccccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGMARIFAE  503 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~--~~~~~kL~DfGla~~~~~  503 (571)
                      |++.|+|.+-+.    ...+.+....+++.|+++|+.|+|++.   +||||||.+||||-  +..++||+|||+.+....
T Consensus       103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999988762    234778888999999999999999999   99999999999993  345899999999875432


Q ss_pred             CCCccceeeecccccccchhhhccC-----CCCcchhhHhHHHHHHHHHhCCCCCCCCchhhhhhhceee
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEG-----LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWL  568 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~~~~~~  568 (571)
                      .-.     ...-+..|.+||.....     ...+.+|||.||++++.++||+.||+ ....+..-+|+|+
T Consensus       176 tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  176 TVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWE  239 (378)
T ss_pred             eeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHH
Confidence            211     12345678999976532     24688999999999999999999998 5555555566554

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=243.97  Aligned_cols=198  Identities=31%  Similarity=0.460  Sum_probs=162.2

Q ss_pred             CCCCceecccCce-eEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccC
Q 008288          351 FSDSNILGQGGFG-PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       351 ~~~~~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      |...+.+|.|..| .||+|.+ +|++||||++-.   ....-..+|+..+..- +||||+++++.-.+....|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            4556788999987 5899999 789999998864   2333567999999988 7999999999999999999999999 


Q ss_pred             CCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---C--CcEEEeecccccccc
Q 008288          429 NGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---D--MNSKISDFGMARIFA  502 (571)
Q Consensus       429 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~--~~~kL~DfGla~~~~  502 (571)
                      .-+|++++... ...........+.+..|+++||++||+.+   ||||||||.||||..   +  ..++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            56899998542 11111222456788999999999999988   999999999999965   3  468999999999887


Q ss_pred             cCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhC-CCCCCCC
Q 008288          503 ESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG-RRNAGSN  556 (571)
Q Consensus       503 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG-~~p~~~~  556 (571)
                      ...... ......||.+|+|||++....-+.++||+||||++|+.++| +.||+.+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence            655442 23445799999999999988888899999999999999995 9999865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=7e-24  Score=200.92  Aligned_cols=183  Identities=40%  Similarity=0.648  Sum_probs=157.9

Q ss_pred             ecccCceeEEEEEEcC-CcEEEEEEccccCcc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCChhh
Q 008288          357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA  434 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  434 (571)
                      ||+|.+|.||++...+ ++++++|++...... ....+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999998754332 34678999999999999999999999999999999999999999999


Q ss_pred             hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccccCCCccceeee
Q 008288          435 ILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRI  513 (571)
Q Consensus       435 ~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~  513 (571)
                      ++....  ..+++..+..++.+++++|.+||+.+   ++|+||+|+||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            984321  46889999999999999999999998   999999999999999 89999999999986644321  11223


Q ss_pred             cccccccchhhhccC-CCCcchhhHhHHHHHHHH
Q 008288          514 VGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEI  546 (571)
Q Consensus       514 ~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~el  546 (571)
                      .+...|++||..... ..+.+.|+|++|+++++|
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            567889999998877 788999999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.91  E-value=3.5e-25  Score=210.43  Aligned_cols=195  Identities=29%  Similarity=0.384  Sum_probs=160.8

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------e
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------E  419 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~  419 (571)
                      .+|.....+|.|.- .|-.+.. -.+++|++|++..  ......++..+|...+..++|+||++++.++.-..      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45666777888887 5555543 2689999998753  23445667889999999999999999999987543      5


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .|+|||+| ..+|...+.     -.++-..+.+|..|++.|++|||+.+   |+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            68999999 668887774     23667888999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .-...   -..+..+.|..|.|||++.+..+...+||||+||++.||++|+..|.+.
T Consensus       167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence            54332   2233457788899999999988999999999999999999999998754

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.91  E-value=3.7e-25  Score=186.40  Aligned_cols=101  Identities=36%  Similarity=0.697  Sum_probs=78.6

Q ss_pred             CCCCC-CCCCCc-CCCChHHHHHHHHHHHhhhccccc---CccccccCCCCCceEEEEeccCCCChhhhHHHHHHHHHHH
Q 008288           29 YNICS-TSTAGS-ARASTIDDNLQNVLTSLASNANAA---KFSNASFGNDSDRVYGLYMCLNYISAETCNDCITTASQDI  103 (571)
Q Consensus        29 ~~~c~-~~~~~~-~~~s~~~~~l~~l~~~l~~~~~~~---~f~~~~~g~~~~~vyg~~~C~~d~~~~~C~~C~~~a~~~~  103 (571)
                      |+.|+ +++++| +++++|++||++||++|...++.+   +|++++.|.++++|||++||++|+++++|..||+.|+..+
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~   80 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI   80 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence            57898 555677 678889999999999999998754   8999988999999999999999999999999999999999


Q ss_pred             HhhCCCcccceEEcCeeEEEecCCcc
Q 008288          104 SKLCPNKTEAIVWEEVCQLRYAYQNF  129 (571)
Q Consensus       104 ~~~C~~~~~~~~~~~~C~~ry~~~~f  129 (571)
                      .+.|+++++|+||++.|+|||++++|
T Consensus        81 ~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   81 SSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHhCCCCceEEEECCCEEEEEECCCC
Confidence            99999999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.91  E-value=2.9e-25  Score=222.29  Aligned_cols=203  Identities=23%  Similarity=0.282  Sum_probs=173.1

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcc------cCCeeeEeeEEEcC
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ------HKNLVKLLGFCVDG  417 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~nIv~l~~~~~~~  417 (571)
                      ++-..+|.+....|+|-|+.|.++... -|+.||||++.+ ++--.+.=+.|+++|++|+      ..|.++|+..|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            456678888999999999999999954 588999999986 3333445678999999994      35789999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeecc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFG  496 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfG  496 (571)
                      ++++||+|-+ ..+|.++|.....+-.|....+..++.|+.-||..|...+   |+|.||||+||||++. ..+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence            9999999977 6689999976666667888999999999999999999988   9999999999999876 568999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .|......+....    .-+.-|.|||++.|-.|+...|+||.||.||||.||+..|.+.
T Consensus       583 SA~~~~eneitPY----LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~  638 (752)
T KOG0670|consen  583 SASFASENEITPY----LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR  638 (752)
T ss_pred             cccccccccccHH----HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence            9987655443322    2345699999999999999999999999999999999999765

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=2e-24  Score=212.66  Aligned_cols=200  Identities=25%  Similarity=0.425  Sum_probs=166.7

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc----CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCc
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGD  418 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~  418 (571)
                      +....+.|..+++||+|.|+.||++++.    .++.||+|.+...+  ......+|+++|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4445577889999999999999999853    46789999887533  345688999999999 6999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeeccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGM  497 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfGl  497 (571)
                      ...+|+||++.-...+++..      ++..++..+.+.+++||.++|.+|   ||||||||+|+|.+.. +.-.|+||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            99999999999999998843      678899999999999999999999   9999999999999755 5679999999


Q ss_pred             ccccccCC------C-----------c-------------------------cceeeecccccccchhhhcc-CCCCcch
Q 008288          498 ARIFAESE------G-----------E-------------------------ANTVRIVGTYGYMAPEYAME-GLYSKKS  534 (571)
Q Consensus       498 a~~~~~~~------~-----------~-------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~  534 (571)
                      +.......      .           .                         .......||++|.|||++.. +..+.+.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            97221100      0           0                         00011479999999999976 4478999


Q ss_pred             hhHhHHHHHHHHHhCCCCCC
Q 008288          535 DVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       535 Dv~slGvil~elltG~~p~~  554 (571)
                      ||||.|||++-+++++.||-
T Consensus       260 Diws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             ceeeccceeehhhccccccc
Confidence            99999999999999999984

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=9.6e-24  Score=201.31  Aligned_cols=200  Identities=20%  Similarity=0.341  Sum_probs=171.9

Q ss_pred             cCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .-+|.+.++||+|+||.++.|+ +-++++||||.-..  ....-++..|.+..+.| ..++|.+++-+...+..-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            4578999999999999999999 45899999996543  23445688999999988 57999999999888888999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-----CCcEEEeecccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMARI  500 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-----~~~~kL~DfGla~~  500 (571)
                      .+ |.+|+++..-  ..+.++..+...++.||+.-++|+|++.   +|.|||||+|+||..     ...+.|+|||+|+.
T Consensus       105 LL-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            88 8899887732  3456999999999999999999999999   999999999999953     34589999999998


Q ss_pred             cccCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      +.+..+..     ......||.+||+-..+.+.+.+++.|+-|||.+++..+-|..||++
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            87665442     22346799999999999999999999999999999999999999985

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=1.5e-23  Score=213.45  Aligned_cols=168  Identities=20%  Similarity=0.266  Sum_probs=130.6

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc--CCcEEEEEEcccc-----CccchHHHHHHHHHHHhcccCCeee-EeeEEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS--DGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVK-LLGFCV  415 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~-l~~~~~  415 (571)
                      +....++|...+.||+|+||+||++.+.  +++.+|||++...     .....+.+.+|++++.+++|+||++ ++..  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3455678999999999999999999864  5777899986532     1223456899999999999999985 4432  


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCC-CCCCeEecCCCcEEEee
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL-KASNVLLDSDMNSKISD  494 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DL-kp~NILl~~~~~~kL~D  494 (571)
                        +..++||||+++++|....    ..+      ...++.|++++|.|||+.+   |+|||| ||+|||++.++++||+|
T Consensus        91 --~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             --CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence              4679999999999996321    111      1467889999999999998   999999 99999999999999999


Q ss_pred             cccccccccCCCccc------eeeecccccccchhhhccC
Q 008288          495 FGMARIFAESEGEAN------TVRIVGTYGYMAPEYAMEG  528 (571)
Q Consensus       495 fGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  528 (571)
                      ||+++.+........      .....++..|++||.+...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999997654332111      1235778889999988643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.90  E-value=4.5e-25  Score=227.03  Aligned_cols=199  Identities=26%  Similarity=0.429  Sum_probs=175.8

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ..++|+....+|.|.+|.|||++.. .++..|+|+++-.......-..+|+-+++..+||||+.++|.+...+..+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3467888899999999999999954 789999999986666677778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+.+|+|+++.   .-.+++++.++....+..++||.|||+.+   -+|||||-.|||+++.|.+|+.|||.+-.+....
T Consensus        93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999999987   45678999999999999999999999999   8999999999999999999999999987665544


Q ss_pred             Cccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~  553 (571)
                      .+.  ..+.||+.|||||+..   .+.|..++|||++|+...|+---++|-
T Consensus       167 ~Kr--ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  167 AKR--KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             hhh--hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence            333  3468999999999863   466899999999999999998777773

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=7.1e-23  Score=208.71  Aligned_cols=202  Identities=22%  Similarity=0.293  Sum_probs=166.3

Q ss_pred             CCCCCceecccCceeEEEEEEcCC--cEEEEEEccccCccchHHHHHHHHHHHhccc----CCeeeEeeEE-EcCceeEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDG--KEVAVKRLSSCSEQGTAEFTNEVLLILKLQH----KNLVKLLGFC-VDGDEKLL  422 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~nIv~l~~~~-~~~~~~~l  422 (571)
                      +|.+.++||+|+||.||++.....  ..+|+|............+..|..++..+..    +++..++... ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            789999999999999999996543  4788887765433333367889999998863    6899999998 47778899


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-----CcEEEeeccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-----MNSKISDFGM  497 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-----~~~kL~DfGl  497 (571)
                      ||+.+ |.+|.++..... .+.++..+.+.|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99976 889999874433 567999999999999999999999999   9999999999999754     4699999999


Q ss_pred             cc--ccccCCCc----c-c-eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 AR--IFAESEGE----A-N-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ++  .+......    . . .....||.+|.+++.+.+...+++.|+||++.++.|++.|..||...
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence            98  43222211    1 1 12346999999999999999999999999999999999999999654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=9.5e-24  Score=192.99  Aligned_cols=201  Identities=21%  Similarity=0.315  Sum_probs=169.3

Q ss_pred             cCCCCCCceecccCceeEEEEE-EcCCcEEEEEEccccCccchHHHHHHHHHHHhccc-CCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ..+|..+++||.|+||.+|.|. ..+|++||||.-+..  ....++.-|..+...+++ ..|+.+..+..+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4678899999999999999999 568999999986542  223457789999999965 778888888889999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~DfGla~~~~  502 (571)
                      .+ +.+|+++..-  ....++..+.+-++.||+.-++|+|.++   +|||||||+|+|..-   ...+.|+||||++.+.
T Consensus        92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            88 8899888742  3345889999999999999999999999   999999999999953   3569999999999876


Q ss_pred             cCCCc-----cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +..+.     .......||.+|.+-..+.+...+.+.|+-|+|.+|..+--|..||+.-
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence            54432     1223357999999999988888999999999999999999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=5.5e-23  Score=205.06  Aligned_cols=134  Identities=25%  Similarity=0.347  Sum_probs=109.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcc-----c---CCeeeEeeEEEcC
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----H---KNLVKLLGFCVDG  417 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~nIv~l~~~~~~~  417 (571)
                      ...+|...++||-|-|++||++.. .+.+-||+|+.+. .+...+..++||++|++++     |   .+||+|++.|...
T Consensus        76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            447888999999999999999985 4677899998875 2344556889999999982     2   4699999999754


Q ss_pred             ----ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec
Q 008288          418 ----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD  485 (571)
Q Consensus       418 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~  485 (571)
                          .+.+||+|++ |-+|-.++... ....++...+.+|++||+.||.|||...  +|||.||||+|||+.
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence                4688999999 55666666432 3344889999999999999999999986  699999999999994

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.87  E-value=2.3e-22  Score=169.41  Aligned_cols=93  Identities=38%  Similarity=0.716  Sum_probs=76.4

Q ss_pred             CChHHHHHHHHHHHHHHHHHhccCCCCcccccccccCCCCCceEEEEeeccCCCccchHHHHHHHHHHhhhhcCCCCCcE
Q 008288          148 SEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADILSCCYFSRGAR  227 (571)
Q Consensus       148 ~~~~~f~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~vygl~QC~~Dl~~~~C~~Cl~~a~~~~~~~c~~~~g~~  227 (571)
                      ++++.|..+++.+|..|...++..+ ..+|+++..+ .++++||||+||++||+++||..||+.|+.+++.+|++++||+
T Consensus        14 ~~~~~f~~~l~~ll~~l~~~a~~~~-~~~f~~~~~~-~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~   91 (106)
T PF01657_consen   14 TDNSTFEQNLNSLLSSLVSNAASSS-SKGFATGSAG-SGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGR   91 (106)
T ss_dssp             -TT-THHHHHHHHHHHHHHHGGGTT--TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEE
T ss_pred             CCCchHHHHHHHHHHHHHHHHhhcc-ccCcEEeecC-CCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEE
Confidence            5666799999999999999988754 3689999874 5788999999999999999999999999999999999999999


Q ss_pred             EEeeeeeeEEEeeee
Q 008288          228 LLSRNCYLRYELYAF  242 (571)
Q Consensus       228 v~~~~C~lRy~~~~f  242 (571)
                      |++++|+||||+|+|
T Consensus        92 v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   92 VWYDSCFLRYENYPF  106 (106)
T ss_dssp             EEESSEEEEEESS--
T ss_pred             EECCCEEEEEECCCC
Confidence            999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=2.8e-20  Score=188.48  Aligned_cols=202  Identities=35%  Similarity=0.538  Sum_probs=169.7

Q ss_pred             CCCCceecccCceeEEEEEEcCCcEEEEEEccccCcc---chHHHHHHHHHHHhcccC-CeeeEeeEEEcCceeEEEEEc
Q 008288          351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ---GTAEFTNEVLLILKLQHK-NLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      |...+.||.|+|+.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +|+++...+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            556778999999999999976  88899988753332   366799999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~~~~~~  505 (571)
                      +.++++.+++........+.......+..|++.++.|+|+.+   ++||||||+||+++..+ .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977632211136889999999999999999999999   99999999999999988 79999999998654443


Q ss_pred             Ccc----ceeeecccccccchhhhcc---CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEA----NTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...    ......|+..|++||.+.+   .......|+|++|++++++++|..||....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            221    2345689999999999987   578899999999999999999999976554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=4e-21  Score=179.94  Aligned_cols=139  Identities=20%  Similarity=0.199  Sum_probs=108.4

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCcc--c-------h-----------------HHHHHHHHHHHhcccCCe
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--G-------T-----------------AEFTNEVLLILKLQHKNL  407 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~nI  407 (571)
                      ...||+|+||.||++...+|++||||+++.....  .       .                 .....|+..+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999878999999998753211  1       0                 112359999999988776


Q ss_pred             eeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeeCCCCCCCeEecC
Q 008288          408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL-HEDSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~L-H~~~~~~iiH~DLkp~NILl~~  486 (571)
                      .....+..  ...++||||++++++.....   ..+.+++.+...++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333222  23489999999887765431   235688999999999999999999 6888   99999999999998 


Q ss_pred             CCcEEEeeccccccc
Q 008288          487 DMNSKISDFGMARIF  501 (571)
Q Consensus       487 ~~~~kL~DfGla~~~  501 (571)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.85  E-value=6.5e-22  Score=225.41  Aligned_cols=148  Identities=21%  Similarity=0.198  Sum_probs=112.2

Q ss_pred             ccc-CCeeeEeeEE-------EcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 008288          402 LQH-KNLVKLLGFC-------VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV  473 (571)
Q Consensus       402 l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ii  473 (571)
                      ++| +||.++++.+       .+....++++|++ +++|.+++..  ....+++.+++.++.||++||.|||+++   |+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            345 5777777776       2334567788987 6699999953  2356999999999999999999999998   99


Q ss_pred             eCCCCCCCeEecCCC-------------------cEEEeecccccccccCCC--------------ccceeeeccccccc
Q 008288          474 HRDLKASNVLLDSDM-------------------NSKISDFGMARIFAESEG--------------EANTVRIVGTYGYM  520 (571)
Q Consensus       474 H~DLkp~NILl~~~~-------------------~~kL~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~  520 (571)
                      ||||||+||||+..+                   .+||+|||+++.......              .......+||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   455666666543211000              00011135788899


Q ss_pred             chhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          521 APEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       521 aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      |||++.+..++.++|||||||+||||++|..|+..
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            99999999999999999999999999999998764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=3.1e-21  Score=182.86  Aligned_cols=172  Identities=15%  Similarity=0.191  Sum_probs=134.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchH---H------HHHHHHHHHhcccCCeeeEeeEEEc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA---E------FTNEVLLILKLQHKNLVKLLGFCVD  416 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~e~~~l~~l~h~nIv~l~~~~~~  416 (571)
                      +-..+|...+.+|.|+||.||.... ++..+++|.+++.......   .      +.+|+..+.+++|++|..+..++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4468899999999999999999655 6778999999753322222   2      5789999999999999999888654


Q ss_pred             C--------ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          417 G--------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       417 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      .        +..+++|||++|.+|.++..       ++.    ....+++.+|..+|+.+   ++||||||+||++++++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence            3        35789999999999987641       222    24569999999999999   99999999999999988


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHH
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII  547 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ell  547 (571)
                       ++|+|||...........              ..++....+..++|+|+||+.+..+.
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999988654221111              11344555678999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=4.9e-20  Score=173.07  Aligned_cols=141  Identities=22%  Similarity=0.211  Sum_probs=110.9

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccc--------------------------hHHHHHHHHHHHhcccCCe
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG--------------------------TAEFTNEVLLILKLQHKNL  407 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~nI  407 (571)
                      ...||+|++|.||++...+|+.||||+++......                          ...+..|.+.+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            46799999999999998789999999987532110                          1123578899999999987


Q ss_pred             eeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecC
Q 008288          408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~  486 (571)
                      .....+...  ..++||||++++++.....   ....++..+...++.|++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544333332  3489999999886543321   23457888999999999999999999 88   99999999999998 


Q ss_pred             CCcEEEeeccccccccc
Q 008288          487 DMNSKISDFGMARIFAE  503 (571)
Q Consensus       487 ~~~~kL~DfGla~~~~~  503 (571)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.2e-19  Score=165.54  Aligned_cols=184  Identities=17%  Similarity=0.117  Sum_probs=138.0

Q ss_pred             CCCceecccCceeEEEEEEcCCcEEEEEEccccCc----cchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEEc
Q 008288          352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE----QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .....|++|+||+|+.+.- ++.+++.+.+.....    -....+.+|++++++++ |++|++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997665 678888777764222    11124789999999995 5889999886    456899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCC-CCCCeEecCCCcEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL-KASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DL-kp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      +++.+|...+.    .      ....+..|+.++|.++|+++   |+|||| ||+|||+++++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99999865431    1      11357789999999999999   999999 7999999999999999999998544322


Q ss_pred             Cc----c-c------eeeecccccccchhhhccC-CCC-cchhhHhHHHHHHHHHhCCCCC
Q 008288          506 GE----A-N------TVRIVGTYGYMAPEYAMEG-LYS-KKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       506 ~~----~-~------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slGvil~elltG~~p~  553 (571)
                      ..    . .      ......++.|++|+...-- ..+ ...++++-|.-+|.++||+.++
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            10    0 0      1112467888888754321 223 6789999999999999999875

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-20  Score=175.31  Aligned_cols=203  Identities=22%  Similarity=0.372  Sum_probs=159.5

Q ss_pred             CCCceecccCceeEEEEEEcCCcEEEEEEcc--ccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      ....+|.+...|..|+|+++ |..+++|++.  ..+....++|.+|.-.++-+.||||+.++|.|.....+.+|..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            33456888999999999995 5566667765  34555667899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |+|..++++ ...-..+..++.+++.+|++|++|||+..++ |.---|.++.++||++.+.+|+ .+-.+...+.     
T Consensus       272 gslynvlhe-~t~vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltaris-mad~kfsfqe-----  343 (448)
T KOG0195|consen  272 GSLYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE-----  343 (448)
T ss_pred             hHHHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhhee-cccceeeeec-----
Confidence            999999976 4445678889999999999999999999732 3344699999999999998875 2222221111     


Q ss_pred             eeeecccccccchhhhccCCC---CcchhhHhHHHHHHHHHhCCCCCCCCchhhhhhh
Q 008288          510 TVRIVGTYGYMAPEYAMEGLY---SKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMY  564 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slGvil~elltG~~p~~~~~~~~~~~~  564 (571)
                       ....-.+.||+||.+..++-   -++.|+|||.+++|||.|...||..-..-+...+
T Consensus       344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk  400 (448)
T KOG0195|consen  344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK  400 (448)
T ss_pred             -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh
Confidence             12245788999999976553   4689999999999999999999975544444433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.80  E-value=1.1e-19  Score=168.61  Aligned_cols=107  Identities=23%  Similarity=0.211  Sum_probs=93.2

Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |+|.+++..  ....+++.+++.++.||++||+|||+++         ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            688888843  2446999999999999999999999876         999999999999999  99987654321    


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                         ..||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence               25789999999999999999999999999999999999999643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=1.8e-18  Score=163.62  Aligned_cols=137  Identities=18%  Similarity=0.220  Sum_probs=106.3

Q ss_pred             CCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc-----ccCCeeeEeeEEEcCc---e-eE
Q 008288          351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-----QHKNLVKLLGFCVDGD---E-KL  421 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~nIv~l~~~~~~~~---~-~~  421 (571)
                      +...+.||+|+||.||.  ++.....+||++........+.+.+|+.+++.+     .||||++++|+++++.   . ..
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999996  443333368988764444567799999999999     5799999999998874   3 33


Q ss_pred             EEEEc--cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCeeeCCCCCCCeEecC----CCcEEEee
Q 008288          422 LVYEF--MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM-LYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISD  494 (571)
Q Consensus       422 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~~LH~~~~~~iiH~DLkp~NILl~~----~~~~kL~D  494 (571)
                      +|+||  .++++|.+++..    +.+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    +.+++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  558999999943    235544  35677888777 9999999   999999999999974    34799999


Q ss_pred             cccc
Q 008288          495 FGMA  498 (571)
Q Consensus       495 fGla  498 (571)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            4444

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.78  E-value=4.5e-19  Score=195.96  Aligned_cols=200  Identities=20%  Similarity=0.239  Sum_probs=161.9

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcc---cCCeeeEeeEEEcCce
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDE  419 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~  419 (571)
                      ..++..+.|.+.+.||+|+||+||+|...+|+.||+|+-++.+.-   +|.-=.+++.+|+   -+.|..+.....-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            445667788999999999999999999888999999987764432   2222223334443   3445556666667788


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-------CCcEEE
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------DMNSKI  492 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-------~~~~kL  492 (571)
                      -+||+||.+.|+|.+++.   ..+.++|.....++.||++-++.||..+   |||+||||+|+||..       ..-++|
T Consensus       769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence            899999999999999993   6677999999999999999999999999   999999999999942       234899


Q ss_pred             eecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCC
Q 008288          493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR  551 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~  551 (571)
                      +|||-+-.+.--.........++|-.+--+|...|..++.+.|.|.|+-+++-|+.|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999875544343444455688999999999999999999999999999999999974

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=7.8e-20  Score=198.25  Aligned_cols=198  Identities=29%  Similarity=0.404  Sum_probs=158.9

Q ss_pred             CCCceecccCceeEEEEEEc-CCcEEEEEEcc----c-cCccc-hHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS----S-CSEQG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~----~-~~~~~-~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .....+|.|.+|.|+..... ..+....|...    . .++.. ...+..|..+-..+.|+|++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999977776632 33434444332    1 11111 122566777778889999998888877777776669


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++ +|..++.   ..+.++..++..++.|+..|+.|||+.|   |.|||||++|+++..++.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9999883   3356889999999999999999999999   999999999999999999999999999877665


Q ss_pred             CCc--cceeeecccccccchhhhccCCCCc-chhhHhHHHHHHHHHhCCCCCCCC
Q 008288          505 EGE--ANTVRIVGTYGYMAPEYAMEGLYSK-KSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       505 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...  .....++|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||...
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a  528 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVA  528 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccc
Confidence            544  4455679999999999999988875 689999999999999999999754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.2e-19  Score=187.85  Aligned_cols=185  Identities=29%  Similarity=0.353  Sum_probs=156.3

Q ss_pred             ecccCceeEEEEE----EcCCcEEEEEEccccCccc--hHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          357 LGQGGFGPVYKGV----LSDGKEVAVKRLSSCSEQG--TAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       357 lG~G~fg~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +|+|.||.|+.+.    .+.++.+++|.+++.....  ......|..++...+ ||.++++...++.+.+.++++++..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7899999999765    3357788999886533211  114567888888886 99999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      |.|...+   .+...+++.....+...++-+++++|+.+   ++|||+|++||+++.+|++++.|||+++..-.....  
T Consensus        82 g~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--  153 (612)
T KOG0603|consen   82 GDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--  153 (612)
T ss_pred             chhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence            9987776   34455777888888889999999999999   999999999999999999999999999876543322  


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                          +||..|||||++.  .....+|+||||++++||++|..||..
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence                8899999999987  457789999999999999999999987

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=1.6e-17  Score=160.86  Aligned_cols=144  Identities=22%  Similarity=0.203  Sum_probs=112.0

Q ss_pred             CCCCCCceecccCceeEEEEE--EcCCcEEEEEEccccCcc------------------------chHHHHHHHHHHHhc
Q 008288          349 SNFSDSNILGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQ------------------------GTAEFTNEVLLILKL  402 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  402 (571)
                      .-|.+.+.||+|+||.||++.  ..+|+.||+|+++.....                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357788999999999999998  468999999998743210                        012356899999999


Q ss_pred             ccCC--eeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCC
Q 008288          403 QHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS  480 (571)
Q Consensus       403 ~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~  480 (571)
                      .+..  ++++++.    ...++||||+++.+|.....   ....+.......++.||+.+|++||+.+  +++|+||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence            7633  4455543    23589999999988866542   2334566677899999999999999986  4999999999


Q ss_pred             CeEecCCCcEEEeecccccccc
Q 008288          481 NVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       481 NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||+++ +++++|+|||++....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=3.4e-17  Score=156.60  Aligned_cols=134  Identities=19%  Similarity=0.301  Sum_probs=112.8

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCcc--------chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +.||+|++|.||+|.. +|..+++|+.......        ....+.+|+.++..+.|++|.....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999998 6788999976532211        123577899999999999988777777777888999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +++++|.+++...      .+ ....++.+++.+|.+||+.+   ++|+|++|+|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988321      12 77889999999999999998   99999999999999 78899999999875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=5.4e-17  Score=153.61  Aligned_cols=144  Identities=20%  Similarity=0.206  Sum_probs=111.5

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCcc----------------------chHHHHHHHHHHHh
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ----------------------GTAEFTNEVLLILK  401 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~  401 (571)
                      +......|...+.||+|+||.||++..++|+.|+||+++.....                      .......|+.++.+
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33344447778899999999999999888999999986532210                      11235678889999


Q ss_pred             cccCC--eeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCC
Q 008288          402 LQHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKA  479 (571)
Q Consensus       402 l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp  479 (571)
                      +.|++  +++.++    ....+++|||+++++|..+..         ......++.++++++.++|+.+   |+||||||
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            98874  444443    245689999999999876541         0335678899999999999988   99999999


Q ss_pred             CCeEecCCCcEEEeeccccccccc
Q 008288          480 SNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       480 ~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      +||++++++.++|+|||++.....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999965443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=5.4e-17  Score=153.73  Aligned_cols=131  Identities=23%  Similarity=0.347  Sum_probs=106.4

Q ss_pred             eecccCceeEEEEEEcCCcEEEEEEccccCc--------cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      .||+|+||.||++.+ ++.++++|.......        ....++.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 678899998543211        11245778999999999887665555556677789999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      ++++|.+++...   ..       .++.+++++|.+||+.+   ++|+|++|+||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999887321   10       78999999999999998   99999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.70  E-value=3.8e-17  Score=159.69  Aligned_cols=196  Identities=23%  Similarity=0.321  Sum_probs=128.0

Q ss_pred             CCCceecccCceeEEEEEEc-CCcEEEEEEccc---cCccchHHHHHHHHHHHhcc----------cCCeeeEeeEEE--
Q 008288          352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQ----------HKNLVKLLGFCV--  415 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~----------h~nIv~l~~~~~--  415 (571)
                      ...+.||.|+++.||.+++. ++++++||+..-   ......+++++|......+.          |-.++.-++...  
T Consensus        15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~   94 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP   94 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred             EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence            34578999999999999986 589999998752   23334556777765555532          222222222221  


Q ss_pred             -------cC---ce-----eEEEEEccCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCC
Q 008288          416 -------DG---DE-----KLLVYEFMPNGSLDAILFD----PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD  476 (571)
Q Consensus       416 -------~~---~~-----~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~D  476 (571)
                             ..   +.     .+++|+-+ .++|..++..    ......+....++.+..|+++.+++||..|   ++|+|
T Consensus        95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd  170 (288)
T PF14531_consen   95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD  170 (288)
T ss_dssp             TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred             CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence                   11   12     25677766 6688777531    111223445556778899999999999999   99999


Q ss_pred             CCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccC--------CCCcchhhHhHHHHHHHHHh
Q 008288          477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG--------LYSKKSDVFSFGVLLIEIIT  548 (571)
Q Consensus       477 Lkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~slGvil~ellt  548 (571)
                      |+|+|++++++|.++|+||+...........     ...+..|.+||.....        .++.+.|.|+||+++|.|++
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999887654332111     1335678999976432        47889999999999999999


Q ss_pred             CCCCCCCC
Q 008288          549 GRRNAGSN  556 (571)
Q Consensus       549 G~~p~~~~  556 (571)
                      |+.||+..
T Consensus       246 ~~lPf~~~  253 (288)
T PF14531_consen  246 GRLPFGLS  253 (288)
T ss_dssp             SS-STCCC
T ss_pred             ccCCCCCC
Confidence            99999865

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.70  E-value=5.4e-18  Score=183.95  Aligned_cols=205  Identities=24%  Similarity=0.266  Sum_probs=156.7

Q ss_pred             CCCCCceecccCceeEEEEEEcCCcEEEEEEccccC-ccchHHHHHHHHHHH--hcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLIL--KLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~--~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++...+.||.+.|=+|.++++++|. |+||++-+.. ......+.++++-++  -++|||.+++.-+-......|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            4666788999999999999998777 8899886533 444555555554444  44899999998887777777888888


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +. .+|.+.+   ..+..+...+..-|+.|++.||..+|..+   |+|||||.+||||++..=+.|+||-.-+...-.++
T Consensus       103 vk-hnLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VK-HNLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hh-hhhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            84 4777777   45667888888999999999999999999   99999999999999998899999976543222211


Q ss_pred             c-cceeeeccc----ccccchhhhccC-----------CCCcchhhHhHHHHHHHHHh-CCCCCCCCchhhhh
Q 008288          507 E-ANTVRIVGT----YGYMAPEYAMEG-----------LYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYG  562 (571)
Q Consensus       507 ~-~~~~~~~gt----~~y~aPE~~~~~-----------~~~~~~Dv~slGvil~ellt-G~~p~~~~~~~~~~  562 (571)
                      . .....+..|    .-|+|||....+           ..+++.||||+||++.||++ |++||.-++|..|.
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr  248 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYR  248 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHh
Confidence            1 111111222    249999976431           15789999999999999998 89999877777663

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=1e-16  Score=174.40  Aligned_cols=137  Identities=22%  Similarity=0.334  Sum_probs=111.5

Q ss_pred             CCCCCCceecccCceeEEEEEEcCCcEEEEEE-cccc-C------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR-LSSC-S------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..|...+.||+|+||.||++.+.+. .+++|+ +.+. .      ......+.+|++++.+++|++|+....+.......
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            3445678999999999999987544 344443 2211 1      11234588999999999999999888888777788


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++++|.+++.           ....++.|++++|.+||+.+   ++||||||+|||+ +++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999998873           45678999999999999998   9999999999999 678999999999986


Q ss_pred             c
Q 008288          501 F  501 (571)
Q Consensus       501 ~  501 (571)
                      .
T Consensus       477 ~  477 (535)
T PRK09605        477 S  477 (535)
T ss_pred             C
Confidence            4

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=2.6e-15  Score=134.73  Aligned_cols=135  Identities=23%  Similarity=0.259  Sum_probs=114.5

Q ss_pred             CCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhccc--CCeeeEeeEEEcCceeEEEEEccCCC
Q 008288          353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       353 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+.+|+.++..++|  .++++++.+....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            35679999999999999844 7899998865433  4578899999999976  58999999888888899999999887


Q ss_pred             ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       431 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      .+..+          +......++.+++++|.+||.....+++|+||+|+||++++++.++++|||++..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76543          5566778899999999999997545599999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.7e-15  Score=141.91  Aligned_cols=137  Identities=24%  Similarity=0.277  Sum_probs=98.6

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCcc--chHH----------------------HHHHHHHHHhcccCC--e
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ--GTAE----------------------FTNEVLLILKLQHKN--L  407 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--I  407 (571)
                      .+.||+|+||.||++...++++||||++++....  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999878999999988653211  1111                      135666666664443  4


Q ss_pred             eeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecC
Q 008288          408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~  486 (571)
                      .+.++.    ...+++|||++++.+......  . ... ......++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~--~-~~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLK--D-VRL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhh--h-hhh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    246899999999554221100  0 001 15678899999999999999 77   99999999999999 


Q ss_pred             CCcEEEeecccccccc
Q 008288          487 DMNSKISDFGMARIFA  502 (571)
Q Consensus       487 ~~~~kL~DfGla~~~~  502 (571)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.62  E-value=8.1e-16  Score=159.72  Aligned_cols=154  Identities=31%  Similarity=0.488  Sum_probs=127.3

Q ss_pred             HHhcccCCeeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCC
Q 008288          399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK  478 (571)
Q Consensus       399 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLk  478 (571)
                      |+.+.|.|+.+++|.+.++...++|.+|+..|+|.+++..  ..-.+++.....++++|++||+|||.-.  -..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            3567899999999999999999999999999999999954  3445899999999999999999999865  23999999


Q ss_pred             CCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCC-------CCcchhhHhHHHHHHHHHhCCC
Q 008288          479 ASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-------YSKKSDVFSFGVLLIEIITGRR  551 (571)
Q Consensus       479 p~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~slGvil~elltG~~  551 (571)
                      ++|+++|....+||.|||+.................-...|.|||.+.+..       .+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999988764311111111122345799999987631       4678999999999999999999


Q ss_pred             CCCCC
Q 008288          552 NAGSN  556 (571)
Q Consensus       552 p~~~~  556 (571)
                      ||+..
T Consensus       157 ~~~~~  161 (484)
T KOG1023|consen  157 PFDLR  161 (484)
T ss_pred             ccccc
Confidence            99764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=4.4e-16  Score=169.27  Aligned_cols=167  Identities=28%  Similarity=0.409  Sum_probs=122.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ..++|+.+++|..|++|.||.++++ ..+.+|+|+ .+.+.    -+.+   ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee-----------------
Confidence            3467888999999999999999976 467888853 32110    0001   22222334333                 


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                          |+-...+   +.-++++..        ++.+++|||+.+   |+|||+||+|.+|+.-|++|+.|||+.+......
T Consensus       136 ----gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                4444444   222333332        378899999998   9999999999999999999999999987532211


Q ss_pred             -------------CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 -------------GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                                   ......+.+||+.|.|||++..+.|...+|+|++|+|+||.+.|..||...
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence                         111223468999999999999999999999999999999999999999766

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.60  E-value=2e-16  Score=161.08  Aligned_cols=124  Identities=29%  Similarity=0.454  Sum_probs=109.0

Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      .+++.|+++...+|.+++.........++...+.++.|++.++.|   ++   .+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            467999999999999999766666778899999999999999999   56   999999999999999999999999998


Q ss_pred             cccccCC----CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh
Q 008288          499 RIFAESE----GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT  548 (571)
Q Consensus       499 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt  548 (571)
                      .......    ........+||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            7654443    2233445689999999999999999999999999999999998

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=1.1e-14  Score=141.37  Aligned_cols=136  Identities=20%  Similarity=0.230  Sum_probs=105.2

Q ss_pred             Cceec-ccCceeEEEEEEcCCcEEEEEEccccC-------------ccchHHHHHHHHHHHhcccCCe--eeEeeEEEcC
Q 008288          354 SNILG-QGGFGPVYKGVLSDGKEVAVKRLSSCS-------------EQGTAEFTNEVLLILKLQHKNL--VKLLGFCVDG  417 (571)
Q Consensus       354 ~~~lG-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~nI--v~l~~~~~~~  417 (571)
                      ...|| .|+.|+||++.. ++..++||++....             ......+.+|++++.+++|++|  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35687 899999999988 47889998774311             1223457889999999998885  6677664433


Q ss_pred             c----eeEEEEEccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          418 D----EKLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       418 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                      .    ..++|||++++ .+|.+++..    ..++..    ...+|+.+|.+||+.|   |+|+||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 689888732    234443    3578999999999999   999999999999999899999


Q ss_pred             eeccccccc
Q 008288          493 SDFGMARIF  501 (571)
Q Consensus       493 ~DfGla~~~  501 (571)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999998753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=2.3e-15  Score=163.63  Aligned_cols=206  Identities=27%  Similarity=0.356  Sum_probs=164.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEcC--CcEEEEEEccccC--ccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSD--GKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~l  422 (571)
                      ...|...+.||+|.|+.|-......  ...+++|.+....  .........|..+-..+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3456667779999999998887533  4456667665432  333344555777777776 9999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeeCCCCCCCeEecCCC-cEEEeecccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH-EDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARI  500 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH-~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~  500 (571)
                      +.||..++++...+.... ....+......+..|+..++.|+| ..+   +.|+||||+|.+++..+ .+++.|||++..
T Consensus        99 ~~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999999987773211 113556667788999999999999 777   99999999999999999 999999999998


Q ss_pred             ccc-CCCccceeeecc-cccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAE-SEGEANTVRIVG-TYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.. ..........+| ++.|++||...+. ...+..|+||.|+++.-+++|..||+...
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence            877 444445555688 9999999998884 45788999999999999999999998653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=9.9e-14  Score=146.30  Aligned_cols=142  Identities=25%  Similarity=0.284  Sum_probs=100.8

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchH----------------------------------------HHH
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA----------------------------------------EFT  393 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~  393 (571)
                      .+.||.|++|+||+|++++|+.||||+.++.......                                        ++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998653211110                                        244


Q ss_pred             HHHHHHHhc----ccCCeeeEeeEE-EcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHhhC
Q 008288          394 NEVLLILKL----QHKNLVKLLGFC-VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK-GMLYLHED  467 (571)
Q Consensus       394 ~e~~~l~~l----~h~nIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~L~~LH~~  467 (571)
                      +|...+.++    +|.+-+.+-.++ ......+|||||++|++|.++......  ..   ....++.++++ .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            455555554    232223333333 234567999999999999887632111  11   23456666666 47889998


Q ss_pred             CCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       468 ~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      +   ++|+|++|.||+++++++++|+|||++..+..
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   99999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=1.2e-13  Score=135.51  Aligned_cols=145  Identities=27%  Similarity=0.367  Sum_probs=107.3

Q ss_pred             ccCCeeeEeeEEEcC---------------------------ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 008288          403 QHKNLVKLLGFCVDG---------------------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN  455 (571)
Q Consensus       403 ~h~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  455 (571)
                      +|||||++.+.|.++                           ...|+||.-. .-+|..++.    ....+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~----~~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLW----TRHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHh----cCCCchHHHHHHHH
Confidence            699999999887542                           2457888766 457888873    23466777888999


Q ss_pred             HHHHHHHHHhhCCCCCeeeCCCCCCCeEe--cCCC--cEEEeecccccccccC----CCccceeeecccccccchhhhcc
Q 008288          456 GIAKGMLYLHEDSRLRIVHRDLKASNVLL--DSDM--NSKISDFGMARIFAES----EGEANTVRIVGTYGYMAPEYAME  527 (571)
Q Consensus       456 qia~~L~~LH~~~~~~iiH~DLkp~NILl--~~~~--~~kL~DfGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~  527 (571)
                      |+++|+.|||+++   |.|||||++||||  |+|+  .+.|+|||.+-.-...    .........-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   9999999999999  4444  4688999987421110    11111222356777899998754


Q ss_pred             CC------CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          528 GL------YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       528 ~~------~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ..      .-.|+|.|+.|-+.||++....||=.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            22      23589999999999999999999843

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.35  E-value=4.7e-12  Score=116.45  Aligned_cols=131  Identities=24%  Similarity=0.181  Sum_probs=97.7

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEccCCCCh
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      .+.|+.|.++.||++.. .++.+++|....... ....+..|+.++..+.+.++ ++++...  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            35688999999999987 478899998765322 23356789999999866554 4455443  3345899999999887


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ....           .....+..+++++|+.||+.+  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5420           111245678999999999987  22369999999999999 66899999999863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.33  E-value=1.2e-12  Score=139.63  Aligned_cols=142  Identities=21%  Similarity=0.261  Sum_probs=93.8

Q ss_pred             CCCCCceecccCceeEEEEEEcC-CcEEEEEEccccCccc----------------------------------hH----
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQG----------------------------------TA----  390 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~----  390 (571)
                      .|+. +.||.|++|+||++++++ |+.||||++++.....                                  .+    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4555 789999999999999877 9999999987542110                                  11    


Q ss_pred             --HHHHHHHHHHhc----ccCCeeeEeeEEEc-CceeEEEEEccCCCChhhhhcCCCCCC----CCCHHHHHHHHHHHHH
Q 008288          391 --EFTNEVLLILKL----QHKNLVKLLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKRG----ILCWRKRTNIVNGIAK  459 (571)
Q Consensus       391 --~~~~e~~~l~~l----~h~nIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~  459 (571)
                        ++.+|...+.++    .+.+.+.+-.++.+ ....+|||||++|+++.++-.. ...+    .+.......++.|   
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHH---
Confidence              133444444444    23333443334333 4567899999999999775311 1111    1222333333333   


Q ss_pred             HHHHHhhCCCCCeeeCCCCCCCeEecCCC----cEEEeeccccccccc
Q 008288          460 GMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGMARIFAE  503 (571)
Q Consensus       460 ~L~~LH~~~~~~iiH~DLkp~NILl~~~~----~~kL~DfGla~~~~~  503 (571)
                          ++..|   ++|+|+||.||+++.++    ++++.|||++..+..
T Consensus       276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                34566   99999999999999888    999999999886644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.26  E-value=1e-10  Score=108.79  Aligned_cols=136  Identities=19%  Similarity=0.159  Sum_probs=99.1

Q ss_pred             ceecccCceeEEEEEEcC-------CcEEEEEEcccc-------------C---------ccchHH----HHHHHHHHHh
Q 008288          355 NILGQGGFGPVYKGVLSD-------GKEVAVKRLSSC-------------S---------EQGTAE----FTNEVLLILK  401 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~----~~~e~~~l~~  401 (571)
                      ..||.|--+.||.|...+       +..+|||+.+..             .         ....+.    ..+|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       479999975421             0         011122    2389999999


Q ss_pred             ccc--CCeeeEeeEEEcCceeEEEEEccCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCeeeCCC
Q 008288          402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDA-ILFDPRKRGILCWRKRTNIVNGIAKGMLYL-HEDSRLRIVHRDL  477 (571)
Q Consensus       402 l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~~L~~L-H~~~~~~iiH~DL  477 (571)
                      +..  -++++++.+    ...++||||+.+..+.. .+    +...++..+...+..+++.+|..| |+.+   ++|+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            854  456677765    56789999997654422 22    122355566777889999999998 8888   999999


Q ss_pred             CCCCeEecCCCcEEEeecccccccc
Q 008288          478 KASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       478 kp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ++.|||++ ++.+.|+|||.+....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 4679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.24  E-value=5.1e-11  Score=125.34  Aligned_cols=166  Identities=19%  Similarity=0.224  Sum_probs=126.7

Q ss_pred             EcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHH
Q 008288          370 LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK  449 (571)
Q Consensus       370 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~  449 (571)
                      ..++.+|.|...+..+........+-++.++.++||||++++..++.++..|||.|-+  ..|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence            3478899998887655545556778899999999999999999999999999999976  345555522      33555


Q ss_pred             HHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCC
Q 008288          450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL  529 (571)
Q Consensus       450 ~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  529 (571)
                      ..-.+.||+.||.|||+.+  .++|++|....|+|++.|..||++|.++............  ...-..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~--~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS--LYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc--chhhhcccChhhcCccc
Confidence            6667899999999999766  4999999999999999999999999988654433221111  11122466777543322


Q ss_pred             CCcchhhHhHHHHHHHHHhC
Q 008288          530 YSKKSDVFSFGVLLIEIITG  549 (571)
Q Consensus       530 ~~~~~Dv~slGvil~elltG  549 (571)
                        -..|.|.||++++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=1.9e-10  Score=110.46  Aligned_cols=141  Identities=21%  Similarity=0.278  Sum_probs=110.4

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCc-cchHHHHHHHHHHHhccc--CCeeeEeeEEEcCc---eeEEEEEccC
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGD---EKLLVYEFMP  428 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~---~~~lv~e~~~  428 (571)
                      +.|+.|..+.||++...+|+.+++|....... .....+..|.+++..+.+  .++++++.+.....   ..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999986678999998764322 235578899999999965  44577777766542   5689999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS----------------------------------------  468 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~----------------------------------------  468 (571)
                      +.++...+..    ..++..+...++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988765521    35777888888999999999998531                                        


Q ss_pred             -------------CCCeeeCCCCCCCeEecC--CCcEEEeeccccc
Q 008288          469 -------------RLRIVHRDLKASNVLLDS--DMNSKISDFGMAR  499 (571)
Q Consensus       469 -------------~~~iiH~DLkp~NILl~~--~~~~kL~DfGla~  499 (571)
                                   ...++|+|++|+||+++.  ++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         234799999999999998  5678999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.19  E-value=2.1e-10  Score=102.47  Aligned_cols=145  Identities=20%  Similarity=0.282  Sum_probs=108.2

Q ss_pred             CCceecccCceeEEEEEEcCCcEEEEEE-ccc-------cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          353 DSNILGQGGFGPVYKGVLSDGKEVAVKR-LSS-------CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       353 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~-------~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ....|-||+-+.|+++.+ .|+...||. +.+       ...-..+...+|++.+.++.--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467899999999999998 577777763 222       11222445789999999997767766666677777888999


Q ss_pred             EccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---cEEEeecccccc
Q 008288          425 EFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARI  500 (571)
Q Consensus       425 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~---~~kL~DfGla~~  500 (571)
                      ||+++ .++.+++....... ...+....++.+|-+.+.-||..+   |||+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 46777774322222 223333688999999999999999   99999999999997654   458999999875


Q ss_pred             cc
Q 008288          501 FA  502 (571)
Q Consensus       501 ~~  502 (571)
                      ..
T Consensus       166 s~  167 (229)
T KOG3087|consen  166 SR  167 (229)
T ss_pred             cc
Confidence            43

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=2.1e-10  Score=103.00  Aligned_cols=131  Identities=23%  Similarity=0.362  Sum_probs=101.4

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEE-cccc-C------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKR-LSSC-S------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~-~~~~-~------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..+++|+-+.++.+.+. |.++++|. +++. .      .-....-.+|+.++.++.--.|.-.+-+..+.+...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774 44466663 2221 1      11123467899999999877776666677788888999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +++..|.+.+...          ...++..+-+-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888332          2567888888899999999   99999999999997665 99999999874

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=8.4e-11  Score=122.67  Aligned_cols=199  Identities=26%  Similarity=0.305  Sum_probs=157.2

Q ss_pred             CCCCCCceecc--cCceeEEEEEE---cCCcEEEEEEccc--cCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          349 SNFSDSNILGQ--GGFGPVYKGVL---SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      ..|...+.+|.  |.+|.||.+..   .++..+++|+-+.  ..+.....-.+|+...+++ .|+|.++....+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            44566788999  99999999986   3678899997442  2234444556777777777 599999988888899999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeec
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK----GMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDF  495 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~Df  495 (571)
                      ++-.|.+ +.+|..+.+.  ....++....+....+..+    ||.++|+..   ++|-|+||.||++..+ ...+++||
T Consensus       194 fiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            9999987 5788777743  2334677778888888888    999999998   9999999999999999 88999999


Q ss_pred             ccccccccCCCc---cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          496 GMARIFAESEGE---ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       496 Gla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      |+...+......   ....+..|...|++||.+ .+.++..+|+|++|.+.+|-.+|-.+..
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhccccc
Confidence            999887655422   112233677889999975 5567899999999999999999877654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.5e-10  Score=111.58  Aligned_cols=155  Identities=23%  Similarity=0.329  Sum_probs=117.4

Q ss_pred             HHHHHhcccCCeeeEeeEEEcCc-----eeEEEEEccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 008288          396 VLLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSR  469 (571)
Q Consensus       396 ~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~  469 (571)
                      ..-+-++.|.||+++..++.+..     ...++.|||+.|++..+|+..+ ....+......+++-||..||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            34555668999999998886543     4678999999999999997533 3445778888899999999999999976 


Q ss_pred             CCeeeCCCCCCCeEecCCCcEEEeecccccccccC---CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHH
Q 008288          470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES---EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI  546 (571)
Q Consensus       470 ~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~el  546 (571)
                      ++|+|+++.-+-|++..++-+||+-- -.......   ..........+-++|.+||.=.....+-.+|||+||+..+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            78999999999999999998888521 11111110   011111223567889999986666677899999999999999


Q ss_pred             HhCCCC
Q 008288          547 ITGRRN  552 (571)
Q Consensus       547 ltG~~p  552 (571)
                      .-|..-
T Consensus       276 ailEiq  281 (458)
T KOG1266|consen  276 AILEIQ  281 (458)
T ss_pred             HHheec
Confidence            887765

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.01  E-value=4.2e-09  Score=107.75  Aligned_cols=169  Identities=22%  Similarity=0.324  Sum_probs=132.5

Q ss_pred             ceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEE----cCceeEEEEEccCC-CChhhh
Q 008288          362 FGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV----DGDEKLLVYEFMPN-GSLDAI  435 (571)
Q Consensus       362 fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~  435 (571)
                      -.+.||+... ||..|++|+++............-++.++++.|+|||++.+++.    .+..+++||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3678999854 89999999996555555545567789999999999999988876    34567899999986 577766


Q ss_pred             hcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          436 LFDPR------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       436 l~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      .+...            .+...++...+.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|+..|....+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            54322            2234678999999999999999999999   99999999999999999999998887766544


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN  552 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p  552 (571)
                      +..                |.+.+.   .+.|.=.||.+++.|.+|...
T Consensus       446 d~~----------------~~le~~---Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT----------------EPLESQ---QQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC----------------cchhHH---hhhhHHHHHHHHHHHhhcccc
Confidence            331                112222   357888999999999999765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.00  E-value=7.8e-09  Score=101.64  Aligned_cols=141  Identities=18%  Similarity=0.115  Sum_probs=101.4

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCcc-ch----------HHHHHHHHHHHhcccCCe--eeEeeEEEc-----
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ-GT----------AEFTNEVLLILKLQHKNL--VKLLGFCVD-----  416 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~nI--v~l~~~~~~-----  416 (571)
                      +.+-+-....|.+..+ +|+.+.||........ ..          ..+.+|...+.++...+|  ++++++.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3344334445667766 6789999976532211 01          137799999988865444  445555543     


Q ss_pred             CceeEEEEEccCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-------CC
Q 008288          417 GDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------DM  488 (571)
Q Consensus       417 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-------~~  488 (571)
                      ....+||+|++++. +|.+++.... ....+......++.+++..+.-||+.|   |+|+|++++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence            23467999999886 8988874321 234566777899999999999999999   999999999999975       46


Q ss_pred             cEEEeecccccc
Q 008288          489 NSKISDFGMARI  500 (571)
Q Consensus       489 ~~kL~DfGla~~  500 (571)
                      .+.|+||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=3.7e-09  Score=97.99  Aligned_cols=125  Identities=26%  Similarity=0.316  Sum_probs=82.9

Q ss_pred             eEEEEEEcCCcEEEEEEccccC--------------c--------c----chHHHHHHHHHHHhcccC--CeeeEeeEEE
Q 008288          364 PVYKGVLSDGKEVAVKRLSSCS--------------E--------Q----GTAEFTNEVLLILKLQHK--NLVKLLGFCV  415 (571)
Q Consensus       364 ~Vy~~~~~~~~~vavK~~~~~~--------------~--------~----~~~~~~~e~~~l~~l~h~--nIv~l~~~~~  415 (571)
                      .||.|...+|+++|||+.+...              .        .    ......+|.+.|.++...  ++++++.+  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            3899998899999999754210              0        0    012367899999999766  56777655  


Q ss_pred             cCceeEEEEEccC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          416 DGDEKLLVYEFMP--NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY-LHEDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       416 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~-LH~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                        +...|||||++  +..+..+...     .++......+..+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              24579999998  6555444311     11134456677888886555 57888   9999999999999888 9999


Q ss_pred             eeccccccc
Q 008288          493 SDFGMARIF  501 (571)
Q Consensus       493 ~DfGla~~~  501 (571)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.83  E-value=1.7e-09  Score=112.99  Aligned_cols=199  Identities=24%  Similarity=0.222  Sum_probs=149.6

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEE--cCCcEEEEEEccccCccchHH--HHHHHHHHHhc-ccCCeeeEeeEEEcCc
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVL--SDGKEVAVKRLSSCSEQGTAE--FTNEVLLILKL-QHKNLVKLLGFCVDGD  418 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~nIv~l~~~~~~~~  418 (571)
                      ......+|..+..||.|.|+.|++...  .++..+++|.+.+.......+  -..|+.+...+ .|.+++.....+....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            334556788999999999999999874  367889999887543333222  24566666665 5888998888888878


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeeccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGM  497 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfGl  497 (571)
                      ..++=-||++++++...+   .....+++...+.+..|++.++.++|+..   ++|+|+||+||++..+ +.-+++|||.
T Consensus       340 ~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccc
Confidence            888999999999887655   22334677788899999999999999888   9999999999999876 7889999999


Q ss_pred             ccccccCCCccceeeeccccccc--chhhhccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYM--APEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~  553 (571)
                      +..+......     .....+++  +|+......+-.+.|++|||.-+.|.++|..-.
T Consensus       414 ~t~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  414 WTRLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             ccccceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccC
Confidence            8642221111     12233444  455555667889999999999999999987653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.79  E-value=1.5e-09  Score=119.28  Aligned_cols=206  Identities=19%  Similarity=0.236  Sum_probs=144.5

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccc---cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      +...+.+.+.+-+-.|.++.++...-. .|...+.|....   ....+.+....+-.+.-..++|-++...--+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            345566777788888999998876532 232233332221   1111222223333333233456666554445566778


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +|+++|..+++|...++.   .+..+.+-....+..+..++++||...   +.|+|++|.|+++..++..++.|||....
T Consensus       880 ~L~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             chhhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence            999999999999888843   345666666677778899999999976   89999999999999999999999984332


Q ss_pred             cccC---------------------C----Cc----cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCC
Q 008288          501 FAES---------------------E----GE----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR  551 (571)
Q Consensus       501 ~~~~---------------------~----~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~  551 (571)
                      ....                     .    ..    .......+|+.|.+||.+.+......+|+|++|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            1100                     0    00    11223578999999999999999999999999999999999999


Q ss_pred             CCCCC
Q 008288          552 NAGSN  556 (571)
Q Consensus       552 p~~~~  556 (571)
                      ||+..
T Consensus      1034 p~na~ 1038 (1205)
T KOG0606|consen 1034 PFNAE 1038 (1205)
T ss_pred             CCCCc
Confidence            99765

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.79  E-value=4.3e-08  Score=93.50  Aligned_cols=135  Identities=21%  Similarity=0.233  Sum_probs=98.2

Q ss_pred             CCCCceecccCceeEEEEEEcCCcEEEEEEccc----------cCc------------cchHHHHHHHHHHHhcccC--C
Q 008288          351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS----------CSE------------QGTAEFTNEVLLILKLQHK--N  406 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~----------~~~------------~~~~~~~~e~~~l~~l~h~--n  406 (571)
                      ..+.++||.|--+.||.|..+.|.+++||.=+.          ...            -......+|.++|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345688999999999999999999999994221          000            1122467899999999655  6


Q ss_pred             eeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 008288          407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       407 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~  486 (571)
                      |++.+++    +.-.+|||++++-.|...-        ++.+....+...|++-+.-+-..|   |||+|+++-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            7777665    5567999999987664432        123334445555555555554566   999999999999999


Q ss_pred             CCcEEEeecccccc
Q 008288          487 DMNSKISDFGMARI  500 (571)
Q Consensus       487 ~~~~kL~DfGla~~  500 (571)
                      +|.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999977654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.75  E-value=4.5e-08  Score=104.16  Aligned_cols=141  Identities=17%  Similarity=0.230  Sum_probs=93.2

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCccchH----------------------------------------HHHH
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA----------------------------------------EFTN  394 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~  394 (571)
                      +-|+.++-|+||+|++++|+.||||+.++.-+....                                        ++..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            679999999999999999999999987653221111                                        1344


Q ss_pred             HHHHHHhc----c-cCCeeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH-HHHHhhCC
Q 008288          395 EVLLILKL----Q-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG-MLYLHEDS  468 (571)
Q Consensus       395 e~~~l~~l----~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~-L~~LH~~~  468 (571)
                      |...+.++    + .++|.--.=+..-.+...|+|||++|..+.++.....  ..++.   ..++..++++ +..+=..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHHHHhcC
Confidence            44444444    1 2333222223334667899999999999988753212  22442   2333333333 22333345


Q ss_pred             CCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       469 ~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                         ++|.|.+|.||+++.++++.+.|||+...+..
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               99999999999999999999999999876644

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.68  E-value=1.4e-07  Score=89.53  Aligned_cols=107  Identities=21%  Similarity=0.292  Sum_probs=84.0

Q ss_pred             hHHHHHHHHHHHhcccCCe--eeEeeEEEcCc----eeEEEEEccCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 008288          389 TAEFTNEVLLILKLQHKNL--VKLLGFCVDGD----EKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGM  461 (571)
Q Consensus       389 ~~~~~~e~~~l~~l~h~nI--v~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L  461 (571)
                      .....+|...+..+....|  ++.+++.+...    ..++|+|++++. +|.+++...   ..++......++.++++.+
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence            3457888888888855443  55666665532    347999999884 799988431   1256677889999999999


Q ss_pred             HHHhhCCCCCeeeCCCCCCCeEecCCC---cEEEeeccccccc
Q 008288          462 LYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIF  501 (571)
Q Consensus       462 ~~LH~~~~~~iiH~DLkp~NILl~~~~---~~kL~DfGla~~~  501 (571)
                      .-||+.|   |+|+|++++|||++.+.   .+.++||+.++..
T Consensus       132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999   99999999999999887   8999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.64  E-value=2.4e-07  Score=92.82  Aligned_cols=192  Identities=17%  Similarity=0.176  Sum_probs=127.9

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeE------EEcCce-eEEEEE
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF------CVDGDE-KLLVYE  425 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~------~~~~~~-~~lv~e  425 (571)
                      ...||+|+-+.+|-.--  -...+-|++.........+   ....|.+. .||-+-.=+.+      .-+++. .-+.|+
T Consensus        16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            46799999999986431  1122447766444333322   23334443 55543321111      112222 457777


Q ss_pred             ccCCCC-hhhhhc---CCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          426 FMPNGS-LDAILF---DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       426 ~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      .+.+.- ...++.   ..+......|...++.++.++.+.+-||..|   .+-+|.+++|+|+.+++.+.|+|-..-..-
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence            776642 233332   1223345789999999999999999999999   899999999999999999999985432221


Q ss_pred             ccCCCccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhC-CCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITG-RRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG-~~p~~~~  556 (571)
                         .......-.+|.+.|.+||...     +..-+..+|-|.||+++++++.| +.||.+-
T Consensus       168 ---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         168 ---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence               2233334468999999999764     33457789999999999999886 9999765

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=9.4e-07  Score=82.56  Aligned_cols=139  Identities=18%  Similarity=0.139  Sum_probs=102.6

Q ss_pred             ecccCceeEEEEEEcCCcEEEEEEccccC------ccchHHHHHHHHHHHhcccCC--eeeEeeEEEcC----ceeEEEE
Q 008288          357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDG----DEKLLVY  424 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~~~~~----~~~~lv~  424 (571)
                      -|+||-+.|++..+ +|+.+-+|+-.+..      +.....|.+|...+.++...+  ++++.......    -.-+||.
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            46788899999887 45579999865211      334567999999999995433  44544222111    1346899


Q ss_pred             EccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--EEEeecccccc
Q 008288          425 EFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMARI  500 (571)
Q Consensus       425 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~--~kL~DfGla~~  500 (571)
                      |-+++ .+|.+++.+. ...+.+......+..++++.+.-||+.+   +.|+|+.++||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97754 5888887432 2235677888899999999999999999   999999999999986666  99999987653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.51  E-value=2.1e-06  Score=82.72  Aligned_cols=132  Identities=17%  Similarity=0.170  Sum_probs=86.2

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC--eeeEeeEEEcCceeEEEEEccCCCC-
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGS-  431 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gs-  431 (571)
                      ..||+|..+.||+.   .+..+++|......  ......+|.+++..+..-.  +++.+.+....+...++||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   35567888876422  3445789999999986544  4677888888888889999999863 


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHhhC-CCCC
Q 008288          432 LDAILFDPRKRGILCWRKRTNIVNGIAKGM---------------------------------------LYLHED-SRLR  471 (571)
Q Consensus       432 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L---------------------------------------~~LH~~-~~~~  471 (571)
                      +...+.       .+......++.++++.+                                       .+|... ....
T Consensus        82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            221110       00011111111111111                                       122111 2235


Q ss_pred             eeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          472 IVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       472 iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      ++|+|+.|.||++++++ +.|+||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            78999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.47  E-value=2.2e-06  Score=80.36  Aligned_cols=139  Identities=15%  Similarity=0.154  Sum_probs=92.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHH---------HHHHHHHHHhccc---CCeeeEeeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE---------FTNEVLLILKLQH---KNLVKLLGF  413 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h---~nIv~l~~~  413 (571)
                      +...+|+..+.+-......|.+-.. +|+.+++|..++......+.         ..+++..+.+++.   .....++.+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4456777777787777777877776 67999999887533322222         2333444444432   222232222


Q ss_pred             EE-----cCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          414 CV-----DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       414 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      .+     -....+++|||++|..|.++..       ++.    .+...+.+.+.-||+.|   +.|+|.+|.|+++.+++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence            22     2345568999999988765531       222    24566778899999999   99999999999998654


Q ss_pred             cEEEeecccccc
Q 008288          489 NSKISDFGMARI  500 (571)
Q Consensus       489 ~~kL~DfGla~~  500 (571)
                       ++++||+.-+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=2.4e-06  Score=90.75  Aligned_cols=143  Identities=16%  Similarity=0.216  Sum_probs=90.7

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccch-------------------------------H------HHHHHH
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT-------------------------------A------EFTNEV  396 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------~------~~~~e~  396 (571)
                      .+.||..+.|+||++++++|+.||||+-++.-+...                               +      +|..|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            367999999999999999999999998665222110                               0      244454


Q ss_pred             HHHHhc----ccCC---eeeEeeEEEc-CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 008288          397 LLILKL----QHKN---LVKLLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS  468 (571)
Q Consensus       397 ~~l~~l----~h~n---Iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~  468 (571)
                      +-..++    .|-+   -|.+=.++.+ .....|+||||+|..+.++..-  ....++...+..-+.+..--+-+  ..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf--~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIF--KTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHH--hcC
Confidence            443333    4444   1222233332 4567899999999887665432  12224544443333332222222  234


Q ss_pred             CCCeeeCCCCCCCeEecC----CCcEEEeeccccccccc
Q 008288          469 RLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAE  503 (571)
Q Consensus       469 ~~~iiH~DLkp~NILl~~----~~~~kL~DfGla~~~~~  503 (571)
                         ++|.|-+|.||+++.    ++.+.+-|||+...+..
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence               999999999999984    67899999999876543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.32  E-value=8.4e-06  Score=79.66  Aligned_cols=140  Identities=17%  Similarity=0.152  Sum_probs=85.9

Q ss_pred             ecccCc-eeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEEccCCCChhh
Q 008288          357 LGQGGF-GPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDA  434 (571)
Q Consensus       357 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~  434 (571)
                      |..|.. ..||+.... +..++||+.....   ..+...|++++..+. +--+++++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 788998764 4788888876432   335678998888883 4456778888877777899999999988764


Q ss_pred             hhc-------------------CCC-CCCCCCHH--HHHHHHH--------------------HHHHHHHHHhh----CC
Q 008288          435 ILF-------------------DPR-KRGILCWR--KRTNIVN--------------------GIAKGMLYLHE----DS  468 (571)
Q Consensus       435 ~l~-------------------~~~-~~~~l~~~--~~~~i~~--------------------qia~~L~~LH~----~~  468 (571)
                      ...                   ... ...++...  .......                    .+.+.+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            321                   100 00011100  0000000                    01111122211    12


Q ss_pred             CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       469 ~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      .+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            34599999999999999987788999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.30  E-value=6e-06  Score=79.67  Aligned_cols=143  Identities=20%  Similarity=0.229  Sum_probs=84.4

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccC--CeeeEeeEEEcC---ceeEEEEEccC
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK--NLVKLLGFCVDG---DEKLLVYEFMP  428 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--nIv~l~~~~~~~---~~~~lv~e~~~  428 (571)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+..|..++..+...  .+++++......   ...+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3568999999999999866 69999987653  4456678898998888543  356666644332   34689999999


Q ss_pred             CCChhh----------------hhc---CC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 008288          429 NGSLDA----------------ILF---DP-RKRGILCWRK---------RTNI------------VNGIAK-GMLYLHE  466 (571)
Q Consensus       429 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~qia~-~L~~LH~  466 (571)
                      +..+..                .+.   .. .....+.+..         ....            ...+.+ .++.+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988877                110   10 0111111100         0000            111222 2333332


Q ss_pred             ----CCCCCeeeCCCCCCCeEec-CCCcEEEeeccccc
Q 008288          467 ----DSRLRIVHRDLKASNVLLD-SDMNSKISDFGMAR  499 (571)
Q Consensus       467 ----~~~~~iiH~DLkp~NILl~-~~~~~kL~DfGla~  499 (571)
                          .....++|+|+.|+|||++ +++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                2334599999999999999 66666899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.30  E-value=9.1e-06  Score=77.10  Aligned_cols=136  Identities=23%  Similarity=0.251  Sum_probs=92.2

Q ss_pred             eecccCceeEEEEEEcCCcEEEEEEccccCccc-------------------hH-----HHHHHHHHHHhcc--cCCeee
Q 008288          356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG-------------------TA-----EFTNEVLLILKLQ--HKNLVK  409 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~~~~e~~~l~~l~--h~nIv~  409 (571)
                      .|.+|--+.||+|...++..+|||+++......                   .+     -..+|..-|.++.  +-.+++
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            456677889999998789999999876421111                   00     1345666666663  334455


Q ss_pred             EeeEEEcCceeEEEEEccCCCCh-hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCC
Q 008288          410 LLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSD  487 (571)
Q Consensus       410 l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~  487 (571)
                      .+++.    ...|||||+...-. .-.|    +.-++...+...+..++++.+.-|-. .+   +||+||+.=|||+. +
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~  202 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-D  202 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-C
Confidence            55543    34799999865421 1112    12223333677788888888888776 55   99999999999999 8


Q ss_pred             CcEEEeeccccccccc
Q 008288          488 MNSKISDFGMARIFAE  503 (571)
Q Consensus       488 ~~~kL~DfGla~~~~~  503 (571)
                      +.+.|+|||-+.....
T Consensus       203 ~~p~iID~~QaV~~~h  218 (268)
T COG1718         203 GEPYIIDVSQAVTIDH  218 (268)
T ss_pred             CeEEEEECccccccCC
Confidence            8999999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.17  E-value=4e-05  Score=71.77  Aligned_cols=130  Identities=22%  Similarity=0.301  Sum_probs=91.6

Q ss_pred             CCCceecccCceeEEEEEEcCCcEEEEEEccccC----------------ccchHHHHHHHHHHHhcc------cCCeee
Q 008288          352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS----------------EQGTAEFTNEVLLILKLQ------HKNLVK  409 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~nIv~  409 (571)
                      +....||+|+.-.||.  ++++....||+..+..                .....+..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3457899999999987  4456667888876544                223456677777666665      788999


Q ss_pred             EeeEEEcCceeEEEEEccCC------CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeE
Q 008288          410 LLGFCVDGDEKLLVYEFMPN------GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL  483 (571)
Q Consensus       410 l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NIL  483 (571)
                      ++|+.+.+...-+|+|.+.+      .+|.+++.    .+.++. ...+.+.   +-..||-+..   |+.+||+|+||+
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv  150 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIV  150 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEE
Confidence            99999999999999998643      35777772    233554 3333333   4445666666   999999999999


Q ss_pred             ecCC---C-cEEEee
Q 008288          484 LDSD---M-NSKISD  494 (571)
Q Consensus       484 l~~~---~-~~kL~D  494 (571)
                      +...   . .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9533   2 577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.15  E-value=4e-07  Score=96.90  Aligned_cols=99  Identities=22%  Similarity=0.475  Sum_probs=75.7

Q ss_pred             HHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc-------cceeeecccccccchhhhcc
Q 008288          455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-------ANTVRIVGTYGYMAPEYAME  527 (571)
Q Consensus       455 ~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~  527 (571)
                      .+++.||.|+|..-  ++||++|.|++|.++..+.+||+.|+.+.........       ....-..-...|.+||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34559999999865  6999999999999999999999999987654431110       00001123557999999999


Q ss_pred             CCCCcchhhHhHHHHHHHHHhCCCC-CCC
Q 008288          528 GLYSKKSDVFSFGVLLIEIITGRRN-AGS  555 (571)
Q Consensus       528 ~~~~~~~Dv~slGvil~elltG~~p-~~~  555 (571)
                      ...+.++|++|+|+++|-+..|.++ +..
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a  212 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA  212 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhc
Confidence            8889999999999999999954444 443

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.07  E-value=1.8e-05  Score=73.72  Aligned_cols=105  Identities=25%  Similarity=0.253  Sum_probs=83.4

Q ss_pred             HHHHHHHHhccc-CCeeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 008288          393 TNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR  471 (571)
Q Consensus       393 ~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~  471 (571)
                      .+|..++..+++ +++++++|.|    ..+++.||...+++......-..-...+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468888888865 6999999999    44779999987766432100011224689999999999999999999865556


Q ss_pred             eeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          472 IVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       472 iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +...|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            999999999999999999999999887544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.04  E-value=6.8e-05  Score=86.11  Aligned_cols=79  Identities=16%  Similarity=0.357  Sum_probs=58.0

Q ss_pred             CceecccCceeEEEEEEcCC---cEEEEEEccccC-ccchHHHHHHHHHHHhcc-cCCe--eeEeeEEEcC---ceeEEE
Q 008288          354 SNILGQGGFGPVYKGVLSDG---KEVAVKRLSSCS-EQGTAEFTNEVLLILKLQ-HKNL--VKLLGFCVDG---DEKLLV  423 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lv  423 (571)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|.++++.+. |.+|  ++++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46788999999999887553   467778765322 223456889999999995 6665  7788887764   467899


Q ss_pred             EEccCCCCh
Q 008288          424 YEFMPNGSL  432 (571)
Q Consensus       424 ~e~~~~gsL  432 (571)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999988653

>PRK10593 hypothetical protein; Provisional

Probab=98.03  E-value=7.8e-05  Score=74.99  Aligned_cols=78  Identities=13%  Similarity=0.101  Sum_probs=57.5

Q ss_pred             CCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhccc---CCeeeEeeEEEcC---ceeEEEEE
Q 008288          352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH---KNLVKLLGFCVDG---DEKLLVYE  425 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~nIv~l~~~~~~~---~~~~lv~e  425 (571)
                      ...+.||+|..+.||+....++ .+++|..+.  ......+..|.+.++.+..   -.++++++++..+   +..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999876555 567776433  1123478899999999843   4678888887543   66899999


Q ss_pred             ccCCCCh
Q 008288          426 FMPNGSL  432 (571)
Q Consensus       426 ~~~~gsL  432 (571)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998764

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.98  E-value=7.2e-05  Score=72.62  Aligned_cols=73  Identities=16%  Similarity=0.260  Sum_probs=46.2

Q ss_pred             ceecccCce-eEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccC---CeeeEeeEEEcCc---eeEEEEEcc
Q 008288          355 NILGQGGFG-PVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK---NLVKLLGFCVDGD---EKLLVYEFM  427 (571)
Q Consensus       355 ~~lG~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---nIv~l~~~~~~~~---~~~lv~e~~  427 (571)
                      +.|+.|+.. .||+.    +..+++|..+.  ......+..|.+++..+...   .+.++++.....+   ..+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            456766665 58875    24577786543  22344788999999888532   3445554443322   347899999


Q ss_pred             CCCChh
Q 008288          428 PNGSLD  433 (571)
Q Consensus       428 ~~gsL~  433 (571)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.98  E-value=1.1e-06  Score=92.63  Aligned_cols=186  Identities=19%  Similarity=0.118  Sum_probs=131.8

Q ss_pred             CCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC-eeeEeeEEEcCceeEEEEEccCC
Q 008288          351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +...+-.+++.+++++|.+-.-.+....+.+...     ....-++++|.+.+||| .+..++-+..+...++.++++..
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~  318 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST  318 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence            3344568899999999987432333335544321     34567889999999999 66666666777778899999877


Q ss_pred             C-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc
Q 008288          430 G-SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       430 g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~  508 (571)
                      + +-....  ......+...+...+.+.-.+++++||+..   -+|+|    ||+..+ +..+..||+....+....   
T Consensus       319 ~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---  385 (829)
T KOG0576|consen  319 GRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---  385 (829)
T ss_pred             CccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence            6 211111  011122444555567777888999999865   48888    777755 678999999887665543   


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ......+++.|++||+..+..+..+.|+|++++--.++.-|-+|-.
T Consensus       386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            2223578999999999999999999999999987777777777643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.89  E-value=0.00015  Score=70.34  Aligned_cols=73  Identities=22%  Similarity=0.236  Sum_probs=48.9

Q ss_pred             ceecccCceeEEEEEEcC--CcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEccCCCC
Q 008288          355 NILGQGGFGPVYKGVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      +.|..|-...+|+....+  ++.+++|+....... ..+...|+.++..+...++ +++++...    ..++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457778888999998754  678999977643222 2334578888888854333 44544332    248999999877


Q ss_pred             h
Q 008288          432 L  432 (571)
Q Consensus       432 L  432 (571)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            6

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.86  E-value=0.00012  Score=65.91  Aligned_cols=129  Identities=19%  Similarity=0.202  Sum_probs=89.1

Q ss_pred             CCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEccCCCC
Q 008288          353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       353 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      ..+.|++|.+|.||++.+. |.++|+|+-+..  .....+..|.+++..++-.++ .+++.+..+    .+.|||+.|..
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            3567999999999999994 568888876643  345678899999999987766 456665433    34599999988


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCC-CCCeEecCCCcEEEeeccccccc
Q 008288          432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLK-ASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       432 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLk-p~NILl~~~~~~kL~DfGla~~~  501 (571)
                      |.+.-...      +-.    -...+++.---|...|   |-|+.|. |...+|-.+..+.|+||..|+..
T Consensus        99 L~~~~~~~------~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          99 LGKLEIGG------DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhhcc------cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            86654111      112    2333444433455555   8888886 55555556669999999998743

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.83  E-value=0.00028  Score=65.57  Aligned_cols=125  Identities=26%  Similarity=0.380  Sum_probs=89.7

Q ss_pred             CCCCCCceecccCc-eeEEEEEEcCCcEEEEEEccc---cCc------------------cchHHHHHHHHHHHhcc---
Q 008288          349 SNFSDSNILGQGGF-GPVYKGVLSDGKEVAVKRLSS---CSE------------------QGTAEFTNEVLLILKLQ---  403 (571)
Q Consensus       349 ~~~~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~---  403 (571)
                      .+++..+.||.|.- |.||++.+ +|+.+|+|.++.   ...                  .....|..|.+...+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999999 688999998321   000                  11234888999888884   


Q ss_pred             cCCe--eeEeeEEEcCc------------------eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 008288          404 HKNL--VKLLGFCVDGD------------------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY  463 (571)
Q Consensus       404 h~nI--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~  463 (571)
                      +.++  ++.+|+..-..                  ...+|.||++...            .+.    .+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4455  88888874221                  1246777664432            122    2335678888899


Q ss_pred             HhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       464 LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      +|..+   |+-+|+++.|..   +  -+|+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc---C--CEEEecccC
Confidence            99999   999999999987   2  389999864

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.82  E-value=0.00014  Score=71.67  Aligned_cols=138  Identities=15%  Similarity=0.076  Sum_probs=80.1

Q ss_pred             ecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEccCCCChhhh
Q 008288          357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGSLDAI  435 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL~~~  435 (571)
                      +..|-...+|+... +++.+++|...........+..+|.++++.+....+ ++++...    ..++||||++|..+..-
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence            45677788998874 677888997654332221245788889988864433 3444443    24689999998765421


Q ss_pred             -----------------hcCCC-CCCCCCHHH-HHHHHHH---------HHHHHHHHhhC-----CCCCeeeCCCCCCCe
Q 008288          436 -----------------LFDPR-KRGILCWRK-RTNIVNG---------IAKGMLYLHED-----SRLRIVHRDLKASNV  482 (571)
Q Consensus       436 -----------------l~~~~-~~~~l~~~~-~~~i~~q---------ia~~L~~LH~~-----~~~~iiH~DLkp~NI  482 (571)
                                       ++... ...+++... ...+..+         +.+.+..+-..     .+..++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             11111 111122211 1111111         11112222111     123489999999999


Q ss_pred             EecCCCcEEEeecccccc
Q 008288          483 LLDSDMNSKISDFGMARI  500 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~  500 (571)
                      ++++++ +.|+||..+..
T Consensus       159 l~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEeCCC-CEEEeccccCc
Confidence            999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.67  E-value=0.00026  Score=71.27  Aligned_cols=143  Identities=17%  Similarity=0.130  Sum_probs=85.9

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC--eeeEeeE------EEcCceeEEEEE
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYE  425 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e  425 (571)
                      .+.|..|....+|+.... +..+++|+...   ........|+.++..+.+.+  +++++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            456777877899998764 45788898764   23345667888888875433  4444432      223456689999


Q ss_pred             ccCCCChhh----hh----------c----CCC----CCCCCCHHHHH----------HHHHHHHHHHHHHhh----CCC
Q 008288          426 FMPNGSLDA----IL----------F----DPR----KRGILCWRKRT----------NIVNGIAKGMLYLHE----DSR  469 (571)
Q Consensus       426 ~~~~gsL~~----~l----------~----~~~----~~~~l~~~~~~----------~i~~qia~~L~~LH~----~~~  469 (571)
                      |++|..+..    ..          +    ...    ......|....          .....+...+.++.+    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876532    00          1    000    00111222111          011223344445443    112


Q ss_pred             CCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          470 LRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       470 ~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ..++|+|+.|.|||++++..+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3499999999999999987778999988763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.60  E-value=0.0011  Score=68.95  Aligned_cols=75  Identities=17%  Similarity=0.189  Sum_probs=53.9

Q ss_pred             ceecccCceeEEEEEEcCC-cEEEEEEcccc----C---ccchHHHHHHHHHHHhcc---cCCeeeEeeEEEcCceeEEE
Q 008288          355 NILGQGGFGPVYKGVLSDG-KEVAVKRLSSC----S---EQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +.||.|.+..||++...+| +.++||.-.+.    .   +........|.+.|..+.   ..++++++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5689999999999998776 58999975421    1   123456677888887762   3457777777  44567899


Q ss_pred             EEccCCCC
Q 008288          424 YEFMPNGS  431 (571)
Q Consensus       424 ~e~~~~gs  431 (571)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.45  E-value=0.001  Score=67.22  Aligned_cols=141  Identities=24%  Similarity=0.329  Sum_probs=84.2

Q ss_pred             ceecccCceeEEEEEEcC-------CcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVLSD-------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~  426 (571)
                      +.+..|-.-.+|+....+       ++.+++|+..... ....+..+|.+++..+....+ +++++.+.    ..+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            345556667899888654       5789999876533 233456788888888854333 45555543    2368999


Q ss_pred             cCCCChhhh-h----------------cCCCCC--C----CCC--HHHHHH--------------------------HHH
Q 008288          427 MPNGSLDAI-L----------------FDPRKR--G----ILC--WRKRTN--------------------------IVN  455 (571)
Q Consensus       427 ~~~gsL~~~-l----------------~~~~~~--~----~l~--~~~~~~--------------------------i~~  455 (571)
                      ++|..+... +                +.....  .    ..+  +.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            988776431 1                110000  0    011  111111                          112


Q ss_pred             HHHHHHHHHhh------CCCCCeeeCCCCCCCeEecCC----CcEEEeecccccc
Q 008288          456 GIAKGMLYLHE------DSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARI  500 (571)
Q Consensus       456 qia~~L~~LH~------~~~~~iiH~DLkp~NILl~~~----~~~kL~DfGla~~  500 (571)
                      .+..-+..|..      .....++|+|+.+.|||++++    +.+.++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22233444432      234569999999999999885    8899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.29  E-value=0.0025  Score=63.32  Aligned_cols=31  Identities=29%  Similarity=0.571  Sum_probs=25.8

Q ss_pred             CCeeeCCCCCCCeEecCCCc-EEEeecccccc
Q 008288          470 LRIVHRDLKASNVLLDSDMN-SKISDFGMARI  500 (571)
Q Consensus       470 ~~iiH~DLkp~NILl~~~~~-~kL~DfGla~~  500 (571)
                      ..++|+|++|.|||++++++ .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            34899999999999997565 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK05231 homoserine kinase; Provisional

Probab=97.27  E-value=0.0067  Score=61.71  Aligned_cols=142  Identities=18%  Similarity=0.204  Sum_probs=77.2

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC--eeeEee------EEEcCceeEEEEE
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLG------FCVDGDEKLLVYE  425 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~------~~~~~~~~~lv~e  425 (571)
                      .+.|+.|....+|+....+| .+++|+....   .......|..++..+...+  +++.+.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            34566777789999887554 6888987521   2233445556665553222  333332      1223556789999


Q ss_pred             ccCCCChhh-----------hh---cCC-C-------CCCCCCH-HHHHH------------HH-HHHHHHHHHHhhC--
Q 008288          426 FMPNGSLDA-----------IL---FDP-R-------KRGILCW-RKRTN------------IV-NGIAKGMLYLHED--  467 (571)
Q Consensus       426 ~~~~gsL~~-----------~l---~~~-~-------~~~~l~~-~~~~~------------i~-~qia~~L~~LH~~--  467 (571)
                      |++|..+..           .+   +.. +       ....+.| .....            .. ..+...++.+.+.  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            999875321           11   110 0       0011112 11111            11 1111222333211  


Q ss_pred             --CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          468 --SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       468 --~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                        -+..+||+|+.|.||+++++...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              12359999999999999876656899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.22  E-value=0.0054  Score=62.05  Aligned_cols=143  Identities=18%  Similarity=0.204  Sum_probs=81.8

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC--eeeEeeE------EEcCceeEEEEE
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYE  425 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e  425 (571)
                      .+.++.|....+|+....++ .+++|+.....  .......|.+++..+....  +++++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999876444 67788765421  2334556677777764322  3444332      122456789999


Q ss_pred             ccCCCChhh-----------h---hcCC-C---C---C--CCCCHHHHH------------HHHHHHHHHHHHHhh----
Q 008288          426 FMPNGSLDA-----------I---LFDP-R---K---R--GILCWRKRT------------NIVNGIAKGMLYLHE----  466 (571)
Q Consensus       426 ~~~~gsL~~-----------~---l~~~-~---~---~--~~l~~~~~~------------~i~~qia~~L~~LH~----  466 (571)
                      |++|..+..           .   ++.. .   .   .  ....|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998865321           0   1110 0   0   0  011121110            011223344555542    


Q ss_pred             CCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       467 ~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .-...++|+|+++.||++++++...|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123459999999999999988877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.18  E-value=0.0024  Score=63.58  Aligned_cols=74  Identities=24%  Similarity=0.324  Sum_probs=49.1

Q ss_pred             CCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcc---cCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       353 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      ..+.|+.|....+|+.. .+++.+.||.-.   ......|..|.+-|+.+.   --.+++++++...++..+|++||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34678889999999987 578899999765   233446788888888883   45578899998888888999999987


Q ss_pred             C
Q 008288          430 G  430 (571)
Q Consensus       430 g  430 (571)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.14  E-value=0.0051  Score=61.75  Aligned_cols=129  Identities=16%  Similarity=0.261  Sum_probs=79.6

Q ss_pred             eEEEEEEcCCcEEEEEEcc-ccCccchHHHHHHHHHHHhccc--CCeeeEeeEEEcCc--eeEEEEEccCCCChhhhhcC
Q 008288          364 PVYKGVLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGD--EKLLVYEFMPNGSLDAILFD  438 (571)
Q Consensus       364 ~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~  438 (571)
                      .+|.... +++++++++-. ...........+|..+++.+.-  --+...++.|.++.  ..+.||+|+++..+.+.+..
T Consensus        40 ~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~  118 (321)
T COG3173          40 DTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP  118 (321)
T ss_pred             ceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc
Confidence            4444443 37888888321 1223345566788888888743  33455677777666  67999999988543322210


Q ss_pred             CCCCCCCCHHHHHHHH-HHHHHHHHHHh--------------------------------------------------hC
Q 008288          439 PRKRGILCWRKRTNIV-NGIAKGMLYLH--------------------------------------------------ED  467 (571)
Q Consensus       439 ~~~~~~l~~~~~~~i~-~qia~~L~~LH--------------------------------------------------~~  467 (571)
                      .    ...    ..++ ..+++.|.-||                                                  .+
T Consensus       119 ~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~  190 (321)
T COG3173         119 E----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN  190 (321)
T ss_pred             c----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence            0    000    1111 23444444444                                                  22


Q ss_pred             -----CCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          468 -----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       468 -----~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                           ++..++|+|+++.||+++.+.-+=+.||+++..-
T Consensus       191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                 2346999999999999999888999999998754

>PLN02236 choline kinase

Probab=97.08  E-value=0.0058  Score=62.83  Aligned_cols=141  Identities=21%  Similarity=0.267  Sum_probs=83.0

Q ss_pred             ceecccCceeEEEEEEcC-----CcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEccC
Q 008288          355 NILGQGGFGPVYKGVLSD-----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~  428 (571)
                      +.|-.|-.-.+|+....+     ++.+++|+.....+.. -+..+|..++..+...++ +++++.+...    .|.||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            345456777899987532     3688999886644333 334789999988865555 3566665332    5899998


Q ss_pred             CCChhhh-----------------hcCCCCC--C-CCCHHHHHHHHHHH-----------------HHHHHHH----hh-
Q 008288          429 NGSLDAI-----------------LFDPRKR--G-ILCWRKRTNIVNGI-----------------AKGMLYL----HE-  466 (571)
Q Consensus       429 ~gsL~~~-----------------l~~~~~~--~-~l~~~~~~~i~~qi-----------------a~~L~~L----H~-  466 (571)
                      +.++..-                 +|.....  . ...+..+.++..++                 ..-+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8776421                 1111100  1 11123332332211                 1111122    21 


Q ss_pred             CCCCCeeeCCCCCCCeEecC-CCcEEEeecccccc
Q 008288          467 DSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARI  500 (571)
Q Consensus       467 ~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~  500 (571)
                      .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22345899999999999986 46899999988764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.93  E-value=0.0075  Score=60.64  Aligned_cols=140  Identities=21%  Similarity=0.236  Sum_probs=96.5

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEcccc------Cc---------------cc-----hHHHHHHHHHHHhcccCCe
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC------SE---------------QG-----TAEFTNEVLLILKLQHKNL  407 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~------~~---------------~~-----~~~~~~e~~~l~~l~h~nI  407 (571)
                      ...|..|--+.||.+.-.+|..+|||+++..      .+               ..     .-....|++-|.+++...|
T Consensus       149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI  228 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI  228 (520)
T ss_pred             ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4568889999999999889999999976421      00               00     0124567778888866554


Q ss_pred             eeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 008288          408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD  487 (571)
Q Consensus       408 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~  487 (571)
                      +-..-+..  ....|||+|+.......-   .-+...++...+..+-.|++.-|.-|-+..  ++||.||.--|+|+ .+
T Consensus       229 P~PePIlL--k~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hd  300 (520)
T KOG2270|consen  229 PCPEPILL--KNHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HD  300 (520)
T ss_pred             CCCCceee--ecceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-EC
Confidence            32111111  123689999853222111   123455777788889999999999888776  59999999999999 56


Q ss_pred             CcEEEeeccccccc
Q 008288          488 MNSKISDFGMARIF  501 (571)
Q Consensus       488 ~~~kL~DfGla~~~  501 (571)
                      |.+.|+|-+-+...
T Consensus       301 G~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  301 GKLYIIDVSQSVEH  314 (520)
T ss_pred             CEEEEEEccccccC
Confidence            68999998877644

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.91  E-value=0.0011  Score=65.27  Aligned_cols=134  Identities=16%  Similarity=0.188  Sum_probs=92.4

Q ss_pred             CCCCCceecccCceeEEEEEEcCCcEEEEEEcc----------cc--------Cccc----hHHHHHHHHHHHhcccC--
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLS----------SC--------SEQG----TAEFTNEVLLILKLQHK--  405 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~----------~~--------~~~~----~~~~~~e~~~l~~l~h~--  405 (571)
                      -+...+.||-|--+-||.+-..+|++.++|.-+          ..        +..+    .-...+|...|+.+..+  
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            356788999999999999999899999988421          00        0111    11356788888888432  


Q ss_pred             CeeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec
Q 008288          406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD  485 (571)
Q Consensus       406 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~  485 (571)
                      -+++.+++    +..++|||++.+-.|...-+      ..+..   .+...+..-+.-|-.+|   +||+|..--||+++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            24444444    45689999998887755431      11222   23344444455666677   99999999999999


Q ss_pred             CCCcEEEeeccccc
Q 008288          486 SDMNSKISDFGMAR  499 (571)
Q Consensus       486 ~~~~~kL~DfGla~  499 (571)
                      +++.++++||--..
T Consensus       237 dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMV  250 (465)
T ss_pred             cCCCEEEeechHhh
Confidence            99999999997654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.74  E-value=0.0042  Score=70.64  Aligned_cols=155  Identities=21%  Similarity=0.239  Sum_probs=113.2

Q ss_pred             HHHHHHHHHHhcccCCeeeEeeEEEcCceeE----EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 008288          391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE  466 (571)
Q Consensus       391 ~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~  466 (571)
                      ...-|.+.+.++.|+|++.++.+..+....-    +..|++..-++...+   +.-+.++....+.+..+..+||.|+|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            3456777888889999999998877654332    445677777777766   455678889999999999999999999


Q ss_pred             CCCCCeeeCCCCCC---CeEecCCCcEEEe--ecccccccccCCCccceeeecccccccchhhhccCCCCc--chhhHhH
Q 008288          467 DSRLRIVHRDLKAS---NVLLDSDMNSKIS--DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK--KSDVFSF  539 (571)
Q Consensus       467 ~~~~~iiH~DLkp~---NILl~~~~~~kL~--DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Dv~sl  539 (571)
                      ..   ..|.-|..+   +--++.++...++  ||+....+........   ..-+..+.+||.......+.  ..|+|.+
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence            86   666655555   5555667777777  8888876654433221   13345677888877666554  4799999


Q ss_pred             HHHHHHHHhCCCCCC
Q 008288          540 GVLLIEIITGRRNAG  554 (571)
Q Consensus       540 Gvil~elltG~~p~~  554 (571)
                      |.++..+..|..+-.
T Consensus       379 gll~~~~~~~~~i~~  393 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISE  393 (1351)
T ss_pred             HHHHhhhhhcCcccc
Confidence            999999999887654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.63  E-value=0.00042  Score=80.15  Aligned_cols=161  Identities=13%  Similarity=-0.027  Sum_probs=112.7

Q ss_pred             HHHHHHHHHHhcccCCeeeEeeEEEc--CceeEEEEEccCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhC
Q 008288          391 EFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHED  467 (571)
Q Consensus       391 ~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~  467 (571)
                      ....|...+++..|+++.....-...  ..+.+..++++..|.+.+.+....+ ...++..-....-.+......-+|+.
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            34555556667789888765443332  3355789999999999888855333 33344433333333335555555544


Q ss_pred             CC--CCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHH
Q 008288          468 SR--LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIE  545 (571)
Q Consensus       468 ~~--~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~e  545 (571)
                      ..  .--+|++||+-|.+|..+.+++++++|+.+..........  ...+++.|+.|++...-.++.++|+|..|..+|+
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~G--l~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFG--LELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhh--hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence            32  2378999999999999999999999999984333222221  2367888999998888888989999999999999


Q ss_pred             HHhCCCCC
Q 008288          546 IITGRRNA  553 (571)
Q Consensus       546 lltG~~p~  553 (571)
                      .--|..+|
T Consensus      1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred             HhcccHHH
Confidence            88888775

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.56  E-value=0.024  Score=57.36  Aligned_cols=32  Identities=28%  Similarity=0.364  Sum_probs=28.1

Q ss_pred             CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       469 ~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +..++|+|+.++|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34599999999999999999999999988763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.52  E-value=0.031  Score=57.04  Aligned_cols=73  Identities=15%  Similarity=0.186  Sum_probs=47.6

Q ss_pred             eecccCceeEEEEEEcCC-cEEEEEEccc-------cCccchHHHHHHHHHHHhcc--cC-CeeeEeeEEEcCceeEEEE
Q 008288          356 ILGQGGFGPVYKGVLSDG-KEVAVKRLSS-------CSEQGTAEFTNEVLLILKLQ--HK-NLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~-nIv~l~~~~~~~~~~~lv~  424 (571)
                      .||.|....||++..++| +.++||.-.+       .-+....+..-|.+.|....  -| .+++++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            478999999999997654 6899996321       11333445566777776652  23 45555444  555667999


Q ss_pred             EccCCC
Q 008288          425 EFMPNG  430 (571)
Q Consensus       425 e~~~~g  430 (571)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.44  E-value=0.0081  Score=57.14  Aligned_cols=123  Identities=20%  Similarity=0.264  Sum_probs=61.0

Q ss_pred             CcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEccCCCChhhh-h--------------
Q 008288          373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGSLDAI-L--------------  436 (571)
Q Consensus       373 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l--------------  436 (571)
                      ++.|+||+....+ ........|..+++.+...++ +++++.+.+    ..|.||+++.+|..- +              
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678888876643 344567889999998876555 455555432    256799877654321 0              


Q ss_pred             --cC--C--CCCCCCCHHHHHHH----------------------HHHHHHHHHHHhh---C--CCCCeeeCCCCCCCeE
Q 008288          437 --FD--P--RKRGILCWRKRTNI----------------------VNGIAKGMLYLHE---D--SRLRIVHRDLKASNVL  483 (571)
Q Consensus       437 --~~--~--~~~~~l~~~~~~~i----------------------~~qia~~L~~LH~---~--~~~~iiH~DLkp~NIL  483 (571)
                        +.  .  .......|..+..+                      ...+.+-+..+.+   .  ....++|+||.|.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              00  0  01111111222111                      0111111222211   1  1134889999999999


Q ss_pred             e-cCCCcEEEeecccccc
Q 008288          484 L-DSDMNSKISDFGMARI  500 (571)
Q Consensus       484 l-~~~~~~kL~DfGla~~  500 (571)
                      + +.++.++|+||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8889999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.39  E-value=0.036  Score=56.71  Aligned_cols=140  Identities=15%  Similarity=0.210  Sum_probs=80.5

Q ss_pred             eecccCceeEEEEEEcC----CcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEccCCC
Q 008288          356 ILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g  430 (571)
                      .|..|-.-.+|+....+    +..|++|+.....+ ..-+-.+|..++..+...++ +++++++. .+   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence            34446667788887543    23788998765443 23345688899998876665 45665552 22   589999877


Q ss_pred             Chhhh-------h----------cCCC---CCCCCCHHHHHHHHHHH----------------------HHHHHH----H
Q 008288          431 SLDAI-------L----------FDPR---KRGILCWRKRTNIVNGI----------------------AKGMLY----L  464 (571)
Q Consensus       431 sL~~~-------l----------~~~~---~~~~l~~~~~~~i~~qi----------------------a~~L~~----L  464 (571)
                      +|..-       +          |...   ...+..|..+.++..++                      .+-+..    +
T Consensus        96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~  175 (330)
T PLN02421         96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT  175 (330)
T ss_pred             CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence            65321       1          1111   01111233322222221                      111111    1


Q ss_pred             hh-CCCCCeeeCCCCCCCeEecC-CCcEEEeecccccc
Q 008288          465 HE-DSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARI  500 (571)
Q Consensus       465 H~-~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~  500 (571)
                      .. ....-++|.|+.+.|||+++ ++.++++||..+..
T Consensus       176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 11234799999999999975 57899999988764

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.37  E-value=0.037  Score=52.24  Aligned_cols=75  Identities=21%  Similarity=0.265  Sum_probs=53.7

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc---ccCCeeeEeeEEEcCceeEEEEEccCCCC
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      +.+..|.--..|.... +..++.||+-..   .....|..|+.-|..+   +.-.+.+++.+-...+..++|+||++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            4455555555565554 567889996432   3345678888777666   44567889999999999999999999876


Q ss_pred             hh
Q 008288          432 LD  433 (571)
Q Consensus       432 L~  433 (571)
                      ++
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            65

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.34  E-value=0.05  Score=56.52  Aligned_cols=73  Identities=14%  Similarity=0.139  Sum_probs=49.3

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEcccc----Cc---cchHHHHHHHHHHHhcc---cCCeeeEeeEEEcCceeEEE
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SE---QGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .+.||.|..-.||+... +++.++||.-.+.    +.   .....-..|.+.|..+.   ..++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            45689999999999886 4567999975421    11   12333445566665553   357888888876  456788


Q ss_pred             EEccCC
Q 008288          424 YEFMPN  429 (571)
Q Consensus       424 ~e~~~~  429 (571)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.24  E-value=0.09  Score=53.15  Aligned_cols=29  Identities=24%  Similarity=0.368  Sum_probs=25.4

Q ss_pred             CCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          470 LRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       470 ~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.15  E-value=0.041  Score=55.45  Aligned_cols=101  Identities=16%  Similarity=0.202  Sum_probs=68.1

Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..|++|++. ++++..+       ....+++.+.|+.+-+.-+.-+..+-  ++-|||+.-.||||+ +|++-|+||-++
T Consensus       300 y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         300 YLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             EEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence            446777764 5554322       22568899999999888888887754  799999999999999 999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHh
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFS  538 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s  538 (571)
                      +.-.. ...      +...+.-.|-... +.-+.+-|||-
T Consensus       369 Rl~~~-q~~------isy~rldhp~lF~-G~dd~QFeIYr  400 (488)
T COG5072         369 RLSYS-QGI------ISYNRLDHPDLFN-GVDDYQFEIYR  400 (488)
T ss_pred             ecccC-Cce------eeccccCchhhhc-CccceeeeHHH
Confidence            84322 211      1112233454444 33355666665

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.72  E-value=0.22  Score=50.86  Aligned_cols=72  Identities=18%  Similarity=0.146  Sum_probs=44.9

Q ss_pred             cCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC--eeeEe---e--EEEcCceeEEEEEccCCCCh
Q 008288          360 GGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLL---G--FCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       360 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~---~--~~~~~~~~~lv~e~~~~gsL  432 (571)
                      +.--.||+....+++.+++|+.++. .....+...|++.+..+....  ++...   |  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            3346799988877888999987642 234456677888877773222  22211   1  12234567789999987643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.65  E-value=0.17  Score=51.40  Aligned_cols=139  Identities=23%  Similarity=0.293  Sum_probs=80.7

Q ss_pred             ecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC------eeeEee----EEEcCceeEEEEEc
Q 008288          357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN------LVKLLG----FCVDGDEKLLVYEF  426 (571)
Q Consensus       357 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------Iv~l~~----~~~~~~~~~lv~e~  426 (571)
                      |.+ .--.+|+....+|+. ++|+....  ....+...|+..+..+.-..      +..+-|    ........+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 445689988866666 88887764  34456677777777773222      222212    11112367789999


Q ss_pred             cCCCChhh-hh--------------c----CCC--C---CCCCCHHH-------------HHHHHHHHHHHHHHHhhCC-
Q 008288          427 MPNGSLDA-IL--------------F----DPR--K---RGILCWRK-------------RTNIVNGIAKGMLYLHEDS-  468 (571)
Q Consensus       427 ~~~gsL~~-~l--------------~----~~~--~---~~~l~~~~-------------~~~i~~qia~~L~~LH~~~-  468 (571)
                      ++|..+.. ..              +    +..  .   .....|..             ......++...+..+.+.- 
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988772 10              0    000  0   01122320             0112334444444444331 


Q ss_pred             ---C---CCeeeCCCCCCCeEecCCCc-EEEeeccccc
Q 008288          469 ---R---LRIVHRDLKASNVLLDSDMN-SKISDFGMAR  499 (571)
Q Consensus       469 ---~---~~iiH~DLkp~NILl~~~~~-~kL~DfGla~  499 (571)
                         .   ..+||+|+.|.||+++.+.. .-++||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               1   22899999999999998875 8999999876

>PRK06148 hypothetical protein; Provisional

Probab=95.46  E-value=0.2  Score=59.07  Aligned_cols=141  Identities=20%  Similarity=0.238  Sum_probs=76.5

Q ss_pred             eecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcc-------cCCeeeEe-e----EEEc-Cc--ee
Q 008288          356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-------HKNLVKLL-G----FCVD-GD--EK  420 (571)
Q Consensus       356 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-------h~nIv~l~-~----~~~~-~~--~~  420 (571)
                      .|+ |..-.+|+....+|+.+++|+.+...  .......|...+..+.       -|.+++-. |    .... ++  ..
T Consensus        32 ~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         32 PLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             ecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            453 34567888887788899999987532  2223344445554441       22333211 1    1111 22  35


Q ss_pred             EEEEEccCCCChhhhh---------------------cCC---CCCCCCCHH-----------------HHHHHHHHHHH
Q 008288          421 LLVYEFMPNGSLDAIL---------------------FDP---RKRGILCWR-----------------KRTNIVNGIAK  459 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l---------------------~~~---~~~~~l~~~-----------------~~~~i~~qia~  459 (571)
                      +-+++|++|..+.+..                     .+.   .....+.|.                 ....++.++.+
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            6789999998775411                     000   001112221                 11223333333


Q ss_pred             HHH-----HHhhCCCCCeeeCCCCCCCeEecCCC--cEE-Eeecccccc
Q 008288          460 GML-----YLHEDSRLRIVHRDLKASNVLLDSDM--NSK-ISDFGMARI  500 (571)
Q Consensus       460 ~L~-----~LH~~~~~~iiH~DLkp~NILl~~~~--~~k-L~DfGla~~  500 (571)
                      ...     .+.+ -+..+||+|+.+.|||++.+.  ++. |+|||.+..
T Consensus       189 ~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            322     1222 123499999999999999875  555 999998753

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.38  E-value=0.087  Score=54.52  Aligned_cols=74  Identities=18%  Similarity=0.129  Sum_probs=49.0

Q ss_pred             CceecccCceeEEEEEEcC-CcEEEEEEccc------cCccchHHHHHHHHHHHhcc--cC-CeeeEeeEEEcCceeEEE
Q 008288          354 SNILGQGGFGPVYKGVLSD-GKEVAVKRLSS------CSEQGTAEFTNEVLLILKLQ--HK-NLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~e~~~l~~l~--h~-nIv~l~~~~~~~~~~~lv  423 (571)
                      .+.||.|.-..||++...+ ++.|+||.-.+      .-+-...+..-|.+.|+...  -| .+++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4568999999999999743 67899985321      11334556667777777662  23 45666554  45556788


Q ss_pred             EEccCC
Q 008288          424 YEFMPN  429 (571)
Q Consensus       424 ~e~~~~  429 (571)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888854

>PTZ00384 choline kinase; Provisional

Probab=95.11  E-value=0.16  Score=52.86  Aligned_cols=74  Identities=20%  Similarity=0.315  Sum_probs=46.8

Q ss_pred             ceecccCceeEEEEEEcCC--cE-----EEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVLSDG--KE-----VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~  426 (571)
                      +.|..|-...+|++...++  ..     |.++..... ....-+-..|+++++.+...++ +++++.+..    .++.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            4455577789999876433  22     444433222 2222344678999999976665 556666643    599999


Q ss_pred             cCCCChh
Q 008288          427 MPNGSLD  433 (571)
Q Consensus       427 ~~~gsL~  433 (571)
                      +++.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9988764

>PTZ00296 choline kinase; Provisional

Probab=95.10  E-value=0.2  Score=53.22  Aligned_cols=74  Identities=12%  Similarity=0.101  Sum_probs=48.7

Q ss_pred             CceecccCceeEEEEEEcC---------CcEEEEEEccccCccchHHHHHHHHHHHhcccCCee-eEeeEEEcCceeEEE
Q 008288          354 SNILGQGGFGPVYKGVLSD---------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLV  423 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv-~l~~~~~~~~~~~lv  423 (571)
                      .+.|..|-.-.+|+....+         ++.|.+++.....+.-. .-..|..++..+...+|- ++++.+.    ...|
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            4456666667888887542         46788888765444333 456788888888666663 4555542    3567


Q ss_pred             EEccCCCCh
Q 008288          424 YEFMPNGSL  432 (571)
Q Consensus       424 ~e~~~~gsL  432 (571)
                      .||+++.+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            999988754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	571
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-47
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-46
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-41
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-41
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-38
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-37
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-37
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-25
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-24
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-23
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-23
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-23
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-23
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-22
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-22
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-22
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-22
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-22
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-22
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-22
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-22
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-22
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-22
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-22
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-22
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-22
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-22
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-22
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-22
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-21
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-21
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-21
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-21
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-21
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-21
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-21
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-21
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		5e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-21
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-21
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-21
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-21
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-20
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-20
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-20
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-20
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-20
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-20
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-20
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-20
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-20
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-20
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-20
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-20
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-20
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-20
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-20
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-20
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-20
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-20
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-20
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-20
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-20
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-20
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-20
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-20
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-20
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-20
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-20
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-20
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-20
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-20
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-19
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-19
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-19
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-19
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-19
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-19
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-19
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-19
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-19
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-19
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-19
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-19
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-19
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-19
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-19
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-19
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-19
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-18
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-18
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-18
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-18
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-18
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-18
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-17
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-17
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-17
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		9e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-16
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-14
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-14
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-14
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		6e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-13
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		4e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		7e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-12
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		8e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-11
3soa_A	444	Full-Length Human Camkii Length = 444		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-11
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		5e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		7e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		9e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		9e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-10
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		8e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		9e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		8e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-09
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-08
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 97/213 (45%), Positives = 139/213 (65%), Gaps = 3/213 (1%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA-EFTNEVLLI 399
           L  L +A+ NFS+ NILG+GGFG VYKG L+DG  VAVKRL     QG   +F  EV +I
Sbjct: 30  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMI 89
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
               H+NL++L GFC+   E+LLVY +M NGS+ + L + P  +  L W KR  I  G A
Sbjct: 90  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 149
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           +G+ YLH+    +I+HRD+KA+N+LLD +  + + DFG+A++    +       + GT G
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGTIG 208
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           ++APEY   G  S+K+DVF +GV+L+E+ITG+R
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 241

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  182 bits (461), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 95/213 (44%), Positives = 137/213 (64%), Gaps = 3/213 (1%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA-EFTNEVLLI 399
           L  L +A+ NF + NILG+GGFG VYKG L+DG  VAVKRL     QG   +F  EV +I
Sbjct: 22  LRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
               H+NL++L GFC+   E+LLVY +M NGS+ + L + P  +  L W KR  I  G A
Sbjct: 82  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           +G+ YLH+    +I+HRD+KA+N+LLD +  + + DFG+A++    +       + G  G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA-VRGXIG 200
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           ++APEY   G  S+K+DVF +GV+L+E+ITG+R
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (417), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 101/219 (46%), Positives = 137/219 (62%), Gaps = 21/219 (9%)
Query: 344 LNLATSNFSD------SNILGQGGFGPVYKGVLSDGKEVAVKRLSS----CSEQGTAEFT 393
           L   T+NF +       N +G+GGFG VYKG +++   VAVK+L++     +E+   +F 
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFD 78
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
            E+ ++ K QH+NLV+LLGF  DGD+  LVY +MPNGSL   L        L W  R  I
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-- 511
             G A G+ +LHE+     +HRD+K++N+LLD    +KISDFG+AR    SE  A TV  
Sbjct: 139 AQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMX 192
Query: 512 -RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            RIVGT  YMAPE A+ G  + KSD++SFGV+L+EIITG
Sbjct: 193 XRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  165 bits (417), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 101/219 (46%), Positives = 137/219 (62%), Gaps = 21/219 (9%)
Query: 344 LNLATSNFSD------SNILGQGGFGPVYKGVLSDGKEVAVKRLSS----CSEQGTAEFT 393
           L   T+NF +       N +G+GGFG VYKG +++   VAVK+L++     +E+   +F 
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFD 78
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
            E+ ++ K QH+NLV+LLGF  DGD+  LVY +MPNGSL   L        L W  R  I
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-- 511
             G A G+ +LHE+     +HRD+K++N+LLD    +KISDFG+AR    SE  A TV  
Sbjct: 139 AQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMX 192
Query: 512 -RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            RIVGT  YMAPE A+ G  + KSD++SFGV+L+EIITG
Sbjct: 193 SRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 96/216 (44%), Positives = 133/216 (61%), Gaps = 15/216 (6%)
Query: 344 LNLATSNFSD------SNILGQGGFGPVYKGVLSDGKEVAVKRLSS----CSEQGTAEFT 393
           L   T+NF +       N +G+GGFG VYKG +++   VAVK+L++     +E+   +F 
Sbjct: 14  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFD 72
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
            E+ ++ K QH+NLV+LLGF  DGD+  LVY +MPNGSL   L        L W  R  I
Sbjct: 73  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 132
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
             G A G+ +LHE+     +HRD+K++N+LLD    +KISDFG+AR   +        RI
Sbjct: 133 AQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRI 189
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           VGT  YMAPE A+ G  + KSD++SFGV+L+EIITG
Sbjct: 190 VGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  157 bits (397), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 94/216 (43%), Positives = 129/216 (59%), Gaps = 15/216 (6%)
Query: 344 LNLATSNFSD------SNILGQGGFGPVYKGVLSDGKEVAVKRLSS----CSEQGTAEFT 393
           L   T+NF +       N  G+GGFG VYKG +++   VAVK+L++     +E+   +F 
Sbjct: 11  LKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQFD 69
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
            E+ +  K QH+NLV+LLGF  DGD+  LVY + PNGSL   L        L W  R  I
Sbjct: 70  QEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKI 129
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
             G A G+ +LHE+     +HRD+K++N+LLD    +KISDFG+AR   +        RI
Sbjct: 130 AQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRI 186
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           VGT  Y APE A+ G  + KSD++SFGV+L+EIITG
Sbjct: 187 VGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/217 (39%), Positives = 134/217 (61%), Gaps = 4/217 (1%)
Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN 394
           + + + L  L  AT+NF    ++G G FG VYKGVL DG +VA+KR +  S QG  EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNI 453
           E+  +   +H +LV L+GFC + +E +L+Y++M NG+L   L+      + + W +R  I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
             G A+G+ YLH  +   I+HRD+K+ N+LLD +   KI+DFG+++   E +       +
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            GT GY+ PEY ++G  ++KSDV+SFGV+L E++  R
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  153 bits (386), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 88/218 (40%), Positives = 137/218 (62%), Gaps = 6/218 (2%)
Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN 394
           + + + L  L  AT+NF    ++G G FG VYKGVL DG +VA+KR +  S QG  EF  
Sbjct: 25  ESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFET 84
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNI 453
           E+  +   +H +LV L+GFC + +E +L+Y++M NG+L   L+      + + W +R  I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
             G A+G+ YLH  +   I+HRD+K+ N+LLD +   KI+DFG+++   E  G+ +   +
Sbjct: 145 CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL-GQTHLXXV 200
Query: 514 V-GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           V GT GY+ PEY ++G  ++KSDV+SFGV+L E++  R
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/220 (35%), Positives = 117/220 (53%), Gaps = 23/220 (10%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE----FTNEVLLI 399
           L +  +  +   I+G GGFG VY+     G EVAVK      ++  ++       E  L 
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIA 458
             L+H N++ L G C+      LV EF   G L+ +L   R    IL      N    IA
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL-----VNWAVQIA 115
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLL-----DSDMNSKI---SDFGMARIFAESEGEANT 510
           +GM YLH+++ + I+HRDLK+SN+L+     + D+++KI   +DFG+AR +  +      
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TK 171
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           +   G Y +MAPE     ++SK SDV+S+GVLL E++TG 
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 126/238 (52%), Gaps = 19/238 (7%)
Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL--SDGKE- 375
           + ++Q   G D +     F     T  +  S  +   ++G G FG VYKG+L  S GK+ 
Sbjct: 19  NLYFQGAMGSDPNQAVLKF-----TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKE 73
Query: 376 --VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
             VA+K L +  +E+   +F  E  ++ +  H N+++L G        +++ E+M NG+L
Sbjct: 74  VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
           D  L +  K G     +   ++ GIA GM YL   + +  VHRDL A N+L++S++  K+
Sbjct: 134 DKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKV 188
Query: 493 SDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           SDFG++R+  E + EA      G     + APE      ++  SDV+SFG+++ E++T
Sbjct: 189 SDFGLSRVL-EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 72/219 (32%), Positives = 117/219 (53%), Gaps = 6/219 (2%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEV 396
           +D + +++   + +    +G G FG V++     G +VAVK L       +   EF  EV
Sbjct: 27  MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREV 85
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            ++ +L+H N+V  +G         +V E++  GSL  +L     R  L  R+R ++   
Sbjct: 86  AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +AKGM YLH +    IVHRDLK+ N+L+D     K+ DFG++R+ A     +      GT
Sbjct: 146 VAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA--AGT 202
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS 555
             +MAPE   +   ++KSDV+SFGV+L E+ T ++  G+
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 119/219 (54%), Gaps = 6/219 (2%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEV 396
           +D + +++   + +    +G G FG V++     G +VAVK L       +   EF  EV
Sbjct: 27  MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREV 85
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            ++ +L+H N+V  +G         +V E++  GSL  +L     R  L  R+R ++   
Sbjct: 86  AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +AKGM YLH +    IVHR+LK+ N+L+D     K+ DFG++R+ A +   + +    GT
Sbjct: 146 VAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGT 202
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS 555
             +MAPE   +   ++KSDV+SFGV+L E+ T ++  G+
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 123/253 (48%), Gaps = 43/253 (16%)
Query: 315 ANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV---LS 371
           A  +  H QH++ RD  LK +                     LG+G FG V+      LS
Sbjct: 2   AMHSGIHVQHIKRRDIVLKRE---------------------LGEGAFGKVFLAECYNLS 40
Query: 372 DGKE---VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 428
             K+   VAVK L   +     +F  E  L+  LQH+++VK  G C DGD  ++V+E+M 
Sbjct: 41  PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK 100
Query: 429 NGSLDA----------ILFD--PRK-RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
           +G L+           IL D  PR+ +G L   +  +I + IA GM+YL   +    VHR
Sbjct: 101 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHR 157
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSD 535
           DL   N L+ +++  KI DFGM+R    ++        +    +M PE  M   ++ +SD
Sbjct: 158 DLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 217
Query: 536 VFSFGVLLIEIIT 548
           V+SFGV+L EI T
Sbjct: 218 VWSFGVILWEIFT 230

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 79/219 (36%), Positives = 118/219 (53%), Gaps = 20/219 (9%)
Query: 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE 395
           ++ +  ETL L          LG G FG V+ G  +   +VAVK L   S    A F  E
Sbjct: 13  EWEVPRETLKLVER-------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAE 64
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIV 454
             L+ +LQH+ LV+L    V  +   ++ E+M NGSL   L  P   GI L   K  ++ 
Sbjct: 65  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMA 121
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             IA+GM ++ E +    +HRDL+A+N+L+   ++ KI+DFG+AR+  ++E    T R  
Sbjct: 122 AQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREG 175
Query: 515 GTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
             +   + APE    G ++ KSDV+SFG+LL EI+T  R
Sbjct: 176 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGK----EVAVKRLSSCS-EQGTAEFTNEVLLI 399
           L  +      +LG G FG VYKG+ + +G+     VA+K L+  +  +   EF +E L++
Sbjct: 12  LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 71
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + H +LV+LLG C+    +L V + MP+G L   + + +    +  +   N    IAK
Sbjct: 72  ASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDN--IGSQLLLNWCVQIAK 128
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM+YL E    R+VHRDL A NVL+ S  + KI+DFG+AR+    E E N         +
Sbjct: 129 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E      ++ +SDV+S+GV + E++T
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/219 (36%), Positives = 118/219 (53%), Gaps = 20/219 (9%)
Query: 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE 395
           ++ +  ETL L          LG G FG V+ G  +   +VAVK L   S    A F  E
Sbjct: 15  EWEVPRETLKLVER-------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAE 66
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIV 454
             L+ +LQH+ LV+L    V  +   ++ E+M NGSL   L  P   GI L   K  ++ 
Sbjct: 67  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMA 123
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             IA+GM ++ E +    +HRDL+A+N+L+   ++ KI+DFG+AR+  ++E    T R  
Sbjct: 124 AQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREG 177
Query: 515 GTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
             +   + APE    G ++ KSDV+SFG+LL EI+T  R
Sbjct: 178 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/219 (36%), Positives = 118/219 (53%), Gaps = 20/219 (9%)
Query: 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE 395
           ++ +  ETL L          LG G FG V+ G  +   +VAVK L   S    A F  E
Sbjct: 16  EWEVPRETLKLVER-------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAE 67
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIV 454
             L+ +LQH+ LV+L    V  +   ++ E+M NGSL   L  P   GI L   K  ++ 
Sbjct: 68  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMA 124
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             IA+GM ++ E +    +HRDL+A+N+L+   ++ KI+DFG+AR+  ++E    T R  
Sbjct: 125 AQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREG 178
Query: 515 GTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
             +   + APE    G ++ KSDV+SFG+LL EI+T  R
Sbjct: 179 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/213 (34%), Positives = 115/213 (53%), Gaps = 20/213 (9%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGK----EVAVKRLSSCS-EQGTAEFTNEVLLI 399
           L  +      +LG G FG VYKG+ + +G+     VA+K L+  +  +   EF +E L++
Sbjct: 35  LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 94
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVN 455
             + H +LV+LLG C+    +L V + MP+G L   + + +     + +L W        
Sbjct: 95  ASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CV 147
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            IAKGM+YL E    R+VHRDL A NVL+ S  + KI+DFG+AR+    E E N      
Sbjct: 148 QIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 204
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              +MA E      ++ +SDV+S+GV + E++T
Sbjct: 205 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 79
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 80  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 134
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 192 SDVWSFGILLTEIVTHGR 209

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 79/219 (36%), Positives = 118/219 (53%), Gaps = 20/219 (9%)
Query: 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE 395
           ++ +  ETL L          LG G FG V+ G  +   +VAVK L   S    A F  E
Sbjct: 7   EWEVPRETLKLVER-------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAE 58
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIV 454
             L+ +LQH+ LV+L    V  +   ++ E+M NGSL   L  P   GI L   K  ++ 
Sbjct: 59  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMA 115
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             IA+GM ++ E +    +HRDL+A+N+L+   ++ KI+DFG+AR+  ++E    T R  
Sbjct: 116 AQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREG 169
Query: 515 GTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
             +   + APE    G ++ KSDV+SFG+LL EI+T  R
Sbjct: 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 80
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 81  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 135
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNE---XTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 193 SDVWSFGILLTEIVTHGR 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 79/219 (36%), Positives = 118/219 (53%), Gaps = 20/219 (9%)
Query: 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE 395
           ++ +  ETL L          LG G FG V+ G  +   +VAVK L   S    A F  E
Sbjct: 17  EWEVPRETLKLVER-------LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAE 68
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIV 454
             L+ +LQH+ LV+L    V  +   ++ E+M NGSL   L  P   GI L   K  ++ 
Sbjct: 69  ANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMA 125
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             IA+GM ++ E +    +HRDL+A+N+L+   ++ KI+DFG+AR+  ++E    T R  
Sbjct: 126 AQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREG 179
Query: 515 GTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
             +   + APE    G ++ KSDV+SFG+LL EI+T  R
Sbjct: 180 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/207 (36%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I KL H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 466 EDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-PVKWMP 214
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 84
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 197 SDVWSFGILLTEIVTHGR 214

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/207 (36%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I KL H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 466 EDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-PVKWMP 228
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 83
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 84  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 196 SDVWSFGILLTEIVTHGR 213

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/198 (37%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 73
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 74  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 128
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 186 SDVWSFGILLTEIVTHGR 203

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 466 EDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KWMP 240
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 466 EDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-PVKWMP 228
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 466 EDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-PVKWMP 213
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 466 EDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KWMP 230
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 466 EDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-PVKWMP 214
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 466 EDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KWMP 220
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 466 EDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-PVKWMP 213
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/224 (31%), Positives = 109/224 (48%), Gaps = 19/224 (8%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAV-KRLSSCSEQGTAEFTNEVLLILKLQHKN 406
            S+     +LG+G FG   K    +  EV V K L    E+    F  EV ++  L+H N
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           ++K +G          + E++  G+L  I+     +    W +R +    IA GM YLH 
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS 126
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR------------IV 514
              + I+HRDL + N L+  + N  ++DFG+AR+  + + +   +R            +V
Sbjct: 127 ---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL 558
           G   +MAPE      Y +K DVFSFG++L EII GR NA  + L
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYL 226

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 466 EDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-PVKWMP 205
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/201 (35%), Positives = 113/201 (56%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VA+K L   +      F  E  ++ KL+H  LV+L  + V 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQL--YAVV 73
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---GIAKGMLYLHEDSRLRI 472
            +E + +V E+M  GSL   L D   R +    K  N+V+    +A GM Y+    R+  
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRAL----KLPNLVDMAAQVAAGMAYIE---RMNY 126
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLY 530
           +HRDL+++N+L+ + +  KI+DFG+AR+  ++E    T R    +   + APE A+ G +
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNE---XTARQGAKFPIKWTAPEAALYGRF 183
Query: 531 SKKSDVFSFGVLLIEIITGRR 551
           + KSDV+SFG+LL E++T  R
Sbjct: 184 TIKSDVWSFGILLTELVTKGR 204

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/198 (37%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 74
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 75  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           +L+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 187 SDVWSFGILLTEIVTHGR 204

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/215 (35%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  ++  +VAVK L   +    A F  E  L+  LQH  LV+L      
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
            +   ++ E+M  GSL   L    + G +   K  +    IA+GM Y+    R   +HRD
Sbjct: 80  EEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKKS 534
           L+A+NVL+   +  KI+DFG+AR+  ++E    T R    +   + APE    G ++ KS
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 535 DVFSFGVLLIEIIT-------GRRNAGSNQLLAYG 562
           DV+SFG+LL EI+T       GR NA     L+ G
Sbjct: 193 DVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG 227

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 74/198 (37%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G  G V+ G  +   +VAVK L   S    A F  E  L+ +LQH+ LV+L    V 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ E+M NGSL   L  P   GI L   K  ++   IA+GM ++ E +    +HR
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+   ++ KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAE---XTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL EI+T  R
Sbjct: 191 SDVWSFGILLTEIVTHGR 208

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 466 EDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           E+     +HRD+ A N LL        +KI DFGMAR    +         +    +M P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E  MEG+++ K+D +SFGVLL EI +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 72/206 (34%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 466 EDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           E+     +HRD+ A N LL        +KI DFGMAR    +         +    +M P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E  MEG+++ K+D +SFGVLL EI +
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 466 EDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMA+ I+  S        ++    +M 
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML-PVKWMP 214
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 76/215 (35%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+ G  ++  +VAVK L   +    A F  E  L+  LQH  LV+L      
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
            +   ++ EFM  GSL   L    + G +   K  +    IA+GM Y+    R   +HRD
Sbjct: 79  EEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKKS 534
           L+A+NVL+   +  KI+DFG+AR+  ++E    T R    +   + APE    G ++ KS
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 535 DVFSFGVLLIEIIT-------GRRNAGSNQLLAYG 562
           +V+SFG+LL EI+T       GR NA     L+ G
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQG 226

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 75/233 (32%), Positives = 111/233 (47%), Gaps = 27/233 (11%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQ 387
           A D F+     ++   N      LG+G FG V+           D   VAVK L   S+ 
Sbjct: 2   AMDTFVQ----HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN 57
Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL---------DAILF- 437
              +F  E  L+  LQH+++VK  G CV+GD  ++V+E+M +G L         DA+L  
Sbjct: 58  ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 117
Query: 438 --DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF 495
             +P     L   +  +I   IA GM+YL   +    VHRDL   N L+  ++  KI DF
Sbjct: 118 EGNPPTE--LTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDF 172
Query: 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           GM+R    ++        +    +M PE  M   ++ +SDV+S GV+L EI T
Sbjct: 173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 72
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 186 SDVWSFGILLTELTTKGR 203

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 331
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 445 SDVWSFGILLTELTTKGR 462

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 362 SDVWSFGILLTELTTKGR 379

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNE---XTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSE 386
           A D ++  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + S 
Sbjct: 5   AADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 63
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR---- 442
           +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R      
Sbjct: 64  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 123
Query: 443 ---GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
                    K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM R
Sbjct: 124 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 181 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 75
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 189 SDVWSFGILLTELTTKGR 206

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 73
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 187 SDVWSFGILLTELTTKGR 204

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 71
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 185 SDVWSFGILLTELTTKGR 202

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 345 NLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSEQGTAEFTNEVL 397
            +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + S +   EF NE  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-------GILCWRKR 450
           ++ +    ++V+LLG    G   L++ E M  G L + L   R               K 
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM R   E++     
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/229 (33%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSE 386
           A D F+  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + S 
Sbjct: 2   AADVFVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 60
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR---- 442
           +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R      
Sbjct: 61  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 120
Query: 443 ---GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
                    K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM R
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 178 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V+           D   VAVK L   SE    +F  E  L+  LQH+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKR----------GILCWRKRTNIVNGIA 458
            G C +G   L+V+E+M +G L+  L    P  +          G L   +   + + +A
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            GM+YL   + L  VHRDL   N L+   +  KI DFGM+R    ++      R +    
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +M PE  +   ++ +SDV+SFGV+L EI T
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V+           D   VAVK L   SE    +F  E  L+  LQH+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKR----------GILCWRKRTNIVNGIA 458
            G C +G   L+V+E+M +G L+  L    P  +          G L   +   + + +A
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            GM+YL   + L  VHRDL   N L+   +  KI DFGM+R    ++      R +    
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +M PE  +   ++ +SDV+SFGV+L EI T
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEW---TARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/197 (35%), Positives = 105/197 (53%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G G FG V+ G   +  +VA+K  R  + SE+   +F  E  +++KL H  LV+L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           ++     LV+EFM +G L   L    +RG+        +   + +GM YL E S   ++H
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYS 531
           RDL A N L+  +   K+SDFGM R   + +  ++T    GT     + +PE      YS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 182
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSDV+SFGVL+ E+ +
Sbjct: 183 SKSDVWSFGVLMWEVFS 199

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ K++H+ LV+L  + V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQL--YAVV 82
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 357 LGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V+           D   VAVK L   SE    +F  E  L+  LQH+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKR----------GILCWRKRTNIVNGIA 458
            G C +G   L+V+E+M +G L+  L    P  +          G L   +   + + +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            GM+YL   + L  VHRDL   N L+   +  KI DFGM+R    ++      R +    
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +M PE  +   ++ +SDV+SFGV+L EI T
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 111/198 (56%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGK-YLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 193 SDVWSFGILLTELTTKGR 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 73/207 (35%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 357 LGQGGFGPVYKGVLSDGK------EVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG VY+G +S         +VAVK L    SEQ   +F  E L+I K  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGIAKGMLYLH 465
            +G  +    + ++ E M  G L + L + R R      L      ++   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 466 EDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGYMA 521
           E+     +HRD+ A N LL        +KI DFGMAR I+  S        ++    +M 
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV-KWMP 228
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 114/231 (49%), Gaps = 18/231 (7%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SC 384
           + A D ++  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + 
Sbjct: 2   VSAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 60
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-- 442
           S +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R    
Sbjct: 61  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 443 -----GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
                      K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            R   E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 249
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  GSL   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+ R+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 363 SDVWSFGILLTELTTKGR 380

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 114/231 (49%), Gaps = 18/231 (7%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SC 384
           + A D ++  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + 
Sbjct: 2   VSAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 60
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-- 442
           S +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R    
Sbjct: 61  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 120
Query: 443 -----GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
                      K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            R   E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 178 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 113/231 (48%), Gaps = 18/231 (7%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SC 384
             A D ++  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + 
Sbjct: 31  FSAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 89
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-- 442
           S +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R    
Sbjct: 90  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 149
Query: 443 -----GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
                      K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM
Sbjct: 150 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 206
Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            R   E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 207 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSE 386
           A D ++  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + S 
Sbjct: 11  AADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 69
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR---- 442
           +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R      
Sbjct: 70  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENN 129
Query: 443 ---GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
                    K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM R
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/231 (32%), Positives = 113/231 (48%), Gaps = 18/231 (7%)
Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SC 384
             A D ++  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + 
Sbjct: 3   FSAADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-- 442
           S +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R    
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 443 -----GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
                      K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            R   E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 179 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  G L   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSE 386
           A D ++  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + S 
Sbjct: 1   AADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 59
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR---- 442
           +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R      
Sbjct: 60  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 119
Query: 443 ---GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
                    K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM R
Sbjct: 120 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 177 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/198 (35%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LGQG FG V+ G  +    VA+K L   +    A F  E  ++ KL+H+ LV+L  + V 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 417 GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +E + +V E+M  G L   L     +  L   +  ++   IA GM Y+    R+  VHR
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLKGEMGK-YLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+  ++  K++DFG+AR+  ++E    T R    +   + APE A+ G ++ K
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 534 SDVFSFGVLLIEIITGRR 551
           SDV+SFG+LL E+ T  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 113/229 (49%), Gaps = 18/229 (7%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSE 386
           A D ++  E   +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + S 
Sbjct: 11  AADVYVPDE-WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 69
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR---- 442
           +   EF NE  ++ +    ++V+LLG    G   L++ E M  G L + L   R      
Sbjct: 70  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 443 ---GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
                    K   +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM R
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              E++      + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G G FG V+ G   +  +VA+K  R  + SE+   +F  E  +++KL H  LV+L G C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           ++     LV+EFM +G L   L    +RG+        +   + +GM YL E     ++H
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYS 531
           RDL A N L+  +   K+SDFGM R   + +  ++T    GT     + +PE      YS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 180
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSDV+SFGVL+ E+ +
Sbjct: 181 SKSDVWSFGVLMWEVFS 197

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ EF+P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 135
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 194
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 11/210 (5%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLI 399
            L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
            +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA 
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIAS 158
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYG 518
           GM YL   S +  VHRDL A N+L++S++  K+SDFG+AR+  +    A T R       
Sbjct: 159 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIR 215
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           + +PE      ++  SDV+S+G++L E+++
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 111/201 (55%), Gaps = 13/201 (6%)
Query: 356 ILGQGGFGPVYKGVL-SDGKE---VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKL 410
           ++G G FG V +G L + GK+   VA+K L    +E+   EF +E  ++ + +H N+++L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
            G   +    +++ EFM NG+LD+ L      G     +   ++ GIA GM YL E   +
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAE---M 137
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG---TYGYMAPEYAME 527
             VHRDL A N+L++S++  K+SDFG++R   E+  +      +G      + APE    
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             ++  SD +S+G+++ E+++
Sbjct: 198 RKFTSASDAWSYGIVMWEVMS 218

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 108/218 (49%), Gaps = 17/218 (7%)
Query: 345 NLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSEQGTAEFTNEVL 397
            +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + S +   EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-------GILCWRKR 450
           ++ +    ++V+LLG    G   L++ E M  G L + L   R               K 
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             +   IA GM YL+ +   + VHRDL A N ++  D   KI DFGM R   E++     
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G G FG V+ G   +  +VA+K  R  + SE+   +F  E  +++KL H  LV+L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           ++     LV+EFM +G L   L    +RG+        +   + +GM YL E     ++H
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYS 531
           RDL A N L+  +   K+SDFGM R   + +  ++T    GT     + +PE      YS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 182
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSDV+SFGVL+ E+ +
Sbjct: 183 SKSDVWSFGVLMWEVFS 199

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G G FG V+ G   +  +VA+K  R  + SE+   +F  E  +++KL H  LV+L G C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           ++     LV+EFM +G L   L    +RG+        +   + +GM YL E     ++H
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYS 531
           RDL A N L+  +   K+SDFGM R   + +  ++T    GT     + +PE      YS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 185
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSDV+SFGVL+ E+ +
Sbjct: 186 SKSDVWSFGVLMWEVFS 202

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 111/202 (54%), Gaps = 13/202 (6%)
Query: 355 NILGQGGFGPVYKGVL-SDGKE---VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
            ++G G FG V +G L + GK+   VA+K L    +E+   EF +E  ++ + +H N+++
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G   +    +++ EFM NG+LD+ L      G     +   ++ GIA GM YL E   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAE--- 134
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG---TYGYMAPEYAM 526
           +  VHRDL A N+L++S++  K+SDFG++R   E+  +      +G      + APE   
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
              ++  SD +S+G+++ E+++
Sbjct: 195 FRKFTSASDAWSYGIVMWEVMS 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 159
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       +
Sbjct: 160 MKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 13/195 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG V+ G   +  +VA+K +   S     +F  E  +++KL H  LV+L G C++
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
                LV+EFM +G L   L    +RG+        +   + +GM YL E     ++HRD
Sbjct: 94  QAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRD 148
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYSKK 533
           L A N L+  +   K+SDFGM R   + +  ++T    GT     + +PE      YS K
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSK 204
Query: 534 SDVFSFGVLLIEIIT 548
           SDV+SFGVL+ E+ +
Sbjct: 205 SDVWSFGVLMWEVFS 219

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 11/210 (5%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLI 399
            L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
            +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA 
Sbjct: 99  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIAS 156
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYG 518
           GM YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       
Sbjct: 157 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 213
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           + +PE      ++  SDV+S+G++L E+++
Sbjct: 214 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 115/209 (55%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 130 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 107/218 (49%), Gaps = 17/218 (7%)
Query: 345 NLATSNFSDSNILGQGGFGPVY----KGVLSDGKE--VAVKRLS-SCSEQGTAEFTNEVL 397
            +A    + S  LGQG FG VY    KGV+ D  E  VA+K ++ + S +   EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-------GILCWRKR 450
           ++ +    ++V+LLG    G   L++ E M  G L + L   R               K 
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             +   IA GM YL+ +   + VHRDL A N  +  D   KI DFGM R   E++     
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            + +    +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A + +   G     ++ G+  +MAPE      +  YS +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 190 SDVYAFGIVLYELMTGQ 206

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXL--LDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 159
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       +
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 123 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 115/209 (55%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 72
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 130 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 159
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       +
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 159
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       +
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRLSSC-SEQGTAEFTNEVL 397
           T  +  S      I+G G  G V  G L    +    VA+K L +  +E+   +F +E  
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++ +  H N+++L G    G   ++V E+M NGSLD  L      G     +   ++ G+
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGV 160
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
             GM YL   S L  VHRDL A NVL+DS++  K+SDFG++R+  +    A T     T 
Sbjct: 161 GAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TG 213
Query: 518 G-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           G     + APE      +S  SDV+SFGV++ E++ 
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 115/209 (55%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 81
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 138
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 139 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 11/210 (5%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLI 399
            L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
            +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA 
Sbjct: 72  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIAS 129
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYG 518
           GM YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       
Sbjct: 130 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 186
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           + +PE      ++  SDV+S+G++L E+++
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 115/209 (55%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 115/209 (55%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 133 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A + +   G     ++ G+  +MAPE      +  YS +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 190 SDVYAFGIVLYELMTGQ 206

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 115/209 (55%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 111/209 (53%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 159
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       +
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 78  -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 131
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A + +   G     ++ G+  +MAPE      +  YS +
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 192 SDVYAFGIVLYELMTGQ 208

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 77
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 134
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 135 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 96
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 154 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 81  -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A + +   G     ++ G+  +MAPE      +  YS +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 195 SDVYAFGIVLYELMTGQ 211

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 74
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 132 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 131
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 190
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 11/210 (5%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLI 399
            L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
            +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA 
Sbjct: 89  GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIAS 146
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYG 518
           GM YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       
Sbjct: 147 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 203
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           + +PE      ++  SDV+S+G++L E+++
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 81  -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 134
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A + +   G     ++ G+  +MAPE      +  YS +
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 195 SDVYAFGIVLYELMTGQ 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 163
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 222
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 130
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 189
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 190 SKFSVASDVWSFGVVLYELFT 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 138
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 197
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 137
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 196
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E+M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 159
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG+ R+  +    A T R       +
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/201 (34%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPVYK---GVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V       L D  G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 132
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 191
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 135
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 194
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +     +K  +I    A+GM YLH  S   I+HRD
Sbjct: 80  -PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHRD 133
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D   KI DFG+A + +   G     ++ G+  +MAPE         YS +
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 194 SDVYAFGIVLYELMTGQ 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 139
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 198
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 132
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 191
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRLSSC-SEQGTAEFTNEVL 397
           T  +  S      I+G G  G V  G L    +    VA+K L +  +E+   +F +E  
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++ +  H N+++L G    G   ++V E+M NGSLD  L      G     +   ++ G+
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGV 160
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
             GM YL   S L  VHRDL A NVL+DS++  K+SDFG++R+  +    A T     T 
Sbjct: 161 GAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TG 213
Query: 518 G-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           G     + APE      +S  SDV+SFGV++ E++ 
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 103 -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 156
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A + +   G     ++ G+  +MAPE      +  YS +
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 217 SDVYAFGIVLYELMTGQ 233

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 136
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 195
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 196 SKFSVASDVWSFGVVLYELFT 216

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L   R        R     ++   +   IA GM 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHRDL A N ++  D   KI DFGM R   E++      + +    +MAP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G G FG V+ G   +  +VA+K  R  + SE+   +F  E  +++KL H  LV+L G C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           ++     LV EFM +G L   L    +RG+        +   + +GM YL E     ++H
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAMEGLYS 531
           RDL A N L+  +   K+SDFGM R   + +  ++T    GT     + +PE      YS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 183
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSDV+SFGVL+ E+ +
Sbjct: 184 SKSDVWSFGVLMWEVFS 200

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 105/197 (53%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 104 -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 157
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A + +   G     ++ G+  +MAPE      +  YS +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 218 SDVYAFGIVLYELMTGQ 234

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 150
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 209
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L   R        R     ++   +   IA GM 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHRDL A N ++  D   KI DFGM R   E++      + +    +MAP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 150
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 209
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L   R        R     ++   +   IA GM 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHRDL A N ++  D   KI DFGM R   E++      + +    +MAP
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 75
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG A++    E E +         +
Sbjct: 133 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 118/231 (51%), Gaps = 27/231 (11%)
Query: 338 FIDLETL---NLATSNFSDS---------NILGQGGFGPVYKGVLS-DGKE---VAVKRL 381
           +ID ET    N A   F+            ++G G FG V  G L   GK    VA+K L
Sbjct: 20  YIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTL 79
Query: 382 S-SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
               +E+   +F  E  ++ +  H N+V L G    G   ++V EFM NG+LDA L   R
Sbjct: 80  KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL---R 136
Query: 441 KR-GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           K  G     +   ++ GIA GM YL +   +  VHRDL A N+L++S++  K+SDFG++R
Sbjct: 137 KHDGQFTVIQLVGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSR 193
Query: 500 IFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +  E + EA      G     + APE      ++  SDV+S+G+++ E+++
Sbjct: 194 VI-EDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 13/202 (6%)
Query: 355 NILGQGGFGPVYKGVLS-DGKE---VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
            ++G G FG V  G L   GK    VA+K L S  +E+   +F +E  ++ +  H N++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G        +++ EFM NGSLD+ L   +  G     +   ++ GIA GM YL +   
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLAD--- 153
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG---TYGYMAPEYAM 526
           +  VHRDL A N+L++S++  K+SDFG++R   +   +      +G      + APE   
Sbjct: 154 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
              ++  SDV+S+G+++ E+++
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMS 235

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG A++    E E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG A++    E E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 113/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG A++    E E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 159
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       +
Sbjct: 160 MKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 159
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       +
Sbjct: 160 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 216
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 113/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 73
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG A++    E E +         +
Sbjct: 131 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 68
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IA+
Sbjct: 69  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 126 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG--VLSDGKE--VAVKRLS-SCSEQGTAEFTNEVLLIL 400
           L  +N S   ++G G FG V  G   L   KE  VA+K L    +E+   +F  E  ++ 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           +  H N+++L G        ++V E M NGSLD+ L     +  +   +   ++ GIA G
Sbjct: 73  QFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI--QLVGMLRGIASG 130
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGY 519
           M YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       +
Sbjct: 131 MKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +PE      ++  SDV+S+G++L E+++
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 113/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG A++    E E +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAE-------FTNEVL 397
           LA +       +G+GGFG V+KG ++ D   VA+K L     +G  E       F  EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++  L H N+VKL G     +   +V EF+P G L   L D  K   + W  +  ++  I
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS----KISDFGMARIFAESEGEANTVR 512
           A G+ Y+ ++    IVHRDL++ N+ L S D N+    K++DFG+++    S        
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSG 185
Query: 513 IVGTYGYMAPEY--AMEGLYSKKSDVFSFGVLLIEIITGR 550
           ++G + +MAPE   A E  Y++K+D +SF ++L  I+TG 
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 132
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVKEPGESPIFWYAPESLTE 191
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L    +R  +   K     + I KGM YL     
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL---GT 135
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HRDL   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EXXKVKEPGESPIFWYAPESLTE 194
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 113/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +L  G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 71
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 129 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 114/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +L  G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L++ + MP G L  + +    +  +  +   N    IAK
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGK----EVAVKRL-SSCSEQGTAEFTNEVLLI 399
           L  +      +LG G FG VYKG+ + DG+     VA+K L  + S +   E  +E  ++
Sbjct: 14  LKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 73
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIA 458
             +    + +LLG C+    +L V + MP G L D +      RG L  +   N    IA
Sbjct: 74  AGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVR---ENRGRLGSQDLLNWCMQIA 129
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           KGM YL +   +R+VHRDL A NVL+ S  + KI+DFG+AR+    E E +         
Sbjct: 130 KGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 186
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +MA E  +   ++ +SDV+S+GV + E++T
Sbjct: 187 WMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 96  -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 149
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A   +   G     ++ G+  +MAPE      +  YS +
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 210 SDVYAFGIVLYELMTGQ 226

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 76  -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 129
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A   +   G     ++ G+  +MAPE      +  YS +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 190 SDVYAFGIVLYELMTGQ 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/220 (33%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAE-------FTNEVL 397
           LA +       +G+GGFG V+KG ++ D   VA+K L     +G  E       F  EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++  L H N+VKL G     +   +V EF+P G L   L D  K   + W  +  ++  I
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS----KISDFGMARIFAESEGEANTVR 512
           A G+ Y+ ++    IVHRDL++ N+ L S D N+    K++DFG ++    S        
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHS-----VSG 185
Query: 513 IVGTYGYMAPEY--AMEGLYSKKSDVFSFGVLLIEIITGR 550
           ++G + +MAPE   A E  Y++K+D +SF ++L  I+TG 
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +     +K  +I    A+GM YLH  S   I+HRD
Sbjct: 91  APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D   KI DFG+A   +   G     ++ G+  +MAPE         YS +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 206 SDVYAFGIVLYELMTGQ 222

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 113/209 (54%), Gaps = 12/209 (5%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +L  G FG VYKG+ + +G++V    A+K L  + S +   E  +E  ++
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 78
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
             + + ++ +LLG C+    +L+  + MP G L  + +    +  +  +   N    IAK
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           GM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +         +
Sbjct: 136 GMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 114/213 (53%), Gaps = 20/213 (9%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEV----AVKRL-SSCSEQGTAEFTNEVLLI 399
           L  + F    +LG G FG VYKG+ + +G++V    A+  L  + S +   E  +E  ++
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVM 105
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVN 455
             + + ++ +LLG C+    +L+  + MP G L   + + +     + +L W        
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CV 158
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            IAKGM YL ED RL  VHRDL A NVL+ +  + KI+DFG+A++    E E +      
Sbjct: 159 QIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              +MA E  +  +Y+ +SDV+S+GV + E++T
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L   R        R     ++   +   IA GM 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHRDL A N ++  D   KI DFGM R   E++      + +    +MAP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV----YKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V    Y  +  + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 412 GFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G C     +   L+ E++P GSL   L   ++R  +   K     + I KGM YL     
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---GT 133
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R +HR+L   N+L++++   KI DFG+ ++  + + E   V+  G     + APE   E
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDK-EYYKVKEPGESPIFWYAPESLTE 192
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SDV+SFGV+L E+ T
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +     +K  +I    A+GM YLH  S   I+HRD
Sbjct: 92  -PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---IIHRD 145
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D   KI DFG+A   +   G     ++ G+  +MAPE         YS +
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 206 SDVYAFGIVLYELMTGQ 222

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++  +G+   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             +  +V ++    SL   L     +  +   K  +I    A+GM YLH  S   I+HRD
Sbjct: 104 -PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIHRD 157
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKK 533
           LK++N+ L  D+  KI DFG+A   +   G     ++ G+  +MAPE      +  YS +
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 534 SDVFSFGVLLIEIITGR 550
           SDV++FG++L E++TG+
Sbjct: 218 SDVYAFGIVLYELMTGQ 234

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 11/200 (5%)
Query: 355 NILGQGGFGPVYKGVLS-DGKE---VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
            ++G G FG V  G L   GK    VA+K L +  +++   +F +E  ++ +  H N++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G        +++ E+M NGSLDA L   +  G     +   ++ GI  GM YL   S 
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYL---SD 149
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGYMAPEYAMEG 528
           +  VHRDL A N+L++S++  K+SDFGM+R+  +    A T R       + APE     
Sbjct: 150 MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 209
Query: 529 LYSKKSDVFSFGVLLIEIIT 548
            ++  SDV+S+G+++ E+++
Sbjct: 210 KFTSASDVWSYGIVMWEVMS 229

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L   R        R     ++   +   IA GM 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHRDL A N ++  D   KI DFGM R   E++      + +    +MAP
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 11/210 (5%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKE---VAVKRLS-SCSEQGTAEFTNEVLLI 399
            +  S  +   ++G G FG V  G L   GK    VA+K L    +E+   +F  E  ++
Sbjct: 18  EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
            +  H N++ L G        ++V E+M NGSLD  L   +  G     +   ++ GI+ 
Sbjct: 78  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGISA 135
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYG 518
           GM YL   S +  VHRDL A N+L++S++  K+SDFG++R+  +    A T R       
Sbjct: 136 GMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 192
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           + APE      ++  SDV+S+G+++ E+++
Sbjct: 193 WTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 11/200 (5%)
Query: 355 NILGQGGFGPVYKGVLS-DGKE---VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
            ++G G FG V  G L   GK    VA+K L +  +++   +F +E  ++ +  H N++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G        +++ E+M NGSLDA L   +  G     +   ++ GI  GM YL   S 
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYL---SD 134
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGYMAPEYAMEG 528
           +  VHRDL A N+L++S++  K+SDFGM+R+  +    A T R       + APE     
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 529 LYSKKSDVFSFGVLLIEIIT 548
            ++  SDV+S+G+++ E+++
Sbjct: 195 KFTSASDVWSYGIVMWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 11/200 (5%)
Query: 355 NILGQGGFGPVYKGVLS-DGKE---VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
            ++G G FG V  G L   GK    VA+K L +  +++   +F +E  ++ +  H N++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G        +++ E+M NGSLDA L   +  G     +   ++ GI  GM YL   S 
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLR--KNDGRFTVIQLVGMLRGIGSGMKYL---SD 128
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG-TYGYMAPEYAMEG 528
           +  VHRDL A N+L++S++  K+SDFGM+R+  +    A T R       + APE     
Sbjct: 129 MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 529 LYSKKSDVFSFGVLLIEIIT 548
            ++  SDV+S+G+++ E+++
Sbjct: 189 KFTSASDVWSYGIVMWEVMS 208

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 112/207 (54%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 147
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E  +  N         +MA
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L   R        R     ++   +   IA GM 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHRDL A N ++  D   KI DFGM R   E+       + +    +MAP
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/203 (36%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 357 LGQGGFGPVY-----KGVLSDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V          + G++VAVK L   S     A+   E+ ++  L H+N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 411 LGFCVD--GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            G C +  G+   L+ EF+P+GSL   L  P+ +  +  +++      I KGM YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 132
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV---RIVGTYGYMAPEYA 525
           R + VHRDL A NVL++S+   KI DFG+ +   E++ E  TV   R    + Y APE  
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY-APECL 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIIT 548
           M+  +   SDV+SFGV L E++T
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 355 NILGQGGFGPVYKGVLS-DGKE---VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVK 409
            ++G G FG V  G L   GK    VA+K L S  +E+   +F +E  ++ +  H N++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G        +++ EFM NGSLD+ L   +  G     +   ++ GIA GM YL +   
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLAD--- 127
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG---TYGYMAPEYAM 526
           +  VHR L A N+L++S++  K+SDFG++R   +   +      +G      + APE   
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
              ++  SDV+S+G+++ E+++
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMS 209

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 350 NFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHK 405
           +F   N+LG+G F  VY+   +  G EVA+K +   +  + G  +   NEV +  +L+H 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           ++++L  +  D +   LV E   NG ++  L +  K       +  + ++ I  GMLYLH
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--FSENEARHFMHQIITGMLYLH 129
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDL  SN+LL  +MN KI+DFG+A        +  T  + GT  Y++PE A
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIA 184
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
               +  +SDV+S G +   ++ GR
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/203 (36%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 357 LGQGGFGPVY-----KGVLSDGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V          + G++VAVK L   S     A+   E+ ++  L H+N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 411 LGFCVD--GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            G C +  G+   L+ EF+P+GSL   L  P+ +  +  +++      I KGM YL   S
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV---RIVGTYGYMAPEYA 525
           R + VHRDL A NVL++S+   KI DFG+ +   E++ E  TV   R    + Y APE  
Sbjct: 145 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY-APECL 201
Query: 526 MEGLYSKKSDVFSFGVLLIEIIT 548
           M+  +   SDV+SFGV L E++T
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQGTAE-------FTNEVL 397
           LA +       +G+GGFG V+KG ++ D   VA+K L     +G  E       F  EV 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++  L H N+VKL G     +   +V EF+P G L   L D  K   + W  +  ++  I
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDI 131
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS----KISDFGMARIFAESEGEANTVR 512
           A G+ Y+ ++    IVHRDL++ N+ L S D N+    K++DF +++    S        
Sbjct: 132 ALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS-----VSG 185
Query: 513 IVGTYGYMAPEY--AMEGLYSKKSDVFSFGVLLIEIITGR 550
           ++G + +MAPE   A E  Y++K+D +SF ++L  I+TG 
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 108/198 (54%), Gaps = 14/198 (7%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+    +   +VAVK +   S    A F  E  ++  LQH  LVKL    V 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 80
Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ EFM  GSL D +  D   +  L   K  +    IA+GM ++ + +    +HR
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIHR 135
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+ + +  KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 534 SDVFSFGVLLIEIIT-GR 550
           SDV+SFG+LL+EI+T GR
Sbjct: 193 SDVWSFGILLMEIVTYGR 210

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L   R        R     ++   +   IA GM 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHR+L A N ++  D   KI DFGM R   E++      + +    +MAP
Sbjct: 145 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 146
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E ++  N         +MA
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/195 (35%), Positives = 106/195 (54%), Gaps = 13/195 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+    +   +VAVK +   S    A F  E  ++  LQH  LVKL    V 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 253
Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ EFM  GSL D +  D   +  L   K  +    IA+GM ++ + +    +HR
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIHR 308
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAMEGLYSKK 533
           DL+A+N+L+ + +  KI+DFG+AR+  ++E    T R    +   + APE    G ++ K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 534 SDVFSFGVLLIEIIT 548
           SDV+SFG+LL+EI+T
Sbjct: 366 SDVWSFGILLMEIVT 380

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 149
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E ++  N         +MA
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 148
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E ++  N         +MA
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 147
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLSD------GKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LGQG FG VY+G   D         VAVK ++ S S +   EF NE  ++      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIVNGIAKGML 462
           LLG    G   L+V E M +G L + L   R        R     ++   +   IA GM 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL+     + VHR+L A N ++  D   KI DFGM R   E++      + +    +MAP
Sbjct: 146 YLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   +G+++  SD++SFGV+L EI +
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 149
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E ++  N         +MA
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 148
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 148
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 167
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM +
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 153
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E ++  N         +MA
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 143
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 148
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E ++  N         +MA
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 140
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 141 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 145
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 166
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 111/207 (53%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM Y
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKY 146
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE--GEANTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E     N         +MA
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 113/207 (54%), Gaps = 21/207 (10%)
Query: 354 SNILGQGGFGPVYKGVL--SDGKEV--AVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLV 408
           + ++G+G FG VY G L  +DGK++  AVK L+  ++ G  ++F  E +++    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 409 KLLGFCVDGD-EKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLY 463
            LLG C+  +   L+V  +M +G L   +     +P  + ++ +  +      +AKGM +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ------VAKGMKF 207
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMA 521
           L   +  + VHRDL A N +LD     K++DFG+AR   + E ++  N         +MA
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E      ++ KSDV+SFGVLL E++T
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 106/199 (53%), Gaps = 18/199 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +GQG  G VY  + ++ G+EVA+++++   +       NE+L++ + ++ N+V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            GDE  +V E++  GSL  ++     D  +   +C            + + +LH +   +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 136
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           ++HRD+K+ N+LL  D + K++DFG        + + +T  +VGT  +MAPE      Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 194
Query: 532 KKSDVFSFGVLLIEIITGR 550
            K D++S G++ IE+I G 
Sbjct: 195 PKVDIWSLGIMAIEMIEGE 213

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE-----QGTAEFTNEVLLILKLQHKNLV 408
            +LG G FG V+KGV + +G+ + +       E     Q     T+ +L I  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           +LLG C  G    LV +++P GSL D +    + RG L  +   N    IAKGM YL E 
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
               +VHR+L A NVLL S    +++DFG+A +    + +           +MA E    
Sbjct: 135 G---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
           G Y+ +SDV+S+GV + E++T
Sbjct: 192 GKYTHQSDVWSYGVTVWELMT 212

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 20/200 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +GQG  G VY  + ++ G+EVA+++++   +       NE+L++ + ++ N+V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            GDE  +V E++  GSL  ++     D  +   +C            + + +LH +   +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 136
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           ++HRD+K+ N+LL  D + K++DFG  A+I  E   ++    +VGT  +MAPE      Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSEMVGTPYWMAPEVVTRKAY 193
Query: 531 SKKSDVFSFGVLLIEIITGR 550
             K D++S G++ IE+I G 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 298 KRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNIL 357
           K++     Q+Q+ ++  ++D ++ Y   +  + DLK +              N     +L
Sbjct: 4   KKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWE----------FPRENLEFGKVL 53
Query: 358 GQGGFGPVYK----GVLSDGK--EVAVKRLSSCSEQGTAE-FTNEVLLILKL-QHKNLVK 409
           G G FG V      G+   G   +VAVK L   ++    E   +E+ ++ +L  H+N+V 
Sbjct: 54  GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-------------DAILFDPRKR-------GILCWRK 449
           LLG C       L++E+   G L             D I ++ +KR        +L +  
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
                  +AKGM +L   S    VHRDL A NVL+      KI DFG+AR          
Sbjct: 174 LLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                    +MAPE   EG+Y+ KSDV+S+G+LL EI +
Sbjct: 231 RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE-----QGTAEFTNEVLLILKLQHKNLV 408
            +LG G FG V+KGV + +G+ + +       E     Q     T+ +L I  L H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           +LLG C  G    LV +++P GSL D +    + RG L  +   N    IAKGM YL E 
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYLEEH 152
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
               +VHR+L A NVLL S    +++DFG+A +    + +           +MA E    
Sbjct: 153 G---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 209
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
           G Y+ +SDV+S+GV + E++T
Sbjct: 210 GKYTHQSDVWSYGVTVWELMT 230

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 20/200 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +GQG  G VY  + ++ G+EVA+++++   +       NE+L++ + ++ N+V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            GDE  +V E++  GSL  ++     D  +   +C            + + +LH +   +
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 136
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           ++HRD+K+ N+LL  D + K++DFG  A+I  E   ++    +VGT  +MAPE      Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSXMVGTPYWMAPEVVTRKAY 193
Query: 531 SKKSDVFSFGVLLIEIITGR 550
             K D++S G++ IE+I G 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 108/200 (54%), Gaps = 20/200 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +GQG  G VY  + ++ G+EVA+++++   +       NE+L++ + ++ N+V  L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            GDE  +V E++  GSL  ++     D  +   +C            + + +LH +   +
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 137
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           ++HRD+K+ N+LL  D + K++DFG  A+I  E   ++    +VGT  +MAPE      Y
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSXMVGTPYWMAPEVVTRKAY 194
Query: 531 SKKSDVFSFGVLLIEIITGR 550
             K D++S G++ IE+I G 
Sbjct: 195 GPKVDIWSLGIMAIEMIEGE 214

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 112/205 (54%), Gaps = 15/205 (7%)
Query: 353 DSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           D  +LG+G +G VY G  LS+   +A+K +     + +     E+ L   L+HKN+V+ L
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 412 G-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT--NIVNGIAKGMLYLHEDS 468
           G F  +G  K+ + E +P GSL A+L    K G L   ++T       I +G+ YLH++ 
Sbjct: 86  GSFSENGFIKIFM-EQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 469 RLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
             +IVHRD+K  NVL+++     KISDFG ++  A       T    GT  YMAPE   +
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEIIDK 197
Query: 528 GL--YSKKSDVFSFGVLLIEIITGR 550
           G   Y K +D++S G  +IE+ TG+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 112/205 (54%), Gaps = 15/205 (7%)
Query: 353 DSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           D  +LG+G +G VY G  LS+   +A+K +     + +     E+ L   L+HKN+V+ L
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 412 G-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT--NIVNGIAKGMLYLHEDS 468
           G F  +G  K+ + E +P GSL A+L    K G L   ++T       I +G+ YLH++ 
Sbjct: 72  GSFSENGFIKIFM-EQVPGGSLSALLRS--KWGPLKDNEQTIGFYTKQILEGLKYLHDN- 127
Query: 469 RLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
             +IVHRD+K  NVL+++     KISDFG ++  A       T    GT  YMAPE   +
Sbjct: 128 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEIIDK 183
Query: 528 GL--YSKKSDVFSFGVLLIEIITGR 550
           G   Y K +D++S G  +IE+ TG+
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 23/221 (10%)
Query: 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNE 395
           +F  ++   +  ++ +  + LG G +G VY GV       VAVK L   + +   EF  E
Sbjct: 20  YFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKE 78
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV- 454
             ++ +++H NLV+LLG C       +V E+MP G+L   L +       C R+    V 
Sbjct: 79  AAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRE-------CNREEVTAVV 131
Query: 455 -----NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
                  I+  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  
Sbjct: 132 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSRLMT---GDTY 185
Query: 510 TVRIVGTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           T      +   + APE      +S KSDV++FGVLL EI T
Sbjct: 186 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           S  +G G FG VYKG       V + ++   + +    F NEV ++ K +H N++  +G+
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
               D   +V ++    SL   L     +  +   +  +I    A+GM YLH  +   I+
Sbjct: 101 MTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---II 154
Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLY 530
           HRD+K++N+ L   +  KI DFG+A + +   G     +  G+  +MAPE         +
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 531 SKKSDVFSFGVLLIEIITG 549
           S +SDV+S+G++L E++TG
Sbjct: 215 SFQSDVYSYGIVLYELMTG 233

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/196 (35%), Positives = 104/196 (53%), Gaps = 20/196 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V+    +   +VAVK +   S    A F  E  ++  LQH  LVKL    V 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 247
Query: 417 GDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            +   ++ EFM  GSL D +  D   +  L   K  +    IA+GM ++ + +    +HR
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIHR 302
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSD 535
           DL+A+N+L+ + +  KI+DFG+AR+ A+               + APE    G ++ KSD
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAINFGSFTIKSD 351
Query: 536 VFSFGVLLIEIIT-GR 550
           V+SFG+LL+EI+T GR
Sbjct: 352 VWSFGILLMEIVTYGR 367

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVL 397
           + L+   +  ++ +  + LG G FG VY+GV       VAVK L   + +   EF  E  
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAA 59
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV--- 454
           ++ +++H NLV+LLG C       ++ EFM  G+L   L +       C R+  + V   
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVSAVVLL 112
Query: 455 ---NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
                I+  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T 
Sbjct: 113 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTXTA 166
Query: 512 RIVGTY--GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +   + APE      +S KSDV++FGVLL EI T
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 106/199 (53%), Gaps = 18/199 (9%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +GQG  G VY  + ++ G+EVA+++++   +       NE+L++ + ++ N+V  L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 416 DGDEKLLVYEFMPNGSLDAIL----FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            GDE  +V E++  GSL  ++     D  +   +C            + + +LH +   +
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 137
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           ++HR++K+ N+LL  D + K++DFG        + + +T  +VGT  +MAPE      Y 
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 195
Query: 532 KKSDVFSFGVLLIEIITGR 550
            K D++S G++ IE+I G 
Sbjct: 196 PKVDIWSLGIMAIEMIEGE 214

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 11/213 (5%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
            ++G+G FG V K      K+VA+K++ S SE+    F  E+  + ++ H N+VKL G C
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGAC 70
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           ++     LV E+   GSL  +L               +     ++G+ YLH      ++H
Sbjct: 71  LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 475 RDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           RDLK  N+LL +     KI DFG A      + + +     G+  +MAPE      YS+K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 534 SDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWS 566
            DVFS+G++L E+IT R+        A+ + W+
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 23/224 (10%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEF 392
           A D   + +   +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF
Sbjct: 2   AMDPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEF 60
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
             E  ++ +++H NLV+LLG C       ++ EFM  G+L   L +       C R+  N
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVN 113
Query: 453 IV------NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
            V        I+  M YL + +    +HRDL A N L+  +   K++DFG++R+     G
Sbjct: 114 AVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---G 167
Query: 507 EANTVRIVGTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +  T      +   + APE      +S KSDV++FGVLL EI T
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 11/213 (5%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
            ++G+G FG V K      K+VA+K++ S SE+    F  E+  + ++ H N+VKL G C
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGAC 71
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           ++     LV E+   GSL  +L               +     ++G+ YLH      ++H
Sbjct: 72  LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 475 RDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           RDLK  N+LL +     KI DFG A      + + +     G+  +MAPE      YS+K
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 184
Query: 534 SDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWS 566
            DVFS+G++L E+IT R+        A+ + W+
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 217

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 125
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTXTAHAGAKF 179
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 73  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 125
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 179
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 68
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 69  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 121
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 122 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTXTAHAGAKF 175
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 120
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 174
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 125
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 179
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 356 ILGQGGFGPVYK---GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           +LG+G FG V K    +      V V   +S   + T+    EV L+ KL H N++KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 413 FCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
              D     +V E    G L D I+    KR          I+  +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 472 IVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           IVHRDLK  N+LL+S   D + KI DFG++  F ++    +    +GT  Y+APE  + G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y +K DV+S GV+L  +++G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 356 ILGQGGFGPVYK---GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           +LG+G FG V K    +      V V   +S   + T+    EV L+ KL H N++KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 413 FCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
              D     +V E    G L D I+    KR          I+  +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 472 IVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           IVHRDLK  N+LL+S   D + KI DFG++  F ++    +    +GT  Y+APE  + G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y +K DV+S GV+L  +++G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 120
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 174
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 80
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 81  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 133
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 134 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 187
Query: 518 --GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 188 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/205 (37%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 357 LGQGGFG--------PVYKGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNL 407
           LG+G FG        P   G    G+ VAVK L + C  Q  + +  E+ ++  L H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 408 VKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           +K  G C D  EK   LV E++P GSL   L  PR    L   +       I +GM YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLA--QLLLFAQQICEGMAYLH 134
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPE 523
                  +HR+L A NVLLD+D   KI DFG+A+   E   E   VR  G     + APE
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYAPE 190
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
              E  +   SDV+SFGV L E++T
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 125
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 179
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 113/233 (48%), Gaps = 35/233 (15%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQG-TAEFT 393
           L+ ++L+   F +   LG+  FG VYKG L         + VA+K L   +E     EF 
Sbjct: 20  LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF-------------DPR 440
           +E +L  +LQH N+V LLG         +++ +  +G L   L              D  
Sbjct: 78  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR- 499
            +  L      ++V  IA GM YL   S   +VH+DL   NVL+   +N KISD G+ R 
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 194
Query: 500 IFAESEGEANTVRIVG----TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           ++A     A+  +++G       +MAPE  M G +S  SD++S+GV+L E+ +
Sbjct: 195 VYA-----ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 122
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 123 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 176
Query: 518 --GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 122
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 123 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 176
Query: 518 --GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/205 (37%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 357 LGQGGFG--------PVYKGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNL 407
           LG+G FG        P   G    G+ VAVK L + C  Q  + +  E+ ++  L H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 408 VKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           +K  G C D  EK   LV E++P GSL   L  PR    L   +       I +GM YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLA--QLLLFAQQICEGMAYLH 134
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPE 523
                  +HR+L A NVLLD+D   KI DFG+A+   E   E   VR  G     + APE
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYAPE 190
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
              E  +   SDV+SFGV L E++T
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 113/233 (48%), Gaps = 35/233 (15%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQG-TAEFT 393
           L+ ++L+   F +   LG+  FG VYKG L         + VA+K L   +E     EF 
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF-------------DPR 440
           +E +L  +LQH N+V LLG         +++ +  +G L   L              D  
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR- 499
            +  L      ++V  IA GM YL   S   +VH+DL   NVL+   +N KISD G+ R 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 500 IFAESEGEANTVRIVG----TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           ++A     A+  +++G       +MAPE  M G +S  SD++S+GV+L E+ +
Sbjct: 178 VYA-----ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
           HKN++ LLG C       ++ E+   G+L   L   R  G+             L  +  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDL 152
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLI 399
           L+   +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 61
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV----- 454
            +++H NLV+LLG C       ++ EFM  G+L   L +       C R+  + V     
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-------CNRQEVSAVVLLYM 114
Query: 455 -NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              I+  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T   
Sbjct: 115 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTXTAHA 168
Query: 514 VGTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              +   + APE      +S KSDV++FGVLL EI T
Sbjct: 169 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/216 (35%), Positives = 115/216 (53%), Gaps = 25/216 (11%)
Query: 347 ATSNFSD----SNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCS-EQGT--AEFTNEVL 397
           +T+ FSD      +LG+G FG V   K  ++ G+E AVK +S    +Q T       EV 
Sbjct: 26  STAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQ 84
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNG 456
           L+ +L H N++KL  F  D     LV E    G L D I+   R   +   R    I+  
Sbjct: 85  LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQ 140
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRI 513
           +  G+ Y+H++   +IVHRDLK  N+LL+S   D N +I DFG++  F  S+   +    
Sbjct: 141 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 194
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +GT  Y+APE  + G Y +K DV+S GV+L  +++G
Sbjct: 195 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 356 ILGQGGFGPVYK---GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           +LG+G FG V K    +      V V   +S   + T+    EV L+ KL H N++KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 413 FCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
              D     +V E    G L D I+    KR          I+  +  G+ Y+H+ +   
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 472 IVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           IVHRDLK  N+LL+S   D + KI DFG++  F ++    +    +GT  Y+APE  + G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRG 197
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y +K DV+S GV+L  +++G
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/216 (35%), Positives = 116/216 (53%), Gaps = 25/216 (11%)
Query: 347 ATSNFSD----SNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCS-EQGTAE--FTNEVL 397
           +T+ FSD      +LG+G FG V   K  ++ G+E AVK +S    +Q T +     EV 
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNG 456
           L+ +L H N++KL  F  D     LV E    G L D I+   R   +   R    I+  
Sbjct: 79  LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQ 134
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRI 513
           +  G+ Y+H++   +IVHRDLK  N+LL+S   D N +I DFG++  F  S+   +    
Sbjct: 135 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 188
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +GT  Y+APE  + G Y +K DV+S GV+L  +++G
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 21  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNG------ 456
           HKN++ LLG C       ++ E+   G+L   L   R  G+  C+    N          
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 457 ------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                 +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 68
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 69  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 121
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 122 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAPAGAKF 175
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 69
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  N V        I
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQI 122
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 123 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAPAGAKF 176
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 357 LGQGGFG--------PVYKGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNL 407
           LG+G FG        P   G    G+ VAVK L   C  Q  + +  E+ ++  L H+++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 408 VKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           VK  G C D  EK   LV E++P GSL   L     R  +   +       I +GM YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG--TYGYMAPE 523
                  +HR L A NVLLD+D   KI DFG+A+   E   E   VR  G     + APE
Sbjct: 130 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYAPE 185
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
              E  +   SDV+SFGV L E++T
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNG------ 456
           HKN++ LLG C       ++ E+   G+L   L   R  G+  C+    N          
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 457 ------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                 +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/205 (36%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 357 LGQGGFG--------PVYKGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNL 407
           LG+G FG        P   G    G+ VAVK L   C  Q  + +  E+ ++  L H+++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 408 VKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           VK  G C D  EK   LV E++P GSL   L     R  +   +       I +GM YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG--TYGYMAPE 523
                  +HR L A NVLLD+D   KI DFG+A+   E   E   VR  G     + APE
Sbjct: 129 AQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH-EYYRVREDGDSPVFWYAPE 184
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
              E  +   SDV+SFGV L E++T
Sbjct: 185 CLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 25  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
           HKN++ LLG C       ++ E+   G+L   L   R  G+             L  +  
Sbjct: 82  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 141
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 142 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
           +NF     +G+G F  VY+   L DG  VA+K++        +  A+   E+ L+ +L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGI---LCWRKRTNIVNGIAK 459
            N++K     ++ +E  +V E    G L  ++  F  +KR I     W+    + + +  
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE- 150
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
                H  SR R++HRD+K +NV + +    K+ D G+ R F+     A++  +VGT  Y
Sbjct: 151 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 202
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEI 546
           M+PE   E  Y+ KSD++S G LL E+
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVL 397
           + L+   +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAA 59
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV--- 454
           ++ +++H NLV+LLG C       ++ EFM  G+L   L +       C R+  + V   
Sbjct: 60  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVSAVVLL 112
Query: 455 ---NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
                I+  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T 
Sbjct: 113 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTFTA 166
Query: 512 RIVGTY--GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +   + APE      +S KSDV++FGVLL EI T
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 7/192 (3%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V  G      +VA+K +   S     EF  E  +++ L H+ LV+L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
                ++ E+M NG L   L + R R     ++   +   + + M YL      + +HRD
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 145
Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDV 536
           L A N L++     K+SDFG++R   + E E ++V       +  PE  M   +S KSD+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDE-ETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 537 FSFGVLLIEIIT 548
           ++FGVL+ EI +
Sbjct: 205 WAFGVLMWEIYS 216

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/216 (35%), Positives = 115/216 (53%), Gaps = 25/216 (11%)
Query: 347 ATSNFSD----SNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCS-EQGT--AEFTNEVL 397
           +T+ FSD      +LG+G FG V   K  ++ G+E AVK +S    +Q T       EV 
Sbjct: 43  STAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQ 101
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNG 456
           L+ +L H N++KL  F  D     LV E    G L D I+   R   +   R    I+  
Sbjct: 102 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQ 157
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRI 513
           +  G+ Y+H++   +IVHRDLK  N+LL+S   D N +I DFG++  F  S+   +    
Sbjct: 158 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 211
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +GT  Y+APE  + G Y +K DV+S GV+L  +++G
Sbjct: 212 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/201 (35%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV---YKGVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V       L D  G  VAVK+L         +F  E+ ++  L    +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 412 G--FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G  +     E  LV E++P+G L   L   R R  L   +     + I KGM YL   SR
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GSR 130
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R VHRDL A N+L++S+ + KI+DFG+A++    + +   VR  G     + APE   +
Sbjct: 131 -RCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
            ++S++SDV+SFGV+L E+ T
Sbjct: 189 NIFSRQSDVWSFGVVLYELFT 209

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 29  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
           HKN++ LLG C       ++ E+   G+L   L   R  G+             L  +  
Sbjct: 86  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 145
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 146 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 28  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
           HKN++ LLG C       ++ E+   G+L   L   R  G+             L  +  
Sbjct: 85  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 144
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 145 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 77  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
           HKN++ LLG C       ++ E+   G+L   L   R  G+             L  +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
           HKN++ LLG C       ++ E+   G+L   L   R  G+             L  +  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/216 (35%), Positives = 115/216 (53%), Gaps = 25/216 (11%)
Query: 347 ATSNFSD----SNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCS-EQGT--AEFTNEVL 397
           +T+ FSD      +LG+G FG V   K  ++ G+E AVK +S    +Q T       EV 
Sbjct: 44  STAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQ 102
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNG 456
           L+ +L H N++KL  F  D     LV E    G L D I+   R   +   R    I+  
Sbjct: 103 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQ 158
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRI 513
           +  G+ Y+H++   +IVHRDLK  N+LL+S   D N +I DFG++  F  S+   +    
Sbjct: 159 VLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 212
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +GT  Y+APE  + G Y +K DV+S GV+L  +++G
Sbjct: 213 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 97/178 (54%), Gaps = 11/178 (6%)
Query: 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
           G++VAVK +    +Q      NEV+++   QH N+V++    + G+E  ++ EF+  G+L
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
             I+   R    L   +   +   + + + YLH      ++HRD+K+ ++LL  D   K+
Sbjct: 130 TDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182
Query: 493 SDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           SDFG  A+I   S+       +VGT  +MAPE     LY+ + D++S G+++IE++ G
Sbjct: 183 SDFGFCAQI---SKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 22/215 (10%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQH 404
           ++S F     LG G +  VYKG+  + G  VA+K +   SE+GT      E+ L+ +L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPN---GSLDAILFDPRKRGILCWRKRTNIVN----GI 457
           +N+V+L       ++  LV+EFM N     +D+       RG+       N+V      +
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL-----ELNLVKYFQWQL 117
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-VGT 516
            +G+ + HE+   +I+HRDLK  N+L++     K+ DFG+AR F       NT    V T
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP---VNTFSSEVVT 171
Query: 517 YGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
             Y AP+  M    YS   D++S G +L E+ITG+
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV---YKGVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V       L D  G  VAVK+L         +F  E+ ++  L    +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 412 GFCV-DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G     G + L LV E++P+G L   L   R R  L   +     + I KGM YL   SR
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GSR 133
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R VHRDL A N+L++S+ + KI+DFG+A++    + +   VR  G     + APE   +
Sbjct: 134 -RCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
            ++S++SDV+SFGV+L E+ T
Sbjct: 192 NIFSRQSDVWSFGVVLYELFT 212

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/216 (35%), Positives = 114/216 (52%), Gaps = 25/216 (11%)
Query: 347 ATSNFSD----SNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCS-EQGTAE--FTNEVL 397
           +T+ FSD      +LG+G FG V   K  ++ G+E AVK +S    +Q T +     EV 
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQ 78
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNG 456
           L+ +L H N+ KL  F  D     LV E    G L D I+   R   +   R    I+  
Sbjct: 79  LLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQ 134
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRI 513
           +  G+ Y H++   +IVHRDLK  N+LL+S   D N +I DFG++  F  S+   +    
Sbjct: 135 VLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--- 188
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +GT  Y+APE  + G Y +K DV+S GV+L  +++G
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 94/178 (52%), Gaps = 11/178 (6%)
Query: 373 GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
           GK+VAVK++    +Q      NEV+++    H N+V +    + GDE  +V EF+  G+L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKI 492
             I+   R    +   +   +   + + + YLH      ++HRD+K+ ++LL SD   K+
Sbjct: 130 TDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 182
Query: 493 SDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           SDFG  A++  E         +VGT  +MAPE      Y  + D++S G+++IE+I G
Sbjct: 183 SDFGFCAQVSKEVPKRKX---LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV---YKGVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V       L D  G  VAVK+L         +F  E+ ++  L    +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 412 GFCV-DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G     G + L LV E++P+G L   L   R R  L   +     + I KGM YL   SR
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GSR 134
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R VHRDL A N+L++S+ + KI+DFG+A++    + +   VR  G     + APE   +
Sbjct: 135 -RCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
            ++S++SDV+SFGV+L E+ T
Sbjct: 193 NIFSRQSDVWSFGVVLYELFT 213

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 12/196 (6%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG+G +G VYK +  + G+ VA+K++    E    E   E+ ++ +    ++VK  G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
              +  +V E+   GS+  I+   R R   L   +   I+    KG+ YLH    +R +H
Sbjct: 95  KNTDLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIH 148
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           RD+KA N+LL+++ ++K++DFG+A    +   + N V  +GT  +MAPE   E  Y+  +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXV--IGTPFWMAPEVIQEIGYNCVA 206
Query: 535 DVFSFGVLLIEIITGR 550
           D++S G+  IE+  G+
Sbjct: 207 DIWSLGITAIEMAEGK 222

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 25/201 (12%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V  G      +VAVK +   S     EF  E   ++KL H  LVK  G C  
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 417 GDEKLLVYEFMPNGSLDAIL------FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
                +V E++ NG L   L       +P +   +C+         + +GM +L      
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY--------DVCEGMAFLESH--- 123
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT---YGYMAPEYAME 527
           + +HRDL A N L+D D+  K+SDFGM R   + +     V  VGT     + APE    
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVFHY 179
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             YS KSDV++FG+L+ E+ +
Sbjct: 180 FKYSSKSDVWAFGILMWEVFS 200

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/201 (36%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 357 LGQGGFGPV---YKGVLSD--GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G FG V       L D  G  VAVK+L         +F  E+ ++  L    +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 412 GFCV-DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           G     G + L LV E++P+G L   L   R R  L   +     + I KGM YL   SR
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--GSR 146
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
            R VHRDL A N+L++S+ + KI+DFG+A++    + +   VR  G     + APE   +
Sbjct: 147 -RCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
            ++S++SDV+SFGV+L E+ T
Sbjct: 205 NIFSRQSDVWSFGVVLYELFT 225

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++H NLV+LLG C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGIAKGMLYLHEDSR 469
                 ++ EFM  G+L   L +       C R+  N V        I+  M YL + + 
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRE-------CNRQEVNAVVLLYMATQISSAMEYLEKKN- 377
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
              +HR+L A N L+  +   K++DFG++R+     G+  T      +   + APE    
Sbjct: 378 --FIHRNLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAY 432
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S KSDV++FGVLL EI T
Sbjct: 433 NKFSIKSDVWAFGVLLWEIAT 453

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  FC   DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 149
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 150 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 206
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 207 SPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G  G V    V S GK VAVK++    +Q      NEV+++   QH+N+V++    +
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            GDE  +V EF+  G+L  I+   R    +   +   +   + + +  LH      ++HR
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHR 149
Query: 476 DLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           D+K+ ++LL  D   K+SDFG  A++  E         +VGT  +MAPE      Y  + 
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEV 206
Query: 535 DVFSFGVLLIEIITG 549
           D++S G+++IE++ G
Sbjct: 207 DIWSLGIMVIEMVDG 221

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  + V        I
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-------CNRQEVSAVVLLYMATQI 120
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 174
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 72
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  + V        I
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVSAVVLLYMATQI 125
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 126 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 179
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 180 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  + V        I
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRE-------CNRQEVSAVVLLYMATQI 120
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 174
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  + V        I
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVSAVVLLYMATQI 120
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 174
Query: 518 G--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G  G V    V S GK VAVK++    +Q      NEV+++   QH+N+V++    +
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            GDE  +V EF+  G+L  I+   R    +   +   +   + + +  LH      ++HR
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHR 140
Query: 476 DLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           D+K+ ++LL  D   K+SDFG  A++  E         +VGT  +MAPE      Y  + 
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEV 197
Query: 535 DVFSFGVLLIEIITG 549
           D++S G+++IE++ G
Sbjct: 198 DIWSLGIMVIEMVDG 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G FG VYK    + G   A K + + SE+   ++  E+ ++    H  +VKLLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
              +  ++ EF P G++DAI+ +   RG L   +   +   + + + +LH     RI+HR
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLE-LDRG-LTEPQIQVVCRQMLEALNFLHSK---RIIHR 141
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLY 530
           DLKA NVL+  + + +++DFG++    ++  + ++   +GT  +MAPE  M     +  Y
Sbjct: 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPY 199
Query: 531 SKKSDVFSFGVLLIEI 546
             K+D++S G+ LIE+
Sbjct: 200 DYKADIWSLGITLIEM 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G  G V    V S GK VAVK++    +Q      NEV+++   QH+N+V++    +
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            GDE  +V EF+  G+L  I+   R    +   +   +   + + +  LH      ++HR
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHR 151
Query: 476 DLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           D+K+ ++LL  D   K+SDFG  A++  E         +VGT  +MAPE      Y  + 
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEV 208
Query: 535 DVFSFGVLLIEIITG 549
           D++S G+++IE++ G
Sbjct: 209 DIWSLGIMVIEMVDG 223

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V  G      +VA+K +   S     EF  E  +++ L H+ LV+L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
                ++ E+M NG L   L + R R     ++   +   + + M YL      + +HRD
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 130
Query: 477 LKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           L A N L++     K+SDFG++R      +  S G    VR      +  PE  M   +S
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR------WSPPEVLMYSKFS 184
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSD+++FGVL+ EI +
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
            +  ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 67
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGI 457
           H NLV+LLG C       ++ EFM  G+L   L +       C R+  + V        I
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-------CNRQEVSAVVLLYMATQI 120
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           +  M YL + +    +HRDL A N L+  +   K++DFG++R+     G+  T      +
Sbjct: 121 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKF 174
Query: 518 --GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + APE      +S KSDV++FGVLL EI T
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G FG VYK    + G   A K + + SE+   ++  E+ ++    H  +VKLLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
              +  ++ EF P G++DAI+ +   RG L   +   +   + + + +LH     RI+HR
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLE-LDRG-LTEPQIQVVCRQMLEALNFLHSK---RIIHR 133
Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLY 530
           DLKA NVL+  + + +++DFG++    ++  + ++   +GT  +MAPE  M     +  Y
Sbjct: 134 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPY 191
Query: 531 SKKSDVFSFGVLLIEI 546
             K+D++S G+ LIE+
Sbjct: 192 DYKADIWSLGITLIEM 207

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G  G V    V S GK VAVK++    +Q      NEV+++   QH+N+V++    +
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            GDE  +V EF+  G+L  I+   R    +   +   +   + + +  LH      ++HR
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHR 144
Query: 476 DLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           D+K+ ++LL  D   K+SDFG  A++  E         +VGT  +MAPE      Y  + 
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEV 201
Query: 535 DVFSFGVLLIEIITG 549
           D++S G+++IE++ G
Sbjct: 202 DIWSLGIMVIEMVDG 216

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +   NT   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 104/228 (45%), Gaps = 24/228 (10%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKG-VLSDGKE-----VAVKRLSSCSEQGTAE-FTN 394
           E      +N      LG G FG V +      GKE     VAVK L S +     E   +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 395 EVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI--------- 444
           E+ ++  L QH+N+V LLG C  G   L++ E+   G L   L   R  G+         
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHN 158
Query: 445 ----LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
               L  R   +  + +A+GM +L   +    +HRD+ A NVLL +   +KI DFG+AR 
Sbjct: 159 PEEQLSSRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                             +MAPE   + +Y+ +SDV+S+G+LL EI +
Sbjct: 216 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGT----AEFTNEVLLILKLQHKNLVKLL 411
           +G+G FG V+ G L +D   VAVK   SC E       A+F  E  ++ +  H N+V+L+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
           G C       +V E +  G  D + F   +   L  +    +V   A GM YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
            +HRDL A N L+      KISDFGM+R  A+    A+         + APE    G YS
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 532 KKSDVFSFGVLLIEIIT 548
            +SDV+SFG+LL E  +
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V  G      +VA+K +   S     EF  E  +++ L H+ LV+L G C  
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
                ++ E+M NG L   L + R R     ++   +   + + M YL      + +HRD
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 130
Query: 477 LKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           L A N L++     K+SDFG++R      +  S G    VR      +  PE  M   +S
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 184
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSD+++FGVL+ EI +
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G  G V    V S GK VAVK++    +Q      NEV+++   QH+N+V++    +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            GDE  +V EF+  G+L  I+   R    +   +   +   + + +  LH      ++HR
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHR 271
Query: 476 DLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           D+K+ ++LL  D   K+SDFG  A++  E         +VGT  +MAPE      Y  + 
Sbjct: 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEV 328
Query: 535 DVFSFGVLLIEIITG 549
           D++S G+++IE++ G
Sbjct: 329 DIWSLGIMVIEMVDG 343

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V  G      +VA+K +   S     EF  E  +++ L H+ LV+L G C  
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
                ++ E+M NG L   L + R R     ++   +   + + M YL      + +HRD
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 129
Query: 477 LKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           L A N L++     K+SDFG++R      +  S G    VR      +  PE  M   +S
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 183
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSD+++FGVL+ EI +
Sbjct: 184 SKSDIWAFGVLMWEIYS 200

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 357 LGQGGFGPV-YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G  G V    V S GK VAVK++    +Q      NEV+++   QH+N+V++    +
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
            GDE  +V EF+  G+L  I+   R    +   +   +   + + +  LH      ++HR
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG---VIHR 194
Query: 476 DLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           D+K+ ++LL  D   K+SDFG  A++  E         +VGT  +MAPE      Y  + 
Sbjct: 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX---LVGTPYWMAPELISRLPYGPEV 251
Query: 535 DVFSFGVLLIEIITG 549
           D++S G+++IE++ G
Sbjct: 252 DIWSLGIMVIEMVDG 266

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKL 402
           N      LG+G FG V K      K       VAVK L  + S     +  +E  ++ ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG------------------- 443
            H +++KL G C      LL+ E+   GSL   L + RK G                   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 444 --ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
              L      +    I++GM YL E   +++VHRDL A N+L+      KISDFG++R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E +      +      +MA E   + +Y+ +SDV+SFGVLL EI+T
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 103/194 (53%), Gaps = 19/194 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G FG V  G    G +VAVK + +     TA+ F  E  ++ +L+H NLV+LLG  V
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 416 DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           +    L +V E+M  GSL   L   R R +L           + + M YL  ++    VH
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 131
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG--TYGYMAPEYAMEGLYSK 532
           RDL A NVL+  D  +K+SDFG+ +       EA++ +  G     + APE   E  +S 
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 533 KSDVFSFGVLLIEI 546
           KSDV+SFG+LL EI
Sbjct: 185 KSDVWSFGILLWEI 198

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 103/194 (53%), Gaps = 19/194 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G FG V  G    G +VAVK + +     TA+ F  E  ++ +L+H NLV+LLG  V
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 416 DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           +    L +V E+M  GSL   L   R R +L           + + M YL  ++    VH
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG--TYGYMAPEYAMEGLYSK 532
           RDL A NVL+  D  +K+SDFG+ +       EA++ +  G     + APE   E  +S 
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 533 KSDVFSFGVLLIEI 546
           KSDV+SFG+LL EI
Sbjct: 366 KSDVWSFGILLWEI 379

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGT----AEFTNEVLLILKLQHKNLVKLL 411
           +G+G FG V+ G L +D   VAVK   SC E       A+F  E  ++ +  H N+V+L+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
           G C       +V E +  G  D + F   +   L  +    +V   A GM YL       
Sbjct: 179 GVCTQKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMAR-----IFAESEGEANTVRIVGTYGYMAPEYAM 526
            +HRDL A N L+      KISDFGM+R     ++A S G    +R V    + APE   
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG----LRQV-PVKWTAPEALN 288
Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
            G YS +SDV+SFG+LL E  +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLV 408
           F+  + +G+G FG VYKG+ +  KEV   ++    E          E+ ++ +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +  G  +   +  ++ E++  GS   +L    K G L       I+  I KG+ YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSE- 135
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
             R +HRD+KA+NVLL    + K++DFG+A    +++ + N    VGT  +MAPE   + 
Sbjct: 136 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 191
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y  K+D++S G+  IE+  G
Sbjct: 192 AYDFKADIWSLGITAIELAKG 212

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/195 (31%), Positives = 93/195 (47%), Gaps = 17/195 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V  G      +VA+K +   S     EF  E  +++ L H+ LV+L G C  
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
                ++ E+M NG L   L + R R     ++   +   + + M YL      + +HRD
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 125
Query: 477 LKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           L A N L++     K+SDFG++R      +  S G    VR      +  PE  M   +S
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 179
Query: 532 KKSDVFSFGVLLIEI 546
            KSD+++FGVL+ EI
Sbjct: 180 SKSDIWAFGVLMWEI 194

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V  G      +VA+K +   S     EF  E  +++ L H+ LV+L G C  
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
                ++ E+M NG L   L + R R     ++   +   + + M YL      + +HRD
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 136
Query: 477 LKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           L A N L++     K+SDFG++R      +  S G    VR      +  PE  M   +S
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 190
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSD+++FGVL+ EI +
Sbjct: 191 SKSDIWAFGVLMWEIYS 207

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 357 LGQGGFGPVYKGVLSDG-----------KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-Q 403
           LG+G FG V   VL++             +VAVK L S  +E+  ++  +E+ ++  + +
Sbjct: 36  LGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKR 450
           HKN++ LLG C       ++ E+   G+L   L      G+             L  +  
Sbjct: 93  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDL 152
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR     +    T
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 103/227 (45%), Gaps = 31/227 (13%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKL 402
           N      LG+G FG V K      K       VAVK L  + S     +  +E  ++ ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG------------------- 443
            H +++KL G C      LL+ E+   GSL   L + RK G                   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 444 --ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
              L      +    I++GM YL E   +++VHRDL A N+L+      KISDFG++R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E +      +      +MA E   + +Y+ +SDV+SFGVLL EI+T
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG G FG V  G      +VA+K +   S     EF  E  +++ L H+ LV+L G C  
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
                ++ E+M NG L   L + R R     ++   +   + + M YL      + +HRD
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 145
Query: 477 LKASNVLLDSDMNSKISDFGMARI-----FAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           L A N L++     K+SDFG++R      +  S G    VR      +  PE  M   +S
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSKFS 199
Query: 532 KKSDVFSFGVLLIEIIT 548
            KSD+++FGVL+ EI +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++H NLV+LLG C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV------NGIAKGMLYLHEDSR 469
                 ++ EFM  G+L   L +       C R+  + V        I+  M YL + + 
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRE-------CNRQEVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPEYAME 527
              +HR+L A N L+  +   K++DFG++R+     G+  T      +   + APE    
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAY 393
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S KSDV++FGVLL EI T
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT 414

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 357 LGQGGFGPVYK----GVLS--DGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           +G+G FG V++    G+L       VAVK L    S    A+F  E  L+ +  + N+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------LCWRKRTN---------- 452
           LLG C  G    L++E+M  G L+  L       +       L  R R +          
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 453 ----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGE 507
               I   +A GM YL E    + VHRDL   N L+  +M  KI+DFG++R I++    +
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           A+    +    +M PE      Y+ +SDV+++GV+L EI +
Sbjct: 232 ADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 103/194 (53%), Gaps = 19/194 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G FG V  G    G +VAVK + +     TA+ F  E  ++ +L+H NLV+LLG  V
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 416 DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           +    L +V E+M  GSL   L   R R +L           + + M YL  ++    VH
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 125
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG--TYGYMAPEYAMEGLYSK 532
           RDL A NVL+  D  +K+SDFG+ +       EA++ +  G     + APE   E  +S 
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 533 KSDVFSFGVLLIEI 546
           KSDV+SFG+LL EI
Sbjct: 179 KSDVWSFGILLWEI 192

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKL 402
           N      LG+G FG V K      K       VAVK L  + S     +  +E  ++ ++
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG------------------- 443
            H +++KL G C      LL+ E+   GSL   L + RK G                   
Sbjct: 84  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 444 --ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
              L      +    I++GM YL E S   +VHRDL A N+L+      KISDFG++R  
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDV 200
Query: 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            E +      +      +MA E   + +Y+ +SDV+SFGVLL EI+T
Sbjct: 201 YEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/194 (37%), Positives = 103/194 (53%), Gaps = 19/194 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G FG V  G    G +VAVK + +     TA+ F  E  ++ +L+H NLV+LLG  V
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIKN---DATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 416 DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           +    L +V E+M  GSL   L   R R +L           + + M YL  ++    VH
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG--TYGYMAPEYAMEGLYSK 532
           RDL A NVL+  D  +K+SDFG+ +       EA++ +  G     + APE   E  +S 
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 533 KSDVFSFGVLLIEI 546
           KSDV+SFG+LL EI
Sbjct: 194 KSDVWSFGILLWEI 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYI---RKIGSFDETCTRFYTA---EIVSA 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E   SK SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 357 LGQGGFGPVYKGVLSDGK----EVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG GG   VY   L++      +VA+K +       E+    F  EV    +L H+N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           ++    + D   LV E++   +L   +      G L      N  N I  G+ + H+   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD--- 129
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
           +RIVHRD+K  N+L+DS+   KI DFG+A+  +E+     T  ++GT  Y +PE A    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 530 YSKKSDVFSFGVLLIEIITGR 550
             + +D++S G++L E++ G 
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 110/226 (48%), Gaps = 25/226 (11%)
Query: 328 RDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSE 386
           +D D+    F  D E L      FSD   +G G FG VY    + + + VA+K++S   +
Sbjct: 39  KDPDVAELFFKDDPEKL------FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK 92
Query: 387 QGTAEFTN---EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
           Q   ++ +   EV  + KL+H N ++  G  +      LV E+    + D  L +  K+ 
Sbjct: 93  QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKP 150
Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
            L   +   + +G  +G+ YLH  +   ++HRD+KA N+LL      K+ DFG A I A 
Sbjct: 151 -LQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206
Query: 504 SEGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEI 546
           +         VGT  +MAPE  +   EG Y  K DV+S G+  IE+
Sbjct: 207 AN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGFC 414
           +G+G +G VYK   S G+ VA+KR+   +E      T   E+ L+ +L H N+V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
                  LV+EFM    L  +L D  K G+   + +  +   + +G+ + H+    RI+H
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RILH 142
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYSKK 533
           RDLK  N+L++SD   K++DFG+AR F      + T  +V T  Y AP+  M    YS  
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS 200
Query: 534 SDVFSFGVLLIEIITGR 550
            D++S G +  E+ITG+
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 102/225 (45%), Gaps = 20/225 (8%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKG-VLSDGKE-----VAVKRLSSCSEQGTAE-FTN 394
           E      +N      LG G FG V +      GKE     VAVK L S +     E   +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 395 EVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
           E+ ++  L QH+N+V LLG C  G   L++ E+   G  D + F  RK  +L       I
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG--DLLNFLRRKSRVLETDPAFAI 156
Query: 454 VNGIAKGMLYLHEDSRL----------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
            N  A     LH  S++            +HRD+ A NVLL +   +KI DFG+AR    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                          +MAPE   + +Y+ +SDV+S+G+LL EI +
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKG-VLSDGKE-----VAVKRLSSCSEQGTAE-FTN 394
           E      +N      LG G FG V +      GKE     VAVK L S +     E   +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 395 EVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDPRKRGILC 446
           E+ ++  L QH+N+V LLG C  G   L++ E+   G L   L        D      L 
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 158
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
            R   +  + +A+GM +L   +    +HRD+ A NVLL +   +KI DFG+AR       
Sbjct: 159 LRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 215
Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                       +MAPE   + +Y+ +SDV+S+G+LL EI +
Sbjct: 216 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/240 (30%), Positives = 114/240 (47%), Gaps = 43/240 (17%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT 393
           A +  +DL+ L L         ++G+G +G VYKG L D + VAVK  S  + Q    F 
Sbjct: 5   ASEPSLDLDNLKLL-------ELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FI 53
Query: 394 NE--VLLILKLQHKNLVKLL----GFCVDGD-EKLLVYEFMPNGSLDAILFDPRKRGILC 446
           NE  +  +  ++H N+ + +        DG  E LLV E+ PNGSL   L          
Sbjct: 54  NEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSD 109
Query: 447 WRKRTNIVNGIAKGMLYLHED------SRLRIVHRDLKASNVLLDSDMNSKISDFGMA-- 498
           W     + + + +G+ YLH +       +  I HRDL + NVL+ +D    ISDFG++  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 499 ----RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS--------KKSDVFSFGVLLIEI 546
               R+    E +   +  VGT  YMAPE  +EG  +        K+ D+++ G++  EI
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 105/197 (53%), Gaps = 11/197 (5%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLVKLLGFC 414
           +G+G +G VYK   S G+ VA+KR+   +E      T   E+ L+ +L H N+V L+   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
                  LV+EFM    L  +L D  K G+   + +  +   + +G+ + H+    RI+H
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RILH 142
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYSKK 533
           RDLK  N+L++SD   K++DFG+AR F      + T  +V T  Y AP+  M    YS  
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYRAPDVLMGSKKYSTS 200
Query: 534 SDVFSFGVLLIEIITGR 550
            D++S G +  E+ITG+
Sbjct: 201 VDIWSIGCIFAEMITGK 217

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 18/222 (8%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKG-VLSDGKE-----VAVKRLSSCSEQGTAE-FTN 394
           E      +N      LG G FG V +      GKE     VAVK L S +     E   +
Sbjct: 31  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 90
Query: 395 EVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDPRKRGILC 446
           E+ ++  L QH+N+V LLG C  G   L++ E+   G L   L        D      L 
Sbjct: 91  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLE 150
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
            R   +  + +A+GM +L   +    +HRD+ A NVLL +   +KI DFG+AR       
Sbjct: 151 LRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 207
Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                       +MAPE   + +Y+ +SDV+S+G+LL EI +
Sbjct: 208 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN---EVLLILKLQHKN 406
           FSD   +G G FG VY    + + + VA+K++S   +Q   ++ +   EV  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
            ++  G  +      LV E+    + D  L +  K+  L   +   + +G  +G+ YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAVTHGALQGLAYLHS 133
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
            +   ++HRD+KA N+LL      K+ DFG A I A +         VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEVIL 184
Query: 527 ---EGLYSKKSDVFSFGVLLIEI 546
              EG Y  K DV+S G+  IE+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 34/218 (15%)
Query: 354 SNILGQGGFGPVYKG-VLSDG--KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLV 408
            +++G+G FG V K  +  DG   + A+KR+    S+    +F  E+ ++ KL  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVN 455
            LLG C       L  E+ P+G+L   L   R                 L  ++  +   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            +A+GM YL   S+ + +HRDL A N+L+  +  +KI+DFG++R           V +  
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKK 188
Query: 516 TYG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           T G     +MA E     +Y+  SDV+S+GVLL EI++
Sbjct: 189 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 102/202 (50%), Gaps = 11/202 (5%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQHKNLV 408
           F+    +G+G FG V+KG+ +  ++V   ++    E          E+ ++ +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           K  G  + G +  ++ E++  GS      D  + G     +   ++  I KG+ YLH + 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           +   +HRD+KA+NVLL    + K++DFG+A    +++ + NT   VGT  +MAPE   + 
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 195
Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
            Y  K+D++S G+  IE+  G 
Sbjct: 196 AYDSKADIWSLGITAIELAKGE 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVK 409
            ++G+G FG VY G   D  +     A+K LS  +E    E F  E LL+  L H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 410 LLGFCV--DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           L+G  +  +G   +L+  +M +G L   +  P++   +  +   +    +A+GM YL E 
Sbjct: 87  LIGIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQ 143
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE----GEANTVRIVGTYGYMAPE 523
              + VHRDL A N +LD     K++DFG+AR   + E     +    R+     + A E
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVKWTALE 198
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
                 ++ KSDV+SFGVLL E++T
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 141
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 70  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 122
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 123 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 89  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 141
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 103/226 (45%), Gaps = 22/226 (9%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKG-VLSDGKE-----VAVKRLSSCSEQGTAE-FTN 394
           E      +N      LG G FG V +      GKE     VAVK L S +     E   +
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 395 EVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--------FDPR---KR 442
           E+ ++  L QH+N+V LLG C  G   L++ E+   G L   L         DP      
Sbjct: 99  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 443 GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
             L  R   +  + +A+GM +L   +    +HRD+ A NVLL +   +KI DFG+AR   
Sbjct: 159 STLSTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                           +MAPE   + +Y+ +SDV+S+G+LL EI +
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/205 (37%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 357 LGQGGFG--------PVYKGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNL 407
           LG+G FG        P   G    G+ VAVK L +    Q  + +  E+ ++  L H+++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 408 VKLLGFCVD-GDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           +K  G C D G   L LV E++P GSL   L  PR    L   +       I +GM YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLA--QLLLFAQQICEGMAYLH 151
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG--YMAPE 523
                  +HRDL A NVLLD+D   KI DFG+A+   E   E   VR  G     + APE
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH-EXYRVREDGDSPVFWYAPE 207
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
              E  +   SDV+SFGV L E++T
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 69  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 121
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 122 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 34/218 (15%)
Query: 354 SNILGQGGFGPVYKG-VLSDG--KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLV 408
            +++G+G FG V K  +  DG   + A+KR+    S+    +F  E+ ++ KL  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVN 455
            LLG C       L  E+ P+G+L   L   R                 L  ++  +   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            +A+GM YL   S+ + +HRDL A N+L+  +  +KI+DFG++R           V +  
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKK 198
Query: 516 TYG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           T G     +MA E     +Y+  SDV+S+GVLL EI++
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 68  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 120
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 74  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 126
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 127 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 67  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 119
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 120 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKE-VAVKR--LSSCSEQGTAEFTNEVLLILKLQHKN 406
           ++    ++G G    V     +  KE VA+KR  L  C +    E   E+  + +  H N
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPN 69
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGS-LDAILF----DPRKRGILCWRKRTNIVNGIAKGM 461
           +V      V  DE  LV + +  GS LD I         K G+L       I+  + +G+
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE-SEGEANTVR--IVGTYG 518
            YLH++ +   +HRD+KA N+LL  D + +I+DFG++   A   +   N VR   VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 519 YMAPEYAMEGL--YSKKSDVFSFGVLLIEIITG 549
           +MAPE  ME +  Y  K+D++SFG+  IE+ TG
Sbjct: 187 WMAPE-VMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 111/215 (51%), Gaps = 19/215 (8%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
           ++T N+  + F    +LG G F  V+  K  L+ GK  A+K +        +   NE+ +
Sbjct: 2   MQTTNIRKT-FIFMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGI 457
           + K++H+N+V L           LV + +  G L D IL    +RG+   +  + ++  +
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQV 115
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVL-LDSDMNSKI--SDFGMARIFAESEGEANTVRIV 514
              + YLHE+    IVHRDLK  N+L L  + NSKI  +DFG++++  E  G  +T    
Sbjct: 116 LSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTA--C 168
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           GT GY+APE   +  YSK  D +S GV+   ++ G
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 142
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 107/213 (50%), Gaps = 18/213 (8%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKE-VAVKR--LSSCSEQGTAEFTNEVLLILKLQHKN 406
           ++    ++G G    V     +  KE VA+KR  L  C +    E   E+  + +  H N
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPN 74
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGS-LDAILF----DPRKRGILCWRKRTNIVNGIAKGM 461
           +V      V  DE  LV + +  GS LD I         K G+L       I+  + +G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE-SEGEANTVR--IVGTYG 518
            YLH++ +   +HRD+KA N+LL  D + +I+DFG++   A   +   N VR   VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 519 YMAPEYAMEGL--YSKKSDVFSFGVLLIEIITG 549
           +MAPE  ME +  Y  K+D++SFG+  IE+ TG
Sbjct: 192 WMAPE-VMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 142
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
            I  +G FG V+K  L +   VAVK +    ++ + +   E+     ++H+NL++ +   
Sbjct: 21  EIKARGRFGCVWKAQLMNDF-VAVK-IFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAE 78
Query: 415 VDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED--- 467
             G     E  L+  F   GSL   L    K  I+ W +  ++   +++G+ YLHED   
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 468 -----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
                 +  I HRD K+ NVLL SD+ + ++DFG+A  F   +   +T   VGT  YMAP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 523 EYAMEGLYSKKSDVF------SFGVLLIEIIT 548
           E  +EG  + + D F      + G++L E+++
Sbjct: 195 E-VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGP-VYKGVLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F   V    L+  +E A+K L       E      T E  ++ +L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 142
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 90  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 142
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 145
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 93  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 145
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
           F+    +G+G FG V+KG+ +   K VA+K +    +E    +   E+ ++ +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 409 KLLGFCVDGDEKLLVYEFMPNGS-LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           K  G  +   +  ++ E++  GS LD  L +P   G L   +   I+  I KG+ YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 123
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
            +   +HRD+KA+NVLL      K++DFG+A    +++ + NT   VGT  +MAPE   +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 178
Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
             Y  K+D++S G+  IE+  G 
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   +I+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 95  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 147
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 148 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 117/230 (50%), Gaps = 28/230 (12%)
Query: 339 IDLETLNLATSNFSDS--NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV 396
           +DL T NL   +       +  +G FG V+K  L + + VAVK +    ++ + +   EV
Sbjct: 12  VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVK-IFPIQDKQSWQNEYEV 69
Query: 397 LLILKLQHKNLVKLLGF-----CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
             +  ++H+N+++ +G       VD D   L+  F   GSL   L    K  ++ W +  
Sbjct: 70  YSLPGMKHENILQFIGAEKRGTSVDVD-LWLITAFHEKGSLSDFL----KANVVSWNELC 124
Query: 452 NIVNGIAKGMLYLHED-------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
           +I   +A+G+ YLHED        +  I HRD+K+ NVLL +++ + I+DFG+A  F   
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVF------SFGVLLIEIIT 548
           +   +T   VGT  YMAPE  +EG  + + D F      + G++L E+ +
Sbjct: 185 KSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLILKLQH 404
            +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 405 KNLVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGIL---CWRKRTNIVNGIAKG 460
              VKL  F    DEKL     +  NG L   +   RK G     C R  T     I   
Sbjct: 92  PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA---EIVSA 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +PE   E    K SD+++ G ++ +++ G
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 27/203 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAV----KRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG G FG VYK   +  KE +V    K + + SE+   ++  E+ ++    H N+VKLL 
Sbjct: 45  LGDGAFGKVYK---AQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
                +   ++ EF   G++DA++ +  +   L   +   +       + YLH++   +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR----IVGTYGYMAPEYAM-- 526
           +HRDLKA N+L   D + K++DFG+      S     T++     +GT  +MAPE  M  
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGV------SAKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 527 ---EGLYSKKSDVFSFGVLLIEI 546
              +  Y  K+DV+S G+ LIE+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 113/221 (51%), Gaps = 19/221 (8%)
Query: 339 IDLETLNL------ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS-SCSEQGTA 390
           +DL T NL          F+    +G+G FG V+KG+ +   K VA+K +    +E    
Sbjct: 11  VDLGTENLYFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 70
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS-LDAILFDPRKRGILCWRK 449
           +   E+ ++ +     + K  G  +   +  ++ E++  GS LD  L +P   G L   +
Sbjct: 71  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQ 125
Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
              I+  I KG+ YLH + +   +HRD+KA+NVLL      K++DFG+A    +++ + N
Sbjct: 126 IATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 182
Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T   VGT  +MAPE   +  Y  K+D++S G+  IE+  G 
Sbjct: 183 T--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++ E+   G+L   L   R  G+             + ++   + 
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAV----KRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG G FG VYK   +  KE +V    K + + SE+   ++  E+ ++    H N+VKLL 
Sbjct: 45  LGDGAFGKVYK---AQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
                +   ++ EF   G++DA++ +  +   L   +   +       + YLH++   +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI------VGTYGYMAPEYAM 526
           +HRDLKA N+L   D + K++DFG++          NT  I      +GT  +MAPE  M
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSA--------KNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 527 -----EGLYSKKSDVFSFGVLLIEI 546
                +  Y  K+DV+S G+ LIE+
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 31/205 (15%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAV----KRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG G FG VYK   +  KE +V    K + + SE+   ++  E+ ++    H N+VKLL 
Sbjct: 45  LGDGAFGKVYK---AQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 101
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
                +   ++ EF   G++DA++ +  +   L   +   +       + YLH++   +I
Sbjct: 102 AFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHDN---KI 156
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI------VGTYGYMAPEYAM 526
           +HRDLKA N+L   D + K++DFG++          NT  I      +GT  +MAPE  M
Sbjct: 157 IHRDLKAGNILFTLDGDIKLADFGVSA--------KNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 527 -----EGLYSKKSDVFSFGVLLIEI 546
                +  Y  K+DV+S G+ LIE+
Sbjct: 209 CETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 112/225 (49%), Gaps = 19/225 (8%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGK---EVAVKRLSSCSE 386
            +LK +  F+  + L +A         LG G FG V +GV    K   +VA+K L   +E
Sbjct: 323 EELKDKKLFLKRDNLLIADIE------LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE 376
Query: 387 QG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL 445
           +  T E   E  ++ +L +  +V+L+G C   +  +LV E    G L   L    KR  +
Sbjct: 377 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEI 433
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
                  +++ ++ GM YL E +    VHR+L A NVLL +   +KISDFG+++    ++
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG-AD 489
Query: 506 GEANTVRIVGTYG--YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               T R  G +   + APE      +S +SDV+S+GV + E ++
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 342 ETLNLATSNFSDSNI-LGQGGFGPVYKGVLSDGK---EVAVKRLSSCSEQG-TAEFTNEV 396
           + L L   N   ++I LG G FG V +GV    K   +VA+K L   +E+  T E   E 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            ++ +L +  +V+L+G C   +  +LV E    G L   L    KR  +       +++ 
Sbjct: 62  QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQ 118
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           ++ GM YL E +    VHRDL A NVLL +   +KISDFG+++    ++    T R  G 
Sbjct: 119 VSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG-ADDSYYTARSAGK 174
Query: 517 Y--GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +   + APE      +S +SDV+S+GV + E ++
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 34/218 (15%)
Query: 354 SNILGQGGFGPVYKG-VLSDG--KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLV 408
            +++G+G FG V K  +  DG   + A+KR+    S+    +F  E+ ++ KL  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVN 455
            LLG C       L  E+ P+G+L   L   R                 L  ++  +   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            +A+GM YL   S+ + +HR+L A N+L+  +  +KI+DFG++R           V +  
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--------GQEVYVKK 195
Query: 516 TYG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           T G     +MA E     +Y+  SDV+S+GVLL EI++
Sbjct: 196 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++  +   G+L   L   R  G+             + ++   + 
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 324 HVQGRDNDLKA-QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLS 382
           HV  +   LK   D  +D  T+      +     LG+GGF   Y+    D KEV   ++ 
Sbjct: 20  HVDPKSAPLKEIPDVLVDPRTMK----RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV 75
Query: 383 SCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438
             S         + + E+ +   L + ++V   GF  D D   +V E     SL  +   
Sbjct: 76  PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL--LELH 133
Query: 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
            R++ +     R  +   I +G+ YLH +   R++HRDLK  N+ L+ DM+ KI DFG+A
Sbjct: 134 KRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
               E +GE     + GT  Y+APE   +  +S + D++S G +L  ++ G+
Sbjct: 190 TKI-EFDGERKKT-LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 357 LGQGGFGPVY--------KGVLSDGKEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V         K    +   VAVK L    +E+  ++  +E+ ++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------LCWRKRTNI 453
           ++ LLG C       ++  +   G+L   L   R  G+             + ++   + 
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR     +    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
           F+    +G+G FG V+KG+ +   K VA+K +    +E    +   E+ ++ +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 409 KLLGFCVDGDEKLLVYEFMPNGS-LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           K  G  +   +  ++ E++  GS LD  L +P   G L   +   I+  I KG+ YLH +
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 138
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
            +   +HRD+KA+NVLL      K++DFG+A    +++ + N    VGT  +MAPE   +
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 193
Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
             Y  K+D++S G+  IE+  G 
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNLV 408
           F+    +G+G FG V+KG+ +   K VA+K +    +E    +   E+ ++ +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 409 KLLGFCVDGDEKLLVYEFMPNGS-LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           K  G  +   +  ++ E++  GS LD  L +P   G L   +   I+  I KG+ YLH +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 123
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
            +   +HRD+KA+NVLL      K++DFG+A    +++ + N    VGT  +MAPE   +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 178
Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
             Y  K+D++S G+  IE+  G 
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 324 HVQGRDNDLKA-QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLS 382
           HV  +   LK   D  +D  T+      +     LG+GGF   Y+    D KEV   ++ 
Sbjct: 20  HVDPKSAPLKEIPDVLVDPRTMK----RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV 75
Query: 383 SCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438
             S         + + E+ +   L + ++V   GF  D D   +V E     SL  +   
Sbjct: 76  PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL--LELH 133
Query: 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
            R++ +     R  +   I +G+ YLH +   R++HRDLK  N+ L+ DM+ KI DFG+A
Sbjct: 134 KRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
               E +GE     + GT  Y+APE   +  +S + D++S G +L  ++ G+
Sbjct: 190 TKI-EFDGERKKX-LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVK 409
           ++LG G F  V   +L++ K     VA+K ++  + +G      NE+ ++ K++H N+V 
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L      G    L+ + +  G L D I+    ++G    R  + ++  +   + YLH+  
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 469 RLRIVHRDLKASNVL---LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            L IVHRDLK  N+L   LD D    ISDFG++++  E  G   +    GT GY+APE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST-ACGTPGYVAPEVL 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
            +  YSK  D +S GV+   ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVK 409
           ++LG G F  V   +L++ K     VA+K ++  + +G      NE+ ++ K++H N+V 
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L      G    L+ + +  G L D I+    ++G    R  + ++  +   + YLH+  
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 469 RLRIVHRDLKASNVL---LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            L IVHRDLK  N+L   LD D    ISDFG++++  E  G   +    GT GY+APE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLST-ACGTPGYVAPEVL 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
            +  YSK  D +S GV+   ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVK 409
           ++LG G F  V   +L++ K     VA+K ++  + +G      NE+ ++ K++H N+V 
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L      G    L+ + +  G L D I+    ++G    R  + ++  +   + YLH+  
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 469 RLRIVHRDLKASNVL---LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            L IVHRDLK  N+L   LD D    ISDFG++++  E  G   +    GT GY+APE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA-CGTPGYVAPEVL 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
            +  YSK  D +S GV+   ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 108/230 (46%), Gaps = 24/230 (10%)
Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL--SDGK--EVAVK--RLSSCSE 386
           K +D  ID   L L         ILG+G FG V +G L   DG   +VAVK  +L + S+
Sbjct: 25  KLEDVVIDRNLLILG-------KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ 77
Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-----LLVYEFMPNGSLDAILFDPRK 441
           +   EF +E   +    H N+++LLG C++   +     +++  FM  G L   L   R 
Sbjct: 78  REIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL 137
Query: 442 R---GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
                 +  +     +  IA GM YL   S    +HRDL A N +L  DM   ++DFG++
Sbjct: 138 ETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +     +             ++A E   + +Y+ KSDV++FGV + EI T
Sbjct: 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVK 409
           ++LG G F  V   +L++ K     VA+K ++  + +G      NE+ ++ K++H N+V 
Sbjct: 24  DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L      G    L+ + +  G L D I+    ++G    R  + ++  +   + YLH+  
Sbjct: 81  LDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 469 RLRIVHRDLKASNVL---LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            L IVHRDLK  N+L   LD D    ISDFG++++  E  G   +    GT GY+APE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTA-CGTPGYVAPEVL 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
            +  YSK  D +S GV+   ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG+GGF   ++   +D KEV   ++   S         + + E+ +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D D   +V E     SL  +    ++R  L   +    +  I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 160
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLK  N+ L+ D+  KI DFG+A    E +GE   V + GT  Y+APE   +  +S 
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 218
Query: 533 KSDVFSFGVLLIEIITGR 550
           + DV+S G ++  ++ G+
Sbjct: 219 EVDVWSIGCIMYTLLVGK 236

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 31/235 (13%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKG-VLSDGKE-----VAVKRLSSCSEQGTAE-FTN 394
           E      +N      LG G FG V +      GKE     VAVK L S +     E   +
Sbjct: 24  EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 83
Query: 395 EVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL--------DAIL--------- 436
           E+ ++  L QH+N+V LLG C  G   L++ E+   G L        +A+L         
Sbjct: 84  ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQD 143
Query: 437 ---FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493
               D      L  R   +  + +A+GM +L   +    +HRD+ A NVLL +   +KI 
Sbjct: 144 PEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIG 200
Query: 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           DFG+AR                   +MAPE   + +Y+ +SDV+S+G+LL EI +
Sbjct: 201 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 324 HVQGRDNDLKA-QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLS 382
           HV  +   LK   D  +D  T+      +     LG+GGF   Y+    D KEV   ++ 
Sbjct: 20  HVDPKSAPLKEIPDVLVDPRTMK----RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV 75
Query: 383 SCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD 438
             S         + + E+ +   L + ++V   GF  D D   +V E     SL  +   
Sbjct: 76  PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL--LELH 133
Query: 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA 498
            R++ +     R  +   I +G+ YLH +   R++HRDLK  N+ L+ DM+ KI DFG+A
Sbjct: 134 KRRKAVTEPEARYFMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
               E +GE     + GT  Y+APE   +  +S + D++S G +L  ++ G+
Sbjct: 190 TKI-EFDGERKK-DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG+GGF   ++   +D KEV   ++   S         + + E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D D   +V E     SL  +    ++R  L   +    +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 136
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLK  N+ L+ D+  KI DFG+A    E +GE   V + GT  Y+APE   +  +S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 533 KSDVFSFGVLLIEIITGR 550
           + DV+S G ++  ++ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 106/219 (48%), Gaps = 17/219 (7%)
Query: 339 IDLETLNL---ATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE--F 392
           +DL T NL   +   + +  ++G+G +G V K    D G+ VA+K+     +    +   
Sbjct: 12  VDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA 71
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT- 451
             E+ L+ +L+H+NLV LL  C       LV+EF+ +  LD +   P        +K   
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            I+NGI  G  + H      I+HRD+K  N+L+      K+ DFG AR  A + GE    
Sbjct: 132 QIINGI--GFCHSH-----NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDD 183
Query: 512 RIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITG 549
             V T  Y APE  +  + Y K  DV++ G L+ E+  G
Sbjct: 184 E-VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 24/209 (11%)
Query: 351 FSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHK 405
           F     LG G F  V   VL++    GK  AVK +   + +G  +   NE+ ++ K++H+
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           N+V L       +   LV + +  G L D I+    ++G    +  + ++  +   + YL
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIV----EKGFYTEKDASTLIRQVLDAVYYL 136
Query: 465 HEDSRLRIVHRDLKASNVLLDS-DMNSKI--SDFGMARIFAESEGEANTVRIV-GTYGYM 520
           H   R+ IVHRDLK  N+L  S D  SKI  SDFG++++    EG+ + +    GT GY+
Sbjct: 137 H---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM----EGKGDVMSTACGTPGYV 189
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           APE   +  YSK  D +S GV+   ++ G
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G   K    SDGK +  K L   S +E       +EV L+ +L+H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 414 CVDGDEKLL--VYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHE--DS 468
            +D     L  V E+   G L +++    ++R  L       ++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              ++HRDLK +NV LD   N K+ DFG+ARI       A T   VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 529 LYSKKSDVFSFGVLLIEI 546
            Y++KSD++S G LL E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG+GGF   ++   +D KEV   ++   S         + + E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D D   +V E     SL  +    ++R  L   +    +  I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 162
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLK  N+ L+ D+  KI DFG+A    E +GE   V + GT  Y+APE   +  +S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 533 KSDVFSFGVLLIEIITGR 550
           + DV+S G ++  ++ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G   K    SDGK +  K L   S +E       +EV L+ +L+H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 414 CVDGDEKLL--VYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHE--DS 468
            +D     L  V E+   G L +++    ++R  L       ++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              ++HRDLK +NV LD   N K+ DFG+ARI    E  A     VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK--EFVGTPYYMSPEQMNRM 191
Query: 529 LYSKKSDVFSFGVLLIEI 546
            Y++KSD++S G LL E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 18/223 (8%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
           IDL  L      F    ++G G +G VYKG      ++A  ++   +     E   E+ +
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM 73
Query: 399 ILKL-QHKNLVKLLGFCVDG------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
           + K   H+N+    G  +        D+  LV EF   GS+  ++ +  K   L      
Sbjct: 74  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIA 132
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            I   I +G+ +LH+    +++HRD+K  NVLL  +   K+ DFG++     + G  NT 
Sbjct: 133 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 188
Query: 512 RIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITG 549
             +GT  +MAPE        +  Y  KSD++S G+  IE+  G
Sbjct: 189 -FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/211 (33%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL---- 410
           LG GGFG V + +  D G++VA+K+     S +    +  E+ ++ KL H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 411 --LGFCVDGDEKLLVYEFMPNGSLDAILFDPR-----KRGILCWRKRTNIVNGIAKGMLY 463
             L      D  LL  E+   G L   L         K G +    RT +++ I+  + Y
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI----RT-LLSDISSALRY 137
Query: 464 LHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           LHE+   RI+HRDLK  N++L      +  KI D G A+     +GE  T   VGT  Y+
Sbjct: 138 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCT-EFVGTLQYL 191
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           APE   +  Y+   D +SFG L  E ITG R
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G +   L   +K      ++    +  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 180
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTELCGTLDYLPP 175
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G +   L   +K      ++    +  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRXXLXGTLDYLPP 180
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINAMLNHENVVKF 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 103/211 (48%), Gaps = 27/211 (12%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL---- 410
           LG GGFG V + +  D G++VA+K+     S +    +  E+ ++ KL H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 411 --LGFCVDGDEKLLVYEFMPNGSLDAIL--FD---PRKRGILCWRKRTNIVNGIAKGMLY 463
             L      D  LL  E+   G L   L  F+     K G +    RT +++ I+  + Y
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI----RT-LLSDISSALRY 136
Query: 464 LHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           LHE+   RI+HRDLK  N++L      +  KI D G A+     +GE  T   VGT  Y+
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCT-EFVGTLQYL 190
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           APE   +  Y+   D +SFG L  E ITG R
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   A    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA---LCGTLDYLPP 175
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 68
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 69  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 121
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAG 202

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKMLNHENVVKF 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGK----EVAVKRLSS-CSEQGTAEFTNEVLLIL 400
           +A  +   + ILG+G FG VY+GV ++ K     VAVK     C+     +F +E +++ 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
            L H ++VKL+G  ++ +   ++ E  P G L   L   R +  L           I K 
Sbjct: 65  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKA 121
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGY 519
           M YL     +  VHRD+   N+L+ S    K+ DFG++R I  E   +A+  R+     +
Sbjct: 122 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 176
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           M+PE      ++  SDV+ F V + EI++
Sbjct: 177 MSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHK 405
           N+     +G+G F  V   + +L+ G+EVA+K +       T+  +   EV ++  L H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           N+VKL           L+ E+   G + D ++   R +      K   IV+ +     Y 
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 127
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H+    RIVHRDLKA N+LLD+DMN KI+DFG +  F    G+ +T    G+  Y APE 
Sbjct: 128 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDT--FCGSPPYAAPEL 181
Query: 525 AMEGLY-SKKSDVFSFGVLLIEIITG 549
                Y   + DV+S GV+L  +++G
Sbjct: 182 FQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG+GGF   ++   +D KEV   ++   S         + + E+ +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D D   +V E     SL  +    ++R  L   +    +  I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 142
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLK  N+ L+ D+  KI DFG+A    E +GE     + GT  Y+APE   +  +S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 200
Query: 533 KSDVFSFGVLLIEIITGR 550
           + DV+S G ++  ++ G+
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEIXINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG+GGF   ++   +D KEV   ++   S         + + E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D D   +V E     SL  +    ++R  L   +    +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLK  N+ L+ D+  KI DFG+A    E +GE     + GT  Y+APE   +  +S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 196
Query: 533 KSDVFSFGVLLIEIITGR 550
           + DV+S G ++  ++ G+
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG+GGF   ++   +D KEV   ++   S         + + E+ +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D D   +V E     SL  +    ++R  L   +    +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLK  N+ L+ D+  KI DFG+A    E +GE     + GT  Y+APE   +  +S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 196
Query: 533 KSDVFSFGVLLIEIITGR 550
           + DV+S G ++  ++ G+
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   A    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA---LCGTLDYLPP 178
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S    +   + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 175
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 175
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 347 ATSNFSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKL- 402
           +  +F     LG G FG V+      +G+  A+K L           E TN+  L+L + 
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--- 459
            H  ++++ G   D  +  ++ +++  G L ++L           RK     N +AK   
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-----------RKSQRFPNPVAKFYA 112
Query: 460 -----GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
                 + YLH      I++RDLK  N+LLD + + KI+DFG A+   +      T  + 
Sbjct: 113 AEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXLC 164
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           GT  Y+APE      Y+K  D +SFG+L+ E++ G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 357 LGQGGFGPVY---KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           LG G +G V      V    + + + R +S S    ++   EV ++  L H N++KL  F
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN------IVNGIAKGMLYLHED 467
             D     LV E    G L    FD      +  R + N      I+  +  G+ YLH+ 
Sbjct: 105 FEDKRNYYLVMECYKGGEL----FDE-----IIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 468 SRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           +   IVHRDLK  N+LL+S   D   KI DFG++ +F   E +      +GT  Y+APE 
Sbjct: 156 N---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPE- 208
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
            +   Y +K DV+S GV+L  ++ G
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTXLCGTLDYLPP 175
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S    +   + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 176
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 121
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 174
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S    +   + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 175
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 180
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 178
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---G 123
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 139
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 192
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 178
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 70
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 123
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAG 204

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 23/223 (10%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           +++D+ ++G G FG VY+  L D G+ VA+K++     QG A    E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 409 KLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +L  F     EK       LV +++P           R +  L        +  + + + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRA 190
Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           PE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S    +   + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTD---LCGTLDYLPP 180
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 124
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRXXLCGTLDYLPP 177
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 10/198 (5%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G   K    SDGK +  K L   S +E       +EV L+ +L+H N+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 414 CVDGDEKLL--VYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHE--DS 468
            +D     L  V E+   G L +++    ++R  L       ++  +   +   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              ++HRDLK +NV LD   N K+ DFG+ARI       A     VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRM 191
Query: 529 LYSKKSDVFSFGVLLIEI 546
            Y++KSD++S G LL E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G +G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLI 399
           ++L  ++FS   I+G+GGFG VY    +D GK  A+K L       +QG     NE +++
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 400 LKLQHKN--LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
             +   +   +  + +     +KL  + + M  G L   L    + G+            
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 299
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           I  G+ ++H  +R  +V+RDLK +N+LLD   + +ISD G+A  F++ +  A+    VGT
Sbjct: 300 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 352
Query: 517 YGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITG 549
           +GYMAPE   +G+ Y   +D FS G +L +++ G
Sbjct: 353 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 23/223 (10%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           +++D+ ++G G FG VY+  L D G+ VA+K++     QG A    E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 409 KLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +L  F     EK       LV +++P           R +  L        +  + + + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YRA 190
Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           PE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 148
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 201
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGK----EVAVKRLSS-CSEQGTAEFTNEVLLIL 400
           +A  +   + ILG+G FG VY+GV ++ K     VAVK     C+     +F +E +++ 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
            L H ++VKL+G  ++ +   ++ E  P G L   L   R +  L           I K 
Sbjct: 81  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKA 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGY 519
           M YL     +  VHRD+   N+L+ S    K+ DFG++R I  E   +A+  R+     +
Sbjct: 138 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 192
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           M+PE      ++  SDV+ F V + EI++
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRXXLCGTLDYLPP 175
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 175
Query: 526 M-EGLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGK----EVAVKRLSS-CSEQGTAEFTNEVLLIL 400
           +A  +   + ILG+G FG VY+GV ++ K     VAVK     C+     +F +E +++ 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
            L H ++VKL+G  ++ +   ++ E  P G L   L   R +  L           I K 
Sbjct: 69  NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKA 125
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANTVRIVGTYGY 519
           M YL     +  VHRD+   N+L+ S    K+ DFG++R I  E   +A+  R+     +
Sbjct: 126 MAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKW 180
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           M+PE      ++  SDV+ F V + EI++
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLI 399
           ++L  ++FS   I+G+GGFG VY    +D GK  A+K L       +QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 400 LKLQHKN--LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
             +   +   +  + +     +KL  + + M  G L   L    + G+            
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 300
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           I  G+ ++H  +R  +V+RDLK +N+LLD   + +ISD G+A  F++ +  A+    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 517 YGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITG 549
           +GYMAPE   +G+ Y   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 23/223 (10%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           +++D+ ++G G FG VY+  L D G+ VA+K++     QG A    E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 409 KLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +L  F     EK       LV +++P           R +  L        +  + + + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YRA 190
Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           PE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLI 399
           ++L  ++FS   I+G+GGFG VY    +D GK  A+K L       +QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 400 LKLQHKN--LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
             +   +   +  + +     +KL  + + M  G L   L    + G+            
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 300
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           I  G+ ++H  +R  +V+RDLK +N+LLD   + +ISD G+A  F++ +  A+    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 517 YGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITG 549
           +GYMAPE   +G+ Y   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCS---EQGTAEFTNEVLLI 399
           ++L  ++FS   I+G+GGFG VY    +D GK  A+K L       +QG     NE +++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 400 LKLQHKN--LVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
             +   +   +  + +     +KL  + + M  G L   L    + G+            
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAE 300
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           I  G+ ++H  +R  +V+RDLK +N+LLD   + +ISD G+A  F++ +  A+    VGT
Sbjct: 301 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 353
Query: 517 YGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITG 549
           +GYMAPE   +G+ Y   +D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 119
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 172
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 206

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQ 403
           N+     LG+G FG V      + G++VA+K      L+    QG  E   E+  +  L+
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H +++KL       DE ++V E+  N   D I+    +R  +  ++       I   + Y
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 118
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
            H   R +IVHRDLK  N+LLD  +N KI+DFG++ I  +      +    G+  Y APE
Sbjct: 119 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPE 172
Query: 524 YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
                LY+  + DV+S GV+L  ++  R
Sbjct: 173 VISGKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 126
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 179
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 213

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRXXLCGTLDYLPP 178
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQ 403
           N+     LG+G FG V      + G++VA+K      L+    QG  E   E+  +  L+
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H +++KL       DE ++V E+  N   D I+    +R  +  ++       I   + Y
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 122
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
            H   R +IVHRDLK  N+LLD  +N KI+DFG++ I  +      +    G+  Y APE
Sbjct: 123 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPE 176
Query: 524 YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
                LY+  + DV+S GV+L  ++  R
Sbjct: 177 VISGKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 16/219 (7%)
Query: 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAE 391
           D  +D  T+      +     LG+GGF   Y+    D KEV   ++   S         +
Sbjct: 17  DVLVDPRTMK----RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK 72
Query: 392 FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
            + E+ +   L + ++V   GF  D D   +V E     SL  +    R++ +     R 
Sbjct: 73  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY 130
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            +   I +G+ YLH +   R++HRDLK  N+ L+ DM+ KI DFG+A    E +GE    
Sbjct: 131 FMRQTI-QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKK- 184
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            + GT  Y+APE   +  +S + D++S G +L  ++ G+
Sbjct: 185 DLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 127
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 182
Query: 526 M-EGLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQ 403
           N+     LG+G FG V      + G++VA+K      L+    QG  E   E+  +  L+
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H +++KL       DE ++V E+  N   D I+    +R  +  ++       I   + Y
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 127
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
            H   R +IVHRDLK  N+LLD  +N KI+DFG++ I  +      +    G+  Y APE
Sbjct: 128 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPE 181
Query: 524 YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
                LY+  + DV+S GV+L  ++  R
Sbjct: 182 VISGKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 175
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 11/208 (5%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 119
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
            H     R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPE 174
Query: 524 YAME-GLYSKKSDVFSFGVLLIEIITGR 550
             +    YS   D++S G +  E++T R
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 174
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY     + K + A+K L     E+   E     EV +   L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     +++HRD+K  N+LL S    KI+DFG + + A S   A    + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAA---LCGTLDYLPP 175
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 124
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 179
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 174
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQ 403
           N+     LG+G FG V      + G++VA+K      L+    QG  E   E+  +  L+
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H +++KL       DE ++V E+  N   D I+    +R  +  ++       I   + Y
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEY 128
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
            H   R +IVHRDLK  N+LLD  +N KI+DFG++ I  +      +    G+  Y APE
Sbjct: 129 CH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPE 182
Query: 524 YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
                LY+  + DV+S GV+L  ++  R
Sbjct: 183 VISGKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 127
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 182
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 175
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH 404
            L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ H
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLH 78
Query: 405 K-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
           + N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + K
Sbjct: 79  ECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIK 134
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           G+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  Y
Sbjct: 135 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRSY 188
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           M+PE      YS +SD++S G+ L+E+  GR   GS 
Sbjct: 189 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSG 225

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPP 180
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E      + +K D++S GVL  E + G+
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAF 121
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 172
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 118
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 169
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 26/227 (11%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL--SDGK--EVAVKRLSS--CSEQGTAEFTN 394
           LE + +    F+   +LG+G FG V +  L   DG   +VAVK L +   +     EF  
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR 74
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGIL 445
           E   + +  H ++ KL+G  +    K      +++  FM +G L A L   R       L
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES- 504
             +     +  IA GM YL   S    +HRDL A N +L  DM   ++DFG++R      
Sbjct: 135 PLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 505 ---EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              +G A+ + +     ++A E   + LY+  SDV++FGV + EI+T
Sbjct: 192 YYRQGCASKLPV----KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLSFCH 120
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 175
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPS---SRRDTLCGTLDYLPP 176
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 118
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 169
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 118
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 169
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S    +   + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDD---LCGTLDYLPP 178
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 121
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 172
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 120
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 171
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 148
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG + + A S    +   + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDD---LCGTLDYLPP 201
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGYMA 521
                R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y A
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWYRA 170
Query: 522 PEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
           PE  +    YS   D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 119
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 170
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
           + L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVL 58
Query: 404 HK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           H+ N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + 
Sbjct: 59  HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 114
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           KG+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRS 168
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           YM+PE      YS +SD++S G+ L+E+  GR
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 120
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 171
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 118
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 169
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGYMA 521
                R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y A
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWYRA 170
Query: 522 PEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
           PE  +    YS   D++S G +  E++T R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 120
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 171
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
           + L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVL 58
Query: 404 HK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           H+ N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + 
Sbjct: 59  HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 114
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           KG+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRS 168
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           YM+PE      YS +SD++S G+ L+E+  GR
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 119
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 170
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 122
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 173
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 121
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 172
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
           + L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVL 58
Query: 404 HK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           H+ N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + 
Sbjct: 59  HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 114
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           KG+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRS 168
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           YM+PE      YS +SD++S G+ L+E+  GR
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G  G V   V    +E      V +KR   C E        E+ +   L H+N+VK 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKF 69
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHEDSR 469
            G   +G+ + L  E+   G L    FD  +  I +         + +  G++YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG--- 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YAMEG 528
           + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE      
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            +++  DV+S G++L  ++ G
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAG 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGYMA 521
                R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y A
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWYRA 172
Query: 522 PEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
           PE  +    YS   D++S G +  E++T R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
           + L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVL 58
Query: 404 HK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           H+ N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + 
Sbjct: 59  HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 114
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           KG+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRS 168
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           YM+PE      YS +SD++S G+ L+E+  GR
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 17/212 (8%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ 403
           + L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVL 58
Query: 404 HK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           H+ N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + 
Sbjct: 59  HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVI 114
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           KG+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRS 168
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           YM+PE      YS +SD++S G+ L+E+  GR
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRL--SSCSEQGTA-EFTNEVLLILKLQH 404
            +F     LG+G FG VY       K + A+K L  +   + G   +   EV +   L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
            N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYC 128
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H     R++HRD+K  N+LL S+   KI+DFG + + A S   +    + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS-VHAPS---SRRTTLCGTLDYLPPEM 181
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
               ++ +K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 355 NILGQGGFGPVYKGVLS-DGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           + LG G FG V  G     G +VAVK   R    S     +   E+  +   +H +++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 411 LGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                   +  +V E++  G L D I     K G L  ++   +   I  G+ Y H   R
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCH---R 134
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             +VHRDLK  NVLLD+ MN+KI+DFG++ + ++ E    +    G+  Y APE     L
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRL 191
Query: 530 YS-KKSDVFSFGVLLIEIITG 549
           Y+  + D++S GV+L  ++ G
Sbjct: 192 YAGPEVDIWSSGVILYALLCG 212

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK----LQHKNLVK 409
           +G+G +G V+K   + + G+ VA+KR+     E+G    T   + +L+     +H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 410 LLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           L   C     D + KL LV+E + +  L   L    + G+     + +++  + +G+ +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFL 136
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H     R+VHRDLK  N+L+ S    K++DFG+ARI++    +     +V T  Y APE 
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 525 AMEGLYSKKSDVFSFGVLLIEI 546
            ++  Y+   D++S G +  E+
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEM 212

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHK 405
           N+     +G+G F  V   + +L+ G+EVA+K +       T+  +   EV ++  L H 
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           N+VKL           L+ E+   G + D ++   R +      K   IV+ +     Y 
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YC 130
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H+    RIVHRDLKA N+LLD+DMN KI+DFG +  F    G+ +     G   Y APE 
Sbjct: 131 HQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDA--FCGAPPYAAPEL 184
Query: 525 AMEGLY-SKKSDVFSFGVLLIEIITG 549
                Y   + DV+S GV+L  +++G
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAF 118
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 169
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 121
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 122 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 172
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTA---EFTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     +      +   EV +   L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 124
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI++FG + + A S   +    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-VHAPS---SRRTTLCGTLDYLPP 177
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH 404
            L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ H
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLH 121
Query: 405 K-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
           + N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + K
Sbjct: 122 ECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIK 177
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           G+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  Y
Sbjct: 178 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRSY 231
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           M+PE      YS +SD++S G+ L+E+  GR
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 14/214 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI++FG + + A S   +    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWS-VHAPS---SRRTTLCGTLDYLPP 178
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN 556
           E     ++ +K D++S GVL  E + G+    +N
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 119
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 170
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKL 402
           +ATS +     +G G +G VYK      G  VA+K  R+ +  E        EV L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 403 Q---HKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           +   H N+V+L+  C     D + K+ LV+E + +  L   L      G L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
               +G+ +LH +    IVHRDLK  N+L+ S    K++DFG+ARI++     A    +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---VV 172
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
            T  Y APE  ++  Y+   D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSCSEQGTAEFTN 394
           D++ID    +  +  F   + LG+G    VY+       K  A+K L    ++       
Sbjct: 40  DYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--T 97
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNI 453
           E+ ++L+L H N++KL        E  LV E +  G L D I+    ++G    R   + 
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADA 153
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANT 510
           V  I + + YLHE+    IVHRDLK  N+L  +   D   KI+DFG+++I    E +   
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLM 207
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             + GT GY APE      Y  + D++S G++   ++ G
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS-EQGTAE--FTNEVLLILKL 402
           A  +F     LG+G FG VY       K + A+K L     E+   E     EV +   L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H     R++HRD+K  N+LL S    KI+DFG +   A S   +    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-CHAPS---SRRTTLSGTLDYLPP 176
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           E     ++ +K D++S GVL  E + G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK----LQHKNLVK 409
           +G+G +G V+K   + + G+ VA+KR+     E+G    T   + +L+     +H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 410 LLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           L   C     D + KL LV+E + +  L   L    + G+     + +++  + +G+ +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFL 136
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H     R+VHRDLK  N+L+ S    K++DFG+ARI++    +     +V T  Y APE 
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 525 AMEGLYSKKSDVFSFGVLLIEI 546
            ++  Y+   D++S G +  E+
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 20/202 (9%)
Query: 357 LGQGGFGPVYKG--VLSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK----LQHKNLVK 409
           +G+G +G V+K   + + G+ VA+KR+     E+G    T   + +L+     +H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 410 LLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           L   C     D + KL LV+E + +  L   L    + G+     + +++  + +G+ +L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFL 136
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H     R+VHRDLK  N+L+ S    K++DFG+ARI++    +     +V T  Y APE 
Sbjct: 137 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 190
Query: 525 AMEGLYSKKSDVFSFGVLLIEI 546
            ++  Y+   D++S G +  E+
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEM 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH 404
            L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ H
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLH 86
Query: 405 K-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
           + N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + K
Sbjct: 87  ECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIK 142
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           G+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VGT  Y
Sbjct: 143 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRSY 196
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           M+PE      YS +SD++S G+ L+E+  GR
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAF 121
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 172
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAF 120
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 171
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTA--EFTNEVLLILKLQHK 405
           N+     +G+G F  V   + VL+ G+EVAVK +       T+  +   EV ++  L H 
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           N+VKL           LV E+   G + D ++   R +      K   IV+ +     Y 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ----YC 130
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H+     IVHRDLKA N+LLD DMN KI+DFG +  F     + +T    G+  Y APE 
Sbjct: 131 HQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-NKLDT--FCGSPPYAAPEL 184
Query: 525 AMEGLY-SKKSDVFSFGVLLIEIITG 549
                Y   + DV+S GV+L  +++G
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK---RGILCWRKRTNIVNGIA 458
            LLG C   G   +++ EF   G+L   L      F P K   +  L           +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           KGM +L   +  + +HRDL A N+LL      KI DFG+AR   +               
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 113/220 (51%), Gaps = 34/220 (15%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFT-NEVLLILKLQ-HKNLVKLLG 412
           LG+G +G V+K +    G+ VAVK++    +  T A+ T  E++++ +L  H+N+V LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 413 FC-VDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
               D D  + LV+++M    L A++    +  IL    +  +V  + K + YLH     
Sbjct: 77  VLRADNDRDVYLVFDYM-ETDLHAVI----RANILEPVHKQYVVYQLIKVIKYLHSGG-- 129
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----------------- 513
            ++HRD+K SN+LL+++ + K++DFG++R F       N + +                 
Sbjct: 130 -LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 514 --VGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
             V T  Y APE  +    Y+K  D++S G +L EI+ G+
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK-----RGILCWRKRTNIVNG 456
            LLG C   G   +++ EF   G+L   L      F P K     +  L           
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +             
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+   RL + +E   +    E+ L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 175
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+   RL + +E   +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+EF+ +  L   +      GI     ++ +   + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 174
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRL--SSCSEQGTA-EFTNEVLLILKLQH 404
            +F     LG+G FG VY       K + A+K L  +   + G   +   EV +   L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
            N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYC 128
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H     R++HRD+K  N+LL S+   KI+DFG + + A S        + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDT---LCGTLDYLPPEM 181
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
               ++ +K D++S GVL  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL 402
           N+     +G+G F  V   + +L+ GKEVAVK     +L+S S Q   +   EV ++  L
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H N+VKL           LV E+   G + D ++   R +      K   IV+ +    
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ--- 127
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            Y H+     IVHRDLKA N+LLD+DMN KI+DFG +  F     + +T    G+  Y A
Sbjct: 128 -YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT--FCGSPPYAA 180
Query: 522 PEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
           PE      Y   + DV+S GV+L  +++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL 402
           N+     +G+G F  V   + +L+ GKEVAVK     +L+S S Q   +   EV ++  L
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H N+VKL           LV E+   G + D ++   R +      K   IV+ +    
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ--- 127
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            Y H+     IVHRDLKA N+LLD+DMN KI+DFG +  F     + +T    G+  Y A
Sbjct: 128 -YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT--FCGSPPYAA 180
Query: 522 PEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
           PE      Y   + DV+S GV+L  +++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 53/234 (22%)
Query: 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           +F +  ++G GGFG V+K     DGK   ++R+   +E+       EV  + KL H N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIV 68
Query: 409 KLLGFCVDGDEKLLVYEFMP---NGSLDAILFDPRK--------------------RGIL 445
              G C DG      +++ P   + SL++  +DP                      +G L
Sbjct: 69  HYNG-CWDG------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 446 -CW-RKRT----------NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493
             W  KR            +   I KG+ Y+H     +++HRDLK SN+ L      KI 
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIG 178
Query: 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
           DFG+       + +    R  GT  YM+PE      Y K+ D+++ G++L E++
Sbjct: 179 DFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 112/228 (49%), Gaps = 23/228 (10%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKL 402
           +ATS +     +G G +G VYK      G  VA+K  R+ +  E        EV L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 403 Q---HKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           +   H N+V+L+  C     D + K+ LV+E + +  L   L      G L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
               +G+ +LH +    IVHRDLK  N+L+ S    K++DFG+ARI++    +     +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALFPVV 172
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR----NAGSNQL 558
            T  Y APE  ++  Y+   D++S G +  E+   +     N+ ++QL
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 220

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 93/212 (43%), Gaps = 19/212 (8%)
Query: 346 LATSNFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSS----CSEQGTAEFTNEVLLIL 400
           L   NF    +LG+G FG V    V   G   AVK L        +      T + +L L
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
              H  L +L       D    V EF+  G L   +F  +K       +       I   
Sbjct: 80  ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISA 136
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIVGTY 517
           +++LH+     I++RDLK  NVLLD + + K++DFGM +     EG  N   T    GT 
Sbjct: 137 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTATFCGTP 188
Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            Y+APE   E LY    D ++ GVLL E++ G
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK------RGILCWRKRTNIVN 455
            LLG C   G   +++ EF   G+L   L      F P K      +  L          
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +            
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 345 NLATSNFSDSNILGQGGFGPVY--KGVLSDGKEVAVK-----RLSSCSEQGTAEFTNEVL 397
           +L   N+     +G+G F  V   + +L+ GKEVAVK     +L+S S Q   +   EV 
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVR 58
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++  L H N+VKL           LV E+   G +   L      G +  ++       I
Sbjct: 59  IMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLV---AHGWMKEKEARAKFRQI 115
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
              + Y H+     IVHRDLKA N+LLD+DMN KI+DFG +  F     + +T    G+ 
Sbjct: 116 VSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT--FCGSP 169
Query: 518 GYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
            Y APE      Y   + DV+S GV+L  +++G
Sbjct: 170 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK---RGILCWRKRTNIVNGIA 458
            LLG C   G   +++ EF   G+L   L      F P K   +  L           +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           KGM +L   +  + +HRDL A N+LL      KI DFG+AR   +               
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSCSEQ---GTAEFTNEV 396
           LE   +  + F    +LG+GGFG V    V + GK  A K+L     +   G A   NE 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD------PRKRGILCWRKR 450
            ++ K+  + +V L       D   LV   M  G L   ++       P  R +      
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF----- 290
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                 I  G+  LH   R RIV+RDLK  N+LLD   + +ISD G+A      EG+   
Sbjct: 291 --YAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK 343
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            R VGT GYMAPE      Y+   D ++ G LL E+I G+
Sbjct: 344 GR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V   +    G++VA+K+LS    SE        E+LL+  +QH+N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 414 CVDGDEKLLVYEF---MPNGSLD-----AILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     Y+F   MP    D      + F   K   L ++        + KG+ Y+H
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ--------MLKGLKYIH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 +VHRDLK  N+ ++ D   KI DFG+AR       +A     V T  Y APE  
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVI 195
Query: 526 MEGL-YSKKSDVFSFGVLLIEIITGR 550
           +  + Y++  D++S G ++ E++TG+
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 19/212 (8%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH 404
            L   +F   + LG G  G V+K        V  ++L     +      N+++  L++ H
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLH 62
Query: 405 K-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
           + N   ++GF      DG E  +  E M  GSLD +L   +K G +  +    +   + K
Sbjct: 63  ECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIK 118
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAESEGEANTVRIVGTYG 518
           G+ YL E  + +I+HRD+K SN+L++S    K+ DFG++ ++  E   E      VGT  
Sbjct: 119 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE-----FVGTRS 171
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           YM+PE      YS +SD++S G+ L+E+  GR
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHK 405
            NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N+VKLL      ++  LV+E + +  L   +      GI     ++ +   + +G+ + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                R++HRDLK  N+L++++   K++DFG+AR F        T  +V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TLWYRAPEIL 174
Query: 526 ME-GLYSKKSDVFSFGVLLIEIITGR 550
           +    YS   D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 76
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 136
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 137 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 190
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 234

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 83
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 143
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 144 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 197
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           +F +  ++G GGFG V+K     DGK   +KR+   +E+       EV  + KL H N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67
Query: 409 KLLGFCVDG---DEK--------------LLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
              G C DG   D +               +  EF   G+L+  + + R+   L      
Sbjct: 68  HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            +   I KG+ Y+H     ++++RDLK SN+ L      KI DFG+       + +    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLV---TSLKNDGKRX 179
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
           R  GT  YM+PE      Y K+ D+++ G++L E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 94
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 154
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 155 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 208
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 88
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 148
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 149 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YR 202
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL 402
           N+     +G+G F  V   + +L+ GKEVAV+     +L+S S Q   +   EV ++  L
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H N+VKL           LV E+   G + D ++   R +      K   IV+ +    
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ--- 127
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            Y H+     IVHRDLKA N+LLD+DMN KI+DFG +  F     + +T    G+  Y A
Sbjct: 128 -YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDT--FCGSPPYAA 180
Query: 522 PEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
           PE      Y   + DV+S GV+L  +++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 87
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 148 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 201
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL 402
           N+     +G+G F  V   + +L+ GKEVAV+     +L+S S Q   +   EV ++  L
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H N+VKL           LV E+   G + D ++   R +      K   IV+ +    
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ--- 127
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            Y H+     IVHRDLKA N+LLD+DMN KI+DFG +  F             G+  Y A
Sbjct: 128 -YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDEFCGSPPYAA 180
Query: 522 PEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
           PE      Y   + DV+S GV+L  +++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA---EFTNEVLLIL 400
           S+ SD      ILG GG   V+    L D ++VAVK L +   +  +    F  E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 401 KLQHKNLVKLL----GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            L H  +V +          G    +V E++   +L  I+      G +  ++   ++  
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIAD 124
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA-NTVRIVG 515
             + + + H++    I+HRD+K +N+L+ +    K+ DFG+AR  A+S      T  ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIG 181
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           T  Y++PE A       +SDV+S G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 357 LGQGGFGPV-----YKGVLSDGK-EVAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLV 408
           LG G FG V     Y  + SD    VAVK L   +     E     L +L     H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNG----------- 456
            LLG C  G   L++ E+   G  D + F  RKR   +C +    I+             
Sbjct: 91  NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
                +AKGM +L   +    +HRDL A N+LL     +KI DFG+AR            
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                  +MAPE     +Y+ +SDV+S+G+ L E+ +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 109
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 223
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSCSEQ---GTAEFTNEV 396
           LE   +  + F    +LG+GGFG V    V + GK  A K+L     +   G A   NE 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD------PRKRGILCWRKR 450
            ++ K+  + +V L       D   LV   M  G L   ++       P  R +      
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF----- 290
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                 I  G+  LH   R RIV+RDLK  N+LLD   + +ISD G+A      EG+   
Sbjct: 291 --YAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIK 343
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            R VGT GYMAPE      Y+   D ++ G LL E+I G+
Sbjct: 344 GR-VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL 402
           N+     +G+G F  V   + +L+ GKEVAVK     +L+S S Q   +   EV ++  L
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H N+VKL           LV E+   G + D ++   R +      K   IV+ +    
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ--- 127
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            Y H+     IVHRDLKA N+LLD+DMN KI+DFG +  F             G   Y A
Sbjct: 128 -YCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDAFCGAPPYAA 180
Query: 522 PEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
           PE      Y   + DV+S GV+L  +++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 87
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 147
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 148 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 201
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 75
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 346 LATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKL 402
           +ATS +     +G G +G VYK      G  VA+K  R+ +  E        EV L+ +L
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 403 Q---HKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           +   H N+V+L+  C     D + K+ LV+E + +  L   L      G L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG-LPAETIKDLM 118
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
               +G+ +LH +    IVHRDLK  N+L+ S    K++DFG+ARI++    +     +V
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALDPVV 172
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
            T  Y APE  ++  Y+   D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 409 KLLGFCV-DGDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 103
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 163
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 164 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YR 217
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 79
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 139
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 140 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSXICSRY-YR 193
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 80
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 140
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 141 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YR 194
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 238

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 109
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 170 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YR 223
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V   +    G++VA+K+LS    SE        E+LL+  +QH+N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 414 CVDGDEKLLVYEF---MP--NGSLDAILFDPRKRGI-LCWRKRTNIVNGIAKGMLYLHED 467
                     Y+F   MP     L  I+      G+     K   +V  + KG+ Y+H  
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA 163
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
               +VHRDLK  N+ ++ D   KI DFG+AR       +A     V T  Y APE  + 
Sbjct: 164 G---VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILS 215
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
            + Y++  D++S G ++ E++TG+
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 357 LGQGGFGPV-----YKGVLSDGK-EVAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLV 408
           LG G FG V     Y  + SD    VAVK L   +     E     L +L     H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNG----------- 456
            LLG C  G   L++ E+   G  D + F  RKR   +C +    I+             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
                +AKGM +L   +    +HRDL A N+LL     +KI DFG+AR            
Sbjct: 172 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKG 228
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                  +MAPE     +Y+ +SDV+S+G+ L E+ +
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 111
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 171
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 172 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YR 225
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 357 LGQGGFGPV-----YKGVLSDGK-EVAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLV 408
           LG G FG V     Y  + SD    VAVK L   +     E     L +L     H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNG----------- 456
            LLG C  G   L++ E+   G  D + F  RKR   +C +    I+             
Sbjct: 109 NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
                +AKGM +L   +    +HRDL A N+LL     +KI DFG+AR            
Sbjct: 167 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 223
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                  +MAPE     +Y+ +SDV+S+G+ L E+ +
Sbjct: 224 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 409 KLLGFCV-DGDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 357 LGQGGFGPV-----YKGVLSDGK-EVAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLV 408
           LG G FG V     Y  + SD    VAVK L   +     E     L +L     H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNG----------- 456
            LLG C  G   L++ E+   G  D + F  RKR   +C +    I+             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
                +AKGM +L   +    +HRDL A N+LL     +KI DFG+AR            
Sbjct: 172 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 228
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                  +MAPE     +Y+ +SDV+S+G+ L E+ +
Sbjct: 229 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 19/212 (8%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQ 403
           +  NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N+VKLL      ++  LV+E + +  L   +      GI     ++ +   + +G+ +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAF 121
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----VGTYGY 519
            H     R++HRDLK  N+L++++   K++DFG+AR F         VR     V T  Y
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP------VRTYXHEVVTLWY 172
Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    YS   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 357 LGQGGFGPVYKGVLSDG-KEVAVKRLSSCS-------------EQGTAEFTNEVLLILKL 402
           LG G +G V      +G  E A+K +                 E+   E  NE+ L+  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
            H N++KL     D     LV EF   G L   + + R +   C     NI+  I  G+ 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDEC--DAANIMKQILSGIC 160
Query: 463 YLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           YLH+ +   IVHRD+K  N+LL+   S +N KI DFG++  F++   +      +GT  Y
Sbjct: 161 YLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLRDRLGTAYY 214
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +APE  ++  Y++K DV+S GV++  ++ G
Sbjct: 215 IAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 357 LGQGGFGPV-----YKGVLSDGK-EVAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLV 408
           LG G FG V     Y  + SD    VAVK L   +     E     L +L     H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-GILCWRKRTNIVNG----------- 456
            LLG C  G   L++ E+   G  D + F  RKR   +C +    I+             
Sbjct: 107 NLLGACTIGGPTLVITEYCCYG--DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
                +AKGM +L   +    +HRDL A N+LL     +KI DFG+AR            
Sbjct: 165 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 221
Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                  +MAPE     +Y+ +SDV+S+G+ L E+ +
Sbjct: 222 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 113
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 173
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 174 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YR 227
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 10/215 (4%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVL-- 397
           LE   +    F D  +LG+GGFG V+   + + GK  A K+L+    +    +   ++  
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 398 LILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            IL   H   +  L +  +    L LV   M  G +   +++  +        R      
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 457 -IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            I  G+ +LH+ +   I++RDLK  NVLLD D N +ISD G+A       G+  T    G
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL--KAGQTKTKGYAG 351
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T G+MAPE  +   Y    D F+ GV L E+I  R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA---EFTNEVLLIL 400
           S+ SD      ILG GG   V+    L D ++VAVK L +   +  +    F  E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 401 KLQHKNLVKLL----GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            L H  +V +          G    +V E++   +L  I+      G +  ++   ++  
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIAD 124
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVG 515
             + + + H++    I+HRD+K +N+++ +    K+ DFG+AR  A+S      T  ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           T  Y++PE A       +SDV+S G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 25/224 (11%)
Query: 350 NFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLIL-KLQHKNL 407
           +++D+ ++G G FG VY+  L D G+ VA+K++          F N  L I+ KL H N+
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNI 154
Query: 408 VKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           V+L  F     EK       LV +++P           R +  L        +  + + +
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 214
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYM 520
            Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N   I   Y Y 
Sbjct: 215 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRY-YR 268
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           APE       Y+   DV+S G +L E++ G+     ++G +QL+
Sbjct: 269 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA---EFTNEVLLIL 400
           S+ SD      ILG GG   V+    L D ++VAVK L +   +  +    F  E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 401 KLQHKNLVKLL----GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            L H  +V +          G    +V E++   +L  I+      G +  ++   ++  
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIAD 124
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVG 515
             + + + H++    I+HRD+K +N+++ +    K+ DFG+AR  A+S      T  ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           T  Y++PE A       +SDV+S G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 10/215 (4%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVL-- 397
           LE   +    F D  +LG+GGFG V+   + + GK  A K+L+    +    +   ++  
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 398 LILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            IL   H   +  L +  +    L LV   M  G +   +++  +        R      
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 457 -IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            I  G+ +LH+ +   I++RDLK  NVLLD D N +ISD G+A       G+  T    G
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL--KAGQTKTKGYAG 351
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T G+MAPE  +   Y    D F+ GV L E+I  R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS----CSEQGTAEFTNEVLL 398
           + L   +F    +LG+G FG V+        +  A+K L        +        + +L
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
            L  +H  L  +       +    V E++  G L   ++  +        + T     I 
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEII 129
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            G+ +LH      IV+RDLK  N+LLD D + KI+DFGM +      G+A T    GT  
Sbjct: 130 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPD 184
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           Y+APE  +   Y+   D +SFGVLL E++ G+
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 10/215 (4%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVL-- 397
           LE   +    F D  +LG+GGFG V+   + + GK  A K+L+    +    +   ++  
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 398 LILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            IL   H   +  L +  +    L LV   M  G +   +++  +        R      
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 457 -IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            I  G+ +LH+ +   I++RDLK  NVLLD D N +ISD G+A       G+  T    G
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL--KAGQTKTKGYAG 351
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T G+MAPE  +   Y    D F+ GV L E+I  R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 357 LGQGGFGPVYKGVL--SDGK--EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG V +G      GK   VAVK L        +   +F  EV  +  L H+NL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G  +    K+ V E  P GSL   L   +   +L    R  +   +A+GM YL     
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 134
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE--ANTVRIVGTYGYMAPEYAME 527
            R +HRDL A N+LL +    KI DFG+ R   +++        R V  + + APE    
Sbjct: 135 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 192
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SD + FGV L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 10/215 (4%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVL-- 397
           LE   +    F D  +LG+GGFG V+   + + GK  A K+L+    +    +   ++  
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 398 LILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            IL   H   +  L +  +    L LV   M  G +   +++  +        R      
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 457 -IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            I  G+ +LH+ +   I++RDLK  NVLLD D N +ISD G+A       G+  T    G
Sbjct: 297 QIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL--KAGQTKTKGYAG 351
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T G+MAPE  +   Y    D F+ GV L E+I  R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 18/209 (8%)
Query: 349 SNFSDSNILGQGGFGPVY---KGVLSDGKEV---AVKRLSSCSEQGTAEFTNEVLLILKL 402
           S F    +LGQG FG V+   K   SD +++    V + ++   +       E  +++++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 403 QHKNLVKL-LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
            H  +VKL   F  +G  KL L+ +F+  G L   L    K  +         +  +A  
Sbjct: 84  NHPFIVKLHYAFQTEG--KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALA 138
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + +LH    L I++RDLK  N+LLD + + K++DFG+++   + E +A +    GT  YM
Sbjct: 139 LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           APE      +++ +D +SFGVL+ E++TG
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 357 LGQGGFGPVYKGVL--SDGK--EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG V +G      GK   VAVK L        +   +F  EV  +  L H+NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G  +    K+ V E  P GSL   L   +   +L    R  +   +A+GM YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 130
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE--ANTVRIVGTYGYMAPEYAME 527
            R +HRDL A N+LL +    KI DFG+ R   +++        R V  + + APE    
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 188
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 357 LGQGGFGPVYKGVL--SDGK--EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG V +G      GK   VAVK L        +   +F  EV  +  L H+NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G  +    K+ V E  P GSL   L   +   +L    R  +   +A+GM YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 130
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAME 527
            R +HRDL A N+LL +    KI DFG+ R   +++        R V  + + APE    
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESLKT 188
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 357 LGQGGFGPVYKGVL--SDGK--EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG V +G      GK   VAVK L        +   +F  EV  +  L H+NL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G  +    K+ V E  P GSL   L   +   +L    R  +   +A+GM YL     
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 134
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE--ANTVRIVGTYGYMAPEYAME 527
            R +HRDL A N+LL +    KI DFG+ R   +++        R V  + + APE    
Sbjct: 135 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 192
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SD + FGV L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 357 LGQGGFGPVYKGVL--SDGK--EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG V +G      GK   VAVK L        +   +F  EV  +  L H+NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G  +    K+ V E  P GSL   L   +   +L    R  +   +A+GM YL     
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 130
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE--ANTVRIVGTYGYMAPEYAME 527
            R +HRDL A N+LL +    KI DFG+ R   +++        R V  + + APE    
Sbjct: 131 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 188
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQH 404
           + N+     LG+G F  V + V  + G E A K +++   S +   +   E  +  KLQH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
            N+V+L     +     LV++ +  G L     D   R        ++ +  I + + Y 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 120
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           H +    IVHR+LK  N+LL S       K++DFG+A    +SE         GT GY++
Sbjct: 121 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 174
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE   +  YSK  D+++ GV+L  ++ G
Sbjct: 175 PEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 357 LGQGGFGPVYKG------VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLV 408
           LG+G FG V +         +  + VAVK L   +   +  A  +   +LI    H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 409 KLLGFCVD-GDEKLLVYEFMPNGSLDAIL------FDPRK-------RGILCWRKRTNIV 454
            LLG C   G   +++ EF   G+L   L      F P K       +  L         
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +           
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 19/213 (8%)
Query: 347 ATSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLI 399
           A++ FSD+      LG+G F  V + V  + G E A K +++   S +   +   E  + 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
            KLQH N+V+L     +     LV++ +  G L     D   R        ++ +  I +
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILE 139
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGT 516
            + Y H +    IVHR+LK  N+LL S       K++DFG+A    +SE         GT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGT 193
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            GY++PE   +  YSK  D+++ GV+L  ++ G
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQH 404
           + N+     LG+G F  V + V  + G E A K +++   S +   +   E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
            N+V+L     +     LV++ +  G L     D   R        ++ +  I + + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           H +    IVHR+LK  N+LL S       K++DFG+A    +SE         GT GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE   +  YSK  D+++ GV+L  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 357 LGQGGFGPVYKGVL--SDGK--EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG V +G      GK   VAVK L        +   +F  EV  +  L H+NL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G  +    K+ V E  P GSL   L   +   +L    R  +   +A+GM YL     
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 140
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAME 527
            R +HRDL A N+LL +    KI DFG+ R   +++        R V  + + APE    
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESLKT 198
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SD + FGV L E+ T
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 357 LGQGGFGPVYKGVL--SDGK--EVAVKRLSS---CSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G FG V +G      GK   VAVK L        +   +F  EV  +  L H+NL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G  +    K+ V E  P GSL   L   +   +L    R  +   +A+GM YL     
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK-- 140
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE--ANTVRIVGTYGYMAPEYAME 527
            R +HRDL A N+LL +    KI DFG+ R   +++        R V  + + APE    
Sbjct: 141 -RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLKT 198
Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
             +S  SD + FGV L E+ T
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 349 SNFSDSNILGQGGFGPVY---KGVLSDGKEV---AVKRLSSCSEQGTAEFTNEVLLILKL 402
           S F    +LGQG FG V+   K   SD +++    V + ++   +       E  +++++
Sbjct: 25  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 84
Query: 403 QHKNLVKL-LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H  +VKL   F  +G +  L+ +F+  G L   L    K  +         +  +A  +
Sbjct: 85  NHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL 140
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            +LH    L I++RDLK  N+LLD + + K++DFG+++   + E +A +    GT  YMA
Sbjct: 141 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 195
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE      +++ +D +SFGVL+ E++TG
Sbjct: 196 PEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQH 404
           + N+     LG+G F  V + V  + G E A K +++   S +   +   E  +  KLQH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
            N+V+L     +     LV++ +  G L     D   R        ++ +  I + + Y 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           H +    IVHR+LK  N+LL S       K++DFG+A    +SE         GT GY++
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYLS 175
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE   +  YSK  D+++ GV+L  ++ G
Sbjct: 176 PEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 16/208 (7%)
Query: 349 SNFSDSNILGQGGFGPVY---KGVLSDGKEV---AVKRLSSCSEQGTAEFTNEVLLILKL 402
           S F    +LGQG FG V+   K   SD +++    V + ++   +       E  +++++
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 403 QHKNLVKL-LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H  +VKL   F  +G +  L+ +F+  G L   L    K  +         +  +A  +
Sbjct: 84  NHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALAL 139
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            +LH    L I++RDLK  N+LLD + + K++DFG+++   + E +A +    GT  YMA
Sbjct: 140 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMA 194
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE      +++ +D +SFGVL+ E++TG
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 345 NLATSNFSDSNILGQGGFGPVYK------GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
           ++ATS +     +G G +G VYK      G     K V V                EV L
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 399 ILKLQ---HKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKR 450
           + +L+   H N+V+L+  C     D + K+ LV+E + +  L   L      G L     
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG-LPAETI 122
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +++    +G+ +LH +    IVHRDLK  N+L+ S    K++DFG+ARI++    +   
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMAL 176
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEI 546
             +V T  Y APE  ++  Y+   D++S G +  E+
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 13/212 (6%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS----CSEQGTAEFTNEVLL 398
           + L   +F    +LG+G FG V+        +  A+K L        +        + +L
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
            L  +H  L  +       +    V E++  G L   ++  +        + T     I 
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEII 128
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            G+ +LH      IV+RDLK  N+LLD D + KI+DFGM +      G+A T    GT  
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPD 183
Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           Y+APE  +   Y+   D +SFGVLL E++ G+
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 37/229 (16%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-- 404
            S+F +  +LGQG FG V K   + D +  A+K++   +E+  +   +EV+L+  L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 405 -----------KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--KRGILCWRKRT 451
                      +N VK +          +  E+  NG+L  ++      ++    WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--- 120
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES------- 504
            +   I + + Y+H      I+HRDLK  N+ +D   N KI DFG+A+    S       
Sbjct: 121 -LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 505 ----EGEA-NTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEII 547
                G + N    +GT  Y+A E     G Y++K D++S G++  E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
           ++F     LG+GGFG V++     D    A+KR+     E    +   EV  + KL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW---------RKRT---NIV 454
           +V+     ++ +    +    P   L   +   RK  +  W         R+R+   +I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI- 513
             IA+ + +LH      ++HRDLK SN+    D   K+ DFG+     + E E   +   
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 514 ---------VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
                    VGT  YM+PE      YS K D+FS G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 17/219 (7%)
Query: 339 IDLETLNLA-TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTN 394
           +DL T NL   S +     LG+G F  V + V +  G+E A K +++   S +   +   
Sbjct: 11  VDLGTENLYFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER 70
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           E  +   L+H N+V+L     +     L+++ +  G L     D   R        ++ +
Sbjct: 71  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCI 127
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANT- 510
             I + +L+ H+   + +VHRDLK  N+LL S +     K++DFG+A    E EGE    
Sbjct: 128 QQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLA---IEVEGEQQAW 181
Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
               GT GY++PE   +  Y K  D+++ GV+L  ++ G
Sbjct: 182 FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 14/214 (6%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRL--SSCSEQGTA-EFTNE 395
           ++        +F     LG+G FG VY       K + A+K L  S   ++G   +   E
Sbjct: 6   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 65
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
           + +   L+H N++++  +  D     L+ EF P G L   L   +K G    ++    + 
Sbjct: 66  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFME 122
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            +A  + Y HE    +++HRD+K  N+L+      KI+DFG + + A S        + G
Sbjct: 123 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPS---LRRRXMCG 175
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           T  Y+ PE      + +K D++  GVL  E + G
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 34/245 (13%)
Query: 317 DTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV 376
           DT+  Y+       +++ ++ ++D + L L      +   LG G FG V KG     K V
Sbjct: 2   DTEV-YESPYADPEEIRPKEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVV 54
Query: 377 AVKRLSSCSEQGTA-----EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431
               +     +        E   E  ++ +L +  +V+++G C + +  +LV E    G 
Sbjct: 55  KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGP 113
Query: 432 LDAILFDPRKRGILCWRKRTNI---VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488
           L+  L   R        K  NI   V+ ++ GM YL E +    VHRDL A NVLL +  
Sbjct: 114 LNKYLQQNRHV------KDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH 164
Query: 489 NSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAPEYAMEGLYSKKSDVFSFGVLL 543
            +KISDFG+++     E          T+G     + APE      +S KSDV+SFGVL+
Sbjct: 165 YAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 220
Query: 544 IEIIT 548
            E  +
Sbjct: 221 WEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 34/245 (13%)
Query: 317 DTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV 376
           DT+  Y+       +++ ++ ++D + L L      +   LG G FG V KG     K V
Sbjct: 2   DTEV-YESPYADPEEIRPKEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVV 54
Query: 377 AVKRLSSCSEQGTA-----EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGS 431
               +     +        E   E  ++ +L +  +V+++G C + +  +LV E    G 
Sbjct: 55  KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGP 113
Query: 432 LDAILFDPRKRGILCWRKRTNI---VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488
           L+  L   R        K  NI   V+ ++ GM YL E +    VHRDL A NVLL +  
Sbjct: 114 LNKYLQQNRHV------KDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQH 164
Query: 489 NSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAPEYAMEGLYSKKSDVFSFGVLL 543
            +KISDFG+++     E          T+G     + APE      +S KSDV+SFGVL+
Sbjct: 165 YAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 220
Query: 544 IEIIT 548
            E  +
Sbjct: 221 WEAFS 225

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V++G    G+ VAVK  SS  E+      E  N V+L    +H+N+   LGF
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGF 67
Query: 414 CVD-------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH- 465
                       +  L+  +   GSL   L       + C R    IV  IA G+ +LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR----IVLSIASGLAHLHI 123
Query: 466 ----EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE---ANTVRIVGTYG 518
                  +  I HRDLK+ N+L+  +    I+D G+A + ++S  +    N  R VGT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKR 182
Query: 519 YMAPEYAMEGLYS------KKSDVFSFGVLLIEI 546
           YMAPE   E +        K+ D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G+G +G VYK   + G+  A+K  RL    E   +    E+ ++ +L+H N+VKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT---NIVNGIAKGMLYLHEDSRLR 471
                 +LV+E + +  L  +L D  + G+     ++    ++NGIA    Y H+    R
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLY 530
           ++HRDLK  N+L++ +   KI+DFG+AR F        T  IV T  Y AP+  M    Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWYRAPDVLMGSKKY 178
Query: 531 SKKSDVFSFGVLLIEIITG 549
           S   D++S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 14/214 (6%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRL--SSCSEQGTA-EFTNE 395
           ++        +F     LG+G FG VY       K + A+K L  S   ++G   +   E
Sbjct: 5   EMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
           + +   L+H N++++  +  D     L+ EF P G L   L   +K G    ++    + 
Sbjct: 65  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFME 121
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            +A  + Y HE    +++HRD+K  N+L+      KI+DFG + + A S        + G
Sbjct: 122 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPS---LRRRXMCG 174
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           T  Y+ PE      + +K D++  GVL  E + G
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V++G    G+ VAVK  SS  E+      E  N V+L    +H+N+   LGF
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGF 67
Query: 414 CVD-------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH- 465
                       +  L+  +   GSL   L       + C R    IV  IA G+ +LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR----IVLSIASGLAHLHI 123
Query: 466 ----EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE---ANTVRIVGTYG 518
                  +  I HRDLK+ N+L+  +    I+D G+A + ++S  +    N  R VGT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKR 182
Query: 519 YMAPEYAMEGLYS------KKSDVFSFGVLLIEI 546
           YMAPE   E +        K+ D+++FG++L E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 16/208 (7%)
Query: 349 SNFSDSNILGQGGFGPVY---KGVLSD-GKEVAVKRL--SSCSEQGTAEFTNEVLLILKL 402
           S+F    +LGQG FG V+   K    D G   A+K L  ++   +       E  ++  +
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADV 87
Query: 403 QHKNLVKL-LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H  +VKL   F  +G +  L+ +F+  G L   L    K  +         +  +A G+
Sbjct: 88  NHPFVVKLHYAFQTEG-KLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALGL 143
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            +LH    L I++RDLK  N+LLD + + K++DFG+++   + E +A +    GT  YMA
Sbjct: 144 DHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMA 198
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE      +S  +D +S+GVL+ E++TG
Sbjct: 199 PEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 98/209 (46%), Gaps = 23/209 (11%)
Query: 350 NFSDSNILGQGGFGPVY--KGVLSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL 402
           N+     +G+G F  V   + +L+ GKEVAVK     +L+S S Q   +   EV +   L
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQ---KLFREVRIXKVL 70
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H N+VKL           LV E+   G + D ++   R +      K   IV+ +    
Sbjct: 71  NHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ--- 127
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            Y H+     IVHRDLKA N+LLD+D N KI+DFG +  F             G   Y A
Sbjct: 128 -YCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN---KLDAFCGAPPYAA 180
Query: 522 PEYAMEGLY-SKKSDVFSFGVLLIEIITG 549
           PE      Y   + DV+S GV+L  +++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 21/208 (10%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
            ++G+G F  V + +  + G++ AVK     + +S     T +   E  +   L+H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG----ILCWRKRTNIVNGIAKGMLYL 464
           +LL          +V+EFM    L    F+  KR     +      ++ +  I + + Y 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           H+++   I+HRD+K  NVLL S  NS   K+ DFG+A    ES G     R VGT  +MA
Sbjct: 147 HDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES-GLVAGGR-VGTPHFMA 201
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE      Y K  DV+  GV+L  +++G
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V++G    G+ VAVK  SS  E+      E  N V+L    +H+N+   LGF
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENI---LGF 96
Query: 414 CVD-------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH- 465
                       +  L+  +   GSL   L       + C R    IV  IA G+ +LH 
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR----IVLSIASGLAHLHI 152
Query: 466 ----EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE---ANTVRIVGTYG 518
                  +  I HRDLK+ N+L+  +    I+D G+A + ++S  +    N  R VGT  
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKR 211
Query: 519 YMAPEYAMEGLYS------KKSDVFSFGVLLIEI 546
           YMAPE   E +        K+ D+++FG++L E+
Sbjct: 212 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 357 LGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAE---FTNEVLLILKLQHKNLVKLL 411
           LG G +G V   K  L+ G E A+K +   S   T+      +EV ++ +L H N++KL 
Sbjct: 29  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 412 GFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
            F  D     LV E    G L D I+     R          I+  +  G  YLH+ +  
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSGTTYLHKHN-- 141
Query: 471 RIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
            IVHRDLK  N+LL+S   D   KI DFG++  F   E        +GT  Y+APE  + 
Sbjct: 142 -IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPE-VLR 196
Query: 528 GLYSKKSDVFSFGVLLIEIITG 549
             Y +K DV+S GV+L  ++ G
Sbjct: 197 KKYDEKCDVWSCGVILYILLCG 218

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL--SSCSEQGTA-EF 392
           D+ T +    +F     LG+G FG VY   L+  K+    VA+K L  S   ++G   + 
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQL 70
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
             E+ +   L H N+++L  +  D     L+ E+ P G L   L   +K      ++   
Sbjct: 71  RREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTAT 127
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
           I+  +A  ++Y H     +++HRD+K  N+LL      KI+DFG + + A S        
Sbjct: 128 IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKT--- 180
Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           + GT  Y+ PE     ++++K D++  GVL  E++ G
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 357 LGQGGFGPVY--KGVLSDGKEVAVKRLSSCSEQGTAE---FTNEVLLILKLQHKNLVKLL 411
           LG G +G V   K  L+ G E A+K +   S   T+      +EV ++ +L H N++KL 
Sbjct: 12  LGSGAYGEVLLCKDKLT-GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 412 GFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
            F  D     LV E    G L D I+     R          I+  +  G  YLH+ +  
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSGTTYLHKHN-- 124
Query: 471 RIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
            IVHRDLK  N+LL+S   D   KI DFG++  F   E        +GT  Y+APE  + 
Sbjct: 125 -IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPE-VLR 179
Query: 528 GLYSKKSDVFSFGVLLIEIITG 549
             Y +K DV+S GV+L  ++ G
Sbjct: 180 KKYDEKCDVWSCGVILYILLCG 201

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 331 DLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA 390
           +++ ++ ++D + L L      +   LG G FG V KG     K V    +     +   
Sbjct: 13  EIRPKEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 66
Query: 391 -----EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL 445
                E   E  ++ +L +  +V+++G C + +  +LV E    G L+  L   R     
Sbjct: 67  PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV--- 122
Query: 446 CWRKRTNI---VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
              K  NI   V+ ++ GM YL E +    VHRDL A NVLL +   +KISDFG+++   
Sbjct: 123 ---KDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 176
Query: 503 ESEGEANTVRIVGTY--GYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             E      +  G +   + APE      +S KSDV+SFGVL+ E  +
Sbjct: 177 ADEN-YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V++G L  G+ VAVK  SS  EQ      E  N VLL    +H N+   LGF
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNI---LGF 67
Query: 414 CVD-------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
                       +  L+  +  +GSL    +D  +R  L       +    A G+ +LH 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHV 123
Query: 467 D-----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE---ANTVRIVGTYG 518
           +      +  I HRD K+ NVL+ S++   I+D G+A + ++        N  R VGT  
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-VGTKR 182
Query: 519 YMAPEYAMEGLYS------KKSDVFSFGVLLIEI 546
           YMAPE   E + +      K +D+++FG++L EI
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 354 SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLL 411
           S +LG+G +  V   V L +GKE AVK +   +    +    EV  + + Q +KN+++L+
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            F  D     LV+E +  GS   IL   +K+     R+ + +V  +A  + +LH      
Sbjct: 78  EFFEDDTRFYLVFEKLQGGS---ILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG--- 131
Query: 472 IVHRDLKASNVLLDSDMN---SKISDF--GMARIFAESEGEANTVRIV---GTYGYMAPE 523
           I HRDLK  N+L +S       KI DF  G       S     T  +    G+  YMAPE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 524 YA-----MEGLYSKKSDVFSFGVLLIEIITG 549
                      Y K+ D++S GV+L  +++G
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 117/259 (45%), Gaps = 35/259 (13%)
Query: 300 KGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQ 359
           KG  R+ + +       DT+  Y+       +++ ++ ++D + L L      +   LG 
Sbjct: 335 KGPQREALPM-------DTEV-YESPYADPEEIRPKEVYLDRKLLTL------EDKELGS 380
Query: 360 GGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA-----EFTNEVLLILKLQHKNLVKLLGFC 414
           G FG V KG     K V    +     +        E   E  ++ +L +  +V+++G C
Sbjct: 381 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 440
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            + +  +LV E    G L+  L   R    +  +    +V+ ++ GM YL E +    VH
Sbjct: 441 -EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN---FVH 493
Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAPEYAMEGL 529
           RDL A NVLL +   +KISDFG+++     E          T+G     + APE      
Sbjct: 494 RDLAARNVLLVTQHYAKISDFGLSKALRADE----NYYKAQTHGKWPVKWYAPECINYYK 549
Query: 530 YSKKSDVFSFGVLLIEIIT 548
           +S KSDV+SFGVL+ E  +
Sbjct: 550 FSSKSDVWSFGVLMWEAFS 568

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 106/231 (45%), Gaps = 33/231 (14%)
Query: 331 DLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA 390
           +++ ++ ++D + L L      +   LG G FG V KG     K V    +     +   
Sbjct: 5   EIRPKEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 58
Query: 391 -----EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL 445
                E   E  ++ +L +  +V+++G C + +  +LV E    G L+  L   R     
Sbjct: 59  PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV--- 114
Query: 446 CWRKRTNI---VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
              K  NI   V+ ++ GM YL E +    VHRDL A NVLL +   +KISDFG+++   
Sbjct: 115 ---KDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168
Query: 503 ESEGEANTVRIVGTYG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             E          T+G     + APE      +S KSDV+SFGVL+ E  +
Sbjct: 169 ADENYYKA----QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G+G +G VYK   + G+  A+K  RL    E   +    E+ ++ +L+H N+VKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT---NIVNGIAKGMLYLHEDSRLR 471
                 +LV+E + +  L  +L D  + G+     ++    ++NGIA    Y H+    R
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLY 530
           ++HRDLK  N+L++ +   KI+DFG+AR F        T  +V T  Y AP+  M    Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 531 SKKSDVFSFGVLLIEIITG 549
           S   D++S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G+G +G VYK   + G+  A+K  RL    E   +    E+ ++ +L+H N+VKL    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT---NIVNGIAKGMLYLHEDSRLR 471
                 +LV+E + +  L  +L D  + G+     ++    ++NGIA    Y H+    R
Sbjct: 70  HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIA----YCHDR---R 120
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLY 530
           ++HRDLK  N+L++ +   KI+DFG+AR F        T  +V T  Y AP+  M    Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEVV-TLWYRAPDVLMGSKKY 178
Query: 531 SKKSDVFSFGVLLIEIITG 549
           S   D++S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 90/162 (55%), Gaps = 15/162 (9%)
Query: 394 NEVLLILKLQHK-NLVKLLGFC----VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
           N+++  L++ H+ N   ++GF      DG E  +  E M  GSLD +L + ++   +   
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKR---IPEE 114
Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA 508
               +   + +G+ YL E  + +I+HRD+K SN+L++S    K+ DFG++    +S   A
Sbjct: 115 ILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--A 170
Query: 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           N+   VGT  YMAPE      YS +SD++S G+ L+E+  GR
Sbjct: 171 NS--FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQH 404
            S +     +GQG FG V+K      G++VA+K++   +E+     T   E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 405 KNLVKLLGFCVDGDEKL--------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
           +N+V L+  C               LV++F  +  L  +L +   +  L   KR  ++  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA---ESEGEANTVRI 513
           +  G+ Y+H   R +I+HRD+KA+NVL+  D   K++DFG+AR F+    S+      R+
Sbjct: 134 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 514 VGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIIT 548
           V T  Y  PE  + E  Y    D++  G ++ E+ T
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 331 DLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA 390
           +++ ++ ++D + L L      +   LG G FG V KG     K V    +     +   
Sbjct: 357 EIRPKEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 410
Query: 391 -----EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL 445
                E   E  ++ +L +  +V+++G C + +  +LV E    G L+  L   R    +
Sbjct: 411 PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---V 466
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
             +    +V+ ++ GM YL E +    VHRDL A NVLL +   +KISDFG+++     E
Sbjct: 467 KDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523
Query: 506 GEANTVRIVGTYG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                     T+G     + APE      +S KSDV+SFGVL+ E  +
Sbjct: 524 ----NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 354 SNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLVKLL 411
           S+ILGQG    V++G     G   A+K  ++ S     +    E  ++ KL HKN+VKL 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL- 72
Query: 412 GFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
            F ++ +     K+L+ EF P GSL  +L +P     L   +   ++  +  GM +L E+
Sbjct: 73  -FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 468 SRLRIVHRDLKASNVL--LDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
               IVHR++K  N++  +  D  S  K++DFG AR   E E +   V + GT  Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 524 YAMEGL--------YSKKSDVFSFGVLLIEIITG 549
                +        Y    D++S GV      TG
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA---EFTNEVLLIL 400
           S+ SD      ILG GG   V+    L   ++VAVK L +   +  +    F  E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 401 KLQHKNLVKLLGF----CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            L H  +V +          G    +V E++   +L  I+      G +  ++   ++  
Sbjct: 68  ALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIAD 124
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVG 515
             + + + H++    I+HRD+K +N+++ +    K+ DFG+AR  A+S      T  ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           T  Y++PE A       +SDV+S G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 355 NILGQGGFGPVYKGVLS-DGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           + LG G FG V  G     G +VAVK   R    S     +   E+  +   +H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 411 LGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                   +  +V E++  G L D I     K G +   +   +   I   + Y H   R
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCH---R 129
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             +VHRDLK  NVLLD+ MN+KI+DFG++ + ++ E   ++    G+  Y APE     L
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPEVISGRL 186
Query: 530 YS-KKSDVFSFGVLLIEIITG 549
           Y+  + D++S GV+L  ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    + A L+   K   L        +  I +G+ Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 165 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQH 404
            S +     +GQG FG V+K      G++VA+K++   +E+     T   E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 405 KNLVKLLGFCVDGDEKL--------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
           +N+V L+  C               LV++F  +  L  +L +   +  L   KR  ++  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA---ESEGEANTVRI 513
           +  G+ Y+H   R +I+HRD+KA+NVL+  D   K++DFG+AR F+    S+      R+
Sbjct: 134 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 514 VGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIIT 548
           V T  Y  PE  + E  Y    D++  G ++ E+ T
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 105/219 (47%), Gaps = 18/219 (8%)
Query: 339 IDLETLNL---ATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRL--SSCSEQGT 389
           +DL T NL   +   +     +G+G FG   K +L     DG++  +K +  S  S +  
Sbjct: 11  VDLGTENLYFQSMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 390 AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
            E   EV ++  ++H N+V+      +     +V ++   G L   +    ++G+L   +
Sbjct: 68  EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLF--Q 123
Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
              I++   +  L L      +I+HRD+K+ N+ L  D   ++ DFG+AR+   +   A 
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +GT  Y++PE      Y+ KSD+++ G +L E+ T
Sbjct: 184 AC--IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQH 404
            S +     +GQG FG V+K      G++VA+K++   +E+     T   E+ ++  L+H
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 405 KNLVKLLGFCVDGDEKL--------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
           +N+V L+  C               LV++F  +  L  +L +   +  L   KR  ++  
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQM 132
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA---ESEGEANTVRI 513
           +  G+ Y+H   R +I+HRD+KA+NVL+  D   K++DFG+AR F+    S+      R+
Sbjct: 133 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 514 VGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIIT 548
           V T  Y  PE  + E  Y    D++  G ++ E+ T
Sbjct: 190 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 354 SNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLVKLL 411
           S+ILGQG    V++G     G   A+K  ++ S     +    E  ++ KL HKN+VKL 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL- 72
Query: 412 GFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
            F ++ +     K+L+ EF P GSL  +L +P     L   +   ++  +  GM +L E+
Sbjct: 73  -FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 468 SRLRIVHRDLKASNVL--LDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
               IVHR++K  N++  +  D  S  K++DFG AR   E E +   V + GT  Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVXLYGTEEYLHPD 185
Query: 524 YAMEGL--------YSKKSDVFSFGVLLIEIITG 549
                +        Y    D++S GV      TG
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA---EFTNEVLLIL 400
           S+ SD      ILG GG   V+    L   ++VAVK L +   +  +    F  E     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 67
Query: 401 KLQHKNLVKLL----GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            L H  +V +          G    +V E++   +L  I+      G +  ++   ++  
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIAD 124
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVG 515
             + + + H++    I+HRD+K +N+++ +    K+ DFG+AR  A+S      T  ++G
Sbjct: 125 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           T  Y++PE A       +SDV+S G +L E++TG
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT--NEVLLILKLQH 404
            S +     +GQG FG V+K      G++VA+K++   +E+     T   E+ ++  L+H
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 405 KNLVKLLGFCVDGDEKL--------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
           +N+V L+  C               LV++F  +  L  +L +   +  L   KR  ++  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQM 133
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA---ESEGEANTVRI 513
           +  G+ Y+H   R +I+HRD+KA+NVL+  D   K++DFG+AR F+    S+      R+
Sbjct: 134 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 514 VGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIIT 548
           V T  Y  PE  + E  Y    D++  G ++ E+ T
Sbjct: 191 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 145 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA---EFTNEVLLIL 400
           S+ SD      ILG GG   V+    L   ++VAVK L +   +  +    F  E     
Sbjct: 25  SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 84
Query: 401 KLQHKNLVKLL----GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            L H  +V +          G    +V E++   +L  I+      G +  ++   ++  
Sbjct: 85  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIAD 141
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA-NTVRIVG 515
             + + + H++    I+HRD+K +N+++ +    K+ DFG+AR  A+S      T  ++G
Sbjct: 142 ACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           T  Y++PE A       +SDV+S G +L E++TG
Sbjct: 199 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 149 ---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 355 NILGQGGFGPVYKGVLS-DGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           + LG G FG V  G     G +VAVK   R    S     +   E+  +   +H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 411 LGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                   +  +V E++  G L D I     K G +   +   +   I   + Y H   R
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCH---R 129
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             +VHRDLK  NVLLD+ MN+KI+DFG++ + ++ E    +    G+  Y APE     L
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---CGSPNYAAPEVISGRL 186
Query: 530 YS-KKSDVFSFGVLLIEIITG 549
           Y+  + D++S GV+L  ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 7/206 (3%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKN 406
             ++    +G+G +G V        K  VA+K++S    Q   + T  E+ ++L+ +H+N
Sbjct: 43  PRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHEN 102
Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           ++ +         + +   ++    ++  L+   K   L        +  I +G+ Y+H 
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS 162
Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYA 525
            +   ++HRDLK SN+L+++  + KI DFG+ARI   E +        V T  Y APE  
Sbjct: 163 AN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIM 219
Query: 526 MEGL-YSKKSDVFSFGVLLIEIITGR 550
           +    Y+K  D++S G +L E+++ R
Sbjct: 220 LNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 153 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 209
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 210 SKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 145 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 201
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 202 SKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 37/229 (16%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-- 404
            S+F +  +LGQG FG V K   + D +  A+K++   +E+  +   +EV+L+  L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 405 -----------KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--KRGILCWRKRT 451
                      +N VK +          +  E+  N +L  ++      ++    WR   
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR--- 120
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES------- 504
            +   I + + Y+H      I+HRDLK  N+ +D   N KI DFG+A+    S       
Sbjct: 121 -LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 505 ----EGEA-NTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEII 547
                G + N    +GT  Y+A E     G Y++K D++S G++  E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA---- 390
           ++ ++D + L L      +   LG G FG V KG     K V    +     +       
Sbjct: 3   KEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 56
Query: 391 -EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
            E   E  ++ +L +  +V+++G C + +  +LV E    G L+  L   R        K
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV------K 109
Query: 450 RTNI---VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
             NI   V+ ++ GM YL E +    VHRDL A NVLL +   +KISDFG+++     E 
Sbjct: 110 DKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 507 EANTVRIVGTYG-----YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                    T+G     + APE      +S KSDV+SFGVL+ E  +
Sbjct: 167 XYKA----QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 206
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 150
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 151 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 207
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 208 SKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 141
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 142 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 198
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 199 SKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 143 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 199
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 200 SKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 26/203 (12%)
Query: 357 LGQGGFGPVYKGVL----SDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL 411
           +G+G FG V++G+     +    VA+K   +C+     E F  E L + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL- 470
           G   + +   ++ E    G L + L   RK  +            +A  +LY ++ S   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-QVRKFSL-----------DLASLILYAYQLSTAL 124
Query: 471 ------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
                 R VHRD+ A NVL+ S+   K+ DFG++R + E        +      +MAPE 
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPES 183
Query: 525 AMEGLYSKKSDVFSFGVLLIEII 547
                ++  SDV+ FGV + EI+
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 22/236 (9%)
Query: 325 VQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC 384
           +  R    KA    I L+  ++         ++G+G FG VY G       + +  +   
Sbjct: 9   LSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERD 68
Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
           +E     F  EV+   + +H+N+V  +G C+      ++       +L +++ D +   +
Sbjct: 69  NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--V 126
Query: 445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK--ISDFGMARI-- 500
           L   K   I   I KGM YLH      I+H+DLK+ NV  D   N K  I+DFG+  I  
Sbjct: 127 LDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD---NGKVVITDFGLFSISG 180
Query: 501 FAESEGEANTVRIV-GTYGYMAPEYAME---------GLYSKKSDVFSFGVLLIEI 546
             ++    + +RI  G   ++APE   +           +SK SDVF+ G +  E+
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 165 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 221
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ----- 403
            +   +++G+G    V + V  + G E AVK +   +E+ + E   EV    + +     
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 404 ----HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNGIA 458
               H +++ L+          LV++ M  G L    FD     +    K T +I+  + 
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRSLL 210
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           + + +LH ++   IVHRDLK  N+LLD +M  ++SDFG +      E       + GT G
Sbjct: 211 EAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS---CHLEPGEKLRELCGTPG 264
Query: 519 YMAPEY---AMEGL---YSKKSDVFSFGVLLIEIITG 549
           Y+APE    +M+     Y K+ D+++ GV+L  ++ G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-RIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+          +   V T  Y APE  + 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 205
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-RIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+          +   V T  Y APE  + 
Sbjct: 150 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN 206
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 207 SKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA-----EFTNEVLLILKLQHKNLVKLL 411
           LG G FG V KG     K V    +     +        E   E  ++ +L +  +V+++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI---VNGIAKGMLYLHEDS 468
           G C + +  +LV E    G L+  L   R        K  NI   V+ ++ GM YL E +
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNRHV------KDKNIIELVHQVSMGMKYLEESN 127
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAPE 523
               VHRDL A NVLL +   +KISDFG+++     E          T+G     + APE
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA----QTHGKWPVKWYAPE 180
Query: 524 YAMEGLYSKKSDVFSFGVLLIEIIT 548
                 +S KSDV+SFGVL+ E  +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNL 407
           + D   +G G +G V   V    G +VA+K+L     SE        E+ L+  ++H+N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 408 VKLLG-FCVDG--DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           + LL  F  D   D+    Y  MP    D  L    K   L   +   +V  + KG+ Y+
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTD--LGKLMKHEKLGEDRIQFLVYQMLKGLRYI 144
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H      I+HRDLK  N+ ++ D   KI DFG+AR  A+SE     V    T  Y APE 
Sbjct: 145 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMXGXVV----TRWYRAPEV 196
Query: 525 AMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +  + Y++  D++S G ++ E+ITG+
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA---- 390
           ++ ++D + L L      +   LG G FG V KG     K V    +     +       
Sbjct: 3   KEVYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 56
Query: 391 -EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
            E   E  ++ +L +  +V+++G C + +  +LV E    G L+  L   R        K
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV------K 109
Query: 450 RTNI---VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
             NI   V+ ++ GM YL E +    VHRDL A NVLL +   +KISDFG+++     E 
Sbjct: 110 DKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166
Query: 507 --EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +A T        Y APE      +S KSDV+SFGVL+ E  +
Sbjct: 167 YYKAQTHGKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 354 SNILGQGGFGPVYKGVLSDG-KEVAVKRLS-------SCSEQGTA-EFTNEVLLILKLQH 404
           S  LG G  G V         K+VA+K +S       S  E   A     E+ ++ KL H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
             ++K+  F  D ++  +V E M  G L D ++ + R +   C      ++  +     Y
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----Y 129
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           LHE+    I+HRDLK  NVLL S   D   KI+DFG ++I     GE + +R + GT  Y
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 182
Query: 520 MAPEYAME---GLYSKKSDVFSFGVLLIEIITG 549
           +APE  +      Y++  D +S GV+L   ++G
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA-----EFTNEVLLILKLQHKNLVKLL 411
           LG G FG V KG     K V    +     +        E   E  ++ +L +  +V+++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI---VNGIAKGMLYLHEDS 468
           G C + +  +LV E    G L+  L   R        K  NI   V+ ++ GM YL E +
Sbjct: 73  GIC-EAESWMLVMEMAELGPLNKYLQQNRHV------KDKNIIELVHQVSMGMKYLEESN 125
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG--EANTVRIVGTYGYMAPEYAM 526
               VHRDL A NVLL +   +KISDFG+++     E   +A T        Y APE   
Sbjct: 126 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECIN 181
Query: 527 EGLYSKKSDVFSFGVLLIEIIT 548
              +S KSDV+SFGVL+ E  +
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 354 SNILGQGGFGPVYKGVLSDG-KEVAVKRLS-------SCSEQGTA-EFTNEVLLILKLQH 404
           S  LG G  G V         K+VA+K +S       S  E   A     E+ ++ KL H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
             ++K+  F  D ++  +V E M  G L D ++ + R +   C      ++  +     Y
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----Y 129
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           LHE+    I+HRDLK  NVLL S   D   KI+DFG ++I     GE + +R + GT  Y
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 182
Query: 520 MAPEYAME---GLYSKKSDVFSFGVLLIEIITG 549
           +APE  +      Y++  D +S GV+L   ++G
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 354 SNILGQGGFGPVYKGVLSDG-KEVAVKRLS-------SCSEQGTA-EFTNEVLLILKLQH 404
           S  LG G  G V         K+VA+K +S       S  E   A     E+ ++ KL H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
             ++K+  F  D ++  +V E M  G L D ++ + R +   C      ++  +     Y
Sbjct: 74  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----Y 128
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           LHE+    I+HRDLK  NVLL S   D   KI+DFG ++I     GE + +R + GT  Y
Sbjct: 129 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 181
Query: 520 MAPEYAME---GLYSKKSDVFSFGVLLIEIITG 549
           +APE  +      Y++  D +S GV+L   ++G
Sbjct: 182 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G+G FG V++G    G+EVAVK  SS  E+       E+   + L+H+N+   LGF + 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGF-IA 65
Query: 417 GDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
            D K         LV ++  +GSL    FD   R  +       +    A G+ +LH + 
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-----VGTYG 518
                +  I HRDLK+ N+L+  +    I+D G+A      +   +T+ I     VGT  
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKR 178
Query: 519 YMAPEYA-----MEGLYS-KKSDVFSFGVLLIEI 546
           YMAPE       M+   S K++D+++ G++  EI
Sbjct: 179 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 357 LGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           LGQG F  ++KGV  +          EV +K L       +  F     ++ KL HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
              G CV GDE +LV EF+  GSLD  L   +    + W  +  +   +A  M +L E++
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              ++H ++ A N+LL  + + K  +    ++     G + TV          P    E 
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKL--SDPGISITVLPKDILQERIPWVPPEC 188
Query: 529 LYSKK-----SDVFSFGVLLIEIITG 549
           + + K     +D +SFG  L EI +G
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA++++S    Q   + T  E+ ++L+ +H+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 205
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 206 SKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 357 LGQGGFGPVYKGVL----SDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL 411
           +G+G FG V++G+     +    VA+K   +C+     E F  E L + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL- 470
           G   + +   ++ E    G L + L   RK  +            +A  +LY ++ S   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-QVRKYSL-----------DLASLILYAYQLSTAL 124
Query: 471 ------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPE 523
                 R VHRD+ A NVL+ S+   K+ DFG++R   +S   +A+  ++     +MAPE
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 182
Query: 524 YAMEGLYSKKSDVFSFGVLLIEII 547
                 ++  SDV+ FGV + EI+
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKL 402
           +    +  D   +G+G +G V K V    G+ +AVKR+ S+  E+   +   ++ ++++ 
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77
Query: 403 QH-KNLVKLLGFCVDGDEKLLVYEFMPNGSLD-------AILFDPRKRGILCWRKRTNIV 454
                +V+  G      +  +  E M + S D       ++L D     IL       I 
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL-----GKIT 131
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
               K + +L E+  L+I+HRD+K SN+LLD   N K+ DFG++    +S  +    R  
Sbjct: 132 LATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT---RDA 186
Query: 515 GTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITGR 550
           G   YMAPE     A    Y  +SDV+S G+ L E+ TGR
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 354 SNILGQGGFGPVYKGVLSDG-KEVAVKRLS-------SCSEQGTA-EFTNEVLLILKLQH 404
           S  LG G  G V         K+VA+K +S       S  E   A     E+ ++ KL H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
             ++K+  F  D ++  +V E M  G L D ++ + R +   C      ++  +     Y
Sbjct: 75  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----Y 129
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           LHE+    I+HRDLK  NVLL S   D   KI+DFG ++I     GE + +R + GT  Y
Sbjct: 130 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 182
Query: 520 MAPEYAME---GLYSKKSDVFSFGVLLIEIITG 549
           +APE  +      Y++  D +S GV+L   ++G
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L  +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 147 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 354 SNILGQGGFGPVYKGVLSDG-KEVAVKRLS-------SCSEQGTA-EFTNEVLLILKLQH 404
           S  LG G  G V         K+VA+K +S       S  E   A     E+ ++ KL H
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
             ++K+  F  D ++  +V E M  G L D ++ + R +   C      ++  +     Y
Sbjct: 81  PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----Y 135
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           LHE+    I+HRDLK  NVLL S   D   KI+DFG ++I     GE + +R + GT  Y
Sbjct: 136 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 188
Query: 520 MAPEYAME---GLYSKKSDVFSFGVLLIEIITG 549
           +APE  +      Y++  D +S GV+L   ++G
Sbjct: 189 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL 411
           +G+G FG V++G+    +     VA+K   +C+     E F  E L + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL- 470
           G   + +   ++ E    G L + L   RK  +            +A  +LY ++ S   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-QVRKYSL-----------DLASLILYAYQLSTAL 124
Query: 471 ------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPE 523
                 R VHRD+ A NVL+ S+   K+ DFG++R   +S   +A+  ++     +MAPE
Sbjct: 125 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 182
Query: 524 YAMEGLYSKKSDVFSFGVLLIEII 547
                 ++  SDV+ FGV + EI+
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL 411
           +G+G FG V++G+    +     VA+K   +C+     E F  E L + +  H ++VKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL- 470
           G   + +   ++ E    G L + L   RK  +            +A  +LY ++ S   
Sbjct: 106 GVITE-NPVWIIMELCTLGELRSFL-QVRKYSL-----------DLASLILYAYQLSTAL 152
Query: 471 ------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPE 523
                 R VHRD+ A NVL+ S+   K+ DFG++R   +S   +A+  ++     +MAPE
Sbjct: 153 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 210
Query: 524 YAMEGLYSKKSDVFSFGVLLIEII 547
                 ++  SDV+ FGV + EI+
Sbjct: 211 SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G+G FG V++G    G+EVAVK  SS  E+       E+   + L+H+N+   LGF + 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGF-IA 64
Query: 417 GDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
            D K         LV ++  +GSL    FD   R  +       +    A G+ +LH + 
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-----VGTYG 518
                +  I HRDLK+ N+L+  +    I+D G+A      +   +T+ I     VGT  
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKR 177
Query: 519 YMAPEYA-----MEGLYS-KKSDVFSFGVLLIEI 546
           YMAPE       M+   S K++D+++ G++  EI
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G+G FG V++G    G+EVAVK  SS  E+       E+   + L+H+N+   LGF + 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGF-IA 70
Query: 417 GDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
            D K         LV ++  +GSL    FD   R  +       +    A G+ +LH + 
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-----VGTYG 518
                +  I HRDLK+ N+L+  +    I+D G+A      +   +T+ I     VGT  
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKR 183
Query: 519 YMAPEYA-----MEGLYS-KKSDVFSFGVLLIEI 546
           YMAPE       M+   S K++D+++ G++  EI
Sbjct: 184 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFT-NEVLLILKLQHKNLV 408
           +++ + +G+G +G V     +  K  VA+K++S    Q   + T  E+ ++L  +H+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            +         + +   ++    ++  L+   K   L        +  I +G+ Y+H  +
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIF-AESEGEANTVRIVGTYGYMAPEYAME 527
              ++HRDLK SN+LL++  + KI DFG+AR+   + +        V T  Y APE  + 
Sbjct: 147 ---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN 203
Query: 528 GL-YSKKSDVFSFGVLLIEIITGR 550
              Y+K  D++S G +L E+++ R
Sbjct: 204 SKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G+G FG V++G    G+EVAVK  SS  E+       E+   + L+H+N+   LGF + 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGF-IA 90
Query: 417 GDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
            D K         LV ++  +GSL    FD   R  +       +    A G+ +LH + 
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 146
Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-----VGTYG 518
                +  I HRDLK+ N+L+  +    I+D G+A      +   +T+ I     VGT  
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKR 203
Query: 519 YMAPEYA-----MEGLYS-KKSDVFSFGVLLIEI 546
           YMAPE       M+   S K++D+++ G++  EI
Sbjct: 204 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 357 LGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL 411
           +G+G FG V++G+    +     VA+K   +C+     E F  E L + +  H ++VKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL- 470
           G   + +   ++ E    G L + L   RK  +            +A  +LY ++ S   
Sbjct: 75  GVITE-NPVWIIMELCTLGELRSFL-QVRKYSL-----------DLASLILYAYQLSTAL 121
Query: 471 ------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPE 523
                 R VHRD+ A NVL+ S+   K+ DFG++R   +S   +A+  ++     +MAPE
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 179
Query: 524 YAMEGLYSKKSDVFSFGVLLIEII 547
                 ++  SDV+ FGV + EI+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTA 390
           +D+ I  E + L          +G+G FG V++G+    +     VA+K   +C+     
Sbjct: 8   RDYEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 60
Query: 391 E-FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
           E F  E L + +  H ++VKL+G   + +   ++ E    G L + L   RK  +     
Sbjct: 61  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSL----- 113
Query: 450 RTNIVNGIAKGMLYLHEDSRL-------RIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
                  +A  +LY ++ S         R VHRD+ A NVL+ S+   K+ DFG++R   
Sbjct: 114 ------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167
Query: 503 ESE-GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
           +S   +A+  ++     +MAPE      ++  SDV+ FGV + EI+
Sbjct: 168 DSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 354 SNILGQGGFGPVYKGVLSDG-KEVAVKRLS-------SCSEQGTA-EFTNEVLLILKLQH 404
           S  LG G  G V         K+VA++ +S       S  E   A     E+ ++ KL H
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
             ++K+  F  D ++  +V E M  G L D ++ + R +   C      ++  +     Y
Sbjct: 214 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----Y 268
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           LHE+    I+HRDLK  NVLL S   D   KI+DFG ++I     GE + +R + GT  Y
Sbjct: 269 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 321
Query: 520 MAPEYAME---GLYSKKSDVFSFGVLLIEIITG 549
           +APE  +      Y++  D +S GV+L   ++G
Sbjct: 322 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G+G FG V++G    G+EVAVK  SS  E+       E+   + L+H+N+   LGF + 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGF-IA 67
Query: 417 GDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
            D K         LV ++  +GSL    FD   R  +       +    A G+ +LH + 
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-----VGTYG 518
                +  I HRDLK+ N+L+  +    I+D G+A      +   +T+ I     VGT  
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKR 180
Query: 519 YMAPEYA-----MEGLYS-KKSDVFSFGVLLIEI 546
           YMAPE       M+   S K++D+++ G++  EI
Sbjct: 181 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAV-----KRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G F  V + V +  G+E A      K+LS+   Q   +   E  +   L+H N+V+L
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRLLKHPNIVRL 75
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
                +     L+++ +  G L     D   R        ++ +  I + +L+ H+   +
Sbjct: 76  HDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---M 129
Query: 471 RIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANT-VRIVGTYGYMAPEYAM 526
            +VHR+LK  N+LL S +     K++DFG+A    E EGE        GT GY++PE   
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLA---IEVEGEQQAWFGFAGTPGYLSPEVLR 186
Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
           +  Y K  D+++ GV+L  ++ G
Sbjct: 187 KDPYGKPVDLWACGVILYILLVG 209

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTA 390
           +D+ I  E + L          +G+G FG V++G+    +     VA+K   +C+     
Sbjct: 5   RDYEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR 57
Query: 391 E-FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
           E F  E L + +  H ++VKL+G   + +   ++ E    G L + L   RK  +     
Sbjct: 58  EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSL----- 110
Query: 450 RTNIVNGIAKGMLYLHEDSRL-------RIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
                  +A  +LY ++ S         R VHRD+ A NVL+ S+   K+ DFG++R   
Sbjct: 111 ------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 164
Query: 503 ESE-GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
           +S   +A+  ++     +MAPE      ++  SDV+ FGV + EI+
Sbjct: 165 DSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 35/227 (15%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGT 389
            +D+ I  E + L          +G+G FG V++G+    +     VA+K   +C+    
Sbjct: 5   TRDYEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV 57
Query: 390 AE-FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWR 448
            E F  E L + +  H ++VKL+G   + +   ++ E    G L + L   RK  +    
Sbjct: 58  REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKYSL---- 111
Query: 449 KRTNIVNGIAKGMLYLHEDSRL-------RIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
                   +A  +LY ++ S         R VHRD+ A NVL+ S+   K+ DFG++R  
Sbjct: 112 -------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 164
Query: 502 AESE-GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
            +S   +A+  ++     +MAPE      ++  SDV+ FGV + EI+
Sbjct: 165 EDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 37/214 (17%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G+G FG V++G    G+EVAVK  SS  E+       E+   + L+H+N+   LGF + 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENI---LGF-IA 103
Query: 417 GDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
            D K         LV ++  +GSL    FD   R  +       +    A G+ +LH + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI-----VGTYG 518
                +  I HRDLK+ N+L+  +    I+D G+A      +   +T+ I     VGT  
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKR 216
Query: 519 YMAPEYA-----MEGLYS-KKSDVFSFGVLLIEI 546
           YMAPE       M+   S K++D+++ G++  EI
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 333 KAQDFFIDLETLNLATSN---FSDSNI-LGQGGFGPVYKGVLSDGK------EVAVKRLS 382
           + QD   +LET  +  SN   F   +I +G+G F  VYKG+ ++        E+  ++L+
Sbjct: 6   QQQDDIEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT 65
Query: 383 SCSEQGTAEFTNEVLLILKLQHKNLVKLLGF---CVDGDE-KLLVYEFMPNGSLDAILFD 438
               Q    F  E   +  LQH N+V+        V G +  +LV E   +G+L   L  
Sbjct: 66  KSERQ---RFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKR 122
Query: 439 PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGM 497
            +   I   R   +    I KG+ +LH  +   I+HRDLK  N+ +     S KI D G+
Sbjct: 123 FKVXKIKVLR---SWCRQILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGL 178
Query: 498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           A +   S  +A    ++GT  + APE   E  Y +  DV++FG   +E  T
Sbjct: 179 ATLKRASFAKA----VIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXAT 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 29/213 (13%)
Query: 354 SNILGQGGFGPVYKGVLSDG-KEVAVKRLS-------SCSEQGTA-EFTNEVLLILKLQH 404
           S  LG G  G V         K+VA++ +S       S  E   A     E+ ++ KL H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
             ++K+  F  D ++  +V E M  G L D ++ + R +   C      ++  +     Y
Sbjct: 200 PCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ----Y 254
Query: 464 LHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           LHE+    I+HRDLK  NVLL S   D   KI+DFG ++I     GE + +R + GT  Y
Sbjct: 255 LHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL----GETSLMRTLCGTPTY 307
Query: 520 MAPEYAME---GLYSKKSDVFSFGVLLIEIITG 549
           +APE  +      Y++  D +S GV+L   ++G
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILK-LQHK 405
           +S+F   ++LG+G +G V        G+ VA+K++    +   A  T   + ILK  +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 406 NLVKLLGF-----CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           N++ +          + +E  ++ E M    L  ++       +L        +    + 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG--------EANTVR 512
           +  LH  +   ++HRDLK SN+L++S+ + K+ DFG+ARI  ES          ++  V 
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 513 IVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR-----RNAGSNQLLAYGM 563
            V T  Y APE  +    YS+  DV+S G +L E+   R     R+     LL +G+
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 24/222 (10%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
           +++  ++G G FG V++  L +  EVA+K++          F N  L I+++ +H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVD 96
Query: 410 LLGFCV-DGDEK-----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           L  F   +GD+K      LV E++P     A     + +  +        +  + + + Y
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           +H    + I HRD+K  N+LLD      K+ DFG A+I     GE N   I   Y Y AP
Sbjct: 157 IHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI--AGEPNVSXICSRY-YRAP 210
Query: 523 EYAMEGL-YSKKSDVFSFGVLLIEIITGRR----NAGSNQLL 559
           E       Y+   D++S G ++ E++ G+      +G +QL+
Sbjct: 211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 351 FSDSNILGQGGFGPVYK----GVLSDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKL 402
           F    +LG+GG+G V++       + GK  A+K L       + + TA    E  ++ ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H  +V L+     G +  L+ E++  G L   L    + GI         +  I+  + 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALG 135
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TVRIVGTYGYMA 521
           +LH+     I++RDLK  N++L+   + K++DFG+ +   ES  +   T    GT  YMA
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFCGTIEYMA 189
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE  M   +++  D +S G L+ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 171 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 351 FSDSNILGQGGFGPVYK----GVLSDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKL 402
           F    +LG+GG+G V++       + GK  A+K L       + + TA    E  ++ ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H  +V L+     G +  L+ E++  G L   L    + GI         +  I+  + 
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL---EREGIFMEDTACFYLAEISMALG 135
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TVRIVGTYGYMA 521
           +LH+     I++RDLK  N++L+   + K++DFG+ +   ES  +   T    GT  YMA
Sbjct: 136 HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHXFCGTIEYMA 189
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE  M   +++  D +S G L+ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDG-KEVAVK--------RLSSCSEQGTAEFT-NEVLL 398
            N+    ILG+G    V + +     KE AVK          S+   Q   E T  EV +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 399 ILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNG 456
           + K+  H N+++L           LV++ M  G L    FD     +    K T  I+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRA 119
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           + + +  LH   +L IVHRDLK  N+LLD DMN K++DFG +      E       + GT
Sbjct: 120 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 173
Query: 517 YGYMAPEYAMEGL------YSKKSDVFSFGVLLIEIITG 549
             Y+APE     +      Y K+ D++S GV++  ++ G
Sbjct: 174 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGFVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDG-KEVAVK--------RLSSCSEQGTAEFT-NEVLL 398
            N+    ILG+G    V + +     KE AVK          S+   Q   E T  EV +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 399 ILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNG 456
           + K+  H N+++L           LV++ M  G L    FD     +    K T  I+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRA 132
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           + + +  LH   +L IVHRDLK  N+LLD DMN K++DFG +      E       + GT
Sbjct: 133 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 186
Query: 517 YGYMAPEYAMEGL------YSKKSDVFSFGVLLIEIITG 549
             Y+APE     +      Y K+ D++S GV++  ++ G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G F  V + V L  G E A K +++   S +   +   E  +   L+H N+V+L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             +     LV++ +  G L     D   R        ++ +  I + +L+ H+   + +V
Sbjct: 72  ISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVV 125
Query: 474 HRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANT-VRIVGTYGYMAPEYAMEGL 529
           HRDLK  N+LL S       K++DFG+A    E +G+        GT GY++PE   +  
Sbjct: 126 HRDLKPENLLLASKCKGAAVKLADFGLA---IEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 530 YSKKSDVFSFGVLLIEIITG 549
           Y K  D+++ GV+L  ++ G
Sbjct: 183 YGKPVDIWACGVILYILLVG 202

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 108/247 (43%), Gaps = 41/247 (16%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
           H+ H Q R    + +      +T+      + + + +G G +G V        G  VAVK
Sbjct: 4   HHHHSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK 59
Query: 380 RLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI-- 435
           +LS   +          E+ L+  ++H+N++ LL              F P  SL+    
Sbjct: 60  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFND 107
Query: 436 ------LFDPRKRGILCWRKRTN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
                 L       I+  +K T+     ++  I +G+ Y+H      I+HRDLK SN+ +
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAV 164
Query: 485 DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLL 543
           + D   KI DFG+AR       +      V T  Y APE  +  + Y++  D++S G ++
Sbjct: 165 NEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 219
Query: 544 IEIITGR 550
            E++TGR
Sbjct: 220 AELLTGR 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 357 LGQGGFGPVYKGVL----SDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL 411
           +G+G FG V++G+     +    VA+K   +C+     E F  E L + +  H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL- 470
           G   + +   ++ E    G L         R  L  RK       +A  +LY ++ S   
Sbjct: 458 GVITE-NPVWIIMELCTLGEL---------RSFLQVRK---FSLDLASLILYAYQLSTAL 504
Query: 471 ------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPE 523
                 R VHRD+ A NVL+ S+   K+ DFG++R   +S   +A+  ++     +MAPE
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 562
Query: 524 YAMEGLYSKKSDVFSFGVLLIEII 547
                 ++  SDV+ FGV + EI+
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 357 LGQGGFGPVY-KGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK-LQHKNLVKLLGFC 414
           LG G FG V+     S G E  +K ++    Q   E     + +LK L H N++K+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
            D     +V E    G L   +   + RG  L       ++  +   + Y H      +V
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 474 HRDLKASNVLL-DSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           H+DLK  N+L  D+  +S  KI DFG+A +F   E   N     GT  YMAPE     + 
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAPEVFKRDV- 202
Query: 531 SKKSDVFSFGVLLIEIITG 549
           + K D++S GV++  ++TG
Sbjct: 203 TFKCDIWSAGVVMYFLLTG 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 85/163 (52%), Gaps = 16/163 (9%)
Query: 394 NEVLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGS-LDAILFDPRKRGILCWRKR 450
            E+ ++ KL H N+VKL+    D +E  L  V+E +  G  ++     P     L   + 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-----LSEDQA 139
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
                 + KG+ YLH     +I+HRD+K SN+L+  D + KI+DFG++  F  S  +A  
Sbjct: 140 RFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALL 194
Query: 511 VRIVGTYGYMAPEYAME--GLYSKKS-DVFSFGVLLIEIITGR 550
              VGT  +MAPE   E   ++S K+ DV++ GV L   + G+
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQGTA 390
           +F  + T    T ++     LG+G F  V + V          K +  K+LS+   Q   
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ--- 75
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
           +   E  +   L+H N+V+L     +     LV++ +  G L     D   R        
Sbjct: 76  KLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADA 132
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGE 507
           ++ ++ I + + ++H+     IVHRDLK  N+LL S       K++DFG+A    E +GE
Sbjct: 133 SHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA---IEVQGE 186
Query: 508 ANT-VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                   GT GY++PE   +  Y K  D+++ GV+L  ++ G
Sbjct: 187 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 352 SDSNILGQGGFGPVYK-GVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           S + ILG G FG V+K    + G ++A K + +   +   E  NE+ ++ +L H NL++L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
                  ++ +LV E++  G L   + D      L        +  I +G+ ++H+   +
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIRHMHQ---M 206
Query: 471 RIVHRDLKASNVL-LDSDMNS-KISDFGMARIFAESEGEANTVRI-VGTYGYMAPEYAME 527
            I+H DLK  N+L ++ D    KI DFG+AR +   E     +++  GT  ++APE    
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPEVVNY 262
Query: 528 GLYSKKSDVFSFGVLLIEIITG 549
              S  +D++S GV+   +++G
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 110/229 (48%), Gaps = 27/229 (11%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
           S + D   LG GG G V+  V +D  K VA+K++     Q       E+ +I +L H N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 408 VKL--------------LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
           VK+              +G   + +   +V E+M     + +     ++G L        
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL-----EQGPLLEEHARLF 125
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIF-AESEGEANTV 511
           +  + +G+ Y+H  +   ++HRDLK +N+ +++ D+  KI DFG+ARI       + +  
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 512 RIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRR-NAGSNQL 558
             + T  Y +P   +    Y+K  D+++ G +  E++TG+   AG+++L
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 100 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 148 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 199
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR  A+          V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYR 196
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR  A+          V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYR 196
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 349 SNFSDSNILGQGGFGPVYKGVLSDG-KEVAVK--------RLSSCSEQGTAEFT-NEVLL 398
            N+    ILG+G    V + +     KE AVK          S+   Q   E T  EV +
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 399 ILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-NIVNG 456
           + K+  H N+++L           LV++ M  G L    FD     +    K T  I+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRA 132
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           + + +  LH   +L IVHRDLK  N+LLD DMN K++DFG +      E       + GT
Sbjct: 133 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLRSVCGT 186
Query: 517 YGYMAPEYAMEGL------YSKKSDVFSFGVLLIEIITG 549
             Y+APE     +      Y K+ D++S GV++  ++ G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR  A+          V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYR 196
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 339 IDLETLNL--ATSNFSDSNI----LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE 391
           +DL T NL   +  FSD  +    +G G +    + V  +   E AVK +       + E
Sbjct: 11  VDLGTENLYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEE 70
Query: 392 FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKR 450
              E+LL    QH N++ L     DG    LV E M  G L D IL    ++     R+ 
Sbjct: 71  I--EILLRYG-QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL----RQKFFSEREA 123
Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL-LDSDMNS---KISDFGMARIFAESEG 506
           + +++ I K + YLH      +VHRDLK SN+L +D   N    +I DFG A+      G
Sbjct: 124 SFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG 180
Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
              T     T  ++APE      Y +  D++S G+LL  ++ G
Sbjct: 181 LLMTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 195 TDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 108/247 (43%), Gaps = 41/247 (16%)
Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
           H+ H Q R    + +      +T+      + + + +G G +G V        G  VAVK
Sbjct: 4   HHHHSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 59
Query: 380 RLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI-- 435
           +LS   +          E+ L+  ++H+N++ LL              F P  SL+    
Sbjct: 60  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFND 107
Query: 436 ------LFDPRKRGILCWRKRTN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
                 L       I+  +K T+     ++  I +G+ Y+H      I+HRDLK SN+ +
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAV 164
Query: 485 DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLL 543
           + D   KI DFG+AR       +      V T  Y APE  +  + Y++  D++S G ++
Sbjct: 165 NEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 219
Query: 544 IEIITGR 550
            E++TGR
Sbjct: 220 AELLTGR 226

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGXVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 357 LGQGGFGPVYKGVL----SDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL 411
           +G+G FG V++G+     +    VA+K   +C+     E F  E L + +  H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL- 470
           G   + +   ++ E    G L + L   RK  +            +A  +LY ++ S   
Sbjct: 78  GVITE-NPVWIIMELCTLGELRSFL-QVRKFSL-----------DLASLILYAYQLSTAL 124
Query: 471 ------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPE 523
                 R VHRD+ A NVL+ +    K+ DFG++R   +S   +A+  ++     +MAPE
Sbjct: 125 AYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 182
Query: 524 YAMEGLYSKKSDVFSFGVLLIEII 547
                 ++  SDV+ FGV + EI+
Sbjct: 183 SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 357 LGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           LGQG F  ++KGV  +          EV +K L       +  F     ++ KL HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
              G C  GDE +LV EF+  GSLD  L   +    + W  +  +   +A  M +L E++
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              ++H ++ A N+LL  + + K  +    ++     G + TV          P    E 
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKL--SDPGISITVLPKDILQERIPWVPPEC 188
Query: 529 LYSKK-----SDVFSFGVLLIEIITG 549
           + + K     +D +SFG  L EI +G
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 375 EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-D 433
           E AVK +       T E   E+LL    QH N++ L     DG    +V E M  G L D
Sbjct: 49  EFAVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLKDVYDDGKYVYVVTELMKGGELLD 105
Query: 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL-LDSDMNS-- 490
            IL    ++     R+ + ++  I K + YLH      +VHRDLK SN+L +D   N   
Sbjct: 106 KIL----RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPES 158
Query: 491 -KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            +I DFG A+      G   T     T  ++APE      Y    D++S GVLL  ++TG
Sbjct: 159 IRICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR-----H 185
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 96  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+   K 
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 97  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 145 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 196
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 89  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 137 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 188
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V     +  G ++AVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 119 ------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 167 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 218
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y+   D++S G ++ E++TGR
Sbjct: 219 APEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 73  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 121 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 172
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 173 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 102 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 95  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 143 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 194
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 92  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 92  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 92  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 140 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR-----HTDDEMTGYVATRWYR 191
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 102 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 96  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 144 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 195
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 102 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 150 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 201
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G FG V++    + G   A K + +  E        E+  +  L+H  LV L     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
           D +E +++YEFM  G L   + D   +  +   +    +  + KG+ ++HE++    VH 
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN---YVHL 173
Query: 476 DLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           DLK  N++  +  ++  K+ DFG+    A  + + +     GT  + APE A        
Sbjct: 174 DLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 230
Query: 534 SDVFSFGVLLIEIITG 549
           +D++S GVL   +++G
Sbjct: 231 TDMWSVGVLSYILLSG 246

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILK-LQHK 405
           +S+F   ++LG+G +G V        G+ VA+K++    +   A  T   + ILK  +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 406 NLVKLLGF-----CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           N++ +          + +E  ++ E M    L  ++       +L        +    + 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG--------EANTVR 512
           +  LH  +   ++HRDLK SN+L++S+ + K+ DFG+ARI  ES          ++    
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 513 IVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR-----RNAGSNQLLAYGM 563
            V T  Y APE  +    YS+  DV+S G +L E+   R     R+     LL +G+
Sbjct: 182 XVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 11/196 (5%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G FG V++    + G   A K + +  E        E+  +  L+H  LV L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
           D +E +++YEFM  G L   + D   +  +   +    +  + KG+ ++HE++    VH 
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHENN---YVHL 279
Query: 476 DLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           DLK  N++  +  ++  K+ DFG+    A  + + +     GT  + APE A        
Sbjct: 280 DLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 534 SDVFSFGVLLIEIITG 549
           +D++S GVL   +++G
Sbjct: 337 TDMWSVGVLSYILLSG 352

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/180 (32%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 375 EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-D 433
           E AVK +       + E   E+LL    QH N++ L     DG    LV E M  G L D
Sbjct: 54  EYAVKVIDKSKRDPSEEI--EILLRYG-QHPNIITLKDVYDDGKHVYLVTELMRGGELLD 110
Query: 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL-LDSDMNS-- 490
            IL    ++     R+ + +++ I K + YLH      +VHRDLK SN+L +D   N   
Sbjct: 111 KIL----RQKFFSEREASFVLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPEC 163
Query: 491 -KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            +I DFG A+      G   T     T  ++APE      Y +  D++S G+LL  ++ G
Sbjct: 164 LRICDFGFAKQLRAENGLLMTP--CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 29/237 (12%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILK-LQHK 405
           +S+F   ++LG+G +G V        G+ VA+K++    +   A  T   + ILK  +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 406 NLVKLLGF-----CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           N++ +          + +E  ++ E M    L  ++       +L        +    + 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG--------EANTVR 512
           +  LH  +   ++HRDLK SN+L++S+ + K+ DFG+ARI  ES          ++    
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTE 181
Query: 513 IVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR-----RNAGSNQLLAYGM 563
            V T  Y APE  +    YS+  DV+S G +L E+   R     R+     LL +G+
Sbjct: 182 YVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 185
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQHKNLVKLLG 412
           LG+G FG V         ++VA+K +S    + +        E+  +  L+H +++KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
                 + ++V E+      D I+   R       R    I+  I     Y H   R +I
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCH---RHKI 129
Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS- 531
           VHRDLK  N+LLD ++N KI+DFG++ I  +      +    G+  Y APE     LY+ 
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVINGKLYAG 186
Query: 532 KKSDVFSFGVLLIEIITGR 550
            + DV+S G++L  ++ GR
Sbjct: 187 PEVDVWSCGIVLYVMLVGR 205

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA-----------EF 392
           L+   S ++    +  G +G V  GV S+G  VA+KR+ +    G               
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEK-----LLVYEFMPNGSLDAILFDPRKRGILCW 447
             E+ L+    H N++ L    V  +E       LV E M    L  ++ D  +R ++  
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHD--QRIVISP 133
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
           +     +  I  G+  LHE     +VHRDL   N+LL  + +  I DF +AR   E   +
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTAD 187
Query: 508 ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEI 546
           AN    V    Y APE  M+   ++K  D++S G ++ E+
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI DFG+AR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----H 197
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 198 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 113 ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+AR       +      V T  Y 
Sbjct: 161 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGYVATRWYR 212
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA-----------EF 392
           L+   S ++    +  G +G V  GV S+G  VA+KR+ +    G               
Sbjct: 17  LHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEK-----LLVYEFMPNGSLDAILFDPRKRGILCW 447
             E+ L+    H N++ L    V  +E       LV E M    L  ++ D  +R ++  
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHD--QRIVISP 133
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
           +     +  I  G+  LHE     +VHRDL   N+LL  + +  I DF +AR   E   +
Sbjct: 134 QHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTAD 187
Query: 508 ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEI 546
           AN    V    Y APE  M+   ++K  D++S G ++ E+
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 357 LGQGGFGPVYKGVL----SDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL 411
           +G+G FG V++G+     +    VA+K   +C+     E F  E L + +  H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL- 470
           G   + +   ++ E    G L + L   RK  +            +A  +LY ++ S   
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFL-QVRKFSL-----------DLASLILYAYQLSTAL 504
Query: 471 ------RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-GEANTVRIVGTYGYMAPE 523
                 R VHRD+ A NVL+ +    K+ DFG++R   +S   +A+  ++     +MAPE
Sbjct: 505 AYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPE 562
Query: 524 YAMEGLYSKKSDVFSFGVLLIEII 547
                 ++  SDV+ FGV + EI+
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +A+GM +L   S  + +HRDL A N+LL  +   KI DFG+AR   ++            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +MAPE   + +YS KSDV+S+GVLL EI +
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G+G +G V+ G    G++VAVK   + +E+ +     E+   + ++H+N++  +   + 
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFT-TEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 417 GD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED----- 467
           G     +  L+ ++  NGSL    +D  K   L  +    +      G+ +LH +     
Sbjct: 103 GTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV--RIVGTYGYMAPEYA 525
            +  I HRDLK+ N+L+  +    I+D G+A  F     E +      VGT  YM PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 526 MEGLYSKK------SDVFSFGVLLIEI 546
            E L          +D++SFG++L E+
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLL 411
           +G G +G V   Y   L   ++VAVK+LS   +          E+ L+  L+H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     D  E  LV   M    L+ I+    K   L       +V  + +G+ Y+H
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM-GADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SNV ++ D   +I DFG+AR     + +      V T  Y APE  
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 200
Query: 526 MEGL-YSKKSDVFSFGVLLIEIITGR 550
           +  + Y++  D++S G ++ E++ G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE---QGTAEFTNEVL 397
           +  L +   ++    ++G+G FG V        ++V   +L S  E   +  + F  E  
Sbjct: 67  IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFD---PRKRGILCWRKRTN 452
            I+   +   V  L FC   D+K L  V E+MP G L  ++ +   P K     W K   
Sbjct: 127 DIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT 180
Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
                A+ +L L     + ++HRD+K  N+LLD   + K++DFG      E+ G  +   
Sbjct: 181 -----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVHCDT 234
Query: 513 IVGTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITG 549
            VGT  Y++PE       +G Y ++ D +S GV L E++ G
Sbjct: 235 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 355 NILGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQGTAEFTN-----EVLLILKLQHKNLV 408
           + LG+G F  VYK    +  + VA+K++         +  N     E+ L+ +L H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            LL          LV++FM    L+ I+ D     +L        +    +G+ YLH+  
Sbjct: 76  GLLDAFGHKSNISLVFDFM-ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              I+HRDLK +N+LLD +   K++DFG+A+ F  S   A   ++V T  Y APE     
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV-TRWYRAPELLFGA 187
Query: 529 -LYSKKSDVFSFGVLLIEII 547
            +Y    D+++ G +L E++
Sbjct: 188 RMYGVGVDMWAVGCILAELL 207

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI D+G+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEV--AVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           ++  N +G+G +G V K  +  G  +  A K++     +    F  E+ ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +L     D  +  LV E    G L   +   R   +        I+  +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH--- 140
Query: 469 RLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           +L + HRDLK  N L      D   K+ DFG+A  F    G+    + VGT  Y++P+  
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQ-V 196
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +EGLY  + D +S GV++  ++ G
Sbjct: 197 LEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 351 FSDSNILGQGGFGPVYKGVLSDGKEV--AVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           ++  N +G+G +G V K  +  G  +  A K++     +    F  E+ ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +L     D  +  LV E    G L   +   R   +        I+  +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH--- 123
Query: 469 RLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           +L + HRDLK  N L      D   K+ DFG+A  F    G+    + VGT  Y++P+  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTK-VGTPYYVSPQ-V 179
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +EGLY  + D +S GV++  ++ G
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 37/229 (16%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-- 404
            S+F +  +LGQG FG V K   + D +  A+K++   +E+  +   +EV L+  L H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQY 63
Query: 405 -----------KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR--KRGILCWRKRT 451
                      +N VK            +  E+  N +L  ++      ++    WR   
Sbjct: 64  VVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR--- 120
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES------- 504
            +   I + + Y+H      I+HR+LK  N+ +D   N KI DFG+A+    S       
Sbjct: 121 -LFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 505 ----EGEA-NTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEII 547
                G + N    +GT  Y+A E     G Y++K D +S G++  E I
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
            ++G+G F  V + +  + G++ AVK     + +S     T +   E  +   L+H ++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG----ILCWRKRTNIVNGIAKGMLYL 464
           +LL          +V+EFM    L    F+  KR     +      ++ +  I + + Y 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           H+++   I+HRD+K   VLL S  NS   K+  FG+A    ES G     R VGT  +MA
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGR-VGTPHFMA 201
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE      Y K  DV+  GV+L  +++G
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 24/218 (11%)
Query: 345 NLATSNFSDSN---ILGQGGFGPVYKGVLSDGK------EVAVKRLSSCSEQGTAEFTN- 394
           NL     +D N   +LG+G FG V   +L+D K       + + +     +    E T  
Sbjct: 12  NLDRVKLTDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTMV 68
Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNI 453
           E  ++  L     +  L  C    ++L  V E++  G L   ++  ++ G     +    
Sbjct: 69  EKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFY 125
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR- 512
              I+ G+ +LH+     I++RDLK  NV+LDS+ + KI+DFGM +   E   +  T R 
Sbjct: 126 AAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTRE 179
Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             GT  Y+APE      Y K  D +++GVLL E++ G+
Sbjct: 180 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL---DAILF--DPRKRGIL 445
           +F NE+ +I  ++++  +   G   + DE  ++YE+M N S+   D   F  D      +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
             +    I+  +     Y+H +    I HRD+K SN+L+D +   K+SDFG +    + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 506 GEANTVRIVGTYGYMAPE-YAMEGLYS-KKSDVFSFGVLL 543
            + +     GTY +M PE ++ E  Y+  K D++S G+ L
Sbjct: 207 IKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
            ++G+G F  V + +  + G++ AVK     + +S     T +   E  +   L+H ++V
Sbjct: 32  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG----ILCWRKRTNIVNGIAKGMLYL 464
           +LL          +V+EFM    L    F+  KR     +      ++ +  I + + Y 
Sbjct: 92  ELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           H+++   I+HRD+K   VLL S  NS   K+  FG+A    ES G     R VGT  +MA
Sbjct: 149 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGR-VGTPHFMA 203
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE      Y K  DV+  GV+L  +++G
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DFG+ R       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEV--AVKRLSS---CSEQGTAEFTNEVLLILK- 401
            S+F    ++G+G FG V        +EV  AVK L       ++      +E  ++LK 
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLA-RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
           ++H  LV L       D+   V +++  G L   L   R+R  L  R R      IA  +
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASAL 152
Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            YLH    L IV+RDLK  N+LLDS  +  ++DFG+ +     E  + T    GT  Y+A
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLA 207
Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           PE   +  Y +  D +  G +L E++ G
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLL 411
           +G G +G V   Y   L   ++VAVK+LS   +          E+ L+  L+H+N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     D  E  LV   M    L+ I+    K   L       +V  + +G+ Y+H
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLM-GADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SNV ++ D   +I DFG+AR     + +      V T  Y APE  
Sbjct: 141 SAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 192
Query: 526 MEGL-YSKKSDVFSFGVLLIEIITGR 550
           +  + Y++  D++S G ++ E++ G+
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 81/180 (45%), Gaps = 17/180 (9%)
Query: 375 EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-D 433
           E AVK +       T E   E+LL    QH N++ L     DG    +V E    G L D
Sbjct: 49  EFAVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLKDVYDDGKYVYVVTELXKGGELLD 105
Query: 434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL-LDSDMNS-- 490
            IL    ++     R+ + ++  I K + YLH      +VHRDLK SN+L +D   N   
Sbjct: 106 KIL----RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPES 158
Query: 491 -KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            +I DFG A+      G   T     T  ++APE      Y    D++S GVLL   +TG
Sbjct: 159 IRICDFGFAKQLRAENGLLXTP--CYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 357 LGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQGTA-EFTNEVLLILKLQHKNLVKLLGF 413
           LG+G +  VYKG   L+D   VA+K +    E+G       EV L+  L+H N+V L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN---------GIAKGMLYL 464
                   LV+E++ +  L   L D       C     NI+N          + +G+ Y 
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDD-------C----GNIINMHNVKLFLFQLLRGLAYC 116
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H   R +++HRDLK  N+L++     K++DFG+AR  A+S         V T  Y  P+ 
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDI 171
Query: 525 AMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +    YS + D++  G +  E+ TGR
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI DF +AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-----LVKL 410
           +G G  G V+K      G  +AVK++      G  E    +L+ L +  K+     +V+ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
            G  +   +  +  E M  G+  A     R +G +  R    +   I K + YL E  + 
Sbjct: 90  FGTFITNTDVFIAMELM--GTC-AEKLKKRMQGPIPERILGKMTVAIVKALYYLKE--KH 144
Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY-----A 525
            ++HRD+K SN+LLD     K+ DFG++    + + +    R  G   YMAPE       
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD---RSAGCAAYMAPERIDPPDP 201
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
            +  Y  ++DV+S G+ L+E+ TG+
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M + +L  ++     +  L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S GV++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M + +L  ++     +  L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S GV++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLL 411
           +G G +G V   Y   L   ++VAVK+LS   +          E+ L+  L+H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     D  E  LV   M    L+ I+    K   L       +V  + +G+ Y+H
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLM-GADLNNIV----KCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SNV ++ D   +I DFG+AR     + +      V T  Y APE  
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 200
Query: 526 MEGL-YSKKSDVFSFGVLLIEIITGR 550
           +  + Y++  D++S G ++ E++ G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 100/247 (40%), Gaps = 45/247 (18%)
Query: 327 GRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS 385
           GRD     Q  F+  +T+ L         +L +GGF  VY+   +  G+E A+KRL S  
Sbjct: 12  GRD-----QSDFVG-QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE 65
Query: 386 EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEK--------LLVYEFMPNGSLDAIL 436
           E+       EV  + KL  H N+V+       G E+        LL+ E    G L   L
Sbjct: 66  EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFL 124
Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
                RG L       I     + + ++H   +  I+HRDLK  N+LL +    K+ DFG
Sbjct: 125 KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFG 183
Query: 497 MA---------------RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS-----KKSDV 536
            A               R   E E   NT     T  Y  PE     LYS     +K D+
Sbjct: 184 SATTISHYPDYSWSAQRRALVEEEITRNT-----TPMYRTPEII--DLYSNFPIGEKQDI 236
Query: 537 FSFGVLL 543
           ++ G +L
Sbjct: 237 WALGCIL 243

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVA-------VKRLSSCSEQGTAEFT-NEV 396
            +   NF    +LG G +G V+      G +         +K+ +   +  T E T  E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 397 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
            ++  ++    +  L +    + KL L+ +++  G L   L    +R      +    V 
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVG 166
Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            I   + +LH   +L I++RD+K  N+LLDS+ +  ++DFG+++ F   E E       G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCG 222
Query: 516 TYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITG 549
           T  YMAP+    G   + K  D +S GVL+ E++TG
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 37/226 (16%)
Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLL 398
           +T+      + + + +G G +G V        G  VAVK+LS   +          E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKR 450
           +  ++H+N++ LL              F P  SL+          L       I+  +K 
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 451 TN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
           T+     ++  I +G+ Y+H      I+HRDLK SN+ ++ D   KI  FG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR-----H 174
Query: 506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            +      V T  Y APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI D G+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
           IA G+ +L       I++RDLK  NV+LDS+ + KI+DFGM +   E+  +  T +   G
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCG 504
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE      Y K  D ++FGVLL E++ G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQME------LDHERMSYLLYQMLXGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V+K    +  E VA+KR  L    E   +    E+ L+ +L+HKN+V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD- 68
Query: 414 CVDGDEKL-LVYEFMP----------NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
            +  D+KL LV+EF            NG LD  +               + +  + KG+ 
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV-------------KSFLFQLLKGLG 115
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           + H  +   ++HRDLK  N+L++ +   K++DFG+AR F        +  +V T  Y  P
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFG-IPVRCYSAEVV-TLWYRPP 170
Query: 523 EYAMEG-LYSKKSDVFSFGVLLIEIITGRR 551
           +      LYS   D++S G +  E+    R
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 19/212 (8%)
Query: 350 NFSDSNIL---GQGGFGPVYKGVLSDGKEV-AVKRLSS--CSEQGTAEFTNEVLLILK-L 402
           NF    IL   G+G FG V     +D K++ A+K ++   C E+       + L I++ L
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +H  LV L     D ++  +V + +  G L   L    ++ +    K   +   I + ++
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL----QQNVHF--KEETVKLFICELVM 126
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
            L      RI+HRD+K  N+LLD   +  I+DF +A +      E     + GT  YMAP
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAP 183
Query: 523 EY--AMEGL-YSKKSDVFSFGVLLIEIITGRR 551
           E   + +G  YS   D +S GV   E++ GRR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI D G+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVG 515
           IA G+ +L       I++RDLK  NV+LDS+ + KI+DFGM +   E+  +  T +   G
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCG 183
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE      Y K  D ++FGVLL E++ G+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +             
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     +G G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E+MP G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     K++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     +G G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E+MP G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     K++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +             
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +             
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR   +             
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 24/226 (10%)
Query: 339 IDLETLNL---ATSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSC--SEQ 387
           +DL T NL   +  NF++     S  LG+G F  V + +  S G+E A K L      + 
Sbjct: 11  VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD 70
Query: 388 GTAEFTNEV-LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
             AE  +E+ +L L      ++ L     +  E +L+ E+   G + ++   P    ++ 
Sbjct: 71  CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVS 129
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIFAE 503
                 ++  I +G+ YLH+++   IVH DLK  N+LL S     + KI DFGM+R    
Sbjct: 130 ENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-- 184
Query: 504 SEGEANTVR-IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             G A  +R I+GT  Y+APE       +  +D+++ G++   ++T
Sbjct: 185 --GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 37/211 (17%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS   +          E+ L+  ++H+N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 414 CVDGDEKLLVYEFMPNGSLDAI--------LFDPRKRGILCWRKRTN-----IVNGIAKG 460
                       F P  SL+          L       I+  +K T+     ++  I +G
Sbjct: 90  ------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y+H      I+HRDLK SN+ ++ D   KI D G+AR       +      V T  Y 
Sbjct: 138 LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR-----HTDDEMTGYVATRWYR 189
Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE  +  + Y++  D++S G ++ E++TGR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE---QGTAEFTNEVL 397
           +  L +   ++    ++G+G FG V        ++V   +L S  E   +  + F  E  
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 398 LILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFD---PRKRGILCWRKRTNI 453
            I+   +   V  L +    D  L +V E+MP G L  ++ +   P K     W +    
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-----WARFYT- 174
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
               A+ +L L     +  +HRD+K  N+LLD   + K++DFG   +    EG       
Sbjct: 175 ----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTA 229
Query: 514 VGTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITG 549
           VGT  Y++PE       +G Y ++ D +S GV L E++ G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 34  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 91
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 92  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 145
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S      V  V T  Y APE  
Sbjct: 146 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMVPFVVTRYYRAPEVI 199
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 200 LGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLL 411
           +G G  G V   +  VL  G  VAVK+LS   +  T A+     L++LK + HKN++ LL
Sbjct: 30  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLH 141
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 142 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRY-YRAPEVI 195
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E++ G
Sbjct: 196 LGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 25  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQME------LDHERMSYLLYQMLXGIKHLH 136
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE---QGTAEFTNEVL 397
           +  L +   ++    ++G+G FG V        ++V   +L S  E   +  + F  E  
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 398 LILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFD---PRKRGILCWRKRTNI 453
            I+   +   V  L +    D  L +V E+MP G L  ++ +   P K     W +    
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-----WARFYT- 179
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
               A+ +L L     +  +HRD+K  N+LLD   + K++DFG   +    EG       
Sbjct: 180 ----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTA 234
Query: 514 VGTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITG 549
           VGT  Y++PE       +G Y ++ D +S GV L E++ G
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRLSSCSEQGTA 390
           +DF    E     T++   F     LG G FG V     +  G   A+K L         
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 391 EFT---NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
           E     NE  ++  +    LVKL     D     +V E+ P G + + L   R+ G    
Sbjct: 84  EIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+++D     K++DFG+A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           LG+G F  V + + +  G+E A K +++   S +   +   E  +   L+H N+V+L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             +     LV++ +  G L     D   R        ++ +  I + + + H +    IV
Sbjct: 72  ISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHCHLNG---IV 125
Query: 474 HRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANT-VRIVGTYGYMAPEYAMEGL 529
           HRDLK  N+LL S       K++DFG+A    E +G+        GT GY++PE   +  
Sbjct: 126 HRDLKPENLLLASKSKGAAVKLADFGLA---IEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 530 YSKKSDVFSFGVLLIEIITG 549
           Y K  D+++ GV+L  ++ G
Sbjct: 183 YGKPVDMWACGVILYILLVG 202

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQME------LDHERMSYLLYQMLXGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE---QGTAEFTNEVL 397
           +  L +   ++    ++G+G FG V        ++V   +L S  E   +  + F  E  
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 398 LILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFD---PRKRGILCWRKRTNI 453
            I+   +   V  L +    D  L +V E+MP G L  ++ +   P K     W +    
Sbjct: 126 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-----WARFYT- 179
Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
               A+ +L L     +  +HRD+K  N+LLD   + K++DFG   +    EG       
Sbjct: 180 ----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTA 234
Query: 514 VGTYGYMAPEY----AMEGLYSKKSDVFSFGVLLIEIITG 549
           VGT  Y++PE       +G Y ++ D +S GV L E++ G
Sbjct: 235 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPEVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M + +L  ++     +  L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLVGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           LG+G F  V + + +  G+E A K +++   S +   +   E  +   L+H N+V+L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             +     LV++ +  G L     D   R        ++ +  I + + + H +    IV
Sbjct: 72  ISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNHCHLNG---IV 125
Query: 474 HRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANT-VRIVGTYGYMAPEYAMEGL 529
           HRDLK  N+LL S       K++DFG+A    E +G+        GT GY++PE   +  
Sbjct: 126 HRDLKPENLLLASKSKGAAVKLADFGLA---IEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 530 YSKKSDVFSFGVLLIEIITG 549
           Y K  D+++ GV+L  ++ G
Sbjct: 183 YGKPVDMWACGVILYILLVG 202

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKR--------LSSCSEQGTAEFTNEVLLILKLQHKN 406
           ++LG+G +G V K VL    E   +R               G A    E+ L+ +L+HKN
Sbjct: 11  DLLGEGSYGKV-KEVLDS--ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 407 LVKLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
           +++L+    + +++   +V E+   G  + +   P KR  +C  +       +  G+ YL
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC--QAHGYFCQLIDGLEYL 125
Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H      IVH+D+K  N+LL +    KIS  G+A        +       G+  +  PE 
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 525 A--MEGLYSKKSDVFSFGVLLIEIITG 549
           A  ++     K D++S GV L  I TG
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            I   I K + +LH  S+L ++HRD+K SNVL+++    K+ DFG++    +S   A T+
Sbjct: 157 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDS--VAKTI 212
Query: 512 RIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGR 550
              G   YMAPE     L    YS KSD++S G+ +IE+   R
Sbjct: 213 D-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 254

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     +G G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     K++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKRLSSCSEQ----GTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G +G VYK + +   E VA+KR+    E+    GTA    EV L+ +LQH+N+++L 
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA--IREVSLLKELQHRNIIELK 99
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
                     L++E+  N     +  +P     +  R   + +  +  G+ + H  SR R
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCH--SR-R 152
Query: 472 IVHRDLKASNVLLD-SDMNS----KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
            +HRDLK  N+LL  SD +     KI DFG+AR F     +  T  I+ T  Y  PE  +
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TLWYRPPEILL 210
Query: 527 EGL-YSKKSDVFSFGVLLIEII 547
               YS   D++S   +  E++
Sbjct: 211 GSRHYSTSVDIWSIACIWAEML 232

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M + +L  ++     +  L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 350 NFSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQGTAEFT-NEVLLILKLQHK 405
            F     LG G FG V     +  G   A+K L      +    E T NE  ++  +   
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 87
Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
            LVKL     D     +V E++P G + + L   R+ G             I     YLH
Sbjct: 88  FLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
               L +++RDLK  N+L+D     +++DFG A+       +  T  + GT  Y+APE  
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEII 196
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y+K  D ++ GVL+ E+  G
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLVKLLGF 413
           LG+G F    K V     +  AVK +S   E  T     + +  LKL   H N+VKL   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT----QKEITALKLCEGHPNIVKLHEV 74
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             D     LV E +  G L   +   +K+      + + I+  +   + ++H+   + +V
Sbjct: 75  FHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 474 HRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           HRDLK  N+L    + ++  KI DFG AR+         T     T  Y APE   +  Y
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNGY 186
Query: 531 SKKSDVFSFGVLLIEIITGR 550
            +  D++S GV+L  +++G+
Sbjct: 187 DESCDLWSLGVILYTMLSGQ 206

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 357 LGQGGFGPVYKGVLSDGKE-VAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V+K    +  E VA+KR  L    E   +    E+ L+ +L+HKN+V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD- 68
Query: 414 CVDGDEKL-LVYEFMP----------NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
            +  D+KL LV+EF            NG LD  +               + +  + KG+ 
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIV-------------KSFLFQLLKGLG 115
Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           + H  +   ++HRDLK  N+L++ +   K+++FG+AR F        +  +V T  Y  P
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWYRPP 170
Query: 523 EYAMEG-LYSKKSDVFSFGVLLIEIITGRR 551
           +      LYS   D++S G +  E+    R
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E+    T++   F     LG G FG V               +L   K V +K
Sbjct: 17  EDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK 76
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 77  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--- 125
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 126 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 182
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 183 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E+ P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+++D     K++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRLSSCSEQGTA 390
           +DF    E     T++   F     LG G FG V     +  G   A+K L         
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 391 EFT---NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
           E     NE  ++  +    LVKL     D     +V E+ P G + + L   R+ G    
Sbjct: 84  EIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+++D     +++DFG+A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 25  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 84
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 85  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSE 141
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 142 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 193
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 194 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 33  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 91  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 144
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 198
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E+    T++   F     LG G FG V               +L   K V +K
Sbjct: 25  EDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK 84
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 85  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--- 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E+    T++   F     LG G FG V               +L   K V +K
Sbjct: 25  EDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK 84
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 85  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--- 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 25  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 84
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 85  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSE 141
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 142 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 193
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 194 GRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E+    T++   F     LG G FG V               +L   K V +K
Sbjct: 25  EDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK 84
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 85  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--- 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 181
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 235
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E+    T++   F     LG G FG V               +L   K V +K
Sbjct: 25  EDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK 84
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E+ P G + + L   
Sbjct: 85  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL--- 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+++D     K++DFG A+
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK 190
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M + +L  ++     +  L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG-TAEFTNEVLLILKLQHKNLVKLLG-FC 414
           +G+G +G VYK    DGK+     L      G +     E+ L+ +L+H N++ L   F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 415 VDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY-----LHEDS 468
              D K+ L++++  +     I F    R     +K   +  G+ K +LY     +H   
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKF---HRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 469 RLRIVHRDLKASNVLLDSDMNS----KISDFGMARIF-AESEGEANTVRIVGTYGYMAPE 523
              ++HRDLK +N+L+  +       KI+D G AR+F +  +  A+   +V T+ Y APE
Sbjct: 146 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 524 YAMEGL-YSKKSDVFSFGVLLIEIITG 549
             +    Y+K  D+++ G +  E++T 
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E+    T++   F     LG G FG V               +L   K V +K
Sbjct: 17  EDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK 76
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 77  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--- 125
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 126 RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 182
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 183 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 25  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 84
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 85  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXE 141
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 142 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 193
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 194 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 33  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 144
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 198
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 70  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 181
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 235
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 26  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 137
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 138 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 191
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E+ P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+++D     K++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 26  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 83
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 84  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 137
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 138 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 191
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 192 LGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 358 GQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLLGFCV 415
            QG     Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL    
Sbjct: 29  AQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 416 ------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                 +  +  LV E M       I  +      L   + + ++  +  G+ +LH    
Sbjct: 87  PQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAG- 139
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  +   
Sbjct: 140 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVILGMG 194
Query: 530 YSKKSDVFSFGVLLIEIITGR 550
           Y +  D++S G ++ E++  +
Sbjct: 195 YKENVDIWSVGCIMGEMVRHK 215

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 358 GQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKLLGFCV 415
            QG     +  VL  G  VAVK+LS   +  T A+     L++LK + HKN++ LL    
Sbjct: 36  AQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT 93
Query: 416 ------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                 +  +  LV E M       I  +      L   + + ++  +  G+ +LH    
Sbjct: 94  PQKTLEEFQDVYLVMELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             I+HRDLK SN+++ SD   KI DFG+AR          T  +V  Y Y APE  +   
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPEVILGMG 201
Query: 530 YSKKSDVFSFGVLLIEIITG 549
           Y+   D++S G ++ E++ G
Sbjct: 202 YAANVDIWSVGCIMGELVKG 221

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 31  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 88
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 89  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 142
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 143 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 196
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 197 LGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M + +L  ++     +  L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELM-DANLSQVI-----QMELDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 197
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
           +   Y +  D++S G ++ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E+    T++   F     LG G FG V               +L   K V +K
Sbjct: 45  EDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK 104
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 105 QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--- 153
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 154 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 210
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 211 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  VL   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 33  IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 90
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  LV E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 91  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 144
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 198
Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
           +   Y +  D++S G ++ E++  +
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E     T++   F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E     T++   F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPAFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E     T++   F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++P G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E+ P G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+++D     +++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 13/106 (12%)
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
           +I   IA+ + +LH      ++HRDLK SN+    D   K+ DFG+     + E E   +
Sbjct: 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 512 RI----------VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEII 547
                       VGT  YM+PE      YS K D+FS G++L E++
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K      GKE A K    R  S S +G +  E   EV ++ +++H N++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +      L   + T  +  I  G+ YLH    
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSK-- 134
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMA-RIFAESEGEANTVRIVGTYGYMAPEY 524
            RI H DLK  N+ LLD ++ +   K+ DFG+A +I A +E +     I GT  ++APE 
Sbjct: 135 -RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPEFVAPEI 189
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
                   ++D++S GV+   +++G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVL 397
            +  ++F    +LG+G FG V   +L    + G+  A+K L      ++   A    E  
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 60
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++   +H  L  L       D    V E+   G L    F   +  +    +       I
Sbjct: 61  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 117
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-GT 516
              + YLH      +V+RD+K  N++LD D + KI+DFG+ +   E   +  T++   GT
Sbjct: 118 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGT 171
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    E+    T++   F     LG G FG V               +L   K V +K
Sbjct: 25  EDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLK 84
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  +   +    LVKL     D     +V E+ P G + + L   
Sbjct: 85  QIEHT--------LNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL--- 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     K++DFG A+
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK 190
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 350 NFSDSNILGQGGFGP-VYKGVLSDGKEVAVKR-LSSCSEQGTAEFTNEVLLILKLQHKNL 407
           +F   ++LG G  G  VY+G+  D ++VAVKR L  C      E     LL    +H N+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQ---LLRESDEHPNV 80
Query: 408 VKLLGFCVDGDEKL----------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++   FC + D +            + E++       +  +P             ++   
Sbjct: 81  IRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----------ITLLQQT 127
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLD-----SDMNSKISDFGMARIFAESEGE-ANTV 511
             G+ +LH    L IVHRDLK  N+L+        + + ISDFG+ +  A      +   
Sbjct: 128 TSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 512 RIVGTYGYMAPEYAMEGLYSKKS---DVFSFGVLLIEIIT 548
            + GT G++APE   E      +   D+FS G +   +I+
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K      GKE A K    R  S S +G +  E   EV ++ +++H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +      L   + T  +  I  G+ YLH    
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSK-- 127
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMA-RIFAESEGEANTVRIVGTYGYMAPEY 524
            RI H DLK  N+ LLD ++ +   K+ DFG+A +I A +E +     I GT  ++APE 
Sbjct: 128 -RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGTPEFVAPEI 182
Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
                   ++D++S GV+   +++G
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVL 397
            +  ++F    +LG+G FG V   +L    + G+  A+K L      ++   A    E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++   +H  L  L       D    V E+   G L    F   +  +    +       I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 114
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-GT 516
              + YLH      +V+RD+K  N++LD D + KI+DFG+ +   E   +  T++   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGT 168
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G E A K    R S  S +G +  E   EV ++ ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L    ++  L   + T+ +  I  G+ YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK-- 134
Query: 470 LRIVHRDLKASNV-LLDSDM---NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            +I H DLK  N+ LLD ++   + K+ DFG+A    E E       I GT  ++APE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 25  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 84
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    L KL     D     +V E+ P G + + L   R+ G    
Sbjct: 85  QIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSE 141
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+++D     K++DFG A+       +
Sbjct: 142 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVK 193
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 194 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G E A K    R S  S +G +  E   EV ++ ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L    ++  L   + T+ +  I  G+ YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK-- 134
Query: 470 LRIVHRDLKASNV-LLDSDM---NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            +I H DLK  N+ LLD ++   + K+ DFG+A    E E       I GT  ++APE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVL 397
            +  ++F    +LG+G FG V   +L    + G+  A+K L      ++   A    E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++   +H  L  L       D    V E+   G L    F   +  +    +       I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 114
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGT 516
              + YLH      +V+RD+K  N++LD D + KI+DFG+ +   E   +  T++   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGT 168
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVL 397
            +  ++F    +LG+G FG V   +L    + G+  A+K L      ++   A    E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++   +H  L  L       D    V E+   G L    F   +  +    +       I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 114
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGT 516
              + YLH      +V+RD+K  N++LD D + KI+DFG+ +   E   +  T++   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGT 168
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAE- 391
           A+ F   ++ + L   +F    ++G+G FG V    L +  +V A+K L+       AE 
Sbjct: 59  AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET 118
Query: 392 --FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL--FDPRKRGILCW 447
             F  E  +++    K +  L     D +   LV ++   G L  +L  F+ R    +  
Sbjct: 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR 178
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                +V  I      +H+   L  VHRD+K  N+L+D + + +++DFG      E +G 
Sbjct: 179 FYLAEMVIAIDS----VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGT 230
Query: 508 ANTVRIVGTYGYMAPEY--AME---GLYSKKSDVFSFGVLLIEIITGR 550
             +   VGT  Y++PE   AME   G Y  + D +S GV + E++ G 
Sbjct: 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVL 397
            +  ++F    +LG+G FG V   +L    + G+  A+K L      ++   A    E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++   +H  L  L       D    V E+   G L    F   +  +    +       I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 114
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGT 516
              + YLH      +V+RD+K  N++LD D + KI+DFG+ +   E   +  T++   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGT 168
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 22/201 (10%)
Query: 357 LGQGGFGPVYKGVLSD---GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           LG+G FG V++  + D   G + AVK++    E   AE   E++    L    +V L G 
Sbjct: 101 LGRGSFGEVHR--MEDKQTGFQCAVKKVRL--EVFRAE---ELMACAGLTSPRIVPLYGA 153
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             +G    +  E +  GSL  ++   +++G L   +    +    +G+ YLH  SR RI+
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR-RIL 207
Query: 474 HRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTV----RIVGTYGYMAPEYAMEG 528
           H D+KA NVLL SD  ++ + DFG A +  + +G   ++     I GT  +MAPE  +  
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGR 266
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
               K DV+S   +++ ++ G
Sbjct: 267 SCDAKVDVWSSCCMMLHMLNG 287

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVL 397
            +  ++F    +LG+G FG V   +L    + G+  A+K L      ++   A    E  
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++   +H  L  L       D    V E+   G L    F   +  +    +       I
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 114
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-GT 516
              + YLH      +V+RD+K  N++LD D + KI+DFG+ +   E   +  T++   GT
Sbjct: 115 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGT 168
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 25  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 84
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    L KL     D     +V E+ P G + + L   R+ G    
Sbjct: 85  QIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSE 141
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+++D     K++DFG A+       +
Sbjct: 142 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVK 193
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 194 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 345 NLATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSS---CSEQGTAEFTNEVL 397
            +  ++F    +LG+G FG V   +L    + G+  A+K L      ++   A    E  
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 62
Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           ++   +H  L  L       D    V E+   G L    F   +  +    +       I
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEI 119
Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGT 516
              + YLH      +V+RD+K  N++LD D + KI+DFG+ +   E   +  T++   GT
Sbjct: 120 VSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGT 173
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G E A K    R S  S +G +  E   EV ++ ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L    ++  L   + T+ +  I  G+ YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK-- 134
Query: 470 LRIVHRDLKASNV-LLDSDM---NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            +I H DLK  N+ LLD ++   + K+ DFG+A    E E       I GT  ++APE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G E A K    R S  S +G +  E   EV ++ ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L    ++  L   + T+ +  I  G+ YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK-- 134
Query: 470 LRIVHRDLKASNV-LLDSDM---NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            +I H DLK  N+ LLD ++   + K+ DFG+A    E E       I GT  ++APE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGT--AEFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G E A K    R S  S +G    E   EV ++ ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L    ++  L   + T+ +  I  G+ YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK-- 134
Query: 470 LRIVHRDLKASNV-LLDSDM---NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            +I H DLK  N+ LLD ++   + K+ DFG+A    E E       I GT  ++APE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 188
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 131
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 188
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSG 212

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 25  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 84
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    L KL     D     +V E+ P G + + L   R+ G    
Sbjct: 85  QIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXE 141
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+++D     K++DFG A+       +
Sbjct: 142 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVK 193
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 194 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G E A K    R S  S +G +  E   EV ++ ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L    ++  L   + T+ +  I  G+ YLH    
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHTK-- 134
Query: 470 LRIVHRDLKASNV-LLDSDM---NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            +I H DLK  N+ LLD ++   + K+ DFG+A    E E       I GT  ++APE  
Sbjct: 135 -KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEIV 190
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSG 214

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 25  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 84
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 85  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 134 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 190
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 191 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEV 396
           ID + LN  T        L +   G ++KG    G ++ VK  ++   S + + +F  E 
Sbjct: 7   IDFKQLNFLTK-------LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 397 LLILKLQHKNLVKLLGFC--VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
             +    H N++ +LG C         L+  +MP GSL  +L +     ++   +     
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFA 117
Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +A+GM +LH    L I    L + +V++D DM ++IS     +   +S G       +
Sbjct: 118 LDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARIS-MADVKFSFQSPGR------M 169
Query: 515 GTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIIT 548
               ++APE      E    + +D++SF VLL E++T
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 5   NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 63
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 64  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 120
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 121 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 177
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 178 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 11  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 70
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 71  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 119
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 120 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK 176
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 177 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G FG V++ V  + G+    K +++          NE+ ++ +L H  L+ L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 416 DGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           D  E +L+ EF+  G L D I  +  K   +   +  N +    +G+ ++HE S   IVH
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHEHS---IVH 172
Query: 475 RDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRI-VGTYGYMAPEYAMEGLYS 531
            D+K  N++ ++   S  KI DFG+A      E     V++   T  + APE        
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVG 228
Query: 532 KKSDVFSFGVLLIEIITG 549
             +D+++ GVL   +++G
Sbjct: 229 FYTDMWAIGVLGYVLLSG 246

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 5   NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 63
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 64  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 120
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 121 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 177
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 178 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 6   NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 64
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 121
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 122 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 179 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 120
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 121 EAVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 173
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 6   NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 64
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 121
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 122 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 179 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 6   NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 64
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 121
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 122 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 178
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 179 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLG 412
           ++LG+G    V   + L   +E AVK +        +    EV ++ + Q H+N+++L+ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  + D   LV+E M  GS   IL    KR      + + +V  +A  + +LH      I
Sbjct: 79  FFEEEDRFYLVFEKMRGGS---ILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---I 132
Query: 473 VHRDLKASNVLLDSDMN---SKISDFGMARIFAESEGEANTVRI------VGTYGYMAPE 523
            HRDLK  N+L +        KI DFG+     +  G+ + +         G+  YMAPE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGI-KLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 524 ----YAMEG-LYSKKSDVFSFGVLLIEIITG 549
               ++ E  +Y K+ D++S GV+L  +++G
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 345 NLATSNFSDSNILGQGGFGPV-YKGVLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLIL 400
            +  + F    +LG+G FG V      + G+  A+K L      ++   A    E  ++ 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
             +H  L  L       D    V E+   G L    F   +  +    +       I   
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 120
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           + YLH  S   +V+RDLK  N++LD D + KI+DFG+ +   E   +  T++   GT  Y
Sbjct: 121 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEY 175
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           +APE   +  Y +  D +  GV++ E++ GR
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 18  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 76
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 77  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 134 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 191 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-G 515
           I   + YLH  S   +V+RDLK  N++LD D + KI+DFG+ +   E   +  T++   G
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCG 311
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 25  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 83
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 84  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 140
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 141 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 197
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 198 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 345 NLATSNFSDSNILGQGGFGPV-YKGVLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLIL 400
            +  + F    +LG+G FG V      + G+  A+K L      ++   A    E  ++ 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
             +H  L  L       D    V E+   G L    F   +  +    +       I   
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 121
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           + YLH  S   +V+RDLK  N++LD D + KI+DFG+ +   E   +  T++   GT  Y
Sbjct: 122 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEY 176
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           +APE   +  Y +  D +  GV++ E++ GR
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 19  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 78
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 79  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 127
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 128 RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 184
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 185 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 18  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 76
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 77  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 134 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 191 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 19  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 77
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 78  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 134
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 135 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 192 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 19  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 77
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 78  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 134
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 135 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 192 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 18  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 76
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 77  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 134 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 191 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 18  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 76
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 77  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 133
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 134 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 190
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 191 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 33  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 91
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 92  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 148
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 149 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 206 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-G 515
           I   + YLH  S   +V+RDLK  N++LD D + KI+DFG+ +   E   +  T++   G
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCG 314
Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y+APE   +  Y +  D +  GV++ E++ GR
Sbjct: 315 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 19  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 77
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 78  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 134
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 135 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 192 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 33  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 91
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 92  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 148
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 149 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 205
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 206 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 345 NLATSNFSDSNILGQGGFGPV-YKGVLSDGKEVAVKRLSS---CSEQGTAEFTNEVLLIL 400
            +  + F    +LG+G FG V      + G+  A+K L      ++   A    E  ++ 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
             +H  L  L       D    V E+   G L    F   +  +    +       I   
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSA 122
Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGY 519
           + YLH  S   +V+RDLK  N++LD D + KI+DFG+ +   E   +  T++   GT  Y
Sbjct: 123 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEY 177
Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           +APE   +  Y +  D +  GV++ E++ GR
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 31/205 (15%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 143
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES---EGEANTVRIVGTYGYMAP 522
                 I+HRDLK SN+++ SD   KI DFG+AR    S   E E      V T  Y AP
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE------VVTRYYRAP 194
Query: 523 EYAMEGLYSKKSDVFSFGVLLIEII 547
           E  +   Y +  D++S G ++ E++
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 19  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 77
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 78  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 134
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 135 TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 191
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 192 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 9/103 (8%)
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            I   I K + +LH  S+L ++HRD+K SNVL+++    K+ DFG++    +   +    
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID- 169
Query: 512 RIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGR 550
              G   YMAPE     L    YS KSD++S G+ +IE+   R
Sbjct: 170 --AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 339 IDLETLNL-----ATSNFSDSNILGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQG 388
           +DL T NL        ++     LG G F  V K      GKE A K    R    S +G
Sbjct: 11  VDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRG 70
Query: 389 TA--EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
            +  E   EV ++ +++H N++ L     +  + +L+ E +  G L   L +      L 
Sbjct: 71  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LT 127
Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV-LLDSDMNS---KISDFGMA-RIF 501
             + T  +  I  G+ YLH     RI H DLK  N+ LLD ++ +   K+ DFG+A +I 
Sbjct: 128 EDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 184
Query: 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           A +E +     I GT  ++APE         ++D++S GV+   +++G
Sbjct: 185 AGNEFK----NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +      L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLH---S 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 22/201 (10%)
Query: 357 LGQGGFGPVYKGVLSD---GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           LG+G FG V++  + D   G + AVK++    E   AE   E++    L    +V L G 
Sbjct: 82  LGRGSFGEVHR--MEDKQTGFQCAVKKVRL--EVFRAE---ELMACAGLTSPRIVPLYGA 134
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             +G    +  E +  GSL  ++   +++G L   +    +    +G+ YLH  SR RI+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR-RIL 188
Query: 474 HRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTV----RIVGTYGYMAPEYAMEG 528
           H D+KA NVLL SD  ++ + DFG A +  + +G    +     I GT  +MAPE  +  
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGR 247
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
               K DV+S   +++ ++ G
Sbjct: 248 SCDAKVDVWSSCCMMLHMLNG 268

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 357 LGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAE--FTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G V+K    D G+ VA+K+     +    +     E+ ++ +L+H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML----YLHEDSR 469
                   LV+E+  +  L  +  D  +RG+       ++V  I    L    + H+ + 
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHEL--DRYQRGV-----PEHLVKSITWQTLQAVNFCHKHN- 122
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EG 528
              +HRD+K  N+L+      K+ DFG AR+        +    V T  Y +PE  + + 
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELLVGDT 178
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
            Y    DV++ G +  E+++G
Sbjct: 179 QYGPPVDVWAIGCVFAELLSG 199

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 357 LGQGGFGPV--YKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           LG+GGF  V   +G L DG   A+KR+    +Q   E   E  +     H N+++L+ +C
Sbjct: 37  LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 415 VD----GDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSR 469
           +       E  L+  F   G+L   +   + +G  L   +   ++ GI +G+  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG- 154
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFG---MARIFAESEGEANTVRIVG----TYGYMAP 522
               HRDLK +N+LL  +    + D G    A I  E   +A T++       T  Y AP
Sbjct: 155 --YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 523 E-YAMEG--LYSKKSDVFSFGVLLIEIITG 549
           E ++++   +  +++DV+S G +L  ++ G
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 330 NDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG 388
           NDL A       E   L  S +    +LG GGFG VY G+ +SD   VA+K +       
Sbjct: 38  NDLHATKLAPGKEKEPL-ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 96
Query: 389 TAEFTN------EVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-P 439
             E  N      EV+L+ K+      +++LL +    D  +L+ E  P    D  LFD  
Sbjct: 97  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFI 153
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMA 498
            +RG L      +    + + + + H      ++HRD+K  N+L+D +    K+ DFG  
Sbjct: 154 TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 210
Query: 499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            +  ++          GT  Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 211 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 357 LGQGGFGPVYK-GVLSDGKEVAVK----RLSSCSEQGTA--EFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K    R +  S +G +  +   EV ++ ++QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L   L +   +  L   + T  +  I  G+ YLH    
Sbjct: 79  LHEVYENKTDVILIGELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS--- 132
Query: 470 LRIVHRDLKASNV-LLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N+ LLD ++     KI DFG+A          N   I GT  ++APE  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVAPEIV 189
Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
                  ++D++S GV+   +++G
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSG 213

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 45  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 104
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 105 QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 153
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 154 RRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 210
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 211 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 358 GQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLLGFCV 415
            QG     Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL    
Sbjct: 30  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 87
Query: 416 ------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                 +  +  +V E M       I  +      L   + + ++  +  G+ +LH    
Sbjct: 88  PQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAG- 140
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  +   
Sbjct: 141 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVILGMG 195
Query: 530 YSKKSDVFSFGVLLIEII 547
           Y +  D++S G ++ E++
Sbjct: 196 YKENVDLWSVGCIMGEMV 213

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 45  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 104
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 105 QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 153
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 154 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 210
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 211 -----RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRI 513
           I+  + YLHE     I++RDLK  NVLLDS+ + K++D+GM +     EG      T   
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXF 170
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            GT  Y+APE      Y    D ++ GVL+ E++ GR
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+++D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRI 513
           I+  + YLHE     I++RDLK  NVLLDS+ + K++D+GM +     EG      T   
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXF 181
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            GT  Y+APE      Y    D ++ GVL+ E++ GR
Sbjct: 182 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKL--- 410
           +G G +G V        G++VA+K++ +  +  T A+ T   L ILK  +H N++ +   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 411 LGFCVDGDEKLLVYEFMP--NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L   V   E   VY  +      L  I+   +    L        +  + +G+ Y+H   
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP---LTLEHVRYFLYQLLRGLKYMHS-- 176
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN--TVRIVGTYGYMAPEYAM 526
             +++HRDLK SN+L++ +   KI DFGMAR    S  E        V T  Y APE  +
Sbjct: 177 -AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 235
Query: 527 E-GLYSKKSDVFSFGVLLIEIITGRR 551
               Y++  D++S G +  E++  R+
Sbjct: 236 SLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 357 LGQGGFGPV---YKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLL 411
           +G G  G V   Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL
Sbjct: 37  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 94
Query: 412 GFCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
                     +  +  +V E M       I  +      L   + + ++  +  G+ +LH
Sbjct: 95  NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLH 148
Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK SN+++ SD   KI DFG+AR    S     T  +V  Y Y APE  
Sbjct: 149 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRY-YRAPEVI 202
Query: 526 MEGLYSKKSDVFSFGVLLIEII 547
           +   Y +  D++S G ++ E++
Sbjct: 203 LGMGYKENVDLWSVGCIMGEMV 224

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 120
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 121 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 173
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG---EANTVRI 513
           I+  + YLHE     I++RDLK  NVLLDS+ + K++D+GM +     EG      T   
Sbjct: 115 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSXF 166
Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            GT  Y+APE      Y    D ++ GVL+ E++ GR
Sbjct: 167 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 357 LGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGT-AEFTNEVLLILK-LQHKNLVKL--- 410
           +G G +G V        G++VA+K++ +  +  T A+ T   L ILK  +H N++ +   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 411 LGFCVDGDEKLLVYEFMP--NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L   V   E   VY  +      L  I+   +    L        +  + +G+ Y+H   
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQP---LTLEHVRYFLYQLLRGLKYMHS-- 177
Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN--TVRIVGTYGYMAPEYAM 526
             +++HRDLK SN+L++ +   KI DFGMAR    S  E        V T  Y APE  +
Sbjct: 178 -AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 236
Query: 527 E-GLYSKKSDVFSFGVLLIEIITGRR 551
               Y++  D++S G +  E++  R+
Sbjct: 237 SLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 18/222 (8%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY-KGVLSDGKEVAVKRL--SSCSEQG 388
           +DF    E     T++   F     LG G FG V     +  G   A+K L      +  
Sbjct: 24  EDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK 83
Query: 389 TAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCW 447
             E T NE  ++  +    LVKL     D     +V E++  G + + L   R+ G    
Sbjct: 84  QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSE 140
Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
                    I     YLH    L +++RDLK  N+L+D     +++DFG A+       +
Sbjct: 141 PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVK 192
Query: 508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
             T  + GT  Y+APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 193 GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+APE  +   Y+K  D ++ GVL+ ++  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 123
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 124 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 176
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 177 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           I+  + YLHE     I++RDLK  NVLLDS+ + K++D+GM +         +T    GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             Y+APE      Y    D ++ GVL+ E++ GR
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 28/201 (13%)
Query: 358 GQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT--AEFTNEVLLILKLQHKNLVKLLGFCV 415
            QG     Y  +L   + VA+K+LS   +  T       E++L+  + HKN++ LL    
Sbjct: 36  AQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 416 ------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                 +  +  +V E M       I  +      L   + + ++  +  G+ +LH    
Sbjct: 94  PQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHSAG- 146
Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES---EGEANTVRIVGTYGYMAPEYAM 526
             I+HRDLK SN+++ SD   KI DFG+AR    S   E E      V T  Y APE  +
Sbjct: 147 --IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE------VVTRYYRAPEVIL 198
Query: 527 EGLYSKKSDVFSFGVLLIEII 547
              Y +  D++S G ++ E++
Sbjct: 199 GMGYKENVDLWSVGCIMGEMV 219

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 357 LGQGGFGPVYKGVLSD---GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           LG+G FG V++  + D   G + AVK++             E++    L    +V L G 
Sbjct: 80  LGRGSFGEVHR--MKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLYGA 132
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             +G    +  E +  GSL  ++   ++ G L   +    +    +G+ YLH     RI+
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RIL 186
Query: 474 HRDLKASNVLLDSDMN-SKISDFGMARIFAESEGEANTV----RIVGTYGYMAPEYAMEG 528
           H D+KA NVLL SD + + + DFG A +  + +G   ++     I GT  +MAPE  M  
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
               K D++S   +++ ++ G
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNG 266

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 120
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 121 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 173
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 124
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 125 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 177
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 125
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 126 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 178
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 125
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 126 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 178
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 33/252 (13%)
Query: 320 FHYQHVQ----GRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE 375
           F  QH+     G D+D KA       E +++    +S    +G GG   V++ VL++ K+
Sbjct: 25  FERQHMDSPDLGTDDDDKASSSA--NECISVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQ 81
Query: 376 V-AVK--RLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNG 430
           + A+K   L     Q    + NE+  + KLQ  +  +++L  + +       +Y  M  G
Sbjct: 82  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECG 138
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
           ++D   +  +K+ I  W +++   N +      +H   +  IVH DLK +N L+   M  
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEA----VHTIHQHGIVHSDLKPANFLIVDGM-L 193
Query: 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS------------DVFS 538
           K+ DFG+A               VGT  YM PE A++ + S +             DV+S
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 539 FGVLLIEIITGR 550
            G +L  +  G+
Sbjct: 253 LGCILYYMTYGK 264

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 125
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 126 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 178
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 31  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 90
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E  P    D  LFD   +RG L      +    + 
Sbjct: 91  VSSGFSGVIRLLDWFERPDSFVLILE-RPEPVQD--LFDFITERGALQEELARSFFWQVL 147
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 148 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 200
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 331 DLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVK--RLSSCSEQ 387
           DL  ++ +   +++++    +S    +G GG   V++ VL++ K++ A+K   L     Q
Sbjct: 12  DLGTENLY--FQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQ 68
Query: 388 GTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL 445
               + NE+  + KLQ  +  +++L  + +       +Y  M  G++D   +  +K+ I 
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSID 125
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
            W +++   N +      +H   +  IVH DLK +N L+   M  K+ DFG+A       
Sbjct: 126 PWERKSYWKNMLEA----VHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDX 180
Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKS------------DVFSFGVLLIEIITGR 550
                   VGT  YM PE A++ + S +             DV+S G +L  +  G+
Sbjct: 181 XXVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 29/237 (12%)
Query: 331 DLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVK--RLSSCSEQ 387
           DL  ++ +   +++++    +S    +G GG   V++ VL++ K++ A+K   L     Q
Sbjct: 12  DLGTENLY--FQSMSVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQ 68
Query: 388 GTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL 445
               + NE+  + KLQ  +  +++L  + +       +Y  M  G++D   +  +K+ I 
Sbjct: 69  TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSID 125
Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
            W +++   N +      +H   +  IVH DLK +N L+   M  K+ DFG+A       
Sbjct: 126 PWERKSYWKNMLEA----VHTIHQHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDT 180
Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKS------------DVFSFGVLLIEIITGR 550
                   VGT  YM PE A++ + S +             DV+S G +L  +  G+
Sbjct: 181 TSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 357 LGQGGFGPVYKGVLSD---GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G FG V++  + D   G + AVK++             E++    L    +V L G 
Sbjct: 66  VGRGSFGEVHR--MKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLYGA 118
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             +G    +  E +  GSL  ++   ++ G L   +    +    +G+ YLH     RI+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RIL 172
Query: 474 HRDLKASNVLLDSDMN-SKISDFGMARIFAESEGEANTVR----IVGTYGYMAPEYAMEG 528
           H D+KA NVLL SD + + + DFG A +  + +G   ++     I GT  +MAPE  M  
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
               K D++S   +++ ++ G
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNG 252

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT  Y+AP   +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 347 ATSNFSDSNILGQGGFGPVYKGVLSDG-KEVAVKRLSSCSEQ--GTAEFTNEVLLILKLQ 403
              N+   +++G+G +G VY     +  K VA+K+++   E          E+ ++ +L+
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 404 HKNLVKLLGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
              +++L    +  D    ++L +   + +  L  +   P     L       I+  +  
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP---IFLTEEHIKTILYNLLL 140
Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR------- 512
           G  ++HE     I+HRDLK +N LL+ D + K+ DFG+AR    SE + N V        
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI-NSEKDTNIVNDLEENEE 196
Query: 513 --------------IVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEII 547
                          V T  Y APE   ++  Y+K  D++S G +  E++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 112/252 (44%), Gaps = 33/252 (13%)
Query: 320 FHYQHVQ----GRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE 375
           F  QH+     G D+D KA       E +++    +S    +G GG   V++ VL++ K+
Sbjct: 25  FERQHMDSPDLGTDDDDKASSSA--NECISVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQ 81
Query: 376 V-AVK--RLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNG 430
           + A+K   L     Q    + NE+  + KLQ  +  +++L  + +       +Y  M  G
Sbjct: 82  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECG 138
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
           ++D   +  +K+ I  W +++   N +      +H   +  IVH DLK +N L+   M  
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEA----VHTIHQHGIVHSDLKPANFLIVDGM-L 193
Query: 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS------------DVFS 538
           K+ DFG+A               VGT  YM PE A++ + S +             DV+S
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 539 FGVLLIEIITGR 550
            G +L  +  G+
Sbjct: 253 LGCILYYMTYGK 264

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVK--RLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLL 411
           +G GG   V++ VL++ K++ A+K   L     Q    + NE+  + KLQ  +  +++L 
Sbjct: 20  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            + +       +Y  M  G++D   +  +K+ I  W +++   N +      +H   +  
Sbjct: 79  DYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----VHTIHQHG 131
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           IVH DLK +N L+   M  K+ DFG+A               VGT  YM PE A++ + S
Sbjct: 132 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSS 189
Query: 532 KKS------------DVFSFGVLLIEIITGR 550
            +             DV+S G +L  +  G+
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 357 LGQGGFGPVYKGVLSD---GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G FG V++  + D   G + AVK++             E++    L    +V L G 
Sbjct: 82  VGRGSFGEVHR--MKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLYGA 134
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
             +G    +  E +  GSL  ++   ++ G L   +    +    +G+ YLH     RI+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RIL 188
Query: 474 HRDLKASNVLLDSDMN-SKISDFGMARIFAESEGEANTVR----IVGTYGYMAPEYAMEG 528
           H D+KA NVLL SD + + + DFG A +  + +G   ++     I GT  +MAPE  M  
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 529 LYSKKSDVFSFGVLLIEIITG 549
               K D++S   +++ ++ G
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNG 268

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILK 401
           S +    +LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 402 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
           +      +++LL +    D  +L+ E M        LFD   +RG L      +    + 
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQ---DLFDFITERGALQEELARSFFWQVL 124
Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           + + + H      ++HRD+K  N+L+D +    K+ DFG   +  ++          GT 
Sbjct: 125 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTR 177
Query: 518 GYMAPEYAMEGLYSKKS-DVFSFGVLLIEIITG 549
            Y  PE+     Y  +S  V+S G+LL +++ G
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVK--RLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLL 411
           +G GG   V++ VL++ K++ A+K   L     Q    + NE+  + KLQ  +  +++L 
Sbjct: 17  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            + +       +Y  M  G++D   +  +K+ I  W +++   N +      +H   +  
Sbjct: 76  DYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----VHTIHQHG 128
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           IVH DLK +N L+   M  K+ DFG+A               VGT  YM PE A++ + S
Sbjct: 129 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSS 186
Query: 532 KKS------------DVFSFGVLLIEIITGR 550
            +             DV+S G +L  +  G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLG 412
           ++LG+G    V   + L   +E AVK +        +    EV ++ + Q H+N+++L+ 
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  + D   LV+E M  GS   IL    KR      + + +V  +A  + +LH      I
Sbjct: 79  FFEEEDRFYLVFEKMRGGS---ILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---I 132
Query: 473 VHRDLKASNVLLDSDMN---SKISDFGMARIFAESEGEANTVRI------VGTYGYMAPE 523
            HRDLK  N+L +        KI DF +     +  G+ + +         G+  YMAPE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGI-KLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 524 ----YAMEG-LYSKKSDVFSFGVLLIEIITG 549
               ++ E  +Y K+ D++S GV+L  +++G
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 357 LGQGGFGPVYKGVLSDGKEV-AVK--RLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLL 411
           +G GG   V++ VL++ K++ A+K   L     Q    + NE+  + KLQ  +  +++L 
Sbjct: 16  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
            + +       +Y  M  G++D   +  +K+ I  W +++   N +      +H   +  
Sbjct: 75  DYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEA----VHTIHQHG 127
Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           IVH DLK +N L+   M  K+ DFG+A               VGT  YM PE A++ + S
Sbjct: 128 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMSS 185
Query: 532 KKS------------DVFSFGVLLIEIITGR 550
            +             DV+S G +L  +  G+
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 34/230 (14%)
Query: 335 QDFFIDLETLNLATSN---FSDSNILGQGGFGPVY------------KGVLSDGKEVAVK 379
           +DF    ET +  T+    F     LG G FG V               +L   K V +K
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 380 RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP 439
           ++            NE  ++  +    LVKL     D     +V E++  G + + L   
Sbjct: 84  QIEHT--------LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           R+ G             I     YLH    L +++RDLK  N+L+D     +++DFG A+
Sbjct: 133 RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
                  +  T  + GT   +APE  +   Y+K  D ++ GVL+ E+  G
Sbjct: 190 -----RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 357 LGQGGFGPVYKGVLSDGKE---VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G FG     ++ D +    VAVK +    E+  A    E++    L+H N+V+    
Sbjct: 27  IGSGNFG--VARLMRDKQSNELVAVKYIER-GEKIAANVKREIINHRSLRHPNIVRFKEV 83
Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
            +      +V E+   G L   + +    G     +       +  G+ Y H    +++ 
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHA---MQVC 137
Query: 474 HRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           HRDLK  N LLD       KI DFG ++    S   +     VGT  Y+APE  ++  Y 
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYD 194
Query: 532 KK-SDVFSFGVLLIEIITG 549
            K +DV+S GV L  ++ G
Sbjct: 195 GKVADVWSCGVTLYVMLVG 213

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 33/252 (13%)
Query: 320 FHYQHVQ----GRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE 375
           F  QH+     G D+D KA       E +++    +S    +G GG   V++ VL++ K+
Sbjct: 25  FERQHMDSPDLGTDDDDKASSSA--NECISVKGRIYSILKQIGSGGSSKVFQ-VLNEKKQ 81
Query: 376 V-AVK--RLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNG 430
           + A+K   L     Q    + NE+  + KLQ  +  +++L  + +       +Y  M  G
Sbjct: 82  IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---YIYMVMECG 138
Query: 431 SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS 490
           ++D   +  +K+ I  W +++   N +      +H   +  IVH DLK +N L+   M  
Sbjct: 139 NIDLNSWLKKKKSIDPWERKSYWKNMLEA----VHTIHQHGIVHSDLKPANFLIVDGM-L 193
Query: 491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS------------DVFS 538
           K+ DFG+A               VG   YM PE A++ + S +             DV+S
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 539 FGVLLIEIITGR 550
            G +L  +  G+
Sbjct: 253 LGCILYYMTYGK 264

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480
           L+V E +  G L + + D R       R+ + I+  I + + YLH    + I HRD+K  
Sbjct: 89  LIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 481 NVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVF 537
           N+L  S   +   K++DFG A+   E+    +      T  Y+APE      Y K  D++
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201
Query: 538 SFGVLLIEIITGRRNAGSNQLLA 560
           S GV++  ++ G     SN  LA
Sbjct: 202 SLGVIMYILLCGYPPFYSNHGLA 224

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           LG+G FG V++ V +  K+  + +              E+ ++   +H+N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 417 GDEKLLVYEFMPN----GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
            +E ++++EF+        ++   F+  +R I+ +      V+ + + + +LH  +   I
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSY------VHQVCEALQFLHSHN---I 123
Query: 473 VHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYG-YMAPEYAMEGL 529
            H D++  N++  +  +S  KI +FG AR         +  R++ T   Y APE     +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 530 YSKKSDVFSFGVLLIEIITG 549
            S  +D++S G L+  +++G
Sbjct: 180 VSTATDMWSLGTLVYVLLSG 199

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            I   I K + +LH  S+L ++HRD+K SNVL+++    K  DFG++    +   +    
Sbjct: 140 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID- 196
Query: 512 RIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGR 550
              G   Y APE     L    YS KSD++S G+  IE+   R
Sbjct: 197 --AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILR 237

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480
           L+V E +  G L + + D R       R+ + I+  I + + YLH    + I HRD+K  
Sbjct: 97  LIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 152
Query: 481 NVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVF 537
           N+L  S   +   K++DFG A+   E+    +      T  Y+APE      Y K  D++
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 209
Query: 538 SFGVLLIEIITGRRNAGSNQLLA 560
           S GV++  ++ G     SN  LA
Sbjct: 210 SLGVIMYILLCGYPPFYSNHGLA 232

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVK------RLSSC--SEQGTAEFTNEVLL 398
           +  +S  + LG G FG V+  V  +  KEV VK       L  C   +    + T E+ +
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF---DPRKRGILCWRKRTNIVN 455
           + +++H N++K+L    +     LV E   +G LD   F    PR    L     + I  
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLA----SYIFR 137
Query: 456 GIAKGMLYLHEDSRLR-IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
            +   + YL    RL+ I+HRD+K  N+++  D   K+ DFG A   A  E         
Sbjct: 138 QLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSA---AYLERGKLFYTFC 190
Query: 515 GTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEII 547
           GT  Y APE  M   Y   + +++S GV L  ++
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480
           L+V E +  G L + + D R       R+ + I+  I + + YLH    + I HRD+K  
Sbjct: 95  LIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 150
Query: 481 NVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVF 537
           N+L  S   +   K++DFG A+   E+    +      T  Y+APE      Y K  D++
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMW 207
Query: 538 SFGVLLIEIITGRRNAGSNQLLA 560
           S GV++  ++ G     SN  LA
Sbjct: 208 SLGVIMYILLCGYPPFYSNHGLA 230

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 25/231 (10%)
Query: 334 AQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAE- 391
           A+ F   ++ + L   +F    ++G+G FG V    + + + + A+K L+       AE 
Sbjct: 59  AKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 118
Query: 392 --FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
             F  E  +++    + +  L     D +   LV ++   G L  +L           + 
Sbjct: 119 ACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLS----------KF 168
Query: 450 RTNIVNGIAK---GMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
              +   +A+   G + L  DS  +L  VHRD+K  NVLLD + + +++DFG   +    
Sbjct: 169 EDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMND 227
Query: 505 EGEANTVRIVGTYGYMAPEY--AME---GLYSKKSDVFSFGVLLIEIITGR 550
           +G   +   VGT  Y++PE   AME   G Y  + D +S GV + E++ G 
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGT 516
           I + +L +    +L  VHRD+K  NVLLD + + +++DFG   +    +G   +   VGT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 255
Query: 517 YGYMAPEY--AME---GLYSKKSDVFSFGVLLIEIITGR 550
             Y++PE   AME   G Y  + D +S GV + E++ G 
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	571
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-119
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-116
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-107
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-84
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-70
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-69
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-66
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-64
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-63
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-63
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-61
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-55
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-53
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-50
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-50
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-50
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-50
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-50
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-50
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-50
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-50
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-49
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-49
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-49
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-49
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-49
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-49
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-49
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-48
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-48
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-48
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-48
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-48
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-48
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-48
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-48
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-48
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-48
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-48
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-48
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-48
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-48
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-48
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-47
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-47
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-47
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-47
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-47
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-47
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-47
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-47
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-47
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-46
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-46
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-46
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-46
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-46
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-46
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-46
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-45
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-45
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-45
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-45
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-42
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-42
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-41
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-41
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-40
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-37
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-36
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-35
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-35
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-34
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-34
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-34
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-34
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-34
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-34
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-33
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-33
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-33
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-33
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-33
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-33
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-33
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-33
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-33
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-32
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-32
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-32
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-32
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-32
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-32
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-31
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-31
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-31
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-31
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-30
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-30
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-30
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-30
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-30
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-30
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-30
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-29
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-29
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-27
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-27
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-25
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-25
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-24
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	4e-24
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	7e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-22
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-21
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-17
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-16
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	9e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	7e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-06
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	6e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  354 bits (910), Expect = e-119
 Identities = 96/227 (42%), Positives = 134/227 (59%), Gaps = 15/227 (6%)

Query: 341 LETLNLATSNFSD------SNILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SEQGTA 390
              L   T+NF +       N +G+GGFG VYKG + +   VAVK+L++     +E+   
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75

Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
           +F  E+ ++ K QH+NLV+LLGF  DGD+  LVY +MPNGSL   L        L W  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             I  G A G+ +LHE+     +HRD+K++N+LLD    +KISDFG+AR   +      T
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557
            RIVGT  YMAPE  + G  + KSD++SFGV+L+EIITG      ++
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  347 bits (893), Expect = e-116
 Identities = 97/214 (45%), Positives = 140/214 (65%), Gaps = 3/214 (1%)

Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGT-AEFTNEVLLI 399
           L  L +A+ NFS+ NILG+GGFG VYKG L+DG  VAVKRL     QG   +F  EV +I
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81

Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIA 458
               H+NL++L GFC+   E+LLVY +M NGS+ + L +  + +  L W KR  I  G A
Sbjct: 82  SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           +G+ YLH+    +I+HRD+KA+N+LLD +  + + DFG+A++    +    T  + GT G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIG 200

Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN 552
           ++APEY   G  S+K+DVF +GV+L+E+ITG+R 
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  324 bits (833), Expect = e-107
 Identities = 86/213 (40%), Positives = 131/213 (61%), Gaps = 4/213 (1%)

Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLIL 400
           L  L  AT+NF    ++G G FG VYKGVL DG +VA+KR +  S QG  EF  E+  + 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90

Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAK 459
             +H +LV L+GFC + +E +L+Y++M NG+L   L+        + W +R  I  G A+
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           G+ YLH  +   I+HRD+K+ N+LLD +   KI+DFG+++   E +    +  + GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN 552
           + PEY ++G  ++KSDV+SFGV+L E++  R  
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  265 bits (679), Expect = 1e-84
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 22/233 (9%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
           +  E L   +       +  +G FG V+K  L   + VAVK      +Q   +   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71

Query: 399 ILKLQHKNLVKLLGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           +  ++H+N+++ +G    G     +  L+  F   GSL   L    K  ++ W +  +I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 455 NGIAKGMLYLHED-------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
             +A+G+ YLHED        +  I HRD+K+ NVLL +++ + I+DFG+A  F   +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 508 ANTVRIVGTYGYMAPEYAMEGL-----YSKKSDVFSFGVLLIEIITGRRNAGS 555
            +T   VGT  YMAPE     +        + D+++ G++L E+ +    A  
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  228 bits (582), Expect = 4e-70
 Identities = 66/245 (26%), Positives = 105/245 (42%), Gaps = 34/245 (13%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--V 396
                 +L   N     ++G+G +G VYKG L D + VAVK  S  + Q    F NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 397 LLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
             +  ++H N+ + +            E LLV E+ PNGSL   L          W    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114

Query: 452 NIVNGIAKGMLYLHED------SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES- 504
            + + + +G+ YLH +       +  I HRDL + NVL+ +D    ISDFG++     + 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 505 -----EGEANTVRIVGTYGYMAPEYAMEGL-------YSKKSDVFSFGVLLIEIITGRRN 552
                E +   +  VGT  YMAPE     +         K+ D+++ G++  EI     +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 553 AGSNQ 557
               +
Sbjct: 235 LFPGE 239

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  223 bits (571), Expect = 8e-69
 Identities = 72/221 (32%), Positives = 113/221 (51%), Gaps = 13/221 (5%)

Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGT 389
           +   D  I    LN+          +G G FG V++     G +VAVK L       +  
Sbjct: 27  MDGDDMDIPWCDLNI-------KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERV 78

Query: 390 AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK 449
            EF  EV ++ +L+H N+V  +G         +V E++  GSL  +L     R  L  R+
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138

Query: 450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN 509
           R ++   +AKGM YLH      IVHR+LK+ N+L+D     K+ DFG++R+  ++    +
Sbjct: 139 RLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLS 195

Query: 510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           +    GT  +MAPE   +   ++KSDV+SFGV+L E+ T +
Sbjct: 196 SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  217 bits (556), Expect = 1e-66
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
            +LG+G FG   K      G+ + +K L    E+    F  EV ++  L+H N++K +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
                    + E++  G+L  I+     +    W +R +    IA GM YLH    + I+
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNII 130

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR------------IVGTYGYMA 521
           HRDL + N L+  + N  ++DFG+AR+  + + +   +R            +VG   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           PE      Y +K DVFSFG++L EII    
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  217 bits (554), Expect = 3e-66
 Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 18/214 (8%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL 398
           ID + + +         ++G+G FG V K      K+VA+K++ S  E     F  E+  
Sbjct: 5   IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQ 54

Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           + ++ H N+VKL G C++     LV E+   GSL  +L               +     +
Sbjct: 55  LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTY 517
           +G+ YLH      ++HRDLK  N+LL +     KI DFG A      + + +     G+ 
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSA 167

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
            +MAPE      YS+K DVFS+G++L E+IT R+
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  211 bits (540), Expect = 1e-64
 Identities = 77/224 (34%), Positives = 112/224 (50%), Gaps = 28/224 (12%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTA----EFTN 394
           ID   L L         I+G GGFG VY+     G EVAVK      ++  +        
Sbjct: 4   IDFAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55

Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           E  L   L+H N++ L G C+      LV EF   G L+ +L   R    +      N  
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWA 111

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--------KISDFGMARIFAESEG 506
             IA+GM YLH+++ + I+HRDLK+SN+L+   + +        KI+DFG+AR +  +  
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171

Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            +      G Y +MAPE     ++SK SDV+S+GVLL E++TG 
Sbjct: 172 MSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  207 bits (530), Expect = 6e-63
 Identities = 71/234 (30%), Positives = 113/234 (48%), Gaps = 22/234 (9%)

Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL- 381
            H     +   A D+ I    + +          +G G FG VYKG      +VAVK L 
Sbjct: 5   HHHHHHGSRDAADDWEIPDGQITVG-------QRIGSGSFGTVYKGKWHG--DVAVKMLN 55

Query: 382 -SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDP 439
            ++ + Q    F NEV ++ K +H N++  +G+      +L +V ++    SL   L   
Sbjct: 56  VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHAS 113

Query: 440 RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
             +     +K  +I    A+GM YLH      I+HRDLK++N+ L  D   KI DFG+A 
Sbjct: 114 ETK--FEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168

Query: 500 IFAESEGEANTVRIVGTYGYMAPE---YAMEGLYSKKSDVFSFGVLLIEIITGR 550
             +   G     ++ G+  +MAPE         YS +SDV++FG++L E++TG+
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  206 bits (527), Expect = 8e-63
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 26/220 (11%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEV 396
           ID + LN           L +   G ++KG    G ++ VK L     S + + +F  E 
Sbjct: 7   IDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
             +    H N++ +LG C          +  +MP GSL  +L +     ++   +     
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFA 117

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             +A+GM +LH    L I    L + +V++D DM ++IS   +   F            +
Sbjct: 118 LDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------M 169

Query: 515 GTYGYMAPEYAMEG----LYSKKSDVFSFGVLLIEIITGR 550
               ++APE A++        + +D++SF VLL E++T  
Sbjct: 170 YAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  207 bits (528), Expect = 9e-63
 Identities = 68/228 (29%), Positives = 110/228 (48%), Gaps = 32/228 (14%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTA------- 390
           +    +            +G+GGFG V+KG  + D   VA+K L     +G         
Sbjct: 16  LADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ 68

Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
           EF  EV ++  L H N+VKL G   +     +V EF+P G L   L D      + W  +
Sbjct: 69  EFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IKWSVK 124

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMARIFAESE 505
             ++  IA G+ Y+  +    IVHRDL++ N+ L S      + +K++DFG+++    S 
Sbjct: 125 LRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS- 182

Query: 506 GEANTVRIVGTYGYMAPE--YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
                  ++G + +MAPE   A E  Y++K+D +SF ++L  I+TG  
Sbjct: 183 ----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  203 bits (519), Expect = 4e-61
 Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 29/239 (12%)

Query: 326 QGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--SS 383
           +     +  Q++ I  E L +         ++G+G FG VY G      EVA++ +    
Sbjct: 17  KASQTSIFLQEWDIPFEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIER 67

Query: 384 CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
            +E     F  EV+   + +H+N+V  +G C+      ++       +L +++ D +   
Sbjct: 68  DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV- 126

Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE 503
            L   K   I   I KGM YLH      I+H+DLK+ NV  D +    I+DFG+  I   
Sbjct: 127 -LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181

Query: 504 SEGEANTVRI---VGTYGYMAPE---------YAMEGLYSKKSDVFSFGVLLIEIITGR 550
            +      ++    G   ++APE            +  +SK SDVF+ G +  E+    
Sbjct: 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  191 bits (488), Expect = 9e-57
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--VLLILKLQHKNLVKLLG 412
             +G+G +G V++G    G+ VAVK  SS   +    +  E  +   + L+H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
             +          L+  +   GSL   L    +   L       IV  IA G+ +LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 469 RLR-----IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI--VGTYGYMA 521
                   I HRDLK+ N+L+  +    I+D G+A + ++S  + +      VGT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 522 PE------YAMEGLYSKKSDVFSFGVLLIEIITGRRNAG 554
           PE              K+ D+++FG++L E+     + G
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  189 bits (483), Expect = 1e-55
 Identities = 53/230 (23%), Positives = 94/230 (40%), Gaps = 34/230 (14%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--V 396
              + + +          +G+G +G V+ G    G++VAVK   +      A +  E  +
Sbjct: 34  TIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEI 82

Query: 397 LLILKLQHKNLVKLLGFCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
              + ++H+N++  +   + G        L+ ++  NGSL   L    K   L  +    
Sbjct: 83  YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLK 138

Query: 453 IVNGIAKGMLYLHEDSRLR-----IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE 507
           +      G+ +LH +         I HRDLK+ N+L+  +    I+D G+A  F     E
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198

Query: 508 ANTVRI--VGTYGYMAPE------YAMEGLYSKKSDVFSFGVLLIEIITG 549
            +      VGT  YM PE                +D++SFG++L E+   
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  185 bits (471), Expect = 2e-53
 Identities = 67/201 (33%), Positives = 94/201 (46%), Gaps = 21/201 (10%)

Query: 357 LGQGGFGPVYKGVL-SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +G+G FG V+ G L +D   VAVK    +      A+F  E  ++ +  H N+V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
                  +V E +  G     L   R  G  L  +    +V   A GM YL        +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAPEYAME 527
           HRDL A N L+      KISDFGM+R  A+    A+       V+      + APE    
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK------WTAPEALNY 289

Query: 528 GLYSKKSDVFSFGVLLIEIIT 548
           G YS +SDV+SFG+LL E  +
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  183 bits (466), Expect = 3e-53
 Identities = 56/221 (25%), Positives = 97/221 (43%), Gaps = 29/221 (13%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNE--VLLILKLQHKNLVKLLG 412
             +G+G FG V++G    G+EVAVK  SS  E+    +  E  +   + L+H+N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 103

Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED- 467
                +       LV ++  +GSL   L     R  +       +    A G+ +LH + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 468 ----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI--VGTYGYMA 521
                +  I HRDLK+ N+L+  +    I+D G+A     +    +      VGT  YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 522 PEYAMEGL-------YSKKSDVFSFGVLLIEIITGRRNAGS 555
           PE  ++           K++D+++ G++  EI       G 
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  176 bits (448), Expect = 1e-50
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 25/210 (11%)

Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
            +LG G FG VYKG+     E     VA+K L  + S +   E  +E  ++  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +LLG C+      L+ + MP G L   + + +    +  +   N    IAKGM YL    
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAP 522
             R+VHRDL A NVL+ +  + KI+DFG+A++    E E +       ++      +MA 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------WMAL 188

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
           E  +  +Y+ +SDV+S+GV + E++T G +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  175 bits (445), Expect = 1e-50
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 25/208 (12%)

Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
             LG+G FG V          + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
             G C     +   L+ E++P GSL   L   + +  +   K     + I KGM YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 132

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYM 520
              R +HRDL   N+L++++   KI DFG+ ++  + +            +       + 
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------WY 184

Query: 521 APEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           APE   E  +S  SDV+SFGV+L E+ T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  174 bits (443), Expect = 2e-50
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
             LG G FG V  G      +VA+K +   S     EF  E  +++ L H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
                  ++ E+M NG L   L     R     ++   +   + + M YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
           RDL A N L++     K+SDFG++R   + E  ++      VR      +  PE  M   
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLMYSK 197

Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
           +S KSD+++FGVL+ EI + G+ 
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKM 220

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  175 bits (446), Expect = 2e-50
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 21/206 (10%)

Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           + LG+G FG V          + G  VAVK+L         +F  E+ ++  L    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
             G       +   LV E++P+G L   L   R R  L   +     + I KGM YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAP 522
              R VHRDL A N+L++S+ + KI+DFG+A++    +       +V   G     + AP
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   + ++S++SDV+SFGV+L E+ T
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFT 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  175 bits (446), Expect = 2e-50
 Identities = 66/206 (32%), Positives = 101/206 (49%), Gaps = 21/206 (10%)

Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
             LG+G FG V          + G+ VAVK+L   +E+   +F  E+ ++  LQH N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 410 LLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
             G C     +   L+ E++P GSL   L   + +  +   K     + I KGM YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT- 163

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMAP 522
              R +HRDL   N+L++++   KI DFG+ ++  + +        V   G     + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT 548
           E   E  +S  SDV+SFGV+L E+ T
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  174 bits (443), Expect = 3e-50
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 30/230 (13%)

Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
           + +D  I  E +           ++G+G FG VY G   D  +     A+K L      Q
Sbjct: 10  EVKDVLIPHERVVT-----HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64

Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVYEFMPNGSLDAILFDPRKRGILC 446
               F  E LL+  L H N++ L+G  +  +    ++  +M +G L   +  P++     
Sbjct: 65  QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN--PT 122

Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE- 505
            +   +    +A+GM YL   +  + VHRDL A N +LD     K++DFG+AR   + E 
Sbjct: 123 VKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179

Query: 506 --GEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              + +      V+      + A E      ++ KSDV+SFGVLL E++T
Sbjct: 180 YSVQQHRHARLPVK------WTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  172 bits (438), Expect = 6e-50
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
             +G G FG V+ G   +  +VA+K +   +     +F  E  +++KL H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           ++     LV EFM +G L   L    +RG+        +   + +GM YL       ++H
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIH 127

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
           RDL A N L+  +   K+SDFGM R   + +  ++T     V+      + +PE      
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVFSFSR 181

Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
           YS KSDV+SFGVL+ E+ + G+ 
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI 204

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  174 bits (442), Expect = 8e-50
 Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 25/210 (11%)

Query: 356 ILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           ++G G FG VYKG+L          VA+K L +  +E+   +F  E  ++ +  H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G        +++ E+M NG+LD  L +          +   ++ GIA GM YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---AN 165

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYMAP 522
           +  VHRDL A N+L++S++  K+SDFG++R+  +      T       +R      + AP
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR------WTAP 219

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
           E      ++  SDV+SFG+++ E++T G R
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  172 bits (439), Expect = 1e-49
 Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 34/217 (15%)

Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LG+G FG V+     +         VAVK L   +     +F  E  L+  LQH+++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIVNGI 457
            G C DGD  ++V+E+M +G L+  L                + +G L   +  +I + I
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE---GEANT---V 511
           A GM+YL   +    VHRDL   N L+ +++  KI DFGM+R    ++      +T   +
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           R      +M PE  M   ++ +SDV+SFGV+L EI T
Sbjct: 200 R------WMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  173 bits (441), Expect = 1e-49
 Identities = 69/210 (32%), Positives = 107/210 (50%), Gaps = 24/210 (11%)

Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
            I+G G  G V  G L    +    VA+K L +  +E+   +F +E  ++ +  H N+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L G    G   ++V E+M NGSLD  L     +      +   ++ G+  GM YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYMAP 522
           L  VHRDL A NVL+DS++  K+SDFG++R+  +    A T       +R      + AP
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR------WTAP 223

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
           E      +S  SDV+SFGV++ E++  G R
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  172 bits (438), Expect = 1e-49
 Identities = 67/228 (29%), Positives = 101/228 (44%), Gaps = 26/228 (11%)

Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
             Q   I   +L +       + ++G+G FG VY G L D        AVK L       
Sbjct: 14  AVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68

Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILC 446
             ++F  E +++    H N++ LLG C+  +   L V  +M +G L   + +        
Sbjct: 69  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 126

Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
            +        +AKGM YL      + VHRDL A N +LD     K++DFG+AR   + E 
Sbjct: 127 VKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE- 182

Query: 507 EANTVRIVGTYG------YMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                 +    G      +MA E      ++ KSDV+SFGVLL E++T
Sbjct: 183 ---YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  172 bits (438), Expect = 1e-49
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 30/232 (12%)

Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
             LG+G FG V          + G++VAVK L         A+   E+ ++  L H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 409 KLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           K  G C +       L+ EF+P+GSL   L  P+ +  +  +++      I KGM YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGY 519
               + VHRDL A NVL++S+   KI DFG+ +     +            V       +
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------W 195

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLAYGM---YWSW 567
            APE  M+  +   SDV+SFGV L E++T    ++    L    +   +   
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  173 bits (440), Expect = 2e-49
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 33/218 (15%)

Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
             LG+G FG V+     +         VAVK L   SE    +F  E  L+  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAIL------------FDPRKRGILCWRKRTNIVNG 456
           +  G C +G   L+V+E+M +G L+  L             +    G L   +   + + 
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-----GEANT- 510
           +A GM+YL   + L  VHRDL   N L+   +  KI DFGM+R    ++     G     
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           +R      +M PE  +   ++ +SDV+SFGV+L EI T
Sbjct: 224 IR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  171 bits (435), Expect = 2e-49
 Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 356 ILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
            LG G FG V  G      +VAVK +   S     EF  E   ++KL H  LVK  G C 
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRG-ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
                 +V E++ NG L   L   R  G  L   +   +   + +GM +L      + +H
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
           RDL A N L+D D+  K+SDFGM R   + +  ++      V+      + APE      
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WSAPEVFHYFK 181

Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
           YS KSDV++FG+L+ E+ + G+ 
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKM 204

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  170 bits (433), Expect = 8e-49
 Identities = 67/233 (28%), Positives = 108/233 (46%), Gaps = 32/233 (13%)

Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGK---EVAVKRL--SSCSE 386
           ++ ++ ++D + L L          LG G FG V KG     K    VAVK L   +   
Sbjct: 6   IRPKEVYLDRKLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP 59

Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
               E   E  ++ +L +  +V+++G C + +  +LV E    G L+  L   ++   + 
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVK 115

Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
            +    +V+ ++ GM YL        VHRDL A NVLL +   +KISDFG+++     E 
Sbjct: 116 DKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

Query: 507 EANT-------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
                      V+      + APE      +S KSDV+SFGVL+ E  + G++
Sbjct: 173 YYKAQTHGKWPVK------WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  170 bits (432), Expect = 1e-48
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 18/204 (8%)

Query: 355 NILGQGGFGPVYKGVLSDGK-EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
           C       ++ EFM  G+L   L +   R  +       +   I+  M YL    +   +
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEG 528
           HRDL A N L+  +   K++DFG++R+       A+      ++      + APE     
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYN 187

Query: 529 LYSKKSDVFSFGVLLIEIIT-GRR 551
            +S KSDV++FGVLL EI T G  
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMS 211

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  172 bits (437), Expect = 1e-48
 Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 26/211 (12%)

Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
            ++G G FG V  G L    +    VA+K L    +E+   +F  E  ++ +  H N+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLYLHEDS 468
           L G        ++V E+M NGSLD+ L   RK        +   ++ GIA GM YL   S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-------VRIVGTYGYMA 521
            +  VHRDL A N+L++S++  K+SDFG+ R+  +    A T       +R      + +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR------WTS 218

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
           PE      ++  SDV+S+G++L E+++ G R
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  170 bits (433), Expect = 1e-48
 Identities = 68/207 (32%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 355 NILGQGGFGPVYKGVL-----SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
             LG+G FG V            G+ VAVK L +    Q  + +  E+ ++  L H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 409 KLLGFCVDGDEK--LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           K  G C D       LV E++P GSL   L    +   +   +       I +GM YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHS-IGLAQLLLFAQQICEGMAYLHA 152

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG-----YMA 521
                 +HRDL A NVLLD+D   KI DFG+A+   E          V   G     + A
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           PE   E  +   SDV+SFGV L E++T
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  169 bits (431), Expect = 1e-48
 Identities = 68/220 (30%), Positives = 99/220 (45%), Gaps = 35/220 (15%)

Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
             LG+  FG VYKG L           VA+K L          EF +E +L  +LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIV 454
           V LLG         +++ +  +G L   L              D   +  L      ++V
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT--- 510
             IA GM YL   S   +VH+DL   NVL+   +N KISD G+ R ++A    +      
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 511 --VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             +R      +MAPE  M G +S  SD++S+GV+L E+ +
Sbjct: 192 LPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  169 bits (431), Expect = 1e-48
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 29/214 (13%)

Query: 356 ILGQGGFGPVYKGVLSDGK--------EVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
            LGQG F  ++KGV  +          EV +K L       +  F     ++ KL HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           V   G CV GDE +LV EF+  GSLD  L   + +  +    +  +   +A  M +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 468 SRLRIVHRDLKASNVLLDSDMNS--------KISDFGMARIFAESEGEANTVRIVGTYGY 519
               ++H ++ A N+LL  + +         K+SD G++      +     +       +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP------W 183

Query: 520 MAPEYAMEG-LYSKKSDVFSFGVLLIEIIT-GRR 551
           + PE        +  +D +SFG  L EI + G +
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  168 bits (429), Expect = 2e-48
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 30/229 (13%)

Query: 335 QDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE---VAVKRL-SSCSEQGTA 390
           +  F+  + L +          LG G FG V +GV    K+   VA+K L     +  T 
Sbjct: 2   KKLFLKRDNLLI------ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 55

Query: 391 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR 450
           E   E  ++ +L +  +V+L+G C   +  +LV E    G L   L   R+   +     
Sbjct: 56  EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNV 112

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             +++ ++ GM YL        VHRDL A NVLL +   +KISDFG+++     +     
Sbjct: 113 AELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169

Query: 511 -------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
                  ++      + APE      +S +SDV+S+GV + E ++ G++
Sbjct: 170 RSAGKWPLK------WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  169 bits (431), Expect = 2e-48
 Identities = 67/248 (27%), Positives = 112/248 (45%), Gaps = 29/248 (11%)

Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----V 376
           H+ H         +++    LE + +  +      ILG+G FG V +G L         V
Sbjct: 6   HHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKV 65

Query: 377 AVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPN 429
           AVK +   + S++   EF +E   +    H N+++LLG C++       + +++  FM  
Sbjct: 66  AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125

Query: 430 GSLDAILFDPRKRG---ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS 486
           G L   L   R       +  +     +  IA GM YL   S    +HRDL A N +L  
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRD 182

Query: 487 DMNSKISDFGMAR-IFAESEGEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFG 540
           DM   ++DFG+++ I++             V+      ++A E   + +Y+ KSDV++FG
Sbjct: 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFG 236

Query: 541 VLLIEIIT 548
           V + EI T
Sbjct: 237 VTMWEIAT 244

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  169 bits (431), Expect = 3e-48
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 25/210 (11%)

Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
            +LG G FG VYKG+     E     VA+K L  + S +   E  +E  ++  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +LLG C+      L+ + MP G L   + + +    +  +   N    IAKGM YL    
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAP 522
             R+VHRDL A NVL+ +  + KI+DFG+A++    E E +       ++      +MA 
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------WMAL 188

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
           E  +  +Y+ +SDV+S+GV + E++T G +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  169 bits (431), Expect = 3e-48
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 30/215 (13%)

Query: 355 NILGQGGFGPVYKGVLSDGKE----VAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLV 408
            +LG+G FG V +  L         VAVK L     +     EF  E   + +  H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 409 KLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPR---KRGILCWRKRTNIVNGIAK 459
           KL+G  +    K      +++  FM +G L A L   R       L  +     +  IA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT-----VRI 513
           GM YL   S    +HRDL A N +L  DM   ++DFG++R I++             V+ 
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204

Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                ++A E   + LY+  SDV++FGV + EI+T
Sbjct: 205 -----WLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  170 bits (433), Expect = 5e-48
 Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 30/230 (13%)

Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQ 387
             Q   I   +L +       + ++G+G FG VY G L D        AVK L       
Sbjct: 78  AVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132

Query: 388 GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMPNGSLDAILFDPRKRGILC 446
             ++F  E +++    H N++ LLG C+  +   L V  +M +G L   + +        
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 190

Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
            +        +AKGM +L   +  + VHRDL A N +LD     K++DFG+AR   + E 
Sbjct: 191 VKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247

Query: 507 EANT--------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           ++          V+      +MA E      ++ KSDV+SFGVLL E++T
Sbjct: 248 DSVHNKTGAKLPVK------WMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  169 bits (429), Expect = 6e-48
 Identities = 70/214 (32%), Positives = 102/214 (47%), Gaps = 29/214 (13%)

Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
             LGQG FG VY+GV     +      VA+K +  + S +   EF NE  ++ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------FDPRKRGILCWRKRTNIVNGIAKG 460
           V+LLG    G   L++ E M  G L + L        +          K   +   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE-----GEANT-VRIV 514
           M YL+     + VHRDL A N ++  D   KI DFGM R   E++     G+    VR  
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205

Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +M+PE   +G+++  SDV+SFGV+L EI T
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  167 bits (425), Expect = 7e-48
 Identities = 70/203 (34%), Positives = 106/203 (52%), Gaps = 18/203 (8%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
             LG G FG V+ G  +   +VAVK L   S      F  E  L+ +LQH+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYA-V 76

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
           V  +   ++ E+M NGSL   L        L   K  ++   IA+GM ++        +H
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
           RDL+A+N+L+   ++ KI+DFG+AR+  ++E  A       ++      + APE    G 
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAINYGT 186

Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
           ++ KSDV+SFG+LL EI+T GR 
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI 209

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  167 bits (425), Expect = 7e-48
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 30/231 (12%)

Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSE 386
              +D+ I  E + L          +G+G FG V++G+    +     VA+K   +  S+
Sbjct: 5   SSTRDYEIQRERIEL-------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD 57

Query: 387 QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILC 446
               +F  E L + +  H ++VKL+G     +   ++ E    G L + L   +    L 
Sbjct: 58  SVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS--LD 114

Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
                     ++  + YL      R VHRD+ A NVL+ S+   K+ DFG++R   +S  
Sbjct: 115 LASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171

Query: 507 EANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
              +     ++      +MAPE      ++  SDV+ FGV + EI+  G +
Sbjct: 172 YKASKGKLPIK------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  168 bits (428), Expect = 7e-48
 Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 43/228 (18%)

Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
             LG+G FG V K      K       VAVK L  + S     +  +E  ++ ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----------- 456
           +KL G C      LL+ E+   GSL   L + RK G        +  +            
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 457 ----------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE 505
                     I++GM YL   + +++VHRDL A N+L+      KISDFG++R ++ E  
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 506 GEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               +     V+      +MA E   + +Y+ +SDV+SFGVLL EI+T
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  166 bits (424), Expect = 9e-48
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 18/201 (8%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
             +G+G FG V  G    G +VAVK + +  + Q    F  E  ++ +L+H NLV+LLG 
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGV 82

Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
            V+    L +V E+M  GSL   L   R R +L           + + M YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-VRIVGTYGYMAPEYAMEGLYS 531
           VHRDL A NVL+  D  +K+SDFG+ +  + ++      V+      + APE   E  +S
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 192

Query: 532 KKSDVFSFGVLLIEIIT-GRR 551
            KSDV+SFG+LL EI + GR 
Sbjct: 193 TKSDVWSFGILLWEIYSFGRV 213

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  167 bits (425), Expect = 1e-47
 Identities = 67/235 (28%), Positives = 95/235 (40%), Gaps = 34/235 (14%)

Query: 332 LKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL--SDGKE--VAVKRL---SSC 384
           L++    I  + L L          LG G FG V +G      GK   VAVK L      
Sbjct: 8   LQSLTCLIGEKDLRL-------LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS 60

Query: 385 SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI 444
             +   +F  EV  +  L H+NL++L G  +      +V E  P GSL   L   +    
Sbjct: 61  QPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH-- 117

Query: 445 LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES 504
                 +     +A+GM YL      R +HRDL A N+LL +    KI DFG+ R   ++
Sbjct: 118 FLLGTLSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174

Query: 505 EGEANT-------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
           +                    + APE      +S  SD + FGV L E+ T G+ 
Sbjct: 175 DDHYVMQEHRKVPFA------WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  168 bits (427), Expect = 1e-47
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 25/210 (11%)

Query: 355 NILGQGGFGPVYKGVLSDGKE-----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLV 408
            +LG G FG V+KGV     E     V +K +      Q     T+ +L I  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +LLG C  G    LV +++P GSL   +     RG L  +   N    IAKGM YL    
Sbjct: 79  RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT------VRIVGTYGYMAP 522
              +VHR+L A NVLL S    +++DFG+A +    + +         ++      +MA 
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK------WMAL 186

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIIT-GRR 551
           E    G Y+ +SDV+S+GV + E++T G  
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  168 bits (427), Expect = 1e-47
 Identities = 71/213 (33%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 355 NILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
             LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLY 463
           V+ +G  +    + ++ E M  G L + L + R    +   L      ++   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 464 LHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAESEGEANTVRIVGTYGY- 519
           L        +HRD+ A N LL        +KI DFGMAR    +          G     
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAML 207

Query: 520 ----MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               M PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  168 bits (428), Expect = 2e-47
 Identities = 73/292 (25%), Positives = 120/292 (41%), Gaps = 41/292 (14%)

Query: 289 FFATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLN--- 345
              TK+I  +R+ T   +       +        +     D  + A     +L       
Sbjct: 18  HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWE 77

Query: 346 LATSNFSDSNILGQGGFGPVYKGVLSDGKE--------VAVKRL-SSCSEQGTAEFTNEV 396
                 +    LG+G FG V         +        VAVK L    +E+  ++  +E+
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137

Query: 397 LLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
            ++  + +HKN++ LLG C       ++ E+   G+L   L   R  G+        +  
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 456 G-------------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IF 501
                         +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR I 
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254

Query: 502 AESEGEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +  T     V+      +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 255 NIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  167 bits (425), Expect = 2e-47
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 38/223 (17%)

Query: 355 NILGQGGFGPVYKGVLSDGKE--------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QH 404
             LG+G FG V         +        VAVK L    +E+  ++  +E+ ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-------- 456
           KN++ LLG C       ++ E+   G+L   L   R  G+        +           
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT 510
                +A+GM YL   +  + +HRDL A NVL+  +   KI+DFG+AR I      +  T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 511 -----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                V+      +MAPE   + +Y+ +SDV+SFGVL+ EI T
Sbjct: 218 NGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  167 bits (426), Expect = 4e-47
 Identities = 71/213 (33%), Positives = 99/213 (46%), Gaps = 27/213 (12%)

Query: 355 NILGQGGFGPVYKGVLSDGK------EVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
             LG G FG VY+G +S         +VAVK L   CSEQ   +F  E L+I K  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLY 463
           V+ +G  +    + ++ E M  G L + L + R    +   L      ++   IA G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 464 LHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAESEGEANTVRIVGTYGY- 519
           L        +HRD+ A N LL        +KI DFGMAR    +          G     
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAML 248

Query: 520 ----MAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               M PE  MEG+++ K+D +SFGVLL EI +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  165 bits (420), Expect = 4e-47
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 23/207 (11%)

Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           ILG+G FG VY+GV ++ K     VAVK     C+     +F +E +++  L H ++VKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           +G   + +   ++ E  P G L   L   +    L           I K M YL     +
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYL---ESI 132

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYA 525
             VHRD+   N+L+ S    K+ DFG++R   + +    +     ++      +M+PE  
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSPESI 186

Query: 526 MEGLYSKKSDVFSFGVLLIEIIT-GRR 551
               ++  SDV+ F V + EI++ G++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQ 213

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  166 bits (423), Expect = 6e-47
 Identities = 64/228 (28%), Positives = 98/228 (42%), Gaps = 43/228 (18%)

Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNL 407
             +G+G FG V++              VAVK L    S    A+F  E  L+ +  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG----------- 456
           VKLLG C  G    L++E+M  G L+  L       +                       
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 457 ----------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESE 505
                     +A GM YL   S  + VHRDL   N L+  +M  KI+DFG++R I++   
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 506 GEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            +A+      +R      +M PE      Y+ +SDV+++GV+L EI +
Sbjct: 230 YKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  166 bits (422), Expect = 7e-47
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 30/215 (13%)

Query: 355 NILGQGGFGPVYKGVLSDGKE---VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
           +++G+G FG V K  +         A+KR+    S+    +F  E+ ++ KL  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKRTNIVNG 456
           LLG C       L  E+ P+G+L   L                     L  ++  +    
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT---VRI 513
           +A+GM YL   S+ + +HRDL A N+L+  +  +KI+DFG++R       +      VR 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 206

Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                +MA E     +Y+  SDV+S+GVLL EI++
Sbjct: 207 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  169 bits (429), Expect = 2e-46
 Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 7/195 (3%)

Query: 355 NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
           C       ++ EFM  G+L   L +  ++  +       +   I+  M YL    +   +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           HR+L A N L+  +   K++DFG++R+       A+         + APE      +S K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399

Query: 534 SDVFSFGVLLIEIIT 548
           SDV++FGVLL EI T
Sbjct: 400 SDVWAFGVLLWEIAT 414

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  164 bits (418), Expect = 2e-46
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 37/222 (16%)

Query: 355 NILGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
             LG+G FG V +         +  + VAVK L    +        +E+ +++ +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 407 LVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--------- 456
           +V LLG C      L+V  EF   G+L   L   R   +       ++            
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 457 ----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT- 510
               +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR I+ + +      
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 511 ----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
               ++      +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 210 ARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  167 bits (426), Expect = 2e-46
 Identities = 71/201 (35%), Positives = 102/201 (50%), Gaps = 18/201 (8%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
             +G+G FG V  G    G +VAVK + +  + Q    F  E  ++ +L+H NLV+LLG 
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGV 254

Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
            V+    L +V E+M  GSL   L   R R +L           + + M YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TVRIVGTYGYMAPEYAMEGLYS 531
           VHRDL A NVL+  D  +K+SDFG+ +  + ++      V+      + APE   E  +S
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 364

Query: 532 KKSDVFSFGVLLIEIIT-GRR 551
            KSDV+SFG+LL EI + GR 
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV 385

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  163 bits (416), Expect = 3e-46
 Identities = 64/223 (28%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
             LG G FG V +       +      VAVK L  S          +E+ ++  L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
           +V LLG C  G   L++ E+   G L   L   R   I        + +           
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT 510
                +AKGM +L   +    +HRDL A N+LL     +KI DFG+AR I  +S      
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 511 -----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                V+      +MAPE     +Y+ +SDV+S+G+ L E+ +
Sbjct: 206 NARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  164 bits (417), Expect = 4e-46
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 34/219 (15%)

Query: 355 NILGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
             LG G FG V +       +      VAVK L S+          +E+ ++  L QH+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-----------DAILFDPRKRGILCWRKRTNIVN 455
           +V LLG C  G   L++ E+   G L           +              R   +  +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT---- 510
            +A+GM +L   +    +HRD+ A NVLL +   +KI DFG+AR I  +S          
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 511 -VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
            V+      +MAPE   + +Y+ +SDV+S+G+LL EI +
Sbjct: 229 PVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  167 bits (425), Expect = 4e-46
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 18/203 (8%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
             LG G FG V+    +   +VAVK +   S      F  E  ++  LQH  LVKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
              +   ++ EFM  GSL   L    +       K  +    IA+GM ++    +   +H
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYAMEGL 529
           RDL+A+N+L+ + +  KI+DFG+AR+  ++E  A       ++      + APE    G 
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGS 361

Query: 530 YSKKSDVFSFGVLLIEIIT-GRR 551
           ++ KSDV+SFG+LL+EI+T GR 
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRI 384

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  170 bits (431), Expect = 5e-46
 Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 30/242 (12%)

Query: 322 YQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE---VAV 378
           ++       +LK +  F+  + L +A         LG G FG V +GV    K+   VA+
Sbjct: 315 FESPFSDPEELKDKKLFLKRDNLLIA------DIELGCGNFGSVRQGVYRMRKKQIDVAI 368

Query: 379 KRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILF 437
           K L     +  T E   E  ++ +L +  +V+L+G C   +  +LV E    G L   L 
Sbjct: 369 KVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV 427

Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM 497
             R+   +       +++ ++ GM YL        VHR+L A NVLL +   +KISDFG+
Sbjct: 428 GKREE--IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482

Query: 498 ARIFAESEGEANT-------VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-G 549
           ++     +            ++      + APE      +S +SDV+S+GV + E ++ G
Sbjct: 483 SKALGADDSYYTARSAGKWPLK------WYAPECINFRKFSSRSDVWSYGVTMWEALSYG 536

Query: 550 RR 551
           ++
Sbjct: 537 QK 538

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  164 bits (416), Expect = 1e-45
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 38/221 (17%)

Query: 357 LGQGGFGPVYKGVLSDGK--------EVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
           LG+G FG V                 +VAVK L S  +E+  ++  +E+ ++  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---------- 456
           ++ LLG C       ++ E+   G+L   L   R  G+      ++              
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 457 ---IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGEANT-- 510
              +A+GM YL   +  + +HRDL A NVL+  D   KI+DFG+AR I      +  T  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 511 ---VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
              V+      +MAPE   + +Y+ +SDV+SFGVLL EI T
Sbjct: 254 RLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  162 bits (413), Expect = 2e-45
 Identities = 78/286 (27%), Positives = 120/286 (41%), Gaps = 53/286 (18%)

Query: 297 RKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNI 356
            K++     Q+Q+ ++  ++D ++ Y   +  + DLK   +    E L           +
Sbjct: 3   YKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLK---WEFPRENLEFG-------KV 52

Query: 357 LGQGGFGPVYKGVLSDGKE------VAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKNLV 408
           LG G FG V         +      VAVK L             +E+ ++ +L  H+N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG------------ 456
            LLG C       L++E+   G L   L   R++      +  N                
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 457 --------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-IFAESEGE 507
                   +AKGM +L        VHRDL A NVL+      KI DFG+AR I ++S   
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 508 ANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                   V+      +MAPE   EG+Y+ KSDV+S+G+LL EI +
Sbjct: 230 VRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  166 bits (422), Expect = 4e-45
 Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 7/194 (3%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
             LGQG FG V+ G  +    VA+K L   +      F  E  ++ KL+H+ LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            + +   +V E+M  GSL   L        L   +  ++   IA GM Y+    R+  VH
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           RDL+A+N+L+  ++  K++DFG+AR+  ++E  A          + APE A+ G ++ KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445

Query: 535 DVFSFGVLLIEIIT 548
           DV+SFG+LL E+ T
Sbjct: 446 DVWSFGILLTELTT 459

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  164 bits (417), Expect = 5e-45
 Identities = 66/194 (34%), Positives = 103/194 (53%), Gaps = 7/194 (3%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
             LGQG FG V+ G  +    VA+K L   +      F  E  ++ KL+H+ LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            + +   +V E+M  GSL   L        L   +  ++   IA GM Y+    R+  VH
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKS 534
           RDL+A+N+L+  ++  K++DFG+AR+  ++E  A          + APE A+ G ++ KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362

Query: 535 DVFSFGVLLIEIIT 548
           DV+SFG+LL E+ T
Sbjct: 363 DVWSFGILLTELTT 376

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  163 bits (415), Expect = 1e-43
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 23/207 (11%)

Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRL-SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
            +G+G FG V++G+    +     VA+K   +  S+    +F  E L + +  H ++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           +G   + +   ++ E    G L + L    ++  L           ++  + YL      
Sbjct: 457 IGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-----VRIVGTYGYMAPEYA 525
           R VHRD+ A NVL+ S+   K+ DFG++R   +S     +     ++      +MAPE  
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESI 564

Query: 526 MEGLYSKKSDVFSFGVLLIEIIT-GRR 551
               ++  SDV+ FGV + EI+  G +
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVK 591

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  153 bits (389), Expect = 1e-42
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 17/203 (8%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
            +G+G F  VYKG+      EVA    +    ++     F  E  ++  LQH N+V+   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 413 FCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
                 +     +LV E M +G+L   L   ++  ++  +   +    I KG+ +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 469 RLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
              I+HRDLK  N+ +     S KI D G+A +   S   A  V  +GT  +MAPE   E
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAV--IGTPEFMAPEMYEE 204

Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
             Y +  DV++FG+ ++E+ T  
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSE 226

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  154 bits (391), Expect = 3e-42
 Identities = 51/238 (21%), Positives = 101/238 (42%), Gaps = 21/238 (8%)

Query: 320 FHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAV 378
            H+ H      DL  ++     +++      +     +G+G FG         DG++  +
Sbjct: 1   MHHHHHHSSGVDLGTENL--YFQSME----KYVRLQKIGEGSFGKAILVKSTEDGRQYVI 54

Query: 379 K--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
           K   +S  S +   E   EV ++  ++H N+V+      +     +V ++   G L   +
Sbjct: 55  KEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114

Query: 437 FDPRKRGI---LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS 493
              +                   I   + ++H+    +I+HRD+K+ N+ L  D   ++ 
Sbjct: 115 NAQKGVLFQEDQILD----WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLG 167

Query: 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           DFG+AR+   +   A     +GT  Y++PE      Y+ KSD+++ G +L E+ T + 
Sbjct: 168 DFGIARVLNSTVELARAC--IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  152 bits (386), Expect = 5e-42
 Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 18/204 (8%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           +G+G F  VY+   L DG  VA+K++        +  A+   E+ L+ +L H N++K   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGMLYLHED 467
             ++ +E  +V E    G L  ++   +K+  L      W         +   + ++H  
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMHSR 155

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
              R++HRD+K +NV + +    K+ D G+ R F+     A+++  VGT  YM+PE   E
Sbjct: 156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHE 210

Query: 528 GLYSKKSDVFSFGVLLIEIITGRR 551
             Y+ KSD++S G LL E+   + 
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQS 234

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  151 bits (384), Expect = 2e-41
 Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 27/251 (10%)

Query: 315 ANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDS-------NILGQGGFGPVYK 367
           A         +Q    + +  +  +  E L      + +          +G+G FG V++
Sbjct: 17  AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHR 76

Query: 368 GV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 424
                 G + AVK  RL     +       E++    L    +V L G   +G    +  
Sbjct: 77  MKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFM 129

Query: 425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL 484
           E +  GSL  ++   ++ G L   +    +    +G+ YLH     RI+H D+KA NVLL
Sbjct: 130 ELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLL 183

Query: 485 DSDMNS-KISDFGMARIFAESEGEANTVR---IVGTYGYMAPEYAMEGLYSKKSDVFSFG 540
            SD +   + DFG A          + +    I GT  +MAPE  M      K D++S  
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC 243

Query: 541 VLLIEIITGRR 551
            +++ ++ G  
Sbjct: 244 CMMLHMLNGCH 254

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  149 bits (379), Expect = 5e-41
 Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 29/247 (11%)

Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKR 380
           H+ H      DL  ++ +    ++      +S    +G GG   V++ +    +  A+K 
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSVK--GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY 59

Query: 381 --LSSCSEQGTAEFTNEVLLILKLQHKNL--VKLLGFCVDGDEKLLVYEFMPNGSLDAIL 436
             L     Q    + NE+  + KLQ  +   ++L  + +      +V E   N  L++ L
Sbjct: 60  VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL 118

Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG 496
              +K+  +   +R +    + + +  +H+     IVH DLK +N L+  D   K+ DFG
Sbjct: 119 ---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFG 171

Query: 497 MARIFAESEGEANTVR--IVGTYGYMAPE-----------YAMEGLYSKKSDVFSFGVLL 543
           +A          + V+   VGT  YM PE              +   S KSDV+S G +L
Sbjct: 172 IANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229

Query: 544 IEIITGR 550
             +  G+
Sbjct: 230 YYMTYGK 236

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  148 bits (376), Expect = 8e-41
 Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 11/201 (5%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
           +LG+G +G VY G  LS+   +A+K +     + +     E+ L   L+HKN+V+ LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            +     +  E +P GSL A+L           +        I +G+ YLH++   +IVH
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 475 RDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPE---YAMEGLY 530
           RD+K  NVL+++     KISDFG ++  A       T    GT  YMAPE       G Y
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGPRG-Y 202

Query: 531 SKKSDVFSFGVLLIEIITGRR 551
            K +D++S G  +IE+ TG+ 
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  145 bits (369), Expect = 6e-40
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 28/222 (12%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
            +F +  ++G GGFG V+K     DGK   +KR+   +E    +   EV  + KL H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66

Query: 408 VKLLGFCVDGDEKL----------------LVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
           V   G     D                   +  EF   G+L+  + + R+   L      
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125

Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            +   I KG+ Y+H     ++++RDLK SN+ L      KI DFG+     +++G+    
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGKRTRS 181

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA 553
              GT  YM+PE      Y K+ D+++ G++L E++     A
Sbjct: 182 --KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  145 bits (368), Expect = 8e-40
 Identities = 64/208 (30%), Positives = 92/208 (44%), Gaps = 18/208 (8%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
            +G G +G   K    SDGK +  K     S +E       +EV L+ +L+H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 413 FCVDGDEKLL--VYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAKGMLYLH 465
             +D     L  V E+   G L +++    K           R  T +   +       H
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK----ECH 128

Query: 466 E--DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
              D    ++HRDLK +NV LD   N K+ DFG+ARI       A T   VGT  YM+PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VGTPYYMSPE 186

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
                 Y++KSD++S G LL E+     
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMP 214

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  146 bits (371), Expect = 1e-39
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 27/213 (12%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL--VKL 410
             +G GG   V++ +    +  A+K   L     Q    + NE+  + KLQ  +   ++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
             + +      +V E   N  L++ L   +K+  +   +R +    + + +  +H+    
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGTYGYMAPE----- 523
            IVH DLK +N L+  D   K+ DFG+A          + V+   VGT  YM PE     
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 524 ------YAMEGLYSKKSDVFSFGVLLIEIITGR 550
                    +   S KSDV+S G +L  +  G+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  147 bits (372), Expect = 3e-39
 Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 27/213 (12%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKLQHKNL--VKL 410
             +G GG   V++ +    +  A+K   L     Q    + NE+  + KLQ  +   ++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
             + +      +V E   N  L++ L   +K+  +   +R +    + + +  +H+    
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVGTYGYMAPE----- 523
            IVH DLK +N L+  D   K+ DFG+A          + V+   VG   YM PE     
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 524 ------YAMEGLYSKKSDVFSFGVLLIEIITGR 550
                    +   S KSDV+S G +L  +  G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  142 bits (361), Expect = 2e-38
 Identities = 54/211 (25%), Positives = 80/211 (37%), Gaps = 24/211 (11%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKL-QH 404
            +F   + LG G +G V+K     DG+  AVK         +  A    EV    K+ QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGIL-----CWRKRTNIVNGIAK 459
              V+L     +G    L  E     SL          G        W      +     
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHC---EAWGASLPEAQVW----GYLRDTLL 168

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
            + +LH      +VH D+K +N+ L      K+ DFG+      + G        G   Y
Sbjct: 169 ALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQ--EGDPRY 222

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           MAPE  ++G Y   +DVFS G+ ++E+    
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  140 bits (354), Expect = 1e-37
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 37/231 (16%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
            S+F +  +LGQG FG V K     D +  A+K++   +E+  +   +EV+L+  L H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63

Query: 407 LVKLLGFCVDGDEKL-------------LVYEFMPNGSL-DAILFDPRKRGILCWRKRT- 451
           +V+     ++    +             +  E+  NG+L D I        +   R    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119

Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            +   I + + Y+H      I+HRDLK  N+ +D   N KI DFG+A+    S       
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 512 RI------------VGTYGYMAPE-YAMEGLYSKKSDVFSFGVLLIEIITG 549
                         +GT  Y+A E     G Y++K D++S G++  E+I  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  140 bits (354), Expect = 2e-37
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
           ILGQG    V++G     G   A+K  ++ S     +    E  ++ KL HKN+VKL   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 414 CVDGDEKL--LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
             +   +   L+ EF P GSL  +L +P     L   +   ++  +  GM +L E     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132

Query: 472 IVHRDLKASNVLL----DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE---- 523
           IVHR++K  N++     D     K++DFG AR   + E +  +  + GT  Y+ P+    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYER 189

Query: 524 ----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
                  +  Y    D++S GV      TG 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (353), Expect = 2e-37
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
           ++F     LG+GGFG V++     D    A+KR+     E    +   EV  + KL+H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 407 LVKLLGFCVDGDE---------KLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           +V+     ++ +          K+ +Y   +     +L   +               +I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR-- 512
             IA+ + +LH      ++HRDLK SN+    D   K+ DFG+     + E E   +   
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 513 --------IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
                    VGT  YM+PE      YS K D+FS G++L E++ 
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  141 bits (357), Expect = 6e-37
 Identities = 51/210 (24%), Positives = 91/210 (43%), Gaps = 19/210 (9%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV-LLILKLQHKNLV 408
           +F   ++LG G  G +    + D ++VAVKR+     +  +    EV LL    +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +      D   + +  E     +L   +   +K       +   ++     G+ +LH   
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136

Query: 469 RLRIVHRDLKASNVLL-----DSDMNSKISDFGMARIFAESEGEANTVR-IVGTYGYMAP 522
            L IVHRDLK  N+L+        + + ISDFG+ +  A      +    + GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 523 EY---AMEGLYSKKSDVFSFGVLLIEIITG 549
           E      +   +   D+FS G +   +I+ 
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  137 bits (348), Expect = 7e-37
 Identities = 55/203 (27%), Positives = 107/203 (52%), Gaps = 10/203 (4%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
              ++    +GQG  G VY  + ++ G+EVA+++++   +       NE+L++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           +V  L   + GDE  +V E++  GSL  ++        +   +   +     + + +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
           +   +++HRD+K+ N+LL  D + K++DFG        + + +T+  VGT  +MAPE   
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVT 189

Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
              Y  K D++S G++ IE+I G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  139 bits (352), Expect = 1e-36
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 22/211 (10%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
           ILGQG    V++G     G   A+K  ++ S     +    E  ++ KL HKN+VKL   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 414 CVDGDEKL--LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
             +   +   L+ EF P GSL  +L +P     L   +   ++  +  GM +L E     
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132

Query: 472 IVHRDLKASNVLL----DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE---- 523
           IVHR++K  N++     D     K++DFG AR   + E +  ++   GT  Y+ P+    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSL--YGTEEYLHPDMYER 189

Query: 524 ----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
                  +  Y    D++S GV      TG 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  136 bits (345), Expect = 3e-36
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 10/203 (4%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
                    +G+G  G V        G++VAVK +    +Q      NEV+++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           +V++    + G+E  ++ EF+  G+L  I+     +  L   +   +   + + + YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
                ++HRD+K+ ++LL  D   K+SDFG     ++   +  ++  VGT  +MAPE   
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVIS 214

Query: 527 EGLYSKKSDVFSFGVLLIEIITG 549
             LY+ + D++S G+++IE++ G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  135 bits (341), Expect = 1e-35
 Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 10/228 (4%)

Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL 381
           + VQ R+   +      +          F     LG+G +G VYK +    G+ VA+K++
Sbjct: 3   ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62

Query: 382 SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK 441
               E    E   E+ ++ +    ++VK  G      +  +V E+   GS+  I+    +
Sbjct: 63  PV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLR 118

Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
              L   +   I+    KG+ YLH     R +HRD+KA N+LL+++ ++K++DFG+A   
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175

Query: 502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            ++  + NTV  +GT  +MAPE   E  Y+  +D++S G+  IE+  G
Sbjct: 176 TDTMAKRNTV--IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  134 bits (339), Expect = 1e-35
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 11/204 (5%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHK 405
              F+    +G+G FG V+KG+     K VA+K +    +E    +   E+ ++ +    
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
            + K  G  +   +  ++ E++  GS   +L    + G L   +   I+  I KG+ YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 136

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
            +   + +HRD+KA+NVLL      K++DFG+A    +++ + NT   VGT  +MAPE  
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVI 191

Query: 526 MEGLYSKKSDVFSFGVLLIEIITG 549
            +  Y  K+D++S G+  IE+  G
Sbjct: 192 KQSAYDSKADIWSLGITAIELARG 215

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  139 bits (352), Expect = 3e-35
 Identities = 64/207 (30%), Positives = 90/207 (43%), Gaps = 17/207 (8%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLL-- 411
            LG GGFG V + +    G++VA+K+          E +  E+ ++ KL H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 412 ----GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
                     D  LL  E+   G L   L        L       +++ I+  + YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 468 SRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
              RI+HRDLK  N++L         KI D G A+   + E        VGT  Y+APE 
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEF--VGTLQYLAPEL 194

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRR 551
             +  Y+   D +SFG L  E ITG R
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFR 221

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  135 bits (343), Expect = 1e-34
 Identities = 72/243 (29%), Positives = 106/243 (43%), Gaps = 23/243 (9%)

Query: 321 HYQHVQGRDNDLKAQDFFIDLET-LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGK 374
           H+ H  GR+N     D        +     + S+       LG G +G V          
Sbjct: 4   HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63

Query: 375 EVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL 432
           E A+K +  +S S    ++   EV ++  L H N++KL  F  D     LV E    G L
Sbjct: 64  ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123

Query: 433 -DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DM 488
            D I+     R          I+  +  G+ YLH+     IVHRDLK  N+LL+S   D 
Sbjct: 124 FDEII----HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDA 176

Query: 489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
             KI DFG++ +F   +        +GT  Y+APE  +   Y +K DV+S GV+L  ++ 
Sbjct: 177 LIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232

Query: 549 GRR 551
           G  
Sbjct: 233 GYP 235

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  133 bits (336), Expect = 1e-34
 Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 15/198 (7%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           ++G+G F  V + +    G++ AVK     + +S     T +   E  +   L+H ++V+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 410 LLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           LL          +V+EFM    L   I+       +      ++ +  I + + Y H+  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148

Query: 469 RLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
              I+HRD+K   VLL S  NS   K+  FG+A    ES   A     VGT  +MAPE  
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVV 205

Query: 526 MEGLYSKKSDVFSFGVLL 543
               Y K  DV+  GV+L
Sbjct: 206 KREPYGKPVDVWGCGVIL 223

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  131 bits (331), Expect = 2e-34
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 13/205 (6%)

Query: 351 FSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           +     LG G FG VYK      G   A K + + SE+   ++  E+ ++    H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           LLG      +  ++ EF P G++DAI+        L   +   +   + + + +LH    
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-----Y 524
            RI+HRDLKA NVL+  + + +++DFG++    ++  + ++   +GT  +MAPE      
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGTPYWMAPEVVMCET 193

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITG 549
             +  Y  K+D++S G+ LIE+   
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQI 218

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  131 bits (331), Expect = 3e-34
 Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 35/232 (15%)

Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
            + +   ++     LG+GGF  V     L DG   A+KR+    +Q   E   E  +   
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82

Query: 402 LQHKNLVKLLGFCVD----GDEKLLVYEFMPNGSLDAILFDPRKRG-------ILCWRKR 450
             H N+++L+ +C+       E  L+  F   G+L   +   + +G       IL     
Sbjct: 83  FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----- 137

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             ++ GI +G+  +H        HRDLK +N+LL  +    + D G           +  
Sbjct: 138 -WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193

Query: 511 VRIV-------GTYGYMAPEYAMEGLYSK-----KSDVFSFGVLLIEIITGR 550
              +        T  Y APE  +  + S      ++DV+S G +L  ++ G 
Sbjct: 194 ALTLQDWAAQRCTISYRAPE--LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  131 bits (332), Expect = 4e-34
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 11/215 (5%)

Query: 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS-SCSEQGTAEFTNE 395
               +   L   +F   + LG G  G V+K      G  +A K +          +   E
Sbjct: 22  TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 81

Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
           + ++ +     +V   G      E  +  E M  GSLD +L    +       K   +  
Sbjct: 82  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSI 138

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            + KG+ YL E    +I+HRD+K SN+L++S    K+ DFG++    +S   AN+   VG
Sbjct: 139 AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF--VG 192

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  YM+PE      YS +SD++S G+ L+E+  GR
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  131 bits (332), Expect = 5e-34
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 31/218 (14%)

Query: 347 ATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS--------SCSEQGTAEFT 393
           A   F       +++G+G    V + V  + G E AVK +            E+      
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 394 NEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRT 451
            E  ++ ++  H +++ L+          LV++ M  G L D +     ++  L  ++  
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETR 203

Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
           +I+  + + + +LH      IVHRDLK  N+LLD +M  ++SDFG +      E +    
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRE- 258

Query: 512 RIVGTYGYMAPE------YAMEGLYSKKSDVFSFGVLL 543
            + GT GY+APE            Y K+ D+++ GV+L
Sbjct: 259 -LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  129 bits (326), Expect = 6e-34
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
           ++ FSD       LG+G F  V + V  + G E A K +     S +   +   E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
           KLQH N+V+L     +     LV++ +  G L + I+     R        ++ +  I +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILE 116

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGT 516
            + Y H      IVHR+LK  N+LL S       K++DFG+A    +SE   +     GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHG--FAGT 170

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLL 543
            GY++PE   +  YSK  D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  129 bits (326), Expect = 6e-34
 Identities = 50/228 (21%), Positives = 84/228 (36%), Gaps = 34/228 (14%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTNEVLLILKL-Q 403
           T+ F +   +G G FG V+K V   DG   A+KR                EV     L Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           H ++V+      + D  L+  E+   GSL DAI  + R        +  +++  + +G+ 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-------------------MNSKISDFGMARIFAE 503
           Y+H      +VH D+K SN+ +                      +  KI D G       
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182

Query: 504 SEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
                      G   ++A E   E   +  K+D+F+  + ++      
Sbjct: 183 RISSPQVE--EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  130 bits (329), Expect = 7e-34
 Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 23/222 (10%)

Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLI 399
           +  +    +  D   +G+G +G V K V    G+ +AVKR+ S+  E+   +   ++ ++
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 400 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN------ 452
           ++      +V+  G      +  +  E M + S D       K                 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGK 129

Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
           I     K + +L E+  L+I+HRD+K SN+LLD   N K+ DFG++    +S  +     
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-- 185

Query: 513 IVGTYGYMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
             G   YMAPE     A    Y  +SDV+S G+ L E+ TGR
Sbjct: 186 -AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  129 bits (326), Expect = 8e-34
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)

Query: 347 ATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS---------SCSEQGTAEF 392
           +T  F +      ILG+G    V + +     KE AVK +             ++     
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 393 TNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKR 450
             EV ++ K+  H N+++L           LV++ M  G L D +     ++  L  ++ 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKET 126

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             I+  + + +  LH+   L IVHRDLK  N+LLD DMN K++DFG +      E +   
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLRE 182

Query: 511 VRIVGTYGYMAPE------YAMEGLYSKKSDVFSFGVLL 543
             + GT  Y+APE            Y K+ D++S GV++
Sbjct: 183 --VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  128 bits (323), Expect = 2e-33
 Identities = 69/207 (33%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
              F++      +LG+G FG V K       +E AVK +  +S   + T+    EV L+ 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
           KL H N++KL     D     +V E    G L D I+    KR          I+  +  
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFS 132

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGT 516
           G+ Y+H+     IVHRDLK  N+LL+S   D + KI DFG++  F ++         +GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGT 186

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLL 543
             Y+APE  + G Y +K DV+S GV+L
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  131 bits (331), Expect = 2e-33
 Identities = 52/222 (23%), Positives = 85/222 (38%), Gaps = 34/222 (15%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEV-LLILKLQHKNLVKLLGF 413
            ILG G  G V       G+ VAVKR+             E+ LL     H N+++    
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCS 77

Query: 414 CVDGDEKLLVYEFMPNGSL-DAIL---FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
                   +  E   N +L D +           +       +++  IA G+ +LH    
Sbjct: 78  ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133

Query: 470 LRIVHRDLKASNVLLDS-------------DMNSKISDFGMARIFAESEGEANTVR--IV 514
           L+I+HRDLK  N+L+ +             ++   ISDFG+ +     +    T      
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 515 GTYGYMAPE-------YAMEGLYSKKSDVFSFGVLLIEIITG 549
           GT G+ APE          +   ++  D+FS G +   I++ 
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  132 bits (333), Expect = 2e-33
 Identities = 75/238 (31%), Positives = 112/238 (47%), Gaps = 28/238 (11%)

Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
           H+ H  GR+N      F             ++   +LG+G FG V K       +E AVK
Sbjct: 4   HHHHSSGRENLYFQGTF----------AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVK 53

Query: 380 RL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAIL 436
            +  +S   + T+    EV L+ KL H N++KL     D     +V E    G L D I+
Sbjct: 54  VINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113

Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKIS 493
               KR          I+  +  G+ Y+H+     IVHRDLK  N+LL+S   D + KI 
Sbjct: 114 ----KRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKII 166

Query: 494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           DFG++  F ++         +GT  Y+APE  + G Y +K DV+S GV+L  +++G  
Sbjct: 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  128 bits (324), Expect = 5e-33
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 24/213 (11%)

Query: 342 ETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
           + L+  +  F+D       +G G +    + +  +   E AVK +       T     E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEI 66

Query: 397 LLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIV 454
            ++L+  QH N++ L     DG    +V E M  G L D IL    ++     R+ + ++
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVL 122

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIFAESEGEANT 510
             I K + YLH      +VHRDLK SN+L   +  +    +I DFG A+      G   T
Sbjct: 123 FTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
                T  ++APE      Y    D++S GVLL
Sbjct: 180 P--CYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  127 bits (321), Expect = 5e-33
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 20/208 (9%)

Query: 345 NLATSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLI 399
           ++ T+N   +     +LG G F  V+       GK  A+K +        +   NE+ ++
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60

Query: 400 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIA 458
            K++H+N+V L           LV + +  G L D IL    +RG+   +  + ++  + 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVL 116

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESEGEANTVRIVG 515
             + YLHE     IVHRDLK  N+L  + + NS   I+DFG++++     G  +T    G
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMST--ACG 169

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
           T GY+APE   +  YSK  D +S GV+ 
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  126 bits (319), Expect = 6e-33
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 24/221 (10%)

Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLIL 400
           ++ +   +      LG+G +G V K   +  G+ +AVKR+ ++ + Q       ++ + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 401 KL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG------ILCWRKRTNI 453
           +       V   G      +  +  E M + SLD        +G      IL       I
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KI 114

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
              I K + +LH  S+L ++HRD+K SNVL+++    K+ DFG++    +     +    
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDID-- 169

Query: 514 VGTYGYMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
            G   YMAPE       +  YS KSD++S G+ +IE+   R
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  131 bits (331), Expect = 6e-33
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 34/254 (13%)

Query: 321 HYQHVQGRDNDLKAQDFFIDLET-LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGK 374
           H+ H      +L  Q   I+    +        +       LG G +G V      +   
Sbjct: 3   HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62

Query: 375 EVAVKRLS-------------SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 421
           E A+K +                 E+   E  NE+ L+  L H N++KL     D     
Sbjct: 63  EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122

Query: 422 LVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS 480
           LV EF   G L + I+     R         NI+  I  G+ YLH+     IVHRD+K  
Sbjct: 123 LVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPE 175

Query: 481 NVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVF 537
           N+LL++    +N KI DFG++  F++          +GT  Y+APE  ++  Y++K DV+
Sbjct: 176 NILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVW 231

Query: 538 SFGVLLIEIITGRR 551
           S GV++  ++ G  
Sbjct: 232 SCGVIMYILLCGYP 245

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  126 bits (318), Expect = 8e-33
 Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 23/229 (10%)

Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
           H+ H  GR+N                    F     LG G FG V+     S G E  +K
Sbjct: 4   HHHHSSGRENLYFQGTI----------DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK 53

Query: 380 RLS-SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILF 437
            ++   S+    +   E+ ++  L H N++K+     D     +V E    G L + I+ 
Sbjct: 54  TINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS 113

Query: 438 DPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISD 494
              +   L       ++  +   + Y H      +VH+DLK  N+L          KI D
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIID 170

Query: 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
           FG+A +F   E   N     GT  YMAPE   +   + K D++S GV++
Sbjct: 171 FGLAELFKSDEHSTN---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  127 bits (321), Expect = 8e-33
 Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 25/211 (11%)

Query: 346 LATSNFSD-------SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVL 397
           +  S F            LG+G F    K V     +  AVK +S   E  T     E+ 
Sbjct: 1   MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT---QKEIT 57

Query: 398 LILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
            +   + H N+VKL     D     LV E +  G L + I     K+      + + I+ 
Sbjct: 58  ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMR 113

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVR 512
            +   + ++H+   + +VHRDLK  N+L    + ++  KI DFG AR+         T  
Sbjct: 114 KLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-- 168

Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
              T  Y APE   +  Y +  D++S GV+L
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  130 bits (329), Expect = 9e-33
 Identities = 73/219 (33%), Positives = 107/219 (48%), Gaps = 23/219 (10%)

Query: 344 LNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNE 395
           +  +T+ FSD      +LG+G FG V        G+E AVK +S      +        E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIV 454
           V L+ +L H N++KL  F  D     LV E    G L D I+     R          I+
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARII 132

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTV 511
             +  G+ Y+H+    +IVHRDLK  N+LL+S   D N +I DFG++  F  S+      
Sbjct: 133 RQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMK 186

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             +GT  Y+APE  + G Y +K DV+S GV+L  +++G 
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  127 bits (320), Expect = 9e-33
 Identities = 66/224 (29%), Positives = 104/224 (46%), Gaps = 20/224 (8%)

Query: 339 IDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVL 397
           IDL  L      F    ++G G +G VYKG  +  G+  A+K +   +     E   E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEIN 72

Query: 398 LILKL-QHKNLVKLLG-----FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKR 450
           ++ K   H+N+    G          D++L LV EF   GS+  ++    K   L     
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWI 131

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
             I   I +G+ +LH+    +++HRD+K  NVLL  +   K+ DFG++     + G  NT
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188

Query: 511 VRIVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLLIEIITG 549
              +GT  +MAPE        +  Y  KSD++S G+  IE+  G
Sbjct: 189 F--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  128 bits (323), Expect = 1e-32
 Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 16/223 (7%)

Query: 340 DLETLNLATSNFSDSNILGQG--GFGPVYKGV-LSDGKEVAVKR--LSSCSEQGTAEFTN 394
            + +       +    ++G+G      V        G+ V V+R  L +CS +       
Sbjct: 16  GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           E+ +     H N+V      +  +E  +V  FM  GS   ++        +       I+
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYIL 134

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI- 513
            G+ K + Y+H       VHR +KAS++L+  D    +S                 V   
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 514 ----VGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGR 550
               V    +++PE   + L  Y  KSD++S G+   E+  G 
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (321), Expect = 1e-32
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
           LG+GGF   ++       +  A K +  S   +    E  + E+ +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D D   +V E     SL  +    ++R  L   +    +  I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 162

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLK  N+ L+ D+  KI DFG+A              + GT  Y+APE   +  +S 
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 220

Query: 533 KSDVFSFGVLLIEIITGR 550
           + DV+S G ++  ++ G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  125 bits (317), Expect = 1e-32
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 14/213 (6%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
            ++    ++G G    V         ++VA+KR++    +    E   E+  + +  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRT-----NIVNGIAKGM 461
           +V      V  DE  LV + +  GS+  I+     +G              I+  + +G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM-ARIFAESEGEANTVR--IVGTYG 518
            YLH++     +HRD+KA N+LL  D + +I+DFG+ A +    +   N VR   VGT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 519 YMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           +MAPE   +   Y  K+D++SFG+  IE+ TG 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  125 bits (317), Expect = 2e-32
 Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 12/198 (6%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
           LG+GGF   ++       +  A K +  S   +    E  + E+ +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F  D D   +V E     SL  +    ++R  L   +    +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNRV 136

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           +HRDLK  N+ L+ D+  KI DFG+A              + GT  Y+APE   +  +S 
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHSF 194

Query: 533 KSDVFSFGVLLIEIITGR 550
           + DV+S G ++  ++ G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  127 bits (321), Expect = 2e-32
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 21/213 (9%)

Query: 342 ETLNLATSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTN 394
           E +  A++ FSD+      LG+G F  V + V  + G E A K +     S +   +   
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 395 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNI 453
           E  +  KLQH N+V+L     +     LV++ +  G L + I+     R        ++ 
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHC 133

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANT 510
           +  I + + Y H      IVHR+LK  N+LL S       K++DFG+A    +SE     
Sbjct: 134 IQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AW 187

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
               GT GY++PE   +  YSK  D+++ GV+L
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (316), Expect = 2e-32
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
           LG GG   VY         +VA+K +       E+    F  EV    +L H+N+V ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
              + D   LV E++   +L   +      G L      N  N I  G+ + H    +RI
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
           VHRD+K  N+L+DS+   KI DFG+A+  +E+     T  ++GT  Y +PE A      +
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 533 KSDVFSFGVLLIEIITGRR 551
            +D++S G++L E++ G  
Sbjct: 192 CTDIYSIGIVLYEMLVGEP 210

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  124 bits (314), Expect = 5e-32
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 28/217 (12%)

Query: 348 TSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
           +  F D      ++LG+G    V   + L   +E AVK +        +    EV ++ +
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 402 LQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
            Q H+N+++L+ F  + D   LV+E M  GS+   I     KR      + + +V  +A 
Sbjct: 67  CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVAS 122

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVR---- 512
            + +LH      I HRDLK  N+L    +     KI DF +      +   +        
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 513 -IVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLL 543
              G+  YMAPE          +Y K+ D++S GV+L
Sbjct: 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  127 bits (320), Expect = 6e-32
 Identities = 61/248 (24%), Positives = 98/248 (39%), Gaps = 37/248 (14%)

Query: 312 IGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-L 370
           +  + +  F +  +   D  +  +               +  S  LG G  G V      
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKAL----------RDEYIMSKTLGSGACGEVKLAFER 157

Query: 371 SDGKEVAVKRLS--------SCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 422
              K+VA++ +S        +           E+ ++ KL H  ++K+  F  D ++  +
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYI 216

Query: 423 VYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN 481
           V E M  G L D ++        L           +   + YLHE     I+HRDLK  N
Sbjct: 217 VLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPEN 269

Query: 482 VLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE---YAMEGLYSKKSD 535
           VLL S   D   KI+DFG ++I  E+        + GT  Y+APE         Y++  D
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 326

Query: 536 VFSFGVLL 543
            +S GV+L
Sbjct: 327 CWSLGVIL 334

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  124 bits (314), Expect = 9e-32
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 19/209 (9%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT---NEVLLILKLQ 403
              FSD   +G G FG VY    + + + VA+K++S   +Q   ++     EV  + KL+
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N ++  G  +      LV E+    + D +         L   +   + +G  +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAY 169

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           LH      ++HRD+KA N+LL      K+ DFG     A     AN+   VGT  +MAPE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANSF--VGTPYWMAPE 220

Query: 524 ---YAMEGLYSKKSDVFSFGVLLIEIITG 549
                 EG Y  K DV+S G+  IE+   
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  126 bits (319), Expect = 9e-32
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 20/207 (9%)

Query: 348 TSNFSDS----NILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLIL 400
            + F++       LG+G F  V + V +  G+E A   +     S +   +   E  +  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65

Query: 401 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAK 459
            L+H N+V+L     +     L+++ +  G L + I+     R        ++ +  I +
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILE 121

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGT 516
            +L+ H+   + +VHR+LK  N+LL S       K++DFG+A    E E +A      GT
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWF-GFAGT 176

Query: 517 YGYMAPEYAMEGLYSKKSDVFSFGVLL 543
            GY++PE   +  Y K  D+++ GV+L
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  124 bits (313), Expect = 2e-31
 Identities = 53/229 (23%), Positives = 94/229 (41%), Gaps = 17/229 (7%)

Query: 323 QHVQGRDNDLKAQDFFIDLETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVA 377
             +   D   +        + + +   +  D       LG G FG V++ V  + G+   
Sbjct: 21  PKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFV 80

Query: 378 VKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAIL 436
            K +++          NE+ ++ +L H  L+ L     D  E +L+ EF+  G L D I 
Sbjct: 81  AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 140

Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISD 494
               +   +   +  N +    +G+ ++HE     IVH D+K  N++ ++   S  KI D
Sbjct: 141 ---AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIID 194

Query: 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
           FG+A     +  E   V    T  + APE          +D+++ GVL 
Sbjct: 195 FGLATKL--NPDEIVKV-TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  121 bits (307), Expect = 2e-31
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 20/205 (9%)

Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL 402
             + +      N +G+G +G V   V        A K++     +    F  E+ ++  L
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63

Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGM 461
            H N+++L     D  +  LV E    G L + ++     + +        I+  +   +
Sbjct: 64  DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAV 119

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            Y H+   L + HRDLK  N L  +   D   K+ DFG+A  F   +    T   VGT  
Sbjct: 120 AYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRT--KVGTPY 173

Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLL 543
           Y++P+  +EGLY  + D +S GV++
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMM 197

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  121 bits (306), Expect = 3e-31
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)

Query: 349 SNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAE-FTNEVL 397
           S   D       LG G F  V K      GKE A K     RLSS     + E    EV 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60

Query: 398 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNG 456
           ++ +++H N++ L     +  + +L+ E +  G L D +     ++  L   + T  +  
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA----EKESLTEDEATQFLKQ 116

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTVR 512
           I  G+ YLH     RI H DLK  N++L      +   K+ DFG+A       G      
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKN- 170

Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
           I GT  ++APE         ++D++S GV+ 
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  123 bits (310), Expect = 5e-31
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
                D       LG G F  V K    S G E A K    R S  S +G    E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
            ++ ++ H N++ L     +  + +L+ E +  G L D +     ++  L   + T+ + 
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIK 122

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
            I  G+ YLH     +I H DLK  N++L        + K+ DFG+A      +G     
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
            I GT  ++APE         ++D++S GV+ 
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (305), Expect = 5e-31
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 15/200 (7%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
           LG+G F  VY+   +  G EVA+K +   +  + G  +   NEV +  +L+H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDP--RKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           +  D +   LV E   NG +          +       +  + ++ I  GMLYLH     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
            I+HRDL  SN+LL  +MN KI+DFG+A        +  T  + GT  Y++PE A    +
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAH 189

Query: 531 SKKSDVFSFGVLLIEIITGR 550
             +SDV+S G +   ++ GR
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  121 bits (307), Expect = 6e-31
 Identities = 57/236 (24%), Positives = 101/236 (42%), Gaps = 27/236 (11%)

Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGK 374
           H+ H      DL  ++ +        +  NF++     S  LG+G F  V + +  S G+
Sbjct: 2   HHHHHHSSGVDLGTENLYFQ------SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQ 55

Query: 375 EVAVK--RLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYEFMPNGS 431
           E A K  +     +   AE  +E+ ++   +    ++ L     +  E +L+ E+   G 
Sbjct: 56  EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115

Query: 432 L-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSD 487
           +    L  P    ++       ++  I +G+ YLH+     IVH DLK  N+LL      
Sbjct: 116 IFSLCL--PELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPL 170

Query: 488 MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
            + KI DFGM+R             I+GT  Y+APE       +  +D+++ G++ 
Sbjct: 171 GDIKIVDFGMSRKI--GHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  122 bits (307), Expect = 9e-31
 Identities = 51/222 (22%), Positives = 89/222 (40%), Gaps = 39/222 (17%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRL--SSCSEQGTAEFTNEVLL--------------IL 400
           L QG F  +      D K  A+K+   S   ++     +N   +              I+
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 401 K-LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIA 458
             ++++  +   G   + DE  ++YE+M N S+            +L       I   + 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIPIQVI 153

Query: 459 K--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
           K           Y+H  +   I HRD+K SN+L+D +   K+SDFG +      + +   
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKG 209

Query: 511 VRIVGTYGYMAPE-YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
               GTY +M PE ++ E  Y+  K D++S G+ L  +    
Sbjct: 210 --SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  125 bits (315), Expect = 1e-30
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 17/210 (8%)

Query: 342 ETLNLATSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
           + + +   +  D       LG G FG V++    + G   A K + +  E        E+
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 205

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
             +  L+H  LV L     D +E +++YEFM  G L + +     +   +   +    + 
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMR 262

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRI 513
            + KG+ ++HE      VH DLK  N++  +  ++  K+ DFG+         ++  V  
Sbjct: 263 QVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKV-T 316

Query: 514 VGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
            GT  + APE A        +D++S GVL 
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  120 bits (304), Expect = 1e-30
 Identities = 53/234 (22%), Positives = 100/234 (42%), Gaps = 23/234 (9%)

Query: 329 DNDLKAQDF-FIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCS 385
            +  K   +  I  +      ++  +   +G G  G V+K      G  +AVK++  S +
Sbjct: 4   GSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN 63

Query: 386 EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKR-- 442
           ++       ++ ++LK      +V+  G  +   +  +  E M     + +    +    
Sbjct: 64  KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP 122

Query: 443 -GILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
             IL       +   I K + YL E     ++HRD+K SN+LLD     K+ DFG++   
Sbjct: 123 ERILG-----KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175

Query: 502 AESEGEANTVRIVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
            + + +  +    G   YMAPE        +  Y  ++DV+S G+ L+E+ TG+
Sbjct: 176 VDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  121 bits (305), Expect = 1e-30
 Identities = 44/191 (23%), Positives = 85/191 (44%), Gaps = 14/191 (7%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG+G FG V++ V  S  K    K +             E+ ++   +H+N++ L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 416 DGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
             +E ++++EF+    + + I         L  R+  + V+ + + + +LH      I H
Sbjct: 72  SMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 475 RDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
            D++  N++  +  +S  KI +FG AR      G+   + +     Y APE     + S 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRL-LFTAPEYYAPEVHQHDVVST 182

Query: 533 KSDVFSFGVLL 543
            +D++S G L+
Sbjct: 183 ATDMWSLGTLV 193

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  120 bits (303), Expect = 2e-30
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
                D       LG G F  V K    S G E A K    R S  S +G    E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
            ++ ++ H N++ L     +  + +L+ E +  G L D +     ++  L   + T+ + 
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIK 122

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
            I  G+ YLH     +I H DLK  N++L        + K+ DFG+A      +G     
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
            I GT  ++APE         ++D++S GV+ 
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (302), Expect = 3e-30
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 348 TSNFSD----SNILGQGGFGPVYKGV-LSDGKEVAVK----RLSSCSEQGT--AEFTNEV 396
             N  D       LG G F  V K    S G + A K    R +  S +G    +   EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVN 455
            ++ ++QH N++ L     +  + +L+ E +  G L D +     ++  L   + T  + 
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLK 121

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----DMNSKISDFGMARIFAESEGEANTV 511
            I  G+ YLH    L+I H DLK  N++L          KI DFG+A       G     
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
            I GT  ++APE         ++D++S GV+ 
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  120 bits (304), Expect = 4e-30
 Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 13/198 (6%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
             S + ILG G FG V+K    + G ++A K + +   +   E  NE+ ++ +L H NL+
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           +L       ++ +LV E++  G L D I+    +   L        +  I +G+ ++H+ 
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQ- 205

Query: 468 SRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
             + I+H DLK  N+L  +      KI DFG+AR +     E   V   GT  ++APE  
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKV-NFGTPEFLAPEVV 260

Query: 526 MEGLYSKKSDVFSFGVLL 543
                S  +D++S GV+ 
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  119 bits (301), Expect = 4e-30
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 33/213 (15%)

Query: 348 TSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK 401
               +D       +LG G  G V +      G++ A+K L         +   EV    +
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQ 77

Query: 402 LQ-HKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW--RKRTNI 453
                ++V +L    +        L++ E M  G L   I     +RG   +  R+   I
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEI 133

Query: 454 VNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESEGEANT 510
           +  I   + +LH      I HRD+K  N+L  S + ++  K++DFG A+    ++    T
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQT 188

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
                T  Y+APE      Y K  D++S GV++
Sbjct: 189 --PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (301), Expect = 5e-30
 Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 27/218 (12%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFC 414
           L +GGF  VY+   +  G+E A+KRL S  E+       EV  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 415 V-------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
                    G  + L+   +  G L   L     RG L       I     + + ++H  
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI----------VGTY 517
            +  I+HRDLK  N+LL +    K+ DFG A   +     + + +             T 
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214

Query: 518 GYMAPEYAMEGLYSK-----KSDVFSFGVLLIEIITGR 550
            Y  PE  +  LYS      K D+++ G +L  +   +
Sbjct: 215 MYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (299), Expect = 6e-30
 Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 11/199 (5%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSS--CSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
           +G+GG G VY+       + VA+K +S    S+         E     +LQ  ++V +  
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           F     +  +    +    L A+L   R++G L   +   IV  I   +   H       
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA---GA 155

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
            HRD+K  N+L+ +D  + + DFG+A    +          VGT  YMAPE   E   + 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDE-KLTQLGNTVGTLYYMAPERFSESHATY 214

Query: 533 KSDVFSFGVLLIEIITGRR 551
           ++D+++   +L E +TG  
Sbjct: 215 RADIYALTCVLYECLTGSP 233

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  118 bits (299), Expect = 7e-30
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 27/204 (13%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS--------SCSEQGTAEFTNEVLLILKLQHKN 406
            LG G  G V         K+VA+K +S        +           E+ ++ KL H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           ++K+  F  D ++  +V E M  G L D ++        L           +   + YLH
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 466 EDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           E     I+HRDLK  NVLL S   D   KI+DFG ++I  E+     T+   GT  Y+AP
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTL--CGTPTYLAP 185

Query: 523 E---YAMEGLYSKKSDVFSFGVLL 543
           E         Y++  D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  119 bits (300), Expect = 7e-30
 Identities = 55/243 (22%), Positives = 83/243 (34%), Gaps = 52/243 (21%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           +GQG +G V   +        A+K     ++   + +       EV L+ KL H N+ +L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 411 LGFCVDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRT------------------ 451
                D     LV E    G L D +          C                       
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 452 ------------------NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--K 491
                             NI+  I   + YLH      I HRD+K  N L  ++ +   K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210

Query: 492 ISDFGMARIFAESEGEANTVR--IVGTYGYMAPE--YAMEGLYSKKSDVFSFGVLLIEII 547
           + DFG+++ F +             GT  ++APE        Y  K D +S GVLL  ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 548 TGR 550
            G 
Sbjct: 271 MGA 273

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (298), Expect = 2e-29
 Identities = 23/231 (9%), Positives = 51/231 (22%), Gaps = 45/231 (19%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
            L  G    V+    +   ++ A+K     +  S               +L  ++  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 412 GFC--------------------------VDGDEKLLVYEFMPNGSL----DAILFDPRK 441
                                              LL+     +  L      + F    
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVF 187

Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
           RG         +   + +    L       +VH      N+ +  D    + D       
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW-- 242

Query: 502 AESEGEANTVRIVGTYGYMAPEYAM--EGLYSKKSDVFSFGVLLIEIITGR 550
               G            Y   E+       ++   + +  G+ +  +    
Sbjct: 243 --KVGTRGPA-SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (292), Expect = 2e-29
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 16/199 (8%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
           LG+G FG VY          +A+K L  +   + G       EV +   L+H N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           +  D     L+ E+ P G++   L   +K      ++    +  +A  + Y H     R+
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SKRV 130

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYS 531
           +HRD+K  N+LL S    KI+DFG +     +         + GT  Y+ PE     ++ 
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTD--LCGTLDYLPPEMIEGRMHD 185

Query: 532 KKSDVFSFGVLLIEIITGR 550
           +K D++S GVL  E + G+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  119 bits (299), Expect = 3e-29
 Identities = 57/218 (26%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 343 TLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV 396
            L +  +   D     S +LG G  G V +       ++ A+K L  C      +   EV
Sbjct: 51  GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREV 105

Query: 397 LLILKLQ-HKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW--R 448
            L  +     ++V+++    +        L+V E +  G L   I      RG   +  R
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTER 161

Query: 449 KRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAESE 505
           + + I+  I + + YLH    + I HRD+K  N+L  S   N+  K++DFG A+    S 
Sbjct: 162 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSH 217

Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
               T     T  Y+APE      Y K  D++S GV++
Sbjct: 218 NSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  117 bits (296), Expect = 3e-29
 Identities = 59/193 (30%), Positives = 88/193 (45%), Gaps = 17/193 (8%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
            LG+G    VY+       K  A+K L    ++       E+ ++L+L H N++KL    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 415 VDGDEKLLVYEFMPNGSL-DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV 473
               E  LV E +  G L D I+    ++G    R   + V  I + + YLHE     IV
Sbjct: 118 ETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE---NGIV 170

Query: 474 HRDLKASNVLL---DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           HRDLK  N+L      D   KI+DFG+++I            + GT GY APE      Y
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAY 227

Query: 531 SKKSDVFSFGVLL 543
             + D++S G++ 
Sbjct: 228 GPEVDMWSVGIIT 240

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (293), Expect = 3e-29
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLL- 411
           LG GG   V+    L D ++VAVK L    +        F  E      L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 412 -GFCVDGDEKLLVY---EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
            G   +     L Y   E++   +L  I+      G +  ++   ++    + + + H  
Sbjct: 80  TG-EAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAM 526
            +  I+HRD+K +N+++ +    K+ DFG+AR  A+S      T  ++GT  Y++PE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
                 +SDV+S G +L E++TG  
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEP 217

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (303), Expect = 6e-29
 Identities = 40/203 (19%), Positives = 75/203 (36%), Gaps = 24/203 (11%)

Query: 357 LGQGGFGPVYKGV--LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKLLGF 413
           +  GG G +Y  +    +G+ V +K L    +         E   + ++ H ++V++  F
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 414 CVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
               D        +V E++   SL            L   +    +  I   + YLH   
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH--- 199

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
            + +V+ DLK  N++L  +   K+ D G                + GT G+ APE     
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV-RT 251

Query: 529 LYSKKSDVFSFGVLLIEIITGRR 551
             +  +D+++ G  L  +     
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  115 bits (290), Expect = 6e-29
 Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 53/232 (22%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS-----------------SCSEQGTAEFTNEVLL 398
           +G+G +G V      +D    A+K LS                                +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 399 --------ILK-LQHKNLVKLLGFCV---DGDEKL-LVYEFMPNGSLDAILFDPRKRGIL 445
                   ILK L H N+VKL    V     ++ L +V+E +  G +     +      L
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPL 134

Query: 446 ----CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
                     +++ GI     YLH     +I+HRD+K SN+L+  D + KI+DFG++  F
Sbjct: 135 SEDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 502 AESEGEANTVRIVGTYGYMAPE--YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
             S+   +    VGT  +MAPE       ++S K  DV++ GV L   + G+
Sbjct: 188 KGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (288), Expect = 4e-28
 Identities = 31/231 (13%), Positives = 66/231 (28%), Gaps = 28/231 (12%)

Query: 342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQGTAEFTNE 395
               L +      ++LG+G F  VY+    D       ++  +K     +       T  
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 396 VLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN--- 452
           +  +        +K     +  +  +LV E    G+L   +           +       
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI---NLYKNTPEKVMPQGLV 174

Query: 453 --IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-----------KISDFGMAR 499
                 +   +  +H+     I+H D+K  N +L +                + D G + 
Sbjct: 175 ISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
                           T G+   E      ++ + D F     +  ++ G 
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  114 bits (286), Expect = 7e-28
 Identities = 30/240 (12%), Positives = 64/240 (26%), Gaps = 54/240 (22%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE----------------------- 391
           +LGQ       +      G+   V          +                         
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 392 -----FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM-PNGSL----DAILFDPRK 441
                F     L+   Q K ++++     D       + +     +L    + +L     
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
              L    R  +   + + +  LH      +VH  L+  +++LD      ++ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE----H 252

Query: 502 AESEGEANTVRIVGTYGYMAPEY-----------AMEGLYSKKSDVFSFGVLLIEIITGR 550
              +G         + G+  PE                L +   D ++ G+++  I    
Sbjct: 253 LVRDGARVVS--SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  114 bits (287), Expect = 8e-28
 Identities = 32/239 (13%), Positives = 67/239 (28%), Gaps = 53/239 (22%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQ-------- 403
           +LGQ       +      G+   V          +    +   EVL +  L+        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 404 --------------HKNLVKLLGFCVDGDEKLLVYEFM----PNGSL----DAILFDPRK 441
                              K++   +D  +  ++  F        +L    + +L     
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF 501
              L    R  +   + + +  LH      +VH  L+  +++LD      ++ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259

Query: 502 AESEGEANTVRIVGTYGYMAPEY----------AMEGLYSKKSDVFSFGVLLIEIITGR 550
              +G +         G+  PE               L +   D ++ G+ +  I    
Sbjct: 260 --RDGASAVSP--IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  113 bits (285), Expect = 2e-27
 Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 40/222 (18%)

Query: 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHKN 406
              +++  ++G G FG V++  L +  EVA+K++          F N E+ ++  ++H N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93

Query: 407 LVKLLGF-----CVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG---- 456
           +V L  F         +  L LV E++P  ++         R    + K    +      
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TV--------YRASRHYAKLKQTMPMLLIK 144

Query: 457 -----IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANT 510
                + + + Y+H    + I HRD+K  N+LLD      K+ DFG A+I     GE N 
Sbjct: 145 LYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNV 199

Query: 511 VRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGR 550
             I   Y Y APE  + G   Y+   D++S G ++ E++ G+
Sbjct: 200 SYICSRY-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  110 bits (278), Expect = 4e-27
 Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 32/212 (15%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLL-----ILKL-----QHK 405
           LG+GGFG V+ G  L+D  +VA+K +      G +  ++ V       +L        H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKG 460
            +++LL +    +  +LV E       D  LFD   ++G L           +V  I   
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQ-D--LFDYITEKGPLGEGPSRCFFGQVVAAIQ-- 153

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGY 519
             + H      +VHRD+K  N+L+D      K+ DFG   +    +         GT  Y
Sbjct: 154 --HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDF--DGTRVY 204

Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
             PE+     Y    + V+S G+LL +++ G 
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  110 bits (278), Expect = 4e-27
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 30/210 (14%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN------EVLLILKLQHK--NL 407
           LG GGFG VY G+ +SD   VA+K +         E  N      EV+L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKGML 462
           ++LL +    D  +L+ E  P    D  LFD   +RG L           ++  +     
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVR---- 163

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           + H      ++HRD+K  N+L+D +    K+ DFG   +    +         GT  Y  
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSP 216

Query: 522 PEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
           PE+     Y  + + V+S G+LL +++ G 
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  109 bits (275), Expect = 6e-27
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 16/199 (8%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAE-FTNEVLLILKLQHKNLVKLLG 412
           LG+G FG VY      +   +A+K L  S   ++G       E+ +   L+H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
           +  D     L+ EF P G L   L   +K G    ++    +  +A  + Y H     ++
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH---ERKV 135

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYS 531
           +HRD+K  N+L+      KI+DFG +     +      T  + GT  Y+ PE      + 
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRT--MCGTLDYLPPEMIEGKTHD 190

Query: 532 KKSDVFSFGVLLIEIITGR 550
           +K D++  GVL  E + G 
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  109 bits (275), Expect = 1e-26
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 28/209 (13%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK--------RLSSCSEQGTAEFTNEVLLILKLQHKNL 407
           LG G FG V+  V     KEV VK              +    + T E+ ++ +++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFD-----PRKRGILCWRKRTNIVNGIAKGML 462
           +K+L    +     LV E   +G LD  LF      PR    L       +V+ +     
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQLVSAVG---- 144

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL       I+HRD+K  N+++  D   K+ DFG A    E      T    GT  Y AP
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL-ERGKLFYTF--CGTIEYCAP 198

Query: 523 EYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
           E  M   Y   + +++S GV L  ++   
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  110 bits (277), Expect = 3e-26
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 41/223 (18%)

Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHK 405
             +++D+ ++G G FG VY+  L D G+ VA+K++          F N E+ ++ KL H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107

Query: 406 NLVKLLGFCVDGDEKL------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG--- 456
           N+V+L  F     EK       LV +++P  ++         R    + +    +     
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TV--------YRVARHYSRAKQTLPVIYV 158

Query: 457 ------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEAN 509
                 + + + Y+H      I HRD+K  N+LLD D    K+ DFG A+      GE N
Sbjct: 159 KLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPN 213

Query: 510 TVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGR 550
              I   Y Y APE  + G   Y+   DV+S G +L E++ G+
Sbjct: 214 VSYICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (267), Expect = 1e-25
 Identities = 58/267 (21%), Positives = 94/267 (35%), Gaps = 66/267 (24%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKN 406
           ++F     +G+GGFG V++     D    A+KR+     E    +   EV  + KL+H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 407 LVKLLGFCVDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKR-----------T 451
           +V+     ++      ++ +   ++ + S D  L  P        + R            
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 452 NIVNGIAKGMLYLH-----------------------EDSRLRI---------------- 472
            +     K  LY+                            L I                
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV----------RIVGTYGYMAP 522
           +HRDLK SN+    D   K+ DFG+     + E E   +            VGT  YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITG 549
           E      YS K D+FS G++L E++  
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYS 272

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  104 bits (262), Expect = 2e-25
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 39/212 (18%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILK-LQHKNLVK 409
           LG+G +G V   V     + VAVK     R   C E    E       I K L H+N+VK
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENVVK 69

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
             G   +G+ + L  E+   G L    FD      +                 ++ G+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGEL----FD-----RIEPDIGMPEPDAQRFFHQLMAGVV- 119

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
              YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y
Sbjct: 120 ---YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
           +APE      +  +  DV+S G++L  ++ G 
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  105 bits (264), Expect = 3e-25
 Identities = 68/212 (32%), Positives = 110/212 (51%), Gaps = 16/212 (7%)

Query: 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKL 402
           ++S F     LG G +  VYKG+  + G  VA+K +   SE+G   TA    E+ L+ +L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA--IREISLMKEL 60

Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPN---GSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
           +H+N+V+L       ++  LV+EFM N     +D+       RG+     +      + +
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY-FQWQLLQ 119

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           G+ + HE+   +I+HRDLK  N+L++     K+ DFG+AR F        +  +V T  Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TLWY 174

Query: 520 MAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
            AP+  M    YS   D++S G +L E+ITG+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (263), Expect = 4e-25
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
             +     +G+G +G VYK   S G+ VA+KR+   +E      T   E+ L+ +L H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80

Query: 407 LVKLLGFCVDGDEKLLVYEFMPN---GSLDA--ILFDPRKRGILCWRKRTNIVNGIAKGM 461
           +V L+          LV+EFM       LD         +  I  ++        + +G+
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ--------LLRGV 132

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            + H+    RI+HRDLK  N+L++SD   K++DFG+AR F      + T  +V T  Y A
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLWYRA 187

Query: 522 PEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
           P+  M    YS   D++S G +  E+ITG+
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  106 bits (266), Expect = 5e-25
 Identities = 53/218 (24%), Positives = 100/218 (45%), Gaps = 37/218 (16%)

Query: 357 LGQGGFGPVYKGV---LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G +G VYK       D K+ A+K++       +A    E+ L+ +L+H N++ L   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 86

Query: 414 CVD-GDEKL-LVYEFM-------------PNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
            +   D K+ L++++                 +   +         L ++        I 
Sbjct: 87  FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------IL 138

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS----KISDFGMARIF-AESEGEANTVRI 513
            G+ YLH +    ++HRDLK +N+L+  +       KI+D G AR+F +  +  A+   +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 514 VGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
           V T+ Y APE  +    Y+K  D+++ G +  E++T  
Sbjct: 196 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  104 bits (262), Expect = 6e-25
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 39/212 (18%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILK-LQHKNLVK 409
           LG+G +G V   V     + VAVK     R   C E    E       I K L H+N+VK
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENVVK 69

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
             G   +G+ + L  E+   G L    FD      +                 ++ G+  
Sbjct: 70  FYGHRREGNIQYLFLEYCSGGEL----FD-----RIEPDIGMPEPDAQRFFHQLMAGVV- 119

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
              YLH    + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y
Sbjct: 120 ---YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
           +APE      +  +  DV+S G++L  ++ G 
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (267), Expect = 1e-24
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 12/216 (5%)

Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEV 396
           LE   +    F D  +LG+GGFG V+   +    ++ A K+L+       +G      E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNI-V 454
            ++ K+  + +V L  +  +    L LV   M  G +   +++  +        R     
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             I  G+ +LH+     I++RDLK  NVLLD D N +ISD G+A      + +       
Sbjct: 296 AQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YA 350

Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           GT G+MAPE  +   Y    D F+ GV L E+I  R
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  103 bits (258), Expect = 2e-24
 Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 28/210 (13%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS----SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           LG+G +G V + +        AVK L          G A    E+ L+ +L+HKN+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71

Query: 412 GFCVDGDE---KL-LVYEFMPNGSLDAILFDPRKRGIL----CWRKRTNIVNGIAKGMLY 463
              V  +E   K+ +V E+   G  +  + D                  +++G+     Y
Sbjct: 72  -VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----Y 124

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV-GTYGYMAP 522
           LH      IVH+D+K  N+LL +    KIS  G+A          +T R   G+  +  P
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL-HPFAADDTCRTSQGSPAFQPP 180

Query: 523 EYAM-EGLYS-KKSDVFSFGVLLIEIITGR 550
           E A     +S  K D++S GV L  I TG 
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  103 bits (258), Expect = 3e-24
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 26/237 (10%)

Query: 321 HYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVK 379
           H+ H  G D   +   F    +++      + +  ++G+G +G V K      G+ VA+K
Sbjct: 5   HHHHSSGVDLGTENLYF----QSME----KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK 56

Query: 380 RLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN---GSLDA 434
           +     +    +     E+ L+ +L+H+NLV LL  C       LV+EF+ +     L+ 
Sbjct: 57  KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE- 115

Query: 435 ILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD 494
                     L ++     +  I  G+ + H      I+HRD+K  N+L+      K+ D
Sbjct: 116 -----LFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCD 167

Query: 495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
           FG AR  A + GE     +  T  Y APE  + +  Y K  DV++ G L+ E+  G 
Sbjct: 168 FGFARTLA-APGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  102 bits (257), Expect = 3e-24
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 350 NFSDSNILGQGGFGPVYKG-VLSDGKEVAVKRLSSCSEQG---TAEFTNEVLLILKLQHK 405
            +   + LG+G +  VYKG        VA+K +    E+G   TA    EV L+  L+H 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA--IREVSLLKDLKHA 60

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPN---GSLD--AILFDPRKRGILCWRKRTNIVNGIAKG 460
           N+V L           LV+E++       LD    + +     +  ++        + +G
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------LLRG 112

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + Y H     +++HRDLK  N+L++     K++DFG+AR  +    +     +V T  Y 
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWYR 167

Query: 521 APEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
            P+  +    YS + D++  G +  E+ TGR
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  103 bits (259), Expect = 3e-24
 Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 43/227 (18%)

Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKL---- 402
              F    + GQG FG V  G     G  VA+K++          F N  L I++     
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76

Query: 403 QHKNLVKLL------GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
            H N+V+L       G     D  L +V E++P+ +L         R    + +R     
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TL--------HRCCRNYYRRQVAPP 127

Query: 456 G---------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESE 505
                     + + +  LH  S + + HRD+K  NVL++    + K+ DFG A+    S 
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SP 184

Query: 506 GEANTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGR 550
            E N   I   Y Y APE  + G   Y+   D++S G +  E++ G 
Sbjct: 185 SEPNVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  101 bits (254), Expect = 4e-24
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNL 407
            +     +G+G +G VYK   + G+  A+K++    E      T   E+ ++ +L+H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLD-AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           VKL          +LV+E +     D   L D  + G+     ++  +  +  G+ Y H+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKS-FLLQLLNGIAYCHD 118

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
               R++HRDLK  N+L++ +   KI+DFG+AR F        T  IV T  Y AP+  M
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLWYRAPDVLM 173

Query: 527 -EGLYSKKSDVFSFGVLLIEIITGR 550
               YS   D++S G +  E++ G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  102 bits (257), Expect = 4e-24
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 22/217 (10%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
           S +     +GQG FG V+K      G++VA+K++   +E+     T   E+ ++  L+H+
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76

Query: 406 NLVKLLGFCVDGDEKL--------LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           N+V L+  C               LV++F  +  L  +L +   +  L   K   ++  +
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK--RVMQML 133

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN---TVRIV 514
             G+ Y+H +   +I+HRD+KA+NVL+  D   K++DFG+AR F+ ++       T R+V
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

Query: 515 GTYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
            T  Y  PE  + E  Y    D++  G ++ E+ T  
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  102 bits (257), Expect = 4e-24
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 25/214 (11%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE---FTN--EVLLILKL 402
             +   + LG+G F  VYK    +  + VA+K++         +    T   E+ L+ +L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 403 QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKR----GILCWRKRTNIVNGI 457
            H N++ LL         + LV++FM    L+ I+ D         I  +          
Sbjct: 70  SHPNIIGLLD-AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM------T 121

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
            +G+ YLH+     I+HRDLK +N+LLD +   K++DFG+A+ F  S   A T ++V T 
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV-TR 176

Query: 518 GYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
            Y APE      +Y    D+++ G +L E++   
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  102 bits (256), Expect = 4e-24
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 27/205 (13%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G+G F  V     +  G+EVA+K +  +  +     +   EV ++  L H N+VKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81

Query: 414 CVDGDEKL-LVYEFMPNGSLDAILFD-PRKRGIL----CWRKRTNIVNGIAKGMLYLHED 467
            ++ ++ L L+ E+   G +    FD     G +       K   IV+ +     Y H  
Sbjct: 82  VIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH-- 131

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA-NTVRIVGTYGYMAPEYAM 526
            + RIVHRDLKA N+LLD+DMN KI+DFG +  F  + G   +     G   Y APE   
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAF--CGAPPYAAPELFQ 186

Query: 527 EGLYS-KKSDVFSFGVLLIEIITGR 550
              Y   + DV+S GV+L  +++G 
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGS 211

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (262), Expect = 6e-24
 Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 13/215 (6%)

Query: 341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEV 396
           LE   +  + F    +LG+GGFG V    +    ++ A K+L        +G A   NE 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
            ++ K+  + +V L  +  +  + L LV   M  G L   ++   + G    R       
Sbjct: 236 QILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            I  G+  LH     RIV+RDLK  N+LLD   + +ISD G+A    E +        VG
Sbjct: 295 -ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKG--RVG 347

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T GYMAPE      Y+   D ++ G LL E+I G+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (253), Expect = 6e-24
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKN 406
            +     +G+G +G V+K       + VA+KR+    +      +   E+ L+ +L+HKN
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 407 LVKLLGFCVDGDEKL-LVYEFMPN---GSLD--AILFDPRKRGILCWRKRTNIVNGIAKG 460
           +V+L       D+KL LV+EF         D      DP       ++        + KG
Sbjct: 63  IVRLHDVLH-SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ--------LLKG 113

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + + H      ++HRDLK  N+L++ +   K+++FG+AR F        +  +V T  Y 
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TLWYR 168

Query: 521 APEYAM-EGLYSKKSDVFSFGVLLIEIITGRR 551
            P+      LYS   D++S G +  E+    R
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (252), Expect = 1e-23
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)

Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTN-EVLLILKLQH 404
            +F    ILG+G F  V      +  +E A+K L      ++    +   E  ++ +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 405 KNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILC-WRKR---TNIVNGIAK 459
              VKL     D DEKL     +  NG L   L   RK G       R     IV+ +  
Sbjct: 90  PFFVKLYFTFQD-DEKLYFGLSYAKNGEL---LKYIRKIGSFDETCTRFYTAEIVSALE- 144

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
              YLH      I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y
Sbjct: 145 ---YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           ++PE   E    K SD+++ G ++ +++ G 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  101 bits (253), Expect = 1e-23
 Identities = 48/200 (24%), Positives = 92/200 (46%), Gaps = 12/200 (6%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHKNLVKLL 411
             +G+G +G V+K      G+ VA+K+     +    +     E+ ++ +L+H NLV LL
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
                     LV+E+  + ++   L D  +RG+     + +I     + + + H   +  
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVK-SITWQTLQAVNFCH---KHN 122

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-EGLY 530
            +HRD+K  N+L+      K+ DFG AR+      +     +  T  Y +PE  + +  Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TRWYRSPELLVGDTQY 180

Query: 531 SKKSDVFSFGVLLIEIITGR 550
               DV++ G +  E+++G 
Sbjct: 181 GPPVDVWAIGCVFAELLSGV 200

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  103 bits (258), Expect = 3e-23
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 20/211 (9%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSC---SEQGTAEFTNE--VL-LILK 401
           ++FS   I+G+GGFG VY    +D  ++ A+K L       +QG     NE  +L L+  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
                +V +  +     +KL  + + M  G L    +   + G+            I  G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMRFYAAEIILG 304

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           + ++H      +V+RDLK +N+LLD   + +ISD G+A  F  S+ + +    VGT+GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHA--SVGTHGYM 357

Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           APE   +G+ Y   +D FS G +L +++ G 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 98.4 bits (246), Expect = 6e-23
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 24/219 (10%)

Query: 347 ATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN-----EVLLIL 400
           ATS +     +G G +G VYK      G  VA+K +   +  G           EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 401 KLQ---HKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLD-AILFDPRKRGILCWRKRT 451
           +L+   H N+V+L+  C     D + K+ LV+E +     D     D      L      
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIK 123

Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
           +++    +G+ +LH +    IVHRDLK  N+L+ S    K++DFG+ARI+  S   A T 
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTP 178

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
            +V T  Y APE  ++  Y+   D++S G +  E+   +
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 26/215 (12%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQHK 405
             +     LG+G +G VYK +     + VA+KR+    E+     T   EV L+ +LQH+
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPN---GSLDA-ILFDPRKRGILCWRKRTNIVNGIAKGM 461
           N+++L           L++E+  N     +D       R      ++        +  G+
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ--------LINGV 145

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNS-----KISDFGMARIFAESEGEANTVRIVGT 516
            + H     R +HRDLK  N+LL     S     KI DFG+AR F        T  I+ T
Sbjct: 146 NFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEII-T 200

Query: 517 YGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGR 550
             Y  PE  +    YS   D++S   +  E++   
Sbjct: 201 LWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 22/215 (10%)

Query: 349 SNFSDSNILGQGGFGPVYKG--VLSDGKEVAVKRLSSCSEQGTAEFTN--EVLLILKLQ- 403
             +     +G+G +G V+K   + + G+ VA+KR+   + +     +   EV ++  L+ 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70

Query: 404 --HKNLVKLL----GFCVDGDEKL-LVYEFMPNGSLD-AILFDPRKRGILCWRKRTNIVN 455
             H N+V+L         D + KL LV+E +     D     D      +      +++ 
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIKDMMF 127

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            + +G+ +LH     R+VHRDLK  N+L+ S    K++DFG+ARI+  S   A T  +V 
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVV- 181

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  Y APE  ++  Y+   D++S G +  E+   +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 95.4 bits (237), Expect = 2e-21
 Identities = 38/113 (33%), Positives = 58/113 (51%), Gaps = 15/113 (13%)

Query: 442 RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR-I 500
           +  L           +AKGM +L   +  + +HRDL A N+LL      KI DFG+AR I
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 501 FAESEGEANT-----VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT 548
           + + +          ++      +MAPE   + +Y+ +SDV+SFGVLL EI +
Sbjct: 244 YKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.7 bits (160), Expect = 9e-12
 Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 19/160 (11%)

Query: 355 NILGQGGFGPVYKGVL------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLILKL-QHKN 406
             LG+G FG V +         +  + VAVK L    +        +E+ +++ +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 407 LVKLLGFCVDGDEKLLV-YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           +V LLG C      L+V  EF   G+L   L            KR   V    KG  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
               +  +  DLK     + S  +S  S F   +  ++ E
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 34/209 (16%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKL-QHKNLVKLLG 412
           LG G FG V  G     G +VAVK L                 +  LKL +H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAKGML 462
                 +  +V E++  G L    FD      +C   R            I++ +     
Sbjct: 79  VISTPTDFFMVMEYVSGGEL----FD-----YICKHGRVEEMEARRLFQQILSAVD---- 125

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           Y H   R  +VHRDLK  NVLLD+ MN+KI+DFG++ +         T    G+  Y AP
Sbjct: 126 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS--CGSPNYAAP 179

Query: 523 EYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
           E     LY+  + D++S GV+L  ++ G 
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGT 208

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 93.6 bits (233), Expect = 8e-21
 Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 57/247 (23%)

Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN-EVLLILKLQHK 405
           +  +S    LG G FG V +    + GK  A+K++          + N E+ ++  L H 
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60

Query: 406 NLVKLL-GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRK--------------- 449
           N++KL+  F   GDE+    +   + +      +                          
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 450 --------RTNIVNG--------------IAKGMLYLHEDSRLRIVHRDLKASNVLLDSD 487
                   ++ I +G              + + + ++H    L I HRD+K  N+L++S 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSK 177

Query: 488 MNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEY---AMEGLYSKKSDVFSFGVLL 543
            N+ K+ DFG A+       E +   I   + Y APE    A E  Y+   D++S G + 
Sbjct: 178 DNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATE--YTPSIDLWSIGCVF 232

Query: 544 IEIITGR 550
            E+I G+
Sbjct: 233 GELILGK 239

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 93.2 bits (232), Expect = 9e-21
 Identities = 63/255 (24%), Positives = 100/255 (39%), Gaps = 58/255 (22%)

Query: 316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GK 374
            D +F+   +           F +           + +   +G G  G V     +   +
Sbjct: 7   RDNNFYSVEIGD-------STFTVL--------KRYQNLKPIGSGAQGIVCAAYDAILER 51

Query: 375 EVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLLG-FCVDGDEKL--- 421
            VA+K+LS         F N         E++L+  + HKN++ LL  F      +    
Sbjct: 52  NVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104

Query: 422 --LVYEFMPNGSLDAI----LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
             +V E M   +L  +    L   R   +L           +  G+ +LH      I+HR
Sbjct: 105 VYIVMELMDA-NLCQVIQMELDHERMSYLLY---------QMLCGIKHLHSAG---IIHR 151

Query: 476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSD 535
           DLK SN+++ SD   KI DFG+AR    S         V T  Y APE  +   Y +  D
Sbjct: 152 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILGMGYKENVD 208

Query: 536 VFSFGVLLIEIITGR 550
           ++S G ++ E+I G 
Sbjct: 209 IWSVGCIMGEMIKGG 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 93.5 bits (233), Expect = 9e-21
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 37/221 (16%)

Query: 350 NFSDSNIL---GQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILK-L 402
           NF    IL   G+G FG V     +D K++ A+K ++   C E+       + L I++ L
Sbjct: 13  NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72

Query: 403 QHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK-- 459
           +H  LV L  +    +E + +V + +  G L   L           ++  +      K  
Sbjct: 73  EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-----------QQNVHFKEETVKLF 120

Query: 460 ------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI 513
                  + YL      RI+HRD+K  N+LLD   +  I+DF +A +      +  T+  
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITTM-- 174

Query: 514 VGTYGYMAPE---YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
            GT  YMAPE         YS   D +S GV   E++ GRR
Sbjct: 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 53/219 (24%)

Query: 342 ETLNLATSNFSD-----SNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNE 395
             L +  +   D     S +LG G  G V +       ++ A+K L  C      +   E
Sbjct: 6   SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE 60

Query: 396 VLLILKL-QHKNLVKLLGFCVDGDEK----LLVYEFMPNGSL-DAILFDPRKRGILCW-- 447
           V L  +  Q  ++V+++    +        L+V E +  G L   I      RG   +  
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTE 116

Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNS--KISDFGMARIFAES 504
           R+ + I+  I + + YLH    + I HRD+K  N+L  S   N+  K++DFG        
Sbjct: 117 REASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG-------- 165

Query: 505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLL 543
                           A E   E  Y K  D++S GV++
Sbjct: 166 ---------------FAKETTGEK-YDKSCDMWSLGVIM 188

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.7 bits (233), Expect = 2e-20
 Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 40/212 (18%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
           LG G FG V  G     G +VAVK     ++ S    G      E+   LKL +H +++K
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQ-NLKLFRHPHIIK 80

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
           L        +  +V E++  G L    FD      +C   R +          I++G+  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGEL----FD-----YICKNGRLDEKESRRLFQQILSGVD- 130

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
              Y H   R  +VHRDLK  NVLLD+ MN+KI+DFG++ +         T    G+  Y
Sbjct: 131 ---YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTS--CGSPNY 181

Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
            APE     LY+  + D++S GV+L  ++ G 
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 91.6 bits (228), Expect = 3e-20
 Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 38/226 (16%)

Query: 348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAE--FTN---------EV 396
            S ++    +  G +G V  GV S+G  VA+KR+ +    G      ++         E+
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 397 LLILKLQHKNLVKLLG-FCVDGDEKL----LVYEFMPN------GSLDAILFDPRKRGIL 445
            L+    H N++ L   F    +  +    LV E M             ++     +   
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ--- 137

Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
                   +  I  G+  LHE     +VHRDL   N+LL  + +  I DF +AR      
Sbjct: 138 ------YFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
              N    V    Y APE  M+   ++K  D++S G ++ E+   +
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 34/208 (16%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G G FG           + VAVK +             E++    L+H N+V+     +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAKGMLYLH 465
                 ++ E+   G L    ++      +C   R +          +++G++    Y H
Sbjct: 87  TPTHLAIIMEYASGGEL----YE-----RICNAGRFSEDEARFFFQQLLSGVS----YCH 133

Query: 466 EDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
               ++I HRDLK  N LLD       KI DFG ++       +  +   VGT  Y+APE
Sbjct: 134 ---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST--VGTPAYIAPE 187

Query: 524 YAMEGLYS-KKSDVFSFGVLLIEIITGR 550
             +   Y  K +DV+S GV L  ++ G 
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.8 bits (223), Expect = 5e-20
 Identities = 25/201 (12%), Positives = 56/201 (27%), Gaps = 45/201 (22%)

Query: 357 LGQGGFGPVYKGVLSD---GKEVAVKRL---SSCSEQGTAEFTNEVLLILKLQHKNLVKL 410
            G       ++ +  D    ++VA+  +       +    E  +  L + ++    + ++
Sbjct: 39  HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           L         L+V E++  GSL  +                  +  +A      H   R 
Sbjct: 97  LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RA 148

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
            +       S V +  D                  G+     ++     M          
Sbjct: 149 GVALSIDHPSRVRVSID------------------GDV----VLAYPATMPDA------- 179

Query: 531 SKKSDVFSFGVLLIEIITGRR 551
           + + D+   G  L  ++  R 
Sbjct: 180 NPQDDIRGIGASLYALLVNRW 200

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 91.8 bits (228), Expect = 6e-20
 Identities = 61/254 (24%), Positives = 96/254 (37%), Gaps = 56/254 (22%)

Query: 316 NDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGK 374
            D  F+   V           F +           + +   +G G  G V         +
Sbjct: 44  VDNQFYSVEVGD-------STFTVL--------KRYQNLKPIGSGAQGIVCAAYDAVLDR 88

Query: 375 EVAVKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL------GFCVDGDE 419
            VA+K+LS         F N         E++L+  + HKN++ LL          +  +
Sbjct: 89  NVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141

Query: 420 KLLVYEFMP---NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD 476
             LV E M       +   L   R   +L           +  G+ +LH      I+HRD
Sbjct: 142 VYLVMELMDANLCQVIQMELDHERMSYLLY---------QMLCGIKHLHS---AGIIHRD 189

Query: 477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDV 536
           LK SN+++ SD   KI DFG+AR    S         V T  Y APE  +   Y +  D+
Sbjct: 190 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVILGMGYKENVDI 246

Query: 537 FSFGVLLIEIITGR 550
           +S G ++ E++  +
Sbjct: 247 WSVGCIMGEMVRHK 260

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 36/211 (17%)

Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKL 410
           LGQG FG V+   K   SD +++ A+K L   +   +       E  +++++ H  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKR----GILCWRKRTNIVNGIAK 459
             +    + KL L+ +F+  G L       ++F     +     +               
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------------- 137

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
            + +LH    L I++RDLK  N+LLD + + K++DFG+++   + E +A +    GT  Y
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192

Query: 520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           MAPE      +++ +D +SFGVL+ E++TG 
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 41/212 (19%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVK-----RLSSCSEQGTAEFTNEVLLILKL-QHKNLVK 409
           LG+G FG V         ++VA+K      L         E   E+   LKL +H +++K
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REIS-YLKLLRHPHIIK 73

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN----------IVNGIAK 459
           L        + ++V E+   G L    FD      +  +KR            I+  I  
Sbjct: 74  LYDVITTPTDIVMVIEYA-GGEL----FD-----YIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
              Y H   R +IVHRDLK  N+LLD ++N KI+DFG++ I         T    G+  Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTS--CGSPNY 173

Query: 520 MAPEYAMEGLYS-KKSDVFSFGVLLIEIITGR 550
            APE     LY+  + DV+S G++L  ++ GR
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 62/249 (24%), Positives = 101/249 (40%), Gaps = 53/249 (21%)

Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVA 377
            F+ Q V           + +           +     +G G +G V   +    G++VA
Sbjct: 9   GFYKQDVNK-------TAWEL--------PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVA 53

Query: 378 VKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL-----GFCVDGDEKL-L 422
           +K+LS         F +         E+LL+  +QH+N++ LL        +       L
Sbjct: 54  IKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYL 106

Query: 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482
           V  FM    L  I+            K   +V  + KG+ Y+H      +VHRDLK  N+
Sbjct: 107 VMPFMQT-DLQKIM-----GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNL 157

Query: 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGV 541
            ++ D   KI DFG+AR              V T  Y APE  +    Y++  D++S G 
Sbjct: 158 AVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212

Query: 542 LLIEIITGR 550
           ++ E++TG+
Sbjct: 213 IMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 17/212 (8%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHK 405
              +++ + +G+G +G V       +   VA+K++S    Q   + T  E+ ++L+ +H+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85

Query: 406 NLVKLLG-FCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           N++ +         E++    +V + M    L  +L    K   L        +  I +G
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLSNDHICYFLYQILRG 140

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-RIVGTYGY 519
           + Y+H  +   ++HRDLK SN+LL++  + KI DFG+AR+          +   V T  Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 520 MAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            APE  +    Y+K  D++S G +L E+++ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 44/230 (19%)

Query: 348 TSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTN---------EVL 397
            S + D   LG GG G V+  V +D  K VA+K++           T+         E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60

Query: 398 LILKLQHKNLVKLL--------------GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRG 443
           +I +L H N+VK+               G   + +   +V E+M    L  +L    ++G
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----EQG 115

Query: 444 ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFA 502
            L        +  + +G+ Y+H  +   ++HRDLK +N+ +++ D+  KI DFG+ARI  
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 503 ESEGEANTV-RIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
                   +   + T  Y +P   +    Y+K  D+++ G +  E++TG+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 56/235 (23%), Positives = 96/235 (40%), Gaps = 29/235 (12%)

Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
            A+   + L+ + L   +F    ++G+G F  V    +    +V A+K ++     ++G 
Sbjct: 45  WAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE 104

Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
                E   +L     + + +L  F    +  L LV E+   G L   L    K G    
Sbjct: 105 VSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDL---LTLLSKFGERIP 160

Query: 448 RKRTN-----IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA 502
            +        IV  I      +H    L  VHRD+K  N+LLD   + +++DFG      
Sbjct: 161 AEMARFYLAEIVMAID----SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKL- 212

Query: 503 ESEGEANTVRIVGTYGYMAPE-------YAMEGLYSKKSDVFSFGVLLIEIITGR 550
            ++G   ++  VGT  Y++PE           G Y  + D ++ GV   E+  G+
Sbjct: 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 33/236 (13%)

Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
            A+ F   ++ + L   +F    ++G+G FG V    L +  +V A+K L+     ++  
Sbjct: 58  WAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE 117

Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
                E   +L     K +  L  +    D  L LV ++   G L  +L           
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS---------- 166

Query: 448 RKRTNIVNGIAK--------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR 499
           +    +   +A+         +  +H+   L  VHRD+K  N+L+D + + +++DFG   
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCL 223

Query: 500 IFAESEGEANTVRIVGTYGYMAPE-----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
              E +G   +   VGT  Y++PE        +G Y  + D +S GV + E++ G 
Sbjct: 224 KLME-DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 37/220 (16%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTN---------EVL 397
            + + D   +G G +G V   V    G +VA+K+L          F +         E+ 
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76

Query: 398 LILKLQHKNLVKLLG-FCVDGDEKL-----LVYEFMPNGSLDAILFDPRKRGILCWRKRT 451
           L+  ++H+N++ LL  F  D          LV  FM    L  ++    K   L   +  
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQ 131

Query: 452 NIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV 511
            +V  + KG+ Y+H      I+HRDLK  N+ ++ D   KI DFG+AR            
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--- 185

Query: 512 RIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
             V T  Y APE  +    Y++  D++S G ++ E+ITG+
Sbjct: 186 --VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.4 bits (216), Expect = 3e-18
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 23/212 (10%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCSEQGTAEFTNEV--------LLI 399
           ++F+   +LG+G FG V         E+ AVK L     +      ++V        +L 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRVLA 396

Query: 400 LKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           L  +   L +L   C    ++L  V E++  G L   ++  ++ G             IA
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIA 452

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
            G+ +L       I++RDLK  NV+LDS+ + KI+DFGM +          T    GT  
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPD 507

Query: 519 YMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           Y+APE      Y K  D ++FGVLL E++ G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 57/231 (24%), Positives = 102/231 (44%), Gaps = 26/231 (11%)

Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEV-AVKRLSSCS--EQGT 389
           + +D    +  L +   ++    ++G+G FG V        ++V A+K LS     ++  
Sbjct: 53  RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 112

Query: 390 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCW 447
           + F  E   I+       +V+L  +    D  L +V E+MP G L  ++       +   
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEK 168

Query: 448 RKR---TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA-RIFAE 503
             R     +V  +      +H    +  +HRD+K  N+LLD   + K++DFG   ++  E
Sbjct: 169 WARFYTAEVVLALD----AIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221

Query: 504 SEGEANTVRIVGTYGYMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGR 550
                +T   VGT  Y++PE       +G Y ++ D +S GV L E++ G 
Sbjct: 222 GMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT-NEVLLILKLQHK 405
           +S+F   ++LG+G +G V        G+ VA+K++    +   A  T  E+ ++   +H+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69

Query: 406 NLVKLLG-FCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           N++ +      D  E      ++ E M    L  ++       +L        +    + 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLSDDHIQYFIYQTLRA 124

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI------- 513
           +  LH  +   ++HRDLK SN+L++S+ + K+ DFG+ARI  ES  + +           
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 514 -VGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGR 550
            V T  Y APE  +    YS+  DV+S G +L E+   R
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 85.6 bits (212), Expect = 6e-18
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 25/205 (12%)

Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLG 412
           LG+G FG V            A+K L       +     T  E  ++   +H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214

Query: 413 FCVDGDEKL-LVYEFMPNGSL------DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           +     ++L  V E+   G L      + +  + R R              I   + YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSALDYLH 265

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
             S   +V+RDLK  N++LD D + KI+DFG+ +   +      T    GT  Y+APE  
Sbjct: 266 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVL 321

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
            +  Y +  D +  GV++ E++ GR
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGR 346

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 42/215 (19%)

Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLSS---CSEQGTAEFT---NEVLLILKLQHKN 406
           LG+GG+G V+   K   ++  ++ A+K L              T     +L   +++H  
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE--EVKHPF 82

Query: 407 LVKLLGFCVDGDEKL-LVYEFMPNGSL------DAILFDPRKR----GILCWRKRTNIVN 455
           +V L+ +      KL L+ E++  G L      + I  +         I           
Sbjct: 83  IVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM--------- 132

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
                + +LH+     I++RDLK  N++L+   + K++DFG+ +         +T    G
Sbjct: 133 ----ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCG 183

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           T  YMAPE  M   +++  D +S G L+ +++TG 
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 60/257 (23%), Positives = 96/257 (37%), Gaps = 45/257 (17%)

Query: 306 QIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV 365
           Q  + +       DF  +      N  +   F        + T        LG G FG V
Sbjct: 12  QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDR------IKT--------LGTGSFGRV 57

Query: 366 YKGVLSDGKEV-AVKRLS--SCSEQGTAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKL 421
                 +     A+K L      +    E T NE  ++  +    LVKL     D     
Sbjct: 58  MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117

Query: 422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK--------GMLYLHEDSRLRIV 473
           +V E++  G + + L           R+        A+           YLH    L ++
Sbjct: 118 MVMEYVAGGEMFSHL-----------RRIGRFSEPHARFYAAQIVLTFEYLHS---LDLI 163

Query: 474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           +RDLK  N+L+D     +++DFG A+     +G   T  + GT   +APE  +   Y+K 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT--LCGTPEALAPEIILSKGYNKA 218

Query: 534 SDVFSFGVLLIEIITGR 550
            D ++ GVL+ E+  G 
Sbjct: 219 VDWWALGVLIYEMAAGY 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 20/202 (9%)

Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
           LG+G FG V            A+K L       +     T   + VL     +H  L  L
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ--NTRHPFLTAL 70

Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHEDS 468
             +     ++L  V E+   G L    F   +  +    +R       I   + YLH   
Sbjct: 71  K-YAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALEYLHS-- 123

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              +V+RD+K  N++LD D + KI+DFG+ +          T    GT  Y+APE   + 
Sbjct: 124 -RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDN 180

Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
            Y +  D +  GV++ E++ GR
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 29/207 (14%)

Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
           LG+G FG V    + +  ++ AVK L      +    E T     +L  L   H  L +L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS-LARNHPFLTQL 89

Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKRGILCWRKRTNIVNGIAKGMLY 463
              C    ++L  V EF+  G L      +  FD  R R              I   +++
Sbjct: 90  F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA---------EIISALMF 139

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           LH+     I++RDLK  NVLLD + + K++DFGM +    +     T    GT  Y+APE
Sbjct: 140 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPE 194

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGR 550
              E LY    D ++ GVLL E++ G 
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 36/229 (15%)

Query: 338 FIDLETLNLA---TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFT 393
           + D E+  +      ++     LG+G +  V++ + +++ ++V VK L    ++   +  
Sbjct: 22  YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 78

Query: 394 NEVLLILKLQ-HKNLVKLLGFCVDGDEK--LLVYEFMPNGSLDAI---LFDPRKRGILCW 447
            E+ ++  L+   N++ L     D   +   LV+E + N     +   L D   R  +  
Sbjct: 79  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-- 136

Query: 448 RKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEG 506
                    I K + Y H  S   I+HRD+K  NV++D +    ++ D+G+A  +    G
Sbjct: 137 -------YEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPG 184

Query: 507 EANTVRIVGTYGYMAPE----YAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           +   VR+   Y +  PE    Y M   Y    D++S G +L  +I  + 
Sbjct: 185 QEYNVRVASRY-FKGPELLVDYQM---YDYSLDMWSLGCMLASMIFRKE 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 62/249 (24%), Positives = 106/249 (42%), Gaps = 52/249 (20%)

Query: 319 DFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVA 377
            F+ Q +           + +           + + + +G G +G V     +  G  VA
Sbjct: 14  TFYRQELNK-------TIWEVP--------ERYQNLSPVGSGAYGSVCAAFDTKTGLRVA 58

Query: 378 VKRLSSCSEQGTAEFTN---------EVLLILKLQHKNLVKLL-----GFCVDGDEKL-L 422
           VK+LS         F +         E+ L+  ++H+N++ LL        ++    + L
Sbjct: 59  VKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 111

Query: 423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV 482
           V   M    L+ I+    K   L       ++  I +G+ Y+H      I+HRDLK SN+
Sbjct: 112 VTHLMGA-DLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNL 163

Query: 483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGV 541
            ++ D   KI DFG+AR  A+          V T  Y APE  +    Y++  D++S G 
Sbjct: 164 AVNEDCELKILDFGLARHTADEMTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGC 218

Query: 542 LLIEIITGR 550
           ++ E++TGR
Sbjct: 219 IMAELLTGR 227

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 29/207 (14%)

Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
           +G+G FG V        +   AVK L   +  ++   +       VLL   ++H  LV L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL-KNVKHPFLVGL 104

Query: 411 LGFCVDGDEKL-LVYEFMPNGSL-----DAILFD-PRKRGILCWRKRTNIVNGIAKGMLY 463
             F     +KL  V +++  G L         F  PR R              IA  + Y
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------EIASALGY 154

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           LH    L IV+RDLK  N+LLDS  +  ++DFG+ +   E     +T    GT  Y+APE
Sbjct: 155 LHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPE 209

Query: 524 YAMEGLYSKKSDVFSFGVLLIEIITGR 550
              +  Y +  D +  G +L E++ G 
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFTNEVLLILKLQHKN--LVKLL 411
           LG+G FG V+        +  A+K L           E T     +L L  ++  L  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 412 GFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
                  E L  V E++  G L   ++  +        + T     I  G+ +LH     
Sbjct: 85  -CTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLHS---K 137

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
            IV+RDLK  N+LLD D + KI+DFGM +     + + NT    GT  Y+APE  +   Y
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKY 195

Query: 531 SKKSDVFSFGVLLIEIITGR 550
           +   D +SFGVLL E++ G+
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQ 215

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 19/203 (9%)

Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVK 409
           ++G+G +  V    L     + A+K +     ++    ++      V       H  LV 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE-QASNHPFLVG 74

Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
           L   C   + +L  V E++  G L   +F  +++  L   +     +  I+  + YLHE 
Sbjct: 75  LH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNYLHE- 128

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
               I++RDLK  NVLLDS+ + K++D+GM +         +T    GT  Y+APE    
Sbjct: 129 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRG 184

Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
             Y    D ++ GVL+ E++ GR
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGR 207

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 62/201 (30%), Positives = 90/201 (44%), Gaps = 17/201 (8%)

Query: 357 LGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVKL 410
           LG+G FG V         E+ AVK L      +    E T     VL  L  +   L +L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPGKPPFLTQL 86

Query: 411 LGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
              C    ++L  V E++  G L   ++  ++ G             IA G+ +L     
Sbjct: 87  H-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS--- 139

Query: 470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL 529
             I++RDLK  NV+LDS+ + KI+DFGM +          T    GT  Y+APE      
Sbjct: 140 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEIIAYQP 197

Query: 530 YSKKSDVFSFGVLLIEIITGR 550
           Y K  D ++FGVLL E++ G+
Sbjct: 198 YGKSVDWWAFGVLLYEMLAGQ 218

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 51/251 (20%), Positives = 99/251 (39%), Gaps = 55/251 (21%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LL 398
              +   +++G G +G V +     + + VA+K++          F + +        + 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 399 ILK-LQHKNLVKLLGFCV----DGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
           IL  L H ++VK+L   +    +  ++L +V E   +     +    R    L       
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLF---RTPVYLTELHIKT 160

Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
           ++  +  G+ Y+H  S   I+HRDLK +N L++ D + K+ DFG+AR     E   + + 
Sbjct: 161 LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217

Query: 513 IVGTYG-------------------------YMAPEYAM-EGLYSKKSDVFSFGVLLIEI 546
           I                              Y APE  + +  Y++  DV+S G +  E+
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

Query: 547 ITGRRNAGSNQ 557
           +   +   +  
Sbjct: 278 LNMIKENVAYH 288

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.0 bits (203), Expect = 6e-17
 Identities = 53/203 (26%), Positives = 92/203 (45%), Gaps = 19/203 (9%)

Query: 356 ILGQGGFGPVYKGVLSDGKEV-AVKRLS--SCSEQGTAEFT---NEVLLILKLQHKNLVK 409
           ++G+G +  V    L     + A++ +     ++    ++      V       H  LV 
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFE-QASNHPFLVG 117

Query: 410 LLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLHED 467
           L   C   + +L  V E++  G L   +F  +++  L   +     +  I+  + YLHE 
Sbjct: 118 LH-SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLP-EEHARFYSAEISLALNYLHE- 171

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
               I++RDLK  NVLLDS+ + K++D+GM +         +T    GT  Y+APE    
Sbjct: 172 --RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEILRG 227

Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
             Y    D ++ GVL+ E++ GR
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGR 250

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 55/272 (20%), Positives = 107/272 (39%), Gaps = 55/272 (20%)

Query: 324 HVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS 382
           H     +  +   +F  ++ +++   N+   +++G+G +G VY     +  K VA+K+++
Sbjct: 2   HHHHHHSSGRENLYFQGIKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60

Query: 383 SCSEQGTAEFTNEV--------LLILK-LQHKNLVKLLG-FCVDGDEKL----LVYEFMP 428
                    F + +        + IL  L+   +++L      D   K     +V E   
Sbjct: 61  RM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD 113

Query: 429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM 488
           +  L  +    +    L       I+  +  G  ++HE     I+HRDLK +N LL+ D 
Sbjct: 114 S-DLKKLF---KTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDC 166

Query: 489 NSKISDFGMARIFAESEGEANTVRI--------------------VGTYGYMAPE---YA 525
           + K+ DFG+AR     +       +                    V T  Y APE     
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ 557
               Y+K  D++S G +  E++   ++  ++ 
Sbjct: 227 EN--YTKSIDIWSTGCIFAELLNMLQSHINDP 256

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.7 bits (195), Expect = 3e-16
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)

Query: 349 SNFSDSNILGQGGFGPVY----KGVLSDGKEVAVKRLS--SCSEQGTAEFT-NEVLLILK 401
            +F     LG G FG V+    +    +G+  A+K L           E T +E L++  
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 402 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK- 459
           + H  ++++ G   D  +++ ++ +++  G L ++L   RK             N +AK 
Sbjct: 63  VTHPFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLL---RKSQRF--------PNPVAKF 110

Query: 460 -------GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR 512
                   + YLH      I++RDLK  N+LLD + + KI+DFG A+          T  
Sbjct: 111 YAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT-- 162

Query: 513 IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           + GT  Y+APE      Y+K  D +SFG+L+ E++ G 
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 79.3 bits (196), Expect = 4e-16
 Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 48/236 (20%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEV--------LL 398
              +     LG+G +G V+K +    G+ VAVK++          F N          ++
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60

Query: 399 ILKL--QHKNLVKLLG-FCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
           IL     H+N+V LL     D D  + LV+++M    L A++    +  IL    +  +V
Sbjct: 61  ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----RANILEPVHKQYVV 115

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRI- 513
             + K + YLH  S   ++HRD+K SN+LL+++ + K++DFG++R F       N + + 
Sbjct: 116 YQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 514 ------------------VGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
                             V T  Y APE  +    Y+K  D++S G +L EI+ G+
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 26/209 (12%)

Query: 357 LGQGGFGPVY---KGVLSDGKEV-AVKRLSS---CSEQGTAEFTNEVLLILKLQHKN--L 407
           LG G +G V+   K    D  ++ A+K L       +  T E T     +L+   ++  L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 408 VKLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG-IAKGMLYLH 465
           V L  +    + KL L+ +++  G L        +R          I  G I   + +LH
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL---FTHLSQRERFT-EHEVQIYVGEIVLALEHLH 176

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPE- 523
           +   L I++RD+K  N+LLDS+ +  ++DFG+++ F   E E A      GT  YMAP+ 
Sbjct: 177 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEYMAPDI 231

Query: 524 --YAMEGLYSKKSDVFSFGVLLIEIITGR 550
                 G + K  D +S GVL+ E++TG 
Sbjct: 232 VRGGDSG-HDKAVDWWSLGVLMYELLTGA 259

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 38/220 (17%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILK---------LQH 404
            LG G F  V+    + +   VA+K +         AE   ++L  +          +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 405 KNLVKLLG-FCVDGDEKL---LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
            +++KLL  F   G   +   +V+E +   +L A++     RGI         V  I+K 
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI-----PLIYVKQISKQ 139

Query: 461 ML----YLHEDSRLRIVHRDLKASNVLLDSDMNS------KISDFGMARIFAESEGEANT 510
           +L    Y+H   R  I+H D+K  NVL++   +       KI+D G A        + + 
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYDEHY 192

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
              + T  Y +PE  +   +   +D++S   L+ E+ITG 
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.4 bits (161), Expect = 6e-12
 Identities = 39/257 (15%), Positives = 75/257 (29%), Gaps = 67/257 (26%)

Query: 345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRL--------SSCSEQGTAEFTNEV 396
            L T        +G+G FG V++ +  D   VA+K +        +   ++   E   E+
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 397 LLILKLQ---------HKNLVKLLGFCV------------------------------DG 417
           ++  +L           +  + L                                     
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL 477
           D+  +V EF   G       +  +  +       +I++ +   +        LR  HRDL
Sbjct: 135 DQLFIVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDL 188

Query: 478 KASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP--EYAMEGLYSKKSD 535
              NVLL      K+      +              + + G      +Y +  L      
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIV 237

Query: 536 VFSFGVLLIEIITGRRN 552
           VF    +  ++ TG  +
Sbjct: 238 VFCDVSMDEDLFTGDGD 254

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.2 bits (154), Expect = 7e-11
 Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 60/282 (21%)

Query: 290 FATKKITRKRKGTARKQIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATS 349
             T+ +  +   + +K+ +++  G  +D ++ Y    G              E       
Sbjct: 13  LGTENLYFQSMSSHKKERKVYNDG-YDDDNYDYIVKNG--------------EKWM---D 54

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQ-- 403
            +   +++G+G FG V K     + + VA+K      +   Q   E    +L ++     
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEV--RLLELMNKHDT 112

Query: 404 --HKNLVKLLGF-------CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIV 454
                +V L          C       LV+E + + +L  +L +   RG+       N+ 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLC-------LVFEML-SYNLYDLLRNTNFRGV-----SLNLT 159

Query: 455 NGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEA 508
              A+ M     +L     L I+H DLK  N+LL +   S  KI DFG +       G+ 
Sbjct: 160 RKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQR 214

Query: 509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
               I   + Y +PE  +   Y    D++S G +L+E+ TG 
Sbjct: 215 IYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 36/214 (16%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G G FG +  G  L   + VA+K     S              L      + ++  F  
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFGP 75

Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRK---RTNIVNGIAKGML----YLHED 467
            G    +V E +  G SL+  LFD      LC R    +T  V  IA  ++    Y+H  
Sbjct: 76  CGKYNAMVLELL--GPSLED-LFD------LCDRTFSLKT--VLMIAIQLISRMEYVHSK 124

Query: 468 SRLRIVHRDLKASNVLLDSDMNSK-----ISDFGMARIFAESEGEA-----NTVRIVGTY 517
           +   +++RD+K  N L+    N       I DF +A+ + + E +          + GT 
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

Query: 518 GYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            YM+      G   S++ D+ + G + +  + G 
Sbjct: 182 RYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 52/220 (23%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQ----HKNL 407
           ++G+G FG V K       + VA+K + +      Q   E    +L  L+ Q      N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI--RILEHLRKQDKDNTMNV 161

Query: 408 VKLLGF-------CVDGDEKLL---VYEFMPNG-----SLDAILFDPRKRGILCWRKRTN 452
           + +L         C+  +  LL   +YE +        SL  +            RK   
Sbjct: 162 IHMLENFTFRNHICMTFE--LLSMNLYELIKKNKFQGFSLPLV------------RK--- 204

Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANT 510
             + I + +  LH   + RI+H DLK  N+LL     S  K+ DFG +      E +   
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVY 257

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
             I   + Y APE  +   Y    D++S G +L E++TG 
Sbjct: 258 TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 30/210 (14%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G G FG +Y G  ++ G+EVA+K     ++       +++  +++     +  +     
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-GGVGIPTIRWCGA 75

Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRT-NIVNGIAKGML----YLHEDSR 469
           +GD  ++V E +  G SL+  LF+       C RK +   V  +A  M+    Y+H  + 
Sbjct: 76  EGDYNVMVMELL--GPSLED-LFN------FCSRKFSLKTVLLLADQMISRIEYIHSKN- 125

Query: 470 LRIVHRDLKASNVLLDSDMNSK---ISDFGMARIFAESEGEA-----NTVRIVGTYGYMA 521
              +HRD+K  N L+          I DFG+A+ + ++             + GT  Y A
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182

Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
                 G+  S++ D+ S G +L+    G 
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 32/211 (15%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV-KLLGFC 414
           +G G FG +Y G  +   +EVA+K  +  ++     +  E  +   LQ    +  +  F 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWFG 72

Query: 415 VDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRT-NIVNGIAKGML----YLHEDS 468
           V+GD  +LV + +  G SL+  LF+       C RK +   V  +A  M+    ++H  S
Sbjct: 73  VEGDYNVLVMDLL--GPSLED-LFN------FCSRKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 469 RLRIVHRDLKASNVLLDSDMNSK---ISDFGMARIFAESEGEA-----NTVRIVGTYGYM 520
               +HRD+K  N L+     +    I DFG+A+ + ++             + GT  Y 
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY- 179

Query: 521 APEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           A      G+  S++ D+ S G +L+  + G 
Sbjct: 180 ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 53/264 (20%), Positives = 91/264 (34%), Gaps = 86/264 (32%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL-SSCSEQGTAEFTNEVLLILK------LQHKNLV 408
           LG G F  V+    +   K VA+K + S+     TA     +L  ++         + +V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 409 KLLG-FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN-------IVNGIAKG 460
           +LL  F + G           NG+   ++F+     +L W  ++N        V  I + 
Sbjct: 105 QLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154

Query: 461 ML----YLHEDSRLRIVHRDLKASNVLL-------------------------------- 484
           +L    YLH  ++ RI+H D+K  N+LL                                
Sbjct: 155 VLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 485 -----------------DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
                               +  KI+D G A    +   E      + T  Y + E  + 
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIG 267

Query: 528 GLYSKKSDVFSFGVLLIEIITGRR 551
             Y+  +D++S   +  E+ TG  
Sbjct: 268 SGYNTPADIWSTACMAFELATGDY 291

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 36/214 (16%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           +G+G FG +++G  L + ++VA+K     S+            +L      +  +  F  
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGIPNVYYFGQ 76

Query: 416 DGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRK---RTNIVNGIAKGML----YLHED 467
           +G   +LV + +  G SL+  L D      LC RK   +T  V   AK ML     +HE 
Sbjct: 77  EGLHNVLVIDLL--GPSLED-LLD------LCGRKFSVKT--VAMAAKQMLARVQSIHEK 125

Query: 468 SRLRIVHRDLKASNVLLDSDMNSK-----ISDFGMARIFAESEGEA-----NTVRIVGTY 517
           S   +V+RD+K  N L+    +       + DFGM + + +   +          + GT 
Sbjct: 126 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 518 GYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            Y        G   S++ D+ + G + +  + G 
Sbjct: 183 RY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 32/175 (18%), Positives = 66/175 (37%), Gaps = 37/175 (21%)

Query: 357 LGQGGFGPVYKGV---------LSDGKEVAVKRLSS----CSEQGTAEFTNEVLLILKLQ 403
             +   G +Y+               ++ ++K  +      +EQ   +   + L + K +
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 404 HKNLVKLLGF-------CVDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVN 455
                 LL               + LV   +  G SL +   D   + +L   +R+  V 
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLS--ERS--VL 162

Query: 456 GIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAES 504
            +A  +L    +LHE+     VH ++ A N+ +D +  S++  + +G A  +  S
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 47/231 (20%), Positives = 85/231 (36%), Gaps = 52/231 (22%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSC-----------SEQGTAEFTNEVLLILKLQHK 405
           +GQGGFG +Y   ++  + V                   +E    +   +   I K    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 406 NLVKLLGFCV-----DGDEKLLVYEFM------PNGSLDAILFDPRKRGILCWRK---RT 451
             +K LG          D+    Y FM          L   +++         ++   +T
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQK-IYE------ANAKRFSRKT 153

Query: 452 NIVNGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAESE 505
             V  ++  +L    Y+HE      VH D+KASN+LL+     ++   D+G+A  +    
Sbjct: 154 --VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 506 G-----EANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
                         GT  + + + A  G+  S++ D+   G  +I+ +TG 
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSID-AHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 52/237 (21%), Positives = 84/237 (35%), Gaps = 70/237 (29%)

Query: 356 ILGQGGFGPVYKGV--LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQ----HKN 406
            LG+G FG V + +       +VA+K    +    E    E    VL  +K +       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI--NVLKKIKEKDKENKFL 83

Query: 407 LVKLLGF-------CVDGDEKLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVN 455
            V +  +       C       + +E      L    F+  K    +           V 
Sbjct: 84  CVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENNFQPY-----PLPHVR 126

Query: 456 GIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNS-------------------KI 492
            +A  +     +LHE    ++ H DLK  N+L  +                       ++
Sbjct: 127 HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           +DFG A  F   + E +T  IV T  Y  PE  +E  +++  DV+S G +L E   G
Sbjct: 184 ADFGSA-TF---DHEHHT-TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 4e-06
 Identities = 83/558 (14%), Positives = 152/558 (27%), Gaps = 185/558 (33%)

Query: 19  HDLAFGDS---PPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAAKFSNASFGNDSD 75
            D  + D+     YN+         R       L+  L  L    N              
Sbjct: 116 RDRLYNDNQVFAKYNVS--------RLQPYL-KLRQALLELRPAKNVL------------ 154

Query: 76  RVYGLYM------CLNYISAETCNDCITTASQDISKLCPNKTEAIVW------------- 116
            + G  +       +   + + C          +      K   I W             
Sbjct: 155 -IDG--VLGSGKTWV---ALDVCLS------YKVQCKMDFK---IFWLNLKNCNSPETVL 199

Query: 117 EEVCQLRY-AYQNFFGQLDVSGNIP-----------------KYNR-L----NISEPE-- 151
           E + +L Y    N+  + D S NI                   Y   L    N+   +  
Sbjct: 200 EMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAW 259

Query: 152 -------------RYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCT- 197
                        R++ V +   +   T +S            +  T  +    L++   
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHH-------SMTLTPDEVKSLLLKYLD 312

Query: 198 ---KDLPADDCITCLHNATADILSCCYFSRGARL---LSRNCYLRYELYAFYKGATEPSI 251
              +DLP +         T +            +   L+     ++          E S+
Sbjct: 313 CRPQDLPREVL-------TTNPRRLSII--AESIRDGLATWDNWKHVNCDKLTTIIESSL 363

Query: 252 LAGNQASGGGKQRKMWMIIVL---ASVVALLLVVFASTGYFFATKKITRK--RKGTARKQ 306
              N       ++    + V    A +  +LL +            +  K  +     KQ
Sbjct: 364 ---NVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420

Query: 307 -----IQLH------KIGDANDTDFH------YQHVQGRDNDLKAQDFFIDLETLNLATS 349
                I +       K+   N+   H      Y   +  D+D    D             
Sbjct: 421 PKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD----DLIPPYL------D 470

Query: 350 NFSDSNI------LGQGGFGPVYKGVLSDGKEVAVK-RLSSCSEQGTAEFTNEVLLILKL 402
            +  S+I      +       +++ V  D + +  K R  S +   +    N  L  LK 
Sbjct: 471 QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKF 529

Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-FDPRKRGILCWRKRTNIVNGIA--- 458
                     +  D D K   YE +    ++AIL F P+    L   K T+++  IA   
Sbjct: 530 YKP-------YICDNDPK---YERL----VNAILDFLPKIEENLICSKYTDLLR-IALMA 574

Query: 459 -KGMLYLHEDSRLRIVHR 475
               ++  E++  + V R
Sbjct: 575 EDEAIF--EEA-HKQVQR 589

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 47/236 (19%), Positives = 78/236 (33%), Gaps = 64/236 (27%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQH---KNLV 408
            +G G FG V     + + K  AVK    +   +     E   ++L  ++       N+V
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEA--DILKKIQNDDINNNNIV 99

Query: 409 KLLGF-------CVDGDEKLLVYEFMPNGSLDAILFDPRK----RGILCWRKRTNIVNGI 457
           K  G        C       L++E      L   L++        G          +   
Sbjct: 100 KYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNNYNGF-----HIEDIKLY 142

Query: 458 AKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA----N 509
              +L    YL +   + + H DLK  N+LLD     K           +          
Sbjct: 143 CIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 510 TVRI------------VGTY----GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
            +++             G+      Y APE  +   +   SD++SFG +L E+ TG
Sbjct: 200 GIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 54/238 (22%), Positives = 89/238 (37%), Gaps = 72/238 (30%)

Query: 356 ILGQGGFGPVYKGV--LSDGKEVAVK---RLSSCSEQGTAEFTNEVLLILKLQ----HKN 406
            LG+G FG V + +   + G+ VAVK    +    E   +E   +VL  L          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI--QVLEHLNTTDPNSTFR 78

Query: 407 LVKLLGF-------CVDGDEKLLVYEFM-PNGSLDAILFDPRK----RGILCWRKRTNIV 454
            V++L +       C       +V+E +  +       +D  K            R + +
Sbjct: 79  CVQMLEWFEHHGHIC-------IVFELLGLS------TYDFIKENGFLPF-----RLDHI 120

Query: 455 NGIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNS-------------------K 491
             +A  +     +LH     ++ H DLK  N+L      +                   K
Sbjct: 121 RKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177

Query: 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG 549
           + DFG A  + + E   +   +V T  Y APE  +   +S+  DV+S G +LIE   G
Sbjct: 178 VVDFGSA-TY-DDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 8e-06
 Identities = 32/176 (18%), Positives = 61/176 (34%), Gaps = 40/176 (22%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV------- 408
           +G GGFG +Y     +  ++ A   +     Q      +E+    ++  K+ +       
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 409 --------KLLGF----CVDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVN 455
                      G           + +V E +  G  L  I                  V 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKST-------VL 154

Query: 456 GIAKGML----YLHEDSRLRIVHRDLKASNVLLDSDMNSKI--SDFGMARIFAESE 505
            +   ML    Y+HE+     VH D+KA+N+LL      ++  +D+G++  +  + 
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A Length = 304

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 19/109 (17%), Positives = 35/109 (32%), Gaps = 32/109 (29%)

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKIS---DFGMARI------------FAESEGEA 508
           ++      ++H D  + ++L D++  + I    DFG A I              E  G  
Sbjct: 185 IYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243

Query: 509 NTVRIVGTYG----------------YMAPEYAMEGLYSKKSDVFSFGV 541
              +I+  Y                 Y + E  + G      D +  G+
Sbjct: 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEGL 292

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	571
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.98
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.94
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.91
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.67
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.08
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.98
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.56
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.46
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.43
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.04
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.01
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.97
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.96
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.69
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.53
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.46
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.37
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.35
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.34
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.3
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.11
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.0
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.89
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.57
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.76
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.6
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	92.78
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	87.52
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.45
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	84.89
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.66

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.8e-48  Score=388.58  Aligned_cols=208  Identities=34%  Similarity=0.508  Sum_probs=181.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|.+.+.||+|+||.||+|++.      +++.||||+++..+....++|.+|++++++++|||||+++|++.+++..
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            3456777899999999999999863      4778999999877777778899999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcE
Q 008288          421 LLVYEFMPNGSLDAILFDP----------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS  490 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~  490 (571)
                      +|||||+++|+|.++|+..          .....++|.+++.|+.||++||+|||+++   |+||||||+||||++++++
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence            9999999999999999532          23456999999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||...+
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~  235 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS  235 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999987654443333333578999999999999999999999999999999999 999997654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=388.21  Aligned_cols=208  Identities=33%  Similarity=0.499  Sum_probs=175.0

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|...++||+|+||.||+|++.      +++.||||+++..+....++|.+|++++++++|||||+++|++.+.+..
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3456677789999999999999864      4788999999877777778899999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          421 LLVYEFMPNGSLDAILFDPR------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      +|||||+++|+|.++++...            ..++++|.+++.|+.||++||+|||+++   |+||||||+||||++++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence            99999999999999996432            2356999999999999999999999988   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ++||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||...+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~  265 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS  265 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence            999999999987655444444445689999999999999999999999999999999999 999997653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.1e-48  Score=384.30  Aligned_cols=203  Identities=29%  Similarity=0.421  Sum_probs=183.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||+||+++.. +++.||||++++.   .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46889999999999999999974 7999999999742   3345677999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++.   +.+.+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999993   4567999999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .........+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  238 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN  238 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            44444455799999999999999999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.3e-47  Score=383.61  Aligned_cols=206  Identities=32%  Similarity=0.448  Sum_probs=178.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ++++..++||+|+||.||+|.+.      +++.||||+++.. .....++|.+|+.++++++|||||+++|++.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34556788999999999999863      4678999999753 3344678999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          422 LVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      |||||+++|+|.++|....             ....++|.+++.|+.||++||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999996422             1346999999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ++||+|||+++...............||+.|||||++.++.++.++|||||||+||||+| |+.||...+
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            999999999987755444333445689999999999999999999999999999999999 899997654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.4e-47  Score=385.01  Aligned_cols=200  Identities=28%  Similarity=0.449  Sum_probs=181.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      +.|+..++||+|+||.||+++.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888899999999999999975 79999999997655666677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++|+|.+++..    +.+++.++..++.||+.||+|||+++   |+||||||+||||++++++||+|||+++.+......
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999999842    45999999999999999999999999   999999999999999999999999999876544332


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus       227 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  274 (346)
T 4fih_A          227 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  274 (346)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence              234689999999999999999999999999999999999999997664

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.3e-47  Score=386.55  Aligned_cols=205  Identities=22%  Similarity=0.390  Sum_probs=175.8

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||||+++..  .....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999974 6999999998743  34456679999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++|+|.+++.. ++...+++.+++.++.||+.||+|||+++   |+||||||+||||++++++||+|||+++.+....
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999853 23456789999999999999999999998   9999999999999999999999999998764322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                      .  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..
T Consensus       180 ~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~  231 (350)
T 4b9d_A          180 E--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK  231 (350)
T ss_dssp             H--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             c--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence            1  122358999999999999999999999999999999999999999876543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=379.26  Aligned_cols=203  Identities=32%  Similarity=0.496  Sum_probs=170.4

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +..+++.+.++||+|+||+||+|+++  ..||||+++.  .+....+.|.+|+.++++++|||||++++++.+ +..+||
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            45567788899999999999999874  3699999874  334556789999999999999999999998865 568999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++..  ..+.+++.+++.|+.||++||+|||+++   ||||||||+||||++++++||+|||+|+....
T Consensus       110 mEy~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          110 TQWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            999999999999954  3456999999999999999999999998   99999999999999999999999999987655


Q ss_pred             CCCccceeeecccccccchhhhcc---CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..........+||+.|||||++.+   +.|+.++|||||||+||||+||+.||...
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~  240 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI  240 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence            444444455689999999999864   45899999999999999999999999754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=386.31  Aligned_cols=200  Identities=28%  Similarity=0.449  Sum_probs=181.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      +.|+..+.||+|+||.||+++.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56888999999999999999975 69999999998666666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++|+|.+++.    .+.+++.++..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+......
T Consensus       231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            9999999984    345999999999999999999999999   999999999999999999999999999876544322


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus       304 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~  351 (423)
T 4fie_A          304 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP  351 (423)
T ss_dssp             --BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence              234689999999999999999999999999999999999999997664

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-46  Score=374.04  Aligned_cols=202  Identities=28%  Similarity=0.372  Sum_probs=171.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc----CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ++|++.+.||+|+||+||+++..    +++.||||++++.  .......+.+|++++++++|||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56889999999999999999852    4788999998753  22334568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++|+|.+++.   +.+.+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999994   4567999999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .....  ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus       178 ~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~  231 (304)
T 3ubd_A          178 DHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR  231 (304)
T ss_dssp             ---CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH
Confidence            43322  2345899999999999999999999999999999999999999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-45  Score=364.50  Aligned_cols=196  Identities=29%  Similarity=0.445  Sum_probs=168.7

Q ss_pred             CCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc----CceeEEEE
Q 008288          352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVY  424 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~  424 (571)
                      +..++||+|+||.||+|.+. +++.||+|++...  .....+.+.+|++++++++|||||++++++.+    ++..+|||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45578999999999999975 6889999998642  34445679999999999999999999999865    34578999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~~~~  503 (571)
                      ||+++|+|.+++.   +.+.+++..+..++.||++||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999994   4567999999999999999999999976 46999999999999984 78999999999975432


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .    .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~  232 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            2    2234689999999998865 6999999999999999999999999653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.1e-46  Score=374.60  Aligned_cols=198  Identities=26%  Similarity=0.328  Sum_probs=171.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .+.|+..++||+|+||.||++++. +|+.||||+++....     ..+|+.++++++|||||++++++.+++..+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            355777889999999999999975 699999999975321     24799999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~~~~~~  505 (571)
                      +++|+|.+++.   ..+.+++.++..++.||+.||+|||+++   |+||||||+||||+.++ ++||+|||+++.+....
T Consensus       132 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999994   4567999999999999999999999998   99999999999999987 69999999998765433


Q ss_pred             Ccc---ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEA---NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~  259 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY  259 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            221   122357999999999999999999999999999999999999999754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-45  Score=377.48  Aligned_cols=217  Identities=29%  Similarity=0.430  Sum_probs=186.9

Q ss_pred             cccChHHHHhhcCCCCCCceecccCceeEEEEEEcC------CcEEEEEEcccc-CccchHHHHHHHHHHHhccc-CCee
Q 008288          337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQH-KNLV  408 (571)
Q Consensus       337 ~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h-~nIv  408 (571)
                      ...+.++.++..++|++.+.||+|+||.||+|.+..      ++.||||+++.. .....+++.+|++++.+++| ||||
T Consensus        52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV  131 (353)
T 4ase_A           52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV  131 (353)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence            345666778888999999999999999999998642      357999999753 33445679999999999965 8999


Q ss_pred             eEeeEEEcC-ceeEEEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 008288          409 KLLGFCVDG-DEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH  474 (571)
Q Consensus       409 ~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH  474 (571)
                      +++|+|.+. +..++||||+++|+|.++|+...             ....+++.+++.++.||++||+|||+++   |||
T Consensus       132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiH  208 (353)
T 4ase_A          132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH  208 (353)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eec
Confidence            999999765 56899999999999999996422             1356899999999999999999999998   999


Q ss_pred             CCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 008288          475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNA  553 (571)
Q Consensus       475 ~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~  553 (571)
                      |||||+|||+++++++||+|||+|+.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||
T Consensus       209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            99999999999999999999999997765544444445689999999999999999999999999999999998 99999


Q ss_pred             CCC
Q 008288          554 GSN  556 (571)
Q Consensus       554 ~~~  556 (571)
                      ...
T Consensus       289 ~~~  291 (353)
T 4ase_A          289 PGV  291 (353)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.2e-45  Score=360.03  Aligned_cols=200  Identities=29%  Similarity=0.469  Sum_probs=163.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||||++++.   .......+.+|+.++++++||||+++++++.+++..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999964 7999999998643   2334567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+ +|+|.+++.   +++.+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 678988883   4567999999999999999999999999   999999999999999999999999999865433


Q ss_pred             CCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .   .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+.
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~  217 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI  217 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence            2   2234589999999999998776 5899999999999999999999987643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.6e-44  Score=357.95  Aligned_cols=201  Identities=27%  Similarity=0.421  Sum_probs=162.7

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc---------
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD---------  418 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~---------  418 (571)
                      +|++.+.||+|+||.||+++.. +|+.||||+++.. .+...+.+.+|++++++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            5788899999999999999975 7899999998743 3344567899999999999999999999987544         


Q ss_pred             ---eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 008288          419 ---EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF  495 (571)
Q Consensus       419 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~Df  495 (571)
                         ..++||||+++|+|.+++.........++..++.++.||++||+|||+++   |+||||||+||||+.++.+||+||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence               36899999999999999965444445677788999999999999999998   999999999999999999999999


Q ss_pred             ccccccccCCCcc----------ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          496 GMARIFAESEGEA----------NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       496 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      |+|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   ||...
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence            9998765443221          1223579999999999999999999999999999999996   77543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-44  Score=361.36  Aligned_cols=200  Identities=28%  Similarity=0.386  Sum_probs=162.4

Q ss_pred             CCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc----eeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e  425 (571)
                      +|.+.+.||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+++    ..+||||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            456678999999999999998 689999999975322 2222345566667889999999999998754    5789999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-----CCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-----SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-----~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      |+++|+|.++++.    ..++|..+.+++.|+++||+|||++     ..++|+||||||+||||++++++||+|||+++.
T Consensus        82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            9999999999943    4589999999999999999999987     133599999999999999999999999999987


Q ss_pred             cccCCCcc--ceeeecccccccchhhhccC------CCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEA--NTVRIVGTYGYMAPEYAMEG------LYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ........  .....+||+.|||||++.+.      .++.++|||||||+||||+||++|+..
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            65443322  22345899999999999764      367899999999999999999887643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-42  Score=356.35  Aligned_cols=202  Identities=24%  Similarity=0.415  Sum_probs=172.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc------Cce
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD------GDE  419 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~------~~~  419 (571)
                      ++|++.+.||+|+||.||++++. +|+.||||+++..  .....+.+.+|+.+|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57899999999999999999974 7999999999743  23345678899999999999999999998764      357


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .+|||||++ |+|.+++   ...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~-g~L~~~i---~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQII---HSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHH---TSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999996 6799888   34567999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCC--ccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEG--EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .+.....  .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~  267 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN  267 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence            7644322  1223346899999999998875 56999999999999999999999998764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.9e-41  Score=345.62  Aligned_cols=198  Identities=22%  Similarity=0.340  Sum_probs=170.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc----CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  421 (571)
                      -.++|++.++||+|+||.||+++.+    +++.||+|++.+.  ....++.+|++++..+ +||||+++++++.+++..+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999999853    4678999998653  3445688999999998 6999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeecccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARI  500 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfGla~~  500 (571)
                      +||||+++|+|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            9999999999999982      3899999999999999999999999   9999999999999877 7999999999986


Q ss_pred             cccCCCc--------------------------cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCC
Q 008288          501 FAESEGE--------------------------ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       501 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~  553 (571)
                      .......                          ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            5432211                          111234799999999999875 5899999999999999999999999


Q ss_pred             CC
Q 008288          554 GS  555 (571)
Q Consensus       554 ~~  555 (571)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            43

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-41  Score=367.76  Aligned_cols=200  Identities=31%  Similarity=0.435  Sum_probs=172.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHH---HHHHHhcccCCeeeEeeEEEcCce
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNE---VLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      .-++|++.+.||+|+||.||+++.. +|+.||||++++..   ........+|   +.+++.++|||||++++++.+.+.
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~  266 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK  266 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence            3467999999999999999999975 69999999986421   2222333444   556667799999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .|+||||++||+|..++.   +.+.+++..+..++.||+.||+|||+++   ||||||||+||||+++|++||+|||+|+
T Consensus       267 lylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence            999999999999999994   4567999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .+....    ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||...
T Consensus       341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            765432    234589999999999975 57999999999999999999999999654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-40  Score=361.93  Aligned_cols=201  Identities=26%  Similarity=0.406  Sum_probs=181.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|++.+.||+|+||.||+++.+ +|+.||+|++........+.+.+|+.+|+.++||||+++++++.+++..++||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57899999999999999999975 79999999998766666778899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC--CcEEEeecccccccccCC
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIFAESE  505 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~--~~~kL~DfGla~~~~~~~  505 (571)
                      ++|+|.+++..  ..+.+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+++.+....
T Consensus       237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            99999998843  3456999999999999999999999999   9999999999999854  899999999998765432


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+
T Consensus       312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~  360 (573)
T 3uto_A          312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN  360 (573)
T ss_dssp             ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence               2334589999999999999999999999999999999999999997664

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.6e-39  Score=325.40  Aligned_cols=215  Identities=40%  Similarity=0.719  Sum_probs=188.5

Q ss_pred             cChHHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       339 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      ++..++...+++|+..+.||+|+||.||++.+.+++.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            34445556788999999999999999999998889999999988766667788999999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      ..++||||+++++|.+++.... ....+++..++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999985432 2235899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~  244 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS  244 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence            98654433333333456899999999999889999999999999999999999999654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.7e-38  Score=316.07  Aligned_cols=202  Identities=27%  Similarity=0.486  Sum_probs=180.9

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|+..+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            45789999999999999999995 47899999998765556677789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++..    ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999843    35899999999999999999999998   99999999999999999999999999986654333


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       172 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  221 (297)
T 3fxz_A          172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP  221 (297)
T ss_dssp             C--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             c--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            2  2235799999999999999999999999999999999999999976543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.6e-38  Score=335.43  Aligned_cols=213  Identities=24%  Similarity=0.338  Sum_probs=184.7

Q ss_pred             cChHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       339 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      ....++.+..++|+..++||+|+||.||++++. +++.||+|++++.   .......+.+|..++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345667788899999999999999999999976 5789999998642   222334488999999999999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      .+.+..++||||+++|+|.+++..  ..+.+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       144 ~~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          144 QDDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999954  2456999999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ||+++........ .....+||+.|+|||++.     .+.++.++||||||+++|||++|+.||...+
T Consensus       219 FGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          219 FGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             CTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             hhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence            9999766443322 222358999999999987     4568999999999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.2e-38  Score=322.64  Aligned_cols=202  Identities=26%  Similarity=0.354  Sum_probs=178.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|+..+.||+|+||.||+++.. +++.||+|++++.   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            467888999999999999999975 6899999998753   234566788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|..++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999884   3456899999999999999999999998   99999999999999999999999999986433


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       158 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  209 (337)
T 1o6l_A          158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence            222  2234579999999999999999999999999999999999999997654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.4e-38  Score=319.41  Aligned_cols=203  Identities=30%  Similarity=0.459  Sum_probs=178.7

Q ss_pred             hcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ..++|+..+.||+|+||.||++.+ .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            346788999999999999999997 57999999998643  334556788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++.   ..+.+++..+..++.||++||+|||+++   |+||||||+|||++.++++||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999984   3456999999999999999999999998   99999999999999999999999999986544


Q ss_pred             CCCccceeeecccccccchhhhccCCCC-cchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYS-KKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ...   ....+||+.|+|||++.+..+. .++||||||+++|||++|+.||...+.
T Consensus       167 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  219 (328)
T 3fe3_A          167 GGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL  219 (328)
T ss_dssp             SCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence            322   2234799999999999888765 899999999999999999999987643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=324.69  Aligned_cols=204  Identities=29%  Similarity=0.411  Sum_probs=174.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      +..++|+..+.||+|+||.||+++.. +++.||||++++.   .......+.+|..++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            45578999999999999999999975 6899999998753   234456688999999998 799999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++|+|..++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            99999999999999984   3456999999999999999999999998   99999999999999999999999999975


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  228 (353)
T 3txo_A          174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN  228 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence            43222  22334589999999999998889999999999999999999999997764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.8e-38  Score=331.10  Aligned_cols=209  Identities=24%  Similarity=0.327  Sum_probs=181.9

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEc
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD  416 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~  416 (571)
                      ...+.+..++|+..+.||+|+||.||+++.. +++.||+|++++.   .......+.+|+.++..++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4566677889999999999999999999975 5889999998642   22334458899999999999999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      .+..++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999999843    35899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccCC----CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGL----YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +++....... ......+||+.|+|||++.+..    ++.++||||||+++|||++|+.||...+
T Consensus       214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  277 (410)
T 3v8s_A          214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  277 (410)
T ss_dssp             TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence            9986544321 1223458999999999998665    7899999999999999999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.2e-37  Score=314.75  Aligned_cols=198  Identities=28%  Similarity=0.473  Sum_probs=178.0

Q ss_pred             CCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      |+..+.||+|+||.||++... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            556678999999999999976 7999999999876666777899999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      ++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||++.........  
T Consensus       127 ~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--  197 (321)
T 2c30_A          127 GALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--  197 (321)
T ss_dssp             CBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred             CCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--
Confidence            99999983    245899999999999999999999998   999999999999999999999999999876543322  


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~  245 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS  245 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            223579999999999999999999999999999999999999997653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.5e-38  Score=320.10  Aligned_cols=205  Identities=28%  Similarity=0.407  Sum_probs=178.6

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCce
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~  419 (571)
                      .+..++|...+.||+|+||.||+++.+ +++.||||++++.   .......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            456678999999999999999999975 6899999998753   234456688899999887 99999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++|+|.+++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999984   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .......  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (345)
T 1xjd_A          167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  222 (345)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            6433222  2234589999999999999999999999999999999999999997654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.4e-38  Score=316.90  Aligned_cols=215  Identities=33%  Similarity=0.506  Sum_probs=174.7

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG  417 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~  417 (571)
                      +...+.+..++|++.+.||+|+||.||++.. +++.||||++....  .....++.+|+.++++++||||+++++++.+.
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            3445556678899999999999999999987 68899999987532  34456789999999999999999999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||||+++++|.+++........+++..++.++.||++||+|||+.+ ++|+||||||+|||+++++.+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            999999999999999999965333345999999999999999999999986 4599999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~  244 (309)
T 3p86_A          186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP  244 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred             Ccccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            975433221  12235789999999999999999999999999999999999999986643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.6e-38  Score=318.19  Aligned_cols=217  Identities=44%  Similarity=0.766  Sum_probs=188.4

Q ss_pred             cccChHHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEE
Q 008288          337 FFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCV  415 (571)
Q Consensus       337 ~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~  415 (571)
                      ..++..++.+..++|+..+.||+|+||.||++...+++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            3567889999999999999999999999999998889999999987533 233446899999999999999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      +.+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||++...+|+||||||+|||+++++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            9999999999999999999996533 345699999999999999999999999222299999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ||++......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||+
T Consensus       178 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          178 FGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            9999876543332 2233469999999999998889999999999999999999999996

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.5e-38  Score=325.70  Aligned_cols=202  Identities=26%  Similarity=0.355  Sum_probs=175.8

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      +..++|+..+.||+|+||.||+++.. +++.||+|++++.   .......+..|..++.++ +||||+++++++.+.+..
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            44567889999999999999999975 5889999998753   233345688999999887 899999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++|+|..++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       129 ~lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99999999999999884   3456999999999999999999999998   99999999999999999999999999985


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ......  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       203 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          203 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             cccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            333222  23345899999999999999999999999999999999999999953

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-37  Score=314.99  Aligned_cols=199  Identities=27%  Similarity=0.428  Sum_probs=177.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++++.   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            457888999999999999999975 6899999998743   223456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999994   3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .     ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  207 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  207 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence            2     223579999999999999999999999999999999999999997654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.4e-38  Score=328.54  Aligned_cols=213  Identities=22%  Similarity=0.316  Sum_probs=184.3

Q ss_pred             cChHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       339 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      ..++++.+..++|+..+.||+|+||.||+++.+ +++.||||++++.   .......+.+|..++.+++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345667778899999999999999999999975 7999999998642   223344588999999999999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                      .+.+..++||||+++|+|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999943  2236899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhc-------cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAM-------EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ||+++........ .....+||+.|+|||++.       +..++.++||||||+++|||++|+.||...+
T Consensus       206 FGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  274 (412)
T 2vd5_A          206 FGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS  274 (412)
T ss_dssp             CTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             chhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence            9999876443221 222358999999999987       3568999999999999999999999997764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-37  Score=312.64  Aligned_cols=205  Identities=31%  Similarity=0.535  Sum_probs=179.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ..++|...+.||+|+||.||++.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            3457788899999999999999975 689999999877667777889999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++..  ....+++.++..++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        88 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           88 YIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CCTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            9999999999953  2456999999999999999999999998   9999999999999999999999999998764433


Q ss_pred             Cccc------------eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEAN------------TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....            .....||+.|+|||.+.+..++.++||||||+++|||++|..|+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            2211            11357999999999999999999999999999999999999998653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.1e-37  Score=310.84  Aligned_cols=204  Identities=29%  Similarity=0.442  Sum_probs=174.1

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|++.+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467888999999999999999964 6899999988532   233456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++.   ..+.+++..+..++.|+++||+|||+.+   |+||||||+|||++.++++||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999984   3456999999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       164 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  217 (294)
T 4eqm_A          164 TSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA  217 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred             cccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            3222 22335789999999999999999999999999999999999999986643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.5e-37  Score=316.30  Aligned_cols=202  Identities=28%  Similarity=0.424  Sum_probs=175.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            57888999999999999999975 78999999986432 23345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++..+.....
T Consensus        87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999983   4456999999999999999999999998   99999999999999999999999999987654433


Q ss_pred             ccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  211 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            333334589999999999987775 78999999999999999999999754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=7.7e-38  Score=323.92  Aligned_cols=208  Identities=16%  Similarity=0.189  Sum_probs=179.4

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEE------EcCCcEEEEEEccccCccchHHHHHHHHHHHhcc---cCCeeeEee
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGV------LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLG  412 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~  412 (571)
                      ..+.+..++|.+.+.||+|+||.||+|.      ..+++.||||+++..   ...++..|+.++..++   |+||+++++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            3445677889999999999999999994      446889999999753   3456778888888886   999999999


Q ss_pred             EEEcCceeEEEEEccCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC----
Q 008288          413 FCVDGDEKLLVYEFMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS----  486 (571)
Q Consensus       413 ~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~----  486 (571)
                      ++...+..++||||+++|+|.+++..  ......+++..++.++.||++||+|||+++   |+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence            99999999999999999999999953  113456999999999999999999999998   999999999999998    


Q ss_pred             -------CCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          487 -------DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       487 -------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                             ++.+||+|||+++.+............+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                   899999999999766544333344456899999999999999999999999999999999999999853

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.2e-37  Score=321.00  Aligned_cols=209  Identities=30%  Similarity=0.474  Sum_probs=179.4

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc--------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      +..++|++.+.||+|+||.||++...        ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            34567888999999999999999852        3457999999753 334566799999999999 8999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                      +.+..++||||+++|+|.+++.....             ...+++.+++.++.||++||+|||+++   |+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence            99999999999999999999864321             235899999999999999999999998   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      |+++++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999999999986654433323333467889999999999999999999999999999999 999997653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.6e-37  Score=315.85  Aligned_cols=201  Identities=25%  Similarity=0.365  Sum_probs=177.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc------cchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      .++|++.+.||+|+||.||++... +|+.||+|+++....      ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            356888899999999999999975 689999999875322      1346789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----cEEEeecc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFG  496 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~----~~kL~DfG  496 (571)
                      ++||||+++|+|.+++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+|||+++++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999993   4567999999999999999999999998   99999999999998876    79999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~  222 (361)
T 2yab_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (361)
T ss_dssp             SCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            9987654322   223579999999999999899999999999999999999999997653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.4e-37  Score=317.47  Aligned_cols=200  Identities=26%  Similarity=0.352  Sum_probs=175.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .++|+..+.||+|+||.||+++.. +++.||+|++++.   .......+.+|..++.++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            356888899999999999999975 6889999999753   233455688999999998 89999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++|+|..++.   ..+.+++..++.++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999984   3456999999999999999999999998   9999999999999999999999999998543


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ....  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       162 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          162 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            3222  22345899999999999999999999999999999999999999964

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.1e-37  Score=318.63  Aligned_cols=204  Identities=28%  Similarity=0.356  Sum_probs=178.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  420 (571)
                      +..++|+..+.||+|+||.||+++.. +++.||||++++.   .......+..|..++..+ +||||+++++++.+.+..
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            45678999999999999999999976 4789999998753   234456788999999988 899999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++|+|.+++.   ..+.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            99999999999999984   3356999999999999999999999998   99999999999999999999999999985


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ......  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  225 (353)
T 2i0e_A          171 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  225 (353)
T ss_dssp             CCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence            432222  2234589999999999999999999999999999999999999998664

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.4e-37  Score=314.18  Aligned_cols=203  Identities=27%  Similarity=0.413  Sum_probs=168.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEE----cCCcEEEEEEccccC----ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      ..++|+..+.||+|+||.||+++.    .+++.||+|++++..    ......+.+|+.++++++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            446788899999999999999997    478999999987532    234456789999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+++++|.+++.   ..+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            9999999999999999984   3456899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  225 (327)
T 3a62_A          169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN  225 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence            75433221  1223478999999999999999999999999999999999999997654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-37  Score=319.91  Aligned_cols=219  Identities=29%  Similarity=0.441  Sum_probs=186.5

Q ss_pred             ccccChHHHHhhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCe
Q 008288          336 DFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNL  407 (571)
Q Consensus       336 ~~~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nI  407 (571)
                      ....+.....+..++|++.+.||+|+||.||++.+      .+++.||||+++.. .....+.+.+|++++.++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            34556777888899999999999999999999984      24678999999753 334456799999999999 79999


Q ss_pred             eeEeeEEEcCce-eEEEEEccCCCChhhhhcCCCC---------------------------------------------
Q 008288          408 VKLLGFCVDGDE-KLLVYEFMPNGSLDAILFDPRK---------------------------------------------  441 (571)
Q Consensus       408 v~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------  441 (571)
                      +++++++.+.+. .++||||+++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            999999987655 8999999999999999965332                                             


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          442 ------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       442 ------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                                        ...+++..++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              122899999999999999999999998   99999999999999999999999999987655


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ...........||+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  300 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  300 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence            444333344578999999999999999999999999999999998 999997653

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.7e-37  Score=315.78  Aligned_cols=199  Identities=27%  Similarity=0.341  Sum_probs=177.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|+..+.||+|+||.||+++.. +++.||+|++++.   .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357888899999999999999975 6899999998642   234456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999984   3356899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .     ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  242 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence            2     223579999999999999999999999999999999999999997664

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-36  Score=309.24  Aligned_cols=201  Identities=21%  Similarity=0.313  Sum_probs=177.3

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            357888999999999999999975 6889999998753 33455688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--CCcEEEeecccccccccC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAES  504 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~--~~~~kL~DfGla~~~~~~  504 (571)
                      +++++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.  ++.+||+|||++..+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999999843  3346999999999999999999999998   999999999999987  789999999999876443


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  207 (321)
T 1tki_A          158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence            2   2234578999999999998889999999999999999999999997654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-36  Score=305.71  Aligned_cols=215  Identities=44%  Similarity=0.700  Sum_probs=186.9

Q ss_pred             cccChHHHHhhcCCCCCC------ceecccCceeEEEEEEcCCcEEEEEEcccc----CccchHHHHHHHHHHHhcccCC
Q 008288          337 FFIDLETLNLATSNFSDS------NILGQGGFGPVYKGVLSDGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQHKN  406 (571)
Q Consensus       337 ~~~~~~~l~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~n  406 (571)
                      ..+..+++...+++|...      +.||+|+||.||++.. +++.||||++...    .+...+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            346777888888888777      8999999999999987 6889999998642    2334567899999999999999


Q ss_pred             eeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 008288          407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       407 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~  486 (571)
                      |+++++++.+.+..++||||+++++|.+++........+++..+..++.||++||.|||+.+   |+||||||+||++++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence            99999999999999999999999999999965445567999999999999999999999998   999999999999999


Q ss_pred             CCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       487 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||...
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            99999999999987654433333334578999999998765 5899999999999999999999999764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7e-37  Score=317.66  Aligned_cols=201  Identities=26%  Similarity=0.368  Sum_probs=176.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ..++|++.+.||+|+||.||++... +++.||+|++...   .......+.+|+.++..++||||+++++++.+.+..++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3467888999999999999999975 5889999998642   23445678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++|+|..++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        93 v~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            999999999999994   3456999999999999999999999998   9999999999999999999999999998664


Q ss_pred             cCCCccceeeecccccccchhhhcc---CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...   .....+||+.|+|||++.+   ..++.++||||||+++|||++|+.||...
T Consensus       167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence            332   2234589999999999864   45899999999999999999999999643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=308.23  Aligned_cols=200  Identities=26%  Similarity=0.371  Sum_probs=176.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc------cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ++|...+.||+|+||.||++... +++.||+|+++....      ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45778899999999999999975 689999999864322      23567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----cEEEeeccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM  497 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~----~~kL~DfGl  497 (571)
                      +||||+++++|.+++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+|||+++++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999993   4456999999999999999999999998   99999999999999887    899999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +........   .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  221 (326)
T 2y0a_A          165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  221 (326)
T ss_dssp             CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            987643322   223479999999999998999999999999999999999999997653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-37  Score=317.13  Aligned_cols=203  Identities=30%  Similarity=0.479  Sum_probs=173.3

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc----ee
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EK  420 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~  420 (571)
                      .+..++|++.+.||+|+||.||+++.. ++.||||+++... ........|+.++.+++||||+++++++....    ..
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           20 YFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             EETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            345678889999999999999999984 8999999987532 33445667899999999999999999998754    46


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCeeeCCCCCCCeEecCCCcE
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED----------SRLRIVHRDLKASNVLLDSDMNS  490 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~----------~~~~iiH~DLkp~NILl~~~~~~  490 (571)
                      ++||||+++|+|.+++..    ..+++..+..++.||++||+|||+.          +   |+||||||+|||+++++.+
T Consensus        98 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCE
T ss_pred             EEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeE
Confidence            999999999999999943    3489999999999999999999998          7   9999999999999999999


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhccC-----CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-----LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ||+|||+++.+.............||+.|+|||++.+.     .++.++||||||+++|||++|+.||...
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            99999999876554443333345799999999999863     4567899999999999999999999653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-36  Score=307.07  Aligned_cols=201  Identities=31%  Similarity=0.445  Sum_probs=172.2

Q ss_pred             cCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|++.+.||+|+||.||++...+++.||+|+++...  ......+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46788899999999999999999889999999987432  2334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++ +|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9985 77777743  3445899999999999999999999998   9999999999999999999999999998664332


Q ss_pred             Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..  .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       174 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  223 (311)
T 3niz_A          174 RS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV  223 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence            22  223478999999999876 56899999999999999999999999754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.5e-37  Score=303.48  Aligned_cols=205  Identities=31%  Similarity=0.524  Sum_probs=179.1

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +..++|+..+.||+|+||.||++...+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++|||
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            4456788889999999999999999889999999997533 345679999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           86 FMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             eCCCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999954  3456899999999999999999999998   9999999999999999999999999998654322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       161 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~  212 (269)
T 4hcu_A          161 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  212 (269)
T ss_dssp             HH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence            11 1122356778999999998999999999999999999999 999997654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.1e-36  Score=312.58  Aligned_cols=200  Identities=30%  Similarity=0.452  Sum_probs=176.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .++|++.+.||+|+||.||++... +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            356888999999999999999975 6899999998643  3344567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---cEEEeeccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIF  501 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~---~~kL~DfGla~~~  501 (571)
                      ||+++|+|.+.+.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++   .+||+|||++...
T Consensus       108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999998883   3456899999999999999999999998   99999999999998654   5999999999876


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....   .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  233 (362)
T 2bdw_A          182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  233 (362)
T ss_dssp             TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            53322   22357999999999999989999999999999999999999999765

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.1e-37  Score=317.94  Aligned_cols=203  Identities=27%  Similarity=0.355  Sum_probs=168.7

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHH-HHhcccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|+..+.||+|+||.||+++.+ +++.||||++++..   ......+..|..+ ++.++||||+++++++.+.+..+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            4467889999999999999999975 58899999987532   2234456667666 46689999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++|+|.+++.   +.+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus       116 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            9999999999999984   3456899999999999999999999998   999999999999999999999999999864


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~  243 (373)
T 2r5t_A          190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN  243 (373)
T ss_dssp             BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred             ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            33222  2234589999999999999999999999999999999999999997664

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.7e-37  Score=312.53  Aligned_cols=206  Identities=26%  Similarity=0.426  Sum_probs=169.8

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee---
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK---  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~---  420 (571)
                      .++|++.+.||+|+||.||++.. .+++.||||+++...   ......+.+|+.++.+++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46788899999999999999996 578999999997532   23345688999999999999999999998876543   


Q ss_pred             -EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          421 -LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       421 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                       ++||||+++++|.+++.   ..+.+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             89999999999999984   3456899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc-cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          500 IFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       500 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                      .+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  225 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV  225 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence            76543222 2223357899999999999999999999999999999999999999876443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-37  Score=313.25  Aligned_cols=213  Identities=31%  Similarity=0.460  Sum_probs=182.2

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      ..+.+..++|+..+.||+|+||.||++...      +++.||||+++.. .....+.+.+|+.++++++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345567789999999999999999999974      3478999999753 334456789999999999999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRK---------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV  473 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ii  473 (571)
                      .+.+..++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+++   |+
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            999999999999999999999854221                     256899999999999999999999998   99


Q ss_pred             eCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCC
Q 008288          474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRN  552 (571)
Q Consensus       474 H~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p  552 (571)
                      ||||||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999986654333223334567899999999999999999999999999999999 9999


Q ss_pred             CCCCc
Q 008288          553 AGSNQ  557 (571)
Q Consensus       553 ~~~~~  557 (571)
                      |...+
T Consensus       277 ~~~~~  281 (343)
T 1luf_A          277 YYGMA  281 (343)
T ss_dssp             TTTSC
T ss_pred             CCCCC
Confidence            97653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=310.02  Aligned_cols=206  Identities=33%  Similarity=0.525  Sum_probs=175.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc----CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      +..++|++.+.||+|+||.||++.+.    .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            34567888999999999999999974    3456999999753 444566799999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++++|.+++..  ..+.+++..++.++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999953  3356999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          501 FAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~  258 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM  258 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence            65433221 1222356778999999998899999999999999999999 99999655

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=303.49  Aligned_cols=202  Identities=29%  Similarity=0.411  Sum_probs=169.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc--------------------------cchHHHHHHHHHH
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--------------------------QGTAEFTNEVLLI  399 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l  399 (571)
                      ..++|++.+.||+|+||.||++... +++.||||++.....                          ...+.+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3467888999999999999999964 688999999864321                          1235688999999


Q ss_pred             HhcccCCeeeEeeEEEc--CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCC
Q 008288          400 LKLQHKNLVKLLGFCVD--GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL  477 (571)
Q Consensus       400 ~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DL  477 (571)
                      ++++||||+++++++.+  .+..++||||+++++|.+++    ....+++..+..++.||++||+|||+++   |+||||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl  163 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI  163 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence            99999999999999987  56789999999999998765    3456999999999999999999999998   999999


Q ss_pred             CCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCC---CCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          478 KASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       478 kp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ||+|||++.++++||+|||+++........  .....||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999876543322  22347999999999987655   4789999999999999999999997


Q ss_pred             CCc
Q 008288          555 SNQ  557 (571)
Q Consensus       555 ~~~  557 (571)
                      ..+
T Consensus       242 ~~~  244 (298)
T 2zv2_A          242 DER  244 (298)
T ss_dssp             CSS
T ss_pred             Ccc
Confidence            654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-36  Score=313.28  Aligned_cols=201  Identities=24%  Similarity=0.335  Sum_probs=178.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|++.+.||+|+||.||++... +++.+|+|++..........+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            57889999999999999999975 68899999998655556667899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--CCcEEEeecccccccccCC
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAESE  505 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~--~~~~kL~DfGla~~~~~~~  505 (571)
                      ++++|.+++..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++......
T Consensus       131 ~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          131 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            99999998843  3346999999999999999999999998   999999999999974  4779999999998764432


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .   .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  254 (387)
T 1kob_A          206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  254 (387)
T ss_dssp             C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence            2   223479999999999999999999999999999999999999997654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-36  Score=303.74  Aligned_cols=201  Identities=27%  Similarity=0.430  Sum_probs=171.3

Q ss_pred             CCCCCCceecccCceeEEEEEEcCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..+.||+|+||.||++...+++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4688889999999999999999889999999986432  33356788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++ +|.+++..  ..+.+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            975 88888843  3356899999999999999999999998   99999999999999999999999999976543222


Q ss_pred             ccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (288)
T 1ob3_A          156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             c--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            1  2234789999999998764 58999999999999999999999997653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-36  Score=309.88  Aligned_cols=203  Identities=27%  Similarity=0.408  Sum_probs=172.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce-------
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-------  419 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-------  419 (571)
                      ++|+..+.||+|+||.||++++. +++.||||+++.. .+...+.+.+|+.++++++||||+++++++.+.+.       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            45788899999999999999986 7999999998743 34456779999999999999999999999866432       


Q ss_pred             --------------------------------------------------eEEEEEccCCCChhhhhcCCCCCCCCCHHH
Q 008288          420 --------------------------------------------------KLLVYEFMPNGSLDAILFDPRKRGILCWRK  449 (571)
Q Consensus       420 --------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~  449 (571)
                                                                        .++||||+++++|.+++.........++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                              789999999999999997655556677888


Q ss_pred             HHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc----------cceeeecccccc
Q 008288          450 RTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE----------ANTVRIVGTYGY  519 (571)
Q Consensus       450 ~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~----------~~~~~~~gt~~y  519 (571)
                      ++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            9999999999999999998   999999999999999999999999999876554321          112234799999


Q ss_pred             cchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          520 MAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       520 ~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      +|||.+.+..++.++||||||+++|||++|..|+.
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence            99999999999999999999999999999988763

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-36  Score=312.02  Aligned_cols=210  Identities=32%  Similarity=0.470  Sum_probs=178.9

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      ..+..++|...+.||+|+||.||++..      .+++.||||+++.. .....+.+.+|+.++.++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            445678899999999999999999996      24568999999743 334566799999999999 8999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeC
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPRK--------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR  475 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~  475 (571)
                      ..+..++||||+++|+|.+++.....                    ...+++..++.++.||++||+|||+++   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            99999999999999999999965322                    134899999999999999999999998   9999


Q ss_pred             CCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008288          476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAG  554 (571)
Q Consensus       476 DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~  554 (571)
                      ||||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987655443333334467889999999999999999999999999999998 999997


Q ss_pred             CC
Q 008288          555 SN  556 (571)
Q Consensus       555 ~~  556 (571)
                      ..
T Consensus       277 ~~  278 (344)
T 1rjb_A          277 GI  278 (344)
T ss_dssp             TC
T ss_pred             cC
Confidence            65

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.6e-37  Score=301.46  Aligned_cols=206  Identities=32%  Similarity=0.443  Sum_probs=179.5

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++..++|+..+.||+|+||.||++...++..||+|+++... ....++.+|+.++.+++||||+++++++.+.+..++||
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            34567788899999999999999999888899999997533 34567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        83 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999843  2345899999999999999999999998   999999999999999999999999999865443


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (268)
T 3sxs_A          158 QYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT  210 (268)
T ss_dssp             CEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             hhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence            222 1222356778999999998889999999999999999999 999997654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.2e-36  Score=313.26  Aligned_cols=203  Identities=27%  Similarity=0.382  Sum_probs=175.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-----CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ++|++.+.||+|+||.||++... +++.||||++...     .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            46888899999999999999975 6899999998532     12245678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc---EEEeecccc
Q 008288          423 VYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMA  498 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~---~kL~DfGla  498 (571)
                      ||||+++++|.+.+... .....+++..+..++.||++||+|||+++   |+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998777432 22345899999999999999999999998   999999999999987654   999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .........  .....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       181 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          181 IQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             EECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             eEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            876543221  22347999999999999999999999999999999999999999764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=319.88  Aligned_cols=202  Identities=24%  Similarity=0.388  Sum_probs=175.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .++|++.+.||+|+||.||++... +|+.+|+|++....  ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            456888899999999999999864 78999999986432  334566899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCcEEEeeccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIF  501 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~---~~~~~kL~DfGla~~~  501 (571)
                      ||+++|+|.+.+.   ..+.+++..+..++.||++||.|||+++   |+||||||+|||++   +++.+||+|||++...
T Consensus        90 E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           90 DLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             CCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999988884   3456999999999999999999999998   99999999999998   4678999999999866


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ......  .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~  217 (444)
T 3soa_A          164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED  217 (444)
T ss_dssp             CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence            543322  223579999999999999899999999999999999999999996653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.2e-36  Score=302.98  Aligned_cols=204  Identities=31%  Similarity=0.450  Sum_probs=161.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467889999999999999999964 68999999987433 3345678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      |++ ++|.+++...   .....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5898887431   22345899999999999999999999998   9999999999999999999999999998664


Q ss_pred             cCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....  .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus       160 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  213 (317)
T 2pmi_A          160 IPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN  213 (317)
T ss_dssp             SCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            33222  123478999999999976 468999999999999999999999997654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-36  Score=315.26  Aligned_cols=206  Identities=32%  Similarity=0.524  Sum_probs=166.4

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc----CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      +..++|++.+.||+|+||.||+|++.    ++..||||+++.. .+...+++.+|+.++++++||||+++++++.+.+..
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            34568999999999999999999864    5678999999753 344566799999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++++|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999953  3346999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          501 FAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~  254 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM  254 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            65433221 1122245778999999999999999999999999999998 99999654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.2e-37  Score=320.68  Aligned_cols=207  Identities=32%  Similarity=0.444  Sum_probs=177.1

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .+..++|...+.||+|+||.||+|.+. +++.||||+++.. ......++.+|+.++++++||||+++++++.+++..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            345567888899999999999999986 7899999998753 23344568899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++|+|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus       190 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            9999999999999853  2345899999999999999999999998   9999999999999999999999999998643


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ............++..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~  319 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL  319 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            3221111111235678999999998899999999999999999998 99999765

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-36  Score=307.73  Aligned_cols=211  Identities=33%  Similarity=0.466  Sum_probs=181.4

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEE
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCV  415 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~  415 (571)
                      ++.+..++|.+.+.||+|+||.||++..      .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            3445667888899999999999999986      23578999999753 3445677899999999999999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPRK---------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH  474 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH  474 (571)
                      +.+..++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+++   |+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence            99999999999999999999964322                     234899999999999999999999998   999


Q ss_pred             CCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCC
Q 008288          475 RDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNA  553 (571)
Q Consensus       475 ~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~  553 (571)
                      |||||+|||+++++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987655443333333467888999999999889999999999999999999 99999


Q ss_pred             CCC
Q 008288          554 GSN  556 (571)
Q Consensus       554 ~~~  556 (571)
                      ...
T Consensus       254 ~~~  256 (314)
T 2ivs_A          254 PGI  256 (314)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            765

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-36  Score=325.26  Aligned_cols=206  Identities=30%  Similarity=0.420  Sum_probs=180.7

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      +..++|...+.||+|+||.||+++.. +|+.||+|++.+..   ......+.+|+.++++++||||+++++++.+.+..+
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  261 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC  261 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence            34567888899999999999999975 69999999986422   234567889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          422 LVYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +||||+++|+|..++.... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.
T Consensus       262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~  338 (543)
T 3c4z_A          262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE  338 (543)
T ss_dssp             EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeee
Confidence            9999999999999886532 2456999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +......  ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       339 ~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          339 LKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             CCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             ccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            6543322  22358999999999999999999999999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=305.55  Aligned_cols=202  Identities=31%  Similarity=0.436  Sum_probs=175.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc--eeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--~~~lv  423 (571)
                      .++|.+.+.||+|+||.||++... +++.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            456888899999999999999975 58999999987533 344667889999999999999999999998765  67999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCcEEEeeccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMAR  499 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl----~~~~~~kL~DfGla~  499 (571)
                      |||+++++|.+++........+++..++.++.||++||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976544455999999999999999999999998   9999999999999    778889999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhc--------cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAM--------EGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ........   ....||+.|+|||++.        +..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            76543322   2347899999999986        57789999999999999999999999964

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-36  Score=327.25  Aligned_cols=204  Identities=31%  Similarity=0.429  Sum_probs=179.7

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      +..++|+..+.||+|+||.||++... +|+.||+|++.+.   .......+.+|+.++.+++||||+++++++.+.+..+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            45567888999999999999999975 7999999998642   2334566889999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++|+|.+++... ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       261 lVmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            999999999999988542 2345899999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....   ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            43322   23358999999999999988999999999999999999999999764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-37  Score=316.93  Aligned_cols=210  Identities=35%  Similarity=0.520  Sum_probs=178.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +..++|++.+.||+|+||.||++.+.      +++.||||+++.. ......++.+|+.++++++||||+++++++.+.+
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34567888999999999999999843      4678999999743 4445567899999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---cEE
Q 008288          419 EKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSK  491 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~---~~k  491 (571)
                      ..++||||+++|+|.+++....    ....+++.+++.++.||++||+|||+++   |+||||||+|||++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEE
Confidence            9999999999999999985422    2345899999999999999999999998   99999999999999554   599


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCch
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQL  558 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~~  558 (571)
                      |+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+.
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~  292 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN  292 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999986544333333333467899999999999999999999999999999998 9999976643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.3e-37  Score=325.64  Aligned_cols=204  Identities=26%  Similarity=0.350  Sum_probs=169.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      +..++|+..+.||+|+||.||++... +++.||||+++..   .......+.+|+.++++++||||+++++++.+.+..+
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            44567999999999999999999964 6899999998742   3344556789999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      +||||+++++|..++.   ..+.+++..+..++.||++||+|||+ .+   |+||||||+|||++.++.+||+|||+++.
T Consensus       225 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          225 FVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EEECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            9999999999999884   34568999999999999999999998 77   99999999999999999999999999986


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ......  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       299 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  353 (446)
T 4ejn_A          299 GIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  353 (446)
T ss_dssp             TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            433222  2234589999999999999999999999999999999999999997654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-36  Score=314.35  Aligned_cols=210  Identities=32%  Similarity=0.469  Sum_probs=181.1

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc--------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFC  414 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~  414 (571)
                      .+..++|.+.+.||+|+||.||++...        .+..||||+++.. .......+.+|+++++++ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            455678888999999999999999852        2357999999753 344557789999999999 999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN  481 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~N  481 (571)
                      .+.+..++||||+++|+|.+++.....             ...+++..++.++.||++||+|||+.+   |+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence            999999999999999999999864321             245999999999999999999999998   9999999999


Q ss_pred             eEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       482 ILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999987655433333333467889999999999999999999999999999999 999997654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-36  Score=307.79  Aligned_cols=201  Identities=21%  Similarity=0.284  Sum_probs=175.7

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|+..+.||+|+||.||++.. .+++.||||++....  ....+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46788999999999999999996 478999999987432  234688999999999 99999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-----EEEeecccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKISDFGMARI  500 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~-----~kL~DfGla~~  500 (571)
                      |+ +++|.+++...  ...+++..++.++.||++||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998532  456999999999999999999999998   999999999999998887     99999999987


Q ss_pred             cccCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~  220 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL  220 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence            65443221     123458999999999999999999999999999999999999999763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-36  Score=309.60  Aligned_cols=213  Identities=29%  Similarity=0.459  Sum_probs=164.2

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEcC-Cc---EEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEE
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSD-GK---EVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCV  415 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~  415 (571)
                      +.+.+..++|+..+.||+|+||.||++.+.. ++   .||||+++..  .....+.+.+|+.++++++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3445677889999999999999999999653 32   7999998753  3445677999999999999999999999998


Q ss_pred             cCcee------EEEEEccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 008288          416 DGDEK------LLVYEFMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       416 ~~~~~------~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~  486 (571)
                      ..+..      ++||||+++++|.+++...   .....+++..++.++.||++||.|||+++   |+||||||+|||+++
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence            87665      8999999999999988532   22235899999999999999999999998   999999999999999


Q ss_pred             CCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       487 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            99999999999987655443333333467888999999999999999999999999999999 999997653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-36  Score=302.28  Aligned_cols=206  Identities=29%  Similarity=0.462  Sum_probs=176.8

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .+..++|+..+.||+|+||.||++.+.++..||+|+++... ...+++.+|++++.+++||||+++++++.+.+..++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            45567888899999999999999999888899999998543 34567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..  ....+++..++.++.|+++||.|||+++   |+||||||+|||+++++.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           99 EYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            99999999999954  2345999999999999999999999998   999999999999999999999999999865432


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       174 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~  226 (283)
T 3gen_A          174 EYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT  226 (283)
T ss_dssp             HHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence            211 1122356778999999998899999999999999999998 999997653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.9e-36  Score=301.11  Aligned_cols=197  Identities=26%  Similarity=0.377  Sum_probs=169.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|+..+.||+|+||.||++... +++.||+|+++..  .......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            46888899999999999999975 6899999998743  23334678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |++++.+..+.   ...+.+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99865444444   23456999999999999999999999998   9999999999999999999999999998664332


Q ss_pred             CccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~  553 (571)
                      ..  .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+
T Consensus       156 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence            22  22347899999999998765 899999999999999999988885

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.8e-36  Score=309.48  Aligned_cols=199  Identities=27%  Similarity=0.436  Sum_probs=173.7

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|.+.+.||+|+||.||++.+ .+++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35788899999999999999997 57899999998642   223345788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+ +|+|.+++.   ..+.+++.++..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 678888773   3456999999999999999999999998   99999999999999999999999999986544


Q ss_pred             CCCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...   ....+||+.|+|||++.+..+ ++++||||||+++|||++|+.||...
T Consensus       161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            322   223479999999999988776 78999999999999999999999765

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.9e-36  Score=297.46  Aligned_cols=203  Identities=36%  Similarity=0.565  Sum_probs=167.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccC----ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      +..++|+..+.||+|+||.||++.+ .++.||||+++...    ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            3456788899999999999999998 48999999986432    233567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC--------CCcEEEe
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS--------DMNSKIS  493 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~--------~~~~kL~  493 (571)
                      +||||+++++|.+++.    ...+++..+..++.|+++||.|||+++..+|+||||||+|||+++        ++.+||+
T Consensus        83 lv~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             EEEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EEEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            9999999999999983    346899999999999999999999988666899999999999986        6789999


Q ss_pred             ecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       494 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      |||++........    ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       159 Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  218 (271)
T 3dtc_A          159 DFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID  218 (271)
T ss_dssp             CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred             cCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999986543322    23478999999999999999999999999999999999999998654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-36  Score=308.09  Aligned_cols=205  Identities=32%  Similarity=0.543  Sum_probs=169.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCc----EEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|+..+.||+|+||.||+|.+. +++    +|++|.++. ......+++.+|+.++++++||||+++++++.+.+ .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            3456888899999999999999964 444    468888864 33455678999999999999999999999998754 7


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++|+||+++|+|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+|||+++++++||+|||+++.
T Consensus        92 ~~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence            799999999999999853  3456999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ..............+|..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  224 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence            655544433344567889999999999999999999999999999999 999997653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.6e-36  Score=312.00  Aligned_cols=196  Identities=28%  Similarity=0.394  Sum_probs=168.8

Q ss_pred             CceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      .+.||+|+||.||++... +|+.||+|+++.......+.+.+|++++.+++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            567999999999999964 6899999999876656677899999999999999999999999999999999999999999


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe--cCCCcEEEeecccccccccCCCccce
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL--DSDMNSKISDFGMARIFAESEGEANT  510 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl--~~~~~~kL~DfGla~~~~~~~~~~~~  510 (571)
                      .+++..  ....+++..+..++.||++||+|||+.+   |+||||||+|||+  ++++.+||+|||+++.+......   
T Consensus       174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---  245 (373)
T 2x4f_A          174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---  245 (373)
T ss_dssp             HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred             HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence            888843  3345899999999999999999999998   9999999999999  56789999999999876543322   


Q ss_pred             eeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       511 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  292 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN  292 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            23469999999999998889999999999999999999999997653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=311.85  Aligned_cols=203  Identities=26%  Similarity=0.352  Sum_probs=170.1

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhccc--CCeeeEeeEEEcCcee
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEK  420 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~~~  420 (571)
                      .+..++|++.+.||+|+||.||++...+++.||||++...  .......+.+|+.++.+++|  |||+++++++.+++..
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            4566789999999999999999999888999999998643  33445678999999999976  9999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||| +.+++|.+++.   ....+++.++..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+++.
T Consensus        85 ~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEEEC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEe-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence            99999 56889999984   3456899999999999999999999998   99999999999997 57899999999987


Q ss_pred             cccCCCccceeeecccccccchhhhcc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAME-----------GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ..............||+.|+|||++.+           ..++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            655443333334579999999999865           6789999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.7e-36  Score=309.30  Aligned_cols=199  Identities=30%  Similarity=0.439  Sum_probs=161.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ..++|++.+.||+|+||.||++... +++.||||+++...  ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567888999999999999999976 58899999997532  34568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~DfGla~~~~  502 (571)
                      |+++++|.+++.   ..+.+++.++..++.||++||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999983   4456999999999999999999999998   999999999999975   8899999999998654


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  253 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE  253 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred             ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            322   122357899999999999999999999999999999999999999654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.5e-36  Score=304.51  Aligned_cols=206  Identities=31%  Similarity=0.470  Sum_probs=173.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE-----cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--c
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--D  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~  418 (571)
                      +..++|++.+.||+|+||.||++++     .+++.||||++........+.+.+|+.++++++||||+++++++...  .
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            3456788899999999999999984     26889999999876666777899999999999999999999998654  4


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++++||+|||++
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             ceEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence            589999999999999999532  335899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .......... ......++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            8765433221 112235677899999999999999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.3e-36  Score=304.37  Aligned_cols=211  Identities=29%  Similarity=0.425  Sum_probs=181.2

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      ..+..++|+..+.||+|+||.||++..      .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            345667888999999999999999985      246789999997543 23456789999999999 9999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCC
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPRK---------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKAS  480 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~  480 (571)
                      +.+..++||||+++|+|.+++.....               ...+++..++.++.||++||.|||+++   |+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            99999999999999999999854321               225899999999999999999999998   999999999


Q ss_pred             CeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          481 NVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       481 NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      |||+++++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999999999999999987665443333333457889999999999999999999999999999999 999997653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.3e-36  Score=312.81  Aligned_cols=207  Identities=21%  Similarity=0.268  Sum_probs=177.8

Q ss_pred             hhcCCCCCCceeccc--CceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQG--GFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ...++|++.+.||+|  +||.||+++.. +++.||||+++..  .......+.+|+.++++++||||+++++++.+++..
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            355678899999999  99999999976 6999999998743  234456688999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999998542 2345899999999999999999999998   99999999999999999999999999865


Q ss_pred             cccCCCc-----cceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGE-----ANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .......     .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||...
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            4332111     11122378999999999987  67999999999999999999999999764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9e-36  Score=295.95  Aligned_cols=199  Identities=24%  Similarity=0.385  Sum_probs=176.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|++.+.||+|+||.||++... ++..+|+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            46788899999999999999975 57799999998766666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccccC
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl---~~~~~~kL~DfGla~~~~~~  504 (571)
                      ++++|.+++.   ..+.+++..+..++.|+++||+|||+++   |+||||||+|||+   +.++.+||+|||++......
T Consensus        89 ~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           89 TGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999998884   3456899999999999999999999998   9999999999999   78899999999999866543


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...   ....||+.|+|||.+.+. ++.++||||||+++|||++|+.||...+
T Consensus       163 ~~~---~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~  211 (277)
T 3f3z_A          163 KMM---RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT  211 (277)
T ss_dssp             SCB---CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cch---hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence            322   234789999999988654 8999999999999999999999997654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.6e-36  Score=303.72  Aligned_cols=217  Identities=29%  Similarity=0.443  Sum_probs=184.5

Q ss_pred             ccChHHHHhhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeee
Q 008288          338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVK  409 (571)
Q Consensus       338 ~~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~  409 (571)
                      ..+.....+..++|.+.+.||+|+||.||++..      .+++.||||+++.. .....+.+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            345667777889999999999999999999984      24688999999753 333456789999999999 7999999


Q ss_pred             EeeEEEcCc-eeEEEEEccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeC
Q 008288          410 LLGFCVDGD-EKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR  475 (571)
Q Consensus       410 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~  475 (571)
                      +++++...+ ..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence            999988765 48999999999999999965332             223889999999999999999999998   9999


Q ss_pred             CCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCC
Q 008288          476 DLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAG  554 (571)
Q Consensus       476 DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~  554 (571)
                      ||||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999987655443333334567889999999999999999999999999999998 999997


Q ss_pred             CCc
Q 008288          555 SNQ  557 (571)
Q Consensus       555 ~~~  557 (571)
                      ...
T Consensus       253 ~~~  255 (316)
T 2xir_A          253 GVK  255 (316)
T ss_dssp             TCC
T ss_pred             ccc
Confidence            643

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.7e-36  Score=305.99  Aligned_cols=210  Identities=30%  Similarity=0.477  Sum_probs=179.6

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc--------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS--------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFC  414 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~  414 (571)
                      .+..++|.+.+.||+|+||.||++...        +++.||||+++.. .......+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            455678889999999999999999863        4678999999753 344566789999999999 899999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN  481 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~N  481 (571)
                      .+.+..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+.+   |+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence            999999999999999999999965322             234899999999999999999999998   9999999999


Q ss_pred             eEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          482 VLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       482 ILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999999999999999987655433333333467889999999998889999999999999999999 999997653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.3e-36  Score=317.51  Aligned_cols=201  Identities=30%  Similarity=0.481  Sum_probs=177.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|.+.+.||+|+||.||++.+. +|+.||||+++...   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            457888899999999999999975 79999999986432   23456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999983   4567999999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...   ....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||...+
T Consensus       169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~  220 (476)
T 2y94_A          169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH  220 (476)
T ss_dssp             TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence            321   223479999999999988765 789999999999999999999998664

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6e-36  Score=332.75  Aligned_cols=205  Identities=28%  Similarity=0.354  Sum_probs=178.7

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCce
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~  419 (571)
                      .+..++|++.+.||+|+||.||++... +++.||||++++.   .......+..|..++..+ +||+|+++++++.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            345678999999999999999999975 6889999998742   234456788999999987 79999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++|+|..++.   ..+.+++..++.++.||+.||+|||+++   |+||||||+||||+.++++||+|||+++
T Consensus       417 ~~lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             EEEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             EEEEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence            999999999999999994   3356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .......  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       491 ~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~  546 (674)
T 3pfq_A          491 ENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED  546 (674)
T ss_dssp             ECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence            5433222  2334689999999999999999999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-35  Score=307.11  Aligned_cols=207  Identities=28%  Similarity=0.322  Sum_probs=179.5

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcc-----cCCeeeEeeE
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----HKNLVKLLGF  413 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~nIv~l~~~  413 (571)
                      .++...+..++|.+.+.||+|+||.||+++.. +++.||||+++. .......+..|+.++.+++     ||||++++++
T Consensus        26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            34444566789999999999999999999974 688999999874 3344566788999999996     9999999999


Q ss_pred             EEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-------
Q 008288          414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------  486 (571)
Q Consensus       414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-------  486 (571)
                      +...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+   |+||||||+|||+++       
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEE
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccc
Confidence            99999999999999 99999998542 2345899999999999999999999998   999999999999975       


Q ss_pred             ------------------CCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh
Q 008288          487 ------------------DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT  548 (571)
Q Consensus       487 ------------------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt  548 (571)
                                        ++.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|||++
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                              7899999999998643322     23478999999999999999999999999999999999


Q ss_pred             CCCCCCCCc
Q 008288          549 GRRNAGSNQ  557 (571)
Q Consensus       549 G~~p~~~~~  557 (571)
                      |+.||...+
T Consensus       255 g~~pf~~~~  263 (360)
T 3llt_A          255 GSLLFRTHE  263 (360)
T ss_dssp             SSCSCCCSS
T ss_pred             CCCCCCCCc
Confidence            999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.6e-36  Score=306.31  Aligned_cols=205  Identities=34%  Similarity=0.516  Sum_probs=172.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcE----EEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKE----VAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|+..+.||+|+||.||++.+. +++.    |++|.+... .......+.+|+.++++++||||+++++++. ++..
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            3467888899999999999999964 4443    788877532 2344556789999999999999999999886 4568


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++|+|.+++..  ..+.+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence            899999999999999853  2456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ..............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  222 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR  222 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence            765544433344578889999999999999999999999999999999 999997653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=299.85  Aligned_cols=202  Identities=23%  Similarity=0.329  Sum_probs=171.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|+..+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            56888999999999999999975 58999999886432  2334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|..++.   ..+.+++..+..++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999999884   3456899999999999999999999998   9999999999999999999999999998765333


Q ss_pred             Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          506 GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ..  .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  208 (311)
T 4agu_A          157 DY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD  208 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence            22  123478999999999876 6689999999999999999999999987643

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.9e-36  Score=322.51  Aligned_cols=207  Identities=32%  Similarity=0.478  Sum_probs=178.5

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ...+..++|+..+.||+|+||.||+|.++++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus       182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            3456677888899999999999999999888999999998643 45678999999999999999999999986 567899


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus       260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            99999999999999532 1235889999999999999999999998   9999999999999999999999999998764


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ...... .....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus       336 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~  389 (454)
T 1qcf_A          336 DNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM  389 (454)
T ss_dssp             CHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            322111 122346778999999998999999999999999999999 99999765

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-35  Score=302.47  Aligned_cols=192  Identities=28%  Similarity=0.391  Sum_probs=151.5

Q ss_pred             CceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEEccCCCC
Q 008288          354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      .+.||+|+||.||++... +++.||||++..   .....+.+|+.++..+. ||||+++++++.+++..++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999975 689999999864   23456789999999996 9999999999999999999999999999


Q ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---cEEEeecccccccccCCCcc
Q 008288          432 LDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NSKISDFGMARIFAESEGEA  508 (571)
Q Consensus       432 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~---~~kL~DfGla~~~~~~~~~~  508 (571)
                      |.+++.   ..+.+++..+..++.||++||+|||+++   |+||||||+|||++.++   .+||+|||+++........ 
T Consensus        93 L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-  165 (325)
T 3kn6_A           93 LFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-  165 (325)
T ss_dssp             HHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence            999984   3456999999999999999999999998   99999999999998765   8999999999865433222 


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                       .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence             22347899999999999999999999999999999999999999754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.9e-36  Score=295.27  Aligned_cols=202  Identities=28%  Similarity=0.426  Sum_probs=176.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|++.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            46788899999999999999975 6899999998643 234456789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++.   ....+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.+||+|||++..+.....
T Consensus        87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            99999999983   3456899999999999999999999998   99999999999999999999999999986654332


Q ss_pred             ccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  211 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  211 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence            222334578999999999987765 78999999999999999999999764

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-35  Score=310.38  Aligned_cols=202  Identities=29%  Similarity=0.508  Sum_probs=163.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCc--eeE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD--EKL  421 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~--~~~  421 (571)
                      .++|++.+.||+|+||.||++... +++.||||++...  .......+.+|+.++.++. ||||+++++++...+  ..+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            467889999999999999999964 7899999998642  3445566889999999997 999999999998654  689


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||++ ++|..++..    ..+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++.+
T Consensus        88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            9999997 589888842    46899999999999999999999998   999999999999999999999999999865


Q ss_pred             ccCC-------------------Cccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESE-------------------GEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....                   ........+||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            3311                   1111233579999999999986 678999999999999999999999997664

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.2e-36  Score=308.07  Aligned_cols=200  Identities=26%  Similarity=0.352  Sum_probs=166.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ..++|+..+.||+|+||.||++... +++.||||++.... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            4568899999999999999999976 78999999997533 334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--EEEeeccccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMARIFAE  503 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~--~kL~DfGla~~~~~  503 (571)
                      |+++|+|.+++.   ..+.+++..+..++.||++||.|||+++   |+||||||+|||++.++.  +||+|||+++....
T Consensus        97 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           97 YASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            999999999884   3456999999999999999999999998   999999999999987765  99999999974332


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcc-hhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKK-SDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..   ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||...
T Consensus       171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  221 (361)
T 3uc3_A          171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP  221 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred             cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence            22   1223479999999999988877655 99999999999999999999754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.1e-36  Score=307.65  Aligned_cols=211  Identities=31%  Similarity=0.462  Sum_probs=180.3

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEcC-C-----cEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEeeEE
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD-G-----KEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLLGFC  414 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~  414 (571)
                      .+.+..++|...+.||+|+||.||++.... +     +.||+|+++.. .....+.+.+|+.++.++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            355677889999999999999999999642 2     47999998753 334456789999999999 899999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeE
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPR-----------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL  483 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NIL  483 (571)
                      .+.+..++||||+++|+|.+++....           ....+++..++.++.||++||+|||+++   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            99999999999999999999985311           1345899999999999999999999998   999999999999


Q ss_pred             ecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          484 LDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       484 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      +++++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999999999999987655443332333467889999999999999999999999999999999 99999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-35  Score=300.52  Aligned_cols=200  Identities=26%  Similarity=0.376  Sum_probs=176.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCcc------chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQ------GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ++|++.+.||+|+||.||++... +++.||+|+++.....      ..+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45788899999999999999975 6899999998643221      3567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----cEEEeeccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM  497 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~----~~kL~DfGl  497 (571)
                      +||||+++++|.+++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        92 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           92 LILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999994   3456899999999999999999999998   99999999999999887    799999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +........   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  222 (321)
T 2a2a_A          166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT  222 (321)
T ss_dssp             CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence            986654322   123468999999999999999999999999999999999999997653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-36  Score=302.33  Aligned_cols=202  Identities=26%  Similarity=0.411  Sum_probs=169.2

Q ss_pred             CCCCCC-ceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +.|.+. +.||+|+||.||++... +++.||||++..........+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            456663 78999999999999954 7899999999876666677899999999995 79999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc---EEEeecccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~---~kL~DfGla~~~~  502 (571)
                      |+++++|.+++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.   +||+|||++....
T Consensus        92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999843   356899999999999999999999998   999999999999988776   9999999997654


Q ss_pred             cCCC-----ccceeeecccccccchhhhcc-----CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEG-----EANTVRIVGTYGYMAPEYAME-----GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....     ........||+.|+|||++.+     ..++.++||||||+++|||++|+.||...
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence            3211     111223468999999999875     55889999999999999999999999765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.7e-36  Score=306.58  Aligned_cols=209  Identities=26%  Similarity=0.335  Sum_probs=172.9

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-----CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-----SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      ...++|++.+.||+|+||.||++... +++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            34567889999999999999999974 6889999988642     34556779999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHHHH
Q 008288          420 KLLVYEFMPNGSLDAILFDPR-------------------------------------KRGILCWRKRTNIVNGIAKGML  462 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~~L~  462 (571)
                      .++||||+++|+|.+++....                                     ....+++..+..++.||++||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            999999999999999884100                                     0122467788899999999999


Q ss_pred             HHhhCCCCCeeeCCCCCCCeEecCCC--cEEEeecccccccccCCCcc--ceeeecccccccchhhhcc--CCCCcchhh
Q 008288          463 YLHEDSRLRIVHRDLKASNVLLDSDM--NSKISDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAME--GLYSKKSDV  536 (571)
Q Consensus       463 ~LH~~~~~~iiH~DLkp~NILl~~~~--~~kL~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv  536 (571)
                      |||+.+   |+||||||+|||++.++  .+||+|||++..+.......  ......||+.|+|||.+.+  ..++.++||
T Consensus       183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence            999998   99999999999998776  89999999998764432221  2234579999999999875  678999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCc
Q 008288          537 FSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       537 ~slGvil~elltG~~p~~~~~  557 (571)
                      ||||+++|||++|+.||...+
T Consensus       260 wslG~il~el~~g~~pf~~~~  280 (345)
T 3hko_A          260 WSAGVLLHLLLMGAVPFPGVN  280 (345)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999999997653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.4e-36  Score=305.73  Aligned_cols=213  Identities=33%  Similarity=0.500  Sum_probs=181.8

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeE
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGF  413 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~  413 (571)
                      .+++++..++|...+.||+|+||.||++...      +++.||+|++... .......+.+|+.++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3445567788999999999999999999854      3678999999753 33445568899999999999999999999


Q ss_pred             EEcCceeEEEEEccCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC
Q 008288          414 CVDGDEKLLVYEFMPNGSLDAILFDPR-------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS  486 (571)
Q Consensus       414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~  486 (571)
                      +.+.+..++||||+++++|.+++....       ....+++..++.++.||++||.|||+++   |+||||||+|||+++
T Consensus        97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~  173 (322)
T 1p4o_A           97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE  173 (322)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred             EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence            999999999999999999999985311       1245789999999999999999999998   999999999999999


Q ss_pred             CCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          487 DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       487 ~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            99999999999986654433222233467889999999999999999999999999999999 89999765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.9e-36  Score=323.37  Aligned_cols=208  Identities=30%  Similarity=0.451  Sum_probs=179.8

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEcC-CcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .++..++|+..+.||+|+||.||+|.+.. +..||||+++... ...+++.+|+.++++++||||+++++++.+.+..++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            34456678888999999999999999864 8899999997633 356789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999999542 2345899999999999999999999998   9999999999999999999999999998764


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       370 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~  424 (495)
T 1opk_A          370 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  424 (495)
T ss_dssp             TCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence            33211 1122345778999999998899999999999999999999 999997653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-35  Score=295.92  Aligned_cols=204  Identities=29%  Similarity=0.458  Sum_probs=170.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC-----ccchHHHHHHHHHHHhcc---cCCeeeEeeEEEc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-----EQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVD  416 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~  416 (571)
                      +..++|++.+.||+|+||.||++.. .+++.||||+++...     ......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467899999999999999999996 478999999986322     222346778888877775   9999999999987


Q ss_pred             Cc-----eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEE
Q 008288          417 GD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK  491 (571)
Q Consensus       417 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~k  491 (571)
                      ..     ..++||||++ ++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     4789999997 5999988542 2334999999999999999999999999   99999999999999999999


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      |+|||+++........   ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  223 (308)
T 3g33_A          161 LADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS  223 (308)
T ss_dssp             ECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred             EeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999866433222   23478999999999999999999999999999999999999997764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.2e-36  Score=295.78  Aligned_cols=205  Identities=31%  Similarity=0.513  Sum_probs=178.3

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +..++|+..+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            3456788889999999999999999888999999997643 344678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++..  ....+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           84 FMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CCTTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999853  2356899999999999999999999998   9999999999999999999999999998654321


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  210 (267)
T 3t9t_A          159 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS  210 (267)
T ss_dssp             HH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence            11 1112356788999999998899999999999999999999 999997654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-35  Score=297.66  Aligned_cols=204  Identities=33%  Similarity=0.520  Sum_probs=162.9

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ++..++|+..+.||+|+||.||+++..  ..+|+|+++..  .....+.+.+|+.++++++||||++++++. ..+..++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence            355678999999999999999999863  46999998643  344456789999999999999999999965 5567899


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++++|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        97 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EEECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence            9999999999999843  3456999999999999999999999998   9999999999999999999999999998665


Q ss_pred             cCCCccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ............||+.|+|||.+.   +..++.++||||||+++|||++|+.||...
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  228 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI  228 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence            433333334457899999999986   567889999999999999999999999764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.5e-36  Score=312.08  Aligned_cols=203  Identities=25%  Similarity=0.336  Sum_probs=170.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhcc--cCCeeeEeeEEEcCceeE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~~~~~  421 (571)
                      +...+|++.+.||+|+||.||++...+++.||||++...  .......+.+|+.++.+++  ||||+++++++...+..+
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            345568999999999999999999888999999998643  3445567899999999996  599999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||| +.+++|.+++..   ...+++.++..++.||++||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+
T Consensus       133 lv~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EEEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             EEEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            9999 568899999843   446899999999999999999999998   99999999999995 588999999999876


Q ss_pred             ccCCCccceeeecccccccchhhhcc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAME-----------GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ............+||+.|+|||++.+           ..++.++||||||+++|||++|+.||...
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence            54433333334579999999999865           46899999999999999999999999753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.7e-35  Score=295.25  Aligned_cols=204  Identities=26%  Similarity=0.400  Sum_probs=178.1

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|...+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            456788899999999999999975 5889999998643   233456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++.   ....+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999883   3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                      ....  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  221 (294)
T 2rku_A          168 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK  221 (294)
T ss_dssp             TTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             Cccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            3222  22347899999999999988999999999999999999999999876443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-35  Score=315.72  Aligned_cols=200  Identities=34%  Similarity=0.469  Sum_probs=173.1

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc-eeEEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLV  423 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-~~~lv  423 (571)
                      .+..++|+..+.||+|+||.||++.+. ++.||||+++...  ..+.+.+|+.++++++||||+++++++.+.+ ..++|
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            355667888899999999999999984 7899999997533  5568999999999999999999999987765 78999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++... ....+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       266 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999999542 2334789999999999999999999998   99999999999999999999999999985432


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ..     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       342 ~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~  390 (450)
T 1k9a_A          342 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI  390 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTS
T ss_pred             cc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            21     12256889999999999999999999999999999998 99999754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-35  Score=316.07  Aligned_cols=198  Identities=27%  Similarity=0.369  Sum_probs=166.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|+..+.||+|+||.||++... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999965 6899999999753  3444667889999999999999999999997653      


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||++++ |...+.     ..+++..+..++.||++||+|||+++   |+||||||+|||++.++++||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999765 555552     23889999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +......   .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~  267 (464)
T 3ttj_A          212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  267 (464)
T ss_dssp             -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            8654322   2233589999999999999999999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-35  Score=300.56  Aligned_cols=215  Identities=29%  Similarity=0.443  Sum_probs=170.5

Q ss_pred             cChHHHHhhcCCCCCCceecccCceeEEEEEEc----CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEee
Q 008288          339 IDLETLNLATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLG  412 (571)
Q Consensus       339 ~~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~  412 (571)
                      ..++.+.+..++|...+.||+|+||.||++...    +++.||+|+++..  .....+.+.+|+.++++++||||+++++
T Consensus        24 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           24 NKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             hhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            345566677888999999999999999999864    3458999998743  3344567899999999999999999999


Q ss_pred             EEEcCce-----eEEEEEccCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 008288          413 FCVDGDE-----KLLVYEFMPNGSLDAILFDP---RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL  484 (571)
Q Consensus       413 ~~~~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl  484 (571)
                      ++.+.+.     .++||||+++++|.+++...   .....+++..++.++.||++||.|||+++   |+||||||+|||+
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli  180 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCML  180 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEE
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEE
Confidence            9987653     48999999999999988432   23456999999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          485 DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       485 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ++++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  253 (313)
T 3brb_A          181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV  253 (313)
T ss_dssp             CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence            9999999999999987654433222333467889999999999999999999999999999999 99999765

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.4e-35  Score=301.58  Aligned_cols=203  Identities=26%  Similarity=0.405  Sum_probs=178.1

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|...+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            456888899999999999999975 5789999998643   234456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++.   ....+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999884   3356899999999999999999999998   99999999999999999999999999986643


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ....  .....||..|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       194 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  246 (335)
T 2owb_A          194 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL  246 (335)
T ss_dssp             TTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             Cccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH
Confidence            3222  2234789999999999999999999999999999999999999987643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.7e-35  Score=292.48  Aligned_cols=201  Identities=29%  Similarity=0.453  Sum_probs=175.8

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .++|++.+.||+|+||.||++... +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            467888999999999999999975 6899999998642  3344567889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc---EEEeeccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGMARIF  501 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~---~kL~DfGla~~~  501 (571)
                      ||+++++|.+.+.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999988874   3456899999999999999999999998   999999999999986655   999999999765


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  211 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED  211 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence            44322   123478999999999999999999999999999999999999996653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=294.31  Aligned_cols=202  Identities=31%  Similarity=0.524  Sum_probs=156.7

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5688889999999999999997 478999999986422   233467899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..  ....+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999853  3356899999999999999999999998   999999999999999999999999999865433


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       166 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          166 HEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence            222  123478999999999998889999999999999999999999997653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-35  Score=295.34  Aligned_cols=202  Identities=28%  Similarity=0.443  Sum_probs=174.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ..++|++.+.||+|+||.||++... +++.||+|++...   .......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4567888999999999999999975 5779999998642   22335668899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++....
T Consensus        87 v~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999884   3356899999999999999999999998   9999999999999999999999999986543


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ...    .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+.
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  212 (279)
T 3fdn_A          161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY  212 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence            322    2234789999999999999999999999999999999999999987643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.1e-36  Score=304.60  Aligned_cols=199  Identities=27%  Similarity=0.387  Sum_probs=174.1

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      .++|+..+.||+|+||.||++... +++.||||+++...        ......+.+|+.++++++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            457888999999999999999964 78899999987532        123445788999999999999999999999999


Q ss_pred             eeEEEEEccCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          419 EKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       419 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      ..++||||+..| +|..++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+|||+
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence            999999999777 9999984   3456999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      +........   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..
T Consensus       177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            987654332   223579999999999988776 8899999999999999999999964

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.5e-36  Score=297.40  Aligned_cols=208  Identities=31%  Similarity=0.449  Sum_probs=181.2

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ..+..++|+..+.||+|+||.||++.+. +++.||+|++... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            3456678888999999999999999976 4889999998753 3456778999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEECCTTEEHHHHHHH-CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEcCCCCcHHHHHHh-cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999999854 23456899999999999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~  217 (288)
T 3kfa_A          163 GDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  217 (288)
T ss_dssp             SSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            43322 2223456888999999999999999999999999999999 999997654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.8e-36  Score=318.03  Aligned_cols=206  Identities=32%  Similarity=0.500  Sum_probs=172.6

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ..+..++|+..+.||+|+||.||+|.+.++..||||+++... ...+++.+|+.++++++||||+++++++.+ +..++|
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            345567788889999999999999999888899999998643 345679999999999999999999999876 678999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++.. .....+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       257 ~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             ECCCTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             ehhhcCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            999999999999942 12245899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .... ......++..|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus       333 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~  385 (452)
T 1fmk_A          333 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  385 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             Ccee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence            3221 1122356788999999999999999999999999999999 99999765

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.6e-35  Score=302.67  Aligned_cols=197  Identities=32%  Similarity=0.487  Sum_probs=170.8

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      +.|+..+.||+|+||.||++.. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3477789999999999999996 478999999986432   233457889999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||++ |+|.+++..  ....+++..+..++.|+++||.|||+.+   |+||||||+|||+++++.+||+|||++......
T Consensus       134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 577777632  3456899999999999999999999998   999999999999999999999999999765432


Q ss_pred             CCccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                            ....||+.|+|||++.   +..++.++||||||+++|||++|+.||...+
T Consensus       208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  257 (348)
T 1u5q_A          208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  257 (348)
T ss_dssp             ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                  1347899999999985   5678999999999999999999999997654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.6e-35  Score=292.84  Aligned_cols=200  Identities=29%  Similarity=0.475  Sum_probs=177.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +.|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            45788899999999999999964 6899999998743 344567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++.    .+.+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++........
T Consensus       102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            99999999983    356899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       175 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  223 (303)
T 3a7i_A          175 K--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH  223 (303)
T ss_dssp             C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             c--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence            2  223478999999999999999999999999999999999999997653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-36  Score=307.81  Aligned_cols=202  Identities=28%  Similarity=0.381  Sum_probs=173.0

Q ss_pred             hcCCCCCCceecccCceeEEEEEE----cCCcEEEEEEccccC----ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSCS----EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG  417 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~  417 (571)
                      ..++|++.+.||+|+||.||+++.    .+++.||||+++...    ......+.+|+.++.++ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            346788899999999999999997    368999999987432    23445678899999999 699999999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||||+++++|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++++||+|||+
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceEEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence            99999999999999999984   3346899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ++.+...... ......||+.|+|||++.+  ..++.++||||||+++|||++|+.||..
T Consensus       206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  264 (355)
T 1vzo_A          206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV  264 (355)
T ss_dssp             EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence            9865433222 2223579999999999986  3478999999999999999999999964

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.9e-36  Score=296.47  Aligned_cols=204  Identities=26%  Similarity=0.415  Sum_probs=163.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC----CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      +..++|++.+.||+|+||.||++....    +..||+|+++.. .....+.+.+|+.++++++||||+++++++ .++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCcc
Confidence            445678889999999999999998643    457999998753 344456789999999999999999999997 45678


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++++|.+++..  ....+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence            899999999999999853  2346899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~  221 (281)
T 1mp8_A          166 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV  221 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence            6543222 1223356788999999998999999999999999999997 99999765

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-35  Score=307.56  Aligned_cols=204  Identities=21%  Similarity=0.254  Sum_probs=167.9

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC------CcEEEEEEccccCccc-----------hHHHHHHHHHHHhcccCCee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD------GKEVAVKRLSSCSEQG-----------TAEFTNEVLLILKLQHKNLV  408 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~nIv  408 (571)
                      ...++|.+.+.||+|+||.||++.+.+      ++.||||++.......           ...+..|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            356689999999999999999999754      4789999987543211           11234455566777899999


Q ss_pred             eEeeEEEcC----ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 008288          409 KLLGFCVDG----DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL  484 (571)
Q Consensus       409 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl  484 (571)
                      ++++++...    ...++||||+ +++|.+++..  ..+.+++..++.++.||+.||+|||+++   |+||||||+|||+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill  185 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL  185 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence            999998775    4578999999 9999999853  3356999999999999999999999998   9999999999999


Q ss_pred             c--CCCcEEEeecccccccccCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          485 D--SDMNSKISDFGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       485 ~--~~~~~kL~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      +  .++.+||+|||+++.+.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9  88999999999998765432211     11234699999999999999999999999999999999999999974

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=298.02  Aligned_cols=200  Identities=32%  Similarity=0.475  Sum_probs=165.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..++|++.+.||+|+||.||++.. .++.||||++..  +...+.+.+|++++++++||||+++++++.+  ..++||||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             CHhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            345677889999999999999998 478999999864  3345678999999999999999999998874  48899999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-EEEeecccccccccCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-SKISDFGMARIFAESE  505 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~-~kL~DfGla~~~~~~~  505 (571)
                      +++++|.+++........+++..++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~  160 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM  160 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence            999999999975444446889999999999999999999932223999999999999998886 7999999997553321


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                           ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       161 -----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          161 -----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             -----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence                 2236899999999999999999999999999999999999999743

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-35  Score=293.51  Aligned_cols=206  Identities=34%  Similarity=0.515  Sum_probs=176.0

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .+..++|+..+.||+|+||.||++...+++.||+|+++... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   86 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT   86 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence            34556788899999999999999999888899999987533 34667999999999999999999999986 45689999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++... ....+++..+..++.|+++||+|||+++   |+||||||+||++++++.+||+|||++......
T Consensus        87 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            999999999998421 1225899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       163 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  215 (279)
T 1qpc_A          163 EYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT  215 (279)
T ss_dssp             CEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence            221 1122356788999999998889999999999999999999 999997653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=294.79  Aligned_cols=204  Identities=32%  Similarity=0.457  Sum_probs=173.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ..++|.....||+|+||.||++... +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            3455666779999999999999964 688999999987666667789999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeecccccccccC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAES  504 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGla~~~~~~  504 (571)
                      |+++++|.+++........+++..+..++.||++||.|||+.+   |+|+||||+||+++. ++.+||+|||++......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9999999999965444446789999999999999999999998   999999999999987 899999999999865432


Q ss_pred             CCccceeeecccccccchhhhccCC--CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ...  .....|++.|+|||.+.+..  ++.++||||||+++|||++|+.||..
T Consensus       177 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          177 NPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             CCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence            221  22347899999999987654  78999999999999999999999964

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.9e-35  Score=299.36  Aligned_cols=202  Identities=28%  Similarity=0.441  Sum_probs=170.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .++|+..+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            356888899999999999999975 58999999986432  233455789999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999998873   3445999999999999999999999998   999999999999999999999999999865443


Q ss_pred             CCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...  .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       178 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          178 GEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            222  2234789999999999875 68999999999999999999999997764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-35  Score=314.04  Aligned_cols=195  Identities=25%  Similarity=0.440  Sum_probs=154.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-----ce
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~  419 (571)
                      .++|++.+.||+|+||.||++... +++.||||++...  .....+.+.+|+.++++++||||+++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367899999999999999999965 7899999998642  334456789999999999999999999998543     56


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+ +++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 578988884   3456999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc-------------------------cceeeecccccccchhhh-ccCCCCcchhhHhHHHHHHHHHhC
Q 008288          500 IFAESEGE-------------------------ANTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEIITG  549 (571)
Q Consensus       500 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltG  549 (571)
                      ........                         ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76432211                         112345789999999986 456799999999999999999993

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.5e-35  Score=293.86  Aligned_cols=202  Identities=19%  Similarity=0.306  Sum_probs=175.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ..++|++.+.||+|+||.||++.. .+++.||||++....  ....+.+|+.++.++ +|+||+++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            456788999999999999999996 579999999986432  334688999999999 8999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-----EEEeeccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKISDFGMAR  499 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~-----~kL~DfGla~  499 (571)
                      ||+ +++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++.++.     +||+|||+++
T Consensus        86 e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 9999999953  2345999999999999999999999998   999999999999987776     9999999998


Q ss_pred             ccccCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .........     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  221 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  221 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence            765543221     123457999999999999999999999999999999999999999763

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-35  Score=300.55  Aligned_cols=205  Identities=32%  Similarity=0.546  Sum_probs=167.5

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcE----EEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKE----VAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~----vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|+..+.||+|+||.||++.+. +++.    |++|.+.. ........+.+|+.++++++||||+++++++.... .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            4567889999999999999999964 4443    57777753 34456678999999999999999999999998765 7


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++++||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             eEEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            899999999999999853  2456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  224 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence            655443333334467889999999999999999999999999999999 999997653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.4e-35  Score=292.94  Aligned_cols=201  Identities=27%  Similarity=0.418  Sum_probs=176.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ..++|++.+.||+|+||.||++... +++.||+|++...   .......+.+|++++++++||||+++++++.+.+..++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            3457888999999999999999975 5788999998642   22335678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++++|.+++.   ..+.+++..+..++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        92 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           92 MLEFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            999999999999884   3346899999999999999999999998   9999999999999999999999999987543


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...    .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  216 (284)
T 2vgo_A          166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS  216 (284)
T ss_dssp             SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence            322    123478999999999999999999999999999999999999997653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.8e-35  Score=310.48  Aligned_cols=200  Identities=26%  Similarity=0.431  Sum_probs=167.2

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-----ce
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~  419 (571)
                      .++|.+.+.||+|+||.||++... +++.||||+++..  .....+.+.+|+.++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467899999999999999999975 6889999999753  334456789999999999999999999999876     56


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||++ ++|.+++.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 59999984   3456999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc--------------------cceeeecccccccchhhh-ccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          500 IFAESEGE--------------------ANTVRIVGTYGYMAPEYA-MEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       500 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            76543221                    112345899999999986 46669999999999999999998655553

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.9e-35  Score=290.88  Aligned_cols=200  Identities=26%  Similarity=0.387  Sum_probs=173.3

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ++|...+.||+|+||.||++... +++.||+|+++...      ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45788899999999999999976 68999999886432      123567899999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----cEEEeeccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM  497 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~----~~kL~DfGl  497 (571)
                      +||||+++++|.+++.   ....+++..+..++.||++||.|||+.+   ++||||||+||++++++    .+||+|||+
T Consensus        85 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999999984   3456899999999999999999999998   99999999999998877    899999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +........   .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  215 (283)
T 3bhy_A          159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET  215 (283)
T ss_dssp             CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence            986543322   223468999999999998999999999999999999999999997653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.7e-35  Score=295.90  Aligned_cols=198  Identities=29%  Similarity=0.415  Sum_probs=166.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHh--cccCCeeeEeeEEEcC----cee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDG----DEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~~~~~----~~~  420 (571)
                      ..++|++.+.||+|+||.||+++. +++.||||++...   ....+..|.+++..  ++||||+++++++...    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            346788999999999999999998 7899999998642   34456677777776  7999999999987543    457


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeeCCCCCCCeEecCCCcEEE
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--------EDSRLRIVHRDLKASNVLLDSDMNSKI  492 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH--------~~~~~~iiH~DLkp~NILl~~~~~~kL  492 (571)
                      ++||||+++|+|.+++.    ...+++..++.++.||++||+|||        +.+   |+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            89999999999999993    346999999999999999999999        777   999999999999999999999


Q ss_pred             eecccccccccCCCcc--ceeeecccccccchhhhccC------CCCcchhhHhHHHHHHHHHhC----------CCCCC
Q 008288          493 SDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAMEG------LYSKKSDVFSFGVLLIEIITG----------RRNAG  554 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slGvil~elltG----------~~p~~  554 (571)
                      +|||+++.........  ......||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999997665443221  11234789999999999876      455799999999999999999          88874


Q ss_pred             C
Q 008288          555 S  555 (571)
Q Consensus       555 ~  555 (571)
                      .
T Consensus       235 ~  235 (301)
T 3q4u_A          235 D  235 (301)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.8e-35  Score=301.74  Aligned_cols=202  Identities=26%  Similarity=0.398  Sum_probs=165.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ..++|++.+.||+|+||.||++... +++.||||+++...  ......+.+|+.++++++||||+++++++.+++..++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            4467899999999999999999964 78999999997432  22345678999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-----CCCcEEEeecccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-----SDMNSKISDFGMA  498 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~-----~~~~~kL~DfGla  498 (571)
                      |||++ ++|.+++.   ....+++..+..++.||++||+|||+.+   |+||||||+|||++     +++.+||+|||++
T Consensus       112 ~e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99997 49988884   3456999999999999999999999998   99999999999994     4556999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +........  .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...+
T Consensus       185 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  242 (329)
T 3gbz_A          185 RAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS  242 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC
Confidence            866433222  2234789999999999874 48999999999999999999999997764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.4e-35  Score=306.71  Aligned_cols=195  Identities=27%  Similarity=0.366  Sum_probs=160.3

Q ss_pred             CCCCC-ceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHh-cccCCeeeEeeEEEc----CceeEE
Q 008288          350 NFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILK-LQHKNLVKLLGFCVD----GDEKLL  422 (571)
Q Consensus       350 ~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~nIv~l~~~~~~----~~~~~l  422 (571)
                      +|... +.||+|+||.||++... +++.||||+++.     ...+.+|++++.+ .+||||+++++++..    .+..++
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            45554 68999999999999975 689999999863     2356788888755 489999999999875    567899


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeeccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMAR  499 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~DfGla~  499 (571)
                      ||||+++|+|.+++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++
T Consensus       137 v~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            99999999999999542 2346999999999999999999999998   999999999999987   7899999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ......   .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence            654322   123457899999999999999999999999999999999999999654

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-35  Score=303.21  Aligned_cols=196  Identities=28%  Similarity=0.453  Sum_probs=169.6

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|+..+.||+|+||.||++... +++.||||+++....    ...+|++++.++ +||||+++++++.+++..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            356888899999999999999975 689999999975432    245788888888 79999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC----CcEEEeeccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARIF  501 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~----~~~kL~DfGla~~~  501 (571)
                      |+++|+|.+++.   ..+.+++..+..++.||+.||+|||+++   |+||||||+|||+.++    +.+||+|||++...
T Consensus        97 ~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999884   3456999999999999999999999998   9999999999998543    35999999999876


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ......  ....+||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence            543322  2235789999999999888899999999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.5e-35  Score=296.82  Aligned_cols=203  Identities=25%  Similarity=0.336  Sum_probs=167.1

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|++.+.||+|+||.||++... +++.||+|++....   +...+.+.+|+.++.+++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            467889999999999999999975 68899999987532   22346788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++.   ..+.+++..+..++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            99999999999984   3356899999999999999999999998   99999999999999999999999999976544


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (309)
T 2h34_A          187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ  239 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred             cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence            3222 1223478999999999999999999999999999999999999997664

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=302.21  Aligned_cols=201  Identities=27%  Similarity=0.406  Sum_probs=165.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc-cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|...+.||+|+||.||++... +++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            46888899999999999999975 789999999874322 2223456899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      ++ ++|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 588887743  2446899999999999999999999998   99999999999999999999999999976543322


Q ss_pred             ccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (324)
T 3mtl_A          156 T--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST  205 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             c--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2  223478999999999876 568999999999999999999999998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.2e-35  Score=296.27  Aligned_cols=199  Identities=28%  Similarity=0.461  Sum_probs=172.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|...+.||+|+||.||++... +++.||+|+++.........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            46778899999999999999975 78999999998655555567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccccC
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl---~~~~~~kL~DfGla~~~~~~  504 (571)
                      ++++|.+++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+||++   ++++.+||+|||++......
T Consensus        89 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           89 SGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             CCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999998884   3456899999999999999999999998   9999999999999   78899999999998754332


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  211 (304)
T 2jam_A          163 I----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET  211 (304)
T ss_dssp             T----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             c----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            1    122468999999999999999999999999999999999999997653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-35  Score=293.80  Aligned_cols=204  Identities=30%  Similarity=0.480  Sum_probs=173.7

Q ss_pred             hcCCCCCCc-eecccCceeEEEEEEc---CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|.+.+ .||+|+||.||++.+.   +++.||||+++.. .....+.+.+|++++++++||||+++++++ ..+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            345566666 8999999999999853   5788999999753 344566799999999999999999999999 556789


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++++|.+++..  ....+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            99999999999999843  3456999999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          502 AESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~  217 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  217 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            5433221 1122356889999999988889999999999999999998 99999765

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-35  Score=296.96  Aligned_cols=197  Identities=27%  Similarity=0.305  Sum_probs=164.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|+..++||+|+||.||++... +++.||||++...  ..........|+..+.++ +||||+++++++.+++..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57888999999999999999976 7999999988642  223334455666666665 8999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+ +++|.+++..  ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++++||+|||++......
T Consensus       137 e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~  210 (311)
T 3p1a_A          137 ELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA  210 (311)
T ss_dssp             ECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred             ecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence            999 6788888743  2346999999999999999999999998   999999999999999999999999998765433


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ..   .....||+.|+|||++.+ .++.++||||||+++|||++|+.|+..
T Consensus       211 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          211 GA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             CC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22   223468999999998876 789999999999999999999776643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-35  Score=293.26  Aligned_cols=203  Identities=27%  Similarity=0.384  Sum_probs=171.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|...+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46778899999999999999974 6889999998753 334567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccc
Q 008288          427 MPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA  502 (571)
Q Consensus       427 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl---~~~~~~kL~DfGla~~~~  502 (571)
                      +++++|.+++... .....+++..+..++.||++||+|||+.+   |+||||||+|||+   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999998888432 22356999999999999999999999998   9999999999999   456789999999998654


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ....   .....||+.|+|||.+. +.++.++||||||+++|||++|+.||...+.
T Consensus       179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~  230 (285)
T 3is5_A          179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL  230 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence            4322   22347899999999875 5689999999999999999999999986643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.5e-35  Score=305.95  Aligned_cols=204  Identities=29%  Similarity=0.415  Sum_probs=177.9

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +..++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++.+++..++|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            34567888999999999999999975 6899999998753 344456789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      |||+++++|.+++.   ..+.+++..+..++.|++.||.|||+. +   |+||||||+|||++.++++||+|||++....
T Consensus       110 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          110 MEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             ECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EECCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999984   345689999999999999999999996 7   9999999999999999999999999987553


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                      ...    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..
T Consensus       184 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  236 (360)
T 3eqc_A          184 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  236 (360)
T ss_dssp             HHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH
T ss_pred             ccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            321    22347899999999999999999999999999999999999999876433

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-35  Score=302.68  Aligned_cols=197  Identities=30%  Similarity=0.458  Sum_probs=166.3

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|+..+.||+|+||.||++... +|+.||||++...  .....+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467888999999999999999974 7999999998642  3334567889999999999999999999998763      


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899999843    45899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.....     .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  230 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  230 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            865432     123478999999999887 679999999999999999999999998764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-35  Score=295.54  Aligned_cols=199  Identities=29%  Similarity=0.439  Sum_probs=172.1

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CC-------cEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DG-------KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      ..++|...+.||+|+||.||++... ++       ..||+|++........+.+.+|+.++++++||||+++++++.+++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4567888899999999999999864 33       479999998766677788999999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--------E
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--------S  490 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~--------~  490 (571)
                      ..++||||+++++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.        +
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            99999999999999999953  2334899999999999999999999998   999999999999998887        9


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhC-CCCCCCC
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITG-RRNAGSN  556 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG-~~p~~~~  556 (571)
                      ||+|||++......      ....+|..|+|||.+.+ ..++.++||||||+++|||++| .+||...
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~  222 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL  222 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc
Confidence            99999998754322      12357889999999987 6789999999999999999995 4555443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.7e-35  Score=290.05  Aligned_cols=201  Identities=35%  Similarity=0.589  Sum_probs=170.1

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccc-------hHHHHHHHHHHHhcccCCeeeEeeEEEcC
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQG-------TAEFTNEVLLILKLQHKNLVKLLGFCVDG  417 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~nIv~l~~~~~~~  417 (571)
                      +..++|+..+.||+|+||.||++.+. +++.||+|++.......       .+.+.+|+.++++++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            34577888999999999999999974 78999999986432211       26789999999999999999999998665


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc-----EEE
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN-----SKI  492 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~-----~kL  492 (571)
                      .  ++||||+++++|.+++..  ....+++..++.++.|+++||+|||+++ .+|+||||||+|||++.++.     +||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             C--eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence            5  699999999999888854  3456999999999999999999999986 45999999999999988776     999


Q ss_pred             eecccccccccCCCccceeeecccccccchhhhc--cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM--EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +|||+++....     ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||...
T Consensus       171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            99999974432     223357899999999984  455789999999999999999999999754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.5e-35  Score=287.84  Aligned_cols=201  Identities=24%  Similarity=0.353  Sum_probs=172.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL  422 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~l  422 (571)
                      ..++|+..+.||+|+||.||++++ +++.||||+++..  .....+.+.+|+.++++++||||+++++++.+.  +..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            446788889999999999999998 4899999998753  344456799999999999999999999999887  77899


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++++|.+++... ....+++..++.++.||++||.|||+.+ .+++||||||+|||+++++.++|.|||+.....
T Consensus        87 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             eecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999999642 2336899999999999999999999875 459999999999999999999999999875432


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCc---chhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSK---KSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..       ...||+.|+|||.+.+..++.   ++||||||+++|||++|+.||...+
T Consensus       165 ~~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  215 (271)
T 3kmu_A          165 SP-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS  215 (271)
T ss_dssp             CT-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred             cc-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            21       236799999999998765444   8999999999999999999997654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-34  Score=297.74  Aligned_cols=203  Identities=28%  Similarity=0.453  Sum_probs=171.2

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--------
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--------  417 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--------  417 (571)
                      ++|++.+.||+|+||.||++.. .+++.||||++...  .......+.+|+.++++++||||+++++++...        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5788899999999999999997 47899999998643  233355788999999999999999999999874        


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||||+++ +|...+..  ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468899999975 66666633  3345999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCc--cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGE--ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++.+......  .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  233 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  233 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9876532221  12233478999999999876 458999999999999999999999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-35  Score=298.82  Aligned_cols=203  Identities=28%  Similarity=0.420  Sum_probs=168.5

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc-----cchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-----QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..++|+..+.||+|+||.||++... +|+.||||+++....     .....+.+|+.++++++||||+++++++.+.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3467899999999999999999975 689999999874221     1234688999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++ +|..++..  ....+++..+..++.|+++||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999986 88888743  3456889999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +......  .....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       162 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~  217 (346)
T 1ua2_A          162 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  217 (346)
T ss_dssp             TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence            6443222  2234789999999998764 58999999999999999999999997764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.4e-35  Score=308.05  Aligned_cols=200  Identities=29%  Similarity=0.421  Sum_probs=163.0

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcC
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG  417 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~  417 (571)
                      ..++|...+.||+|+||.||++... +++.||||++....        ......+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3578999999999999999999965 68999999986421        1222358899999999999999999999754 


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CcEEEee
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISD  494 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~---~~~kL~D  494 (571)
                      +..++||||+++++|.+++.   ..+.+++..+..++.||++||+|||+++   |+||||||+|||++.+   ..+||+|
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence            55789999999999999883   4556999999999999999999999998   9999999999999754   4599999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhcc---CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ||+++......   ......||+.|+|||++.+   ..++.++||||||+++|||++|+.||...
T Consensus       286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            99998764332   2223579999999999863   56889999999999999999999999654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-35  Score=308.79  Aligned_cols=202  Identities=31%  Similarity=0.437  Sum_probs=174.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc--eeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--~~~lv  423 (571)
                      .++|.+.+.||+|+||.||++... +++.||||+++... ......+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            456888999999999999999975 58999999997533 344567889999999999999999999998765  67999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCcEEEeeccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMAR  499 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl----~~~~~~kL~DfGla~  499 (571)
                      |||+++++|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999965444445999999999999999999999998   9999999999999    777889999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhcc--------CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAME--------GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .......   .....||+.|+|||++.+        ..++.++||||||+++|||++|+.||..
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            6644322   223478999999999865        5678899999999999999999999964

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.6e-35  Score=301.49  Aligned_cols=202  Identities=18%  Similarity=0.239  Sum_probs=165.8

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc----CCcEEEEEEccccCcc-----------chHHHHHHHHHHHhcccCCeeeEe
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSCSEQ-----------GTAEFTNEVLLILKLQHKNLVKLL  411 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~nIv~l~  411 (571)
                      ..++|.+.+.||+|+||.||++...    ++..+|+|++......           ....+.+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            4567899999999999999999975    5778999988753321           122366788889999999999999


Q ss_pred             eEEEc----CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC
Q 008288          412 GFCVD----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD  487 (571)
Q Consensus       412 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~  487 (571)
                      +++..    ....++||||+ +++|.+++.   ..+.+++..++.++.||++||+|||+++   |+||||||+|||++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISG---QNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCB---GGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence            99988    77889999999 999999984   3347999999999999999999999998   9999999999999988


Q ss_pred             C--cEEEeecccccccccCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          488 M--NSKISDFGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       488 ~--~~kL~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      +  .+||+|||+++.+.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            7  99999999998764332111     11234789999999999999999999999999999999999999954

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-35  Score=296.63  Aligned_cols=211  Identities=29%  Similarity=0.483  Sum_probs=172.7

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEc-
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD-  416 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~-  416 (571)
                      ++..+....++|++.+.||+|+||.||++... +++.||||++... ......+.+|+.++.++ +||||+++++++.. 
T Consensus        15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            34445556788999999999999999999974 7899999998753 33456789999999999 89999999999987 


Q ss_pred             -----CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEE
Q 008288          417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK  491 (571)
Q Consensus       417 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~k  491 (571)
                           .+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+|
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k  169 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK  169 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence                 46789999999999999998542 2356899999999999999999999998   99999999999999999999


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      |+|||++.........  .....||+.|+|||.+.     +..++.++||||||+++|||++|+.||...+
T Consensus       170 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          170 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999865433221  22347899999999987     5668999999999999999999999997654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.6e-35  Score=296.37  Aligned_cols=203  Identities=32%  Similarity=0.473  Sum_probs=172.3

Q ss_pred             cCCCCCCceecccCceeEEEEEE-----cCCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ce
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DE  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~  419 (571)
                      .++|+..+.||+|+||.||++++     .+++.||+|+++.. .......+.+|+.++++++||||+++++++.+.  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            45578889999999999999984     36889999999743 344567899999999999999999999999877  56


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++++|.+++..  ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            8899999999999999843  3345899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCc-cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          500 IFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       500 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  231 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS  231 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence            76544322 112234678889999999999999999999999999999999998643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-34  Score=299.32  Aligned_cols=208  Identities=26%  Similarity=0.401  Sum_probs=170.4

Q ss_pred             hHHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCcc-----------chHHHHHHHHHHHhcccCCeee
Q 008288          341 LETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQ-----------GTAEFTNEVLLILKLQHKNLVK  409 (571)
Q Consensus       341 ~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~nIv~  409 (571)
                      ..++....++|...+.||+|+||.||++...+++.||||++......           ..+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            45677788999999999999999999999888999999998642211           1367899999999999999999


Q ss_pred             EeeEEEc-----CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 008288          410 LLGFCVD-----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL  484 (571)
Q Consensus       410 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl  484 (571)
                      +++++..     ....++||||++ |+|.+++..  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999854     335799999997 577777743  3456999999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecccccccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          485 DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       485 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.++.+||+|||++........   .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999975433322   223478999999999887 678999999999999999999999998764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-34  Score=299.42  Aligned_cols=201  Identities=27%  Similarity=0.455  Sum_probs=174.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc--------cchHHHHHHHHHHHhc-ccCCeeeEeeEEEc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKL-QHKNLVKLLGFCVD  416 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~  416 (571)
                      ..++|.+.+.||+|+||.||++.+. +|+.||||+++....        ...+.+.+|+.++.++ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            3467888999999999999999985 799999999865331        1134578999999999 89999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      .+..++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+|+||||+|||+++++.+||+|||
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecC
Confidence            999999999999999999984   3456899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhcc------CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAME------GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ++..+.....   .....||+.|+|||++.+      ..++.++||||||+++|||++|+.||...
T Consensus       246 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          246 FSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            9987654322   223579999999999863      35889999999999999999999999765

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.7e-35  Score=294.42  Aligned_cols=203  Identities=29%  Similarity=0.451  Sum_probs=171.8

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .++|++.+.||+|+||.||++... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467888999999999999999975 5899999999876667778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++++|.+++..  ....+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            999999998843  2345899999999999999999999998   99999999999999999999999999764322111


Q ss_pred             ccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        ......||+.|+|||.+.     +..++.++||||||+++|||++|+.||...+
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  226 (302)
T 2j7t_A          173 --KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN  226 (302)
T ss_dssp             --C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             --ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence              112347899999999983     6678999999999999999999999998654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-35  Score=321.61  Aligned_cols=206  Identities=32%  Similarity=0.500  Sum_probs=176.9

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++..++|++.+.||+|+||.||++.+.++..||||+++... ...+++.+|+.++++++||||+++++++.+ +..++|
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv  339 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  339 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence            345567788889999999999999999888899999998643 345679999999999999999999999876 678999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++.. .....+++.+++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       340 ~e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          340 TEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             ECCCTTEEHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             eehhcCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            999999999999942 12245899999999999999999999998   99999999999999999999999999986643


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       416 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~  468 (535)
T 2h8h_A          416 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM  468 (535)
T ss_dssp             HHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred             Ccee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2111 1112346788999999999999999999999999999999 99999765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-34  Score=292.30  Aligned_cols=202  Identities=28%  Similarity=0.457  Sum_probs=173.0

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ..++|+..+.||+|+||.||++... +|+.||+|++...  .....+.+|+.++.+++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567888999999999999999975 5899999998753  345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++++|.+++..  ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999842  3456899999999999999999999998   9999999999999999999999999997664432


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ..  .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  229 (314)
T 3com_A          180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH  229 (314)
T ss_dssp             SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            22  223478999999999999999999999999999999999999997654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5e-35  Score=298.00  Aligned_cols=209  Identities=34%  Similarity=0.529  Sum_probs=173.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  418 (571)
                      +..++|++.+.||+|+||.||++.+      .+++.||||++... ......++.+|+.++++++||||+++++++.+.+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            4567889999999999999999983      25778999999743 4455667899999999999999999999999999


Q ss_pred             eeEEEEEccCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEE
Q 008288          419 EKLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSK  491 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~k  491 (571)
                      ..++||||+++++|.+++....    ....+++..++.++.||++||.|||+.+   |+||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999996432    1245899999999999999999999998   999999999999984   45699


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      |+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  250 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS  250 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence            999999976544333222233467889999999999999999999999999999998 999997653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.3e-35  Score=293.35  Aligned_cols=208  Identities=31%  Similarity=0.442  Sum_probs=172.7

Q ss_pred             HHHhhcCCCCCCc-eecccCceeEEEEEE---cCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEc
Q 008288          343 TLNLATSNFSDSN-ILGQGGFGPVYKGVL---SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVD  416 (571)
Q Consensus       343 ~l~~~~~~~~~~~-~lG~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~  416 (571)
                      ++.+..++|.+.+ .||+|+||.||++.+   .+++.||||+++...  ....+++.+|+.++++++||||+++++++ .
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            3344556777777 999999999999964   246889999987532  23356799999999999999999999999 5


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      .+..++||||+++++|.+++..   .+.+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCC
Confidence            6778899999999999999943   456899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          497 MARIFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       497 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ++.......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  225 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  225 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            998765443221 1122346788999999998889999999999999999999 999997653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-35  Score=297.41  Aligned_cols=206  Identities=32%  Similarity=0.541  Sum_probs=169.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC-----CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD-----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      +..++|...+.||+|+||.||++....     +..||||+++.. .......+.+|+.++++++||||+++++++.+.+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            345677888999999999999998642     235999998753 33445678999999999999999999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++++|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++
T Consensus       121 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999853  3356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          500 IFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ......... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~  254 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL  254 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence            765432221 1222356788999999999999999999999999999999 99999654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.7e-35  Score=299.95  Aligned_cols=205  Identities=31%  Similarity=0.440  Sum_probs=177.2

Q ss_pred             hcCCCCCCceecccCceeEEEEEE-----cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEE--cCce
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV--DGDE  419 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~--~~~~  419 (571)
                      ..++|+..+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++.  +.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            446788899999999999999984     368899999998766666778999999999999999999999987  4556


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++++|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence            8899999999999999843  2345899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ......... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence            765433221 122246788899999999888999999999999999999999998644

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-35  Score=299.84  Aligned_cols=211  Identities=27%  Similarity=0.365  Sum_probs=162.7

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeEEE------
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCV------  415 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~------  415 (571)
                      +.+...+|++.+.||+|+||.||++... +++.||||++..........+.+|+.++.++. ||||+++++++.      
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3455668889999999999999999964 78999999987666666778999999999995 999999999984      


Q ss_pred             --cCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEe
Q 008288          416 --DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKIS  493 (571)
Q Consensus       416 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~  493 (571)
                        .....+++|||++ |+|.+++......+.+++..++.++.||+.||.|||+.+ ++|+||||||+|||+++++.+||+
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence              3445789999995 788888754334567999999999999999999999975 459999999999999999999999


Q ss_pred             ecccccccccCCCcc----------ceeeecccccccchhhh---ccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          494 DFGMARIFAESEGEA----------NTVRIVGTYGYMAPEYA---MEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       494 DfGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      |||++..........          ......||+.|+|||.+   .+..++.++||||||+++|||++|+.||...
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            999998765432211          11134689999999998   5667899999999999999999999999754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.7e-35  Score=288.23  Aligned_cols=202  Identities=29%  Similarity=0.455  Sum_probs=169.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ..++|.+.+.||+|+||.||++... +++.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4567888999999999999999976 7999999998642   23345678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++++|.+++..   .+.+++..+..++.||++||.|||+++   ++|+||||+||+++.++.+||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence            9999999999999843   346899999999999999999999998   9999999999999999999999999998664


Q ss_pred             cCCCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....   .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...+
T Consensus       163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  215 (276)
T 2h6d_A          163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH  215 (276)
T ss_dssp             C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            4321   123468999999999987765 689999999999999999999997654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1e-34  Score=300.41  Aligned_cols=197  Identities=30%  Similarity=0.463  Sum_probs=155.8

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC------c
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------D  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~  418 (571)
                      .++|+..+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999996 46899999998642  334456788999999999999999999998754      5


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++++|++ +++|.+++.    ...+++..+..++.||++||.|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999998 789988873    246999999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  234 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  234 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            865432     223478999999999887 678999999999999999999999997764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-34  Score=293.63  Aligned_cols=203  Identities=25%  Similarity=0.383  Sum_probs=172.6

Q ss_pred             cCCCCCC-ceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEE
Q 008288          348 TSNFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       348 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .++|.+. +.||+|+||.||++... +++.||+|+++..  .......+.+|+.++.++ +||||+++++++.+.+..++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            3455555 78999999999999975 6899999998743  334467789999999999 56999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeeccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMAR  499 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~DfGla~  499 (571)
                      ||||+++++|.+++.. .....+++..++.++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++
T Consensus       107 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             EEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            9999999999999843 23456999999999999999999999998   999999999999987   7899999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       183 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          183 KIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             EC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            6643322   223578999999999999999999999999999999999999997654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=7.6e-35  Score=312.94  Aligned_cols=200  Identities=33%  Similarity=0.499  Sum_probs=175.4

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|+..+.||+|+||.||++... +++.||||++...   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356888899999999999999975 7899999998643   234567799999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARI  500 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl---~~~~~~kL~DfGla~~  500 (571)
                      |||+++++|.+.+.   ..+.+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999998884   3456999999999999999999999998   9999999999999   5678999999999986


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.....   .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+
T Consensus       179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  231 (484)
T 3nyv_A          179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN  231 (484)
T ss_dssp             BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence            644332   223479999999999866 68999999999999999999999997764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-35  Score=294.53  Aligned_cols=209  Identities=28%  Similarity=0.445  Sum_probs=159.8

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .+..++|++.+.||+|+||.||++.. .+++.||||++.... .....++.+|+.++.+++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            45678899999999999999999985 478999999986432 3445678899999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          423 VYEFMPNGSLDAILFD-----PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      ||||+++++|.+++..     ......+++..+..++.||++||.|||+.+   |+||||||+||++++++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999998852     123456999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCC---ccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 ARIFAESEG---EANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +........   ........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  230 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY  230 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence            876543221   111223478999999999876 56899999999999999999999999765

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=319.26  Aligned_cols=204  Identities=30%  Similarity=0.471  Sum_probs=168.9

Q ss_pred             hcCCCCCCc-eecccCceeEEEEEEc---CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..+++...+ .||+|+||.||+|.+.   ++..||||+++.. .....+++.+|++++++++||||+++++++.. +..+
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEE
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeE
Confidence            334444444 7999999999999864   4667999999854 33456789999999999999999999999976 5689


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++|+|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+||||++++.+||+|||+++.+
T Consensus       412 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~  486 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKAL  486 (613)
T ss_dssp             EEEECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred             EEEEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence            99999999999999943  3456999999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          502 AESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~  543 (613)
T 2ozo_A          487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM  543 (613)
T ss_dssp             C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            4432211 1112245688999999999999999999999999999998 99999765

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-34  Score=311.64  Aligned_cols=199  Identities=32%  Similarity=0.498  Sum_probs=172.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|++.+.||+|+||.||++... +++.||||++...  .......+.+|++++++++||||+++++++.+.+..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            46888899999999999999975 7899999998642  23456778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~---~~~~~kL~DfGla~~~~  502 (571)
                      |+++++|.+.+.   ..+.+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++...
T Consensus       102 ~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          102 LYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999988874   3356999999999999999999999998   99999999999995   45679999999998664


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....   .....||+.|+|||++.+ .++.++||||||+++|||++|+.||...+
T Consensus       176 ~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~  226 (486)
T 3mwu_A          176 QNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN  226 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4322   223479999999999875 58999999999999999999999997654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-34  Score=294.12  Aligned_cols=199  Identities=34%  Similarity=0.447  Sum_probs=171.1

Q ss_pred             CCCCceecccCceeEEEEEEc-----CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC--ceeEE
Q 008288          351 FSDSNILGQGGFGPVYKGVLS-----DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL  422 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~l  422 (571)
                      |+..+.||+|+||.||++.+.     +++.||||+++.. .......+.+|++++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            478899999999999988642     6889999999753 334456789999999999999999999999874  56789


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999843    34899999999999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCc-cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            43322 1122346788899999999988999999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-34  Score=311.45  Aligned_cols=199  Identities=31%  Similarity=0.467  Sum_probs=169.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|+..+.||+|+||.||++... +++.||+|+++...  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46888999999999999999975 68899999987532  3446678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~---~~~kL~DfGla~~~~  502 (571)
                      |+++|+|.+.+.   ....+++..+..++.||++||.|||+.+   |+||||||+|||++.+   +.+||+|||++....
T Consensus       117 ~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          117 CYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999988873   3456899999999999999999999998   9999999999999764   459999999998765


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....   .....||+.|+|||++. +.++.++||||||+++|||++|+.||...+
T Consensus       191 ~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  241 (494)
T 3lij_A          191 NQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT  241 (494)
T ss_dssp             TTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence            4322   22357999999999876 569999999999999999999999998664

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=288.76  Aligned_cols=204  Identities=26%  Similarity=0.364  Sum_probs=171.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC----ccchHHHHHHHHHHHhcccCCeeeEeeEEE--cCceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS----EQGTAEFTNEVLLILKLQHKNLVKLLGFCV--DGDEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~--~~~~~~  421 (571)
                      ++|.+.+.||+|+||.||++... +++.||+|+++...    ......+.+|+.++++++||||+++++++.  +.+..+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            67999999999999999999964 68899999987432    234567899999999999999999999984  455789


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||++++ |.+++.. .....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        85 lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence            999999877 6666543 23456899999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCccceeeecccccccchhhhccCC--CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGL--YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .............||+.|+|||.+.+..  ++.++||||||+++|||++|+.||...+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  217 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN  217 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence            5433333333457899999999987644  4789999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.2e-34  Score=286.82  Aligned_cols=200  Identities=28%  Similarity=0.423  Sum_probs=170.2

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc----Ccee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~  420 (571)
                      ...|...+.||+|+||.||++... ++..|++|++...  .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            344677789999999999999974 6889999988642  34456678999999999999999999999875    4568


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCcEEEeeccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMAR  499 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~-~~~~~kL~DfGla~  499 (571)
                      ++||||+++++|.+++.   ....+++..++.++.||++||.|||+.+ .+|+||||||+|||++ +++.+||+|||++.
T Consensus       105 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            89999999999999994   3356899999999999999999999975 3599999999999997 78999999999997


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ......    .....||+.|+|||.+. +.++.++||||||+++|||++|+.||...
T Consensus       181 ~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence            543322    22347899999999876 45899999999999999999999999763

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-34  Score=289.12  Aligned_cols=204  Identities=28%  Similarity=0.412  Sum_probs=170.5

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC----CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      +..++|...+.||+|+||.||++...+    +..||+|+++.. .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            355678888999999999999998643    336999998754 34456678999999999999999999999765 457


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++++|.+++..  ....+++..+..++.||++||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        88 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence            899999999999999843  2345899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ........ .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus       163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~  218 (281)
T 3cc6_A          163 IEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL  218 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence            65432221 222356888999999998999999999999999999998 99999644

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.1e-36  Score=309.71  Aligned_cols=200  Identities=16%  Similarity=0.205  Sum_probs=162.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccc---cCccchHHHHHHH---HHHHhcccCCeeeEe-------e
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS---CSEQGTAEFTNEV---LLILKLQHKNLVKLL-------G  412 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~h~nIv~l~-------~  412 (571)
                      ..++|...+.||+|+||.||+++. .+|+.||||++..   ......+.+.+|+   .++++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            346788889999999999999995 5799999999873   2334556788999   555566899999998       6


Q ss_pred             EEEcCce-----------------eEEEEEccCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 008288          413 FCVDGDE-----------------KLLVYEFMPNGSLDAILFDPR----KRGILCWRKRTNIVNGIAKGMLYLHEDSRLR  471 (571)
Q Consensus       413 ~~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~  471 (571)
                      ++.+.+.                 .++||||+ +|+|.+++....    ....+++..++.|+.||++||+|||+++   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            6655532                 78999999 689999985311    1223446888899999999999999998   


Q ss_pred             eeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccC-----------CCCcchhhHhHH
Q 008288          472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-----------LYSKKSDVFSFG  540 (571)
Q Consensus       472 iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG  540 (571)
                      |+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999985322     2233467 999999999887           799999999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 008288          541 VLLIEIITGRRNAGSN  556 (571)
Q Consensus       541 vil~elltG~~p~~~~  556 (571)
                      +++|||++|+.||...
T Consensus       301 ~il~elltg~~Pf~~~  316 (377)
T 3byv_A          301 LVIYWIWCADLPITKD  316 (377)
T ss_dssp             HHHHHHHHSSCCC---
T ss_pred             HHHHHHHHCCCCCccc
Confidence            9999999999999654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.8e-34  Score=309.95  Aligned_cols=200  Identities=32%  Similarity=0.464  Sum_probs=172.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc-------------cchHHHHHHHHHHHhcccCCeeeEeeE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-------------QGTAEFTNEVLLILKLQHKNLVKLLGF  413 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~nIv~l~~~  413 (571)
                      .++|.+.+.||+|+||.||++... +++.||+|++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            467889999999999999999975 688999999864321             335678999999999999999999999


Q ss_pred             EEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC---cE
Q 008288          414 CVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM---NS  490 (571)
Q Consensus       414 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~---~~  490 (571)
                      +.+.+..++||||+++|+|.+++.   ..+.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999988884   3456999999999999999999999998   99999999999998775   69


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ||+|||++........   .....||+.|+|||++. +.++.++||||||+++|||++|+.||...+
T Consensus       189 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  251 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN  251 (504)
T ss_dssp             EECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999987654322   22347999999999886 468999999999999999999999998764

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.1e-35  Score=295.32  Aligned_cols=208  Identities=24%  Similarity=0.331  Sum_probs=174.2

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEE----cCce
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV----DGDE  419 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~----~~~~  419 (571)
                      .+..++|+..+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.    ....
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            35567899999999999999999997 578999999987666666778999999999999999999999987    3457


Q ss_pred             eEEEEEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          420 KLLVYEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      .++||||+++++|.+++... .....+++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            78999999999999988531 23466999999999999999999999998   999999999999999999999999998


Q ss_pred             cccccCCCcc-------ceeeecccccccchhhhccCC---CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          499 RIFAESEGEA-------NTVRIVGTYGYMAPEYAMEGL---YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       499 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ..........       ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            7543221110       011235799999999987554   68999999999999999999999853

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-34  Score=291.06  Aligned_cols=202  Identities=28%  Similarity=0.454  Sum_probs=166.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEE-----------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV-----------  415 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~-----------  415 (571)
                      .++|...+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367888999999999999999976 58999999998766666778999999999999999999999874           


Q ss_pred             ---cCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCcEE
Q 008288          416 ---DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSK  491 (571)
Q Consensus       416 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~-~~~~~k  491 (571)
                         +.+..++||||++ |+|.+++.    .+.+++..+..++.||++||+|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3467899999997 69999983    356899999999999999999999998   99999999999997 567999


Q ss_pred             EeecccccccccCCCc-cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          492 ISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       492 L~DfGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      |+|||+++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            9999999876432211 11223467899999998875 678999999999999999999999998764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-34  Score=291.73  Aligned_cols=204  Identities=26%  Similarity=0.439  Sum_probs=165.1

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|++.+.||+|+||.||++.. .+++.||+|+++..   .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35688899999999999999996 47899999998742   234456788999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          424 YEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      |||+++++|.+++... .....+++..++.++.||++||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999988431 13456899999999999999999999998   9999999999999999999999999998654


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .....  .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            43222  22346899999999999999999999999999999999999999654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.9e-34  Score=297.74  Aligned_cols=198  Identities=28%  Similarity=0.374  Sum_probs=163.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|+..+.||+|+||.||++... +++.||||++...  .......+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467889999999999999999964 6889999998642  3344567889999999999999999999998765      


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+++ +|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 6777773     24889999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  230 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  230 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            8654322   1223478999999999999999999999999999999999999997764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.3e-34  Score=286.87  Aligned_cols=200  Identities=30%  Similarity=0.425  Sum_probs=173.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---------ccchHHHHHHHHHHHhcc-cCCeeeEeeEEEc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---------EQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD  416 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~  416 (571)
                      .++|+..+.||+|+||.||++... +++.||||+++...         ....+.+.+|+.++.++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            467888999999999999999975 68999999986432         122456789999999995 9999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      .+..++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999984   3456899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhc------cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAM------EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ++........   .....|++.|+|||.+.      ...++.++||||||+++|||++|+.||...
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  232 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  232 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence            9986644322   22347899999999985      456889999999999999999999999765

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-34  Score=294.00  Aligned_cols=205  Identities=31%  Similarity=0.501  Sum_probs=171.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEE--EEEEccc-cCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEV--AVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~v--avK~~~~-~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|+..+.||+|+||.||++... ++..+  ++|.++. ......+.+.+|++++.++ +||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            3467888999999999999999964 56644  8998874 2344556789999999999 8999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          422 LVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      +||||+++++|.+++....             ....+++..++.++.||++||+|||+++   |+||||||+|||++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence            9999999999999996532             2346999999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .+||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~  246 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  246 (327)
T ss_dssp             CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             eEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence            99999999987432221   1122356889999999998889999999999999999998 999997654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-34  Score=289.56  Aligned_cols=204  Identities=32%  Similarity=0.477  Sum_probs=168.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEcC----CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEE-cCceeE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCV-DGDEKL  421 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~-~~~~~~  421 (571)
                      ..+|+..+.||+|+||.||++.+.+    ...+++|.+... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3457778999999999999998642    235899988753 3345567899999999999999999999865 456789


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++++|.+++..  ....+++..++.++.|+++||+|||+++   |+||||||+|||+++++.+||+|||+++..
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999954  3456899999999999999999999998   999999999999999999999999999866


Q ss_pred             ccCCCc--cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          502 AESEGE--ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       502 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ......  .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  236 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  236 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence            443221  12223467889999999999999999999999999999999 56666544

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-34  Score=302.73  Aligned_cols=200  Identities=25%  Similarity=0.422  Sum_probs=166.3

Q ss_pred             cCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce------eE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------KL  421 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~------~~  421 (571)
                      ..+|...+.||+|+||.||++++..+..+|+|++......    ..+|+++++.++||||+++++++...+.      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3468889999999999999999877777999988643222    2379999999999999999999965433      78


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCcEEEeecccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARI  500 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~-~~~~~kL~DfGla~~  500 (571)
                      +||||++++.+..+.........+++..+..++.||++||+|||+++   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655544322233556999999999999999999999998   99999999999999 799999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .......   ....+|+.|+|||++.+. .++.++||||||+++|||++|+.||...+
T Consensus       192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  246 (394)
T 4e7w_A          192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES  246 (394)
T ss_dssp             CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            6443322   234789999999998765 58999999999999999999999998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.7e-34  Score=299.30  Aligned_cols=202  Identities=25%  Similarity=0.389  Sum_probs=166.5

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC------
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------  417 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------  417 (571)
                      ....++|+..+.||+|+||.||++.. .+|+.||||++.....    ...+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45667899999999999999999996 4799999999865322    234799999999999999999998543      


Q ss_pred             --------------------------------ceeEEEEEccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHH
Q 008288          418 --------------------------------DEKLLVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYL  464 (571)
Q Consensus       418 --------------------------------~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~L  464 (571)
                                                      ...++||||++ ++|.+.+.. ......+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            33789999998 577766642 12345699999999999999999999


Q ss_pred             hhCCCCCeeeCCCCCCCeEec-CCCcEEEeecccccccccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHH
Q 008288          465 HEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVL  542 (571)
Q Consensus       465 H~~~~~~iiH~DLkp~NILl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvi  542 (571)
                      |+.+   |+||||||+|||++ +++.+||+|||+++........   ....+|+.|+|||.+.+. .++.++||||||++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9998   99999999999998 6889999999999866443322   234689999999998875 48999999999999


Q ss_pred             HHHHHhCCCCCCCCc
Q 008288          543 LIEIITGRRNAGSNQ  557 (571)
Q Consensus       543 l~elltG~~p~~~~~  557 (571)
                      +|||++|+.||...+
T Consensus       232 l~ell~g~~pf~~~~  246 (383)
T 3eb0_A          232 FGELILGKPLFSGET  246 (383)
T ss_dssp             HHHHHHSSCSSCCSS
T ss_pred             HHHHHhCCCCCCCCC
Confidence            999999999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-35  Score=301.90  Aligned_cols=202  Identities=32%  Similarity=0.499  Sum_probs=160.4

Q ss_pred             CCCCCceecccCceeEEEEEEc--CC--cEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEc-CceeEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS--DG--KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLV  423 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv  423 (571)
                      .|...+.||+|+||.||+|.+.  ++  ..||+|.++.. .....+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999863  22  36899998743 33456779999999999999999999998764 4578999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999953  3345889999999999999999999998   99999999999999999999999999986644


Q ss_pred             CCCcc--ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          504 SEGEA--NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       504 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      .....  ......+|+.|+|||.+.+..++.++||||||+++|||++ |++||...
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~  300 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  300 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence            32211  1223457788999999999999999999999999999999 77788654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.1e-35  Score=289.67  Aligned_cols=208  Identities=28%  Similarity=0.405  Sum_probs=172.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc--CceeEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLL  422 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~l  422 (571)
                      .++|+..+.||+|+||.||++... +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+  .+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357888899999999999999975 6899999998743  33445678999999999999999999998754  567899


Q ss_pred             EEEccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          423 VYEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      ||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+  ..+|+||||||+|||+++++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999985421 2345899999999999999999999976  2349999999999999999999999999997


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ........  .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  220 (279)
T 2w5a_A          165 ILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS  220 (279)
T ss_dssp             HC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence            65433221  122468999999999999899999999999999999999999998654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.5e-34  Score=304.66  Aligned_cols=198  Identities=28%  Similarity=0.448  Sum_probs=162.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC------ceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~  421 (571)
                      .+|+..+.||+|+||.||++++. +++.||||++.....    ...+|++++++++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35778899999999999999975 689999999865322    234799999999999999999998542      2356


Q ss_pred             EEEEccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-CcEEEeeccccc
Q 008288          422 LVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMAR  499 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-~~~kL~DfGla~  499 (571)
                      +||||+++ +|..++.. ......+++..+..++.||++||+|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            89999976 55554421 123456999999999999999999999998   9999999999999965 678999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .+......   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+
T Consensus       206 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~  261 (420)
T 1j1b_A          206 QLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  261 (420)
T ss_dssp             ECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             hcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            76443222   234789999999998764 68999999999999999999999997764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.9e-34  Score=296.89  Aligned_cols=202  Identities=25%  Similarity=0.437  Sum_probs=172.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-----cee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~  420 (571)
                      .++|+..+.||+|+||.||++... +++.||||++... .......+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457899999999999999999965 6889999999743 333446789999999999999999999998765     367


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||++ ++|.+++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            89999997 58988883    245899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCcc-ceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          501 FAESEGEA-NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  236 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  236 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence            65432221 1233579999999998765 458999999999999999999999997653

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.1e-34  Score=302.13  Aligned_cols=199  Identities=22%  Similarity=0.308  Sum_probs=171.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhc------ccCCeeeEeeEEEcCcee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKL------QHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~nIv~l~~~~~~~~~~  420 (571)
                      ..+|++.+.||+|+||.||++... +++.||||+++.. ......+.+|+.++..+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457889999999999999999865 5899999999753 33445678899888887      567999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc--EEEeecccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN--SKISDFGMA  498 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~--~kL~DfGla  498 (571)
                      ++||||+. ++|.+++... ....+++..+..++.||++||+|||+.+   |+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 6888888542 2345899999999999999999999998   999999999999999887  999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .......     ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            7543321     23478999999999999999999999999999999999999997764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.8e-34  Score=296.38  Aligned_cols=202  Identities=25%  Similarity=0.395  Sum_probs=175.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccc-----------------hHHHHHHHHHHHhcccCCeee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQG-----------------TAEFTNEVLLILKLQHKNLVK  409 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~nIv~  409 (571)
                      ..++|.+.+.||+|+||.||++.. +++.||||++.......                 ...+.+|+.++++++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            346889999999999999999999 89999999986422111                 178999999999999999999


Q ss_pred             EeeEEEcCceeEEEEEccCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCe
Q 008288          410 LLGFCVDGDEKLLVYEFMPNGSLDAI------LFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNV  482 (571)
Q Consensus       410 l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NI  482 (571)
                      +++++.+.+..++||||+++++|.++      +.. .....+++..+..++.||++||.|||+ .+   |+||||||+||
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni  183 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI  183 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence            99999999999999999999999998      522 225679999999999999999999999 88   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccC-CCCc-chhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSK-KSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +++.++.+||+|||++......    ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||...+
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999865433    22334789999999999877 5666 9999999999999999999997653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.6e-34  Score=287.71  Aligned_cols=195  Identities=30%  Similarity=0.487  Sum_probs=170.2

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEc-----------
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-----------  416 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-----------  416 (571)
                      .+|+..+.||+|+||.||++... +++.||+|+++...    ..+.+|++++.+++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            46788899999999999999975 79999999987533    356789999999999999999998864           


Q ss_pred             -----CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEE
Q 008288          417 -----GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK  491 (571)
Q Consensus       417 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~k  491 (571)
                           ....++||||+++++|.+++.. .....+++..++.++.||++||.|||+++   |+|+||||+|||+++++.+|
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHH-GGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence                 4457899999999999999853 22356899999999999999999999998   99999999999999999999


Q ss_pred             EeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       492 L~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      |+|||++.........   ....|++.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus       163 l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          163 IGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             ECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             ECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            9999999876543221   23468999999999999999999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.1e-34  Score=295.99  Aligned_cols=209  Identities=24%  Similarity=0.315  Sum_probs=161.5

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce-
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-  419 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-  419 (571)
                      +......++|++.+.||+|+||.||++... +++.||||++... ........+|+..+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            344566788999999999999999999975 6899999988653 2334456788888999999999999999976433 


Q ss_pred             ------eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCeeeCCCCCCCeEecC-CCcE
Q 008288          420 ------KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--EDSRLRIVHRDLKASNVLLDS-DMNS  490 (571)
Q Consensus       420 ------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH--~~~~~~iiH~DLkp~NILl~~-~~~~  490 (571)
                            .++||||++++.+..+.........+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987533332221234566899999999999999999999  877   999999999999997 8999


Q ss_pred             EEeecccccccccCCCccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          491 KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ||+|||+++........   ....||+.|+|||++.+.. ++.++||||||+++|||++|+.||...+
T Consensus       172 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~  236 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN  236 (360)
T ss_dssp             EECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence            99999999876543322   2347899999999987654 8999999999999999999999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.5e-34  Score=286.55  Aligned_cols=200  Identities=24%  Similarity=0.354  Sum_probs=170.8

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|++.+.||+|+||.||++... +++.||+|+++..  ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            356888899999999999999975 7999999998753  334456788999999999 999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---------------
Q 008288          424 YEFMPNGSLDAILFDPR-KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---------------  487 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~---------------  487 (571)
                      |||+++++|.+++.... ....+++..++.++.||++||+|||+++   |+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999985321 1256899999999999999999999998   9999999999999844               


Q ss_pred             ----CcEEEeecccccccccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          488 ----MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       488 ----~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                          ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|||++|++|+...
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                479999999998664432      23589999999999866 5678999999999999999999877544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.6e-35  Score=296.17  Aligned_cols=205  Identities=31%  Similarity=0.485  Sum_probs=176.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE-----cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc--
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL-----SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD--  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--  418 (571)
                      +..++|++.+.||+|+||.||++.+     .+++.||||++........+.+.+|++++++++||||+++++++...+  
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            4456788899999999999999984     368899999998766666778999999999999999999999987654  


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+++++|.+++..  ....+++..++.++.||++||+|||+.+   |+||||||+|||+++++.+||+|||++
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ceEEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence            67899999999999999953  2345899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccc-eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          499 RIFAESEGEAN-TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       499 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ........... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            87654432211 1223567789999999988899999999999999999999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.7e-34  Score=289.83  Aligned_cols=193  Identities=22%  Similarity=0.380  Sum_probs=169.5

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeEEEc--CceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVD--GDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv  423 (571)
                      .++|++.+.||+|+||.||++.. .+++.||||+++.   ...+.+.+|+.++.+++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            46788899999999999999986 4789999999874   33467899999999997 9999999999988  6678999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEeecccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFA  502 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~~~  502 (571)
                      |||+++++|..++.      .+++..+..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999999883      3889999999999999999999998   99999999999999776 89999999998664


Q ss_pred             cCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .....   ....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       183 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          183 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            43322   23478999999999887 6789999999999999999999999943

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-34  Score=287.28  Aligned_cols=202  Identities=30%  Similarity=0.409  Sum_probs=168.6

Q ss_pred             CCCCCceecccCceeEEEEEEc-CC---cEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee-EEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DG---KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-LLV  423 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~-~lv  423 (571)
                      .|...++||+|+||.||++.+. ++   ..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. +++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3445689999999999999853 22   37999998753 334556789999999999999999999999876665 899


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+.+++|.+++..  ....+++..+..++.|+++||+|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999954  3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCC--ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCC-CCCC
Q 008288          504 SEG--EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN-AGSN  556 (571)
Q Consensus       504 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p-~~~~  556 (571)
                      ...  ........+++.|+|||.+.+..++.++||||||+++|||++|+.| |...
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~  232 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI  232 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC
Confidence            321  1122234678899999999999999999999999999999995555 4443

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.5e-34  Score=292.14  Aligned_cols=198  Identities=30%  Similarity=0.428  Sum_probs=166.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC--------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      ++|.+.+.||+|+||.||++... +++.||||++....        ......+.+|++++++++||||+++++++..++ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            56888899999999999999975 68899999986422        122345889999999999999999999987665 


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc---EEEeecc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFG  496 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~---~kL~DfG  496 (571)
                      .++||||+++++|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.   +||+|||
T Consensus        89 ~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            899999999999999883   4456999999999999999999999998   999999999999987654   9999999


Q ss_pred             cccccccCCCccceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          497 MARIFAESEGEANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       497 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ++........   .....||+.|+|||.+.   ...++.++||||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  222 (322)
T 2ycf_A          163 HSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  222 (322)
T ss_dssp             TCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCST
T ss_pred             cceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            9986543221   12346899999999974   466899999999999999999999999654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.4e-34  Score=292.81  Aligned_cols=207  Identities=25%  Similarity=0.341  Sum_probs=171.0

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhcc--cCCeeeEeeEEEcC
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDG  417 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~  417 (571)
                      ..+.+..++|++.+.||+|+||.||++...+++.||||++...  .......+.+|+.++.+++  ||||+++++++.+.
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            3455667789999999999999999999888999999998642  3345567899999999997  59999999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||| +.+++|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||+++ +.+||+|||+
T Consensus       101 ~~~~lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A          101 QYIYMVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             SEEEEEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             CEEEEEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence            99999999 66889999984   3456899999999999999999999998   999999999999964 8999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhcc-----------CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAME-----------GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +................||+.|+|||.+.+           ..++.++||||||+++|||++|+.||...
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            987654433323334578999999999875           46889999999999999999999999753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.8e-34  Score=289.67  Aligned_cols=203  Identities=27%  Similarity=0.439  Sum_probs=171.8

Q ss_pred             hcCCCCCCceecccCceeEEEEEE--cCCcEEEEEEccccC--ccchHHHHHHHHHHHhc---ccCCeeeEeeEEE----
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL--SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKL---QHKNLVKLLGFCV----  415 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~----  415 (571)
                      ..++|++.+.||+|+||.||++..  .+++.||+|+++...  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457889999999999999999997  368899999986422  22334567888877776   8999999999987    


Q ss_pred             -cCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          416 -DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       416 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                       .....++||||++ ++|.+++... ....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567889999997 6999988542 2345899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ||++.......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  223 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            99998654322   1223478999999999999999999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.6e-34  Score=286.11  Aligned_cols=200  Identities=21%  Similarity=0.349  Sum_probs=167.3

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEE-EcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC-VDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e  425 (571)
                      .++|+..+.||+|+||.||+++. .+++.||||++....  ....+.+|+.++..++|++++..+..+ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            46799999999999999999996 578999999876432  233578999999999888776665554 66778899999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl---~~~~~~kL~DfGla~~~~  502 (571)
                      |+ +++|.+++..  ....+++..+..++.||++||.|||+++   |+||||||+|||+   ++++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             cc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            99 9999999853  2345999999999999999999999998   9999999999999   788999999999998765


Q ss_pred             cCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          503 ESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       503 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence            543321     12245789999999999999999999999999999999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.7e-34  Score=317.31  Aligned_cols=196  Identities=33%  Similarity=0.461  Sum_probs=164.8

Q ss_pred             ceecccCceeEEEEEEc---CCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLS---DGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      +.||+|+||.||+|.+.   +++.||||+++...  ....+++.+|+.++.+++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999753   46789999997532  3345789999999999999999999999864 557899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc-c
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-A  508 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~-~  508 (571)
                      |+|.+++.   ....+++..++.++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999994   3456899999999999999999999998   999999999999999999999999999876543322 1


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ......+|..|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  577 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  577 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            1222356788999999999999999999999999999998 999997653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.1e-34  Score=293.49  Aligned_cols=203  Identities=27%  Similarity=0.463  Sum_probs=171.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-----cee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~  420 (571)
                      .++|+..+.||+|+||.||++... +|+.||||+++.. .......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467888999999999999999975 6899999999743 333456688999999999999999999988764     678


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||++ ++|.+++..    ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 689888843    45899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCcc--------ceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          501 FAESEGEA--------NTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       501 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ........        ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  228 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY  228 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            65332111        1123478999999998764 6789999999999999999999999987653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-34  Score=289.62  Aligned_cols=204  Identities=27%  Similarity=0.338  Sum_probs=159.5

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC-cc-chHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQ-GTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ++..++|+..+.||+|+||.||++.. .+++.||+|+++... .. ..+.+.++...++.++||||+++++++.+++..+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            34567888999999999999999997 478999999987532 22 2233445555677889999999999999999999


Q ss_pred             EEEEccCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          422 LVYEFMPNGSLDAILFD-PRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      +||||++ ++|.+++.. ......+++..+..++.||+.||.|||++ +   |+||||||+|||++.++++||+|||++.
T Consensus        83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T 3fme_A           83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISG  158 (290)
T ss_dssp             EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred             EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcc
Confidence            9999997 488776632 12345699999999999999999999997 8   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhh----ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYA----MEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ........   ....||+.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          159 YLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence            66443222   223689999999996    566789999999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.1e-33  Score=288.72  Aligned_cols=202  Identities=24%  Similarity=0.353  Sum_probs=174.0

Q ss_pred             cCCCCCCceecccCceeEEEEEE-c-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCC------eeeEeeEEEcCce
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-S-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN------LVKLLGFCVDGDE  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------Iv~l~~~~~~~~~  419 (571)
                      .++|++.+.||+|+||.||++.. . +++.||||+++.. ......+.+|+.++..++|++      |+++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46788999999999999999986 3 6889999998753 344567889999999997765      9999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-------------
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-------------  486 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-------------  486 (571)
                      .++||||+ +++|.+++... ....+++..+..++.||++||+|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88999888542 2346899999999999999999999998   999999999999987             


Q ss_pred             ------CCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchhh
Q 008288          487 ------DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA  560 (571)
Q Consensus       487 ------~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~  560 (571)
                            ++.+||+|||++.......     ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  6689999999997643321     23478999999999999999999999999999999999999998765433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.6e-34  Score=285.08  Aligned_cols=200  Identities=21%  Similarity=0.349  Sum_probs=170.1

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEE-EcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC-VDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e  425 (571)
                      .++|+..+.||+|+||.||+++. .+++.||||++....  ...++.+|+.++..++|++++..+..+ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46788999999999999999996 579999999986533  234688999999999988766555544 66777899999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl---~~~~~~kL~DfGla~~~~  502 (571)
                      |+ +++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||+   ++++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 9999999852  2346999999999999999999999998   9999999999999   588899999999998765


Q ss_pred             cCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          503 ESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       503 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            543321     12345789999999999999999999999999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.6e-34  Score=294.14  Aligned_cols=196  Identities=31%  Similarity=0.469  Sum_probs=167.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee----
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK----  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~----  420 (571)
                      .++|...+.||+|+||.||++... +|+.||||++...  .+.....+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467888999999999999999965 6899999998753  333456788999999999999999999999887765    


Q ss_pred             --EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          421 --LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       421 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                        ++||||++ ++|..++.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 68888772     23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.....     .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  246 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  246 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            865332     223478999999999987 678999999999999999999999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5e-34  Score=298.12  Aligned_cols=198  Identities=24%  Similarity=0.309  Sum_probs=168.2

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcc--------cCCeeeEeeEEE---
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ--------HKNLVKLLGFCV---  415 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~nIv~l~~~~~---  415 (571)
                      .++|.+.+.||+|+||.||+++.. +++.||||+++.. ......+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999864 6889999999753 344567889999999985        788999999988   


Q ss_pred             -cCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCC-----
Q 008288          416 -DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDM-----  488 (571)
Q Consensus       416 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~-----  488 (571)
                       +....++||||+. ++|.+.+.. .....+++..++.++.||++||.|||++ +   |+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             5667899999994 555444432 2335699999999999999999999998 8   99999999999998775     


Q ss_pred             --------------------------------------------cEEEeecccccccccCCCccceeeecccccccchhh
Q 008288          489 --------------------------------------------NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY  524 (571)
Q Consensus       489 --------------------------------------------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~  524 (571)
                                                                  .+||+|||++.......     ....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChh
Confidence                                                        79999999998654322     23478999999999


Q ss_pred             hccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          525 AMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       525 ~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +.+..++.++||||||+++|||++|+.||...
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~  296 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPH  296 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999999999999999754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.9e-34  Score=286.59  Aligned_cols=200  Identities=34%  Similarity=0.466  Sum_probs=165.8

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-ceeEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVY  424 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~  424 (571)
                      +..++|+..+.||+|+||.||++.. .++.||||+++..  ...+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            3456788899999999999999988 5889999998753  3556789999999999999999999997655 4689999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++... ....+++..+..++.|+++||+|||+++   ++||||||+||++++++.+||+|||++......
T Consensus        95 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999998431 1223789999999999999999999998   999999999999999999999999998755432


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .     ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  219 (278)
T 1byg_A          171 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  219 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             c-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence            2     12357889999999999999999999999999999998 999997653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=298.57  Aligned_cols=199  Identities=17%  Similarity=0.249  Sum_probs=169.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEcC---------CcEEEEEEccccCccchHHHHHHHHHHHhcccCCeee---------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSD---------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVK---------  409 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~---------  409 (571)
                      .++|.+.+.||+|+||.||++....         ++.||+|++...     ..+.+|++++.+++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4678899999999999999999753         789999998753     36789999999999999887         


Q ss_pred             ------EeeEEEc-CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          410 ------LLGFCVD-GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       410 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                            +++++.. ++..++||||+ +++|.+++... ....+++..++.++.||++||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  6677765 67889999999 99999999532 2366999999999999999999999998   99999999999


Q ss_pred             EecCCC--cEEEeecccccccccCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          483 LLDSDM--NSKISDFGMARIFAESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       483 Ll~~~~--~~kL~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      |++.++  .+||+|||+++.+.......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  89999999998765432211     11234789999999999999999999999999999999999999975


Q ss_pred             C
Q 008288          556 N  556 (571)
Q Consensus       556 ~  556 (571)
                      .
T Consensus       271 ~  271 (352)
T 2jii_A          271 C  271 (352)
T ss_dssp             G
T ss_pred             C
Confidence            4

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.9e-35  Score=297.93  Aligned_cols=198  Identities=32%  Similarity=0.507  Sum_probs=160.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHH--HHhcccCCeeeEeeEEEc-----Cc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLL--ILKLQHKNLVKLLGFCVD-----GD  418 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~nIv~l~~~~~~-----~~  418 (571)
                      +..++|++.+.||+|+||.||+++. +++.||||+++...   ...+..|.++  +..++||||+++++.+..     ..
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            4457888999999999999999987 78999999987432   2344444444  445899999999975532     33


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC---------CCCCeeeCCCCCCCeEecCCCc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED---------SRLRIVHRDLKASNVLLDSDMN  489 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~---------~~~~iiH~DLkp~NILl~~~~~  489 (571)
                      ..++||||+++|+|.+++..    ...++..+..++.||++||+|||+.         +   |+||||||+|||++.++.
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred             eEEEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence            56899999999999999942    3358999999999999999999998         7   999999999999999999


Q ss_pred             EEEeecccccccccCCC------ccceeeecccccccchhhhcc-------CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          490 SKISDFGMARIFAESEG------EANTVRIVGTYGYMAPEYAME-------GLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       490 ~kL~DfGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      +||+|||+++.+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|+.||.
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            99999999987654321      111223479999999999976       356789999999999999999977763

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-34  Score=291.12  Aligned_cols=197  Identities=27%  Similarity=0.448  Sum_probs=160.6

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc--ccCCeeeEeeEEEcC----c
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL--QHKNLVKLLGFCVDG----D  418 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~nIv~l~~~~~~~----~  418 (571)
                      ....++|++.+.||+|+||.||+++.. ++.||||++...   ....+..|.+++...  +||||+++++++...    .
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            344568999999999999999999984 899999998642   233445566666554  999999999999887    6


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeCCCCCCCeEecCCCcEEEe
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-----RLRIVHRDLKASNVLLDSDMNSKIS  493 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----~~~iiH~DLkp~NILl~~~~~~kL~  493 (571)
                      ..++||||+++|+|.+++..    ..+++..++.++.|++.||.|||+..     +++|+||||||+|||++.++.+||+
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            78999999999999999942    35899999999999999999999980     1129999999999999999999999


Q ss_pred             ecccccccccCCCccc--eeeecccccccchhhhccCCCCcc------hhhHhHHHHHHHHHhC
Q 008288          494 DFGMARIFAESEGEAN--TVRIVGTYGYMAPEYAMEGLYSKK------SDVFSFGVLLIEIITG  549 (571)
Q Consensus       494 DfGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slGvil~elltG  549 (571)
                      |||++..+........  .....||+.|+|||.+.+...+.+      +||||||+++|||++|
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            9999976644332211  123478999999999987766655      9999999999999999

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-34  Score=292.60  Aligned_cols=214  Identities=28%  Similarity=0.418  Sum_probs=174.5

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG  417 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~  417 (571)
                      ......+..++|+..+.||+|+||.||++...+  .+++|+++..  .....+.+.+|+.++++++||||+++++++.+.
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            445556778899999999999999999999753  5999988642  233445678999999999999999999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||||+++++|.+++..  ....+++..+..++.||++||+|||+++   |+||||||+|||++ ++.+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence            999999999999999999943  3346899999999999999999999998   99999999999998 67999999999


Q ss_pred             ccccccCCC---ccceeeecccccccchhhhcc---------CCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhh
Q 008288          498 ARIFAESEG---EANTVRIVGTYGYMAPEYAME---------GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY  561 (571)
Q Consensus       498 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~  561 (571)
                      +........   ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||...+....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  251 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI  251 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            876532211   111223468999999999874         4578999999999999999999999987654433

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-33  Score=297.16  Aligned_cols=197  Identities=27%  Similarity=0.438  Sum_probs=151.4

Q ss_pred             CceecccCceeEEEEEEc---CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEc--CceeEEEEEccC
Q 008288          354 SNILGQGGFGPVYKGVLS---DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP  428 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  428 (571)
                      .++||+|+||.||++.+.   +++.||||++...  .....+.+|+.++++++||||+++++++..  ....++||||++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            458999999999999965   5789999999753  234568899999999999999999999954  677899999996


Q ss_pred             CCChhhhhcC------CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe----cCCCcEEEeecccc
Q 008288          429 NGSLDAILFD------PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL----DSDMNSKISDFGMA  498 (571)
Q Consensus       429 ~gsL~~~l~~------~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl----~~~~~~kL~DfGla  498 (571)
                      + +|.+++..      ......+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.+||+|||++
T Consensus       104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence            4 77666631      122335899999999999999999999998   9999999999999    67789999999999


Q ss_pred             cccccCCCc-cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGE-ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +........ .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            876543221 222345789999999999874 5899999999999999999999999644

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-34  Score=287.04  Aligned_cols=205  Identities=31%  Similarity=0.442  Sum_probs=165.1

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc--CCc--EEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS--DGK--EVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      ..++|+..+.||+|+||.||++.+.  +++  .||||+++..   .....+.+.+|+.++++++||||+++++++...+ 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            4567888999999999999999853  233  6899998753   2344667899999999999999999999998765 


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++++|.+++..  ..+.+++..+..++.||++||.|||+++   |+|+||||+||+++.++.+||+|||++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            8899999999999999853  2356899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          500 IFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       500 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ......... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~  229 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN  229 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence            765443221 1223457788999999998889999999999999999999 999997654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.5e-34  Score=299.92  Aligned_cols=198  Identities=10%  Similarity=0.080  Sum_probs=152.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhc--ccCCeeeEe-------eEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKL--QHKNLVKLL-------GFC  414 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~nIv~l~-------~~~  414 (571)
                      ..+|...+.||+|+||.||++.+. +++.||||++....   ......+.+|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345788899999999999999975 78999999997643   23345577886555555  699988755       444


Q ss_pred             EcC-----------------ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCC
Q 008288          415 VDG-----------------DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKR------TNIVNGIAKGMLYLHEDSRLR  471 (571)
Q Consensus       415 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~L~~LH~~~~~~  471 (571)
                      ...                 ...++||||++ ++|.+++...  ...+.+..+      ..++.||++||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            332                 33799999998 8999999532  223445555      678899999999999998   


Q ss_pred             eeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhC
Q 008288          472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITG  549 (571)
Q Consensus       472 iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG  549 (571)
                      |+||||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++||||||+++|||++|
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998653211     13357799999999987  6799999999999999999999


Q ss_pred             CCCCCCC
Q 008288          550 RRNAGSN  556 (571)
Q Consensus       550 ~~p~~~~  556 (571)
                      +.||...
T Consensus       290 ~~Pf~~~  296 (371)
T 3q60_A          290 FLPFGLV  296 (371)
T ss_dssp             SCSTTBC
T ss_pred             CCCCCCc
Confidence            9999755

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.9e-33  Score=289.48  Aligned_cols=196  Identities=31%  Similarity=0.467  Sum_probs=167.1

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce-----
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-----  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-----  419 (571)
                      .++|...+.||+|+||.||++... +|+.||||++...  .+.....+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357888899999999999999975 6899999998643  33345678899999999999999999999987754     


Q ss_pred             -eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          420 -KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       420 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                       .++||||++ ++|.+++.     ..+++..+..++.||++||.|||+++   |+||||||+|||+++++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 68887762     24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      +.....     .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            865332     223478999999999887 678999999999999999999999998764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.4e-33  Score=281.76  Aligned_cols=200  Identities=32%  Similarity=0.487  Sum_probs=173.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .++|++.+.||+|+||.||++... +++.||+|++...  .......+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            357888999999999999999975 7899999998643  2345677899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC---CcEEEeeccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD---MNSKISDFGMARIF  501 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~---~~~kL~DfGla~~~  501 (571)
                      ||+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++|+||||+||+++.+   +.+||+|||++...
T Consensus       101 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999888742   346899999999999999999999998   9999999999999764   46999999999866


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ......   ....+++.|+|||.+.+ .++.++||||||+++|||++|+.||...+
T Consensus       175 ~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (287)
T 2wei_A          175 QQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN  226 (287)
T ss_dssp             CCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence            443221   22368899999998865 48999999999999999999999997653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.1e-33  Score=299.90  Aligned_cols=201  Identities=22%  Similarity=0.349  Sum_probs=171.9

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhccc-CCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|++.++||+|+||.||+++. .+++.||||++....  ...++..|++++..++| ++|..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46789999999999999999996 478999999876432  23357899999999976 566677777788888999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---cCCCcEEEeecccccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---DSDMNSKISDFGMARIFA  502 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl---~~~~~~kL~DfGla~~~~  502 (571)
                      |+ +++|.+++..  ....+++..++.|+.||+.||+|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 9999999853  2346999999999999999999999998   9999999999999   688999999999998765


Q ss_pred             cCCCcc-----ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          503 ESEGEA-----NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ......     ......||+.|+|||.+.+..++.++||||||++||||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~  216 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL  216 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence            543321     122457999999999999999999999999999999999999999753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.1e-33  Score=289.49  Aligned_cols=200  Identities=27%  Similarity=0.388  Sum_probs=170.3

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHh--cccCCeeeEeeEEEcCc----
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILK--LQHKNLVKLLGFCVDGD----  418 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~~~~~~----  418 (571)
                      ....++|.+.+.||+|+||.||+++. +++.||||+++..   ....+.+|.+++..  ++||||+++++++...+    
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            34456899999999999999999998 5899999998642   34567889999888  79999999999998876    


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCeeeCCCCCCCeEecCCCcE
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH--------EDSRLRIVHRDLKASNVLLDSDMNS  490 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH--------~~~~~~iiH~DLkp~NILl~~~~~~  490 (571)
                      ..++||||+++|+|.+++..    ..+++..++.++.|+++||+|||        +.+   |+||||||+|||+++++++
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred             eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence            78999999999999999942    35899999999999999999999        777   9999999999999999999


Q ss_pred             EEeecccccccccCCCcc--ceeeecccccccchhhhccCC------CCcchhhHhHHHHHHHHHhC----------CCC
Q 008288          491 KISDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAMEGL------YSKKSDVFSFGVLLIEIITG----------RRN  552 (571)
Q Consensus       491 kL~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGvil~elltG----------~~p  552 (571)
                      ||+|||++..........  ......||+.|+|||.+.+..      ++.++||||||+++|||++|          +.|
T Consensus       187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p  266 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  266 (342)
T ss_dssp             EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence            999999998765443221  122347899999999987653      34789999999999999999          778


Q ss_pred             CCC
Q 008288          553 AGS  555 (571)
Q Consensus       553 ~~~  555 (571)
                      |..
T Consensus       267 ~~~  269 (342)
T 1b6c_B          267 YYD  269 (342)
T ss_dssp             TTT
T ss_pred             ccc
Confidence            854

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.3e-33  Score=290.10  Aligned_cols=202  Identities=23%  Similarity=0.323  Sum_probs=170.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcc-cC-----CeeeEeeEEEcCce
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HK-----NLVKLLGFCVDGDE  419 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----nIv~l~~~~~~~~~  419 (571)
                      ..++|++.+.||+|+||.||++... +++.||||+++.. .....++..|+.++..++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3568999999999999999999975 6889999999752 334566788999988885 44     49999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCCcEEEeeccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGM  497 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~--~~~~~kL~DfGl  497 (571)
                      .++||||++ ++|.+++... ....+++..+..++.||+.||.|||++. .+|+||||||+|||++  .++.+||+|||+
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            999999996 5998888542 2245899999999999999999999531 2399999999999994  578899999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++......     ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       208 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          208 SCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            98664321     23478999999999999999999999999999999999999998764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-33  Score=311.22  Aligned_cols=208  Identities=26%  Similarity=0.410  Sum_probs=173.4

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEcC----CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG  417 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~  417 (571)
                      ...+..++|+..+.||+|+||.||+|.+..    +..||+|+++.. .....+.+.+|+.++++++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            444566788899999999999999998742    457999998753 3344567899999999999999999999985 4


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence            668999999999999999953  2345899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus       538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  597 (656)
T 2j0j_A          538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  597 (656)
T ss_dssp             CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9876443222 1223456789999999998999999999999999999997 999997653

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.4e-34  Score=287.79  Aligned_cols=202  Identities=26%  Similarity=0.415  Sum_probs=172.6

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCcc------chHHHHHHHHHHHhcc--cCCeeeEeeEEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQ------GTAEFTNEVLLILKLQ--HKNLVKLLGFCV  415 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~nIv~l~~~~~  415 (571)
                      ....++|++.+.||+|+||.||++.. .+++.||||+++.....      ....+.+|+.++++++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34567889999999999999999996 47899999998653221      2245778999999996  599999999999


Q ss_pred             cCceeEEEEEccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCcEEEe
Q 008288          416 DGDEKLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKIS  493 (571)
Q Consensus       416 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~-~~~~~kL~  493 (571)
                      +.+..++|||++.+ ++|.+++.   ..+.+++..+..++.||++||+|||+.+   |+||||||+|||++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999976 89999984   3456899999999999999999999998   99999999999999 78999999


Q ss_pred             ecccccccccCCCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          494 DFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       494 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      |||++........    ....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus       193 Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          193 DFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             CCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             eCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            9999987653321    23468999999999987765 68899999999999999999999754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7e-33  Score=284.77  Aligned_cols=199  Identities=22%  Similarity=0.335  Sum_probs=169.5

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CC-cEEEEEEccccCccchHHHHHHHHHHHhcccCC------eeeEeeEEEcCce
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DG-KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN------LVKLLGFCVDGDE  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------Iv~l~~~~~~~~~  419 (571)
                      .++|++.+.||+|+||.||++... ++ +.||+|+++.. ......+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468899999999999999999974 34 68999998753 344567889999999998766      8999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe---------------
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL---------------  484 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl---------------  484 (571)
                      .++||||+ +++|.+++.. .....+++..+..++.||++||+|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 5566555533 22346899999999999999999999998   9999999999999               


Q ss_pred             ----cCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          485 ----DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       485 ----~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                          +.++.+||+|||+++......     ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                567899999999997643322     23478999999999999999999999999999999999999998764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.6e-33  Score=285.19  Aligned_cols=203  Identities=29%  Similarity=0.411  Sum_probs=152.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHH-HHHhcccCCeeeEeeEEEcCceeEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      +..++|+..+.||+|+||.||++... +++.||||+++... .....++..|+. +++.++||||+++++++.+.+..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            45578889999999999999999975 78999999997532 333445556665 6677899999999999999999999


Q ss_pred             EEEccCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          423 VYEFMPNGSLDAILFD--PRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      ||||+++ +|.+++..  ......+++..+..++.|+++||.|||+. +   |+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999975 77776632  11245689999999999999999999998 8   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhh----ccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYA----MEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .......   .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||..
T Consensus       175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             ecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            6644322   1233689999999998    456689999999999999999999999965

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3e-33  Score=280.85  Aligned_cols=194  Identities=29%  Similarity=0.498  Sum_probs=160.9

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEc-----------
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-----------  416 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-----------  416 (571)
                      ++|+..+.||+|+||.||++... +++.||||+++. .......+.+|+.++++++||||+++++++.+           
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            46788899999999999999974 789999999864 33455678999999999999999999998865           


Q ss_pred             --CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          417 --GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       417 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                        .+..++||||+++++|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence              3567899999999999999953  3345788999999999999999999998   99999999999999999999999


Q ss_pred             cccccccccCCC------------ccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHh
Q 008288          495 FGMARIFAESEG------------EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIIT  548 (571)
Q Consensus       495 fGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~ellt  548 (571)
                      ||++........            ........||+.|+|||.+.+. .++.++||||||+++|||++
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            999986643211            1112234789999999999764 68999999999999999998

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.8e-33  Score=290.17  Aligned_cols=199  Identities=23%  Similarity=0.346  Sum_probs=168.4

Q ss_pred             hcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcc-----------cCCeeeEeeEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----------HKNLVKLLGFC  414 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~nIv~l~~~~  414 (571)
                      ..++|.+.+.||+|+||.||++.. .+++.||||++.. .......+.+|+.++.+++           ||||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            346788999999999999999996 4789999999875 3334567889999999886           89999999999


Q ss_pred             EcCc----eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEec----
Q 008288          415 VDGD----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLD----  485 (571)
Q Consensus       415 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~----  485 (571)
                      ...+    ..+++||++ +++|.+++... ....+++..+..++.||+.||+|||++ +   |+||||||+|||++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            8654    678999999 89999988542 234589999999999999999999998 8   99999999999994    


Q ss_pred             --CCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          486 --SDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       486 --~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                        ..+.+||+|||++.......     ....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence              44579999999998654322     2247899999999999999999999999999999999999999754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-33  Score=285.36  Aligned_cols=201  Identities=25%  Similarity=0.427  Sum_probs=164.4

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCc------cchHHHHHHHHHHHhc----ccCCeeeEeeEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE------QGTAEFTNEVLLILKL----QHKNLVKLLGFC  414 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~nIv~l~~~~  414 (571)
                      .-.++|++.+.||+|+||.||++.. .+++.||||+++....      .....+.+|+.++.++    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            3457899999999999999999986 4788999999875322      1233466899999998    899999999999


Q ss_pred             EcCceeEEEEEc-cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCcEEE
Q 008288          415 VDGDEKLLVYEF-MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKI  492 (571)
Q Consensus       415 ~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~-~~~~~kL  492 (571)
                      ...+..++|||+ +++++|.+++..   .+.+++..++.++.||++||+|||+.+   |+||||||+||+++ +++.+||
T Consensus       108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred             ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence            999999999999 789999999843   446899999999999999999999998   99999999999999 8899999


Q ss_pred             eecccccccccCCCccceeeecccccccchhhhccCCCC-cchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          493 SDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS-KKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +|||++........    ....|+..|+|||.+.+..+. .++||||||+++|||++|+.||...
T Consensus       182 ~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  242 (312)
T 2iwi_A          182 IDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD  242 (312)
T ss_dssp             CCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             EEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence            99999987654322    234689999999999877664 5899999999999999999999754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.5e-33  Score=284.10  Aligned_cols=197  Identities=26%  Similarity=0.331  Sum_probs=145.5

Q ss_pred             cCCCCCC-ceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEc----CceeE
Q 008288          348 TSNFSDS-NILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKL  421 (571)
Q Consensus       348 ~~~~~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~  421 (571)
                      .++|.+. +.||+|+||.||++... +++.||||++....    ....+....+..++||||+++++++..    +...+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4567774 46999999999999976 68999999986521    222233344566799999999999876    44578


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeecccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMA  498 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~DfGla  498 (571)
                      +||||+++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999642 2346999999999999999999999998   999999999999976   455999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            7654322    12347899999999998888999999999999999999999999654

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.9e-33  Score=293.83  Aligned_cols=199  Identities=26%  Similarity=0.347  Sum_probs=156.2

Q ss_pred             CCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          351 FSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      |...+.||+|+||+||.....+|+.||||++...   ....+.+|+.++.++ +||||+++++++.+++..++||||++ 
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred             eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence            3446789999999998766668999999998642   234678999999987 89999999999999999999999995 


Q ss_pred             CChhhhhcCCCCCC----CCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC-------------CcEEE
Q 008288          430 GSLDAILFDPRKRG----ILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD-------------MNSKI  492 (571)
Q Consensus       430 gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~-------------~~~kL  492 (571)
                      |+|.+++.......    ..++..++.++.||+.||+|||+++   |+||||||+|||++.+             +.+||
T Consensus        93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            69999995432211    1133456789999999999999998   9999999999999754             48999


Q ss_pred             eecccccccccCCCcc--ceeeecccccccchhhhcc-------CCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          493 SDFGMARIFAESEGEA--NTVRIVGTYGYMAPEYAME-------GLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       493 ~DfGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      +|||+++.........  ......||+.|+|||++.+       ..++.++||||||+++|||++ |+.||+..
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            9999998765433221  1223579999999999976       568999999999999999999 99999754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.8e-33  Score=304.78  Aligned_cols=202  Identities=32%  Similarity=0.445  Sum_probs=174.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEc------Ccee
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD------GDEK  420 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~------~~~~  420 (571)
                      ++|.+.+.||+|+||.||++... +|+.||||+++.. .......+.+|+.++++++||||+++++++..      ++..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            67999999999999999999964 6899999998753 44456678999999999999999999998765      6678


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc---EEEeeccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN---SKISDFGM  497 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~---~kL~DfGl  497 (571)
                      ++||||+++++|.+++........+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence            999999999999999976555556999999999999999999999998   999999999999997665   99999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +.........   ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       171 a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~  226 (676)
T 3qa8_A          171 AKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN  226 (676)
T ss_dssp             CCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence            9876543322   2357899999999999999999999999999999999999999654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-33  Score=295.14  Aligned_cols=204  Identities=25%  Similarity=0.369  Sum_probs=161.3

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~l  422 (571)
                      +.+...+|...+.||+|+||.|+.....+++.||||++.....   ..+.+|+.+++++ +||||+++++++.+.+..++
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            3445567888899999999997655556899999999875332   2356899999999 89999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-----CCcEEEeeccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGM  497 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-----~~~~kL~DfGl  497 (571)
                      ||||++ |+|.+++...  ...+.+..+..++.||++||.|||+++   |+||||||+|||++.     ...+||+|||+
T Consensus        96 v~E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            999996 5999988542  223455566789999999999999998   999999999999953     33688999999


Q ss_pred             ccccccCCCc-cceeeecccccccchhhhc---cCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          498 ARIFAESEGE-ANTVRIVGTYGYMAPEYAM---EGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ++........ .......||+.|+|||++.   ...++.++||||||+++|||++ |+.||+..
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence            9876543221 2223457999999999997   4567889999999999999999 99999654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6e-34  Score=291.22  Aligned_cols=193  Identities=18%  Similarity=0.215  Sum_probs=160.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccC--------ccchHHHHHHHHHHHhcc---------cCCeee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCS--------EQGTAEFTNEVLLILKLQ---------HKNLVK  409 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~nIv~  409 (571)
                      ..++|+..+.||+|+||.||+++. +|+.||||+++...        ....+.+.+|+.++++++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            346688889999999999999998 78999999987532        233477899999999986         777777


Q ss_pred             EeeEEE-----------------c-------------CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH
Q 008288          410 LLGFCV-----------------D-------------GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK  459 (571)
Q Consensus       410 l~~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~  459 (571)
                      +.+++.                 +             .+..++||||+++|++.+.+.    ...+++..++.++.||+.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence            766542                 2             678999999999997655552    245899999999999999


Q ss_pred             HHHHHh-hCCCCCeeeCCCCCCCeEecCCC--------------------cEEEeecccccccccCCCccceeeeccccc
Q 008288          460 GMLYLH-EDSRLRIVHRDLKASNVLLDSDM--------------------NSKISDFGMARIFAESEGEANTVRIVGTYG  518 (571)
Q Consensus       460 ~L~~LH-~~~~~~iiH~DLkp~NILl~~~~--------------------~~kL~DfGla~~~~~~~~~~~~~~~~gt~~  518 (571)
                      ||+||| +.+   |+||||||+|||++.++                    .+||+|||+++.....       ..+||+.
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            999999 888   99999999999999887                    8999999999865432       2479999


Q ss_pred             ccchhhhccCCCCcchhhHhHHHH-HHHHHhCCCCCCC
Q 008288          519 YMAPEYAMEGLYSKKSDVFSFGVL-LIEIITGRRNAGS  555 (571)
Q Consensus       519 y~aPE~~~~~~~~~~~Dv~slGvi-l~elltG~~p~~~  555 (571)
                      |+|||++.+.. +.++||||++.+ .+++++|..||..
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence            99999998766 899999998776 7888999999853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.3e-33  Score=280.89  Aligned_cols=201  Identities=25%  Similarity=0.424  Sum_probs=152.3

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc-cc-hHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-QG-TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ...++|+..+.||+|+||.||++... +++.||||++..... .. .+.+.++..+++.++||||+++++++.+.+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            44567888899999999999999975 789999999875322 22 2334455567788899999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      ||||+ ++.+..+..  .....+++..+..++.||++||.|||++ +   |+|+||||+|||++.++.+||+|||++...
T Consensus       102 v~e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          102 AMELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EECCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            99999 555655552  2245689999999999999999999995 7   999999999999999999999999999765


Q ss_pred             ccCCCccceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .....   .....||+.|+|||.+.     ...++.++||||||+++|||++|+.||..
T Consensus       176 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          176 VDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence            44322   22346899999999984     45688999999999999999999999975

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.98  E-value=5.8e-33  Score=310.30  Aligned_cols=192  Identities=22%  Similarity=0.352  Sum_probs=165.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEc--CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce-----
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS--DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-----  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-----  419 (571)
                      .++|++.+.||+|+||.||++.+.  +++.||||++... .......+.+|++++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999975  6899999998643 33445678899999999999999999999987665     


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++++|.+++..     .+++.+++.++.||++||.|||+++   |+||||||+|||++++ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            6999999999999887622     5899999999999999999999998   9999999999999886 89999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      .....      ....||+.|+|||++.++. +.++||||||+++|||++|..||..
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence            65432      2347899999999987654 8999999999999999999998764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=2.6e-31  Score=265.27  Aligned_cols=173  Identities=13%  Similarity=0.106  Sum_probs=151.2

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      .++|++.+.||+|+||.||++... +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367889999999999999999975 58999999997532   23346789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++++|.+++..    + ....++..++.||++||+|||+++   |+||||||+|||+++++.+||++++       
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999832    2 356678899999999999999998   9999999999999999999997432       


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                                     |++|       ++.++||||||+++|||++|+.||...+
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                           3333       6889999999999999999999997653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=2e-31  Score=280.25  Aligned_cols=201  Identities=17%  Similarity=0.205  Sum_probs=154.6

Q ss_pred             hcCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC---ccchHHHHHHHHHHHhccc-CCee---------e---
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQH-KNLV---------K---  409 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~nIv---------~---  409 (571)
                      ...+|...+.||+|+||.||++.+ .+|+.||||+++...   ....+.+.+|+.++..++| +|..         .   
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            344567778999999999999995 479999999987322   2336778999999999977 3211         1   


Q ss_pred             ---------EeeEEEc-----CceeEEEEEccCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 008288          410 ---------LLGFCVD-----GDEKLLVYEFMPNGSLDAILFD----PRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR  471 (571)
Q Consensus       410 ---------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~  471 (571)
                               +..+...     ....+++|+.+ +++|.+++..    ......+++..++.++.||++||+|||+++   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                     1111111     12345667754 7899888831    223456888999999999999999999998   


Q ss_pred             eeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhh----------ccCCCCcchhhHhHHH
Q 008288          472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA----------MEGLYSKKSDVFSFGV  541 (571)
Q Consensus       472 iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slGv  541 (571)
                      |+||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++||||||+
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            999999999999999999999999998764332     233477 999999999          5556889999999999


Q ss_pred             HHHHHHhCCCCCCCCc
Q 008288          542 LLIEIITGRRNAGSNQ  557 (571)
Q Consensus       542 il~elltG~~p~~~~~  557 (571)
                      ++|||++|+.||...+
T Consensus       306 il~elltg~~Pf~~~~  321 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDA  321 (413)
T ss_dssp             HHHHHHHSSCCCCTTG
T ss_pred             HHHHHHHCCCCCCCcc
Confidence            9999999999997653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=2.4e-30  Score=259.97  Aligned_cols=175  Identities=27%  Similarity=0.397  Sum_probs=148.9

Q ss_pred             CCCCCC-ceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHH-HhcccCCeeeEeeEEEc----CceeE
Q 008288          349 SNFSDS-NILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLI-LKLQHKNLVKLLGFCVD----GDEKL  421 (571)
Q Consensus       349 ~~~~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~nIv~l~~~~~~----~~~~~  421 (571)
                      ++|... +.||+|+||.||++.. .+++.||+|+++.     ...+.+|+.++ +..+||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            345555 7799999999999997 4789999999864     23567888888 55599999999999887    67789


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeecccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMA  498 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~DfGla  498 (571)
                      +||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHH-CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999954 22346999999999999999999999998   999999999999998   788999999998


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....                        +..++.++||||||+++|||++|+.||...
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            6432                        234678999999999999999999999654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.2e-30  Score=280.79  Aligned_cols=183  Identities=16%  Similarity=0.130  Sum_probs=128.7

Q ss_pred             ecccCceeEEEEE-EcCCcEEEEEEcccc----------CccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeEEEE
Q 008288          357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSC----------SEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       357 lG~G~fg~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      .+.|+.|.+..++ .--|+.+++|.+.+.          ++...+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            4566666665544 235889999998642          123345699999999999 7999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||++|++|.+++.   ..++++..   +|+.||++||+|||+++   ||||||||+||||++++++||+|||+++.....
T Consensus       322 Eyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999994   34566654   48899999999999999   999999999999999999999999999876543


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCC
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR  551 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~  551 (571)
                      ...  ....+||+.|||||++.+ .+..++|+|++|+++++|.++..
T Consensus       393 ~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          393 CSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             -CC--SHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             Ccc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            322  233589999999999865 46778999999998887755543

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.94  E-value=1.9e-27  Score=198.75  Aligned_cols=103  Identities=23%  Similarity=0.435  Sum_probs=93.1

Q ss_pred             CCCCCCCCCCCCCCcCCCChHHHHHHHHHHHhhhccccc--CccccccC-CCCCceEEEEeccCCCChhhhHHHHHHHHH
Q 008288           25 DSPPYNICSTSTAGSARASTIDDNLQNVLTSLASNANAA--KFSNASFG-NDSDRVYGLYMCLNYISAETCNDCITTASQ  101 (571)
Q Consensus        25 ~~~~~~~c~~~~~~~~~~s~~~~~l~~l~~~l~~~~~~~--~f~~~~~g-~~~~~vyg~~~C~~d~~~~~C~~C~~~a~~  101 (571)
                      +.++++.|+.  ++|+++|+|++||+.||++|+++++.+  +|+++..| .++++|||++|||||+++++|..||+.|+.
T Consensus         3 t~~v~~~Cn~--~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~   80 (108)
T 3a2e_A            3 TAFVSSACNT--QKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVN   80 (108)
T ss_dssp             CCEEEEEECS--SBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHT
T ss_pred             cceeeeecCC--CccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHH
Confidence            4567889976  789999999999999999999998766  45555554 467999999999999999999999999999


Q ss_pred             HHHhhCCCcccceEEcCeeEEEecCCcc
Q 008288          102 DISKLCPNKTEAIVWEEVCQLRYAYQNF  129 (571)
Q Consensus       102 ~~~~~C~~~~~~~~~~~~C~~ry~~~~f  129 (571)
                      ++.+.||++++|+||+|.|+||||+++|
T Consensus        81 ~~~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           81 RIFSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             THHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence            9999999999999999999999999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=7.7e-27  Score=252.73  Aligned_cols=185  Identities=18%  Similarity=0.208  Sum_probs=146.9

Q ss_pred             CCceecccCceeEEEEEEcCCcEEEEEEccccCc--------cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       353 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ..+.||+|+||.||++.. .++.+++|+......        ...+.+.+|++++++++||||+++..++...+..++||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            357899999999999955 678889987643211        11345799999999999999997766767788889999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++++|.+++..           +..++.|+++||+|||+++   |+||||||+|||+++  ++||+|||+++.....
T Consensus       419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            99999999999843           5689999999999999998   999999999999998  9999999999876543


Q ss_pred             CCcc-----ceeeecccccccchhhhcc--CCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          505 EGEA-----NTVRIVGTYGYMAPEYAME--GLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       505 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ....     ......||+.|||||++..  ..|+...|+|+..+-.++.+.++.+|.
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2221     1124589999999999976  568888999999999999998888774

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.91  E-value=1.2e-24  Score=181.71  Aligned_cols=104  Identities=24%  Similarity=0.405  Sum_probs=93.7

Q ss_pred             CcccccCCCCCCChHHHHHHHHHHHHHHHHHhccCCCCcccccccccCCCCCceEEEEeeccCCCccchHHHHHHHHHHh
Q 008288          137 GNIPKYNRLNISEPERYRSVVNNTLSDLITKLSAFDPFEMYATDEVPFTNSDTFYALVQCTKDLPADDCITCLHNATADI  216 (571)
Q Consensus       137 ~~~~~~~~~~~~~~~~f~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~vygl~QC~~Dl~~~~C~~Cl~~a~~~~  216 (571)
                      .....||..++++++.|+.+++.+|..|...++.++  .+|+++..+..+.++||||+||+||+++++|..||+.|+.++
T Consensus         5 ~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~--~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~   82 (108)
T 3a2e_A            5 FVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSG--YDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI   82 (108)
T ss_dssp             EEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTT--SEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred             eeeeecCCCccCCCChHHHHHHHHHHHHHhhCcccc--CCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence            345678888999999999999999999999887642  467777776667789999999999999999999999999999


Q ss_pred             hhhcCCCCCcEEEeeeeeeEEEeeee
Q 008288          217 LSCCYFSRGARLLSRNCYLRYELYAF  242 (571)
Q Consensus       217 ~~~c~~~~g~~v~~~~C~lRy~~~~f  242 (571)
                      +++|++++||+||+++|+||||+++|
T Consensus        83 ~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           83 FSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHCCCCceEEEECCCEEEEEeCCcC
Confidence            99999999999999999999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=3.6e-23  Score=205.58  Aligned_cols=163  Identities=18%  Similarity=0.131  Sum_probs=126.7

Q ss_pred             HHHhhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCc------------------cchHHHHHHHHHHHhccc
Q 008288          343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE------------------QGTAEFTNEVLLILKLQH  404 (571)
Q Consensus       343 ~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h  404 (571)
                      .+......|...+.||+|+||.||++...+|+.||+|+++....                  .....+.+|+.++++++ 
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence            34445566777899999999999999997799999999864221                  12456889999999998 


Q ss_pred             CCeeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEe
Q 008288          405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLL  484 (571)
Q Consensus       405 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl  484 (571)
                       | +++.+++. .+..++||||+++++|.+ +..         .....++.|+++||.|||+.+   |+||||||+|||+
T Consensus       163 -~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl  226 (282)
T 1zar_A          163 -G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV  226 (282)
T ss_dssp             -T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred             -C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence             4 55555443 366799999999999988 411         124469999999999999998   9999999999999


Q ss_pred             cCCCcEEEeecccccccccCCCccceeeecccccccchhhhcc----------CCCCcchhhHh
Q 008288          485 DSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME----------GLYSKKSDVFS  538 (571)
Q Consensus       485 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Dv~s  538 (571)
                      + ++.+||+|||+++.               +..++|||++..          ..+...+|+|.
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9 99999999999863               345788998753          33455566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=4.3e-19  Score=173.87  Aligned_cols=136  Identities=19%  Similarity=0.193  Sum_probs=106.4

Q ss_pred             CCCCceecccCceeEEEEEE-cCCcE--EEEEEccccCcc------------------------chHHHHHHHHHHHhcc
Q 008288          351 FSDSNILGQGGFGPVYKGVL-SDGKE--VAVKRLSSCSEQ------------------------GTAEFTNEVLLILKLQ  403 (571)
Q Consensus       351 ~~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  403 (571)
                      |.+.+.||+|+||.||++.. .+|+.  ||||+++.....                        ....+.+|+.++.++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56678999999999999997 68889  999987542111                        0125789999999998


Q ss_pred             cCCe--eeEeeEEEcCceeEEEEEccCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCeeeC
Q 008288          404 HKNL--VKLLGFCVDGDEKLLVYEFMPN-G----SLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH-EDSRLRIVHR  475 (571)
Q Consensus       404 h~nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH-~~~~~~iiH~  475 (571)
                      |++|  +.++..    +..+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8864  444432    467899999942 4    66665421      234567789999999999999 888   9999


Q ss_pred             CCCCCCeEecCCCcEEEeeccccccc
Q 008288          476 DLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       476 DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      ||||+|||+++  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.67  E-value=3.8e-17  Score=166.75  Aligned_cols=142  Identities=13%  Similarity=0.132  Sum_probs=101.2

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCc--------------cchHH--------HHHHHHHHHhcc
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE--------------QGTAE--------FTNEVLLILKLQ  403 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l~~l~  403 (571)
                      ....-|.+...||+|+||.||+|...+|+.||||+++....              .....        ...|...|.++.
T Consensus        92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~  171 (397)
T 4gyi_A           92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY  171 (397)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence            33344888999999999999999988999999998753210              00111        234555666665


Q ss_pred             cCCeeeEeeEEEcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeE
Q 008288          404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVL  483 (571)
Q Consensus       404 h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NIL  483 (571)
                      +.++....-+..  ...+|||||+++++|..+...         .....++.||+.+|.+||+.+   ||||||||.|||
T Consensus       172 ~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NIL  237 (397)
T 4gyi_A          172 EEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNIL  237 (397)
T ss_dssp             HTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             hcCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEE
Confidence            444321111111  234799999999888765411         124568899999999999998   999999999999


Q ss_pred             ecCCC----------cEEEeeccccccc
Q 008288          484 LDSDM----------NSKISDFGMARIF  501 (571)
Q Consensus       484 l~~~~----------~~kL~DfGla~~~  501 (571)
                      +++++          .+.|+||+-+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98876          3899999987644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=1.9e-12  Score=126.55  Aligned_cols=142  Identities=18%  Similarity=0.106  Sum_probs=112.0

Q ss_pred             CCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ..|.....++.|+.+.||+... +++.+++|+...........+.+|+.+++.+. +..+++++++..+.+..++||||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            4576677788888899999886 47899999986432233446889999999984 677889999999988999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS---------------------------------------  468 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~---------------------------------------  468 (571)
                      +|.+|.+.+.        +......++.+++++|..||+..                                       
T Consensus        93 ~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           93 DGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             SSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             CCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            9999987641        11223478899999999999821                                       


Q ss_pred             -----------------CCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          469 -----------------RLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       469 -----------------~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                                       ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             1348999999999999876666799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=2.7e-11  Score=117.88  Aligned_cols=129  Identities=19%  Similarity=0.151  Sum_probs=98.9

Q ss_pred             cccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC--eeeEeeEEEcCceeEEEEEccCCCChhhh
Q 008288          358 GQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNGSLDAI  435 (571)
Q Consensus       358 G~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~  435 (571)
                      +.|..+.||+....+|+.+++|.....   ....+..|+.+++.+.+.+  +++++++...++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            456669999998777888999987643   2346789999999986545  566888888888889999999998884  


Q ss_pred             hcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------------
Q 008288          436 LFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-----------------------------------------------  468 (571)
Q Consensus       436 l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----------------------------------------------  468 (571)
                      ...      .+   ...++.++++.|..||+..                                               
T Consensus       104 ~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (264)
T 1nd4_A          104 SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL  174 (264)
T ss_dssp             TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred             cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence            211      11   2357788888888888753                                               


Q ss_pred             --------CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          469 --------RLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       469 --------~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                              ...++|+|++|+|||++++..+.|+||+.+..
T Consensus       175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                    11299999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.08  E-value=4.8e-10  Score=114.82  Aligned_cols=142  Identities=16%  Similarity=0.246  Sum_probs=107.1

Q ss_pred             CCceecccCceeEEEEEEcCCcEEEEEEcc--ccC-ccchHHHHHHHHHHHhcc--cCCeeeEeeEEEcC---ceeEEEE
Q 008288          353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLS--SCS-EQGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDG---DEKLLVY  424 (571)
Q Consensus       353 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~  424 (571)
                      ..+.|+.|.+..||+.... +..+++|+..  ... ......+.+|..+++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3567899999999998874 5688888776  322 122456889999999996  45678888888776   4589999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC------------------------------------
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS------------------------------------  468 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~------------------------------------  468 (571)
                      ||+++..+.+..     ...++..++..++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998874321     123678888999999999999999831                                    


Q ss_pred             -------------------CCCeeeCCCCCCCeEecCCCc--EEEeecccccc
Q 008288          469 -------------------RLRIVHRDLKASNVLLDSDMN--SKISDFGMARI  500 (571)
Q Consensus       469 -------------------~~~iiH~DLkp~NILl~~~~~--~kL~DfGla~~  500 (571)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               245999999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.98  E-value=3.4e-10  Score=113.12  Aligned_cols=187  Identities=18%  Similarity=0.241  Sum_probs=123.1

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCC--eeeEeeEEEcCc---eeEEEEEcc
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKN--LVKLLGFCVDGD---EKLLVYEFM  427 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--Iv~l~~~~~~~~---~~~lv~e~~  427 (571)
                      .+.++.|....||+..    ..+++|+...  ......+.+|..+++.+ .+..  +++++......+   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999853    5688897653  23456788999999888 3433  345555443333   347899999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC---------------------------------------
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS---------------------------------------  468 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~---------------------------------------  468 (571)
                      +|.+|.....     ..++..++..++.++++.|..||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865331     23677788888999999999998621                                       


Q ss_pred             ----------------CCCeeeCCCCCCCeEecC--CCcEEEeecccccccccCCCccceee------------eccccc
Q 008288          469 ----------------RLRIVHRDLKASNVLLDS--DMNSKISDFGMARIFAESEGEANTVR------------IVGTYG  518 (571)
Q Consensus       469 ----------------~~~iiH~DLkp~NILl~~--~~~~kL~DfGla~~~~~~~~~~~~~~------------~~gt~~  518 (571)
                                      .+.++|+|++|.||++++  +..+.|+||+.+..-.....-.....            .....+
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                            134899999999999998  45678999998864322110000000            000001


Q ss_pred             ccc-hhhhccCCCCcchhhHhHHHHHHHHHhCCCCC
Q 008288          519 YMA-PEYAMEGLYSKKSDVFSFGVLLIEIITGRRNA  553 (571)
Q Consensus       519 y~a-PE~~~~~~~~~~~Dv~slGvil~elltG~~p~  553 (571)
                      ... |+....  .....+.|+++.++|++.+|+.+|
T Consensus       254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111 222111  122368999999999999999886

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=1e-06  Score=87.74  Aligned_cols=136  Identities=21%  Similarity=0.191  Sum_probs=97.7

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccC---CeeeEeeEEE-cCceeEEEEEccCC
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHK---NLVKLLGFCV-DGDEKLLVYEFMPN  429 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~~  429 (571)
                      .+.++.|....||+.    +..+++|+..  .......+..|..++..+.+.   .+++++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456788888899987    5778888753  223456788999999999652   3566777664 45567899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-----------------------------------------  468 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----------------------------------------  468 (571)
                      .++.....     ..++..+...++.++++.|..||+..                                         
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            98876321     12455566666677777776666532                                         


Q ss_pred             ----------------CCCeeeCCCCCCCeEecC---CCc-EEEeecccccc
Q 008288          469 ----------------RLRIVHRDLKASNVLLDS---DMN-SKISDFGMARI  500 (571)
Q Consensus       469 ----------------~~~iiH~DLkp~NILl~~---~~~-~kL~DfGla~~  500 (571)
                                      .+.++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            224699999999999987   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.46  E-value=5.8e-07  Score=91.57  Aligned_cols=80  Identities=5%  Similarity=-0.014  Sum_probs=57.0

Q ss_pred             cee-cccCceeEEEEEEc-------CCcEEEEEEccccC---ccchHHHHHHHHHHHhcc-c--CCeeeEeeEEEcC---
Q 008288          355 NIL-GQGGFGPVYKGVLS-------DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQ-H--KNLVKLLGFCVDG---  417 (571)
Q Consensus       355 ~~l-G~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~nIv~l~~~~~~~---  417 (571)
                      +.| +.|....+|+....       +++.+++|+.....   ......+..|..+++.+. +  -.+++++.+..+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            557 78888999998764       26788999765422   111246788999998884 3  3567788887665   


Q ss_pred             ceeEEEEEccCCCChhh
Q 008288          418 DEKLLVYEFMPNGSLDA  434 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~  434 (571)
                      +..++||||++|..+.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            35689999999877653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.43  E-value=1e-06  Score=85.92  Aligned_cols=135  Identities=20%  Similarity=0.203  Sum_probs=98.0

Q ss_pred             eecccCce-eEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEEccCCCCh
Q 008288          356 ILGQGGFG-PVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSL  432 (571)
Q Consensus       356 ~lG~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL  432 (571)
                      .+..|..+ .||+.... ++..+++|+-...   ...++..|...++.+. +-.+.+++.++.+.+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445554 68988754 4678899976532   3456788999998884 44477889999999999999999999888


Q ss_pred             hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------------
Q 008288          433 DAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS--------------------------------------------  468 (571)
Q Consensus       433 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--------------------------------------------  468 (571)
                      .+....       .......+..++++.|.-||+..                                            
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            765421       11223456677777777777531                                            


Q ss_pred             -----------CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          469 -----------RLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       469 -----------~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                                 .+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       11289999999999999877778999998763

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.04  E-value=1.9e-05  Score=81.58  Aligned_cols=75  Identities=11%  Similarity=0.118  Sum_probs=50.1

Q ss_pred             CceecccCceeEEEEEEc-CCcEEEEEEccccCc-------cchHHHHHHHHHHHhccc--C-CeeeEeeEEEcCceeEE
Q 008288          354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-------QGTAEFTNEVLLILKLQH--K-NLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-nIv~l~~~~~~~~~~~l  422 (571)
                      .+.||.|..+.||++... +++.++||...+...       .....+..|.+++..+..  + .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            457899999999999754 568899997653211       223456789888888742  3 34556544  3455689


Q ss_pred             EEEccCCC
Q 008288          423 VYEFMPNG  430 (571)
Q Consensus       423 v~e~~~~g  430 (571)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.01  E-value=2.1e-05  Score=77.42  Aligned_cols=79  Identities=20%  Similarity=0.243  Sum_probs=58.6

Q ss_pred             CCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhccc---CCeeeEeeEEEcCceeEEEEEc
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH---KNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      .....+.+|.|..+.||+.++.+|+.+++|+...........+..|...|+.+..   -.+++++++    +..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence            3444677999999999999999999999998765444444567899999998842   234555554    345789999


Q ss_pred             cCCCCh
Q 008288          427 MPNGSL  432 (571)
Q Consensus       427 ~~~gsL  432 (571)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.97  E-value=4.6e-05  Score=76.65  Aligned_cols=140  Identities=14%  Similarity=0.194  Sum_probs=80.4

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhccc--CCeeeEee------EEEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLG------FCVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~------~~~~~~~~~lv~e~  426 (571)
                      +.|+.|....||+....+ ..+++|+....    ..++..|..++..+..  -.+++++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETT-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCC-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            456667788999998754 45899988752    2334455565655532  12344443      22346678899999


Q ss_pred             cCCCChh-----h------h---hc----CC--C-C----CCCCCHHHH-------------------------------
Q 008288          427 MPNGSLD-----A------I---LF----DP--R-K----RGILCWRKR-------------------------------  450 (571)
Q Consensus       427 ~~~gsL~-----~------~---l~----~~--~-~----~~~l~~~~~-------------------------------  450 (571)
                      ++|..+.     .      .   ++    ..  . .    .....|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542     0      0   11    10  0 0    011123211                               


Q ss_pred             HHHHHHHHHHHHHHhh----------CCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          451 TNIVNGIAKGMLYLHE----------DSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       451 ~~i~~qia~~L~~LH~----------~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      ..+..++.+++.+|++          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111234445666763          123459999999999999888899999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.96  E-value=4.6e-05  Score=75.79  Aligned_cols=140  Identities=18%  Similarity=0.136  Sum_probs=93.0

Q ss_pred             CCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcc---cCCeeeEeeEEEcCceeEEEEEccC
Q 008288          352 SDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      ...+.|+.|....+|+... ++..+++|+....   ....+..|...|+.+.   ...+++++.+....+..++||||++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3356789999999999886 5778899976542   3556889999998884   3568889998888888999999999


Q ss_pred             CCChhh--------h---hcCC-C--CC--------C--------CCCHHHHH---HHH----------------HHHHH
Q 008288          429 NGSLDA--------I---LFDP-R--KR--------G--------ILCWRKRT---NIV----------------NGIAK  459 (571)
Q Consensus       429 ~gsL~~--------~---l~~~-~--~~--------~--------~l~~~~~~---~i~----------------~qia~  459 (571)
                      +..+..        .   |+.. .  .-        +        .-+|....   ++.                .++.+
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            876521        1   1111 1  00        0        12454321   111                11222


Q ss_pred             HH-HHHhh-CCCCCeeeCCCCCCCeEecCCCcEEEeecc
Q 008288          460 GM-LYLHE-DSRLRIVHRDLKASNVLLDSDMNSKISDFG  496 (571)
Q Consensus       460 ~L-~~LH~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfG  496 (571)
                      -+ ..|.. ..++.++|+|+.+.|++++.++ +.|+|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22 23432 2346699999999999999887 8999984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.69  E-value=0.00018  Score=74.82  Aligned_cols=79  Identities=11%  Similarity=0.051  Sum_probs=45.8

Q ss_pred             CCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccC---CCCcchhhHhHHHHHHHH
Q 008288          470 LRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG---LYSKKSDVFSFGVLLIEI  546 (571)
Q Consensus       470 ~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slGvil~el  546 (571)
                      ..++|+|++|.|||++.++ ++|+||+.+..-.....-..... .-...|.+|+.....   .-....++......+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            4599999999999998776 99999998864321110000000 001235566544311   112234555777777777


Q ss_pred             HhCC
Q 008288          547 ITGR  550 (571)
Q Consensus       547 ltG~  550 (571)
                      +.++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.53  E-value=0.00044  Score=68.25  Aligned_cols=71  Identities=11%  Similarity=0.142  Sum_probs=46.2

Q ss_pred             CceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEcc-CCCC
Q 008288          354 SNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFM-PNGS  431 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~~gs  431 (571)
                      .+.|+.|....+|+.     +.+++|+....... .....+|..+++.+...++ +++++.  +.+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            577888999999998     66888887653222 2234578888877743333 455544  344467899999 6655


Q ss_pred             h
Q 008288          432 L  432 (571)
Q Consensus       432 L  432 (571)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.46  E-value=0.00049  Score=68.52  Aligned_cols=143  Identities=15%  Similarity=0.088  Sum_probs=79.9

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC--eeeEeeE------EEcCceeEEEEEc
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYEF  426 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e~  426 (571)
                      +.|+.|....+|+....++ .+++|+....  .....+..|..++..+...+  +++++..      ....+..+++++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            4567788889999987555 6888987652  12234567777777774323  3333321      1234567899999


Q ss_pred             cCCCChhh----h----------hc----CCCCC-----CCCCHHHHHH------------HHHHHHHHHHHHhhC----
Q 008288          427 MPNGSLDA----I----------LF----DPRKR-----GILCWRKRTN------------IVNGIAKGMLYLHED----  467 (571)
Q Consensus       427 ~~~gsL~~----~----------l~----~~~~~-----~~l~~~~~~~------------i~~qia~~L~~LH~~----  467 (571)
                      ++|..+..    .          ++    .....     +...|.....            +...+.+.++.+++.    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            99865421    0          11    10000     0011222110            011234445555432    


Q ss_pred             CCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       468 ~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      .+..++|+|+++.|||++++..+.|+||+.+..
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            123599999999999998876668999988753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.37  E-value=0.00071  Score=69.04  Aligned_cols=141  Identities=18%  Similarity=0.240  Sum_probs=83.6

Q ss_pred             ceecccCceeEEEEEEc--------CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEE
Q 008288          355 NILGQGGFGPVYKGVLS--------DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e  425 (571)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.+...++ +++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45777778889998864        2478999986432 2345567789999988843333 566666543    29999


Q ss_pred             ccCCCChhhh-----------------hcCC--CCCCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 008288          426 FMPNGSLDAI-----------------LFDP--RKRGILC--WRKRTNIVNGIAK-------------------GMLY--  463 (571)
Q Consensus       426 ~~~~gsL~~~-----------------l~~~--~~~~~l~--~~~~~~i~~qia~-------------------~L~~--  463 (571)
                      |++|.+|..-                 ++..  .......  +.++.++..++..                   .+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998665311                 1111  1111222  3445555444322                   1222  


Q ss_pred             --HhhC-CCCCeeeCCCCCCCeEecCC----CcEEEeecccccc
Q 008288          464 --LHED-SRLRIVHRDLKASNVLLDSD----MNSKISDFGMARI  500 (571)
Q Consensus       464 --LH~~-~~~~iiH~DLkp~NILl~~~----~~~kL~DfGla~~  500 (571)
                        |... ....++|+|+.+.|||++++    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              2222 23459999999999999876    7899999998763

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.35  E-value=0.00035  Score=72.81  Aligned_cols=73  Identities=18%  Similarity=0.245  Sum_probs=50.2

Q ss_pred             CceecccCceeEEEEEEcC--------CcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEE
Q 008288          354 SNILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~  424 (571)
                      .+.|+.|....+|+....+        ++.+++|+....  .....+.+|..++..+...++ +++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3567888889999998753        578999987431  111456689999988854444 567766532    3899


Q ss_pred             EccCCCCh
Q 008288          425 EFMPNGSL  432 (571)
Q Consensus       425 e~~~~gsL  432 (571)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987544

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.34  E-value=0.001  Score=66.67  Aligned_cols=141  Identities=15%  Similarity=0.107  Sum_probs=71.8

Q ss_pred             ceecccCcee-EEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhccc--CCeeeEeeEEEcCceeEEEEEccCCCC
Q 008288          355 NILGQGGFGP-VYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       355 ~~lG~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      +.|+.|.... +|+....+++.+++|.......   .++..|+.++..+..  -.+++++.+..+.  .+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            3455554443 6676654467787876543221   234566777766643  2345666654333  378999997766


Q ss_pred             hhhhhc---------------------CCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 008288          432 LDAILF---------------------DPRK--RGILCWRKRT-------N-------------IVNGIAKGMLYLH---  465 (571)
Q Consensus       432 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~qia~~L~~LH---  465 (571)
                      +.+.+.                     ....  ...++.....       .             ....+.+.++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            543321                     1000  0111111100       0             0011112222221   


Q ss_pred             hCCCCCeeeCCCCCCCeEecCC----CcEEEeecccccc
Q 008288          466 EDSRLRIVHRDLKASNVLLDSD----MNSKISDFGMARI  500 (571)
Q Consensus       466 ~~~~~~iiH~DLkp~NILl~~~----~~~kL~DfGla~~  500 (571)
                      ......++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123459999999999999875    6799999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.30  E-value=0.002  Score=64.27  Aligned_cols=142  Identities=16%  Similarity=0.152  Sum_probs=81.8

Q ss_pred             ceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC--eeeEeeE-----EEcCceeEEEEEcc
Q 008288          355 NILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN--LVKLLGF-----CVDGDEKLLVYEFM  427 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~-----~~~~~~~~lv~e~~  427 (571)
                      ..++ |....||+....+|+.+++|...+.. .....+..|..++..+....  +++++..     ....+..+++||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 77788999877677789999886421 23446677888888774322  3444443     12245567899999


Q ss_pred             CCCChhh-----h---------hc----CC--CCCCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 008288          428 PNGSLDA-----I---------LF----DP--RKRGILCWRKR----------------------TNIVNGIAKGMLYLH  465 (571)
Q Consensus       428 ~~gsL~~-----~---------l~----~~--~~~~~l~~~~~----------------------~~i~~qia~~L~~LH  465 (571)
                      +|..+..     .         ++    ..  ......++...                      ...+.+++..+.-+-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8754321     0         01    10  01111222111                      111122222222221


Q ss_pred             h-CCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          466 E-DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       466 ~-~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      . ..+..++|+|++++|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1233489999999999998 4 899999988753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.11  E-value=0.0039  Score=65.29  Aligned_cols=74  Identities=18%  Similarity=0.113  Sum_probs=49.0

Q ss_pred             CceecccCceeEEEEEEcC-CcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEEccCCCC
Q 008288          354 SNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNGS  431 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~gs  431 (571)
                      .+.|+.|-...+|+....+ +..+++|+.....+ ...+...|..++..+...++ +++++.+.  +  .+||||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3567888889999998754 47888998754322 22223689999998865555 56777662  2  25999998755


Q ss_pred             h
Q 008288          432 L  432 (571)
Q Consensus       432 L  432 (571)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.00  E-value=0.0016  Score=66.27  Aligned_cols=73  Identities=11%  Similarity=0.070  Sum_probs=45.0

Q ss_pred             ceecccCceeEEEEEEcC---------CcEEEEEEccccCccchHHHHHHHHHHHhcccCC-eeeEeeEEEcCceeEEEE
Q 008288          355 NILGQGGFGPVYKGVLSD---------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~  424 (571)
                      +.|+.|..-.+|+....+         ++.+++|+.....+ ...+...|..++..+...+ ++++++..  .  .++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            456777778899988753         26888888754322 2223467888888885444 34666543  2  37899


Q ss_pred             EccCCCCh
Q 008288          425 EFMPNGSL  432 (571)
Q Consensus       425 e~~~~gsL  432 (571)
                      ||+++.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.89  E-value=0.0053  Score=61.62  Aligned_cols=66  Identities=12%  Similarity=0.065  Sum_probs=42.5

Q ss_pred             cCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhccc---CCeeeEeeE------EEcCceeEEEEEccCCC
Q 008288          360 GGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH---KNLVKLLGF------CVDGDEKLLVYEFMPNG  430 (571)
Q Consensus       360 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~nIv~l~~~------~~~~~~~~lv~e~~~~g  430 (571)
                      |....||+....+| .+++|+......      ..|+.++..+..   |.+++++..      ....+..+++|||++|.
T Consensus        34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            33678999987666 899998765331      355666665532   224454432      23456778999999987


Q ss_pred             Ch
Q 008288          431 SL  432 (571)
Q Consensus       431 sL  432 (571)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            65

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.76  E-value=0.047  Score=56.33  Aligned_cols=74  Identities=9%  Similarity=0.055  Sum_probs=49.5

Q ss_pred             CceecccCceeEEEEEEcC--------CcEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEE
Q 008288          354 SNILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~  424 (571)
                      .+.+..|-.-.+|+....+        ++.+++|+.....+ ...+..+|..+++.+...++ +++++.+    ..++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            3557777788999998753        57899998654332 22345688888888853333 5566533    237899


Q ss_pred             EccCCCCh
Q 008288          425 EFMPNGSL  432 (571)
Q Consensus       425 e~~~~gsL  432 (571)
                      ||+++.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.60  E-value=0.16  Score=52.04  Aligned_cols=29  Identities=24%  Similarity=0.423  Sum_probs=24.8

Q ss_pred             eeeCCCCCCCeEe------cCCCcEEEeecccccc
Q 008288          472 IVHRDLKASNVLL------DSDMNSKISDFGMARI  500 (571)
Q Consensus       472 iiH~DLkp~NILl------~~~~~~kL~DfGla~~  500 (571)
                      ++|+|+.+.|||+      +++..+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4467799999998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=92.78  E-value=0.2  Score=46.16  Aligned_cols=102  Identities=12%  Similarity=0.032  Sum_probs=65.8

Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCccc
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN  509 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~  509 (571)
                      -+|.++|.  ....++++++++.++.|.++.|.-+-... .+ ..+=+.|..|++..+|.+.+.+ ..+.          
T Consensus        33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            36888884  35678999999999999999988762211 11 1333457999999999988763 1110          


Q ss_pred             eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCC
Q 008288          510 TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR  551 (571)
Q Consensus       510 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~  551 (571)
                          .....+.+||... ...+.+.=|||||+++|.-+--..
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence                0122356888653 345678899999999998876333

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=87.52  E-value=0.15  Score=33.81  Aligned_cols=11  Identities=55%  Similarity=0.498  Sum_probs=4.3

Q ss_pred             eehhHHHHHHH
Q 008288          270 IVLASVVALLL  280 (571)
Q Consensus       270 iv~~~~~~v~~  280 (571)
                      |+.+++..+++
T Consensus        13 IA~gVVgGv~~   23 (44)
T 2ks1_B           13 IATGMVGALLL   23 (44)
T ss_dssp             STHHHHHHHHH
T ss_pred             EEeehhHHHHH
Confidence            33444433333

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.45  E-value=2.2  Score=39.11  Aligned_cols=83  Identities=10%  Similarity=0.043  Sum_probs=60.7

Q ss_pred             ccCCeeeEeeEEEcCceeEEEEEccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCC
Q 008288          403 QHKNLVKLLGFCVDGDEKLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASN  481 (571)
Q Consensus       403 ~h~nIv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~N  481 (571)
                      .||++++. .+-.+++...+.++.-+. -++.. +      ..++...+++++.+|+...++++.     -+|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            68888876 466666666666664432 23332 2      237789999999999998866654     4788899999


Q ss_pred             eEecCCCcEEEeecccc
Q 008288          482 VLLDSDMNSKISDFGMA  498 (571)
Q Consensus       482 ILl~~~~~~kL~DfGla  498 (571)
                      |+++.++.+++.=-|+-
T Consensus       110 L~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             EEECTTSCEEESCCEET
T ss_pred             EEEcCCCCEEEEEccCc
Confidence            99999999999876653

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=84.89  E-value=0.2  Score=33.04  Aligned_cols=7  Identities=14%  Similarity=0.107  Sum_probs=2.6

Q ss_pred             eehhHHH
Q 008288          270 IVLASVV  276 (571)
Q Consensus       270 iv~~~~~  276 (571)
                      |+.+++.
T Consensus        12 IA~gVVg   18 (44)
T 2l2t_A           12 IAAGVIG   18 (44)
T ss_dssp             HHHHHHH
T ss_pred             EEEeehH
Confidence            3333333

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.66  E-value=4.5  Score=37.15  Aligned_cols=82  Identities=10%  Similarity=0.030  Sum_probs=59.8

Q ss_pred             ccCCeeeEeeEEEcCceeEEEEEccCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhCCCCCeeeCCCCCC
Q 008288          403 QHKNLVKLLGFCVDGDEKLLVYEFMPNG-SLDAILFDPRKRGILCWRKRTNIVNGIAKGML-YLHEDSRLRIVHRDLKAS  480 (571)
Q Consensus       403 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~-~LH~~~~~~iiH~DLkp~  480 (571)
                      .||++  -..+-.+++...+.++--+++ ++.. +      ..++...+++++.+|+.... ++++     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            67888  334446777777777755333 3333 2      23778899999999888777 5554     578889999


Q ss_pred             CeEecCCCcEEEeecccc
Q 008288          481 NVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       481 NILl~~~~~~kL~DfGla  498 (571)
                      ||+++.++.++|.-.|+-
T Consensus       114 NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GEEECTTCCEEESCCEET
T ss_pred             eEEEeCCCcEEEEEcCCc
Confidence            999999999999877764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	571
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-55
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-55
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-54
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-45
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-45
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-23

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 2e-66
 Identities = 63/206 (30%), Positives = 105/206 (50%), Gaps = 9/206 (4%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
              +    +G G FG VYKG       V +  +++ + Q    F NEV ++ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
             +G+     +  +V ++    SL   L     +      K  +I    A+GM YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM-- 526
              I+HRDLK++N+ L  D+  KI DFG+A + +   G     ++ G+  +MAPE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 527 -EGLYSKKSDVFSFGVLLIEIITGRR 551
            +  YS +SDV++FG++L E++TG+ 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 7e-65
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 11/210 (5%)

Query: 344 LNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILK 401
           + L   +F   + LG G  G V+K      G  +A K +    +     +   E+ ++ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGM 461
                +V   G      E  +  E M  GSLD +L   +K G +  +    +   + KG+
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117

Query: 462 LYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            YL    + +I+HRD+K SN+L++S    K+ DFG++    +S         VGT  YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMS 171

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           PE      YS +SD++S G+ L+E+  GR 
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 1e-60
 Identities = 69/203 (33%), Positives = 104/203 (51%), Gaps = 7/203 (3%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
                   LG G FG V+ G  +   +VAVK L          F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +L       +   ++ E+M NGSL   L  P     L   K  ++   IA+GM ++ E +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN 129

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
               +HRDL+A+N+L+   ++ KI+DFG+AR+  ++E  A          + APE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 529 LYSKKSDVFSFGVLLIEIITGRR 551
            ++ KSDV+SFG+LL EI+T  R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGR 208

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 3e-59
 Identities = 65/236 (27%), Positives = 107/236 (45%), Gaps = 29/236 (12%)

Query: 322 YQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKR 380
           Y+HV     DL  +DF+  +  L             G G FG VYK          A K 
Sbjct: 1   YEHVT---RDLNPEDFWEIIGEL-------------GDGAFGKVYKAQNKETSVLAAAKV 44

Query: 381 LSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
           + + SE+   ++  E+ ++    H N+VKLL      +   ++ EF   G++DA++    
Sbjct: 45  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--E 102

Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
               L   +   +       + YLH+    +I+HRDLKA N+L   D + K++DFG++  
Sbjct: 103 LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159

Query: 501 FAESEGEANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRR 551
              +    ++   +GT  +MAPE  M     +  Y  K+DV+S G+ LIE+     
Sbjct: 160 NTRTIQRRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 5e-59
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 7/203 (3%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           S  +    +G G FG V+ G   +  +VA+K +         +F  E  +++KL H  LV
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +L G C++     LV+EFM +G L    +   +RG+        +   + +GM YL E  
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE-- 119

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              ++HRDL A N L+  +   K+SDFGM R   + +   ++        + +PE     
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 177

Query: 529 LYSKKSDVFSFGVLLIEIITGRR 551
            YS KSDV+SFGVL+ E+ +  +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-58
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 7/203 (3%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
            + +    LG G FG V  G      +VA+K +         EF  E  +++ L H+ LV
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +L G C       ++ E+M NG L   L + R R     ++   +   + + M YL    
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE--- 117

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
             + +HRDL A N L++     K+SDFG++R   + E   ++V       +  PE  M  
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYS 176

Query: 529 LYSKKSDVFSFGVLLIEIITGRR 551
            +S KSD+++FGVL+ EI +  +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (495), Expect = 3e-58
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 19/211 (9%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT---AEFTNEVLLILKLQ 403
              FSD   +G G FG VY    + + + VA+K++S   +Q      +   EV  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLY 463
           H N ++  G  +      LV E+    + D +      +  L   +   + +G  +G+ Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130

Query: 464 LHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE 523
           LH      ++HRD+KA N+LL      K+ DFG A I A +         VGT  +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPE 181

Query: 524 YAM---EGLYSKKSDVFSFGVLLIEIITGRR 551
             +   EG Y  K DV+S G+  IE+   + 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 1e-57
 Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 7/203 (3%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
            +      LGQG FG V+ G  +    VA+K L          F  E  ++ KL+H+ LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
           +L       +   +V E+M  GSL   L        L   +  ++   IA GM Y+    
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVE--- 130

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
           R+  VHRDL+A+N+L+  ++  K++DFG+AR+  ++E  A          + APE A+ G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189

Query: 529 LYSKKSDVFSFGVLLIEIITGRR 551
            ++ KSDV+SFG+LL E+ T  R
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGR 212

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-57
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 10/210 (4%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHKN 406
           ++     +G G +G   K    SDGK +  K L   S +E       +EV L+ +L+H N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 407 LVKLLGFCVDGDEKLL--VYEFMPNGSLDAILFDPRK-RGILCWRKRTNIVNGIAKGMLY 463
           +V+     +D     L  V E+   G L +++    K R  L       ++  +   +  
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 464 LHE--DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
            H   D    ++HRDLK +NV LD   N K+ DFG+ARI       A       T  YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMS 182

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           PE      Y++KSD++S G LL E+     
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMP 212

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 6e-57
 Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 13/204 (6%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
                   +G+G FG V  G    G +VAVK + +  +     F  E  ++ +L+H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63

Query: 409 KLLGFCVDGDEKL-LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           +LLG  V+    L +V E+M  GSL   L   R R +L           + + M YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
                VHRDL A NVL+  D  +K+SDFG+ +  + ++             + APE   E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174

Query: 528 GLYSKKSDVFSFGVLLIEIITGRR 551
             +S KSDV+SFG+LL EI +  R
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR 198

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-56
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS-SCSEQGTAEFTNEVLLILKLQHKNL 407
           ++     LG+G +G V   V     + VAVK +    +         E+ +   L H+N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           VK  G   +G+ + L  E+   G L   +        +         + +  G++YLH  
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG- 121

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM- 526
             + I HRD+K  N+LLD   N KISDFG+A +F  +  E    ++ GT  Y+APE    
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRRN 552
              +++  DV+S G++L  ++ G   
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELP 205

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 9e-56
 Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 10/205 (4%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN 406
              ++    +GQG  G VY  + ++ G+EVA+++++   +       NE+L++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           +V  L   + GDE  +V E++  GSL  ++ +          +   +     + + +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS 134

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
               +++HRD+K+ N+LL  D + K++DFG        + + +T  +VGT  +MAPE   
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
              Y  K D++S G++ IE+I G  
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEP 214

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (476), Expect = 1e-55
 Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 25/234 (10%)

Query: 338 FID---LETLNLATSNFSDS---------NILGQGGFGPVYKGVLSDGKE----VAVKRL 381
           FID    E  N A   F+            ++G G FG V  G L    +    VA+K L
Sbjct: 3   FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62

Query: 382 -SSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPR 440
            S  +E+   +F +E  ++ +  H N++ L G        +++ EFM NGSLD+  F  +
Sbjct: 63  KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQ 120

Query: 441 KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI 500
             G     +   ++ GIA GM YL     +  VHRDL A N+L++S++  K+SDFG++R 
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 501 FAESEGEANTVRIVG---TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
             +   +      +G      + APE      ++  SDV+S+G+++ E+++   
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (475), Expect = 2e-55
 Identities = 66/240 (27%), Positives = 101/240 (42%), Gaps = 31/240 (12%)

Query: 340 DLETLNLATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLS-SCSEQGTAEF 392
            L +L    +N      +G+G FG V++              VAVK L    S    A+F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------- 444
             E  L+ +  + N+VKLLG C  G    L++E+M  G L+  L       +        
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 445 -------------LCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSK 491
                        L   ++  I   +A GM YL E    + VHRDL   N L+  +M  K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 492 ISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           I+DFG++R    ++             +M PE      Y+ +SDV+++GV+L EI +   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 2e-55
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)

Query: 355 NILGQGGFGPVYKGVLSD-GKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
             +G+G F  VYKG+ ++   EVA   L     ++     F  E  ++  LQH N+V+  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 412 GFCVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
                  +     +LV E M +G+L   L   ++  ++  +   +    I KG+ +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 468 SRLRIVHRDLKASNVLLDSDMNS-KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
           +   I+HRDLK  N+ +     S KI D G+A +   S        ++GT  +MAPE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-Y 185

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
           E  Y +  DV++FG+ ++E+ T   
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEY 210

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-55
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 14/207 (6%)

Query: 349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
            +F     LG+G FG VY          +A+K L            +   EV +   L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
            N+++L G+  D     L+ E+ P G++   L   +K      ++    +  +A  + Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H     R++HRD+K  N+LL S    KI+DFG +     S        + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRR 551
               ++ +K D++S GVL  E + G+ 
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP 202

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  186 bits (472), Expect = 4e-55
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 7/204 (3%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL 407
           ++ +  + LG G +G VY+GV       VAVK L   + +   EF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           V+LLG C       ++ EFM  G+L   L +   R  +       +   I+  M YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME 527
            +   +HRDL A N L+  +   K++DFG++R+       A+         + APE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190

Query: 528 GLYSKKSDVFSFGVLLIEIITGRR 551
             +S KSDV++FGVLL EI T   
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM 214

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 4e-55
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 12/214 (5%)

Query: 344 LNLATSNFSDSNI-LGQGGFGPVYKGVL---SDGKEVAVKRLSSCSEQG-TAEFTNEVLL 398
           L L   N   ++I LG G FG V +GV        +VA+K L   +E+  T E   E  +
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62

Query: 399 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
           + +L +  +V+L+G C   +  +LV E    G L   L   R+   +       +++ ++
Sbjct: 63  MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVS 119

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEAN-TVRIVGTY 517
            GM YL        VHRDL A NVLL +   +KISDFG+++     +             
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
            + APE      +S +SDV+S+GV + E ++  +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 6e-55
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 18/227 (7%)

Query: 333 KAQDFFIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSDGK----EVAVKRLSSCSEQG 388
             Q   I   +L +   +F+   ++G+G FG VY G L D        AVK L+  ++ G
Sbjct: 16  AVQHVVIGPSSLIV---HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 70

Query: 389 -TAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-LLVYEFMPNGSLDAILFDPRKRGILC 446
             ++F  E +++    H N++ LLG C+  +   L+V  +M +G L   + +      + 
Sbjct: 71  EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130

Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
                 +          +   +  + VHRDL A N +LD     K++DFG+AR   + E 
Sbjct: 131 DLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185

Query: 507 EANTVR--IVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           ++   +        +MA E      ++ KSDV+SFGVLL E++T   
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 232

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 6e-55
 Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 19/220 (8%)

Query: 338 FIDLETLNLATSNFSDSNILGQGGFGPVYKGVLSD---GKEVAVKRL--SSCSEQGTAEF 392
           ++D + L L      +   LG G FG V KG        K VAVK L   +       E 
Sbjct: 2   YLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 55

Query: 393 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTN 452
             E  ++ +L +  +V+++G C + +  +LV E    G L+  L    +   +  +    
Sbjct: 56  LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIE 111

Query: 453 IVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-V 511
           +V+ ++ GM YL        VHRDL A NVLL +   +KISDFG+++     E       
Sbjct: 112 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168

Query: 512 RIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
                  + APE      +S KSDV+SFGVL+ E  +  +
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 1e-54
 Identities = 75/274 (27%), Positives = 115/274 (41%), Gaps = 41/274 (14%)

Query: 306 QIQLHKIGDANDTDFHYQHVQGRDNDLKAQDFFIDLETLNLATSNFSDSNILGQGGFGPV 365
           Q+Q+ ++  ++D ++ Y   +  + DLK   +    E       N     +LG G FG V
Sbjct: 4   QLQMVQVTGSSDNEYFYVDFREYEYDLK---WEFPRE-------NLEFGKVLGSGAFGKV 53

Query: 366 YKGVLSD------GKEVAVKRLSSCSEQGTAE-FTNEVLLILKL-QHKNLVKLLGFCVDG 417
                          +VAVK L   ++    E   +E+ ++ +L  H+N+V LLG C   
Sbjct: 54  MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113

Query: 418 DEKLLVYEFMPNGSLDAILFDPRKR--------------------GILCWRKRTNIVNGI 457
               L++E+   G L   L   R++                     +L +         +
Sbjct: 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTY 517
           AKGM +L        VHRDL A NVL+      KI DFG+AR                  
Sbjct: 174 AKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230

Query: 518 GYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
            +MAPE   EG+Y+ KSDV+S+G+LL EI +   
Sbjct: 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 4e-54
 Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 23/229 (10%)

Query: 357 LGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD 416
           +G+G FG V++G    G+EVAVK  SS  E+ +     E+   + L+H+N++  +     
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 417 GDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED----- 467
            +       LV ++  +GSL   L     R  +       +    A G+ +LH +     
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV--RIVGTYGYMAPEYA 525
            +  I HRDLK+ N+L+  +    I+D G+A     +    +      VGT  YMAPE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 526 MEGL------YSKKSDVFSFGVLLIEIITGRRNAGSNQLLAYGMYWSWL 568
            + +        K++D+++ G++  EI       G ++      Y    
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 3e-53
 Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 12/216 (5%)

Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSDGKE-----VAVKRLS-SCSEQGTAEFTNEV 396
           T  +  S  +   ++G G FG VYKG+L          VA+K L    +E+   +F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 397 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNG 456
            ++ +  H N+++L G        +++ E+M NG+LD   F   K G     +   ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118

Query: 457 IAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT-VRIVG 515
           IA GM YL     +  VHRDL A N+L++S++  K+SDFG++R+  +      T      
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 516 TYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
              + APE      ++  SDV+SFG+++ E++T   
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 211

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-52
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 12/209 (5%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKE----VAVKRLS-SCSEQGTAEFTNEVLLILKL 402
           + F    +LG G FG VYKG+ + +G++    VA+K L  + S +   E  +E  ++  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68

Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
            + ++ +LLG C+      L+ + MP G L    +    +  +  +   N    IAKGM 
Sbjct: 69  DNPHVCRLLGICLTSTV-QLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           YL      R+VHRDL A NVL+ +  + KI+DFG+A++    E E +         +MA 
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           E  +  +Y+ +SDV+S+GV + E++T   
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS 211

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 4e-52
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 10/206 (4%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
           +F    ILG+G F  V     L+  +E A+K L       E      T E  ++ +L H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
             VKL     D ++      +  NG L   +    K G             I   + YLH
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 I+HRDLK  N+LL+ DM+ +I+DFG A++ +    +A     VGT  Y++PE  
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRR 551
            E    K SD+++ G ++ +++ G  
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLP 208

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-51
 Identities = 63/226 (27%), Positives = 90/226 (39%), Gaps = 26/226 (11%)

Query: 349 SNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCSEQGTAE-FTNEVLLILK 401
           +  S    LG G FG V +              VAVK L   +     E   +E+ ++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 402 L-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI---------------L 445
           L  H N+V LLG C  G   L++ E+   G L   L   R   I               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
                 +    +AKGM +L        +HRDL A N+LL     +KI DFG+AR      
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
                        +MAPE     +Y+ +SDV+S+G+ L E+ +   
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  177 bits (451), Expect = 2e-51
 Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 11/199 (5%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC 414
            LG G FG V++    + G   A K + +  E        E+  +  L+H  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            D +E +++YEFM  G L   +    +   +   +    +  + KG+ ++HE      VH
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147

Query: 475 RDLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
            DLK  N++  +  ++  K+ DFG+       +   +     GT  + APE A       
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 533 KSDVFSFGVLLIEIITGRR 551
            +D++S GVL   +++G  
Sbjct: 205 YTDMWSVGVLSYILLSGLS 223

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-50
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 24/221 (10%)

Query: 349 SNFSDSNILGQGGFGPVYKGVLSDG---KEVAVKRLS-SCSEQGTAEFTNEVLLILKL-Q 403
           ++    +++G+G FG V K  +       + A+KR+    S+    +F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 404 HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAIL-------------FDPRKRGILCWRKR 450
           H N++ LLG C       L  E+ P+G+L   L                     L  ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 451 TNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANT 510
            +    +A+GM YL +    + +HRDL A N+L+  +  +KI+DFG++R           
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183

Query: 511 VRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
                   +MA E     +Y+  SDV+S+GVLL EI++   
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-50
 Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 17/217 (7%)

Query: 349 SNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLS-SCSEQGTAEFTNEVLLILK 401
              + S  LGQG FG VY+GV            VA+K ++ + S +   EF NE  ++ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 402 LQHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRK-------RGILCWRKRTNIV 454
               ++V+LLG    G   L++ E M  G L + L   R               K   + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 455 NGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
             IA GM YL+ +   + VHRDL A N ++  D   KI DFGM R   E++      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 515 GTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
               +M+PE   +G+++  SDV+SFGV+L EI T   
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (438), Expect = 1e-49
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 11/198 (5%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G FG V++ V  + G+    K +++          NE+ ++ +L H  L+ L     
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
           D  E +L+ EF+  G L   +    +   +   +  N +    +G+ ++HE     IVH 
Sbjct: 97  DKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151

Query: 476 DLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           D+K  N++ ++   S  KI DFG+A      E          T  + APE          
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFY 208

Query: 534 SDVFSFGVLLIEIITGRR 551
           +D+++ GVL   +++G  
Sbjct: 209 TDMWAIGVLGYVLLSGLS 226

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 6e-49
 Identities = 61/210 (29%), Positives = 89/210 (42%), Gaps = 14/210 (6%)

Query: 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLSSC---SEQGTAEFTNEVLLILKL 402
           +      LG G FG V +G           VAVK L        +   +F  EV  +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 403 QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
            H+NL++L G  +    K+ V E  P GSL       + +G       +     +A+GM 
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMA 521
           YL      R +HRDL A N+LL +    KI DFG+ R   +++            + + A
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           PE      +S  SD + FGV L E+ T  +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-48
 Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 26/226 (11%)

Query: 349 SNFSDSNILGQGGFGPVYKGVL--------SDGKEVAVKRL-SSCSEQGTAEFTNEVLLI 399
                   LG+G FG V             +   +VAVK L S  +E+  ++  +E+ ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 400 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGI-------------L 445
             + +HKN++ LLG C       ++ E+   G+L   L   R  G+             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 446 CWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE 505
             +   +    +A+GM YL      + +HRDL A NVL+  D   KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
               T        +MAPE   + +Y+ +SDV+SFGVLL EI T   
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 1e-47
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 12/201 (5%)

Query: 356 ILGQGGFGPVYKGVLSDGKE----VAVKRLSSCSEQGTAE-FTNEVLLILKLQHKNLVKL 410
            +G+G FG V++G+    +     VA+K   +C+     E F  E L + +  H ++VKL
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 411 LGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRL 470
           +G   + +   ++ E    G L +  F   ++  L           ++  + YL      
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---K 127

Query: 471 RIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY 530
           R VHRD+ A NVL+ S+   K+ DFG++R   E        +      +MAPE      +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 531 SKKSDVFSFGVLLIEIITGRR 551
           +  SDV+ FGV + EI+    
Sbjct: 187 TSASDVWMFGVCMWEILMHGV 207

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  167 bits (424), Expect = 2e-47
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 22/216 (10%)

Query: 343 TLNLATSNFSDSNILGQGGFGPVYKGVLSD-GKEVAVKRLS---SCSEQGTAEFTNEVLL 398
           T+N    +FS   I+G+GGFG VY    +D GK  A+K L       +QG     NE ++
Sbjct: 2   TMN----DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57

Query: 399 ILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVN 455
           +  +       +V +       D+   + + M  G L   L    + G+           
Sbjct: 58  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAA 114

Query: 456 GIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVG 515
            I  G+ ++H      +V+RDLK +N+LLD   + +ISD G+A  F++ +        VG
Sbjct: 115 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167

Query: 516 TYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
           T+GYMAPE   +G+ Y   +D FS G +L +++ G 
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-46
 Identities = 51/207 (24%), Positives = 99/207 (47%), Gaps = 7/207 (3%)

Query: 348 TSNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-FTNEVLLILKLQHK 405
              +++ + +G+G +G V       +   VA+K++S    Q   +    E+ ++L+ +H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
           N++ +         + +   ++    + A L+   K   L        +  I +G+ Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTV-RIVGTYGYMAPEY 524
                 ++HRDLK SN+LL++  + KI DFG+AR+          +   V T  Y APE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 525 AMEG-LYSKKSDVFSFGVLLIEIITGR 550
            +    Y+K  D++S G +L E+++ R
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 7e-46
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 8/199 (4%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGT-AEFTNEVLLILKLQHKNLVKLLG 412
           ++LG G F  V         K VA+K ++  + +G      NE+ ++ K++H N+V L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 413 FCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRI 472
               G    L+ + +  G L   +    ++G    R  + ++  +   + YLH+   +  
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 473 VHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSK 532
             +        LD D    ISDFG++++              GT GY+APE   +  YSK
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSK 188

Query: 533 KSDVFSFGVLLIEIITGRR 551
             D +S GV+   ++ G  
Sbjct: 189 AVDCWSIGVIAYILLCGYP 207

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 7e-46
 Identities = 64/225 (28%), Positives = 91/225 (40%), Gaps = 25/225 (11%)

Query: 349 SNFSDSNILGQGGFGPVYKGV------LSDGKEVAVKRLSSCSEQGTAE--FTNEVLLIL 400
                   LG+G FG V +         +  + VAVK L   +         +   +LI 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 401 KLQHKNLVKLLGFCV-DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILC 446
              H N+V LLG C   G   +++ EF   G+L   L   R              +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 447 WRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG 506
                     +AKGM +L      + +HRDL A N+LL      KI DFG+AR   +   
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
                       +MAPE   + +Y+ +SDV+SFGVLL EI +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-45
 Identities = 44/198 (22%), Positives = 87/198 (43%), Gaps = 12/198 (6%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG+G FG V++ V  S  K    K +             E+ ++   +H+N++ L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 416 DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHR 475
             +E ++++EF+    +   +        L  R+  + V+ + + + +LH      I H 
Sbjct: 72  SMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126

Query: 476 DLKASNVLLDSDMNS--KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKK 533
           D++  N++  +  +S  KI +FG AR     +   N   +     Y APE     + S  
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 534 SDVFSFGVLLIEIITGRR 551
           +D++S G L+  +++G  
Sbjct: 184 TDMWSLGTLVYVLLSGIN 201

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 3e-45
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 13/207 (6%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEV-LLILKLQH 404
           +F    +LG+G FG V+        +  A+K L       +        E  +L L  +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
             L  +       +    V E++  G L   +   +        + T     I  G+ +L
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 119

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
           H      IV+RDLK  N+LLD D + KI+DFGM +     + + NT    GT  Y+APE 
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 174

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRR 551
            +   Y+   D +SFGVLL E++ G+ 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  159 bits (404), Expect = 4e-45
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 15/207 (7%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQH 404
            +F     LG G FG V+      +G+  A+K L        +      +E L++  + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 405 KNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYL 464
             ++++ G   D  +  ++ +++  G L ++L   ++      +     V       L L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117

Query: 465 HEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEY 524
                  I++RDLK  N+LLD + + KI+DFG A+   +      T  + GT  Y+APE 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEV 172

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRR 551
                Y+K  D +SFG+L+ E++ G  
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  158 bits (401), Expect = 5e-45
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 26/218 (11%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---------SCSEQGTAEFTNEVLLI 399
           N+    ILG+G    V + +     KE AVK +             ++       EV ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 400 LKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIA 458
            K+  H N+++L           LV++ M  G L   L    ++  L  ++   I+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 459 KGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYG 518
           + +  LH+   L IVHRDLK  N+LLD DMN K++DFG +      E       + GT  
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174

Query: 519 YMAPEYAMEGL------YSKKSDVFSFGVLLIEIITGR 550
           Y+APE     +      Y K+ D++S GV++  ++ G 
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 5e-45
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)

Query: 350 NFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV 408
           +++D+ ++G G FG VY+  L   G+ VA+K++             E+ ++ KL H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76

Query: 409 KLLGFCVDGDEK------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           +L  F     EK       LV +++P           R +  L        +  + + + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   + +       Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYRA 190

Query: 522 PEYAMEGL-YSKKSDVFSFGVLLIEIITGRR 551
           PE       Y+   DV+S G +L E++ G+ 
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  158 bits (400), Expect = 6e-45
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
           ILG GG   V+    L   ++VAVK L    +        F  E      L H  +V + 
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 412 GFCVDGDEKL----LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
                         +V E++   +L  I+      G +  ++   ++    + + + H+ 
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSHQ- 129

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE-ANTVRIVGTYGYMAPEYAM 526
               I+HRD+K +N+++ +    K+ DFG+AR  A+S      T  ++GT  Y++PE A 
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
                 +SDV+S G +L E++TG  
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEP 212

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE-----FTNEVLLILKLQHKNLV 408
           + LG+G F  VYK    +  + VA+K++         +        E+ L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 409 KLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
            LL          LV++FM                +L        +    +G+ YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAME- 527
              I+HRDLK +N+LLD +   K++DFG+A+ F            V T  Y APE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 528 GLYSKKSDVFSFGVLLIEIITGR 550
            +Y    D+++ G +L E++   
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 2e-42
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 11/206 (5%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKN 406
           NF     +G+G +G VYK      G+ VA+K  RL + +E   +    E+ L+ +L H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           +VKLL      ++  LV+EF+          D      +      + +  + +G+ + H 
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPE-YA 525
               R++HRDLK  N+L++++   K++DFG+AR F            V T  Y APE   
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEILL 175

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRR 551
               YS   D++S G +  E++T R 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  150 bits (378), Expect = 9e-42
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 11/204 (5%)

Query: 350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNL 407
            +     +G+G +G VYK   + G+  A+K  RL    E   +    E+ ++ +L+H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 408 VKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED 467
           VKL          +LV+E +       +       G L      + +  +  G+ Y H+ 
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD- 118

Query: 468 SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM- 526
              R++HRDLK  N+L++ +   KI+DFG+AR F     +      + T  Y AP+  M 
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPDVLMG 174

Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
              YS   D++S G +  E++ G 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-40
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 21/205 (10%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGF 413
           +LG G  G V +       ++ A+K L  C +        EV L  +  Q  ++V+++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73

Query: 414 CVDGDEK----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
             +        L+V E +  G L + + D R       R+ + I+  I + + YLH    
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS--- 129

Query: 470 LRIVHRDLKASNVLLDSDMNS---KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
           + I HRD+K  N+L  S   +   K++DFG A+         +      T  Y+APE   
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLG 186

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRR 551
              Y K  D++S GV++  ++ G  
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYP 211

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-40
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 20/207 (9%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAE------FTNEVLLILKLQ--HKN 406
           +LG GGFG VY G+ +SD   VA+K +         E         EV+L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 407 LVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
           +++LL +    D  +L+ E               +RG L      +    + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 467 DSRLRIVHRDLKASNVLLDSD-MNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                ++HRD+K  N+L+D +    K+ DFG   +  ++          GT  Y  PE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181

Query: 526 M-EGLYSKKSDVFSFGVLLIEIITGRR 551
                + + + V+S G+LL +++ G  
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI 208

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-40
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 20/205 (9%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRL------SSCSEQGTAEFTNEVLLILKLQHKNLVK 409
           LG G F  V K    S G + A K +      SS       +   EV ++ ++QH N++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 410 LLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSR 469
           L     +  + +L+ E +  G L        ++  L   + T  +  I  G+ YLH    
Sbjct: 78  LHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNGVYYLHS--- 131

Query: 470 LRIVHRDLKASNVLLDSDMNS----KISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
           L+I H DLK  N++L          KI DFG+A              I GT  ++APE  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIV 188

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGR 550
                  ++D++S GV+   +++G 
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGA 213

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-40
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 20/209 (9%)

Query: 355 NILGQGGFGPVYKG--VLSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKL---QHKNL 407
             +G+G +G V+K   + + G+ VA+KR+   +  E        EV ++  L   +H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 408 VKLLGFCVDGDEK-----LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGML 462
           V+L   C            LV+E +          D      +      +++  + +G+ 
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLD 130

Query: 463 YLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAP 522
           +LH     R+VHRDLK  N+L+ S    K++DFG+ARI++          +V T  Y AP
Sbjct: 131 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAP 184

Query: 523 EYAMEGLYSKKSDVFSFGVLLIEIITGRR 551
           E  ++  Y+   D++S G +  E+   + 
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (368), Expect = 3e-40
 Identities = 41/206 (19%), Positives = 82/206 (39%), Gaps = 18/206 (8%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFC- 414
           +G G FG +Y G  ++ G+EVA+K    C +    +   E  +   +Q    +  + +C 
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            +GD  ++V E +     D              +    + + +   + Y+H       +H
Sbjct: 73  AEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIH 126

Query: 475 RDLKASNVLLDSDMNSKI---SDFGMARIFAESEGEAN-----TVRIVGTYGYMAPEYAM 526
           RD+K  N L+       +    DFG+A+ + ++    +        + GT  Y +    +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 527 EGLYSKKSDVFSFGVLLIEIITGRRN 552
               S++ D+ S G +L+    G   
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLP 212

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-39
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 20/217 (9%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHK 405
           S +     +GQG FG V+K      G++VA+K++   +  E        E+ ++  L+H+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 406 NLVKLLGFCVDGDEK--------LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGI 457
           N+V L+  C               LV++F  +                   +   ++  +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQML 126

Query: 458 AKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVR--IVG 515
             G+ Y+H +   +I+HRD+KA+NVL+  D   K++DFG+AR F+ ++          V 
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 516 TYGYMAPEYAM-EGLYSKKSDVFSFGVLLIEIITGRR 551
           T  Y  PE  + E  Y    D++  G ++ E+ T   
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (359), Expect = 5e-39
 Identities = 36/208 (17%), Positives = 79/208 (37%), Gaps = 20/208 (9%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFC 414
           +G+G FG +++G  L + ++VA+K           +  +E      L     +  +  F 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVH 474
            +G   +LV + +     D +            +        +   +  +HE     +V+
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVY 124

Query: 475 RDLKASNVLLDSDMNS-----KISDFGMARIFAESEGEANTVR-----IVGTYGYMAPEY 524
           RD+K  N L+    +       + DFGM + + +   + +        + GT  YM+   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 525 AMEGLYSKKSDVFSFGVLLIEIITGRRN 552
            +    S++ D+ + G + +  + G   
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLP 212

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-38
 Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 10/200 (5%)

Query: 355 NILGQGGFGPVYKGV-LSDGKEVAVK--RLSSCSEQGTAEFTNEVLLILKLQHKNLVKLL 411
             +G+G +G V+K       + VA+K  RL    E   +    E+ L+ +L+HKN+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 412 GFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLR 471
                  +  LV+EF          +     G L      + +  + KG+ + H      
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 472 IVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYS 531
           ++HRDLK  N+L++ +   K+++FG+AR F        +  +V  +           LYS
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 532 KKSDVFSFGVLLIEIITGRR 551
              D++S G +  E+    R
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-38
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 12/206 (5%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
           +F    +LG+G FG V      + G+  A+K L      ++   A    E  ++   +H 
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
            L  L       D    V E+   G L   L    +  +    +       I   + YLH
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLH 122

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
                 +V+RD+K  N++LD D + KI+DFG+ +        A      GT  Y+APE  
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 177

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRR 551
            +  Y +  D +  GV++ E++ GR 
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 5e-36
 Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 23/212 (10%)

Query: 349 SNFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRL--SSCSEQGTAEFTNEVLLILKLQHK 405
           + + D   +G G +G V   V    G +VA+K+L     SE        E+ L+  ++H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 406 NLVKLLGFCVDGD------EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAK 459
           N++ LL      +      +  LV  FM       +     K   L   +   +V  + K
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 460 GMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGY 519
           G+ Y+H      I+HRDLK  N+ ++ D   KI DFG+AR     + ++     V T  Y
Sbjct: 133 GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184

Query: 520 MAPEYAMEGL-YSKKSDVFSFGVLLIEIITGR 550
            APE  +  + Y++  D++S G ++ E+ITG+
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  134 bits (339), Expect = 1e-35
 Identities = 53/206 (25%), Positives = 81/206 (39%), Gaps = 15/206 (7%)

Query: 350 NFSDSNILGQGGFGPVYKGV-LSDGKEVAVKRLS---SCSEQGTAEFTNEVLLILKLQHK 405
            F     LG G FG V        G   A+K L        +      NE  ++  +   
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 406 NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLH 465
            LVKL     D     +V E++  G + + L    + G             I     YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 466 EDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYA 525
               L +++RDLK  N+L+D     +++DFG A+          T  + GT   +APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEII 210

Query: 526 MEGLYSKKSDVFSFGVLLIEIITGRR 551
           +   Y+K  D ++ GVL+ E+  G  
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYP 236

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (322), Expect = 1e-33
 Identities = 48/237 (20%), Positives = 103/237 (43%), Gaps = 25/237 (10%)

Query: 324 HVQGRDNDLKAQDFFIDLETLNLATSNFSDSNI---LGQGGFGPVYKGV-LSDGKEVAVK 379
            V    N  + ++++ D E+  +   N  D  +   LG+G +  V++ + +++ ++V VK
Sbjct: 8   RVYTDVNTHRPREYW-DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK 66

Query: 380 RLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKL--LVYEFMPNGSLDAIL 436
            L    ++   +   E+ ++  L+   N++ L     D   +   LV+E + N     + 
Sbjct: 67  ILKPVKKK---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123

Query: 437 FDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNS-KISDF 495
                   L        +  I K + Y H    + I+HRD+K  NV++D +    ++ D+
Sbjct: 124 ------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDW 174

Query: 496 GMARIFAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRR 551
           G+A  +   +        V +  +  PE  ++  +Y    D++S G +L  +I  + 
Sbjct: 175 GLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 5e-32
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 18/213 (8%)

Query: 350 NFSDSNILGQGGFGPVYKGVL----SDGKEVAVKRLS----SCSEQGTAEFTNEVLLILK 401
           NF    +LG G +G V+          GK  A+K L         + T     E  ++  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 402 LQHK-NLVKLLGFCVDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           ++    LV L        +  L+ +++  G L   L    +      +        + + 
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGEI 138

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYM 520
           +L L    +L I++RD+K  N+LLDS+ +  ++DFG+++ F   E E       GT  YM
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYM 197

Query: 521 APEYAMEGL--YSKKSDVFSFGVLLIEIITGRR 551
           AP+    G   + K  D +S GVL+ E++TG  
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-31
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 21/204 (10%)

Query: 356 ILGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLG 412
            +G G  G V         + VA+K+LS    ++        E++L+  + HKN++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 413 FCV------DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE 466
                    +  +  LV E M       I  +          + + ++  +  G+ +LH 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137

Query: 467 DSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAM 526
                I+HRDLK SN+++ SD   KI DFG+AR    S         V T  Y APE  +
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVIL 191

Query: 527 EGLYSKKSDVFSFGVLLIEIITGR 550
              Y +  D++S G ++ E++  +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-30
 Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 19/202 (9%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLS--SCSEQGTAEFTNEVLLILKLQHKNLVKLLGF 413
           +G G +G V        G  VAVK+LS    S         E+ L+  ++H+N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 414 CVDGD-----EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS 468
                       + +   +    L+ I     K   L       ++  I +G+ Y+H   
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLTDDHVQFLIYQILRGLKYIHS-- 139

Query: 469 RLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEG 528
              I+HRDLK SN+ ++ D   KI DFG+AR       +  T  +   +           
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWM 194

Query: 529 LYSKKSDVFSFGVLLIEIITGR 550
            Y++  D++S G ++ E++TGR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  116 bits (291), Expect = 3e-29
 Identities = 46/209 (22%), Positives = 86/209 (41%), Gaps = 18/209 (8%)

Query: 357 LGQGGFGPVYKGV-LSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCV 415
           LG G F  V+    + +   VA+K +    +  T    +E+ L+ ++   +  K      
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 416 DGDEKLLVY--EFMPNGSLDAILFDPRKRGILCWRKRTN-----------IVNGIAKGML 462
           +   KLL +     PNG    ++F+     +L   K+             I   +  G+ 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 463 YLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGMARIFAESEGEANTVRIVGTYGYMA 521
           Y+H   R  I+H D+K  NVL++  D    +    +A +      + +    + T  Y +
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 522 PEYAMEGLYSKKSDVFSFGVLLIEIITGR 550
           PE  +   +   +D++S   L+ E+ITG 
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 94.8 bits (235), Expect = 4e-23
 Identities = 30/174 (17%), Positives = 54/174 (31%), Gaps = 28/174 (16%)

Query: 355 NILGQGGFGPVYKGVLSDGKEVAVKRL----------SSCSEQGTAEFTNEVLLILKLQH 404
            ++G+G    V+        E  VK                + G   F+   +   + + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 405 KNLVKLLGFCV----DGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKG 460
           + L KL G  V      +   ++ E +              R  +       +++ I + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDE--VLDMILEE 115

Query: 461 MLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIV 514
           +   +      IVH DL   NVL+  +    I DF  +    E        R V
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV 165

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	571
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.65
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.09
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.61
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.15
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.74
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.4

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=367.18  Aligned_cols=202  Identities=28%  Similarity=0.424  Sum_probs=177.1

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|++.+.||+|+||.||++++. +|+.||||+++... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            46888999999999999999975 68999999987432 33455789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++|+|.+++.   ..+.+++.++..++.||++||+|||+++   |+||||||+|||+++++++||+|||+++.......
T Consensus        85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            99999999983   4567999999999999999999999998   99999999999999999999999999987765444


Q ss_pred             ccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .......+||+.|||||++.+..+ +.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~  209 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP  209 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence            433445689999999999988776 67899999999999999999999654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=363.89  Aligned_cols=200  Identities=27%  Similarity=0.494  Sum_probs=180.6

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|+..+.||+|+||.||++.. .+|+.||||+++.......+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4799999999999999999996 479999999998655566678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++|+|.+++..    +.+++.++..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++.+......
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            99999998742    45999999999999999999999998   999999999999999999999999999876543322


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       173 --~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             --BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             --ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence              234589999999999999999999999999999999999999997654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-45  Score=360.94  Aligned_cols=203  Identities=33%  Similarity=0.514  Sum_probs=170.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      +..++|++.+.||+|+||.||+|+++  ..||||+++..  ++...+.|.+|+.++++++||||+++++++.+ +..++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            45678999999999999999999864  46999998643  44556789999999999999999999998754 568999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+||||++++.+||+|||+++....
T Consensus        82 ~Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          82 TQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            999999999999854  3356999999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCCccceeeecccccccchhhhcc---CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...........||+.|||||++.+   ..++.++|||||||++|||+||+.||...
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~  212 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI  212 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence            544444455689999999999864   34899999999999999999999999754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-45  Score=356.83  Aligned_cols=200  Identities=28%  Similarity=0.446  Sum_probs=178.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++.+.   .......+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888899999999999999975 6899999998642   2344567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++.   +.+.+++..+..++.||++||+|||+++   |+||||||+|||+++++.+||+|||++......
T Consensus        86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999984   4456999999999999999999999998   999999999999999999999999999765433


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .    .....||+.|||||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  209 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY  209 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH
Confidence            2    2345799999999999999999999999999999999999999987643

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=362.39  Aligned_cols=203  Identities=29%  Similarity=0.421  Sum_probs=177.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||++... +++.||||++++.   .+...+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46888999999999999999974 7899999998642   2345567999999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|.+++.   ..+.+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999883   4567999999999999999999999998   999999999999999999999999999877654


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  214 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN  214 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC
Confidence            44434445689999999999999999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-45  Score=360.24  Aligned_cols=202  Identities=29%  Similarity=0.433  Sum_probs=178.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      +.|++.+.||+|+||.||+|+.. +++.||||+++.......+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45788899999999999999975 68999999998767777788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++|+|.+++..  ..+.+++.++..++.||++||+|||+++   |+||||||+|||++.++++||+|||+++........
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  166 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCccc
Confidence            99999998743  3456999999999999999999999998   999999999999999999999999999765432221


Q ss_pred             cceeeecccccccchhhhc-----cCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAM-----EGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                        .....||+.|+|||++.     +..++.++|||||||++|||++|+.||...+
T Consensus       167 --~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~  219 (288)
T d2jfla1         167 --RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN  219 (288)
T ss_dssp             --HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             --ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence              22357999999999984     4558999999999999999999999997653

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=370.13  Aligned_cols=203  Identities=30%  Similarity=0.424  Sum_probs=179.5

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ++..++|++.+.||+|+||+||+++.. +|+.||+|+++.. .+.....+.+|+.++++++||||+++++++.+++..++
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            345678999999999999999999974 7899999998753 33445678999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED-SRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~-~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      ||||+++|+|.+++.   +.+.+++..+..++.||++||.|||++ +   |+||||||+|||+++++++||+|||+|+.+
T Consensus        82 VmEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             EEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999994   345699999999999999999999974 7   999999999999999999999999999866


Q ss_pred             ccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....    ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+
T Consensus       156 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         156 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             HHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             CCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence            4322    224589999999999999999999999999999999999999997653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=353.83  Aligned_cols=203  Identities=31%  Similarity=0.511  Sum_probs=168.8

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +.++|+..+.||+|+||.||+|.+.+++.||||+++.. ....+++.+|++++++++||||++++|++.+++..++||||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            34678888999999999999999988899999999763 34457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++|+|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+|||+++++++||+|||+++.......
T Consensus        82 ~~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          82 MEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             CTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             cCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999998854  3456899999999999999999999998   99999999999999999999999999987654432


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhC-CCCCCCC
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG-RRNAGSN  556 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG-~~p~~~~  556 (571)
                      .. .....||+.|+|||++.+..++.++||||||+++|||+|+ ++||...
T Consensus       157 ~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~  206 (263)
T d1sm2a_         157 TS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR  206 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred             ee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence            22 2235789999999999999999999999999999999995 5555544

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-44  Score=358.20  Aligned_cols=206  Identities=31%  Similarity=0.445  Sum_probs=179.6

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      +++..++|+..+.||+|+||.||+|++. +++.||||+++.. ....+++.+|+.++++++||||+++++++.+++..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            3455667888899999999999999975 5889999999753 3456789999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++|+|.+++.. .....+++..++.++.||++||+|||+++   |+||||||+||||++++++||+|||+++...
T Consensus        91 v~E~~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence            9999999999999854 23456999999999999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ...... .....|++.|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus       167 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         167 GDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             SSSSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCCcee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            443222 2234688999999999999999999999999999999997776543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-45  Score=357.04  Aligned_cols=208  Identities=28%  Similarity=0.405  Sum_probs=167.3

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc--CceeEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLV  423 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv  423 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||||+++..  ++...+.+.+|++++++++||||+++++++.+  ++..++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            56888999999999999999974 6899999998753  34445678999999999999999999999865  4567899


Q ss_pred             EEccCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          424 YEFMPNGSLDAILFDP-RKRGILCWRKRTNIVNGIAKGMLYLHEDS--RLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      |||+++|+|.+++... .....+++..++.++.||+.||+|||+++  ..+|+||||||+||||++++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999988532 23457999999999999999999999865  23599999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      +......  .....||+.|||||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~  219 (269)
T d2java1         164 LNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ  219 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence            6543322  2345899999999999999999999999999999999999999976643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=346.23  Aligned_cols=207  Identities=29%  Similarity=0.446  Sum_probs=183.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ..++|+..++||+|+||.||+|++++++.||||+++... ...+++.+|+.++++++||||++++|++.+++..++||||
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            347899999999999999999999888999999998643 3457899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +++|+|..++..  ....+++..+.+++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus        81 ~~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          81 MANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             CTTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             cCCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            999999998753  3456899999999999999999999998   99999999999999999999999999987655433


Q ss_pred             ccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCchhh
Q 008288          507 EANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLA  560 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~~~~  560 (571)
                      . ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||+..+...
T Consensus       156 ~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             C-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             e-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence            2 2334578999999999999999999999999999999998 899998764433

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=354.45  Aligned_cols=204  Identities=33%  Similarity=0.495  Sum_probs=174.8

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      +..++|++.+.||+|+||.||+|.+++++.||||+++.. ....+++.+|++++++++||||+++++++.+ +..++|||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            445678888999999999999999988899999999753 3455679999999999999999999998754 56789999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++|+|.+++.. .....+++..++.|+.||++||+|||+++   |+||||||+||||++++.+||+|||+++......
T Consensus        88 y~~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          88 YMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             CCTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             eCCCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999998743 22335899999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCC-CCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRN-AGSN  556 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p-~~~~  556 (571)
                      ... .....||+.|+|||++.++.++.++|||||||++|||+||..| +...
T Consensus       164 ~~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~  214 (272)
T d1qpca_         164 YTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (272)
T ss_dssp             EEC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence            222 2234789999999999999999999999999999999996555 4443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=358.83  Aligned_cols=202  Identities=26%  Similarity=0.353  Sum_probs=180.8

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      -++|++.+.||+|+||.||+++.. +|+.||||++++.   .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            457889999999999999999974 7999999998742   234567789999999999999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|..++.   +.+.+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        84 ~ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999983   4566899999999999999999999999   99999999999999999999999999986544


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....  ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+
T Consensus       158 ~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         158 DGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             TTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence            3322  234589999999999999999999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.8e-44  Score=355.29  Aligned_cols=205  Identities=32%  Similarity=0.537  Sum_probs=165.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCc---EEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGK---EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~---~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      .++|++.++||+|+||+||+|.+. +++   .||||++.. ..+...++|.+|+.++++++|||||++++++.+++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            456777899999999999999975 232   588998864 344556779999999999999999999999999999999


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ||||+++|+|.+++..  ..+.+++.+++.++.||++||+|||+++   |+||||||+||||++++++||+|||+++.+.
T Consensus       105 v~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            9999999999998853  3456999999999999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCccc---eeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          503 ESEGEAN---TVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       503 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      .......   .....||+.|||||.+.++.++.++|||||||++|||+| |+.||...+
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~  238 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT  238 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC
Confidence            4432221   222467899999999999999999999999999999998 899997654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-43  Score=346.17  Aligned_cols=196  Identities=29%  Similarity=0.445  Sum_probs=168.2

Q ss_pred             CCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc----CceeEEEE
Q 008288          352 SDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVY  424 (571)
Q Consensus       352 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~  424 (571)
                      +..++||+|+||.||+|++. +++.||+|++...  .+...+.+.+|++++++++||||+++++++.+    +...++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            45568999999999999975 6889999998642  34455678999999999999999999999865    45678999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec-CCCcEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD-SDMNSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~-~~~~~kL~DfGla~~~~~  503 (571)
                      ||+++|+|.+++.   +...+++..++.++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+++....
T Consensus        92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999984   3456999999999999999999999975 4599999999999996 578999999999975433


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .    .....+||+.|||||++.+ .++.++|||||||++|||++|+.||...
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~  215 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC  215 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence            2    2234589999999998865 5999999999999999999999999654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.2e-43  Score=357.07  Aligned_cols=201  Identities=26%  Similarity=0.402  Sum_probs=180.4

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            47889999999999999999974 79999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCCcEEEeecccccccccCC
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~--~~~~~kL~DfGla~~~~~~~  505 (571)
                      ++|+|.+++..  ..+.+++..+..++.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+++.+....
T Consensus       106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999998843  3456999999999999999999999999   99999999999995  45789999999998765433


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .   .....||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus       181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  229 (350)
T d1koaa2         181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN  229 (350)
T ss_dssp             C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC
Confidence            2   234589999999999999999999999999999999999999998664

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-43  Score=357.65  Aligned_cols=209  Identities=33%  Similarity=0.480  Sum_probs=177.9

Q ss_pred             HhhcCCCCCCceecccCceeEEEEEEcC-C-----cEEEEEEccc-cCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEc
Q 008288          345 NLATSNFSDSNILGQGGFGPVYKGVLSD-G-----KEVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD  416 (571)
Q Consensus       345 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~  416 (571)
                      ++..++|++.+.||+|+||+||+|++.. +     ..||+|++.. ........+.+|+.++.++ +|||||++++++.+
T Consensus        33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            3556788899999999999999998643 2     3689998864 3444566789999999998 89999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCC
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDPRK--------------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRD  476 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~D  476 (571)
                      .+..++||||+++|+|.+++.....                    ...+++..++.++.||++||+|||+++   |+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence            9999999999999999999965321                    245899999999999999999999998   99999


Q ss_pred             CCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCC
Q 008288          477 LKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGS  555 (571)
Q Consensus       477 Lkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~  555 (571)
                      |||+|||++.++++||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987665554433344578999999999999999999999999999999998 8999976


Q ss_pred             C
Q 008288          556 N  556 (571)
Q Consensus       556 ~  556 (571)
                      .
T Consensus       270 ~  270 (325)
T d1rjba_         270 I  270 (325)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-43  Score=352.41  Aligned_cols=196  Identities=31%  Similarity=0.474  Sum_probs=172.8

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .|+..+.||+|+||.||+|+.. +++.||||+++...   ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4788899999999999999964 78899999987533   2334568999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++|+|..++.   ..+.+++.++..++.||++||.|||+++   |+||||||+|||+++++++||+|||+++..... 
T Consensus        96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            999999987763   3456999999999999999999999998   999999999999999999999999999865432 


Q ss_pred             Cccceeeecccccccchhhhcc---CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAME---GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                           ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||...+
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~  218 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  218 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence                 23479999999999864   458999999999999999999999997654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-43  Score=353.31  Aligned_cols=200  Identities=28%  Similarity=0.433  Sum_probs=161.8

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      +.|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56888899999999999999975 68999999987433 33345688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCcEEEeeccccccccc
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAE  503 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~---~~~~~kL~DfGla~~~~~  503 (571)
                      +++|+|.+++.   ..+.+++.++..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++....
T Consensus        89 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          89 VSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             cCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999994   3567999999999999999999999998   99999999999994   578999999999986543


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...   ....+||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus       163 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~  213 (307)
T d1a06a_         163 GSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN  213 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC
Confidence            322   234579999999999999999999999999999999999999997654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.7e-43  Score=352.77  Aligned_cols=198  Identities=27%  Similarity=0.427  Sum_probs=178.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||+++.+ +|+.||||++++.   .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            46888999999999999999974 6999999998642   2345667899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+++|+|..++.   ....+++..+..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999999883   4556889999999999999999999998   999999999999999999999999999876433


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .     ...+||+.|||||++.+..++.++|||||||++|||++|+.||...+
T Consensus       158 ~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~  205 (316)
T d1fota_         158 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN  205 (316)
T ss_dssp             B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             c-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence            2     23589999999999999999999999999999999999999998764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=349.53  Aligned_cols=205  Identities=30%  Similarity=0.475  Sum_probs=174.3

Q ss_pred             hcCCCCCCc-eecccCceeEEEEEEc---CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSN-ILGQGGFGPVYKGVLS---DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|...+ +||+|+||.||+|.+.   ++..||||+++.. .+...++|.+|++++++++||||+++++++.. +..+
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            345566666 4999999999999864   3557999999754 34456789999999999999999999999865 4678


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      +||||+++|+|.+++..  .+..+++..++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++.+
T Consensus        85 lvmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcc
Confidence            99999999999998843  3456999999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          502 AESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...+
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~  217 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  217 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence            5543222 2223468999999999999999999999999999999998 999997653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9e-43  Score=354.84  Aligned_cols=201  Identities=24%  Similarity=0.332  Sum_probs=179.8

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||||+++.........+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46889999999999999999974 79999999998665556677889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec--CCCcEEEeecccccccccCC
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD--SDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~--~~~~~kL~DfGla~~~~~~~  505 (571)
                      ++|+|.+++.  .....+++.+++.++.||+.||.|||+++   |+||||||+||||+  .++.+||+|||++..+....
T Consensus       109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            9999988773  23456999999999999999999999998   99999999999997  67899999999998765432


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  232 (352)
T d1koba_         184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED  232 (352)
T ss_dssp             C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            2   234579999999999999999999999999999999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=344.28  Aligned_cols=201  Identities=25%  Similarity=0.364  Sum_probs=177.3

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccC------ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCS------EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  421 (571)
                      ++|++.+.||+|+||.||+++.. +|+.||||++++..      ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            56888999999999999999974 78999999986421      223567999999999999999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC----cEEEeeccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM----NSKISDFGM  497 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~----~~kL~DfGl  497 (571)
                      +||||+++|+|.+++.   ..+.+++..++.++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||+
T Consensus        90 iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999984   3456999999999999999999999998   99999999999998776    499999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      +........   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~  221 (293)
T d1jksa_         164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK  221 (293)
T ss_dssp             CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH
Confidence            987644322   2234789999999999999999999999999999999999999987643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-43  Score=346.57  Aligned_cols=202  Identities=33%  Similarity=0.492  Sum_probs=169.1

Q ss_pred             cCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      .++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++||||+++++++. ++..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            4578888999999999999999988889999999753 345578999999999999999999999985 45689999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++|+|..++.. .....++|.+++.++.||++||+|||+.+   |+||||||+||||++++++||+|||+++........
T Consensus        94 ~~g~l~~~~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhh-cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            99999988843 22345999999999999999999999998   999999999999999999999999999876543322


Q ss_pred             cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          508 ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      . .....||+.|+|||.+.++.++.++||||||+++|||++|+.|+...
T Consensus       170 ~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~  217 (285)
T d1fmka3         170 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG  217 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             e-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence            2 23357899999999999999999999999999999999976665443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-43  Score=343.61  Aligned_cols=196  Identities=33%  Similarity=0.457  Sum_probs=166.9

Q ss_pred             ceecccCceeEEEEEEcC---CcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEccCC
Q 008288          355 NILGQGGFGPVYKGVLSD---GKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN  429 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  429 (571)
                      ++||+|+||.||+|.+.+   ++.||||+++..  ++...+++.+|++++++++||||+++++++.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643   468999998643  23345679999999999999999999999865 457899999999


Q ss_pred             CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCcc-
Q 008288          430 GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGEA-  508 (571)
Q Consensus       430 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~-  508 (571)
                      |+|.+++.   ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.+....... 
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999984   4456999999999999999999999998   9999999999999999999999999998765443322 


Q ss_pred             ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          509 NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       509 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||...+
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~  215 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  215 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC
Confidence            2233578999999999999999999999999999999998 999997654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=344.45  Aligned_cols=203  Identities=32%  Similarity=0.526  Sum_probs=166.5

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCC-----cEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDG-----KEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      ..+.|+..++||+|+||.||+|.+++.     ..||||+++.. .+....+|.+|+.++++++||||++++|++.+.+..
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            345677789999999999999997532     37999998743 344456789999999999999999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+.++++.+++..  ....+++.+++.++.||++||+|||+.+   |+||||||+||||++++.+||+|||+++.
T Consensus        85 ~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999888743  3456999999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCc-cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCC
Q 008288          501 FAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAG  554 (571)
Q Consensus       501 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~  554 (571)
                      ....... .......||+.|+|||.+.++.++.++||||||+++|||++|+.|+.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~  214 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY  214 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence            6543322 22233468999999999999999999999999999999999666653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-42  Score=351.91  Aligned_cols=199  Identities=26%  Similarity=0.335  Sum_probs=178.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  424 (571)
                      ++|++.+.||+|+||.||++++. +|+.||||++++.   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47888999999999999999975 7999999998642   2344567899999999999999999999999999999999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccC
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAES  504 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~  504 (571)
                      ||+.+|+|..++.   +.+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999883   3456999999999999999999999998   999999999999999999999999999876432


Q ss_pred             CCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          505 EGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       505 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .     ....||+.|||||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       195 ~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~  243 (350)
T d1rdqe_         195 T-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP  243 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             c-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence            2     235799999999999999999999999999999999999999987643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-42  Score=344.59  Aligned_cols=201  Identities=28%  Similarity=0.413  Sum_probs=176.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHHHHHHH-hcccCCeeeEeeEEEcCceeEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~nIv~l~~~~~~~~~~~lv  423 (571)
                      ++|++.+.||+|+||+||+|+.. +++.||||++++.   .....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57888999999999999999975 6999999999742   2344556677777665 68999999999999999999999


Q ss_pred             EEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccccc
Q 008288          424 YEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAE  503 (571)
Q Consensus       424 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~  503 (571)
                      |||+++|+|.+++.   ..+.+++.++..++.||+.||+|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999994   4456899999999999999999999998   99999999999999999999999999986544


Q ss_pred             CCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         156 GDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence            3322  233589999999999999999999999999999999999999998764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-42  Score=345.32  Aligned_cols=218  Identities=29%  Similarity=0.417  Sum_probs=183.7

Q ss_pred             HHHHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          342 ETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       342 ~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      .++++..++|++.+.||+|+||.||+|+..      +++.||||+++... ....+++.+|+.++++++||||+++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345567788999999999999999999864      35789999997533 33456799999999999999999999999


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPR---------------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIV  473 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~ii  473 (571)
                      ...+..+++|||+++|+|.+++....                     ....+++..++.++.|++.||+|||+++   |+
T Consensus        86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv  162 (301)
T d1lufa_          86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  162 (301)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence            99999999999999999999985321                     1234899999999999999999999998   99


Q ss_pred             eCCCCCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCC-CC
Q 008288          474 HRDLKASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR-RN  552 (571)
Q Consensus       474 H~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~-~p  552 (571)
                      ||||||+||||+.++++||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus       163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence            99999999999999999999999998765544444444567899999999999999999999999999999999986 57


Q ss_pred             CCCCchhhhh
Q 008288          553 AGSNQLLAYG  562 (571)
Q Consensus       553 ~~~~~~~~~~  562 (571)
                      |...+.....
T Consensus       243 ~~~~~~~e~~  252 (301)
T d1lufa_         243 YYGMAHEEVI  252 (301)
T ss_dssp             TTTSCHHHHH
T ss_pred             CCCCCHHHHH
Confidence            7766544433

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.7e-42  Score=337.28  Aligned_cols=206  Identities=25%  Similarity=0.408  Sum_probs=170.5

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC---ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc----e
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS---EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----E  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~  419 (571)
                      .++|++.+.||+|+||.||+++. .+|+.||||+++...   ......+.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36788999999999999999996 479999999997532   333556899999999999999999999987654    3


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++++|..++.   ..+.+++.+++.++.||++||+|||+++   |+||||||+|||++.++..+|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            789999999999998883   4457999999999999999999999998   9999999999999999999999999987


Q ss_pred             ccccCCCc-cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCchh
Q 008288          500 IFAESEGE-ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQLL  559 (571)
Q Consensus       500 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~~  559 (571)
                      ........ ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+..
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~  220 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV  220 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH
Confidence            65433222 2233458999999999999999999999999999999999999999876433

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-41  Score=333.01  Aligned_cols=200  Identities=30%  Similarity=0.419  Sum_probs=175.4

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCc---------cchHHHHHHHHHHHhcc-cCCeeeEeeEEEcC
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSE---------QGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG  417 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~  417 (571)
                      ++|++.+.||+|+||+||+++. .+++.||||+++....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5788899999999999999997 4789999999864321         12235889999999996 99999999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||||+++|+|.+++.   .++.+++.+++.++.||++||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999994   4567999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhcc------CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAME------GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++.+......   ....||+.|+|||.+.+      ..++.++||||+||++|||++|+.||...+
T Consensus       157 a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~  219 (277)
T d1phka_         157 SCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  219 (277)
T ss_dssp             CEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence            9876543322   23579999999999853      347889999999999999999999998765

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-41  Score=348.75  Aligned_cols=199  Identities=31%  Similarity=0.431  Sum_probs=171.0

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc---CccchHHHHHH---HHHHHhcccCCeeeEeeEEEcCcee
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC---SEQGTAEFTNE---VLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e---~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      -++|++.+.||+|+||.||+++.. +|+.||||++.+.   .......+.+|   +.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            367889999999999999999975 6999999998632   12222334444   6666677899999999999999999


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++|+|.+++.   +...+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.
T Consensus        83 ~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999984   3456899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +.....    ....||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         157 FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             CSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             cCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence            654322    23479999999999975 56899999999999999999999999765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=342.84  Aligned_cols=202  Identities=32%  Similarity=0.552  Sum_probs=169.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCc----EEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGK----EVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL  422 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  422 (571)
                      ++|+..++||+|+||.||+|.+. +|+    +||+|+++. .+....+++.+|++++++++||||+++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46888999999999999999964 444    689998864 3455677899999999999999999999999865 5678


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFA  502 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~  502 (571)
                      ++|++.+++|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+|||+++++++||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8899999999888743  3556999999999999999999999998   9999999999999999999999999999876


Q ss_pred             cCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCC
Q 008288          503 ESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSN  556 (571)
Q Consensus       503 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~  556 (571)
                      ............||+.|+|||.+.++.++.++||||||+++|||+| |+.||+..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~  217 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  217 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence            5554444445578999999999999999999999999999999998 89999765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-41  Score=338.78  Aligned_cols=200  Identities=21%  Similarity=0.318  Sum_probs=176.3

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      ++|++.+.||+|+||+||+|... +++.||||+++... .....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            57888999999999999999975 68899999997643 33456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCC--CcEEEeecccccccccCC
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSD--MNSKISDFGMARIFAESE  505 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~--~~~kL~DfGla~~~~~~~  505 (571)
                      ++|+|.+++..  ....+++.++..++.||++||+|||+++   |+||||||+|||++.+  .++||+|||+++......
T Consensus        84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            99999999942  3346999999999999999999999998   9999999999999854  589999999998654332


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                         ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~  207 (321)
T d1tkia_         159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence               2234578999999999999999999999999999999999999997764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=335.57  Aligned_cols=205  Identities=26%  Similarity=0.415  Sum_probs=165.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC----CcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCcee
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD----GKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK  420 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  420 (571)
                      +..++|++.+.||+|+||.||+|++..    +..||||+++.. .+...+.+.+|+.++++++||||+++++++. ++..
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            445678889999999999999998643    346899988753 3444567999999999999999999999985 4678


Q ss_pred             EEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          421 LLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       421 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ++||||+++|+|.+++..  ....+++..++.++.||++||+|||+++   |+||||||+||++++++.+||+|||+++.
T Consensus        83 ~iv~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence            999999999999988743  3456899999999999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          501 FAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       501 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||++ |++||...+
T Consensus       158 ~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~  214 (273)
T d1mp8a_         158 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK  214 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC
Confidence            6543322 2234578999999999999999999999999999999998 899997653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=339.08  Aligned_cols=214  Identities=29%  Similarity=0.425  Sum_probs=171.7

Q ss_pred             ChHHHHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhc-ccCCeeeEe
Q 008288          340 DLETLNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKL-QHKNLVKLL  411 (571)
Q Consensus       340 ~~~~l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~  411 (571)
                      +..+.++..++|++.+.||+|+||.||+|.+.      +++.||||+++.. .....+.+.+|..++.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            44556677788999999999999999999853      2468999999743 344456688888888887 689999999


Q ss_pred             eEEEcC-ceeEEEEEccCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCC
Q 008288          412 GFCVDG-DEKLLVYEFMPNGSLDAILFDPR-------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDL  477 (571)
Q Consensus       412 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DL  477 (571)
                      +++... +..++||||+++|+|.+++....             ....+++.+++.++.||++||+|||+++   |+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence            998765 46889999999999999985322             1345899999999999999999999998   999999


Q ss_pred             CCCCeEecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCC-CCCCCC
Q 008288          478 KASNVLLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR-RNAGSN  556 (571)
Q Consensus       478 kp~NILl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~-~p~~~~  556 (571)
                      ||+||||++++++||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++|. .||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999998765554444444568999999999999999999999999999999999964 577654

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-41  Score=335.17  Aligned_cols=196  Identities=28%  Similarity=0.384  Sum_probs=167.5

Q ss_pred             CceecccCceeEEEEEEc-CCcEEEEEEccccCc-----cchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEcc
Q 008288          354 SNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE-----QGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM  427 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  427 (571)
                      +++||+|+||+||+|+.. +|+.||||+++....     ...+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999964 699999999864322     12346889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      +++++..+.   .....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++........
T Consensus        83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            998877766   34566899999999999999999999998   999999999999999999999999999866543322


Q ss_pred             cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          508 ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       508 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  ...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus       157 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~  205 (299)
T d1ua2a_         157 Y--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS  205 (299)
T ss_dssp             C--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             c--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC
Confidence            2  23479999999999875 457999999999999999999999997653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=330.97  Aligned_cols=201  Identities=34%  Similarity=0.479  Sum_probs=165.8

Q ss_pred             hcCCCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEc-CceeEEEEE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYE  425 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e  425 (571)
                      .-++|+..+.||+|+||.||+|++ .|++||||+++.  +...+++.+|++++++++||||++++|++.+ .+..++|||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            345677789999999999999998 578999999975  3445779999999999999999999999865 456899999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+++|+|.+++.. .....+++..+++++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 y~~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~  157 (262)
T d1byga_          82 YMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  157 (262)
T ss_dssp             CCTTEEHHHHHHH-HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             ccCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC
Confidence            9999999999853 12235899999999999999999999998   9999999999999999999999999998654322


Q ss_pred             CccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCchh
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLL  559 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~~~  559 (571)
                           ....++..|+|||.+.++.+++++||||||+++|||+| |+.||...+..
T Consensus       158 -----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~  207 (262)
T d1byga_         158 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK  207 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred             -----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence                 12367889999999999999999999999999999998 78888765433

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-41  Score=333.39  Aligned_cols=211  Identities=32%  Similarity=0.463  Sum_probs=178.0

Q ss_pred             hhcCCCCCCceecccCceeEEEEEEcC--------CcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEE
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVLSD--------GKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCV  415 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  415 (571)
                      +..++|++.+.||+|+||.||+|+...        +..||||+++... .....++.+|...+.++ +||||+++++++.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            456678888999999999999998532        2479999997543 34557788999999988 8999999999999


Q ss_pred             cCceeEEEEEccCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          416 DGDEKLLVYEFMPNGSLDAILFDPRK-------------RGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       416 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                      +++..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||+++   |+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence            99999999999999999999964321             245899999999999999999999998   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCchh
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLL  559 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~~~  559 (571)
                      |++.++.+||+|||+++...............+|+.|+|||.+.++.+++++||||||+++|||++ |+.||...+..
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            999999999999999998766655544555678999999999999999999999999999999998 78898766443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-41  Score=332.29  Aligned_cols=208  Identities=30%  Similarity=0.419  Sum_probs=166.9

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc--CC--cEEEEEEcccc---CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCce
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS--DG--KEVAVKRLSSC---SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDE  419 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  419 (571)
                      ..++|++.+.||+|+||.||+|++.  ++  ..||||++++.   .+...++|.+|+.++++++||||++++|++.+ +.
T Consensus         6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~   84 (273)
T d1u46a_           6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP   84 (273)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence            3466888899999999999999863  22  37899998743   33445679999999999999999999999976 46


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+++|++.+.+..  ..+.+++..++.++.||++||.|||+++   |+||||||+|||++.++++||+|||+++
T Consensus        85 ~~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             hheeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhh
Confidence            7899999999999887743  3456999999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCcc-ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCchhh
Q 008288          500 IFAESEGEA-NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQLLA  560 (571)
Q Consensus       500 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~~~~  560 (571)
                      ......... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~  222 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ  222 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH
Confidence            765543332 2223467889999999999999999999999999999998 899997664443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=331.81  Aligned_cols=202  Identities=28%  Similarity=0.420  Sum_probs=171.8

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC--ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS--EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...  +.....+.+|++++++++||||+++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5788999999999999999997 479999999996432  3346678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      |+.++.+.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+++......
T Consensus        82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            997655544432  23456999999999999999999999998   9999999999999999999999999998664433


Q ss_pred             CccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ...  ....||+.|+|||.+.... ++.++|||||||++|||++|+.||...+
T Consensus       157 ~~~--~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~  207 (298)
T d1gz8a_         157 RTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS  207 (298)
T ss_dssp             BCT--TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccc--eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence            222  2347999999999887655 5889999999999999999999997664

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-40  Score=328.68  Aligned_cols=201  Identities=26%  Similarity=0.411  Sum_probs=174.1

Q ss_pred             CCCCCCceecccCceeEEEEEEcCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|+..+.||+|+||+||+|++++|+.||||+++..  .+...+.+.+|+.++++++||||+++++++.+++..++++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            578889999999999999999989999999998643  334467899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCC
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEG  506 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~  506 (571)
                      +.++.+..+.   ...+.+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9888887776   44567999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          507 EANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       507 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      .  .....+++.|++||.+.+. .++.++||||||+++|||++|+.||...+
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~  205 (286)
T d1ob3a_         156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS  205 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             c--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC
Confidence            2  2234689999999998754 56999999999999999999999997664

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=333.77  Aligned_cols=211  Identities=33%  Similarity=0.488  Sum_probs=181.1

Q ss_pred             HHhhcCCCCCCceecccCceeEEEEEEc------CCcEEEEEEcccc-CccchHHHHHHHHHHHhcccCCeeeEeeEEEc
Q 008288          344 LNLATSNFSDSNILGQGGFGPVYKGVLS------DGKEVAVKRLSSC-SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD  416 (571)
Q Consensus       344 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~  416 (571)
                      +++..++|+..+.||+|+||.||+|.+.      +++.||||+++.. .......+.+|+.++++++||||+++++++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            3445567888899999999999999863      3578999999753 33445568999999999999999999999999


Q ss_pred             CceeEEEEEccCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCc
Q 008288          417 GDEKLLVYEFMPNGSLDAILFDP-------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMN  489 (571)
Q Consensus       417 ~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~  489 (571)
                      ++..++||||+++|+|.+++...       .....+++..+..++.|+++||.|||+++   |+||||||+|||++++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence            99999999999999999987521       22345789999999999999999999998   999999999999999999


Q ss_pred             EEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhC-CCCCCCCc
Q 008288          490 SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITG-RRNAGSNQ  557 (571)
Q Consensus       490 ~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG-~~p~~~~~  557 (571)
                      +||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|| +.||...+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~  240 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  240 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence            999999999877665544444455789999999999999999999999999999999998 47776654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-40  Score=333.90  Aligned_cols=209  Identities=30%  Similarity=0.429  Sum_probs=179.6

Q ss_pred             hhcCCCCCCceecccCceeEEEEEE------cCCcEEEEEEccccC-ccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcC
Q 008288          346 LATSNFSDSNILGQGGFGPVYKGVL------SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDG  417 (571)
Q Consensus       346 ~~~~~~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~  417 (571)
                      +..++|++.+.||+|+||.||+|++      .+++.||||+++... .....++.+|+.+++++ +||||+++++++.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            4556788889999999999999985      246689999997533 34455789999999999 799999999999999


Q ss_pred             ceeEEEEEccCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCe
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPR---------------KRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNV  482 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NI  482 (571)
                      +..++||||+++|+|.++++...               ....+++..++.++.||++||+|||+++   ++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            99999999999999999986422               2345899999999999999999999998   99999999999


Q ss_pred             EecCCCcEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHh-CCCCCCCCc
Q 008288          483 LLDSDMNSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIIT-GRRNAGSNQ  557 (571)
Q Consensus       483 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~ellt-G~~p~~~~~  557 (571)
                      |++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+| |++||...+
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999997765544444445688999999999999999999999999999999999 566665543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-40  Score=335.36  Aligned_cols=196  Identities=27%  Similarity=0.372  Sum_probs=168.2

Q ss_pred             CCCCCCc-eecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEc----CceeE
Q 008288          349 SNFSDSN-ILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVD----GDEKL  421 (571)
Q Consensus       349 ~~~~~~~-~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~----~~~~~  421 (571)
                      ++|.+.. .||+|+||.||+|+. .+++.||||+++.     ...+.+|+.++.++ +||||+++++++.+    +...+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            4677664 699999999999996 4789999999864     23567899987665 89999999999875    45689


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC---CCcEEEeecccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS---DMNSKISDFGMA  498 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~---~~~~kL~DfGla  498 (571)
                      +||||+++|+|.+++.. .....+++.++..++.||+.||+|||+++   |+||||||+|||+++   ++.+||+|||++
T Consensus        86 ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            99999999999999954 22346999999999999999999999998   999999999999975   467999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~  216 (335)
T d2ozaa1         162 KETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  216 (335)
T ss_dssp             EECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred             eeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence            876543322   2357999999999999999999999999999999999999999654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-40  Score=329.49  Aligned_cols=205  Identities=30%  Similarity=0.475  Sum_probs=171.3

Q ss_pred             hcCCCCCCceecccCceeEEEEEEc-CCc--EEEEEEccc-cCccchHHHHHHHHHHHhc-ccCCeeeEeeEEEcCceeE
Q 008288          347 ATSNFSDSNILGQGGFGPVYKGVLS-DGK--EVAVKRLSS-CSEQGTAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL  421 (571)
Q Consensus       347 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  421 (571)
                      ..++|++.+.||+|+||.||+|++. ++.  .||||+++. ......+++.+|++++.++ +||||+++++++.+++..+
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            3467788899999999999999975 444  478888764 3444566799999999999 7999999999999999999


Q ss_pred             EEEEccCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC
Q 008288          422 LVYEFMPNGSLDAILFDP-------------RKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM  488 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~  488 (571)
                      +||||+++|+|.++++..             .....+++..+..++.||++||.|||+.+   |+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCC
Confidence            999999999999999643             23467999999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCC-CCCCCCc
Q 008288          489 NSKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGR-RNAGSNQ  557 (571)
Q Consensus       489 ~~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~-~p~~~~~  557 (571)
                      .+||+|||+++........   ....||..|+|||.+.++.++.++||||||+++|||++|. .||...+
T Consensus       165 ~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~  231 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  231 (309)
T ss_dssp             CEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence            9999999999765433222   2346899999999999999999999999999999999975 5676654

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=326.06  Aligned_cols=198  Identities=26%  Similarity=0.421  Sum_probs=169.0

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCc------cchHHHHHHHHHHHhcc--cCCeeeEeeEEEcCce
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSE------QGTAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDE  419 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~~~  419 (571)
                      ++|++.+.||+|+||.||+|+.. +|+.||||+++....      ....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57888999999999999999974 789999999864221      11234678999999996  8999999999999999


Q ss_pred             eEEEEEccCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-CCcEEEeeccc
Q 008288          420 KLLVYEFMPN-GSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-DMNSKISDFGM  497 (571)
Q Consensus       420 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-~~~~kL~DfGl  497 (571)
                      .++||||+.+ +++.+++.   .+..+++.++..++.||++||+|||+++   |+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 57777773   3456999999999999999999999998   999999999999985 47999999999


Q ss_pred             ccccccCCCccceeeecccccccchhhhccCCC-CcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          498 ARIFAESEGEANTVRIVGTYGYMAPEYAMEGLY-SKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       498 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ++......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus       158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence            98654322    223579999999999987765 67899999999999999999999765

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-39  Score=324.02  Aligned_cols=198  Identities=32%  Similarity=0.507  Sum_probs=168.7

Q ss_pred             CceecccCceeEEEEEEcCC----cEEEEEEccc-cCccchHHHHHHHHHHHhcccCCeeeEeeEEEc-CceeEEEEEcc
Q 008288          354 SNILGQGGFGPVYKGVLSDG----KEVAVKRLSS-CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEFM  427 (571)
Q Consensus       354 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~  427 (571)
                      .++||+|+||+||+|++.++    ..||||+++. .+....++|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999997532    2589999974 345556789999999999999999999999875 56889999999


Q ss_pred             CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCCCc
Q 008288          428 PNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESEGE  507 (571)
Q Consensus       428 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~~~  507 (571)
                      ++|+|.+++..  ....+++..++.++.|+++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999854  3445788899999999999999999998   999999999999999999999999999876544322


Q ss_pred             c--ceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          508 A--NTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       508 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~  237 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD  237 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCC
Confidence            1  222346899999999999999999999999999999999988887543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-40  Score=328.42  Aligned_cols=200  Identities=27%  Similarity=0.389  Sum_probs=161.6

Q ss_pred             CCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc----eeEEEEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLLVYE  425 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e  425 (571)
                      +|...+.||+|+||.||+|++ +|+.||||+++... ........|+..+.+++||||+++++++.+++    ..++|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            455678899999999999997 68999999986432 11222334555556789999999999998654    5789999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS-----RLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      |+++|+|.+++..    ..++|..++.++.|++.||+|||+..     .++|+||||||+||||++++++||+|||+++.
T Consensus        82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            9999999999943    35899999999999999999999741     23499999999999999999999999999987


Q ss_pred             cccCCCcc--ceeeecccccccchhhhccCC------CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          501 FAESEGEA--NTVRIVGTYGYMAPEYAMEGL------YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       501 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ........  ......||+.|+|||++.+..      ++.++||||||++||||+||..||+.
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            75543322  223458999999999987643      57799999999999999999988754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-39  Score=322.87  Aligned_cols=202  Identities=26%  Similarity=0.408  Sum_probs=169.4

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-C-CcEEEEEEcccc--CccchHHHHHHHHHHHhc---ccCCeeeEeeEEEc----
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-D-GKEVAVKRLSSC--SEQGTAEFTNEVLLILKL---QHKNLVKLLGFCVD----  416 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~----  416 (571)
                      .++|++.+.||+|+||+||++++. + ++.||||+++..  .+.....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999973 4 667999998642  233344567888877766   79999999999863    


Q ss_pred             -CceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeec
Q 008288          417 -GDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDF  495 (571)
Q Consensus       417 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~Df  495 (571)
                       ....+++|||++++++.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             346789999999887765543  34456899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          496 GMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       496 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      |+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~  219 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS  219 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC
Confidence            9987654332   2234589999999999999999999999999999999999999997664

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-38  Score=323.50  Aligned_cols=207  Identities=24%  Similarity=0.415  Sum_probs=170.5

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccC-ccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc----eeE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCS-EQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKL  421 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~  421 (571)
                      +++|++.++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35788999999999999999996 479999999997533 344567899999999999999999999987653    235


Q ss_pred             EEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccccc
Q 008288          422 LVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIF  501 (571)
Q Consensus       422 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~  501 (571)
                      ++++++.+|+|.+++..    ..+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55666779999999842    35899999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCc-cceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCchhhh
Q 008288          502 AESEGE-ANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQLLAY  561 (571)
Q Consensus       502 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~~~~~  561 (571)
                      ...... ......+||+.|+|||++.. ..++.++||||+|+++|||++|+.||...+..+.
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~  221 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ  221 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH
Confidence            544322 12234579999999999854 5578999999999999999999999987654333

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.9e-38  Score=315.59  Aligned_cols=201  Identities=19%  Similarity=0.303  Sum_probs=172.9

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhccc-CCeeeEeeEEEcCceeEEEEE
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      .++|++.+.||+|+||.||+|++. +|+.||||+++...  ....+.+|++++..++| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            467899999999999999999965 68999999886432  23457889999999965 899999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecC-----CCcEEEeecccccc
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDS-----DMNSKISDFGMARI  500 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~-----~~~~kL~DfGla~~  500 (571)
                      |+ +++|.+++..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 7899888843  3346899999999999999999999999   999999999999964     57899999999987


Q ss_pred             cccCCCc-----cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          501 FAESEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       501 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      +......     ......+||+.|||||.+.+..+++++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~  216 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  216 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence            6543322     1223458999999999999999999999999999999999999999754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-38  Score=318.27  Aligned_cols=203  Identities=27%  Similarity=0.430  Sum_probs=170.0

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccc--cCccchHHHHHHHHHHHhcccCCeeeEeeEEEc--------C
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSS--CSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD--------G  417 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--------~  417 (571)
                      ++|++.++||+|+||+||+|+. .+|+.||||++..  ..+....++.+|++++++++||||+++++++..        +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6788999999999999999997 4799999999863  234456678999999999999999999999865        3


Q ss_pred             ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccc
Q 008288          418 DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGM  497 (571)
Q Consensus       418 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGl  497 (571)
                      +..++||||++++.+..+.   .....+++..+..++.||++||.|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            4578999999888777665   34556889999999999999999999998   99999999999999999999999999


Q ss_pred             ccccccCCCc--cceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          498 ARIFAESEGE--ANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       498 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ++.+......  ......+||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~  226 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  226 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC
Confidence            9766543222  122234799999999998765 68999999999999999999999998654

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-38  Score=323.49  Aligned_cols=198  Identities=28%  Similarity=0.435  Sum_probs=165.3

Q ss_pred             CCCCCceecccCceeEEEEEEc-CCcEEEEEEccccCccchHHHHHHHHHHHhcccCCeeeEeeEEEcC------ceeEE
Q 008288          350 NFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEKLL  422 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~l  422 (571)
                      +|+..++||+|+||+||++++. +|+.||||+++....    ...+|++++++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4677889999999999999975 699999999975332    234799999999999999999998643      24689


Q ss_pred             EEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEeeccccccc
Q 008288          423 VYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIF  501 (571)
Q Consensus       423 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~~  501 (571)
                      ||||++++.+..+.........+++.++..++.||++||+|||+++   |+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987755554432234567999999999999999999999998   99999999999999775 8999999999876


Q ss_pred             ccCCCccceeeecccccccchhhhcc-CCCCcchhhHhHHHHHHHHHhCCCCCCCCc
Q 008288          502 AESEGEANTVRIVGTYGYMAPEYAME-GLYSKKSDVFSFGVLLIEIITGRRNAGSNQ  557 (571)
Q Consensus       502 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slGvil~elltG~~p~~~~~  557 (571)
                      ......   ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus       174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~  227 (350)
T d1q5ka_         174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  227 (350)
T ss_dssp             CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence            543322   23479999999998875 568999999999999999999999997764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-38  Score=321.02  Aligned_cols=200  Identities=30%  Similarity=0.451  Sum_probs=166.7

Q ss_pred             cCCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCc------
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGD------  418 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------  418 (571)
                      .++|++.+.||+|+||+||+|... +|+.||||+++..  ++...+.+.+|+.+|++++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467889999999999999999964 6999999999742  3344567899999999999999999999998765      


Q ss_pred             eeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccc
Q 008288          419 EKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMA  498 (571)
Q Consensus       419 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla  498 (571)
                      ..++||||+ +.+|..+..    .+.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            468999999 667777763    346999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCchhh
Q 008288          499 RIFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQLLA  560 (571)
Q Consensus       499 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~~~~  560 (571)
                      +......     ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+...
T Consensus       169 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~  226 (346)
T d1cm8a_         169 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD  226 (346)
T ss_dssp             EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             eccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH
Confidence            8654332     234789999999998764 57899999999999999999999998775433

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-38  Score=318.54  Aligned_cols=201  Identities=28%  Similarity=0.390  Sum_probs=172.6

Q ss_pred             CCCCCCceecccCceeEEEEEEc----CCcEEEEEEcccc----CccchHHHHHHHHHHHhccc-CCeeeEeeEEEcCce
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS----DGKEVAVKRLSSC----SEQGTAEFTNEVLLILKLQH-KNLVKLLGFCVDGDE  419 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~  419 (571)
                      ++|++.+.||+|+||+||+++..    +|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            56889999999999999999852    4789999998642    22345678899999999976 899999999999999


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .+++|||+.+|+|.+++.   ..+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999983   4456788999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCccceeeecccccccchhhhccC--CCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEG--LYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      .+....... .....|++.|++||.+.+.  .++.++|||||||+||||++|+.||...
T Consensus       178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~  235 (322)
T d1vzoa_         178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  235 (322)
T ss_dssp             ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            765443332 2335799999999999764  4688999999999999999999999654

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-37  Score=308.88  Aligned_cols=199  Identities=26%  Similarity=0.360  Sum_probs=173.7

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcCceeEEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  425 (571)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++..  .+.....+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            47888999999999999999974 7889999998643  33446778999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeecccccccccCC
Q 008288          426 FMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMARIFAESE  505 (571)
Q Consensus       426 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~~~~~~  505 (571)
                      ++.+++|..++.   ..+.+++..+..++.|+++||+|||+++   |+||||||+|||++.++++||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999988874   4566899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             CccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCC
Q 008288          506 GEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGS  555 (571)
Q Consensus       506 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~  555 (571)
                      ...  ....++..|++||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus       156 ~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         156 RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             SCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             ccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence            322  2235778899999987655 68999999999999999999999643

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-37  Score=310.05  Aligned_cols=200  Identities=21%  Similarity=0.315  Sum_probs=165.7

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcccCC-eeeEeeEEEcCceeEEEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVYEF  426 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~  426 (571)
                      ++|++.+.||+|+||.||+|++ .+|+.||||++....  ...++..|+++++.++|+| |+.+..+..+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            4689999999999999999996 468999999887532  2345789999999998766 45556666788888999999


Q ss_pred             cCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEec---CCCcEEEeeccccccccc
Q 008288          427 MPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLD---SDMNSKISDFGMARIFAE  503 (571)
Q Consensus       427 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~---~~~~~kL~DfGla~~~~~  503 (571)
                      + +++|...+.  ...+.+++..+..++.|+++||+|||+++   |+||||||+|||++   .+..+||+|||+++.+..
T Consensus        85 ~-~~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 455555543  23456999999999999999999999999   99999999999985   355799999999997755


Q ss_pred             CCCc-----cceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGE-----ANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~  216 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL  216 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccccc
Confidence            4322     1223458999999999999999999999999999999999999999754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7e-37  Score=309.49  Aligned_cols=193  Identities=22%  Similarity=0.371  Sum_probs=167.1

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcC--ceeEEEE
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDG--DEKLLVY  424 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~  424 (571)
                      ++|++.++||+|+||+||+|+. .+|+.||||+++..   ..+++.+|+.++++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5789999999999999999997 47999999998753   3457889999999995 99999999999743  5688999


Q ss_pred             EccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCC-cEEEeeccccccccc
Q 008288          425 EFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDM-NSKISDFGMARIFAE  503 (571)
Q Consensus       425 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~-~~kL~DfGla~~~~~  503 (571)
                      ||+++++|..+.      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997764      34899999999999999999999999   99999999999998655 699999999987654


Q ss_pred             CCCccceeeecccccccchhhhccCC-CCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          504 SEGEANTVRIVGTYGYMAPEYAMEGL-YSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       504 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                      ...   .....+|+.|+|||.+.+.. ++.++||||+|++++||++|+.||...
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            332   22347899999999987654 799999999999999999999999654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-37  Score=311.25  Aligned_cols=199  Identities=28%  Similarity=0.422  Sum_probs=167.0

Q ss_pred             cCCCCCCceecccCceeEEEEEE-cCCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEcC-----ce
Q 008288          348 TSNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE  419 (571)
Q Consensus       348 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~  419 (571)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++..  +....+.+.+|++++++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999996 47999999999753  233455788999999999999999999998643     34


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .+++++++.+|+|.+++.    .+.+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            467778888999999983    245999999999999999999999998   9999999999999999999999999997


Q ss_pred             ccccCCCccceeeecccccccchhhhccC-CCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEG-LYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      ......     ....||+.|+|||.+.+. .++.++||||||+++|||++|+.||...+.
T Consensus       170 ~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~  224 (348)
T d2gfsa1         170 HTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH  224 (348)
T ss_dssp             CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence            553322     234789999999987765 468999999999999999999999977643

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=309.51  Aligned_cols=198  Identities=27%  Similarity=0.356  Sum_probs=161.5

Q ss_pred             CCCCCCceecccCceeEEEEEEc-CCcEEEEEEcccc--CccchHHHHHHHHHHHhcccCCeeeEeeEEEc------Cce
Q 008288          349 SNFSDSNILGQGGFGPVYKGVLS-DGKEVAVKRLSSC--SEQGTAEFTNEVLLILKLQHKNLVKLLGFCVD------GDE  419 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~------~~~  419 (571)
                      ++|++.++||+|+||+||+|.+. +|+.||||+++..  +......+.+|+.++++++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57899999999999999999975 6999999999743  33445568899999999999999999999964      367


Q ss_pred             eEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          420 KLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       420 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      .++||||+.++.+..+.      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999776555442      34899999999999999999999999   9999999999999999999999999988


Q ss_pred             ccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCCch
Q 008288          500 IFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSNQL  558 (571)
Q Consensus       500 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~~~  558 (571)
                      .......   .....+|+.|+|||++.+..+++++||||+||+++||++|+.||...+.
T Consensus       168 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~  223 (355)
T d2b1pa1         168 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY  223 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence            6544322   2234789999999999999999999999999999999999999976643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=3.3e-32  Score=278.79  Aligned_cols=199  Identities=23%  Similarity=0.293  Sum_probs=159.6

Q ss_pred             CCCCCCceecccCceeEEEEEE-cCCcEEEEEEccccCccchHHHHHHHHHHHhcc-----------cCCeeeEeeEEEc
Q 008288          349 SNFSDSNILGQGGFGPVYKGVL-SDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-----------HKNLVKLLGFCVD  416 (571)
Q Consensus       349 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~nIv~l~~~~~~  416 (571)
                      .+|++.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4588999999999999999997 47999999999753 233456788999888875           5789999988865


Q ss_pred             C--ceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCeeeCCCCCCCeEecCCCc----
Q 008288          417 G--DEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHE-DSRLRIVHRDLKASNVLLDSDMN----  489 (571)
Q Consensus       417 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiH~DLkp~NILl~~~~~----  489 (571)
                      .  ...++++++...+..............+++..+..++.||++||+|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            4  4556677766555433333233455678999999999999999999998 66   999999999999986653    


Q ss_pred             --EEEeecccccccccCCCccceeeecccccccchhhhccCCCCcchhhHhHHHHHHHHHhCCCCCCCC
Q 008288          490 --SKISDFGMARIFAESEGEANTVRIVGTYGYMAPEYAMEGLYSKKSDVFSFGVLLIEIITGRRNAGSN  556 (571)
Q Consensus       490 --~kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slGvil~elltG~~p~~~~  556 (571)
                        ++|+|||.+.......     ....||+.|+|||++.+..++.++||||+|++++||++|+.||...
T Consensus       169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence              8999999987554322     2347999999999999999999999999999999999999999644

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=2.4e-23  Score=192.45  Aligned_cols=163  Identities=18%  Similarity=0.170  Sum_probs=119.3

Q ss_pred             CCceecccCceeEEEEEEcCCcEEEEEEccccCc------------------cchHHHHHHHHHHHhcccCCeeeEeeEE
Q 008288          353 DSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSE------------------QGTAEFTNEVLLILKLQHKNLVKLLGFC  414 (571)
Q Consensus       353 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~nIv~l~~~~  414 (571)
                      +.++||+|+||.||+|+..+|++||||+++....                  ........|...+.++.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4678999999999999988999999998653110                  0112345688889999999999887653


Q ss_pred             EcCceeEEEEEccCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCeeeCCCCCCCeEecCCCcEEEee
Q 008288          415 VDGDEKLLVYEFMPNGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDSRLRIVHRDLKASNVLLDSDMNSKISD  494 (571)
Q Consensus       415 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH~DLkp~NILl~~~~~~kL~D  494 (571)
                          ..+++|||+++..+..          ++......++.|++++|.|||+++   |+||||||+|||++++ .++|+|
T Consensus        84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD  145 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID  145 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred             ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence                3479999998866543          233445678999999999999998   9999999999999865 489999


Q ss_pred             cccccccccCCCccceeeecccccccch--hh---hccCCCCcchhhHhHHHHH
Q 008288          495 FGMARIFAESEGEANTVRIVGTYGYMAP--EY---AMEGLYSKKSDVFSFGVLL  543 (571)
Q Consensus       495 fGla~~~~~~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~Dv~slGvil  543 (571)
                      ||++..........          |...  +.   ...+.|+.++|+||+.--+
T Consensus       146 FG~a~~~~~~~~~~----------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWRE----------ILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHHH----------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcHH----------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99997543222111          1111  10   1235678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.65  E-value=7.5e-08  Score=91.23  Aligned_cols=142  Identities=19%  Similarity=0.118  Sum_probs=99.8

Q ss_pred             CCCCCceecccCceeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcc-cCCeeeEeeEEEcCceeEEEEEccC
Q 008288          350 NFSDSNILGQGGFGPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMP  428 (571)
Q Consensus       350 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  428 (571)
                      .|...+..+.++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+..+++..++||++++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~   93 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD   93 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred             ceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecc
Confidence            444444434444568998865 56778889877555455556788888888773 4446788888888889999999999


Q ss_pred             CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 008288          429 NGSLDAILFDPRKRGILCWRKRTNIVNGIAKGMLYLHEDS----------------------------------------  468 (571)
Q Consensus       429 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~----------------------------------------  468 (571)
                      +.++......        ......++.++++.|..||+..                                        
T Consensus        94 G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          94 GVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             SEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             cccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            9888665421        1112335666677777777431                                        


Q ss_pred             ----------------CCCeeeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          469 ----------------RLRIVHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       469 ----------------~~~iiH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                                      ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                            11279999999999999876677999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.09  E-value=5.9e-06  Score=77.26  Aligned_cols=129  Identities=19%  Similarity=0.153  Sum_probs=87.5

Q ss_pred             ecccCc-eeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhccc--CCeeeEeeEEEcCceeEEEEEccCCCChh
Q 008288          357 LGQGGF-GPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNGSLD  433 (571)
Q Consensus       357 lG~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~gsL~  433 (571)
                      +..|.. +.||+...+++..+++|......   ...+..|...++.+..  -.+++++.+..+.+..++||+++++.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444443 67899988778888999765432   3346778888877743  33577888888888899999999887654


Q ss_pred             hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------------------------------------------
Q 008288          434 AILFDPRKRGILCWRKRTNIVNGIAKGMLYLHED----------------------------------------------  467 (571)
Q Consensus       434 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~----------------------------------------------  467 (571)
                      ...        ...   ..++.++.+.|.-||+.                                              
T Consensus        95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (255)
T d1nd4a_          95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  163 (255)
T ss_dssp             TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             ccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence            321        111   11233444444444421                                              


Q ss_pred             ---------CCCCeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          468 ---------SRLRIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       468 ---------~~~~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                               .++.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                     11237999999999999987767899999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.61  E-value=7.7e-05  Score=74.35  Aligned_cols=75  Identities=12%  Similarity=0.121  Sum_probs=48.3

Q ss_pred             ceecccCceeEEEEEEc-CCcEEEEEEcccc-------CccchHHHHHHHHHHHhcc-c--CCeeeEeeEEEcCceeEEE
Q 008288          355 NILGQGGFGPVYKGVLS-DGKEVAVKRLSSC-------SEQGTAEFTNEVLLILKLQ-H--KNLVKLLGFCVDGDEKLLV  423 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv  423 (571)
                      +.||.|..-.||+.... +++.++||.-.+.       -+....+...|.+.+..+. +  ..+++++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            46899999999999865 4678999964321       1122334556888877662 2  345666654  45567899


Q ss_pred             EEccCCCC
Q 008288          424 YEFMPNGS  431 (571)
Q Consensus       424 ~e~~~~gs  431 (571)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.15  E-value=0.00094  Score=64.33  Aligned_cols=135  Identities=16%  Similarity=0.109  Sum_probs=78.2

Q ss_pred             eeEEEEEEcCCcEEEEEEccccCccchHHHHHHHHHHHhcccCCee--eEe-----eEEEcCceeEEEEEccCCCChhh-
Q 008288          363 GPVYKGVLSDGKEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNLV--KLL-----GFCVDGDEKLLVYEFMPNGSLDA-  434 (571)
Q Consensus       363 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv--~l~-----~~~~~~~~~~lv~e~~~~gsL~~-  434 (571)
                      =.||+...++|+.+++|+.++. ....+++..|...+..+....|.  ..+     .....++..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            4799999989999999988753 22445678888888888543332  111     12234566788999987643311 


Q ss_pred             ----h-------------hcC--CCCCCCCCH-------------------H---HHHHHHHHHHHHHHHH-hhCCCCCe
Q 008288          435 ----I-------------LFD--PRKRGILCW-------------------R---KRTNIVNGIAKGMLYL-HEDSRLRI  472 (571)
Q Consensus       435 ----~-------------l~~--~~~~~~l~~-------------------~---~~~~i~~qia~~L~~L-H~~~~~~i  472 (571)
                          +             ...  ...+..+++                   .   .....+.++...+.-+ .+..+..+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0             000  011111111                   1   1122223333333222 12223458


Q ss_pred             eeCCCCCCCeEecCCCcEEEeecccccc
Q 008288          473 VHRDLKASNVLLDSDMNSKISDFGMARI  500 (571)
Q Consensus       473 iH~DLkp~NILl~~~~~~kL~DfGla~~  500 (571)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999744  45899998863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.74  E-value=0.0019  Score=63.96  Aligned_cols=72  Identities=18%  Similarity=0.265  Sum_probs=49.1

Q ss_pred             ceecccCceeEEEEEEcCC--------cEEEEEEccccCccchHHHHHHHHHHHhcccCCe-eeEeeEEEcCceeEEEEE
Q 008288          355 NILGQGGFGPVYKGVLSDG--------KEVAVKRLSSCSEQGTAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYE  425 (571)
Q Consensus       355 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e  425 (571)
                      +.|+.|-.=.+|+...+++        +.|++++... . .......+|..+++.+.-.++ +++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4577788889999987543        4566666542 2 234466789999998854454 567777643    68999


Q ss_pred             ccCCCCh
Q 008288          426 FMPNGSL  432 (571)
Q Consensus       426 ~~~~gsL  432 (571)
                      |+++.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.40  E-value=0.18  Score=47.02  Aligned_cols=29  Identities=34%  Similarity=0.406  Sum_probs=26.4

Q ss_pred             CeeeCCCCCCCeEecCCCcEEEeeccccc
Q 008288          471 RIVHRDLKASNVLLDSDMNSKISDFGMAR  499 (571)
Q Consensus       471 ~iiH~DLkp~NILl~~~~~~kL~DfGla~  499 (571)
                      ++||+|+.++||+++.+...-|+||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            49999999999999988777899999876